Citrus Sinensis ID: 014039
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 432 | 2.2.26 [Sep-21-2011] | |||||||
| P43294 | 443 | Serine/threonine-protein | yes | no | 0.997 | 0.972 | 0.736 | 0.0 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | yes | no | 0.972 | 0.969 | 0.608 | 1e-149 | |
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | no | no | 0.671 | 0.631 | 0.586 | 1e-106 | |
| Q04859 | 622 | Serine/threonine-protein | yes | no | 0.659 | 0.458 | 0.580 | 1e-102 | |
| P20793 | 622 | Serine/threonine-protein | yes | no | 0.659 | 0.458 | 0.583 | 1e-102 | |
| P20794 | 623 | Serine/threonine-protein | yes | no | 0.659 | 0.457 | 0.583 | 1e-102 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | no | 0.659 | 0.453 | 0.587 | 1e-101 | |
| Q62726 | 629 | Serine/threonine-protein | no | no | 0.659 | 0.453 | 0.587 | 1e-101 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | no | 0.659 | 0.450 | 0.580 | 1e-100 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | no | 0.659 | 0.562 | 0.534 | 2e-91 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 659 bits (1700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/436 (73%), Positives = 381/436 (87%), Gaps = 5/436 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKLNHP
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NG
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 128
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSS Y+PA+
Sbjct: 129 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 188
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR++SIS++E
Sbjct: 189 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 248
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T YP+HD LELR
Sbjct: 249 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIHD-LELR 307
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLK 358
L+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E+ LFC +
Sbjct: 308 LDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSENFLFCPGVN 367
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVE-SSLSLSFSSIQHPSTGVPQSAGYAIT-SLQPNLLD 416
+ E +VFWSLLSPD+N + APVE S LSLSFS +Q + G PQS+G+ +T S+QPN+LD
Sbjct: 368 NDREPSVFWSLLSPDENGLHAPVESSPLSLSFSPMQQHTVGPPQSSGFTMTSSMQPNMLD 427
Query: 417 CPFLAVSSPLQQSHCL 432
P++AVS+P QQSH L
Sbjct: 428 RPWMAVSAPFQQSHYL 443
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1363), Expect = e-149, Method: Compositional matrix adjust.
Identities = 266/437 (60%), Positives = 331/437 (75%), Gaps = 17/437 (3%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
MERYK++ E+GDGTCG V++A+N ET EIVAVKKMKRKF+ WEEC++LREVKAL+KLNHP
Sbjct: 1 MERYKVIREIGDGTCGNVFRAYNTETNEIVAVKKMKRKFFQWEECISLREVKALQKLNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEV EN+ELFFIFE ME NLY ++RERQ FSE EIR+FM Q+LQGLA+MH NG
Sbjct: 61 NIVKLKEVTMENHELFFIFENMECNLYDVIRERQAAFSEEEIRNFMVQILQGLAYMHNNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVT+ +KIADFGLARE+SS PPYT+YVSTRWYRAPEVLLQSS+Y+PAI
Sbjct: 121 YFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSAYTPAI 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAELFTLSP+FPG SE DQLYK+C +LG PD T +PE N+ R S ++ +I
Sbjct: 181 DMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSFNFFQI 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLH----DP 296
P NL ++IPNA++EAIDLI QLCSWDP RRPTA+Q+LQHPFFNV WVP PLH
Sbjct: 241 PPRNLWELIPNATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVGNWVPRPLHASHTKT 300
Query: 297 LELRLNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFC 354
+E R N P LELNLWDFGTEP+D +L LTL++KPS + +NVP+ +E+IL
Sbjct: 301 IETRPN-----PRLELNLWDFGTEPEDNYLDLTLSLKPSFPGTDFSNNVPEHTKEEILLY 355
Query: 355 SDLKDHSEQTVFWSLLSPDQNRMRAPVESSLSLSF---SSIQHPSTGVPQSAGYAITSLQ 411
++ Q+ FW L++ D+ P SS ++ P+ G S + ++ LQ
Sbjct: 356 PGFENPPVQSGFWPLVASDRPMGDVPAMSSWPQAYVVDGQATLPAVGFSGSP-FGLSPLQ 414
Query: 412 PNLLDCPFLAVSSPLQQ 428
PNL + + ++P++Q
Sbjct: 415 PNLFEN--RSFATPIRQ 429
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (991), Expect = e-106, Method: Compositional matrix adjust.
Identities = 170/290 (58%), Positives = 234/290 (80%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M+R+K+++E+GDGT G V++A N + E+VAVKKMKRK+Y +EECM+LREVK+LR++NHP
Sbjct: 1 MDRFKMIKEVGDGTFGSVWRAINKQNGEVVAVKKMKRKYYSFEECMSLREVKSLRRMNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEV+REN+ L+FI EYME NLY +M++R PFSE E+R++ Q+ Q LA+MH+ G
Sbjct: 61 NIVKLKEVIRENDILYFIMEYMECNLYQLMKDRVKPFSEAEVRNWCFQIFQALAYMHQRG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLV+ DV+K+ADFGLARE++S+PPYTEYVSTRWYRAPEVLLQSS Y A+
Sbjct: 121 YFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSIYDSAV 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWA+GAI+AEL TL P+FPG SE D++ K+C ++G+PD ++P+ +++ + + ++
Sbjct: 181 DMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKFQFPQV 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
L++++ + S EA+DLI LCSWDP +RP A + LQH FF T+VP
Sbjct: 241 SGNQLAEVMTSVSSEAVDLISSLCSWDPCKRPKAAEVLQHTFFQGCTFVP 290
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 372 bits (954), Expect = e-102, Method: Compositional matrix adjust.
Identities = 166/286 (58%), Positives = 226/286 (79%), Gaps = 1/286 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY +++LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+F+FEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+T P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+HP+F V
Sbjct: 241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQV 286
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 372 bits (954), Expect = e-102, Method: Compositional matrix adjust.
Identities = 167/286 (58%), Positives = 225/286 (78%), Gaps = 1/286 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+T P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+HP+F V
Sbjct: 241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQV 286
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-102, Method: Compositional matrix adjust.
Identities = 167/286 (58%), Positives = 225/286 (78%), Gaps = 1/286 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+ L P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+HP+F V
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQV 286
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 369 bits (947), Expect = e-101, Method: Compositional matrix adjust.
Identities = 168/286 (58%), Positives = 224/286 (78%), Gaps = 1/286 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY +++LGDGT G V ++E+ E++A+KKMKRKFY WEECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEV+REN+ L+FIFEYM+ NLY +++ER F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NIVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRDLKPENLL +++KIADFGLARE+ S PPYT+YVSTRWYRAPEVLL+S++YS
Sbjct: 121 FFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG I+AE++TL P+FPG SEID ++K+C +LG P T +PE +S ++ + +
Sbjct: 181 IDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFLWPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+P NL +IPNAS EAI L+ L WDP +RPTA QAL++P+F +
Sbjct: 241 CIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQI 286
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (946), Expect = e-101, Method: Compositional matrix adjust.
Identities = 168/286 (58%), Positives = 224/286 (78%), Gaps = 1/286 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY +++LGDGT G V ++E+ E++A+KKMKRKFY WEECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEV+REN+ L+FIFEYM+ NLY +++ER F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NIVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRDLKPENLL +++KIADFGLARE+ S PPYT+YVSTRWYRAPEVLL+S++YS
Sbjct: 121 FFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG I+AE++TL P+FPG SEID ++K+C +LG P T +PE +S ++ + +
Sbjct: 181 IDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFIWPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+P NL +IPNAS EAI L+ L WDP +RPTA QAL++P+F +
Sbjct: 241 CIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQI 286
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-100, Method: Compositional matrix adjust.
Identities = 166/286 (58%), Positives = 223/286 (77%), Gaps = 1/286 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V ++E+ E++A+KKMKRKFY WEECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTIRQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N++KLKEV+REN+ L+FIFEYM+ NLY +++ER F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRDLKPENLL +++KIADFGLARE+ S PPYT+YVSTRWYRAPEVLL+S++YS
Sbjct: 121 FFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG I+AE++TL P+FPG SEID ++K+C +LG P T +PE +S ++ + +
Sbjct: 181 IDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFRWPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+P NL +IPNAS EA+ L+ + WDP +RPTA QAL++P+F V
Sbjct: 241 CVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQV 286
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (863), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 154/288 (53%), Positives = 219/288 (76%), Gaps = 3/288 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
ME+Y+ ++++GDG G V KA +V+T EIVA+K+MK+KF W+EC+ LRE+KAL+KL HP
Sbjct: 1 MEKYQFIKQVGDGAYGDVIKAIDVKTGEIVAIKRMKKKFSDWKECIQLREIKALKKLKHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KL E++ E +ELFF+FEY+E+NLY +++R E IR+ + Q+LQ L MH NG
Sbjct: 61 NIVKLLEIILERDELFFVFEYLENNLYESIKDRTKLLPETTIRNIIYQILQALHFMHTNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
+FHRDLKPEN+++ + LKIADFGLARE+ S PP+T+Y+STRWYRAPEVLL+ + Y+ I
Sbjct: 121 FFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYNAPI 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
D+WAVGAI+AEL++L P+FPG SEIDQL+K+C I+G+P + + ++ + ++ +
Sbjct: 181 DIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTFPNV 240
Query: 241 LP--IN-LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
P IN LS ++PNA+ +AI+LI L +DPL+RPT QALQH +F V
Sbjct: 241 QPPSINPLSTLLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFKV 288
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 432 | ||||||
| 255580503 | 433 | mak, putative [Ricinus communis] gi|2235 | 0.997 | 0.995 | 0.850 | 0.0 | |
| 224065415 | 434 | predicted protein [Populus trichocarpa] | 1.0 | 0.995 | 0.822 | 0.0 | |
| 30682312 | 435 | serine/threonine-protein kinase MHK [Ara | 0.997 | 0.990 | 0.738 | 0.0 | |
| 296088149 | 447 | unnamed protein product [Vitis vinifera] | 0.905 | 0.874 | 0.791 | 0.0 | |
| 15235551 | 443 | serine/threonine-protein kinase MHK [Ara | 0.997 | 0.972 | 0.736 | 0.0 | |
| 79325075 | 444 | serine/threonine-protein kinase MHK [Ara | 0.997 | 0.970 | 0.720 | 0.0 | |
| 297790790 | 447 | predicted protein [Arabidopsis lyrata su | 0.993 | 0.959 | 0.747 | 0.0 | |
| 166811 | 443 | protein kinase [Arabidopsis thaliana] | 0.997 | 0.972 | 0.733 | 0.0 | |
| 359494796 | 466 | PREDICTED: serine/threonine-protein kina | 0.900 | 0.834 | 0.790 | 0.0 | |
| 334186479 | 444 | serine/threonine-protein kinase MHK [Ara | 0.997 | 0.970 | 0.723 | 0.0 |
| >gi|255580503|ref|XP_002531076.1| mak, putative [Ricinus communis] gi|223529322|gb|EEF31290.1| mak, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/434 (85%), Positives = 402/434 (92%), Gaps = 3/434 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
MERYKIL ELGDGTCG V+KAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP
Sbjct: 1 MERYKILGELGDGTCGNVFKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NIIKLKEVVRENNELFFIFEYME+NLY IMRER+ PF+E EIRSFMSQMLQGLAHMHRNG
Sbjct: 61 NIIKLKEVVRENNELFFIFEYMEYNLYQIMRERERPFTEEEIRSFMSQMLQGLAHMHRNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
Y HRDLKPENLLVTNDVLKIADFGLARE+SS PPYTEYVSTRWYRAPEVLLQSS+Y+PAI
Sbjct: 121 YLHRDLKPENLLVTNDVLKIADFGLAREVSSAPPYTEYVSTRWYRAPEVLLQSSTYTPAI 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVG ILAELFTLSPIFPG+SEIDQLYK+CC+LG PDWT FP ATNISRL++I YSEI
Sbjct: 181 DMWAVGTILAELFTLSPIFPGESEIDQLYKICCVLGTPDWTTFPGATNISRLMNICYSEI 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
LP NL DIIPNAS+EAIDLI +LCSWDPL+RPTA+QALQHPFF+V WVPYP+ DPLEL+
Sbjct: 241 LPANLCDIIPNASLEAIDLIMRLCSWDPLKRPTAEQALQHPFFHVGMWVPYPIRDPLELK 300
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKP--SNLEMVHNVPQGMQEDILFCSDLK 358
LN++G+KPNLELNLWDFG EPDDCFLGLTLAVKP SNL+ VHNV QGM+E+ILFCSDLK
Sbjct: 301 LNSIGAKPNLELNLWDFGAEPDDCFLGLTLAVKPSISNLDAVHNVSQGMEENILFCSDLK 360
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVESSLSLSFSSIQHPSTGVPQSAGYAITSLQPNLLDCP 418
DH EQ+VFWSLLSPDQN + PV+SSLSLSFSSIQHPS VPQS+G+AITSLQPN+LDCP
Sbjct: 361 DHQEQSVFWSLLSPDQNGLHPPVQSSLSLSFSSIQHPSV-VPQSSGFAITSLQPNILDCP 419
Query: 419 FLAVSSPLQQSHCL 432
L +SSP+QQSH L
Sbjct: 420 LLGMSSPIQQSHYL 433
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065415|ref|XP_002301806.1| predicted protein [Populus trichocarpa] gi|222843532|gb|EEE81079.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/434 (82%), Positives = 399/434 (91%), Gaps = 2/434 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
MERYKILEE+GDGTCGCV+KA N+ETYEIVAVKKMKRKFYFWE+CMNLREVKAL KLNHP
Sbjct: 1 MERYKILEEIGDGTCGCVFKAVNIETYEIVAVKKMKRKFYFWEDCMNLREVKALHKLNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEVVREN+ELFFIFEYME+NLY +MRE+Q FSE EIR+FMSQ+LQGLAHMHRNG
Sbjct: 61 NIVKLKEVVRENSELFFIFEYMEYNLYQLMREKQRSFSEEEIRNFMSQVLQGLAHMHRNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPEN+LVT DVLKIADFGLARE+SS PPYTEYVSTRWYRAPEVLLQSS+Y+PAI
Sbjct: 121 YFHRDLKPENVLVTKDVLKIADFGLAREVSSAPPYTEYVSTRWYRAPEVLLQSSTYTPAI 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAI+AELFTLSPIFPG+SEIDQLYK+CC+LG P+ TAFP+ATN+S+L+++S +++
Sbjct: 181 DMWAVGAIIAELFTLSPIFPGESEIDQLYKICCVLGTPELTAFPKATNVSQLMNLSCADM 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
LP NLSDIIPNAS+EAIDLI QLCSWDPL+RPTADQ+LQHPFF+V WVPYPL DPLEL+
Sbjct: 241 LPANLSDIIPNASLEAIDLIMQLCSWDPLKRPTADQSLQHPFFHVGMWVPYPLRDPLELK 300
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKP--SNLEMVHNVPQGMQEDILFCSDLK 358
LNN G KPNLELNLWDFG EPDDCFLGLTLAVKP SNLE V NVPQGM+ED +FCSDLK
Sbjct: 301 LNNKGPKPNLELNLWDFGAEPDDCFLGLTLAVKPSVSNLEAVRNVPQGMREDFVFCSDLK 360
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVESSLSLSFSSIQHPSTGVPQSAGYAITSLQPNLLDCP 418
EQ+VFWSLLSPDQN + PVESSLSLSFSSIQHPS GVPQS+G+ ITSLQPN LDCP
Sbjct: 361 GRQEQSVFWSLLSPDQNGIHPPVESSLSLSFSSIQHPSVGVPQSSGFTITSLQPNFLDCP 420
Query: 419 FLAVSSPLQQSHCL 432
+A+SSPLQQSH L
Sbjct: 421 LMAMSSPLQQSHYL 434
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30682312|ref|NP_849370.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] gi|13430824|gb|AAK26034.1|AF360324_1 putative serine/threonine-specific protein kinase MHK [Arabidopsis thaliana] gi|15810587|gb|AAL07181.1| putative serine/threonine-specific protein kinase MHK [Arabidopsis thaliana] gi|332657814|gb|AEE83214.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/436 (73%), Positives = 382/436 (87%), Gaps = 5/436 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
MERYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKLNHP
Sbjct: 1 MERYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NG
Sbjct: 61 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSS Y+PA+
Sbjct: 121 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR++SIS++E
Sbjct: 181 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T YP+HD LELR
Sbjct: 241 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIHD-LELR 299
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLK 358
L+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E+ LFC +
Sbjct: 300 LDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSENFLFCPGVN 359
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVE-SSLSLSFSSIQHPSTGVPQSAGYAIT-SLQPNLLD 416
+ E +VFWSLLSPD+N + APVE S LSLSFS +Q + G PQS+G+ +T S+QPN+LD
Sbjct: 360 NDREPSVFWSLLSPDENGLHAPVESSPLSLSFSPMQQHTVGPPQSSGFTMTSSMQPNMLD 419
Query: 417 CPFLAVSSPLQQSHCL 432
P++AVS+P QQSH L
Sbjct: 420 RPWMAVSAPFQQSHYL 435
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088149|emb|CBI35594.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/394 (79%), Positives = 355/394 (90%), Gaps = 3/394 (0%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
MERY+IL+E+GDGTCG VYKA N+ETYEIVAVKKMKRKF+FWEECMNLREVK+LRKLNHP
Sbjct: 1 MERYRILKEVGDGTCGTVYKALNMETYEIVAVKKMKRKFFFWEECMNLREVKSLRKLNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NIIKLKE+VRENNELFFIFE+ME+NLY +M E++ P SE EIRSFMSQ+LQGLAHMH+NG
Sbjct: 61 NIIKLKEIVRENNELFFIFEHMEYNLYQLMGEQKRPLSEEEIRSFMSQVLQGLAHMHKNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN+V+KIADFGLARE+SSMPPYT+YVSTRWYRAPEVL QSSSY+PAI
Sbjct: 121 YFHRDLKPENLLVTNNVIKIADFGLAREVSSMPPYTDYVSTRWYRAPEVLFQSSSYTPAI 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAELFTL PIFPG+SEIDQLYK+CC+LG PDWT F EATNISRL+S+SYSEI
Sbjct: 181 DMWAVGAILAELFTLCPIFPGESEIDQLYKICCVLGTPDWTIFSEATNISRLLSVSYSEI 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
LP NLSDIIPNAS+EA DLI QLCSWDPL RPTA+QAL+HPFF+V WVP+PL DP +++
Sbjct: 241 LPANLSDIIPNASLEATDLIMQLCSWDPLGRPTAEQALKHPFFHVGKWVPHPLPDPFQMK 300
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKP--SNLEMVHNVPQGMQEDILFCSDLK 358
N+ +KPNLELNLWDFG EPDDCFLGLTLAVKP SNLEMVH V QG EDILFCS +
Sbjct: 301 QNDT-AKPNLELNLWDFGREPDDCFLGLTLAVKPSVSNLEMVHKVSQGTGEDILFCSGFQ 359
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVESSLSLSFSSI 392
D S ++VFWS+LSPD+N + V++SLSLSF S+
Sbjct: 360 DSSGKSVFWSVLSPDRNGIDTSVDASLSLSFRSV 393
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15235551|ref|NP_193038.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] gi|21431785|sp|P43294.2|MHK_ARATH RecName: Full=Serine/threonine-protein kinase MHK gi|5123943|emb|CAB45501.1| serine/threonine-specific protein kinase MHK [Arabidopsis thaliana] gi|7268004|emb|CAB78344.1| serine/threonine-specific protein kinase MHK [Arabidopsis thaliana] gi|332657815|gb|AEE83215.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/436 (73%), Positives = 381/436 (87%), Gaps = 5/436 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKLNHP
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NG
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 128
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSS Y+PA+
Sbjct: 129 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 188
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR++SIS++E
Sbjct: 189 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 248
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T YP+HD LELR
Sbjct: 249 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIHD-LELR 307
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLK 358
L+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E+ LFC +
Sbjct: 308 LDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSENFLFCPGVN 367
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVE-SSLSLSFSSIQHPSTGVPQSAGYAIT-SLQPNLLD 416
+ E +VFWSLLSPD+N + APVE S LSLSFS +Q + G PQS+G+ +T S+QPN+LD
Sbjct: 368 NDREPSVFWSLLSPDENGLHAPVESSPLSLSFSPMQQHTVGPPQSSGFTMTSSMQPNMLD 427
Query: 417 CPFLAVSSPLQQSHCL 432
P++AVS+P QQSH L
Sbjct: 428 RPWMAVSAPFQQSHYL 443
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79325075|ref|NP_001031622.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] gi|332657816|gb|AEE83216.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/437 (72%), Positives = 375/437 (85%), Gaps = 6/437 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKLNHP
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NG
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 128
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSS Y+PA+
Sbjct: 129 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 188
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR++SIS++E
Sbjct: 189 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 248
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T YP+HD LELR
Sbjct: 249 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIHD-LELR 307
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLK 358
L+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E+ LFC +
Sbjct: 308 LDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSENFLFCPGVN 367
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVE--SSLSLSFSSIQHPSTGVPQSAGYAIT-SLQPNLL 415
+ E +VFWSLLSPD+N + APVE S +Q + G PQS+G+ +T S+QPN+L
Sbjct: 368 NDREPSVFWSLLSPDENGLHAPVESSPLSLSFSSPMQQHTVGPPQSSGFTMTSSMQPNML 427
Query: 416 DCPFLAVSSPLQQSHCL 432
D P++AVS+P QQSH L
Sbjct: 428 DRPWMAVSAPFQQSHYL 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297790790|ref|XP_002863280.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297309114|gb|EFH39539.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/435 (74%), Positives = 379/435 (87%), Gaps = 6/435 (1%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
RYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKLNHP+I
Sbjct: 14 RYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHPHI 73
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
IKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NGYF
Sbjct: 74 IKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNGYF 133
Query: 123 HRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDM 182
HRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSSSY+PA+DM
Sbjct: 134 HRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSSYTPAVDM 193
Query: 183 WAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242
WAVGAILAEL+ LSP+FPG+SEIDQLYK+CC+LG PDWT PEA +ISR++SIS++E
Sbjct: 194 WAVGAILAELYALSPLFPGESEIDQLYKICCVLGKPDWTTLPEAKSISRIMSISHTEFPQ 253
Query: 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELRLN 302
++D++PNA+ EAIDLI +LCSWDPL+RPTADQAL HPFF++ T YPLHD LELRLN
Sbjct: 254 TRIADLLPNAAPEAIDLINRLCSWDPLKRPTADQALNHPFFSMATQASYPLHD-LELRLN 312
Query: 303 NMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLKDH 360
NM + PNLELNLWDF TEP++CFLGLTLAVKPS LEMV NV M E+ LF + +
Sbjct: 313 NMAAMPNLELNLWDFNTEPEECFLGLTLAVKPSAPKLEMVPNVSHDMSENFLFFPGVNND 372
Query: 361 SEQTVFWSLLSPDQNRMRAPVE-SSLSLSFSSIQHPST-GVPQSAGYAIT-SLQPNLLDC 417
E +VFWSLLSPD+N + PVE S LSLSFS +QH +T G PQS G+ +T S+QPN+LD
Sbjct: 373 REPSVFWSLLSPDENGLHTPVESSPLSLSFSPMQHHTTLGPPQSTGFTMTSSVQPNMLDR 432
Query: 418 PFLAVSSPLQQSHCL 432
P++AVS+P QQSH L
Sbjct: 433 PWMAVSAPFQQSHYL 447
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|166811|gb|AAA18854.1| protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/436 (73%), Positives = 380/436 (87%), Gaps = 5/436 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKL HP
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLKHP 68
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NG
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 128
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSS Y+PA+
Sbjct: 129 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 188
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR++SIS++E
Sbjct: 189 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 248
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T YP+HD LELR
Sbjct: 249 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIHD-LELR 307
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLK 358
L+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E+ LFC +
Sbjct: 308 LDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSENFLFCPGVN 367
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVE-SSLSLSFSSIQHPSTGVPQSAGYAIT-SLQPNLLD 416
+ E +VFWSLLSPD+N + APVE S LSLSFS +Q + G PQS+G+ +T S+QPN+LD
Sbjct: 368 NDREPSVFWSLLSPDENGLHAPVESSPLSLSFSPMQQHTVGPPQSSGFTMTSSMQPNMLD 427
Query: 417 CPFLAVSSPLQQSHCL 432
P++AVS+P QQSH L
Sbjct: 428 RPWMAVSAPFQQSHYL 443
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494796|ref|XP_002268075.2| PREDICTED: serine/threonine-protein kinase MHK-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/392 (79%), Positives = 353/392 (90%), Gaps = 3/392 (0%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
RY+IL+E+GDGTCG VYKA N+ETYEIVAVKKMKRKF+FWEECMNLREVK+LRKLNHPNI
Sbjct: 65 RYRILKEVGDGTCGTVYKALNMETYEIVAVKKMKRKFFFWEECMNLREVKSLRKLNHPNI 124
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
IKLKE+VRENNELFFIFE+ME+NLY +M E++ P SE EIRSFMSQ+LQGLAHMH+NGYF
Sbjct: 125 IKLKEIVRENNELFFIFEHMEYNLYQLMGEQKRPLSEEEIRSFMSQVLQGLAHMHKNGYF 184
Query: 123 HRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDM 182
HRDLKPENLLVTN+V+KIADFGLARE+SSMPPYT+YVSTRWYRAPEVL QSSSY+PAIDM
Sbjct: 185 HRDLKPENLLVTNNVIKIADFGLAREVSSMPPYTDYVSTRWYRAPEVLFQSSSYTPAIDM 244
Query: 183 WAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242
WAVGAILAELFTL PIFPG+SEIDQLYK+CC+LG PDWT F EATNISRL+S+SYSEILP
Sbjct: 245 WAVGAILAELFTLCPIFPGESEIDQLYKICCVLGTPDWTIFSEATNISRLLSVSYSEILP 304
Query: 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELRLN 302
NLSDIIPNAS+EA DLI QLCSWDPL RPTA+QAL+HPFF+V WVP+PL DP +++ N
Sbjct: 305 ANLSDIIPNASLEATDLIMQLCSWDPLGRPTAEQALKHPFFHVGKWVPHPLPDPFQMKQN 364
Query: 303 NMGSKPNLELNLWDFGTEPDDCFLGLTLAVKP--SNLEMVHNVPQGMQEDILFCSDLKDH 360
+ +KPNLELNLWDFG EPDDCFLGLTLAVKP SNLEMVH V QG EDILFCS +D
Sbjct: 365 DT-AKPNLELNLWDFGREPDDCFLGLTLAVKPSVSNLEMVHKVSQGTGEDILFCSGFQDS 423
Query: 361 SEQTVFWSLLSPDQNRMRAPVESSLSLSFSSI 392
S ++VFWS+LSPD+N + V++SLSLSF S+
Sbjct: 424 SGKSVFWSVLSPDRNGIDTSVDASLSLSFRSV 455
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334186479|ref|NP_001190712.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] gi|332657818|gb|AEE83218.1| serine/threonine-protein kinase MHK [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/445 (72%), Positives = 382/445 (85%), Gaps = 14/445 (3%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK-------- 52
MERYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVK
Sbjct: 1 MERYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKDGDVVLRL 60
Query: 53 -ALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
ALRKLNHP+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQ
Sbjct: 61 QALRKLNHPHIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQ 120
Query: 112 GLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
GLAHMH+NGYFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLL
Sbjct: 121 GLAHMHKNGYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLL 180
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
QSS Y+PA+DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR
Sbjct: 181 QSSLYTPAVDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISR 240
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291
++SIS++E ++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T Y
Sbjct: 241 IMSISHTEFPQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASY 300
Query: 292 PLHDPLELRLNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQE 349
P+HD LELRL+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E
Sbjct: 301 PIHD-LELRLDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSE 359
Query: 350 DILFCSDLKDHSEQTVFWSLLSPDQNRMRAPVE-SSLSLSFSSIQHPSTGVPQSAGYAIT 408
+ LFC + + E +VFWSLLSPD+N + APVE S LSLSFS +Q + G PQS+G+ +T
Sbjct: 360 NFLFCPGVNNDREPSVFWSLLSPDENGLHAPVESSPLSLSFSPMQQHTVGPPQSSGFTMT 419
Query: 409 -SLQPNLLDCPFLAVSSPLQQSHCL 432
S+QPN+LD P++AVS+P QQSH L
Sbjct: 420 SSMQPNMLDRPWMAVSAPFQQSHYL 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 432 | ||||||
| TAIR|locus:2123221 | 444 | MHK [Arabidopsis thaliana (tax | 0.997 | 0.970 | 0.718 | 1.1e-174 | |
| TAIR|locus:2134746 | 464 | AT4G19110 [Arabidopsis thalian | 0.671 | 0.625 | 0.586 | 1.2e-97 | |
| TAIR|locus:2163583 | 499 | AT5G45430 [Arabidopsis thalian | 0.687 | 0.595 | 0.569 | 3.7e-96 | |
| UNIPROTKB|E2RE89 | 589 | MAK "Uncharacterized protein" | 0.717 | 0.526 | 0.556 | 4.2e-96 | |
| UNIPROTKB|E2RP10 | 623 | MAK "Uncharacterized protein" | 0.717 | 0.497 | 0.556 | 4.2e-96 | |
| UNIPROTKB|E1BWM1 | 625 | MAK "Uncharacterized protein" | 0.659 | 0.456 | 0.580 | 7.8e-95 | |
| UNIPROTKB|F1RV90 | 624 | MAK "Uncharacterized protein" | 0.717 | 0.496 | 0.556 | 1.1e-94 | |
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.659 | 0.457 | 0.587 | 6.1e-94 | |
| UNIPROTKB|Q2YDJ7 | 382 | MAK "Uncharacterized protein" | 0.659 | 0.746 | 0.587 | 6.1e-94 | |
| UNIPROTKB|P20794 | 623 | MAK "Serine/threonine-protein | 0.717 | 0.497 | 0.553 | 1e-93 |
| TAIR|locus:2123221 MHK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1697 (602.4 bits), Expect = 1.1e-174, P = 1.1e-174
Identities = 314/437 (71%), Positives = 374/437 (85%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RYKILEELGDGTCG VYKA N+ETYE+VAVKKMKRKFY+WEEC+NLREVKALRKLNHP
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+IIKLKE+VRE+NELFFIFE M+HNLYHIM+ER+ PFSEGEIRSFMSQMLQGLAHMH+NG
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 128
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLVTN++LKIADFGLARE++SMPPYTEYVSTRWYRAPEVLLQSS Y+PA+
Sbjct: 129 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 188
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWAVGAILAEL+ L+P+FPG+SEIDQLYK+CC+LG PDWT FPEA +ISR++SIS++E
Sbjct: 189 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 248
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELR 300
++D++PNA+ EAIDLI +LCSWDPL+RPTAD+AL HPFF++ T YP+HD LELR
Sbjct: 249 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIHD-LELR 307
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPS--NLEMVHNVPQGMQEDILFCSDLK 358
L+NM + PNLELNLWDF EP++CFLGLTLAVKPS LEM+ NV Q M E+ LFC +
Sbjct: 308 LDNMAALPNLELNLWDFNREPEECFLGLTLAVKPSAPKLEMLRNVSQDMSENFLFCPGVN 367
Query: 359 DHSEQTVFWSLLSPDQNRMRAPVEXX--XXXXXXXIQHPSTGVPQSAGYAITS-LQPNLL 415
+ E +VFWSLLSPD+N + APVE +Q + G PQS+G+ +TS +QPN+L
Sbjct: 368 NDREPSVFWSLLSPDENGLHAPVESSPLSLSFSSPMQQHTVGPPQSSGFTMTSSMQPNML 427
Query: 416 DCPFLAVSSPLQQSHCL 432
D P++AVS+P QQSH L
Sbjct: 428 DRPWMAVSAPFQQSHYL 444
|
|
| TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 170/290 (58%), Positives = 236/290 (81%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M+RYK+++E+GDGT G V++A N +T E+VA+KKMK+K+Y W+EC+NLREVK+LR++NHP
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEV+REN+ L+F+FEYME NLY +M++RQ F+E +I+++ Q+ QGL++MH+ G
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQRG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLV+ D++KIADFGLARE++S PP+TEYVSTRWYRAPEVLLQS Y+ +
Sbjct: 121 YFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKV 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWA+GAI+AEL +L PIFPG SE D++YK+C ++G P + E N++ I+ + ++
Sbjct: 181 DMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQL 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
+ LS ++P+AS +AI+LI +LCSWDP RPTA + LQHPFF +VP
Sbjct: 241 PGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVP 290
|
|
| TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 3.7e-96, P = 3.7e-96
Identities = 169/297 (56%), Positives = 234/297 (78%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
MERY +L+E+GDGT G V++A N +T E+VA+K+MK+K++ WEEC+NLREVK+L ++NHP
Sbjct: 1 MERYTLLKEVGDGTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMNHP 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KLKEV+REN+ L+F+FEYME NLY +M++R F+E +IR++ Q+ QGL++MH+ G
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRPKHFAESDIRNWCFQVFQGLSYMHQRG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
YFHRDLKPENLLV+ DV+KIAD GLARE+ S PPYTEYVSTRWYRAPEVLLQS Y+ +
Sbjct: 121 YFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSKV 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
DMWA+GAI+AEL +L P+FPG SE D++YK+C ++G+P + E N++ +I+ + +
Sbjct: 181 DMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQF 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPL 297
++LS ++P AS +A++LI +LCSWDP RPT +ALQHPFF ++P L L
Sbjct: 241 PGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSLRPKL 297
|
|
| UNIPROTKB|E2RE89 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 4.2e-96, Sum P(2) = 4.2e-96
Identities = 176/316 (55%), Positives = 238/316 (75%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+TL P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV-ETWVPYPLHDPLE 298
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+H +F V + P H L+
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHQYFQVGQVLGPSSHHPELK 300
Query: 299 LRLNN----MGSKPNL 310
LN + SKP+L
Sbjct: 301 QSLNKQVQPLESKPSL 316
|
|
| UNIPROTKB|E2RP10 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 4.2e-96, Sum P(2) = 4.2e-96
Identities = 176/316 (55%), Positives = 238/316 (75%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+TL P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV-ETWVPYPLHDPLE 298
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+H +F V + P H L+
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHQYFQVGQVLGPSSHHPELK 300
Query: 299 LRLNN----MGSKPNL 310
LN + SKP+L
Sbjct: 301 QSLNKQVQPLESKPSL 316
|
|
| UNIPROTKB|E1BWM1 MAK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 7.8e-95, Sum P(2) = 7.8e-95
Identities = 166/286 (58%), Positives = 229/286 (80%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY I+++LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTIMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+F+FEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNMMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLL-VTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL + +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCIGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSIYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+TL P+FPG SE+D+++K+C +LG P + +PE ++S ++ + +
Sbjct: 181 IDIWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYHLSSAMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+PI+L +IPNAS EAI L+ + +W+P +RPTA QAL++P+F V
Sbjct: 241 CVPISLKTLIPNASSEAIQLMSDMLNWNPKKRPTASQALKYPYFQV 286
|
|
| UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
Identities = 176/316 (55%), Positives = 238/316 (75%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+TL P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV-ETWVPYPLH---- 294
PINL +IPNAS EAI L+ ++ SWDP +RPTA QAL+HP+F V + P H
Sbjct: 241 CAPINLKTLIPNASNEAIQLMTEMLSWDPKKRPTASQALKHPYFQVGQVLGPSSHHLESK 300
Query: 295 DPLELRLNNMGSKPNL 310
PL ++ + SKP++
Sbjct: 301 QPLNKQVQPLESKPSV 316
|
|
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 168/286 (58%), Positives = 227/286 (79%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS+YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+TL P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+HP+F V
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQV 286
|
|
| UNIPROTKB|Q2YDJ7 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 168/286 (58%), Positives = 227/286 (79%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS+YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+TL P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+HP+F V
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQV 286
|
|
| UNIPROTKB|P20794 MAK "Serine/threonine-protein kinase MAK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
Identities = 175/316 (55%), Positives = 237/316 (75%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M RY + +LGDGT G V + E+ E+VA+K+MKRKFY W+ECMNLREVK+L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
N+IKLKEV+REN+ L+FIFEYM+ NLY +M++R F E IR+ M Q+LQGLA +H++G
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120
Query: 121 YFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
+FHRD+KPENLL +++KIADFGLAREL S PPYT+YVSTRWYRAPEVLL+SS YS
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+WAVG+I+AEL+ L P+FPG SE+D+++K+C +LG P + +PE ++ ++ + +
Sbjct: 181 IDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV-ETWVPYPLH---- 294
+PINL +IPNAS EAI L+ ++ +WDP +RPTA QAL+HP+F V + P H
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSNHLESK 300
Query: 295 DPLELRLNNMGSKPNL 310
L +L + SKP+L
Sbjct: 301 QSLNKQLQPLESKPSL 316
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q84SN3 | CDKF3_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.6086 | 0.9722 | 0.9699 | yes | no |
| P43294 | MHK_ARATH | 2, ., 7, ., 1, 1, ., 2, 2 | 0.7362 | 0.9976 | 0.9729 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_Genewise1_v1.C_LG_II4024 | hypothetical protein (435 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 432 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-177 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-130 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-118 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-105 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-104 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-100 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-98 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-98 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-97 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-92 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-92 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-90 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-85 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-82 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-81 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-78 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-77 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-75 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-74 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-74 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-73 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-73 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-73 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-72 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-72 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-72 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-71 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-70 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-70 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-69 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-69 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-67 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-67 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-66 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-63 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-62 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-60 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-58 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-56 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-56 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-56 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-56 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-55 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-53 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-53 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-50 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-49 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-46 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-44 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-43 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-43 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-43 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-43 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-43 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-42 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-33 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-31 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-28 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-27 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-21 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-18 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 7e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 494 bits (1275), Expect = e-177
Identities = 181/283 (63%), Positives = 230/283 (81%), Gaps = 3/283 (1%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNI 62
YK++++LGDGT G VY A N ET E+VA+KKMK+KFY WEECMNLREVK+LRKLN HPNI
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+KLKEV REN+EL+F+FEYME NLY +M++R+ PFSE IRS + Q+LQGLAH+H++G+
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 122 FHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
FHRDLKPENLLV+ +V+KIADFGLARE+ S PPYT+YVSTRWYRAPE+LL+S+SYS +
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
D+WA+G I+AEL+TL P+FPG SEIDQLYK+C +LG P +PE ++ + + +
Sbjct: 181 DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
P +L +IPNAS EAIDLI + WDP +RPTA QALQHP+F
Sbjct: 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 376 bits (968), Expect = e-130
Identities = 140/283 (49%), Positives = 194/283 (68%), Gaps = 3/283 (1%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNI 62
Y+ L ++G+GT G VYKA + T EIVA+KK+K +F LRE+K L++LNHPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
IKL +V R +L+ +FE+M+ +LY ++++RQ E I+S++ Q+LQGLA H +G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 123 HRDLKPENLLV-TNDVLKIADFGLARELSSMP-PYTEYVSTRWYRAPEVLLQSSSYSPAI 180
HRDLKPENLL+ T VLK+ADFGLAR S PYT YV TRWYRAPE+LL YS +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
D+W+VG I AEL + P+FPG SEIDQL+K+ LG PD +P+ T+++R S+ +
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ L + PNAS +A+DL+ Q+ +DP +R TA+QAL HP+F
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 345 bits (887), Expect = e-118
Identities = 126/285 (44%), Positives = 184/285 (64%), Gaps = 8/285 (2%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE---CMNLREVKALRKLNHP 60
Y+ LE+LG+GT G VYKA + +T EIVA+KK++ EE LRE+ L++L HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+KL +V+ +L+ +FEY + +L + +R P S I+S M Q+L+GLA+ H +
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRDLKP+N+L+ D VLK+ADFGLAR + YT V T WYRAPE+LL S YS
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
A+D+W+VG I AE+ T P+FPGDSEIDQL+K+ ILG P ++P T + ++
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD-YKPTFP 237
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ P +L ++P E IDL+ ++ ++P +R +A +AL+HP+F
Sbjct: 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 312 bits (802), Expect = e-105
Identities = 132/283 (46%), Positives = 193/283 (68%), Gaps = 4/283 (1%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNI 62
YKIL ++G+GT V KA + +T + A+K MK+ F E+ NLRE++ALR+L+ HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 63 IKLKEVV--RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
++L EV+ R+ L +FE M+ NLY +++ R+ P E ++S+M Q+L+ L HMHRNG
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
FHRD+KPEN+L+ +D+LK+ADFG R + S PPYTEY+STRWYRAPE LL Y P +
Sbjct: 121 IFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
D+WAVG + E+ +L P+FPG +E+DQ+ K+ +LG PD + SR ++ ++
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD-AEVLKKFRKSRHMNYNFPSK 239
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
L ++PNAS E +DL+ +L ++DP R TA QAL+HP+F
Sbjct: 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 311 bits (799), Expect = e-104
Identities = 117/291 (40%), Positives = 181/291 (62%), Gaps = 15/291 (5%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRKLN 58
Y+ + ++G+GT G VYKA N +T E+VA+KK++ E +RE+K L+KL
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR----MENEKEGFPITAIREIKLLQKLR 56
Query: 59 HPNIIKLKEVVRE--NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
HPNI++LKE+V ++ +FEYM+H+L ++ ++ F+E +I+ +M Q+L+GL ++
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM--PPYTEYVSTRWYRAPEVLLQS 173
H NG HRD+K N+L+ ND VLK+ADFGLAR + YT V T WYR PE+LL +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
+ Y P +DMW+VG ILAELF PIF G +E++QL K+ + G+P +P + +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236
Query: 234 SISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
++ + L + + A+DL+ +L + DP +R +ADQALQH +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 300 bits (771), Expect = e-100
Identities = 127/287 (44%), Positives = 183/287 (63%), Gaps = 6/287 (2%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM--KRKFYFWEECMNLREVKALRKLNHP 60
RYKIL +G+G G V+KA + ET E VA+KK+ +R LRE+KAL+ HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA-LREIKALQACQHP 59
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
++KL +V + + EYM +L ++R+ + P E +++S+M +L+G+A+MH NG
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS--MPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRDLKP NLL++ D VLKIADFGLAR S Y+ V+TRWYRAPE+L + Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
P +D+WAVG I AEL SP+FPG+++I+QL V LG P+ +P T++ I++
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
E PI L +I P+AS EA+DL+ L +DP +R +A +AL+HP+F
Sbjct: 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 296 bits (760), Expect = 1e-98
Identities = 126/296 (42%), Positives = 180/296 (60%), Gaps = 11/296 (3%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKR-KFYFWEECMN---LREVKALRKLN 58
RY+ ++LG+GT VYKA + ET IVA+KK+K + ++ +N LRE+K L++L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HPNII L +V + + +FE+ME +L +++++ I + +I+S+M L+GL ++H
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSSY 176
N HRDLKP NLL+ +D VLK+ADFGLAR S T V TRWYRAPE+L + Y
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
+DMW+VG I AEL P PGDS+IDQL K+ LG P +P T S +
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT--SLPDYVE 238
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYP 292
+ P L I P AS +A+DL+ +L + +P +R TA QAL+HP+F + P P
Sbjct: 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF---SNDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 294 bits (756), Expect = 2e-98
Identities = 114/282 (40%), Positives = 167/282 (59%), Gaps = 30/282 (10%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
Y+ILE+LG+G+ G VY A + +T ++VA+K +K+K + LRE+K L+KL HPNI+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 64 KLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
+L +V + ++L+ + EY E +L+ ++++R SE E R ++ Q+L L ++H G
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 123 HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
HRDLKPEN+L+ D +K+ADFGLAR+L T +V T Y APEVLL Y A+D
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGKAVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
+W++G IL EL T P FPGD ++ +L+K +G P P +IS
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFK---KIGKPKPPFPPPEWDISP---------- 225
Query: 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
EA DLI +L DP +R TA++ALQHPFF
Sbjct: 226 -------------EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 293 bits (752), Expect = 7e-97
Identities = 126/308 (40%), Positives = 177/308 (57%), Gaps = 24/308 (7%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHPN 61
RY++L+ +G G G V A + T VA+KK+ F + LRE+K LR L H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 62 IIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
II L +++R + N+++ + E ME +L+ +++ Q P ++ I+ F+ Q+L+GL ++
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL 119
Query: 117 HRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPY----TEYVSTRWYRAPEVLL 171
H HRDLKP N+LV +N LKI DFGLAR + TEYV TRWYRAPE+LL
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL 179
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN--- 228
SS Y+ AID+W+VG I AEL T P+FPG IDQL + +LG P T+
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+ L S+ LS + P AS EAIDL+ ++ +DP +R TAD+AL HP+
Sbjct: 240 RNYLKSLPKKP--KKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA---- 293
Query: 289 VPYPLHDP 296
LHDP
Sbjct: 294 ---QLHDP 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 278 bits (713), Expect = 4e-92
Identities = 117/284 (41%), Positives = 164/284 (57%), Gaps = 28/284 (9%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNHPNI 62
Y++L +LG G+ G VYKA + T +IVAVK + KR ++ RE++ LR+L+HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 63 IKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
++L + + + L+ + EY E +L+ + R P SE E + Q+L+GL ++H NG
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 122 FHRDLKPEN-LLVTNDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRDLKPEN LL N V+KIADFGLA++L S T +V T WY APEVLL + Y P
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
+D+W++G IL EL T P F G++ +DQL + ILG P S SE
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPP--------LEFDEPKWSSGSE 231
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
EA DLI + + DP +RPTA++ LQHP+F
Sbjct: 232 ---------------EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 279 bits (716), Expect = 5e-92
Identities = 128/296 (43%), Positives = 178/296 (60%), Gaps = 21/296 (7%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE-----CMNLREVKALRK 56
+ Y+ L + +GT G VY+A + +T EIVA+KK+K +E +LRE+ L K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK----MEKEKEGFPITSLREINILLK 60
Query: 57 LNHPNIIKLKEVV--RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
L HPNI+ +KEVV ++++ + EY+EH+L +M + PF + E++ M Q+L G+A
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQ 172
H+H N HRDLK NLL+ N +LKI DFGLARE S + PYT+ V T WYRAPE+LL
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG 180
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPD---WTAFPEATNI 229
+ YS AIDMW+VG I AEL T P+FPG SEIDQL K+ +LG P W F E
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240
Query: 230 SRLISISYSEILPINLSDIIPNASM--EAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ Y L P S+ DL+ +L ++DP +R +A+ AL+HP+F
Sbjct: 241 KKKTFTKYPY---NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (701), Expect = 8e-90
Identities = 115/291 (39%), Positives = 162/291 (55%), Gaps = 12/291 (4%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
+Y++L +G+G G V K N T EIVA+KK K E+ LREVK LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRH 59
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+ LKE R L+ +FEY+E L ++ +RS++ Q+LQ +A+ H +
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELS--SMPPYTEYVSTRWYRAPEVLLQSSSY 176
HRD+KPEN+LV+ + VLK+ DFG AR L P T+YV+TRWYRAPE+L+ ++Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG--APDWTA-FPEATNISRLI 233
+D+WA+G I+AEL P+FPGDS+IDQLY + LG P F + +
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239
Query: 234 SISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S+ + P S A+D + DP R T D+ LQHP+F
Sbjct: 240 FPEPSQPESLERR--YPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 260 bits (667), Expect = 7e-85
Identities = 116/287 (40%), Positives = 180/287 (62%), Gaps = 11/287 (3%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE----CMNLREVKALRKLNH 59
Y+ +E++G+GT G VYKA + T EIVA+KK++ + E+ +RE+ L++LNH
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNH 57
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIM-RERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI++L +VV N+L+ +FE+++ +L M I+S++ Q+LQG+A+ H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSY 176
+ HRDLKP+NLL+ LK+ADFGLAR + YT V T WYRAPE+LL S Y
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S +D+W++G I AE+ P+FPGDSEIDQL+++ LG PD +P T++ +
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-T 236
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ + +LS ++PN + +DL+ ++ +DP +R +A ALQHP+F
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 2e-82
Identities = 118/318 (37%), Positives = 188/318 (59%), Gaps = 41/318 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM----------KRKFYFWEECMNLRE 50
+ +Y+IL++LG G G V+KA + T E+VA+KK+ +R F RE
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF---------RE 56
Query: 51 VKALRKL-NHPNIIKLKEVVR-ENN-ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
+ L++L +HPNI+KL V++ EN+ +++ +FEYME +L+ ++R I + R M
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR-ANI-LEDVHKRYIMY 114
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSM------PPYTEYVS 160
Q+L+ L ++H HRDLKP N+L+ +D +K+ADFGLAR LS + P T+YV+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDW 220
TRWYRAPE+LL S+ Y+ +DMW+VG IL E+ P+FPG S ++QL K+ ++G P
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS- 233
Query: 221 TAFPEATNISRLISI--SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
E+ ++ S L +++P AS +A+DL+ +L ++P +R TA++AL
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293
Query: 279 QHPFFNVETWVPYPLHDP 296
+HP+ H+P
Sbjct: 294 EHPYVA-------QFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 6e-81
Identities = 120/298 (40%), Positives = 166/298 (55%), Gaps = 21/298 (7%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
RYK +E +G G G V A + + + VA+KK+ F + LRE+K LR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---DVPTLAKRTLRELKILRHF 61
Query: 58 NHPNIIKLKEVVRENNELF----FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
H NII +++++R F + + ME +L+HI+ Q P +E IR F+ Q+L+GL
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGL 120
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPP-----YTEYVSTRWYRAP 167
++H HRDLKP NLLV D L+I DFG+AR LSS P TEYV+TRWYRAP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
E+LL Y+ AIDMW+VG I AE+ +FPG + + QL + +LG+P
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-EEVLNRI 239
Query: 228 NISRLISI--SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
R+ + P+ S I P AS EA+DL+ Q+ +DP R T +QALQHPF
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 2e-78
Identities = 112/313 (35%), Positives = 171/313 (54%), Gaps = 38/313 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-----KRKFYFWEECMNLREVKALR 55
+ Y+IL +LG+GT G VYKA ++T +VA+KK+ K F LRE+K L+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILK 62
Query: 56 KLNHPNIIKLKEVV--------RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
KL HPN++ L ++ R+ ++ + YM+H+L ++ + +E +I+ +M
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP------------ 154
Q+L+G+ ++H N HRD+K N+L+ N +LKIADFGLAR PP
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCI 214
YT V TRWYR PE+LL Y+ A+D+W +G + AE+FT PI G S+IDQL+ + +
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242
Query: 215 LGAPDWTAFPEATNI----SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR 270
G P +P ++ +Y P L + E +DL+ +L S DP +
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNY----PRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 271 RPTADQALQHPFF 283
R TA AL+HP+F
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 1e-77
Identities = 116/293 (39%), Positives = 173/293 (59%), Gaps = 19/293 (6%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM---NLREVKALRKL--- 57
Y+ L E+G+G G VYKA ++ T VA+KK++ EE + LRE+ L++L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALLKQLESF 58
Query: 58 NHPNIIKLKEV---VRENNE--LFFIFEYMEHNLYHIMRERQIP-FSEGEIRSFMSQMLQ 111
HPNI++L +V R + E L +FE+++ +L + + P I+ M Q+L+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
G+ +H + HRDLKP+N+LVT+D +KIADFGLAR S T V T WYRAPEVL
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
LQSS Y+ +DMW+VG I AELF P+F G SE DQL K+ ++G P +P ++
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
R S+ P + +P E +DL+ ++ +++P +R +A +ALQHP+F
Sbjct: 238 R---SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 5e-75
Identities = 118/300 (39%), Positives = 167/300 (55%), Gaps = 35/300 (11%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----------LREVKA 53
++ L +G+GT G VY+A + + EIVA+KK++ M+ LRE+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---------MDNERDGIPISSLREITL 59
Query: 54 LRKLNHPNIIKLKEVV--RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
L L HPNI++LKEVV + + +F + EY E +L ++ PFSE +++ M Q+L+
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 112 GLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMP-PYTEYVSTRWYRAPEV 169
GL ++H N HRDLK NLL+T LKIADFGLAR P T V T WYRAPE+
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP------DWTAF 223
LL ++Y+ AIDMWAVG ILAEL P+ PG SEI+QL + +LG P ++
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
P + L Y+ NL P S + L+ L +DP +R TA++AL+ +F
Sbjct: 240 PLVGKFT-LPKQPYN-----NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 1e-74
Identities = 118/287 (41%), Positives = 173/287 (60%), Gaps = 17/287 (5%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE-----CMNLREVKALRKLNHPN 61
+E++G+GT G VYKA N T E+VA+KK++ E +RE+ L++LNHPN
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLD----TETEGVPSTAIREISLLKELNHPN 60
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ---IPFSEGEIRSFMSQMLQGLAHMHR 118
I+KL +V+ N+L+ +FE++ +L M IP I+S++ Q+LQGLA H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL--IKSYLFQLLQGLAFCHS 118
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSY 176
+ HRDLKP+NLL+ T +K+ADFGLAR + YT V T WYRAPE+LL Y
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S A+D+W++G I AE+ T +FPGDSEIDQL+++ LG PD +P T++ S
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-S 237
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ + + S ++P + DL+ Q+ +DP +R +A AL HPFF
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 8e-74
Identities = 115/313 (36%), Positives = 180/313 (57%), Gaps = 34/313 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM---KRKFYFWEECM-NLREVKALRKL 57
RY+ L +G+G G V A + T VA+KK+ + + + C LRE+K LR+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTF----CQRTLREIKILRRF 60
Query: 58 NHPNIIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
H NII + +++R N+++ + E ME +LY +++ + + S I+ F+ Q+L+G
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRG 118
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPY----TEYVSTRWYRAP 167
L ++H HRDLKP NLL+ TN LKI DFGLAR + TEYV+TRWYRAP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
E++L S Y+ AID+W+VG ILAE+ + P+FPG + QL + +LG P
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL---N 235
Query: 228 NISRLISISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
I L + +Y + LP + + + PNA +A+DL+ ++ +++P +R T ++AL HP+
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY- 294
Query: 284 NVETWVPYPLHDP 296
+E + HDP
Sbjct: 295 -LEQY-----HDP 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 1e-73
Identities = 118/308 (38%), Positives = 176/308 (57%), Gaps = 27/308 (8%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLN 58
+Y ++ +G G G V A N ET E VA+KK+ F + ++ LRE+K LR L+
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLD 62
Query: 59 HPNIIKLKEVVREN-----NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
H N+I +K+++ N+++ ++E M+ +L+ I+R Q S+ + F+ Q+L+GL
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGL 121
Query: 114 AHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPY-TEYVSTRWYRAPEVLL 171
++H HRDLKP NLL+ N LKI DFGLAR S + TEYV TRWYRAPE+LL
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT--AFPEATNI 229
S Y+ AID+W+VG I AEL P+FPG + QL + +LG+P F
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 230 SRLI-SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
R I S+ Y+ + + + P+A+ AIDL+ ++ +DP +R T ++AL HP+
Sbjct: 242 RRYIRSLPYTP--RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA---- 295
Query: 289 VPYPLHDP 296
LHDP
Sbjct: 296 ---SLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 4e-73
Identities = 107/316 (33%), Positives = 164/316 (51%), Gaps = 35/316 (11%)
Query: 3 RYKILEELGDGTCGCVYKAF--NVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLN 58
+Y+I +G GT G VYKA N + + A+KK K + RE+ LR+L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 59 HPNIIKLKEVVRENNE--LFFIFEYMEHNLYHIM----RERQIPFSEGEIRSFMSQMLQG 112
H N++ L EV E+ + ++ +F+Y EH+L+ I+ + +++ ++S + Q+L G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSSM--PPYTE--YVSTRW 163
+ ++H N HRDLKP N+LV + V+KI D GLAR ++ P V T W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---------IDQLYKVCCI 214
YRAPE+LL + Y+ AID+WA+G I AEL TL PIF G DQL ++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 215 LGAP---DW---TAFPEATNISRLISI-SYSEILPINLSDIIPNASMEAIDLIWQLCSWD 267
LG P DW PE + + +Y + + DL+ +L +D
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 268 PLRRPTADQALQHPFF 283
P +R TA++AL+HP+F
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 7e-73
Identities = 132/315 (41%), Positives = 180/315 (57%), Gaps = 35/315 (11%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETY--EIVAVKKMKRKFYFWEECMN-LREVKALRKL-N 58
RY++++ELG G G V A N ET E VA+KK+ F LRE+K LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 59 HPNIIKL--KEVVREN--NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
H NI L ++V NEL+ E ME +L+ I+R Q P ++ +SF+ Q+L GL
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-PLTDAHFQSFIYQILCGLK 119
Query: 115 HMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMP----PY-TEYVSTRWYRAPE 168
++H HRDLKP NLLV D LKI DFGLAR S P + TEYV+TRWYRAPE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
++L SY+ AID+W+VG ILAEL P+F G +DQL ++ +LG PD E T
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD-----EET- 233
Query: 229 ISRLISI---SYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
+SR+ S +Y LP I PNA+ A+DL+ +L ++DP +R + ++AL+HP
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
Query: 282 FFNVETWVPYPLHDP 296
+ + W HDP
Sbjct: 294 YLAI--W-----HDP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 1e-72
Identities = 110/294 (37%), Positives = 183/294 (62%), Gaps = 16/294 (5%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE-----CMNLREVKALR 55
M++Y+ +E++G+GT G VYKA + T E +A+KK++ + +E +RE+ L+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE----QEDEGVPSTAIREISLLK 56
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGE--IRSFMSQMLQGL 113
++ H NI++L++VV L+ +FEY++ +L M + F++ I++++ Q+L+G+
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGI 115
Query: 114 AHMHRNGYFHRDLKPENLLV--TNDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVL 170
A+ H + HRDLKP+NLL+ + LK+ADFGLAR + +T V T WYRAPE+L
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
L S YS +D+W+VG I AE+ P+FPGDSEID+L+K+ ILG P+ +P T++
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
S ++ + P +L+ ++P +DL+ ++ DP +R TA AL+H +F
Sbjct: 236 DYKS-AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 3e-72
Identities = 110/284 (38%), Positives = 166/284 (58%), Gaps = 5/284 (1%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
+K LE+LG+GT VYK N T EIVA+K++ +RE+ +++L H NI+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 64 KLKEVVRENNELFFIFEYMEHNLYHIM--RERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+L +V+ N+L +FEYM+ +L M + ++SF Q+L+G+A H N
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 122 FHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRDLKP+NLL+ LK+ADFGLAR + ++ V T WYRAP+VLL S +YS +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
ID+W+VG I+AE+ T P+FPG + DQL K+ I+G P + +P + + ++
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE-YKPTFPR 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
P +L + P+A IDL+ +L +P R +A ALQHP+F
Sbjct: 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 4e-72
Identities = 119/299 (39%), Positives = 178/299 (59%), Gaps = 20/299 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM---NLREVKALRKLN 58
+ Y+ LE++G+GT G VYKA + T ++VA+KK + + EE + LRE+ L+ L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLS 58
Query: 59 H-PNIIKLKEV--VRENN---ELFFIFEYMEHNLYHIM----RERQIPFSEGEIRSFMSQ 108
I++L +V V E N L+ +FEY++ +L M R P I+SFM Q
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELS-SMPPYTEYVSTRWYR 165
+L+G+AH H++G HRDLKP+NLLV +LKIAD GL R S + YT + T WYR
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225
APEVLL S+ YS +D+W+VG I AE+ P+FPGDSE+ QL + +LG P +P
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ + + + P +LS +P+ S E +DL+ ++ +DP +R +A AL HP+F+
Sbjct: 239 VSKLRDW--HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 2e-71
Identities = 110/307 (35%), Positives = 161/307 (52%), Gaps = 35/307 (11%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-----KRKFYFWEECMNLREVKALRKL 57
+Y+ L ++G GT G V+KA + +T +IVA+KK+ K F LRE+K L+ L
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALREIKILQLL 68
Query: 58 NHPNIIKLKEVVR-----ENN---ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQM 109
H N++ L E+ R N + +FE+ EH+L ++ + + F+ EI+ M +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-----SMPPYTEYVSTRW 163
L GL ++HRN HRD+K N+L+T D +LK+ADFGLAR S YT V T W
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
YR PE+LL Y P IDMW G I+AE++T SPI G++E QL + + G+ +
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248
Query: 224 PEATNISRLISISYSEI-LPINLSDIIP------NASMEAIDLIWQLCSWDPLRRPTADQ 276
P + + ++ LP + A+DLI +L DP +R AD
Sbjct: 249 PGVDKLE-----LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303
Query: 277 ALQHPFF 283
AL H FF
Sbjct: 304 ALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 5e-70
Identities = 110/298 (36%), Positives = 172/298 (57%), Gaps = 18/298 (6%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK---RKFYFWEECMNLREVKALRKL 57
++++ I+ ++G+GT G VYKA + +T E+VA+KK++ K F +RE+K LR+L
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF--PITAIREIKILRQL 63
Query: 58 NHPNIIKLKEVV----------RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
NH NI+ LKE+V ++ + +FEYM+H+L ++ + FSE I+SFM
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR--ELSSMPPYTEYVSTRWY 164
Q+L+GL + H+ + HRD+K N+L+ N +K+ADFGLAR PYT V T WY
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
R PE+LL Y PAID+W+ G IL ELFT PIF + E+ QL + + G+P +P
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ + ++ + L + A+DL+ + + DP +R TA++AL P+
Sbjct: 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 6e-70
Identities = 117/332 (35%), Positives = 179/332 (53%), Gaps = 39/332 (11%)
Query: 2 ERYKILEE-LGDGTCGCVYKAFNVETYEIVAVKKMK---------RKFYFWEEC----MN 47
ERY LG+GT G V KA++ T +IVA+KK+K + C
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
LRE+K + ++ H NI+ L +V E + + + + M +L ++ +R+I +E +++ +
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV-DRKIRLTESQVKCILL 126
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP------------ 154
Q+L GL +H+ + HRDL P N+ + + + KIADFGLAR P
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 155 ---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
T V T WYRAPE+L+ + Y A+DMW+VG I AEL T P+FPG++EIDQL ++
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 212 CCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR 271
+LG P+ +P+A + + ++ P +L I PNAS +AIDL+ L +PL R
Sbjct: 247 FELLGTPNEDNWPQAKKLP--LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 272 PTADQALQHPFFNVETWVPYPLH-DPLELRLN 302
+A +AL+H +F PL DP +L N
Sbjct: 305 ISAKEALKHEYFKS-----DPLPCDPSQLPFN 331
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 1e-69
Identities = 109/319 (34%), Positives = 170/319 (53%), Gaps = 50/319 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF---------YFWEECMNLREVK 52
+RY+ L +G G G V AF+ +T VA+KK+ R F Y RE++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--------RELR 66
Query: 53 ALRKLNHPNIIKLKEV------VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFM 106
L+ ++H N+I L +V + + +++ + M +L +I++ ++ S+ I+ +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLV 124
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSS-MPPYTEYVSTRWY 164
Q+L+GL ++H G HRDLKP N+ V D LKI DFGLAR M T YV+TRWY
Sbjct: 125 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM---TGYVATRWY 181
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
RAPE++L Y+ +D+W+VG I+AEL T +FPG IDQL ++ ++G PD
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD----- 236
Query: 225 EATNISRLISIS---YSEILPI----NLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277
+ ++ S S Y + LP + ++ A+ AIDL+ ++ DP +R TA +A
Sbjct: 237 -EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 278 LQHPFFNVETWVPYPLHDP 296
L HP+ HDP
Sbjct: 296 LAHPYLA-------EYHDP 307
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 3e-69
Identities = 112/291 (38%), Positives = 178/291 (61%), Gaps = 18/291 (6%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE----CMNLREVKALRKLNH 59
Y +E++G+GT G VYK N +T +IVA+KK++ + EE +RE+ L++L H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQH 58
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSE----GEIRSFMSQMLQGLAH 115
PNI+ L++V+ + + L+ IFE++ +L + +P + ++S++ Q+LQG+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLD--SLPKGQYMDAELVKSYLYQILQGILF 116
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTEYVSTRWYRAPEVLLQ 172
H HRDLKP+NLL+ N V+K+ADFGLAR +P YT V T WYRAPEVLL
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLG 175
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
S YS +D+W++G I AE+ T P+F GDSEIDQL+++ ILG P +P T++
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ ++ + +L + N + +DL+ ++ +DP +R +A +AL HP+F
Sbjct: 236 KN-TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 1e-67
Identities = 107/293 (36%), Positives = 164/293 (55%), Gaps = 18/293 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
E+Y+ L ++G+G+ G V+K N ET +IVA+KK F E+ LRE++ L++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQ 56
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
L HPN++ L EV R +L +FEY +H + + + + E I+ + Q LQ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 117 HRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQ 172
H++ HRD+KPEN+L+T +K+ DFG AR L+ P YT+YV+TRWYRAPE+L+
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPELLVG 174
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG--APDWTAFPEATNIS 230
+ Y P +D+WA+G + AEL T P++PG S++DQLY + LG P
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ +SI E L PN S A+ + DP R + ++ L+HP+F
Sbjct: 235 KGLSIPEPETR-EPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 3e-67
Identities = 109/300 (36%), Positives = 166/300 (55%), Gaps = 32/300 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC-----MNLREVKALRK 56
E+Y+ L +G+G+ G V K + ET +IVA+KK F E+ + +RE++ L++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQ 56
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
L H N++ L EV R L+ +FE+++H + + + E +R ++ Q+L+G+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 117 HRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQ 172
H + HRD+KPEN+LV+ + V+K+ DFG AR L++ P YT+YV+TRWYRAPE+L+
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGEVYTDYVATRWYRAPELLVG 174
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI--- 229
+ Y A+D+WAVG ++ E+ T P+FPGDS+IDQLY + LG P I
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG----NLIPRHQEIFQK 230
Query: 230 ------SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
RL + L P S +DL Q DP RP++ Q L H FF
Sbjct: 231 NPLFAGMRLPEVKE----IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 4e-66
Identities = 109/292 (37%), Positives = 171/292 (58%), Gaps = 19/292 (6%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE------CMNLREVKALRK 56
+Y+ LE++G+GT G V+KA N ET+EIVA+K+++ ++ LRE+ L++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKE 55
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
L H NI++L +V+ + +L +FEY + +L ++SFM Q+L+GLA
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 117 HRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSS 174
H + HRDLKP+NLL+ N LK+ADFGLAR + Y+ V T WYR P+VL +
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 175 SYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
YS +IDMW+ G I AEL P+FPG+ DQL ++ +LG P ++P +S+L
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP---GVSKLP 232
Query: 234 SISYSEILP--INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ P +L +++P + DL+ L +P++R +A++ALQHP+F
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 8e-66
Identities = 115/296 (38%), Positives = 171/296 (57%), Gaps = 16/296 (5%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHPN 61
RYKI E +G G+ G V A + T E VA+KK+ F + LRE+K LR L HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 62 IIKLKEVV-----RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
I+++K ++ RE +++ +FE ME +L+ +++ + + F+ Q+L+ L ++
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI 119
Query: 117 HRNGYFHRDLKPENLLVTNDV-LKIADFGLAR-ELSSMPP---YTEYVSTRWYRAPEVLL 171
H FHRDLKP+N+L D LKI DFGLAR + P +T+YV+TRWYRAPE L
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 178
Query: 172 QS--SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
S S Y+PAID+W++G I AE+ T P+FPG + + QL + +LG P N
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 230 -SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+R S + P+ S PNA A+ L+ +L ++DP RPTA++AL P+F
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 9e-63
Identities = 80/187 (42%), Positives = 115/187 (61%), Gaps = 4/187 (2%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV 69
LG+G G VY A + +T + VA+K +K++ LRE++ L+KLNHPNI+KL V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 70 RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKP 128
+ N L+ + EY E +L +++E + SE EI + Q+L+GL ++H NG HRDLKP
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 129 ENLLVT--NDVLKIADFGLARELSSMPPY-TEYVSTRWYRAPEVLLQSSSYSPAIDMWAV 185
EN+L+ N +K+ADFGL++ L+S V T Y APEVLL YS D+W++
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 186 GAILAEL 192
G IL EL
Sbjct: 181 GVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 4e-62
Identities = 104/292 (35%), Positives = 167/292 (57%), Gaps = 13/292 (4%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE---CMNLREVKALRKL 57
+E YK L++LG+G+ VYK + T ++VA+K+++ + EE +RE L+ L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIREASLLKDL 60
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H NI+ L +++ L +FEY++ +L M + S +R F+ Q+L+GLA+ H
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 118 RNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP--YTEYVSTRWYRAPEVLLQSS 174
+ HRDLKP+NLL++ LK+ADFGLAR S+P Y+ V T WYR P+VLL S+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLI 233
YS ++DMW VG I E+ T P+FPG +++ DQL+K+ +LG P +P ++
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239
Query: 234 SISYSEILPINLSDIIPNASM--EAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S+ P L + P +L + ++P +R +A +A++HP+F
Sbjct: 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 5e-60
Identities = 116/291 (39%), Positives = 172/291 (59%), Gaps = 15/291 (5%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPN 61
++++L +G+G G V K + ET EIVA+KK K E + LRE+K LR L N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
I++LKE R +L+ +FEY+E N+ ++ E ++RS++ Q+++ + H+N
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 122 FHRDLKPENLLVT-NDVLKIADFGLARELS--SMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+KPENLL++ NDVLK+ DFG AR LS S YTEYV+TRWYR+PE+LL + Y
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL-GAPYGK 180
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG---APDWTAF---PEATNISRL 232
A+DMW+VG IL EL P+FPG+SEIDQL+ + +LG A F P + R
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL-RF 239
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
++++ + L I+ + + +DL+ L +P R +Q L HP F
Sbjct: 240 PAVNHPQSLERRYLGIL-SGVL--LDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 102/286 (35%), Positives = 160/286 (55%), Gaps = 4/286 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+E Y L++LG+GT V+K + T +VA+K+++ + C +REV L+ L H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+ L +++ L +FEY++ +L + S ++ FM Q+L+GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTEYVSTRWYRAPEVLLQSSSYS 177
HRDLKP+NLL+ LK+ADFGLAR S+P Y+ V T WYR P+VLL S+ YS
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
IDMW VG IL E+ T P+FPG + ++L+ + +LG P +P T+ S +
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ L + P + IDL+ L ++ R +A+ AL+H +F
Sbjct: 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 2e-57
Identities = 104/286 (36%), Positives = 165/286 (57%), Gaps = 4/286 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
ME Y LE+LG+GT V+K + T +VA+K+++ + C +REV L+ L H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+ L ++V + L +FEY++ +L M + S ++ F+ Q+L+GLA+ HR
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTEYVSTRWYRAPEVLLQSSSYS 177
HRDLKP+NLL+ LK+ADFGLAR S+P Y+ V T WYR P+VLL SS YS
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
IDMW VG I E+ + P+FPG + D+L+ + +LG P +P ++ + ++
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ P L + P E I+L+ + ++ +R +A++A++H +F
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 1e-56
Identities = 94/290 (32%), Positives = 143/290 (49%), Gaps = 39/290 (13%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHPN 61
+ E LG G+ G VY A + +T E++AVK ++ EE L RE++ L L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 62 IIKLK--EVVRENNELFFIFEYM-EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
I++ E E N L EY+ +L ++ ++ E IR + Q+L+GLA++H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSS--MPPYTE-YVSTRWYRAPEVLLQSS 174
NG HRD+K N+LV +D V+K+ADFG A+ L T T ++ APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y A D+W++G + E+ T P + + + LYK+ P+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE-------------- 224
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+P +LS+ EA D + + DP +RPTAD+ LQHPF
Sbjct: 225 -------IPEHLSE-------EAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 111/294 (37%), Positives = 171/294 (58%), Gaps = 19/294 (6%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL---REVKALRKL-- 57
+Y+ + E+G G G VYKA + + VA+K ++ + E+ + L REV L++L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN--EDGLPLSTVREVALLKRLEA 58
Query: 58 -NHPNIIKLKEV---VRENNE--LFFIFEYMEHNLYHIMRERQIPFSEGE-IRSFMSQML 110
+HPNI++L +V R + E + +FE+++ +L + + P E I+ M Q L
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
+GL +H N HRDLKPEN+LVT+ +K+ADFGLAR S T V T WYRAPEV
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
LLQS+ Y+ +DMW+VG I AE+F P+F G+SE DQL K+ ++G P +P +
Sbjct: 179 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
R ++S P + ++P L+ ++ +++P +R +A +ALQHPFF
Sbjct: 238 PRG---AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-56
Identities = 113/311 (36%), Positives = 164/311 (52%), Gaps = 31/311 (9%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF---YFWEECMNLREVKALRKLN 58
ERY L+++G G G V A + T E VA+KK+ R F F + RE+ L+ +
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA--YRELTLLKHMQ 72
Query: 59 HPNIIKLKEV------VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
H N+I L +V E + + + YM+ +L IM P SE +++ + QML G
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCG 129
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
L ++H G HRDLKP NL V D LKI DFGLAR + T YV TRWYRAPEV+L
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVIL 187
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
Y+ +D+W+VG I+AE+ T +F G +DQL ++ + G P F +
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-PEFVQKLE--D 244
Query: 232 LISISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
+ SY + LP + S + P AS +A+DL+ ++ D +R TA +AL+HP+F+
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD--- 301
Query: 288 WVPYPLHDPLE 298
D E
Sbjct: 302 ----SFRDADE 308
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 5e-56
Identities = 100/286 (34%), Positives = 162/286 (56%), Gaps = 4/286 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+E Y L++LG+GT VYK + T +VA+K+++ + C +REV L+ L H
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
NI+ L +++ L +FEY++ +L + + + ++ F+ Q+L+GL + HR
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTEYVSTRWYRAPEVLLQSSSYS 177
HRDLKP+NLL+ LK+ADFGLAR S+P Y+ V T WYR P++LL S+ YS
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
IDMW VG I E+ T P+FPG + +QL+ + ILG P +P + S +Y
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ L + P + +L+ +L ++ +R +A++A++HP+F
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 7e-55
Identities = 105/315 (33%), Positives = 171/315 (54%), Gaps = 47/315 (14%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLN 58
RY L LG G+ G V+ A + + + VAVKK+ + + LRE+K +R+L+
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI-----VLTDPQSVKHALREIKIIRRLD 60
Query: 59 HPNIIKLKEVV----RENNE----------LFFIFEYMEHNLYHIMRERQIPFSEGEIRS 104
H NI+K+ EV+ + E ++ + EYME +L +++ Q P SE R
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARL 118
Query: 105 FMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPY------T 156
FM Q+L+GL ++H HRDLKP N+ + + VLKI DFGLAR + P Y +
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD--PHYSHKGYLS 176
Query: 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG 216
E + T+WYR+P +LL ++Y+ AIDMWA G I AE+ T P+F G E++Q+ +
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL---- 232
Query: 217 APDWTAFPEATNISRLISISYSEILPIN------LSDIIPNASMEAIDLIWQLCSWDPLR 270
+ + + L+++ S + L D++P + EA+D + Q+ +++P+
Sbjct: 233 --ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290
Query: 271 RPTADQALQHPFFNV 285
R TA++AL HP+ +
Sbjct: 291 RLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 107/300 (35%), Positives = 162/300 (54%), Gaps = 17/300 (5%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHP 60
RY L+ +G G G V A + T + VA+KK+ + F RE+K L+ L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 61 NIIKLKEV-VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NII L ++ + +++F+ E + +L+ ++ R P + I+ F+ Q+L+GL ++H
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA 127
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
G HRDLKP N+L+ N LKI DFGLAR P T YVSTR+YRAPE++L Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP--DWTAFPEATNISRLISIS 236
+D+W+ G I AE+ P+FPG ++Q + +LG P D + N R + S
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ-S 244
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
+ P+ S+ NA AIDL+ ++ +DP +R +A +AL HP+ P HDP
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA-------PYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 8e-53
Identities = 103/309 (33%), Positives = 166/309 (53%), Gaps = 26/309 (8%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF---YFWEECMNLREVKALRKLN 58
+RY+ L+++G G G V A + T VA+KK+ R F F + RE++ L+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMK 72
Query: 59 HPNIIKLKEVVREN------NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
H N+I L +V + ++ + + +M +L +M+ ++ SE I+ + QML+G
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL--SEDRIQFLVYQMLKG 130
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
L ++H G HRDLKP NL V D LKI DFGLAR+ S T YV TRWYRAPEV+L
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVIL 188
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP--DWTAFPEATNI 229
Y+ +D+W+VG I+AE+ T P+F G +DQL ++ + G P ++ ++ +
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289
+ + ++PNA+ A++++ ++ D R TA +AL HP+F
Sbjct: 249 KNYVK-KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE----- 302
Query: 290 PYPLHDPLE 298
HDP +
Sbjct: 303 --EFHDPED 309
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 8e-53
Identities = 106/313 (33%), Positives = 157/313 (50%), Gaps = 43/313 (13%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-------REVKALR 55
RY+ L+ +G G G V A++ T + VA+KK+ R F N+ RE+ ++
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF------QNVTHAKRAYRELVLMK 70
Query: 56 KLNHPNIIKLKEV------VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQM 109
+NH NII L V + E +++ + E M+ NL ++ Q+ + + QM
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQM 127
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
L G+ H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPE
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPD--------W 220
V+L Y +D+W+VG I+ E+ + +FPG IDQ K+ LG P
Sbjct: 188 VIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNAS--------MEAIDLIWQLCSWDPLRRP 272
T N + S+ E+ P + P S +A DL+ ++ DP +R
Sbjct: 247 TVRNYVENRPKYAGYSFEELFP---DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303
Query: 273 TADQALQHPFFNV 285
+ D ALQHP+ NV
Sbjct: 304 SVDDALQHPYINV 316
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 85/288 (29%), Positives = 141/288 (48%), Gaps = 37/288 (12%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHPN 61
+Y+I++++G G+ G VY ++ +K++ +E + L EVK L+KLNHPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMH 117
IIK E E +L + EY + +L ++++ PF E +I + Q+ L ++H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 118 RNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQSSS 175
HRD+KP+N+ +T N ++K+ DFG+++ LSS + V T +Y +PE L Q+
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE-LCQNKP 179
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
Y+ D+W++G +L EL TL F G++ ++ K+
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL----------------------- 216
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ PI S E +L+ L DP RP+ Q LQ PF
Sbjct: 217 -KGQYPPIP-----SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 109/308 (35%), Positives = 168/308 (54%), Gaps = 28/308 (9%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHP 60
ERY+ L +G G G V A++ + VAVKK+ R F RE++ L+ + H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 61 NIIKLKEV------VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N+I L +V + NE++ + M +L +I++ +++ S+ ++ + Q+L+GL
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKL--SDEHVQFLIYQLLRGLK 132
Query: 115 HMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
++H G HRDLKP N+ V D L+I DFGLAR+ T YV+TRWYRAPE++L
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNW 190
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA-TNISRL 232
Y+ +D+W+VG I+AEL +FPG+ IDQL ++ ++G P PE IS
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS----PEVLKKISSE 246
Query: 233 ISISYSEILPI----NLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+ Y + LP +L I A+ AIDL+ ++ D +R +A +AL HP+F
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF----- 301
Query: 289 VPYPLHDP 296
Y HDP
Sbjct: 302 SQY--HDP 307
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 103/291 (35%), Positives = 162/291 (55%), Gaps = 13/291 (4%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHP 60
ERY+ L +G G G V AF+ +T VAVKK+ R F RE++ L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 61 NIIKLKEV------VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N+I L +V + E N+++ + M +L +I++ +++ ++ ++ + Q+L+GL
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLK 134
Query: 115 HMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
++H HRDLKP NL V D LKI DFGLAR T YV+TRWYRAPE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNW 192
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y+ +D+W+VG I+AEL T +FPG IDQL + ++G P + ++ S
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252
Query: 234 SISYSEILP-INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
I +P +N +++ A+ A+DL+ ++ D +R TA QAL H +F
Sbjct: 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 172 bits (435), Expect = 2e-49
Identities = 101/382 (26%), Positives = 158/382 (41%), Gaps = 39/382 (10%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHP- 60
Y+IL +LG+G+ G VY A + + +VA+K + +K E LRE++ L LNHP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 61 NIIKLKEVVRENNELFFIFEYME-HNLYHIMRER--QIPFSEGEIRSFMSQMLQGLAHMH 117
NI+KL + ++ L+ + EY++ +L ++++ + P SE E ++Q+L L ++H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 118 RNGYFHRDLKPENLLVT--NDVLKIADFGLARELSS-------MPPYTEYVSTRWYRAPE 168
G HRD+KPEN+L+ V+K+ DFGLA+ L + V T Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 169 VLLQSS--SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
VLL S S + D+W++G L EL T P F G+ +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---------------- 222
Query: 227 TNISRLISISYSEILPINLSDIIP-NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
++I + L LS P S A DL+ +L + DP R ++ L H
Sbjct: 223 --TLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 286 ETWVPYPLHDPLELRLNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQ 345
L D L+ + + G L + SN
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNG 340
Query: 346 GMQEDILFCSDLKDHSEQTVFW 367
S L +
Sbjct: 341 VSSSPHNSSSLLLSTASSKRSS 362
|
Length = 384 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-49
Identities = 103/286 (36%), Positives = 151/286 (52%), Gaps = 7/286 (2%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
Y LE+LG+G+ VYK + ++VA+K + K +RE L+ L H NI+
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 64 KLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
L +++ L F+FEYM +L M + +R FM Q+L+GLA++H H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 124 RDLKPENLLVTN-DVLKIADFGLARELSSMP--PYTEYVSTRWYRAPEVLLQSSSYSPAI 180
RDLKP+NLL++ LK+ADFGLAR S+P Y+ V T WYR P+VLL ++ YS A+
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 181 DMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
D+W G I E+ P FPG S++ +QL K+ +LG P +P + + +
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLP 245
Query: 240 ILPINLSDIIPNASM--EAIDLIWQLCSWDPLRRPTADQALQHPFF 283
P L + S +A DL Q+ P R +A AL HP+F
Sbjct: 246 CKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 108/296 (36%), Positives = 169/296 (57%), Gaps = 20/296 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETY-EIVAVKKMKRKFYFWEECMNL---REVKALRKL 57
++Y+ + E+G+G G V+KA +++ VA+K+++ + EE M L REV LR L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHL 58
Query: 58 N---HPNIIKLKEVV---RENNE--LFFIFEYMEHNLYHIMRERQIPFSEGE-IRSFMSQ 108
HPN+++L +V R + E L +FE+++ +L + + P E I+ M Q
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAP 167
+L+GL +H + HRDLKP+N+LVT+ +K+ADFGLAR S T V T WYRAP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
EVLLQSS Y+ +D+W+VG I AE+F P+F G S++DQL K+ ++G P +P
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ R + PI + + DL+ + +++P +R +A AL HP+F
Sbjct: 238 ALPR-QAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 4e-48
Identities = 82/281 (29%), Positives = 138/281 (49%), Gaps = 31/281 (11%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
++ILE++G G G VYKA + T + VA+K +K + +E + E++ L+K HPNI+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNIV 60
Query: 64 KLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
K + +EL+ + E+ +L +++ +E +I ++L+GL ++H NG
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 123 HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
HRD+K N+L+T+D +K+ DFGL+ +LS V T ++ APEV+ Y D
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDYKAD 179
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
+W++G EL P + + L+K+ G P L +
Sbjct: 180 IWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPP------------GLRNPEK---- 222
Query: 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
S E D + + +P +RPTA+Q L+HPF
Sbjct: 223 ----------WSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 91/287 (31%), Positives = 145/287 (50%), Gaps = 39/287 (13%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKR---KFYFWEECMNLREVKALRKLNH 59
Y++ + +G G G VYK N+ET + VA+K++ K + M E+ L+ L H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ--EIDLLKNLKH 58
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI+K + ++ L+ I EY E+ +L I+ ++ PF E + ++ Q+LQGLA++H
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYVSTRWYRAPEVLLQSSSY 176
G HRD+K N+L T D V+K+ADFG+A +L+ + V T ++ APEV ++ S
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV-IEMSGA 176
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S A D+W++G + EL T +P + + + L+++ D PE
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV----QDDHPPLPE----------- 221
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S E D + Q DP RPTA Q L+HP+
Sbjct: 222 --------------GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 95/265 (35%), Positives = 145/265 (54%), Gaps = 14/265 (5%)
Query: 30 VAVKKMKRKFYFWEECMN-LREVKALRKLNHPNIIKLKEVVRENN-----ELFFIFEYME 83
VA+KKM F C RE+K L H N++ ++++ + E++ + E M+
Sbjct: 28 VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ 87
Query: 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIAD 142
+L+ I+ Q P S ++ F+ Q+L+GL ++H G HRD+KP NLLV ++ VLKI D
Sbjct: 88 SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146
Query: 143 FGLAR--ELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFP 200
FGLAR E T+ V T++YRAPE+L+ S Y+ A+D+W+VG I AEL +F
Sbjct: 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206
Query: 201 GDSEIDQLYKVCCILGAPDWTAFPEATNISR---LISISYSEILPINLSDIIPNASMEAI 257
S I QL + +LG P A A +R L LP+ L + A+ EA+
Sbjct: 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPV-LYTLSSQATHEAV 265
Query: 258 DLIWQLCSWDPLRRPTADQALQHPF 282
L+ ++ +DP +R +A AL HP+
Sbjct: 266 HLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-44
Identities = 91/283 (32%), Positives = 134/283 (47%), Gaps = 42/283 (14%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKE 67
LG G+ G V +T ++ A+K +K+K E L E L ++NHP I+KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
+ +L+ + EY H+ +E + FSE R + ++++ L ++H G +RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 126 LKPENLLVTND-VLKIADFGLARELSSMPPYT-EYVSTRWYRAPEVLLQSSSYSPAIDMW 183
LKPEN+L+ D +K+ DFGLA+ELSS T + T Y APEV L Y A+D W
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV-LLGKGYGKAVDWW 177
Query: 184 AVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPI 243
++G +L E+ T P F + ++Y+ IL P FPE
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDR-KEIYEK--ILKDPL--RFPE------------------ 214
Query: 244 NLSDIIPNASMEAIDLIWQLCSWDPLRRPT---ADQALQHPFF 283
S EA DLI L DP +R A++ HPFF
Sbjct: 215 -------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 106/319 (33%), Positives = 165/319 (51%), Gaps = 31/319 (9%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
++RY+ L+ +G G G V A++ VA+KK+ R F RE+ ++ +NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 60 PNIIKL------KEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
NII L ++ + E +++ + E M+ NL ++ Q+ + + QML G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPEV+L
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 191
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP--------DWTAFP 224
Y +D+W+VG I+ E+ +FPG IDQ KV LG P T
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 225 EATNISRLISISYSEILPINL----SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
N + +++ ++ P +L S+ + +A DL+ ++ DP +R + D+ALQH
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311
Query: 281 PFFNVETWVPYPLHDPLEL 299
P+ NV W +DP E+
Sbjct: 312 PYINV--W-----YDPAEV 323
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 3e-43
Identities = 98/289 (33%), Positives = 154/289 (53%), Gaps = 7/289 (2%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ Y+ LE+LG+G+ VYK + ++VA+K ++ + +RE L+ L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
I+ L +++ L +FEY+ +L M + ++ F+ Q+L+GL+++H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 122 FHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTEYVSTRWYRAPEVLLQSSSYSP 178
HRDLKP+NLL+++ LK+ADFGLAR S+P Y+ V T WYR P+VLL S+ YS
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLISISY 237
+DMW VG I E+ FPG +I DQL ++ +LG P+ +P ++ +
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243
Query: 238 SEILPINLSDIIPNASM--EAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ P NL S A DL +L P R +A AL H +F+
Sbjct: 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 112/321 (34%), Positives = 161/321 (50%), Gaps = 37/321 (11%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
++RY+ L+ +G G G V AF+ VAVKK+ R F RE+ L+ +NH
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 60 PNIIKL------KEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
NII L ++ + E +++ + E M+ NL ++ + + + QML G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 136
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPEV+L
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL- 195
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDW--------TAFP 224
Y +D+W+VG I+ EL S IF G IDQ KV LG P T
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255
Query: 225 EATNISRLISISYSEILPINLSDIIPNAS-------MEAIDLIWQLCSWDPLRRPTADQA 277
N + IS+ E+ P I P+ S +A DL+ ++ DP +R + D+A
Sbjct: 256 YVENRPQYPGISFEELFP---DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 278 LQHPFFNVETWVPYPLHDPLE 298
L+HP+ V W +DP E
Sbjct: 313 LRHPYITV--W-----YDPAE 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 5e-43
Identities = 105/315 (33%), Positives = 170/315 (53%), Gaps = 45/315 (14%)
Query: 9 ELGDGTCGCVYKAFNVETYEI--VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
++G GT G VYKA + + A+K+++ C RE+ LR+L HPN+I L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQ 64
Query: 67 EVV--RENNELFFIFEYMEHNLYHIMR--------ERQIPFSEGEIRSFMSQMLQGLAHM 116
+V + +++ +F+Y EH+L+HI++ ++ + G ++S + Q+L G+ ++
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 117 HRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS-MPPYTEY---VSTRWYRAP 167
H N HRDLKP N+LV + +KIAD G AR +S + P + V T WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---------DQLYKVCCILGAP 218
E+LL + Y+ AID+WA+G I AEL T PIF E DQL ++ ++G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 219 ---DW---TAFPEATNI----SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDP 268
DW PE + + R + S I + + P++ +A L+ +L + DP
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS--KAFHLLQKLLTMDP 302
Query: 269 LRRPTADQALQHPFF 283
++R T++QA+Q P+F
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 6e-43
Identities = 108/322 (33%), Positives = 160/322 (49%), Gaps = 39/322 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
++RY+ L+ +G G G V A++ VA+KK+ R F RE+ ++ +NH
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60 PNIIKLKEV------VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
NII L V + E +++ + E M+ NL ++ Q+ + + QML G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 139
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPEV+L
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 198
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP--------DWTAFP 224
Y +D+W+VG I+ E+ +FPG IDQ KV LG P T
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258
Query: 225 EATNISRLISISYSEILPINLSDIIPNASME--------AIDLIWQLCSWDPLRRPTADQ 276
N + S+ ++ P D++ A E A DL+ ++ D +R + D+
Sbjct: 259 YVENRPKYAGYSFEKLFP----DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 277 ALQHPFFNVETWVPYPLHDPLE 298
ALQHP+ NV W +DP E
Sbjct: 315 ALQHPYINV--W-----YDPSE 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 95/297 (31%), Positives = 162/297 (54%), Gaps = 25/297 (8%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
YK+ +G+G+ G VY+A ++T E VA+KK+ + + RE+ ++ LNH NII
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNLNHINII 122
Query: 64 KLK-----EVVRENNELFF---IFEYMEHNLYHIMR-----ERQIPFSEGEIRSFMSQML 110
LK E ++N + F + E++ ++ M+ +P ++ S+ Q+
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY--QLC 180
Query: 111 QGLAHMHRNGYFHRDLKPENLLV--TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
+ LA++H HRDLKP+NLL+ LK+ DFG A+ L + Y+ +R+YRAPE
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
++L +++Y+ ID+W++G I+AE+ PIF G S +DQL ++ +LG P E
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN- 299
Query: 229 ISRLISISYSEILPINLSDIIPNASM-EAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
I + ++ P +L + P + +AI+ I Q ++PL+R +AL PFF+
Sbjct: 300 -PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355
|
Length = 440 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 8e-42
Identities = 84/310 (27%), Positives = 134/310 (43%), Gaps = 62/310 (20%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN-HP 60
+K + +G+G+ V A ET + A+K + ++ E+ + E + L +LN HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
IIKL ++ L+F+ EY + L +R+ E R + +++L L ++H
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYLHSK 121
Query: 120 GYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTE--------------------- 157
G HRDLKPEN+L+ D+ +KI DFG A+ L
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA 217
+V T Y +PE+L + + + D+WA+G I+ ++ T P F G +E Y
Sbjct: 182 FVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNE----YLT------ 230
Query: 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA--- 274
+ +IL + S PN +A DLI +L DP R
Sbjct: 231 -------------------FQKILKLEYS-FPPNFPPDAKDLIEKLLVLDPQDRLGVNEG 270
Query: 275 -DQALQHPFF 283
D+ HPFF
Sbjct: 271 YDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 1e-40
Identities = 104/315 (33%), Positives = 166/315 (52%), Gaps = 45/315 (14%)
Query: 9 ELGDGTCGCVYKAFNVETYEI--VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
++G GT G VYKA + + A+K+++ C RE+ LR+L HPN+I L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHPNVIALQ 64
Query: 67 EVV--RENNELFFIFEYMEHNLYHIMR--------ERQIPFSEGEIRSFMSQMLQGLAHM 116
+V + +++ +F+Y EH+L+HI++ ++ + ++S + Q+L G+ ++
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 117 HRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS-MPPYTEY---VSTRWYRAP 167
H N HRDLKP N+LV + +KIAD G AR +S + P + V T WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---------DQLYKVCCILGAP 218
E+LL + Y+ AID+WA+G I AEL T PIF E DQL ++ ++G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 219 ---DWT---AFPE----ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDP 268
DW PE + R + S I + + P++ + L+ +L + DP
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS--KVFLLLQKLLTMDP 302
Query: 269 LRRPTADQALQHPFF 283
+R T++QALQ P+F
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 5 KILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMN------LREVKAL 54
+ ++LG+G G VYK + VAVK +K E+ LRE + +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK------EDASEQQIEEFLREARIM 55
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
RKL+HPN++KL V E L+ + EYME +L +R+ + S ++ SF Q+ +G+
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST------RWYRA 166
++ + HRDL N LV + V+KI+DFGL+R+L Y RW A
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKLPIRWM-A 171
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTL 195
PE L+ ++ D+W+ G +L E+FTL
Sbjct: 172 PES-LKEGKFTSKSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 86/286 (30%), Positives = 138/286 (48%), Gaps = 35/286 (12%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK--RKFYFWEECMNL--REVKALRKLN 58
R++ E LG G+ G VY+ N++ + AVK++ +E + +E+ L KL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HPNI++ RE + L+ E + + ++ F E IR + Q+L GL ++H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+K N+LV TN V+K+ADFG+A+++ + + ++ APEV+ Q Y
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
A D+W++G + E+ T G P W+ ++ + I
Sbjct: 181 LAADIWSLGCTVLEMAT---------------------GKPPWSQL---EGVAAVFKIGR 216
Query: 238 SEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
S+ LP IP+ S EA D I + DP RPTA + L+HPF
Sbjct: 217 SKELP-----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-39
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 5 KILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMN------LREVKAL 54
++ ++LG+G G VYK T VAVK +K E L E +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK------EGASEEEREEFLEEASIM 55
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+KL+HPNI++L V + L+ + EYM +L +R+ + ++ Q+ +G+
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT----EYVSTRWYRAPE 168
++ + HRDL N LVT + V+KI+DFGL+R++ Y + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
L+ ++ D+W+ G +L E+FTL
Sbjct: 175 S-LKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 5 KILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMN------LREVKAL 54
+ ++LG+G G VYK VAVK +K E+ LRE + +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK------EDASEQQIEEFLREARIM 55
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQG 112
RKL+HPNI+KL V E L + EYM +L +R+ + S ++ SF Q+ +G
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST------RWYR 165
+ ++ + HRDL N LV + V+KI+DFGL+R+L Y RW
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYKVKGGKLPIRWM- 171
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTL 195
APE L+ ++ D+W+ G +L E+FTL
Sbjct: 172 APES-LKEGKFTSKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 89/306 (29%), Positives = 134/306 (43%), Gaps = 70/306 (22%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVK-----KMKRKFYFWEECMNLREVKALRKLN 58
Y++LE +G G+ G V K +I+ K M K E+ + EV LR+L
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK----EKQQLVSEVNILRELK 57
Query: 59 HPNIIKL--KEVVRENNELFFIFEYMEH-----NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
HPNI++ + + R N L+ + EY E + +ER+ E I ++Q+L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-YIEEEFIWRILTQLLL 116
Query: 112 GLAHMHRNGY-----FHRDLKPENL-LVTNDVLKIADFGLAREL--SSMPPYTEYVSTRW 163
L H HRDLKP N+ L N+ +K+ DFGLA+ L S T YV T +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPY 175
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
Y +PE L SY D+W++G ++ EL LSP F
Sbjct: 176 YMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPF------------------------ 210
Query: 224 PEATNISRLIS-ISYSEILPI------NLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ 276
A N +L S I + I L+++I SM +++ DP +RP+ ++
Sbjct: 211 -TARNQLQLASKIKEGKFRRIPYRYSSELNEVI--KSM--LNV-------DPDKRPSTEE 258
Query: 277 ALQHPF 282
LQ P
Sbjct: 259 LLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 85/290 (29%), Positives = 140/290 (48%), Gaps = 41/290 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL--REVKALRKLNH 59
E YK LE++G+G G VYKA + T + VA+KKM+ ++ L E+ ++ H
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKH 74
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI+ + +EL+ + EYM+ L I+ + + +E +I ++LQGL ++H
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSY 176
HRD+K +N+L++ D +K+ADFG A +L+ V T ++ APEV+ Y
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK-RKDY 193
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP--EATNISRLIS 234
P +D+W++G + E+ G P + P A L
Sbjct: 194 GPKVDIWSLGIMCIEM---------------------AEGEPPYLREPPLRA-----LFL 227
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
I+ I P+ + S E D + + DP +RP+A++ LQHPF
Sbjct: 228 ITTKGIPPLKNPE---KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 37/285 (12%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHPN 61
+K+L++LG G+ G VYK + + A+K++ +E + + E++ L +NHPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 62 IIKLKEVVRENNELFFIFEYME-HNLYHIMRERQI---PFSEGEIRSFMSQMLQGLAHMH 117
II KE + N+L + EY +L + +R+ E EI Q+L+GL +H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 118 RNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
HRDLK N LLV ND++KI D G+++ L T+ + T Y APEV + Y
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEV-WKGRPY 178
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S D+W++G +L E+ T +P F S D YKV +P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-------GKYPP----------- 220
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
I P S + + I + P RP D+ L P
Sbjct: 221 -----------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-36
Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLNHP 60
+ ++ LG G+ G VYK + T +I A+KK + + LRE+K LR P
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKK----IHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
++K + E+ + EYM+ + ++ E + Q+L+GL ++H
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 121 Y-FHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYS 177
+ HRD+KP NLL+ + +KIADFG+++ L ++ +V T Y +PE +Q SYS
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178
Query: 178 PAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
A D+W++G L E P P G P + + +I
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLP--------------PGQPSF--------FELMQAIC 216
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLC-SWDPLRRPTADQALQHPF 282
P +L S E D I C DP +RP+A + LQHPF
Sbjct: 217 DGP--PPSLPAEE--FSPEFRDFI-SACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-35
Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 38/289 (13%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR---------EVKALRKLN 58
E +G GT G VY A NV T E++AVK+++ + + E++ L+ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
H NI++ L EY+ F E +R F Q+L+GLA++H
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR---WYRAPEVL-LQS 173
G HRDLK +NLLV D + KI+DFG++++ + + +S + ++ APEV+ S
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
YS +D+W++G ++ E+F + + I ++K+ AP
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP--------------- 231
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
PI D+ N S A+D + + +P RPTA + LQHPF
Sbjct: 232 --------PIP-PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 89/293 (30%), Positives = 140/293 (47%), Gaps = 45/293 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL----REVKALRKL 57
E Y++++ +G GT G VYKA ++ T E+VA+K +K E + +E+ L++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-----LEPGDDFEIIQQEISMLKEC 57
Query: 58 NHPNIIKLKEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
HPNI+ ++L+ + EY ++Y + R P SE +I + L+GL
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGL 114
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLL 171
A++H G HRD+K N+L+T D +K+ADFG++ +L+ ++ ++ T ++ APEV
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 172 QSSS--YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
Y D+WA+G EL L P P + P +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQP--------------------PMFDLHP----M 210
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
L IS S P L D S D I + + DP +RPTA + LQHPF
Sbjct: 211 RALFLISKSNFPPPKLKD-KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 47/295 (15%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-----REVKALRKL 57
R++ ++G GT G VY A N++T E++AVK+++ + E+K L L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR----IQDNDPKTIKEIADEMKVLELL 56
Query: 58 NHPNIIKLKEVVRENNELFFIFEY-MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
HPN++K V +++ EY L ++ +I E IR + Q+L+GLA++
Sbjct: 57 KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYL 115
Query: 117 HRNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSS----MPPYTE-YVSTRWYRAPEVL 170
H +G HRD+KP N L N V+K+ DFG A +L + M + T Y APEV+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 171 L--QSSSYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEAT 227
+ + A D+W++G ++ E+ T + D+E ++ V G P+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--AGHK--PPIPD-- 229
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ LS E D + + DP +RPTA + LQHPF
Sbjct: 230 --------------SLQLSP-------EGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 8 EELGDGTCGCVYKAF---NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64
++LG+G G VYK VAVK +K E L+E + ++KL HPN+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 65 LKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSF-MSQMLQ-------GLAH 115
L V E L+ + EYME +L +R+ + F E + + +L G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE----YVSTRWYRAPEVL 170
+ + HRDL N LV D V+KI+DFGL+R++ Y + + RW APE
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APES- 178
Query: 171 LQSSSYSPAIDMWAVGAILAELFTL 195
L+ ++ D+W+ G +L E+FTL
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 83/297 (27%), Positives = 139/297 (46%), Gaps = 58/297 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHP 60
E + ILE+LG+G+ G VYKA + ET ++VA+K + + E+ + +E+ L++ + P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 61 NIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I+K +N +L+ + EY + IM+ +E EI + + Q L+GL ++H N
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+K N+L+ + K+ADFG++ +L+ +M + T ++ APEV+ + Y+
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYN 177
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
D+W++G E+ P Y
Sbjct: 178 NKADIWSLGITAIEMAEGKP--------------------------------------PY 199
Query: 238 SEILPINLSDIIPNA-----------SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S+I P+ +IPN S E D + + DP RP+A Q LQHPF
Sbjct: 200 SDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 46/292 (15%)
Query: 13 GTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPNIIKLKEVVR 70
G G V+ A T +I A+K +K+ + ++ L E L + P ++KL +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 71 ENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPE 129
L+ + EY+ +L ++ E R ++++++ L ++H NG HRDLKP+
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPD 122
Query: 130 NLLVTND-VLKIADFGLAR----ELSSMPPYTEY-----VSTRWYRAPEVLLQSSSYSPA 179
N+L+ ++ LK+ DFGL++ E V T Y APEV+L +S
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL-GQGHSKT 181
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
+D W++G IL E P F G++ + + G +W PE
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEW---PE-------------- 222
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA---DQALQHPFFNVETW 288
S EAIDLI +L DP +R A ++ HPFF W
Sbjct: 223 ---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC---MN--LREVKALRKLN 58
Y+++E +G G VY A + E VA+K++ E+C ++ +EV+A+ + N
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRID-----LEKCQTSVDELRKEVQAMSQCN 57
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP---FSEGEIRSFMSQMLQGLA 114
HPN++K +EL+ + Y+ +L IM+ P E I + + ++L+GL
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL-----SSMPPYTEYVSTRWYRAPE 168
++H NG HRD+K N+L+ D +KIADFG++ L + +V T + APE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
V+ Q Y D+W+ G EL T GA ++ +P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELAT---------------------GAAPYSKYPPMKV 215
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ + + L + S +I DP +RPTA++ L+H FF
Sbjct: 216 LMLTLQ-NDPPSLETGADYKKYSKSFR--KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 73/239 (30%), Positives = 114/239 (47%), Gaps = 34/239 (14%)
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYH-IMRERQIPFSEGEIRSF 105
L E+ L L HPNII ++N L EY LY I+R++ F E + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE-YVSTRW 163
+ Q++ ++++H+ G HRD+K N+ +T ++K+ DFG+++ L S E V T +
Sbjct: 107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
Y +PE L Q Y+ D+WA+G +L EL TL F
Sbjct: 167 YMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF------------------------ 201
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ATN L+ +I+ N + ++ S E I L+ L DP +RPTAD+ L P
Sbjct: 202 -DATNPLNLV----VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 78/289 (26%), Positives = 121/289 (41%), Gaps = 39/289 (13%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPNIIKLKE 67
LG G G V A+K +K++ E + L + NHP I+KL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 68 VVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL 126
++ ++ + EY L+ I+R+R + F E R +++ ++ ++H G +RDL
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 127 KPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAV 185
KPENLL+ +N +K+ DFG A++L S + T Y APE++L Y ++D W++
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSL 178
Query: 186 GAILAELFTLSPIFPGDSEIDQLYKVC-CILGAPDWTAFPEATNISRLISISYSEILPIN 244
G +L EL T P F D E ++ IL FP
Sbjct: 179 GILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFP-------------------- 216
Query: 245 LSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNVETW 288
A DLI QL +P R +H +FN W
Sbjct: 217 -----NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-31
Identities = 89/287 (31%), Positives = 141/287 (49%), Gaps = 36/287 (12%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKLNHPN 61
RY+I++++G+G+ G +Y A E +K++ K E+ + +EV L K+ HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 62 IIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I+ +EN LF + EY + + I R+R + FSE +I S+ Q+ GL H+H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 120 GYFHRDLKPENLLVTND--VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSY 176
HRD+K +N+ ++ + V K+ DFG+AR+L+ SM V T +Y +PE+ Q+ Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNRPY 179
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
+ D+W++G +L EL TL F G++ + K+C AP
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP------------------ 221
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
I PN S + LI QL P RP+ L+ PF
Sbjct: 222 -----------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM----KRKFYFWEECMNLREVKALRKL 57
+ + L E+G G+ G VY A +V T E+VA+KKM K+ W++ ++EV+ L++L
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI--IKEVRFLQQL 72
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
HPN I+ K + + + EY + I+ + P E EI + LQGLA++H
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL--QSS 174
+ HRD+K N+L+T +K+ADFG A S + P +V T ++ APEV+L
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y +D+W++G EL P + + LY + A N S +S
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------------AQNDSPTLS 235
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ SD + + P RP++++ L+H F
Sbjct: 236 -------SNDWSD-------YFRNFVDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 71/222 (31%), Positives = 115/222 (51%), Gaps = 21/222 (9%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKK------MKRKFYFWEECMNLREVKALRKL 57
+KI +++G G VYKA + +VA+KK M K ++C L+E+ L++L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR--QDC--LKEIDLLKQL 59
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIM---RERQIPFSEGEIRSFMSQMLQGL 113
+HPN+IK ENNEL + E + +L ++ ++++ E I + Q+ L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 114 AHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSS--MPPYTEYVSTRWYRAPEVL 170
HMH HRD+KP N+ +T V+K+ D GL R SS ++ V T +Y +PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPER- 177
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVC 212
+ + Y+ D+W++G +L E+ L F GD LY +C
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLC 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 80/291 (27%), Positives = 137/291 (47%), Gaps = 50/291 (17%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKM----------KRKFYFWEECMNLREVKALRKLNH 59
+G G+ G VY N + E++AVK++ RK + RE+ L++L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQH 65
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI++ + + L EY+ + F E +R+F+ Q+L+GL ++H
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR-------WYRAPEVLL 171
G HRD+K N+LV N +KI+DFG++++L + T+ R ++ APEV+
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
Q +SY+ D+W++G ++ E+ T FP +++ ++K+
Sbjct: 186 Q-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG------------------- 225
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
P +I N S EAID + + D +RPTA + L+HPF
Sbjct: 226 ------ENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 88/295 (29%), Positives = 143/295 (48%), Gaps = 39/295 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
+ ++I+ ELGDG G VYKA + ET A K ++ + EE + + E+ L + H
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKH 61
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI+ L E N+L+ + E+ + L IM E + +E +IR QML+ L +H
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGL-ARELSSMPPYTEYVSTRWYRAPEVLL----Q 172
+ HRDLK N+L+T D +K+ADFG+ A+ S++ ++ T ++ APEV+ +
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
+ Y D+W++G L EL + P + + L K IL + P +
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK---ILKSE-----PPTLDQPSK 233
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
S S+++ L L DP RPTA + L+HPF + ++
Sbjct: 234 WSSSFNDFLKSCLVK-------------------DPDDRPTAAELLKHPFVSDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 81/289 (28%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVK-----KMKRKFYFWEECMNLREVKALRKL 57
+Y+ + +G G G V+ ++V +K +M + E E + L+ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD----ERLAAQNECQVLKLL 56
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLY--HIMRERQIPFSEGEIRSFMSQMLQGLAH 115
+HPNII+ E E+ L + EY +I + E I F Q+L L H
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 116 MHRNGYFHRDLKPENLLVT--NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
+H HRDLK +N+L+ V+KI DFG+++ LSS V T Y +PE L +
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEG 175
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y+ D+WA+G +L EL +L F EA N+ L+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAF-------------------------EAANLPALV 210
Query: 234 -SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
I PI SD S + LI + + DP +RP Q + P
Sbjct: 211 LKIMSGTFAPI--SD---RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 72/212 (33%), Positives = 111/212 (52%), Gaps = 12/212 (5%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKM----KRKFYFWEECMNLREVKALRKLNHPNI 62
L E+G G+ G VY A N T E+VAVKKM K+ W++ ++EVK L++L HPN
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI--IKEVKFLQQLKHPNT 83
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
I+ K + + + + EY + ++ + P E EI + LQGLA++H +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 123 HRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL--QSSSYSPA 179
HRD+K N+L+T +K+ADFG A S P +V T ++ APEV+L Y
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSA---SKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
+D+W++G EL P + + LY +
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 58/296 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-----------RE 50
E + +LE +G G+ G VYKA + T ++VA+K ++L +E
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----------VIDLEEAEDEIEDIQQE 49
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQM 109
++ L + P I K + ++L+ I EY + +++ E I + ++
Sbjct: 50 IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREV 107
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSS-MPPYTEYVSTRWYRA 166
L GL ++H G HRD+K N+L++ DV K+ADFG++ +L+S M +V T ++ A
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDV-KLADFGVSGQLTSTMSKRNTFVGTPFWMA 166
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
PEV+ Q S Y D+W++G EL P S++ + +V
Sbjct: 167 PEVIKQ-SGYDEKADIWSLGITAIELAKGEPPL---SDLHPM-RV--------------- 206
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
L I + + + S D + + DP RP+A + L+H F
Sbjct: 207 -----LFLIPKNNPPSLEGNKF----SKPFKDFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 85/289 (29%), Positives = 132/289 (45%), Gaps = 47/289 (16%)
Query: 4 YKILEELGDGTCGCVYKAF---NVETYEI--VAVKKMKRKFYFWEECMNLREVKALRKLN 58
++IL ++G G+ G V+K + Y + + + KM R+ EE + E + L KL+
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER--EEA--IDEARVLAKLD 57
Query: 59 HPNIIKLKEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
II+ E + +L + EY E H L + R R P E ++ F Q+L GLA
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR--PLPEDQVWRFFIQILLGLA 115
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQ 172
H+H HRD+K NL + D +KI D G+A+ LS + V T +Y +PE L +
Sbjct: 116 HLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCE 174
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
Y+ D+WA+G +L E T F +++ + K+ I G FP
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRG-----VFPP------- 220
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
+S YS+ L LI Q + D +RP Q L++P
Sbjct: 221 VSQMYSQQL---------------AQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 61/299 (20%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-------------LRE 50
+++L +G G G V V+K K F + MN L E
Sbjct: 2 FELLRVIGKGAFGKVCI-----------VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNE 50
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NL-YHIMRERQIPFSEGEIRSFMSQ 108
+ L++LNHP ++ L ++ ++ + + + +L YH+ +++ FSE +++ ++ +
Sbjct: 51 RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE 108
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAP 167
++ L ++H G HRD+KP+N+L+ + I DF +A +++ T T Y AP
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 168 EVLLQSSSYSPAIDMWAVGAILAE-LFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
EV L YS A+D W++G E L P + G
Sbjct: 169 EV-LCRQGYSVAVDWWSLGVTAYECLRGKRP-YRG------------------------- 201
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR--PTADQALQHPFF 283
SR I S EAID I +L DP +R HP+F
Sbjct: 202 --HSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 49/292 (16%)
Query: 3 RYKILEELGDGTCGCVYKAFNV------ETYEI--VAVKKMKRKFYFWEECMNLREVKAL 54
+Y ++++G+G+ G KA V + Y I + + KM K E + +EV L
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPK----EREESRKEVAVL 53
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYH-IMRERQIPFSEGEIRSFMSQMLQG 112
+ HPNI++ +E EN L+ + +Y E +LY I +R + F E +I + Q+
Sbjct: 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVL 170
L H+H HRD+K +N+ +T D +K+ DFG+AR L S++ + T +Y +PE+
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI- 172
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
++ Y+ D+WA+G +L E+ TL F EA N+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAF-------------------------EAGNMK 207
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
L+ +I+ + + + S + +L+ QL +P RP+ + L+ F
Sbjct: 208 NLV----LKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 83/287 (28%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
L ELG G G V K + T +I+AVK ++ + + LRE+ L K N P I+
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 67 EVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMS-QMLQGLAHMHRN-GYFH 123
N ++ EYM+ +L I++E Q E I ++ +L+GL ++H H
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 124 RDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDM 182
RD+KP N+LV + +K+ DFG++ +L + T +V T Y APE +Q + YS D+
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDI 182
Query: 183 WAVGAILAELFTL-----SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
W++G L EL T P D + L I+ P RL S +
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQ---YIVNEPP----------PRLPSGKF 229
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
S + D + DP RP+ + L+HPF
Sbjct: 230 SP---------------DFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 82/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKM----KRKFYFWEECMNLREVKALRKLNHPNI 62
L E+G G+ G VY A +V E+VA+KKM K+ W++ ++EV+ L+KL HPN
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI--IKEVRFLQKLRHPNT 77
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
I+ + + + + EY + ++ + P E EI + LQGLA++H +
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 123 HRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL--QSSSYSPA 179
HRD+K N+L++ ++K+ DFG A S M P +V T ++ APEV+L Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
+D+W++G EL P + + LY + A N S + +
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHI--------------AQNESPALQSGHWS 240
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
N D + ++ I P RPT++ L+H F E
Sbjct: 241 EYFRNFVD----SCLQKI----------PQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 77/291 (26%), Positives = 136/291 (46%), Gaps = 44/291 (15%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVKKMK----RKFYFWEECMNLR-EVKALRKLNHPNI 62
++LG G Y+A +V+T ++AVK++ E LR E++ + +LNHP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
I++ E++ E+M + + F E I ++ Q+L+GL+++H N
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 123 HRDLKPENLLV--TNDVLKIADFGLARELSSMPPYT-----EYVSTRWYRAPEVLLQSSS 175
HRD+K NLL+ T L+IADFG A L++ + + T + APEVL +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL-RGEQ 184
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQL---YKVCCILGAPDWTAFPEATNISRL 232
Y + D+W+VG ++ E+ T P + + + L +K+ AP
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS------------- 231
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+P +LS + + ++ ++L P RP + + L+HP F
Sbjct: 232 --------IPEHLSPGLRDVTLRCLEL-------QPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 46/293 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK----RKFYFWEECMNLREVKALRKL 57
E +++++ +G GT G VYKA NV T E+ A+K +K F ++ E+ ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ-----EIIMMKDC 63
Query: 58 NHPNIIKLKEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
H NI+ ++L+ E+ ++YH+ P SE +I + LQGL
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGL 119
Query: 114 AHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEV-- 169
++H G HRD+K N+L+T N +K+ADFG++ +++ ++ ++ T ++ APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+ + Y+ D+WAVG EL L P P + P +
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQP--------------------PMFDLHP----M 215
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
L ++ S P L D + S + + +P +RPTA++ LQHPF
Sbjct: 216 RALFLMTKSNFQPPKLKDKM-KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 12/212 (5%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKM----KRKFYFWEECMNLREVKALRKLNHPNI 62
L E+G G+ G VY A +V T E+VA+KKM K+ W++ ++EVK L+++ HPN
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI--IKEVKFLQRIKHPNS 87
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
I+ K + + + EY + ++ + P E EI + LQGLA++H +
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 123 HRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL--QSSSYSPA 179
HRD+K N+L+T +K+ADFG A S P +V T ++ APEV+L Y
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSA---SIASPANSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
+D+W++G EL P + + LY +
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPN 61
++IL ++G G G V+ A +T EIVA+K+MK+ F + L E L
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
++KL +++ L+ EY+ + + SE R +M++M + + +H GY
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 122 FHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
HRDLKPEN L+ +K+ DFGL++ + + V + Y APEV L+ Y +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA--NSVVGSPDYMAPEV-LRGKGYDFTV 179
Query: 181 DMWAVGAILAELFTLSPIFPGDSEID---QLYKVCCILGAPDWTAFPEATNISRLISISY 237
D W++G +L E P F G + + L L P + P
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRF----------- 227
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
NLSD EA DLI +L + R + + HPFF W
Sbjct: 228 ------NLSD-------EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR-EVKALRKL-NH 59
++++E +G+GT G VYKA + +T ++VA+K M +E ++ E LRK NH
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSNH 62
Query: 60 PNIIKLKEVVRENN------ELFFIFEYMEH----NLYHIMRERQIPFSEGEIRSFMSQM 109
PNI + N +L+ + E +L +R++ E I + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLAREL-SSMPPYTEYVSTRWYRAP 167
L+GLA++H N HRD+K +N+L+T + +K+ DFG++ +L S++ ++ T ++ AP
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 168 EVLLQSS----SYSPAIDMWAVG--AI-LAE 191
EV+ SY D+W++G AI LA+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELAD 213
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 43/284 (15%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK-LNHPNIIKLKEV 68
LG GT G VY A ++ T +A+K++ + L E AL L H NI++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 69 VRENNELFFIFEYMEH----NLYHIMRERQIPFSEGE--IRSFMSQMLQGLAHMHRNGYF 122
EN F +ME +L ++R + P + E I + Q+L+GL ++H N
Sbjct: 74 DSENG---FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 123 HRDLKPENLLVT--NDVLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQS-SSYSP 178
HRD+K +N+LV + V+KI+DFG ++ L+ + P TE + T Y APEV+ + Y
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
D+W++G + E+ T P F LG P F +
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIE-------------LGEPQAAMF----------KVGMF 227
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+I P +I + S EA + I + DP +R +A LQ PF
Sbjct: 228 KIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 18/198 (9%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLNHPNI 62
L+ELG G G V+ + VA+K ++ E M+ + E K + KL+HPN+
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIR------EGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 63 IKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
++L V + +F + EYM + L + +RER+ + S + + + ++ NG+
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 122 FHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRW---YRAPEVLLQSSSYS 177
HRDL N LV D V+K++DFGLAR + YT T++ + PEV S +S
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDY-SRFS 179
Query: 178 PAIDMWAVGAILAELFTL 195
D+W+ G ++ E+F+
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 5 KILEELGDGTCGCVYKA---FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
I + +G G G V + + VA+K +K + L E + + +HPN
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLA----HM 116
II+L+ VV ++ + I EYME+ +L +RE F+ G++ ML+G+A ++
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL----VGMLRGIASGMKYL 122
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEY---VSTRWYRAPEVLL 171
Y HRDL N+LV ++ V K++DFGL+R L S YT + RW APE +
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEA-I 180
Query: 172 QSSSYSPAIDMWAVGAILAELFT 194
++ A D+W+ G ++ E+ +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 18/213 (8%)
Query: 4 YKILEELGDGTCGCVYKA-FNVETYEIVAVKKM--------KRKFYFWEECMNL-REVKA 53
Y +LE LG G GCVYK ++A+K++ K K + ++ EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 54 LRK-LNHPNIIKLKEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQ 108
+++ L HPNI++ + EN+ L+ + + +E ++ ++E++ F+E I + Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 109 MLQGLAHMHRNGYF-HRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRA 166
M+ L ++H+ HRDL P N +L +D + I DFGLA++ T V T Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIF 199
PE++ ++ Y D+WA G IL ++ TL P F
Sbjct: 182 PEIV-KNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 89/291 (30%), Positives = 140/291 (48%), Gaps = 41/291 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
E ++I+ ELGDG G VYKA N ET + A K ++ K EE + + E++ L NH
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNH 68
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
P I+KL + +L+ + E+ IM E +E +I+ QML+ L ++H
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGL-ARELSSMPPYTEYVSTRWYRAPEVLL----Q 172
HRDLK N+L+T D +K+ADFG+ A+ + ++ ++ T ++ APEV++ +
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
+ Y D+W++G L E+ + P E + L
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP------------------------PHHELNPMRVL 224
Query: 233 ISISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ I+ SE P LS P+ SME D + P RP+A Q L+HPF
Sbjct: 225 LKIAKSE--PPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 75/305 (24%), Positives = 129/305 (42%), Gaps = 75/305 (24%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKALR 55
++ ++ LG G+ G V + + + A+K K+K+ E +N E + L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV----EHVLN--EKRILQ 56
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
+ HP ++ L ++++ L+ + EY+ L+ +R+ F E R + +Q++ L
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALE 115
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR-W-------YR 165
++H +RDLKPENLL+ +D +KI DFG A+ V R + Y
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYL 165
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK--VCCILGAPDWTAF 223
APE+ + S Y A+D WA+G ++ E+ P F D Q+Y+ + + F
Sbjct: 166 APEI-ILSKGYGKAVDWWALGILIYEMLAGYPPF-FDDNPIQIYEKILEGKV------RF 217
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQAL 278
P S +A DLI L D +R +
Sbjct: 218 P-------------------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252
Query: 279 QHPFF 283
HP+F
Sbjct: 253 NHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 90/298 (30%), Positives = 137/298 (45%), Gaps = 39/298 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
E ++I+ ELGDG G VYKA N ET + A K + K EE + + E+ L +H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 61
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI+KL + N L+ + E+ +M E + P +E +IR Q L+ L ++H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGL-ARELSSMPPYTEYVSTRWYRAPEVLLQSSS- 175
N HRDLK N+L T D +K+ADFG+ A+ ++ ++ T ++ APEV++ +S
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 176 ---YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
Y D+W++G L E+ + P + + L K+ P A P SR
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA--KSEPPTLAQP-----SRW 234
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
S D + + +D W T Q LQHPF V + P
Sbjct: 235 SS---------EFKDFLKKCLEKNVDARW-----------TTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 5/214 (2%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
+Y +L +G+G+ G +V + + A+K+++ + +E L K+ HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 63 IKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+ KE + L+ + EY + + I +R F E I + QM G+ H+H
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 121 YFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYT-EYVSTRWYRAPEVLLQSSSYSP 178
HRD+K +N+ +T N +K+ DFG AR L+S Y YV T +Y PE+ ++ Y+
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI-WENMPYNN 179
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVC 212
D+W++G IL EL TL F +S + + KVC
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 74/287 (25%), Positives = 138/287 (48%), Gaps = 34/287 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
++Y E++G G G VY A ++ T + VA+K+M + +E + + E+ +R+ +PN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI-INEILVMRENKNPN 77
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ + +EL+ + EY+ +L ++ E + EG+I + + LQ L +H N
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALDFLHSNQ 135
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K +N+L+ D +K+ DFG +++ + V T ++ APEV+ + +Y P
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 194
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
+D+W++G + E+ P + ++ + LY + PE N RL ++
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------NGTPELQNPERLSAVFR- 246
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
D + + D RR +A + LQHPF +
Sbjct: 247 -------------------DFLNRCLEMDVDRRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 73/287 (25%), Positives = 137/287 (47%), Gaps = 34/287 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
++Y E++G G G VY A +V T + VA+K+M + +E + + E+ +R+ HPN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI-INEILVMRENKHPN 77
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ + +EL+ + EY+ +L ++ E + EG+I + + LQ L +H N
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQ 135
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K +N+L+ D +K+ DFG +++ + V T ++ APEV+ + +Y P
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 194
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
+D+W++G + E+ P + ++ + LY + G P+ +S +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---LQNPEKLSAIFR---- 246
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
D + + D +R +A + LQHPF +
Sbjct: 247 -------------------DFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 74/287 (25%), Positives = 138/287 (48%), Gaps = 34/287 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
++Y E++G G G VY A +V T + VA+++M + +E + + E+ +R+ +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ + +EL+ + EY+ +L ++ E + EG+I + + LQ L +H N
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQ 136
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K +N+L+ D +K+ DFG +++ + V T ++ APEV+ + +Y P
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 195
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
+D+W++G + E+ P + ++ + LY + PE N
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------NGTPELQN---------- 238
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
P LS I + +D+ D +R +A + LQH F +
Sbjct: 239 ---PEKLSAIFRDFLNRCLDM-------DVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 46/291 (15%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRK----FYFWEECMNLREVKALRKLNH 59
Y++++ +G GT G VYKA N+ T E+ AVK +K + F ++ E+ +++ H
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ-----EIFMVKECKH 65
Query: 60 PNIIKLKEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
NI+ +L+ EY ++YH+ P SE +I + LQGLA+
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAY 121
Query: 116 MHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEV--LL 171
+H G HRD+K N+L+T N +K+ADFG+A +++ ++ ++ T ++ APEV +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
++ Y+ D+WAVG EL L P P + P +
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQP--------------------PMFDLHP----MRA 217
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
L +S S P L D S + + + +P +RPTA++ L H F
Sbjct: 218 LFLMSKSNFQPPKLKDKT-KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 36/279 (12%)
Query: 9 ELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKLNHPNIIKLKE 67
++G+G+ G V A + T VAVKKM RK E N EV +R HPNI+++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN--EVVIMRDYQHPNIVEMYS 83
Query: 68 VVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL 126
+EL+ + E++E L I+ ++ +E +I + +L+ L+ +H G HRD+
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIATVCLAVLKALSFLHAQGVIHRDI 141
Query: 127 KPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWA 184
K +++L+T+D +K++DFG ++S +P V T ++ APEV + Y +D+W+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV-ISRLPYGTEVDIWS 200
Query: 185 VGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244
+G ++ E+ P + + + + ++ + LP
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRI--------------------------RDNLPPK 234
Query: 245 LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
L ++ S + ++ DP +R TA + L HPF
Sbjct: 235 LKNLH-KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 2 ERY-KILEELGDGTCGCVYKA----FNVETYEIVAVKKMKRKFYFWEECMNL------RE 50
+R+ K +++LG+G G V T E VAVK + RE
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH------SGEEQHRSDFERE 56
Query: 51 VKALRKLNHPNIIKLKEVVRE--NNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMS 107
++ LR L+H NI+K K V + L I EY+ +L ++ + + + F S
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELSSMPPYTEYVS------ 160
Q+ +G+ ++ Y HRDL N+LV ++ L KI+DFGLA+ L Y Y
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY--YYVKEPGES 174
Query: 161 -TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
WY APE L S S A D+W+ G L ELFT
Sbjct: 175 PIFWY-APECLRTSKFSS-ASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-23
Identities = 67/235 (28%), Positives = 115/235 (48%), Gaps = 17/235 (7%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK----RKFYFWEECMNLREVKALRK 56
+ ++I +++G G VY+A + VA+KK++ +C ++E+ L++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADC--IKEIDLLKQ 58
Query: 57 LNHPNIIKLKEVVRENNELFFIFEY-----MEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
LNHPN+IK E+NEL + E + + H +++++ E + + Q+
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCS 117
Query: 112 GLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRAPEV 169
L HMH HRD+KP N+ +T V+K+ D GL R SS V T +Y +PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE- 176
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
+ + Y+ D+W++G +L E+ L F GD LY +C + D+ P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQCDYPPLP 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 88/294 (29%), Positives = 137/294 (46%), Gaps = 49/294 (16%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V A T E+ AVK +K+ + EC M + V AL HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ + LFF+ EY+ ++HI R + F E R + ++++ GL +H G +
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLK +N+L+ ++ +KIADFG+ +E + + + T Y APE+L Y PA+D
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL-SYQPYGPAVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
WA+G +L E+ F GD E D+L++ SI E+
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDE-DELFQ-----------------------SILEDEVR 214
Query: 242 -PINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQAL-QHPFFNVETWV 289
P LS EA ++ + +P +R PT +Q + HPFF W
Sbjct: 215 YPRWLSK-------EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 5e-23
Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64
+++E+G G G V+ + +E + VA+K ++ E+ + E + + KL+HP +++
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDF--IEEAQVMMKLSHPKLVQ 63
Query: 65 LKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
L V E + + +FE+MEH L +R ++ FS+ + + +G+A++ + H
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 124 RDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW---YRAPEVLLQSSSYSPA 179
RDL N LV N V+K++DFG+ R + YT T++ + +PEV S YS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEV-FSFSKYSSK 181
Query: 180 IDMWAVGAILAELFT 194
D+W+ G ++ E+F+
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 7e-23
Identities = 80/289 (27%), Positives = 116/289 (40%), Gaps = 37/289 (12%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKE 67
LG G G V T ++ A KK+ +K E M L E K L K++ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
++L + M YHI + F E + +Q++ GL H+H+ +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 126 LKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWA 184
LKPEN+L+ + ++I+D GLA EL T Y APEV LQ Y ++D +A
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV-LQGEVYDFSVDWFA 179
Query: 185 VGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244
+G L E+ I G + E L + +
Sbjct: 180 LGCTLYEM---------------------IAGRSPFRQRKEKVEKEELKRRTLEM--AVE 216
Query: 245 LSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNVETW 288
D S EA DL L DP +R +AD+ +HP F W
Sbjct: 217 YPD---KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-----------REVK 52
Y+ LE +G G G VY+ +V T +VA+K +NL REV
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK-----------IINLDTPDDDVSDIQREVA 51
Query: 53 ALRKLNH---PNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQ 108
L +L PNI K + L+ I EY E ++ +M+ P +E I + +
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIRE 109
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRA 166
+L L ++H+ G HRD+K N+LVTN +K+ DFG+A L + + +V T ++ A
Sbjct: 110 VLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMA 169
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSP 197
PEV+ + Y D+W++G + E+ T +P
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 60/291 (20%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKALRKLNHPN 61
+G G G VYK + T + A+K ++R+ RE++ LR +NHPN
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQI--------CREIEILRDVNHPN 133
Query: 62 IIKLKEVVRENNELFFIFEYMEHNL---YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
++K ++ N E+ + E+M+ HI E+ + Q+L G+A++HR
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHR 186
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVL---LQS 173
HRD+KP NLL+ + +KIADFG++R L+ +M P V T Y +PE + L
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 174 SSYSP-AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP-DWTAFPEATNISR 231
+Y A D+W++G + E + F +G DW + A
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFG--------------VGRQGDWASLMCA----- 287
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
I +S P AS E I +P +R +A Q LQHPF
Sbjct: 288 -ICMSQPPEAP-------ATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 84/296 (28%), Positives = 138/296 (46%), Gaps = 51/296 (17%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V A T E+ A+K +K+ + +C M + + AL HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ + LFF+ EY+ ++ I R R+ F E R + +++ L +HR+G +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLK +N+L+ + K+ADFG+ +E + + T + T Y APE+L Q Y P++D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL-QELEYGPSVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
WA+G ++ E+ P F D+E D L++ SI + ++L
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNE-DDLFE-----------------------SILHDDVL 214
Query: 242 -PINLSDIIPNASMEAIDLIWQLCSWDPLRR-------PTADQALQHPFFNVETWV 289
P+ LS EA+ ++ + +P +R D QHPFF WV
Sbjct: 215 YPVWLSK-------EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 41/253 (16%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRK 56
E K+ +LG G G V+ +N T VAVK +K M+ L+E + ++K
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK------PGTMSPEAFLQEAQIMKK 57
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRE---RQIPFSEGEIRSFMSQMLQG 112
L H +++L V E ++ + EYM +L ++ +++ ++ +Q+ +G
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEG 115
Query: 113 LAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW---YRAPE 168
+A++ Y HRDL N+LV N V KIADFGLAR + YT ++ + APE
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPE 174
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPGDS------EIDQLYKVCCILGAPD-- 219
++ D+W+ G +L E+ T + +PG + ++++ Y++ P+
Sbjct: 175 AAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL 233
Query: 220 -------WTAFPE 225
W PE
Sbjct: 234 YDLMLQCWDKDPE 246
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 9e-22
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMK--------RKFYFWEECMNLREVKALRKLNHPN 61
LG G G VY ++V+T +AVK++ +K EC E++ L+ L H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC----EIQLLKNLQHER 65
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
I++ +R++ L EYM + +E R + Q+L+G+ ++H N
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 122 FHRDLKPENLLV-TNDVLKIADFGLAREL----SSMPPYTEYVSTRWYRAPEVLLQSSSY 176
HRD+K N+L + +K+ DFG ++ L SS T ++ +PEV+ Y
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS-GEGY 184
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
D+W+VG + E+ T P W F I ++ +
Sbjct: 185 GRKADVWSVGCTVVEMLT---------------------EKPPWAEFEAMAAIFKIATQP 223
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ LP ++S A + + + + +RP+A++ L+H F
Sbjct: 224 TNPQLPSHVSPD-------ARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 82/293 (27%), Positives = 137/293 (46%), Gaps = 47/293 (16%)
Query: 3 RYKILEELGDGTCGCVY-----KAFNVETYEI---VAVKKMKRKFYFWEECMNLREVKAL 54
RY + + LG G+ G VY KA E ++ + V ++ E +E + L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN----ETVQANQEAQLL 56
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIP---FSEGEIRSFMSQML 110
KL+HP I+K E + I EY E +L + E + SE ++ + Q+L
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEV 169
G+ +MH+ HRDLK +N+ + N++LKI DFG++R L S T + T +Y +PE
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
L + Y D+W++G IL E+ L+ F G + + + ++ + PE
Sbjct: 177 L-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV----EGPTPSLPE---- 227
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+YS L N+ M++ + + DP RP+A + L++PF
Sbjct: 228 ------TYSRQL---------NSIMQS------MLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRK---LNHPNIIK 64
+G GT G VY+ +T I A+K + +K E + E L + P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 65 LKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
LK + +++L+ + +YM +H+ +E + FSE + ++++++ L H+H+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 123 HRDLKPENLLV-TNDVLKIADFGLAR-ELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
+RDLKPEN+L+ + + DFGL++ L+ + T Y APEVLL Y+ +
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 181 DMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCC 213
D W++G ++ E+ SP + D++ Q+Y+
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQ--QMYRNIA 210
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 24/210 (11%)
Query: 2 ERY-KILEELGDGTCGCV----YKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+RY K + LG+G G V Y N T E+VAVK +KR+ +E+ L+
Sbjct: 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62
Query: 57 LNHPNIIKLKEVVRENNE--LFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
L H NI+K K E L I EY+ +L + + ++ ++ + F Q+ +G+
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQICEGM 120
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR--------WY 164
A++H Y HRDL N+L+ ND ++KI DFGLA+ ++P EY R WY
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK---AVPEGHEYYRVREDGDSPVFWY 177
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
A E L+ + +S A D+W+ G L EL T
Sbjct: 178 -AVEC-LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 70/238 (29%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKK------MKRKFYFWEECMNLREVKAL 54
+ ++I +++G G VY+A + + VA+KK M K ++C ++E+ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDC--VKEIDLL 56
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEHN------LYHIMRERQIPFSEGEIRSFMSQ 108
++LNHPN+IK + E+NEL + E + Y ++R IP E + + Q
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP--ERTVWKYFVQ 114
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRA 166
+ + HMH HRD+KP N+ +T V+K+ D GL R SS V T +Y +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
PE + + Y+ D+W++G +L E+ L F GD L+ +C + D+ P
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKIEQCDYPPLP 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 62/250 (24%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 1 MERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFY--FWEECMNLREVKA 53
+ + LEELG+G G VYK + VA+K +K +E +E +
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--QEAEL 61
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYH---IMR-------------ERQIPF 97
+ L HPNI+ L V + +FEY+ H H + +
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 98 SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155
+ Q+ G+ ++ + + HRDL N LV +KI+DFGL+R++ S Y
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 156 ---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT--LSPIFP-GDSEIDQLY 209
+ RW PE +L ++ D+W+ G +L E+F+ L P + + E+ ++
Sbjct: 182 VQSKSLLPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 210 KVCCILGAPD 219
+ +L P+
Sbjct: 240 RSRQLLPCPE 249
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 36/279 (12%)
Query: 9 ELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKLNHPNIIKLKE 67
++G+G+ G V A + VAVK M RK E N EV +R H N++++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN--EVVIMRDYQHQNVVEMYK 85
Query: 68 VVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL 126
EL+ + E+++ L I+ Q +E +I + +LQ L ++H G HRD+
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 127 KPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWA 184
K +++L+T D +K++DFG ++S +P V T ++ APEV + + Y +D+W+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV-ISRTPYGTEVDIWS 202
Query: 185 VGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244
+G ++ E+ P + DS + + + + +P P+ N ++ S +L
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPP----PKLKNAHKI-----SPVLR-- 248
Query: 245 LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
D + ++ + +P R TA + L HPF
Sbjct: 249 -------------DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 60/189 (31%), Positives = 97/189 (51%), Gaps = 9/189 (4%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE--CMNLREVKALRKLNHPNIIKLKE 67
LG GT G V T + A+K +K++ ++ L E + L+ HP + LK
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
+ ++ L F+ EY +H+ RER FSE R + ++++ L ++H +RD
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 126 LKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMW 183
LK ENL++ D +KI DFGL +E +S + T Y APEV L+ + Y A+D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWW 179
Query: 184 AVGAILAEL 192
+G ++ E+
Sbjct: 180 GLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 4e-21
Identities = 74/287 (25%), Positives = 138/287 (48%), Gaps = 34/287 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
++Y E++G G G V+ A +V T + VA+K++ + +E + + E+ +++L +PN
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI-INEILVMKELKNPN 77
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ + +ELF + EY+ +L ++ E + E +I + + LQ L +H N
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHANQ 135
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K +N+L+ D +K+ DFG +++ + V T ++ APEV+ + +Y P
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 194
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
+D+W++G + E+ P + ++ + LY + PE N
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------NGTPELQN---------- 237
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
P LS I D + + D +R +A + LQHPF +
Sbjct: 238 ---PEKLSPIFR-------DFLNRCLEMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
++ELG G G V+ + VA+K + E+ + E K + KL+HP +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFI--EEAKVMMKLSHPKLVQLY 65
Query: 67 EVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
V + L+ + E+ME+ L + +R+RQ S+ + S + +G+ ++ RN + HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 126 LKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVLLQSSSYS 177
L N LV++ V+K++DFG+ R + EY S+ +W PEV S YS
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKW-SPPEVFN-FSKYS 179
Query: 178 PAIDMWAVGAILAELFT 194
D+W+ G ++ E+FT
Sbjct: 180 SKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 61/229 (26%), Positives = 112/229 (48%), Gaps = 20/229 (8%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR-------EVKAL 54
+ + ++ +G GT G V+ + + A+K M E + L+ E + L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP-----EVIRLKQEQHVHNEKRVL 55
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
++++HP II+L + L+ + EY+ L+ +R FS + S+++ L
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCAL 114
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
++H +RDLKPEN+L+ + +K+ DFG A++L +T T Y APEV +Q
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWT-LCGTPEYLAPEV-IQ 171
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221
S ++ A+D WA+G ++ E+ P F D+ K+ + G ++
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-----PN 61
L+ + G G VY A T + A+K +K+ + + VKA R + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN--QVTNVKAERAIMMIQGESPY 58
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+ KL + + L+ + EY+ + + E + ++++++ G+ +H+ G
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 122 FHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
HRD+KPENLL+ LK+ DFGL+R ++V T Y APE +L
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSR-NGLENK--KFVGTPDYLAPETIL-GVGDDKMS 174
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL-GAPDWTAFPEATNISRLISISYSE 239
D W++G ++ E P F ++ D ++ IL +W +
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAET-PDAVFDN--ILSRRINWPEEVKEF------------ 219
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ---HPFFNVETW 288
S EA+DLI +L DP +R A+ + HPFF W
Sbjct: 220 ------------CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 82/307 (26%), Positives = 134/307 (43%), Gaps = 64/307 (20%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALR-------- 55
++ L LG G G V A +T E+ A+K +K+ + EV++L
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-----EVESLMCEKRIFET 55
Query: 56 --KLNHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQ 111
HP ++ L + + + F+ EY + HI + FSE + + ++
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAACVVL 112
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVSTRWYRAP 167
GL ++H N +RDLK +NLL+ + +KIADFGL +E M + + T + AP
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFCGTPEFLAP 170
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
EVL + +SY+ A+D W +G ++ E+ FPGD E ++++
Sbjct: 171 EVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFD----------------- 211
Query: 228 NISRLISISYSEIL-PINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHP 281
SI E+ P L S EAI ++ +L +P RR A+ + P
Sbjct: 212 ------SIVNDEVRYPRFL-------SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258
Query: 282 FFNVETW 288
FF W
Sbjct: 259 FFRDINW 265
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 78/326 (23%), Positives = 136/326 (41%), Gaps = 80/326 (24%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF---------YFWEECMNLREVK 52
+ +++++ +G G G V+ + +T ++ A+K + RK + E R++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAE----RDIL 55
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQML 110
A + P I+KL ++ L+ + EYM + ++R+ P E R ++++++
Sbjct: 56 A--DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFP--EETARFYIAELV 111
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA----------------------- 146
L +H+ G+ HRD+KP+N+L+ D +K+ADFGL
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 147 RELSSMPPYTEY-------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIF 199
L + + V T Y APEV L+ + Y D W++G IL E+ P F
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEV-LRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 200 PGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDL 259
D+ + I++ E L + S EAIDL
Sbjct: 231 YSDT-----------------------LQETYNKIINWKESLRFPPDPPV---SPEAIDL 264
Query: 260 IWQLCSWDPLRR-PTADQALQHPFFN 284
I +L DP R + ++ HPFF
Sbjct: 265 ICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-20
Identities = 54/175 (30%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 49 REVKALRKLNHPNIIKL-KEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
RE +L HPNI+ L LF +FEY+ + GE M
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLML 86
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTNDVL----KIADFGLARELS--------SMPPY 155
Q+L LA H G HRDLKP+N++V+ + K+ DFG+ L ++
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK 210
TE + T Y APE L+ +P D++A G I E T + G S + LY+
Sbjct: 147 TEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 44/289 (15%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKE 67
+G G+ G V + +T I A+K +++ E L E L ++N P I+ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
+ +L+ + ++ +H+ RE + F R + +++L L ++H+ +RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 126 LKPENLLVT-NDVLKIADFGLAR-ELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMW 183
LKPEN+L+ + + DFGL + + + T Y APE+LL Y+ A+D W
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYTKAVDWW 177
Query: 184 AVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242
+G +L E+ T L P + D ++++Y+ IL P FP+
Sbjct: 178 TLGVLLYEMLTGLPPFY--DENVNEMYRK--ILQEP--LRFPD----------------- 214
Query: 243 INLSDIIPNASMEAIDLIWQLCSWDPLRR---PTADQALQHPFFNVETW 288
+A DL+ L S DP RR A + HPFF+ +W
Sbjct: 215 --------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 52/293 (17%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVKKM----------KRKFYFWEECMNLREVKALRKL 57
E LG G G VY +++AVK++ ++++ +E EV L+ L
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQE-----EVDLLKSL 59
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H NI++ ++N + E++ + R P E + Q+L G+A++H
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 118 RNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVS-------TRWYRAPEV 169
N HRD+K N +L+ N ++K+ DFG AR L+ + + + + T ++ APEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+ S Y D+W++G + E+ T G P + +
Sbjct: 180 -INESGYGRKSDIWSIGCTVFEMAT---------------------GKPPLASMDR---L 214
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ + I L L D + S AID + + D RP+A Q L+H F
Sbjct: 215 AAMFYIGAHRGLMPRLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 24/223 (10%)
Query: 1 MERYKIL--EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKAL 54
MER I +LG G G VY+ + VAVK +K E+ M L+E +
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVM 56
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFM-SQMLQG 112
+++ HPN+++L V + I E+M + NL +RE + +M +Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 113 LAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW---YRAPE 168
+ ++ + + HRDL N LV N ++K+ADFGL+R L + YT + ++ + APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE 175
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFT--LSPIFPGDSEIDQLY 209
L + +S D+WA G +L E+ T +SP +PG ++ Q+Y
Sbjct: 176 S-LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG-IDLSQVY 215
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 2 ERY-KILEELGDGTCG----CVYKAFNVETYEIVAVKKMK-------RKFYFWEECMNLR 49
ER+ K +++LG G G C Y T E+VAVKK++ R F R
Sbjct: 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--------R 54
Query: 50 EVKALRKLNHPNIIKLKEVV--RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFM 106
E++ L+ L H NI+K K V L + EY+ + +L +++ + ++ +
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELSSMPPYTEYVSTR--- 162
SQ+ +G+ ++ Y HRDL N+LV ++ KI DFGL + L P EY R
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKVREPG 171
Query: 163 -----WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS 196
WY APE L +S +S A D+W+ G +L ELFT S
Sbjct: 172 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 78/285 (27%), Positives = 119/285 (41%), Gaps = 31/285 (10%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
L LG+G G V K T I A+K + + LRE++ + P I+K
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 67 EVVREN--NELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+ + + EY E ++Y +++R E + +L+GL+++H
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 121 YFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRD+KP N+L+T +K+ DFG++ EL + T + T +Y APE +Q YS
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE-RIQGKPYSIT 183
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
D+W++G L E+ FP + E P I L I
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGE-------------------PPLGPIELLSYIVNMP 224
Query: 240 I--LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
L + I S E D I Q DP RRPT L+HP+
Sbjct: 225 NPELKDEPGNGI-KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 6 ILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMN------LREVKAL 54
+ ELG+G G V+ E+VAVK +K E N RE + L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK------ETASNDARKDFEREAELL 62
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH---NLY------HIMRERQIPFSEGEIRSF 105
H NI+K V E + +FEYMEH N + + GE+
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT-- 120
Query: 106 MSQMLQ-------GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-- 155
+SQ+LQ G+ ++ + HRDL N LV D V+KI DFG++R++ + Y
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180
Query: 156 --TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
+ RW PE ++ ++ D+W+ G +L E+FT
Sbjct: 181 GGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 84/310 (27%), Positives = 140/310 (45%), Gaps = 60/310 (19%)
Query: 4 YKILEELGDGTCGCVY---KAFNVETYEIVAVKKMKR-----KFYFWEECMNLREV-KAL 54
+++L LG G G V+ K + ++ A+K +K+ K E R+V +A+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEY-----MEHNLYHIMRERQIPFSEGEIRSFMSQM 109
R+ P ++ L + + +L I +Y + +LY RE F+E E+R +++++
Sbjct: 62 RR--CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REH---FTESEVRVYIAEI 114
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE----YVSTRWY 164
+ L H+H+ G +RD+K EN+L+ ++ + + DFGL++E + E + T Y
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGTIEY 172
Query: 165 RAPEVLLQ-SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
APEV+ S + A+D W++G + EL T + F D E +
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---------------- 216
Query: 224 PEATNISRLISISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRR---PTADQALQ 279
+ ISR I S P S EA D I +L DP +R AD+
Sbjct: 217 --QSEISRRILKS---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265
Query: 280 HPFFNVETWV 289
HPFF W
Sbjct: 266 HPFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 65/214 (30%), Positives = 114/214 (53%), Gaps = 15/214 (7%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V A E+ + AVK +K+ + EC M + + +L + NHP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ + LFF+ E++ ++HI + R+ F E R + +++ L +H G +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLK +N+L+ ++ K+ADFG+ +E + + + + T Y APE+L Q Y P++D
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL-QEMLYGPSVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL 215
WA+G +L E+ F ++E D L++ IL
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENE-DDLFE--AIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 59/190 (31%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKE 67
LG GT G V + + A+K +K++ E L E + L+ HP + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
+ + L F+ EY+ +H+ RER FSE R + ++++ L ++H +RD
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 126 LKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMW 183
LK ENL++ D +KI DFGL +E ++ + T Y APEV L+ + Y A+D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV-LEDNDYGRAVDWW 179
Query: 184 AVGAILAELF 193
+G ++ E+
Sbjct: 180 GLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 66/235 (28%), Positives = 114/235 (48%), Gaps = 34/235 (14%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKALRKLNH 59
E++G G G VYK ++ VAVK +KRKF L+E + L++ +H
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKF--------LQEAEILKQYDH 51
Query: 60 PNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI+KL V + ++ + E + +L +R+++ + ++ G+ ++
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 119 NGYFHRDLKPENLLVT-NDVLKIADFGLARE----LSSMPPYTEYVSTRWYRAPEVLLQS 173
HRDL N LV N+VLKI+DFG++RE + ++ + + +W APE L
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEA-LNY 169
Query: 174 SSYSPAIDMWAVGAILAELFTL--SPIFPGDS------EIDQLYKVCCILGAPDW 220
Y+ D+W+ G +L E F+L +P +PG S I+ Y++ P+
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTP-YPGMSNQQTRERIESGYRMPAPQLCPEE 223
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 66/256 (25%), Positives = 113/256 (44%), Gaps = 22/256 (8%)
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
L E L+ +NHP++I++K+ + + + +LY + +R P +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRA 166
Q+L+GL ++H HRD+K EN+ + + D + I D G A+ P + T A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAE-------LFTLSPIFPGDSEID---QLYKVCCILG 216
PEVL + Y+ D+W+ G +L E +F P P + L K+ L
Sbjct: 225 PEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283
Query: 217 A-PDWTAFPEATNISRLIS--ISYS--EILPINLSDIIP--NASMEAIDLIWQLCSWDPL 269
P+ FP SRL+ I Y+ E P N ++ L+ ++ ++D
Sbjct: 284 VHPE--EFPRDPG-SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340
Query: 270 RRPTADQALQHPFFNV 285
RP+A++ L +P F
Sbjct: 341 MRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + + +LG G G V++ VA+K +K ++ +EV+AL++L H +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQ-DFQKEVQALKRLRHKH 63
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMH 117
+I L V ++ I E ME +L +R + +P + + Q+ +G+A++
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVA--SLIDMACQVAEGMAYLE 121
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY---VSTRWYRAPEVLLQS 173
HRDL N+LV D V K+ADFGLAR + Y + +W APE
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKW-TAPEAASH- 178
Query: 174 SSYSPAIDMWAVGAILAELFTLSPI-FPG 201
++S D+W+ G +L E+FT + +PG
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 44/277 (15%)
Query: 26 TYEIVAVKKMKRKFYFWEECMNL----REVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81
T +I A+K MK+ +E ++ R++ ++ N P I +L+ ++ + L+ + EY
Sbjct: 25 TGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS--NSPWIPQLQYAFQDKDNLYLVMEY 82
Query: 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLK 139
+L ++ + F E + ++++++ + +H+ GY HRD+KPEN+L+ +K
Sbjct: 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIK 142
Query: 140 IADFGLARELSS--MPPYTEYVSTRWYRAPEVLL-----QSSSYSPAIDMWAVGAILAEL 192
+ADFG A L++ M V T Y APEVL +Y D W++G I E+
Sbjct: 143 LADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 193 -FTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPN 251
+ SP F + I+ + FPE P
Sbjct: 203 IYGRSP-FHEGTSAKTYNN---IMNFQRFLKFPED-----------------------PK 235
Query: 252 ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
S + +DLI L R + HPFF+ W
Sbjct: 236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLNHPN 61
L+ELG G G V Y+ VA+K +K E M+ + E K + KL+H
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIK------EGSMSEDEFIEEAKVMMKLSHEK 60
Query: 62 IIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+++L V + ++ + EYM + L + +RE F ++ + +G+A++
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVLLQ 172
+ HRDL N LV + +K++DFGL+R + EY S+ RW PEVLL
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKFPVRW-SPPEVLLY 175
Query: 173 SSSYSPAIDMWAVGAILAELFTL 195
S +S D+WA G ++ E+++L
Sbjct: 176 -SKFSSKSDVWAFGVLMWEVYSL 197
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 9 ELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
++G G G V++A E + +VAVK +K + + RE + + +HPNI+
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 64 KLKEVVRENNELFFIFEYMEH-NLYHIMRER---------------------QIPFSEGE 101
KL V + +FEYM + +L +R R +P S E
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 102 IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----T 156
Q+ G+A++ + HRDL N LV + V+KIADFGL+R + S Y
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
+ + RW PE + + Y+ D+WA G +L E+F+
Sbjct: 192 DAIPIRWM-PPESIFY-NRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 81/329 (24%), Positives = 136/329 (41%), Gaps = 77/329 (23%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL----NHPNI 62
++ +G G G V +T I A+KK+++ +E + V+A R + ++P +
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE--QVAHVRAERDILAEADNPWV 63
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
+KL ++ N L+ I EY+ + ++ F+E E R ++++ + + +H+ GY
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 123 HRDLKPENLLVTND-VLKIADFGL------------ARELSSMPPYTEYVSTR------- 162
HRD+KP+NLL+ +K++DFGL R LS P
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 163 ----W----------------YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD 202
W Y APEV LQ + Y+ D W++G I+ E+ P F D
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 203 SEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQ 262
+ + K+ I++ E L ++ S EA DLI +
Sbjct: 243 NPQETYRKI-----------------------INWKETLQF-PDEV--PLSPEAKDLIKR 276
Query: 263 LCSWDPLRR---PTADQALQHPFFNVETW 288
LC + RR ++ HPFF W
Sbjct: 277 LCC-EAERRLGNNGVNEIKSHPFFKGVDW 304
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 58/187 (31%), Positives = 95/187 (50%), Gaps = 9/187 (4%)
Query: 50 EVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQM 109
E L + HP I+ L + +L+ I EY+ + ER+ F E ++S++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 110 LQGLAHMHRNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTE-YVSTRWYRAP 167
L H+H+ G +RDLKPEN LL +K+ DFGL +E T + T Y AP
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---IDQLYKVCCILGAPDWTAFP 224
E+ L S + A+D W++GA++ ++ T +P F ++ ID++ K L P + P
Sbjct: 170 EI-LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GKLNLPPYLT-P 225
Query: 225 EATNISR 231
EA ++ +
Sbjct: 226 EARDLLK 232
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 44/235 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVET----YEI-VAVKKMKRKFYFWEECMN------LRE 50
+R + + LG+G G V KA V VAVK +K ++ + E
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK------DDATEKDLSDLVSE 65
Query: 51 VKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP------------ 96
++ ++ + H NII L V + L+ + EY H NL +R R+ P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 97 ---FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM 152
++ ++ SF Q+ +G+ + HRDL N+LVT + V+KIADFGLAR++ +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
Query: 153 PPYTEYVSTR----WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG 201
Y + + R W APE L Y+ D+W+ G +L E+FTL SP +PG
Sbjct: 186 DYYRKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 1 MERYKILEELGDGTCGCVYK--AFNVETYEI---VAVKKMKRKFYFWEECMNLREVKALR 55
E+ ++ ELG G+ G VY+ A V E VA+K + E L E ++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER---------QIPFSEGEIRSF 105
+ N ++++L VV + E M +L +R R P + +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY------ 158
+++ G+A++ + HRDL N +V D +KI DFG+ R++ T+Y
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY----ETDYYRKGGK 180
Query: 159 --VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+ RW APE L+ ++ D+W+ G +L E+ TL
Sbjct: 181 GLLPVRWM-APES-LKDGVFTTKSDVWSFGVVLWEMATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 9/189 (4%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKE 67
LG GT G V T A+K ++++ E + E + L+ HP + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
+ ++ L F+ EY +H+ RER F+E R + ++++ L ++H +RD
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 126 LKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMW 183
+K ENL++ D +KI DFGL +E +S + T Y APEV L+ + Y A+D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWW 179
Query: 184 AVGAILAEL 192
+G ++ E+
Sbjct: 180 GLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 79/331 (23%), Positives = 127/331 (38%), Gaps = 90/331 (27%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR--------EVKAL 54
+K ++ LG G G V+ T ++ A+K + +K M R E + L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK------EMIKRNKVKRVLTEQEIL 55
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEY-MEHNLYHIMRERQIP---FSEGEIRSFMSQML 110
L+HP + L + L + +Y L+ +++ + P SE R + +++L
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVL 113
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTEY--------- 158
L ++H G +RDLKPEN+L+ +L +DF L+++ PP
Sbjct: 114 LALEYLHLLGIVYRDLKPENILLHESGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 159 ---------------------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAE-LFTLS 196
V T Y APEV + + A+D W +G +L E L+ +
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 197 PIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEA 256
P F G + + IL FP + +S A
Sbjct: 231 P-FKGSNRDETFSN---ILKKE--VTFPGSPPVSS-----------------------SA 261
Query: 257 IDLIWQLCSWDPLRR----PTADQALQHPFF 283
DLI +L DP +R A + QHPFF
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 97/347 (27%), Positives = 154/347 (44%), Gaps = 51/347 (14%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V A T E A+K +K+ + EC M R V AL HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLTHL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ LFF+ EY+ ++HI + F E R + ++++ GL +H+ G +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLK +N+L+ D +KIADFG+ +E ++ + + T Y APE+ L+ Y+ ++D
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQKYNESVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
W+ G +L E+ F G+ E D+L+ IL FP R I
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDE-DELFD--SILNDRPH--FP------RWI-------- 219
Query: 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL-QHPFFNVETWVPYPLHDPLELR 300
S EA D + +L DP +R D + QHPFF W + LE R
Sbjct: 220 -----------SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW------ERLEKR 262
Query: 301 LNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGM 347
KP ++ D + D F + + P + +++ ++ Q
Sbjct: 263 EIPPPFKPKVKSPS-DA-SNFDREFTNEKVRLSPVDKKLLASMDQEQ 307
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 10 LGDGTCGCVYKA-----FNVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
LG G G VY+ + I VAVK +++ E+ L+E + NHPNI+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 64 KLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQML-------QGLAH 115
KL V N + I E ME +L +R+ ++ + + + ++L +G +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT-LKELLDICLDVAKGCVY 121
Query: 116 MHRNGYFHRDLKPENLLVTND------VLKIADFGLARELSSMPPYTE----YVSTRWYR 165
+ + + HRDL N LV+ V+KI DFGLAR++ Y + + RW
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM- 180
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQLYKV 211
APE LL ++ D+W+ G ++ E+ TL P +P + + L V
Sbjct: 181 APESLLD-GKFTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 8e-18
Identities = 74/280 (26%), Positives = 135/280 (48%), Gaps = 34/280 (12%)
Query: 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEV 68
++G+G+ G V A T + VAVKKM + E + EV +R +H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL-FNEVVIMRDYHHENVVDMYNS 87
Query: 69 VRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLK 127
+EL+ + E++E L I+ ++ +E +I + +L+ L+++H G HRD+K
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 128 PENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAV 185
+++L+T+D +K++DFG ++S +P V T ++ APEV + Y +D+W++
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV-ISRLPYGTEVDIWSL 204
Query: 186 GAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINL 245
G ++ E+ I G P + P + R+ + LP +
Sbjct: 205 GIMVIEM---------------------IDGEPPYFNEPPLQAMRRI-----RDNLPPRV 238
Query: 246 SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
D +S+ L L +P +R TA + LQHPF +
Sbjct: 239 KDSHKVSSVLRGFLDLMLVR-EPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-18
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 6/199 (3%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + LE +G G+ G V+K + T ++VA+K + + E +E+ L + + P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+ K + +L+ I EY+ + ++R PF E +I + + ++L+GL ++H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEK 121
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQSSSYSP 178
HRD+K N+L++ +K+ADFG+A +L+ +V T ++ APEV +Q S+Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IQQSAYDS 180
Query: 179 AIDMWAVGAILAELFTLSP 197
D+W++G EL P
Sbjct: 181 KADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 84/333 (25%), Positives = 143/333 (42%), Gaps = 72/333 (21%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK-------ALRK 56
+++ E LG G+ G V A + T E A+K +K++ E + +++V+ L +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQEKSILME 74
Query: 57 LNHPNIIKLKEVVRENNELFFIFEY-MEHNLY-HIMRERQIPFSEGEIRSFMS-QMLQGL 113
L+HP I+ + ++ N ++F+ E+ + L+ H+ + + P ++ F +++
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFP---NDVAKFYHAELVLAF 131
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
++H +RDLKPENLL+ N +K+ DFG A+++ +T T Y APEV +Q
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFT-LCGTPEYLAPEV-IQ 188
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
S + A+D W +G +L E P F D+
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------------------------- 222
Query: 233 ISISYSEILPINLSDIIPN-ASMEAIDLIWQLCSWDP------LRRPTADQALQHPFFNV 285
Y +IL L PN A DL+ L D L+ AD HP+F+
Sbjct: 223 ---IYEKILAGRLK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVAD-VKNHPYFHG 276
Query: 286 ETW-------VPYPLHDPLELRLNNMGSKPNLE 311
W P P+ +R+ + G N E
Sbjct: 277 ANWDKLYARYYPAPIP----VRVKSPGDTSNFE 305
|
Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 69/278 (24%), Positives = 133/278 (47%), Gaps = 34/278 (12%)
Query: 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEV 68
++G+G+ G V A + ++VAVKKM + E + EV +R H N++++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 85
Query: 69 VRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLK 127
+EL+ + E++E L I+ ++ +E +I + +L+ L+ +H G HRD+K
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 128 PENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAV 185
+++L+T+D +K++DFG ++S +P V T ++ APE L+ Y P +D+W++
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSL 202
Query: 186 GAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINL 245
G ++ E+ P + + + + + + LP L
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMI--------------------------RDNLPPKL 236
Query: 246 SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ + S + +L DP +R TA + L+HPF
Sbjct: 237 KN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E K++++LG G G V+ + + + VAVK +K + L E ++ L H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAF--LEEANLMKTLQHDK 62
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRER-----QIPFSEGEIRSFMSQMLQGLAH 115
+++L VV + ++ I EYM +L ++ +P ++ F +Q+ +G+A+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAY 118
Query: 116 MHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELSSMPPYTEYVSTRW---YRAPEVLL 171
+ R Y HRDL+ N+LV+ ++ KIADFGLAR + YT ++ + APE +
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEA-I 176
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPI-FPGDSEID 206
S++ D+W+ G +L E+ T I +PG S D
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 28/233 (12%)
Query: 5 KILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLNH 59
++L +LG G G V++ +N T VAVK +K M+ L E + ++KL H
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLK------PGTMDPKDFLAEAQIMKKLRH 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
P +I+L V ++ + E M++ L ++ ++ +Q+ G+A++
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 118 RNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRW---YRAPEVLLQS 173
Y HRDL N+LV N++ K+ADFGLAR + Y ++ + APE L
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAAL-Y 178
Query: 174 SSYSPAIDMWAVGAILAELFTLSPI-FPGDS------EIDQLYKVCCILGAPD 219
+ +S D+W+ G +L E+ T + +PG + ++DQ Y++ C G P
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK 231
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 5 KILEELGDGTCG----CVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNH 59
K + +LG+G G C Y T E VAVK +K + +L +E++ LR L H
Sbjct: 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYH 65
Query: 60 PNIIKLKEVVRENN----ELFFIF-------EYMEHNLYHIMRERQIPFSEGEIRSFMSQ 108
NI+K K + E+ +L F EY+ N I ++Q+ ++ Q
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA--------VQ 117
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR----- 162
+ +G+ ++ Y HRDL N+LV ++ +KI DFGL + + + Y
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177
Query: 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
WY APE L+QS Y A D+W+ G L EL T
Sbjct: 178 WY-APECLIQSKFYI-ASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 10 LGDGTCGCVYKAFNVET-----YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64
LG+G G V KA Y VAVK +K E L E L+++NHP++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 65 LKEVVRENNELFFIFEYMEH-NLYHIMRE-RQI----------------------PFSEG 100
L ++ L I EY ++ +L +RE R++ + G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 101 EIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTE-- 157
++ SF Q+ +G+ ++ HRDL N+LV +KI+DFGL+R++ Y +
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 158 --YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG 201
+ +W A E L Y+ D+W+ G +L E+ TL +P +PG
Sbjct: 188 KGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 52/294 (17%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----WEECMNLREVKALRKLNHPNIIKL 65
+G G+ G V A + + AVK +++K + M R V L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ ++L+F+ +Y+ +H+ RER F E R + +++ L ++H +
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLKPEN+L+ + + + DFGL +E + + + T Y APEVL + Y +D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVD 178
Query: 182 MWAVGAILAE-LFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
W +GA+L E L+ L P + SR + Y I
Sbjct: 179 WWCLGAVLYEMLYGLPPFY------------------------------SRDTAEMYDNI 208
Query: 241 L--PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ----HPFFNVETW 288
L P+ L PN S+ A L+ L D +R A H FF+ W
Sbjct: 209 LNKPLRLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE----CMNLREVKALRKLNHPNIIKL 65
+G G+ G V A AVK +++K ++ M R V L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ +L+F+ +Y+ +H+ RER F E R + +++ + ++H +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 124 RDLKPENLLV-TNDVLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPA 179
RDLKPEN+L+ + + + DFGL +E + P + + T Y APEV L+ Y
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEV-LRKEPYDRT 176
Query: 180 IDMWAVGAILAE-LFTLSPIFPGDSEIDQLY 209
+D W +GA+L E L+ L P + D + Q+Y
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRD--VSQMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 51/311 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKA 53
E Y++++ +G G G V + T ++ A+K K +FWEE R++ A
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
N P +++L +++ L+ + EYM +L ++M +P E R + ++++
Sbjct: 99 FA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EKWARFYTAEVVLA 154
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSS--MPPYTEYVSTRWYRAPEV 169
L +H G+ HRD+KP+N+L+ + LK+ADFG +++ M V T Y +PEV
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 170 LLQSSS---YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
L Y D W+VG L E+ F DS + K I+ + FP+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMNHKNSLTFPDD 271
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFN 284
+IS+ EA +LI + +R R ++ +H FF
Sbjct: 272 NDISK-----------------------EAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 308
Query: 285 VETWVPYPLHD 295
+ W L D
Sbjct: 309 NDQWAWETLRD 319
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 77/298 (25%), Positives = 131/298 (43%), Gaps = 60/298 (20%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK--------ALRKLNHPN 61
+G G+ G V A + AVK +++K +N +E K L+ + HP
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-----VLNRKEQKHIMAERNVLLKNVKHPF 57
Query: 62 IIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ L + +L+F+ +++ +H+ RER P E R + +++ L ++H
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAAEIASALGYLHSI 115
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
+RDLKPEN+L+ + + + DFGL +E ++ T + T Y APEV ++ Y
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-IRKQPYD 174
Query: 178 PAIDMWAVGAILAE-LFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
+D W +GA+L E L+ L P + R ++
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFY------------------------------CRDVAEM 204
Query: 237 YSEIL--PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFFNVETW 288
Y IL P+ L P AS+ A ++ +L D RR A + +HPFF +W
Sbjct: 205 YDNILHKPLVLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 53/172 (30%), Positives = 92/172 (53%), Gaps = 9/172 (5%)
Query: 30 VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYH 88
VA+K +K + + L E + + +HPNII L+ VV ++ + + EYME+ +L
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 89 IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLAR 147
+R+ F+ ++ + + G+ ++ GY HRDL N+LV +N V K++DFGL+R
Sbjct: 95 FLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154
Query: 148 ELSSMP--PYTEY---VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
L P YT + RW APE + ++ A D+W+ G ++ E+ +
Sbjct: 155 VLEDDPEAAYTTRGGKIPIRW-TAPEA-IAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 11/208 (5%)
Query: 3 RYKILEELGDG-TCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNH 59
+Y++L + G G C C +A T ++ A K++++K E M L E + L K+N
Sbjct: 4 QYRVLGKGGFGEVCACQVRA----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
++ L + L + M +HI F E + +++L GL +H
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
R +RDLKPEN+L+ + ++I+D GLA ++ V T Y APEV L + Y
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV-LNNQRY 178
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSE 204
+ + D W +G ++ E+ F G E
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 4/198 (2%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + LE++G G+ G V+K + T ++VA+K + + E +E+ L + + P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+ K ++ +L+ I EY+ + E P E +I + + ++L+GL ++H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKK 122
Query: 122 FHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRD+K N+L++ + +K+ADFG+A +L+ + +V T ++ APEV+ Q S+Y
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSK 181
Query: 180 IDMWAVGAILAELFTLSP 197
D+W++G EL P
Sbjct: 182 ADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 6/188 (3%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKE 67
LG G G V T ++ A KK+ +K + E M L E + L K+N P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
L + M YHI + + + +Q+ G+ H+H +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 126 LKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWA 184
+KPEN+L+ +++D GLA EL T+ T Y APE+L + YS +D +A
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYPVDWFA 179
Query: 185 VGAILAEL 192
+G + E+
Sbjct: 180 MGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 40/243 (16%)
Query: 50 EVKALRKLNHPNIIKLKEVVRENNELFFIFEY-----MEHNLYHIMRERQIPFSEGEIRS 104
E+ L +H I+K + + +++L I EY + + ++E +PF E E+
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEH-LPFQEYEVGL 173
Query: 105 FMSQMLQGLAHMHRNGYFHRDLKPENL-LVTNDVLKIADFGLARELS---SMPPYTEYVS 160
Q++ L +H HRDLK N+ L+ ++K+ DFG +++ S S+ + +
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDW 220
T +Y APE L + YS DMW++G IL EL TL F G S+ + + +V + G D
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYD- 289
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
P +S M+A L+ L S +P RPT Q L
Sbjct: 290 -------------------PFPCPVSS-----GMKA--LLDPLLSKNPALRPTTQQLLHT 323
Query: 281 PFF 283
F
Sbjct: 324 EFL 326
|
Length = 478 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 8 EELGDGTCGCVYKA-FNVETYEI--VAVKKMKRKFYFWEECMN--LREVKALRKLNHPNI 62
++LGDG+ G V + ++ ++ VAVK +K + M+ L+E + L+H N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 63 IKLKEVVRENNELFFIFEYME-HNLYHIMRERQIP-FSEGEIRSFMSQMLQGLAHMHRNG 120
I+L VV + L + E +L +R+ + F + + Q+ G+ ++
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 121 YFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYR------APEVLLQS 173
+ HRDL N+L+ ++D +KI DFGL R L + YV + APE L++
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAWCAPES-LRT 174
Query: 174 SSYSPAIDMWAVGAILAELFT 194
++S A D+W G L E+FT
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 4 YKILEELGDG-TCGCVYKAFNVETYEIVAVKKM------KRKFYFWEECMNLREVKALRK 56
Y++L + G G C C +A T ++ A KK+ KRK E M L E + L K
Sbjct: 5 YRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRK----GEAMALNEKQILEK 56
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
+N ++ L + L + M +HI F E + +++ GL
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 115 HMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
+HR +RDLKPEN+L+ + ++I+D GLA E+ V T Y APEV +++
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV-VKN 175
Query: 174 SSYSPAIDMWAVGAILAEL 192
Y+ + D W +G ++ E+
Sbjct: 176 ERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-17
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 5 KILEELGDGTCGCVYK-----AFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH 59
KI E +G G G V + E + VA+K +K + + L E + + +H
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIF--VAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNII L+ VV ++ + I E+ME+ L +R+ F+ ++ + + G+ ++
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLAREL---SSMPPYTEY----VSTRWYRAPEVL 170
Y HRDL N+LV +N V K++DFGL+R L +S P YT + RW APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEA- 182
Query: 171 LQSSSYSPAIDMWAVGAILAELFT 194
+ ++ A D+W+ G ++ E+ +
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 80/338 (23%), Positives = 138/338 (40%), Gaps = 82/338 (24%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL----NH 59
+ ++ +G G G V V+T + A+K +++ VKA R + ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRN--QAAHVKAERDILAEADN 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
++KL ++ + L+F+ +Y+ ++ ++ I F E R +++++ + +H+
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLAREL-----------------SSMPPYTEY-- 158
G+ HRD+KP+N+L+ D +K+ DFGL SM P E+
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 159 -------------------------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF 193
V T Y APEVLL+ + Y+ D W+VG IL E+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 238
Query: 194 TLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNAS 253
P F D+ + KV +W + ++L S
Sbjct: 239 VGQPPFLADTPAETQLKVI------NWETTLHIPSQAKL--------------------S 272
Query: 254 MEAIDLIWQLC--SWDPLRRPTADQALQHPFFNVETWV 289
EA DLI +LC + D L + AD+ HPFF +
Sbjct: 273 REASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFA 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 51/304 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKK------MKRK--FYFWEECMNLREVKA 53
E + +++ +G G G V + + ++ A+K +KR +FWEE R++ A
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
N I++L +++ L+ + EYM +L ++M IP E R + ++++
Sbjct: 99 HA--NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP--EKWARFYTAEVVLA 154
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSS--MPPYTEYVSTRWYRAPEV 169
L +H G+ HRD+KP+N+L+ + LK+ADFG ++ + M V T Y +PEV
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214
Query: 170 LL---QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
L Y D W+VG L E+ F DS + K I+ + FP+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMDHKNSLTFPDD 271
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFN 284
IS+ +A DLI + +R R D+ HPFF
Sbjct: 272 IEISK-----------------------QAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
Query: 285 VETW 288
+ W
Sbjct: 309 NDQW 312
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 67/254 (26%), Positives = 121/254 (47%), Gaps = 44/254 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
E K++++LG G G V+ + + VA+K +K + M+ L E +++L
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLK------QGSMSPEAFLAEANLMKQL 58
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
HP +++L VV + ++ I EYME+ + + I + ++ +Q+ +G+A
Sbjct: 59 QHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 116 MHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVS-------TRWYRAP 167
+ R Y HRDL+ N+LV+ + KIADFGLAR + EY + +W AP
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIED----NEYTAREGAKFPIKW-TAP 172
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPGDS------EIDQLYKVCCILGAPD- 219
E + +++ D+W+ G +L E+ T I +PG + +++ Y++ P+
Sbjct: 173 EA-INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231
Query: 220 --------WTAFPE 225
W PE
Sbjct: 232 LYELMRLCWKEKPE 245
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 57/190 (30%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNH---PNIIK 64
+G G G VY +T ++ A+K + +K + E + L E L ++ P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 65 LKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHR 124
+ ++L FI + M H + FSE E+R + ++++ GL HMH +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 125 DLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMW 183
DLKP N+L+ + ++I+D GLA + S P+ V T Y APEVL + ++Y + D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWF 180
Query: 184 AVGAILAELF 193
++G +L +L
Sbjct: 181 SLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 2e-16
Identities = 82/314 (26%), Positives = 132/314 (42%), Gaps = 68/314 (21%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKLNH 59
+ Y++++++G+G G V+ + T E K + R E+ + EV +R+L H
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 60 PNIIKL--KEVVRENNELFFIFEYMEHNLYHIMRERQIPF------SEGEIRSFMSQMLQ 111
NI++ + + + N +L+ + E+ + + R Q + E I Q+L
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAG--DLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 112 GLAHMHR-----NG--YFHRDLKPENLLVTNDV------------------LKIADFGLA 146
LA+ H NG HRDLKP+N+ ++ + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 147 RELSSMPPYTEYVSTRWYRAPEVLL-QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI 205
+ + V T +Y +PE+LL ++ SY DMWA+G I+ EL +
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--------- 240
Query: 206 DQLYKVCCILGAPDWTAFPEATNISRLIS-ISYSEILPINLSDIIPNASMEAIDLIWQLC 264
T F +A N S+LIS + LPI S E LI L
Sbjct: 241 ---------------TPFHKANNFSQLISELKRGPDLPIK------GKSKELNILIKNLL 279
Query: 265 SWDPLRRPTADQAL 278
+ RP+A Q L
Sbjct: 280 NLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVK-------KMKRKFYFWEECMNLREVKALRKLNH--- 59
+G G G VY +T ++ A+K KMK+ E + L E L ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLALNERIMLSLVSTGDC 56
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
P I+ + ++L FI + M H + FSE E+R + ++++ GL HMH
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
+RDLKP N+L+ + ++I+D GLA + S P+ V T Y APEVL + +Y
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDS 175
Query: 179 AIDMWAVGAILAELF 193
+ D +++G +L +L
Sbjct: 176 SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 61/234 (26%), Positives = 121/234 (51%), Gaps = 9/234 (3%)
Query: 7 LEELGDGTCGCVY---KAFNVETYEIVAVKKMKRKFYFWEECMNLR-EVKALRKLNHPNI 62
L+ LG G+ G V+ K + ++ A+K +K+ + + + E L ++NHP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
+KL + +L+ I +++ +++ F+E +++ +++++ L H+H G
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 123 HRDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
+RDLKPEN+L+ + +K+ DFGL++E + + T Y APEV + ++ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQSA 179
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVC-CILGAPDWTAFPEATNISRLI 233
D W+ G ++ E+ T S F G + + + LG P + + PEA ++ R +
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLS-PEAQSLLRAL 232
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI----------- 95
L+E+K + +L +PNII+L V ++ L I EYME+ +L + +R+I
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 96 PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154
S + Q+ G+ ++ + HRDL N LV N +KIADFG++R L S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 155 Y----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
Y + RW +LL ++ A D+WA G L E+FTL
Sbjct: 185 YRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/190 (31%), Positives = 94/190 (49%), Gaps = 10/190 (5%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKE 67
LG GT G V T A+K +K++ E L E + L+ HP + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 68 VVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-RNGYFHR 124
+ ++ L F+ EY +H+ RER FSE R + ++++ L ++H +R
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 125 DLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDM 182
DLK ENL++ D +KI DFGL +E + + T Y APEV L+ + Y A+D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDW 179
Query: 183 WAVGAILAEL 192
W +G ++ E+
Sbjct: 180 WGLGVVMYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 15/224 (6%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKE 67
E LG G G V+K ++ VAVK K + L E + L++ +HPNI+KL
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 68 VVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL 126
V + ++ + E + + +R+++ ++ F G+A++ HRDL
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 127 KPENLLV-TNDVLKIADFGLARELSS---MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDM 182
N LV N+VLKI+DFG++R+ + + +W APE L YS D+
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPEA-LNYGRYSSESDV 177
Query: 183 WAVGAILAELFTLSPI-FPGDS------EIDQLYKVCCILGAPD 219
W+ G +L E F+L +PG + ++++ Y++ C PD
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD 221
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 3 RYKILEELGDG-TCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNH 59
+Y++L + G G C C +A T ++ A KK+++K E M L E + L K+N
Sbjct: 4 QYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
++ L + L + M +HI + F EG + +++ GL +H
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
+ +RDLKPEN+L+ + ++I+D GLA + V T Y APEV +++ Y
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV-VKNERY 178
Query: 177 SPAIDMWAVGAILAEL 192
+ + D WA+G +L E+
Sbjct: 179 TFSPDWWALGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 77/304 (25%), Positives = 135/304 (44%), Gaps = 48/304 (15%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMK--RKFYFWEECMNLREVKALRK-LNH- 59
+++L+ LG G G V+ V ++ + MK +K ++ + R+ L H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 60 ---PNIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
P ++ L + + +L I +Y+ E + RER F E E++ + +++ L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLAL 118
Query: 114 AHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEY--VSTRWYRAPEVL 170
H+H+ G +RD+K EN+L+ +N + + DFGL++E Y T Y AP+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 171 L-QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+ A+D W++G ++ EL T + F D E + I
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS------------------QAEI 220
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PT-ADQALQHPFFN 284
SR I + P +S + A D+I +L DP +R P+ AD+ +HPFF
Sbjct: 221 SRRI-LKSEPPYPQEMSAL-------AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
Query: 285 VETW 288
W
Sbjct: 273 KINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 15/210 (7%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V A T E+ A+K +K+ + EC M + V AL+ P + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQL 66
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ + L+F+ EY+ +YHI + + F E + + +++ GL +HR G +
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 124 RDLKPENLLVTND-VLKIADFGLARE--LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
RDLK +N+++ ++ +KIADFG+ +E + + T + T Y APE++ Y ++
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIAPEII-AYQPYGKSV 182
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYK 210
D WA G +L E+ P F G+ E D+L++
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 74/294 (25%), Positives = 130/294 (44%), Gaps = 55/294 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + LE +G G+ G VYK + T E+VA+K + + E +E+ L + + P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I + + +L+ I EY+ + +++ P E I + + ++L+GL ++H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSER 121
Query: 121 YFHRDLKPENLLVTN--DVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+K N+L++ DV K+ADFG+A +L+ + +V T ++ APEV+ Q S+Y
Sbjct: 122 KIHRDIKAANVLLSEQGDV-KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYD 179
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
D+W++G EL P
Sbjct: 180 FKADIWSLGITAIELAKGEP--------------------------------------PN 201
Query: 238 SEILPINLSDIIPNASMEAI---------DLIWQLCSWDPLRRPTADQALQHPF 282
S++ P+ + +IP S + + + + DP RPTA + L+H F
Sbjct: 202 SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 80/299 (26%), Positives = 134/299 (44%), Gaps = 49/299 (16%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNH 59
+ L LG G+ G V A T E+ A+K +K+ + EC M + V AL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KP 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
P + +L + + L+F+ EY+ +YHI + + F E + +++ GL +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLH 118
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT--EYVSTRWYRAPEVLLQSS 174
G +RDLK +N+++ + +KIADFG+ +E + T + T Y APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y ++D WA G +L E+ P F G+ E D+L+ + E
Sbjct: 178 -YGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELF-----------QSIMEHN------- 217
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQALQ-HPFFNVETW 288
+SY + L S EA+ + L + P +R PT ++ ++ H FF W
Sbjct: 218 VSYPKSL-----------SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE----CMNLREVKALRKLNHPNIIKL 65
+G G+ G V A + + AVK +++K ++ M+ R V L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ ++L+F+ +Y+ YH+ RER F E R + +++ L ++H +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 124 RDLKPENLLV-TNDVLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLKPEN+L+ + + + DFGL +E + + + T Y APEV L Y +D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV-LHKQPYDRTVD 178
Query: 182 MWAVGAILAE-LFTLSPIF 199
W +GA+L E L+ L P +
Sbjct: 179 WWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 65/195 (33%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKM------KRKFYFWEECMNLREVKALRKLNHPNII 63
LG G G V T ++ A KK+ KRK Y E M E + L K++ I+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAM--VEKRILAKVHSRFIV 56
Query: 64 KLKEVVRENNELFFIFEYMEHN--LYHI--MRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
L + +L + M YHI + E F E + +Q++ GL H+H+
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQSSSYS 177
+RDLKPEN+L+ ND ++I+D GLA EL T+ Y T + APE LLQ Y
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE-LLQGEEYD 175
Query: 178 PAIDMWAVGAILAEL 192
++D +A+G L E+
Sbjct: 176 FSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 39/241 (16%)
Query: 49 REVKALRKLNHPNIIKLKEVVR-ENNELFFIFEYMEH-NLYHIMRERQ---IPFSEGEIR 103
+E + L +L HPNI+ +E E+ L+ + + E +LYH ++E++ +P E ++
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP--ENQVV 105
Query: 104 SFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPY-TEYVST 161
+ Q+ L ++H HRDLK +N+ +T +++K+ D G+AR L + + + T
Sbjct: 106 EWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT 165
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221
+Y +PE L + Y+ D+WA+G + E+ TL F
Sbjct: 166 PYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAF---------------------- 202
Query: 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
A +++ L+ LP D P E +LI + S P +RP+ L+ P
Sbjct: 203 ---NAKDMNSLVYRIIEGKLPPMPKDYSP----ELGELIATMLSKRPEKRPSVKSILRQP 255
Query: 282 F 282
+
Sbjct: 256 Y 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETY--EIVAVKKMKR------KFYFWEECMNLREVK 52
+ K+ +G G G V Y + VAVK +K F L E
Sbjct: 5 SKELKLGATIGKGEFGDVMLG----DYRGQKVAVKCLKDDSTAAQAF--------LAEAS 52
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR-SFMSQML 110
+ L HPN+++L VV + N L+ + EYM +L +R R + F +
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
+G+ ++ + HRDL N+LV+ D V K++DFGLA+E +S + + +W APE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-ASQGQDSGKLPVKW-TAPEA 170
Query: 170 LLQSSSYSPAIDMWAVGAILAELFT 194
L+ +S D+W+ G +L E+++
Sbjct: 171 -LREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP---------- 96
L+E+K + +L PNII+L V ++ L I EYME+ +L + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 97 FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPY 155
S + +Q+ G+ ++ + HRDL N LV N +KIADFG++R L S Y
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 156 ----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+ RW +LL ++ A D+WA G L E+ TL
Sbjct: 187 RIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 84/336 (25%), Positives = 150/336 (44%), Gaps = 53/336 (15%)
Query: 4 YKILEELGDGTCGCVY---KAFNVETYEIVAVKKMKR-----KFYFWEECMNLREVKALR 55
+++L+ LG G G V+ K +T ++ A+K +++ K E R V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
+ P ++ L + +L I +Y+ ++ + +R FSE E+R + +++ L
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALE 119
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARE-LSSMPPYT-EYVSTRWYRAPEVLL 171
H+H+ G +RD+K EN+L+ ++ + + DFGL++E LS T + T Y APE++
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ A+D W++G ++ EL T + F + E + + +SR
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT------------------QSEVSR 221
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNVE 286
I + P EA DL+ +L DP +R A + +HPFF
Sbjct: 222 RI-LKCDPPFP-------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
Query: 287 TWVPYPLHDPLELRLNNMGSKPNL--ELNLWDFGTE 320
W L LR N +P++ EL++ +F E
Sbjct: 274 DWE------ALALRKVNPPFRPSIRNELDVGNFAEE 303
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 9/172 (5%)
Query: 30 VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYH 88
VA+K +K + + L E + + +H NII+L+ VV + I EYME+ L
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 89 IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147
+R+ FS ++ + + G+ ++ Y HRDL N+LV ++ K++DFGL+R
Sbjct: 96 YLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155
Query: 148 ELSSMPPYTEYVS-----TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
L P T S RW APE + ++ A D+W+ G ++ E+ +
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRW-TAPEA-IAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 78/304 (25%), Positives = 131/304 (43%), Gaps = 51/304 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKA 53
E Y +++ +G G G V + + ++ A+K K +FWEE R++ A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
N P +++L +++ L+ + EYM +L ++M +P E + + ++++
Sbjct: 99 FA--NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLA 154
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLAREL--SSMPPYTEYVSTRWYRAPEV 169
L +H G HRD+KP+N+L+ + LK+ADFG ++ + M V T Y +PEV
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 170 LLQSSS---YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
L Y D W+VG L E+ F DS + K I+ + FPE
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK---IMDHKNSLNFPED 271
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFN 284
IS+ A +LI + +R R ++ QHPFF
Sbjct: 272 VEISK-----------------------HAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308
Query: 285 VETW 288
+ W
Sbjct: 309 NDQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 76/300 (25%), Positives = 137/300 (45%), Gaps = 46/300 (15%)
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
NHP ++ L + + LFF+ EY+ ++H+ R+R++P E R + +++ L +
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISLALNY 111
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQS 173
+H G +RDLK +N+L+ ++ +K+ D+G+ +E L + + T Y APE+ L+
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI-LRG 170
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y ++D WA+G ++ E+ G S D I+G+ D P+ L
Sbjct: 171 EDYGFSVDWWALGVLMFEMMA------GRSPFD-------IVGSSD---NPDQNTEDYLF 214
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQ-HPFFNVET 287
+ + + I S S++A ++ + DP R T +Q HPFF
Sbjct: 215 QVILEKQIRIPRS-----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
Query: 288 WVPYPLHDPLELRLNNMGSKPNL--ELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQ 345
W D +E + KPN+ E L +F D F + + P + ++V + Q
Sbjct: 270 W------DLMEQKQVVPPFKPNISGEFGLDNF----DAQFTNEPVQLTPDDDDIVRKIDQ 319
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
E LG G G VYKA+++ T I+AVK + + + E++ L K + P II
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 67 EVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL 126
N + E+M+ + R+IP E + +++GL ++ HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY--RKIP--EHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 127 KPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAV 185
KP N+LV T +K+ DFG++ +L + T YV T Y APE + Y D+W++
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAPERIS-GEQYGIHSDVWSL 179
Query: 186 GAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINL 245
G EL +P Q+ K L P + + I +LP+
Sbjct: 180 GISFMELALGRFPYP------QIQKNQGSL-------MP--LQLLQCIVDEDPPVLPVGQ 224
Query: 246 SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
S + + I Q P RP + + HPF
Sbjct: 225 ------FSEKFVHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 88/359 (24%), Positives = 148/359 (41%), Gaps = 63/359 (17%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V+ A T + A+K +K+ + EC M + V +L HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHPFLTHL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ LFF+ EY+ ++HI + + ++++ GL +H G +
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLK +N+L+ D +KIADFG+ +E + + T Y APE+LL Y+ ++D
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL-GQKYNTSVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
W+ G +L E+ F G E + + R+ + Y L
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------------------RMDNPCYPRWL 219
Query: 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL-QHPFFNVETWVPYPLHDPLELR 300
+ EA D++ +L +P RR + QHPFF W LE R
Sbjct: 220 -----------TREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW------SALEER 262
Query: 301 LNNMGSKPNLELNLWDFGTEPDDC------FLGLTLAVKPSNLEMVHNVPQGMQEDILF 353
KP ++ +DC FL + ++ +++++ Q M E+ F
Sbjct: 263 EIEPPFKPKVK--------SANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFENFSF 313
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 49/296 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM--------KRKFYFWEECMNLREVKA 53
+++ + LG G G VY ++ +T +AVK++ K EC E++
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQL 57
Query: 54 LRKLNHPNIIKLKEVVRENNE--LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
L+ L H I++ +R+ E L EYM + +E R + Q+LQ
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ 117
Query: 112 GLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSM----PPYTEYVSTRWYRA 166
G++++H N HRD+K N+L + +K+ DFG ++ + ++ T ++ +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
PEV + Y D+W+V + E+ T P W +
Sbjct: 178 PEV-ISGEGYGRKADVWSVACTVVEMLT---------------------EKPPWAEYEAM 215
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
I ++ + +LP +SD D + Q+ + RRPTA+ L+HPF
Sbjct: 216 AAIFKIATQPTKPMLPDGVSD-------ACRDFLKQIFVEEK-RRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 79/292 (27%), Positives = 122/292 (41%), Gaps = 48/292 (16%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-PNII 63
+ L E+G GTCG VYK +T ++AVK+M+R E L ++ + K + P I+
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 64 KLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSE---GEIRSFMSQMLQGLAHMHRNG 120
K ++++F E M L +++ Q P E G++ + + L L H G
Sbjct: 78 KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--G 135
Query: 121 YFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL---LQSSSY 176
HRD+KP N+L+ + +K+ DFG++ L T Y APE + + Y
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
D+W++G L EL T FP YK C T F
Sbjct: 196 DIRADVWSLGISLVELAT--GQFP--------YKNCK-------TEF------------- 225
Query: 237 YSEILPINLSDIIP------NASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
E+L L + P S + + + D +RP + LQHPF
Sbjct: 226 --EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 30 VAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEHN--L 86
VAVK +K + E + E+K + L NH NI+ L + I EY + L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 87 YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGL 145
+ R+R+ + ++ SF Q+ +G+A + HRDL N+L+T+ ++KI DFGL
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187
Query: 146 ARELSSMPPYTEYVSTRW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFP 200
AR++ + Y + R + APE + Y+ D+W+ G +L E+F+L +P +P
Sbjct: 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNP-YP 245
Query: 201 G 201
G
Sbjct: 246 G 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 45/220 (20%)
Query: 9 ELGDGTCGCVYKA--FNVETYE---IVAVKKMK------RKFYFWEECMNLREVKALRKL 57
ELG+G G V+ A +N+ + +VAVK +K RK + RE + L L
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF-------QREAELLTNL 64
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMR----------ERQIPFSEGEIRSFM 106
H +I+K V + + L +FEYM+H +L +R + Q ++GE+ +
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG--L 122
Query: 107 SQMLQ-------GLAHMHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELSSMPPYT-- 156
SQML G+ ++ + HRDL N LV ++L KI DFG++R++ S Y
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182
Query: 157 --EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
+ RW PE ++ ++ D+W+ G IL E+FT
Sbjct: 183 GHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 67/251 (26%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 50 EVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEG----EIRSF 105
E+ AL +LNH NI+K++E++R + I + + +LY M + + + + R+
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY--VSTR 162
M Q+L + ++H HRD+K EN+ + D + + DFG A +Y V T
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFT--LSPIFPGDSEI-DQLYKVCCILGAPD 219
+PE +L Y D+W+ G IL ++ + PI G + QL K+ L D
Sbjct: 333 ATNSPE-ILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391
Query: 220 WTAFPE-ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLC---SWDPLRRPTAD 275
FP+ + I + + ++ +I N + A D + L ++D RP A
Sbjct: 392 -EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPA-DFEYPLVKMLTFDWHLRPGAA 449
Query: 276 QALQHPFFNVE 286
+ L P F+ E
Sbjct: 450 ELLALPLFSAE 460
|
Length = 501 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 7/152 (4%)
Query: 48 LREVKALRKLNHPNIIKLKEV-VRENNELFFIFEYM-EHNLYHIMRERQIPFSEGE-IRS 104
L E + +L H N+++L V V E L+ + EYM + +L +R R G+ +
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 105 FMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRW 163
F + + + ++ N + HRDL N+LV+ D V K++DFGL +E SS T + +W
Sbjct: 107 FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW 165
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
APE L+ +S D+W+ G +L E+++
Sbjct: 166 -TAPEA-LREKKFSTKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V A E AVK +K+ + EC M + V AL N P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTHL 61
Query: 66 KEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ LFF+ E++ ++HI + + + ++++ GL +H G +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQFLHSKGIIY 119
Query: 124 RDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAID 181
RDLK +N+++ D +KIADFG+ +E + + + T Y APE+ LQ Y+ ++D
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI-LQGLKYTFSVD 178
Query: 182 MWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241
W+ G +L E+ F GD E D+L++ + D +P R I
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV----DTPHYP------RWI-------- 219
Query: 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ-HPFFNVETW 288
+ E+ D++ +L DP RR ++ HPFF W
Sbjct: 220 -----------TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 57/175 (32%), Positives = 92/175 (52%), Gaps = 25/175 (14%)
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSE---------------GEI 102
H NII L ++ L+ I EY NL +R R+ P E ++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST 161
S Q+ +G+ ++ HRDL N+LVT N+V+KIADFGLAR+++++ Y + +
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 162 RW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQLYKV 211
R + APE L Y+ D+W+ G ++ E+FTL SP +PG +++L+K+
Sbjct: 200 RLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG-IPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 1 MERYKIL--EELGDGTCGCVYKAFNVETYEI--------VAVKKMK------RKFYFWEE 44
++R+ I+ ELG+G G K F E Y + VAVK +K RK +
Sbjct: 2 IKRHNIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--- 55
Query: 45 CMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYH-----------IMRER 93
RE + L L H +I+K V E + L +FEYM+H + +M E
Sbjct: 56 ----REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 94 QIP--FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELS 150
P ++ ++ Q+ G+ ++ + HRDL N LV ++L KI DFG++R++
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171
Query: 151 SMPPYT----EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
S Y + RW PE ++ ++ D+W++G +L E+FT
Sbjct: 172 STDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 85/320 (26%), Positives = 135/320 (42%), Gaps = 47/320 (14%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
+ ILE G G + + +T E V +K +R E LR +NHP+II
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-------GTATEAHILRAINHPSII 146
Query: 64 KLKEVVRENNELFFIFEYMEHNLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
+LK N I + +LY ++ +R I + I + +L+ + ++H N
Sbjct: 147 QLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICD--ILAIERSVLRAIQYLHENRII 204
Query: 123 HRDLKPENLLVTN--DVLKIADFGLARELSSMP------PYTEYVSTRWYRAPEVLLQSS 174
HRD+K EN+ + + DV + DFG A P Y + T APE LL
Sbjct: 205 HRDIKAENIFINHPGDVC-LGDFGAA----CFPVDINANKYYGWAGTIATNAPE-LLARD 258
Query: 175 SYSPAIDMWAVGAILAELFTL-SPIFP-----GDSEIDQLYKVCCILGAPDWTAFP-EAT 227
Y PA+D+W+ G +L E+ T +F GD + D+ K+ FP +A
Sbjct: 259 PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318
Query: 228 NISRLISISY---------SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
I I S L NL ++ ++ LI ++ ++D RP+A+ L
Sbjct: 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYEL----PIDLEYLICKMLAFDAHHRPSAEALL 374
Query: 279 QHPFFNVETWVPYPLHDPLE 298
F +P P +P+E
Sbjct: 375 DFAAFQD---IPDPYPNPME 391
|
Length = 391 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 22/195 (11%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVKKMK-----RKFYFWEECMNLREVKALRKLNHPNI 62
E +G+G G V + T + VAVK +K + F L E + KL+H N+
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAF--------LEETAVMTKLHHKNL 61
Query: 63 IKLKEVVRENNELFFIFEYMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNG 120
++L V+ N L+ + E M NL + +R R + S ++ F + +G+ ++
Sbjct: 62 VRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRDL N+LV+ D V K++DFGLAR + SM + +W APE L+ +S
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKW-TAPEA-LKHKKFSSK 177
Query: 180 IDMWAVGAILAELFT 194
D+W+ G +L E+F+
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 74/314 (23%), Positives = 116/314 (36%), Gaps = 51/314 (16%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR------EVKALRKL 57
I + D + K T +VAVKK + C E+ R+L
Sbjct: 4 TLIGKCFEDLMIVHLAKH--KPTNTLVAVKK-----INLDSCSKEDLKLLQQEIITSRQL 56
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIP--FSEGEIRSFMSQMLQGLAH 115
HPNI+ ++EL+ + M + + + P E I + +L L +
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDY 116
Query: 116 MHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELSSM------------PPYTEYVSTR 162
+H G+ HR +K ++L++ D ++ R SM P + +
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 163 WYRAPEVLLQS-SSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLY--KVC----CI 214
W +PEVL Q+ Y+ D+++VG EL P D Q+ KV C+
Sbjct: 174 WL-SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK--DMPATQMLLEKVRGTVPCL 230
Query: 215 LGAPDWTAFPEATNISRLISISYSEILPINLS--DIIPNASM-EAIDLIWQLC-SWDPLR 270
L D + +P + S P N D + E +LC DP
Sbjct: 231 L---DKSTYPL--YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285
Query: 271 RPTADQALQHPFFN 284
RP+A Q L H FF
Sbjct: 286 RPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 31/216 (14%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
E K+ ++LG G G V+ A +N T VAVK MK E L E ++ L H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAF--LAEANVMKTLQHD 61
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMR-----ERQIPFSEGEIRSFMSQMLQGLA 114
++KL VV + ++ I E+M +L ++ ++ +P ++ F +Q+ +G+A
Sbjct: 62 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMA 116
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS-------TRWYRA 166
+ + Y HRDL+ N+LV+ V KIADFGLAR + EY + +W A
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKW-TA 171
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPG 201
PE + S++ D+W+ G +L E+ T I +PG
Sbjct: 172 PEA-INFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 58/175 (33%), Positives = 89/175 (50%), Gaps = 25/175 (14%)
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP---------------FSEGEI 102
H NII L ++ L+ I EY NL +R R+ P S ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST 161
S Q+ +G+ ++ HRDL N+LVT D V+KIADFGLAR++ + Y + +
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 162 RW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQLYKV 211
R + APE L Y+ D+W+ G +L E+FTL SP +PG +++L+K+
Sbjct: 203 RLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHP 60
+ ++I+E +G GT G V+K N + AVK + EE E L+ L +HP
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--AEYNILKALSDHP 75
Query: 61 NIIKL-----KEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
N++K K+ V+ ++L+ + E +L +R E I + + L
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVSTRWYRAPEV 169
GL H+H N HRD+K N+L+T + +K+ DFG++ +L+S V T ++ APEV
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 170 LL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
+ S+Y D+W++G EL P + L+K+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 69/235 (29%), Positives = 115/235 (48%), Gaps = 29/235 (12%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
E +++++LG+G G V+ +N T VAVK +K E L E + ++KL H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESF--LEEAQIMKKLRHD 61
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIM------RERQIPFSEGEIRSFMSQMLQGLA 114
+++L VV E ++ + EYM R ++P + +Q+ G+A
Sbjct: 62 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLP----NLVDMAAQVAAGMA 116
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRW---YRAPEVL 170
++ R Y HRDL+ N+LV + V KIADFGLAR L YT ++ + APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPI-FPGDS------EIDQLYKVCCILGAP 218
L ++ D+W+ G +L EL T + +PG + ++++ Y++ C P
Sbjct: 176 LY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP 229
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/174 (31%), Positives = 88/174 (50%), Gaps = 23/174 (13%)
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP---------------FSEGEI 102
H NII L ++ L+ + EY NL +R R+ P + ++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST 161
S Q+ +G+ ++ HRDL N+LVT D V+KIADFGLAR++ ++ Y + +
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 162 RW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPGDSEIDQLYKV 211
R + APE L Y+ D+W+ G +L E+FTL +PG +++L+K+
Sbjct: 197 RLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 9 ELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNL---REVKALRKLNHP 60
ELG+G G V+ A + +VAVK +K E RE + L L H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQ 67
Query: 61 NIIKLKEVVRENNELFFIFEYMEH---NLY--------HIMRERQI----PFSEGEIRSF 105
+I++ V E L +FEYM H N + I+ + + G++ +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----TEYVS 160
SQ+ G+ ++ + HRDL N LV V+KI DFG++R++ S Y +
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
RW PE +L ++ D+W+ G +L E+FT
Sbjct: 188 IRWM-PPESILY-RKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 74/243 (30%), Positives = 117/243 (48%), Gaps = 39/243 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEI----------VAVKKMKRKFYFWEECMNLREV 51
+R + + LG+G G V +A E Y I VAVK +K + + E+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRA---EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 52 KALRKLN-HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP----------FSE 99
+ ++ + H NII L V + L+ I EY NL +R R+ P E
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 100 GEIR-----SFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153
++ S Q+ +G+ ++ HRDL N+LVT D V+KIADFGLAR + +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 154 PYTEYVSTRW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQL 208
Y + + R + APE L Y+ D+W+ G ++ E+FTL SP +PG +++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSP-YPG-IPVEEL 245
Query: 209 YKV 211
+K+
Sbjct: 246 FKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 13/210 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ ++ + ELG G G V K + + I+A K + + +RE++ L + N P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRE-RQIPFSEGEIRSFMS-QMLQGLAHM-H 117
I+ + E+ E+M+ +L +++E ++IP EI +S +L+GLA++
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP---EEILGKVSIAVLRGLAYLRE 121
Query: 118 RNGYFHRDLKPENLLV-TNDVLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSS 175
++ HRD+KP N+LV + +K+ DFG++ +L SM +V TR Y +PE LQ +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTH 178
Query: 176 YSPAIDMWAVGAILAEL-FTLSPIFPGDSE 204
YS D+W++G L EL PI P D++
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMN--LREVKALRKLNHPN 61
L ELG G G V K + + I M RK E N +RE+K L + N P
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLI-----MARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I+ + E+ E+M+ +L ++++ +IP E + +L+GL ++
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--ENILGKISIAVLRGLTYLREK 118
Query: 120 -GYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSSY 176
HRD+KP N+LV + +K+ DFG++ +L SM +V TR Y +PE LQ + Y
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHY 175
Query: 177 SPAIDMWAVGAILAELFT-LSPIFPGDS 203
+ D+W++G L E+ PI P D+
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 12/192 (6%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
+ I L G+ GCV+++ + + + V VK +Y ++ E + LR+L+HP ++
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKA---GWY----ASSVHEARLLRRLSHPAVL 223
Query: 64 KLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
L +V + +LY + R P ++ + Q+L + ++H G H
Sbjct: 224 ALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283
Query: 124 RDLKPENLLV-TNDVLKIADFG---LARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
RD+K EN+LV + + + DFG AR S P + T APEV L Y+P+
Sbjct: 284 RDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEV-LAGDPYTPS 342
Query: 180 IDMWAVGAILAE 191
+D+W+ G ++ E
Sbjct: 343 VDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 67/288 (23%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMK--------RKFYFWEECMNLREVKALRKLNHPN 61
LG G G VY ++V+T +A K+++ K EC E++ L+ L H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQHER 65
Query: 62 IIKLKEVVRENNE--LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I++ +R+ E L EYM + +E R + Q+L+G++++H N
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSM----PPYTEYVSTRWYRAPEVLLQSS 174
HRD+K N+L + +K+ DFG ++ L ++ T ++ +PEV+
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI-SGE 184
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y D+W++G + E+ T P W + I ++ +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKP---------------------PWAEYEAMAAIFKIAT 223
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ LP ++S+ A D + + + RP+A++ L+HPF
Sbjct: 224 QPTNPQLPSHISE-------HARDFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMK--------RKFYFWEECMNLREVKALRKLNHPN 61
LG G G VY ++ +T +AVK+++ K EC E++ L+ L H
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLKNLLHER 65
Query: 62 IIKLKEVVRENNE--LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I++ +R+ E L E+M + +E R + Q+L+G++++H N
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSM----PPYTEYVSTRWYRAPEVLLQSS 174
HRD+K N+L + +K+ DFG ++ L ++ T ++ +PEV +
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV-ISGE 184
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y D+W+VG + E+ T P W F I ++ +
Sbjct: 185 GYGRKADIWSVGCTVVEMLT---------------------EKPPWAEFEAMAAIFKIAT 223
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ +LP ++SD D + ++ L RP+AD+ L+H F
Sbjct: 224 QPTNPVLPPHVSD-------HCRDFLKRIFVEAKL-RPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 43/290 (14%)
Query: 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPNII 63
+L+ELG G G VYK + T +A+K+++ + E N + E+ L K P I+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIV 62
Query: 64 KLKEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM-HR 118
++ EYM+ LY + E +R +++GL +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG-IPEDVLRRITYAVVKGLKFLKEE 121
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL-----LQ 172
+ HRD+KP N+LV N +K+ DFG++ L + T + + Y APE + Q
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGGPNQ 180
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
+ +Y+ D+W++G + E LG +P
Sbjct: 181 NPTYTVQSDVWSLGLSILE---------------------MALG-----RYPYPPETYAN 214
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
I S I+ + + S +A D + + + P RRPT Q L+HP+
Sbjct: 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
++++E +G+GT G VYK +V+T ++ A+K M EE E+ L+K +H I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK--LEINMLKKYSHHRNI 75
Query: 64 KL-------KEVVRENNELFFIFEYMEHNLYH--IMRERQIPFSEGEIRSFMSQMLQGLA 114
K +++L+ + E+ + + E I ++L+GLA
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLL- 171
H+H + HRD+K +N+L+T N +K+ DFG++ +L ++ ++ T ++ APEV+
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 172 ---QSSSYSPAIDMWAVGAILAELFTLSP 197
++Y D+W++G E+ +P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 56/185 (30%), Positives = 98/185 (52%), Gaps = 16/185 (8%)
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM-EHNLYHIMRERQIPFSE-GEIRSF 105
L+E + ++KL H ++ L VV E ++ + E+M + +L ++E + + ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW- 163
+Q+ G+A++ R Y HRDL+ N+LV N V KIADFGLAR L YT ++
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFP 166
Query: 164 --YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPGD------SEIDQLYKVCCI 214
+ APE L ++ D+W+ G +L EL T + +PG ++++ Y++ C
Sbjct: 167 IKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP 225
Query: 215 LGAPD 219
G P+
Sbjct: 226 QGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNH 59
+ L LG G+ G V A T E+ A+K +K+ + EC M + V AL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KP 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
P + +L + + L+F+ EY+ +Y I + + F E + +++ GL +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLH 118
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARE--LSSMPPYTEYVSTRWYRAPEVLLQSS 174
G +RDLK +N+++ ++ +KIADFG+ +E + T + T Y APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEII-AYQ 176
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK 210
Y ++D WA G +L E+ F G+ E D+L++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
E ++ +LG G G V+ +N T VA+K +K E L+E + ++KL H
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAF--LQEAQVMKKLRHE 61
Query: 61 NIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
+++L VV E ++ + EYM L + E ++ +Q+ G+A++ R
Sbjct: 62 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRW---YRAPEVLLQSS 174
Y HRDL+ N+LV N V K+ADFGLAR L YT ++ + APE L
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY-G 178
Query: 175 SYSPAIDMWAVGAILAELFTLSPI-FPG 201
++ D+W+ G +L EL T + +PG
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 38/222 (17%)
Query: 5 KILEELGDGTCGCVYKAF----NVETYEIVAVKKMK--RKFYFWEECMNLREVKALRKLN 58
+ +EELG+ G +YK ++ ++VA+K +K W E +E + +L+
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ--QEASLMAELH 65
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYH---IMRERQIPFS--------EGEIRSFMS 107
HPNI+ L VV + + +FEY+ H IMR P S +G ++S +
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRS---PHSDVGCSSDEDGTVKSSLD 122
Query: 108 ---------QMLQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPY-- 155
Q+ G+ ++ + + H+DL N+L+ + +KI+D GL+RE+ S Y
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 156 --TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+ RW PE ++ +S D+W+ G +L E+F+
Sbjct: 183 QPKSLLPIRWM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 8 EELGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKALRKLNH 59
E +G G G V+ VAVK +K KF L+E + L++ +H
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKF--------LQEARILKQYSH 52
Query: 60 PNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI++L V + ++ + E ++ + +R E+ + G+ ++
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 119 NGYFHRDLKPENLLVT-NDVLKIADFGLARE----LSSMPPYTEYVSTRWYRAPEVLLQS 173
HRDL N LVT +VLKI+DFG++RE + + + + +W APE L
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEA-LNY 170
Query: 174 SSYSPAIDMWAVGAILAELFTL 195
YS D+W+ G +L E F+L
Sbjct: 171 GRYSSESDVWSFGILLWEAFSL 192
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 4 YKILEELGDG-TCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHP 60
Y++L + G G C C +A T ++ A KK+++K E M L E + L K+N
Sbjct: 5 YRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 61 NIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
++ L + L + M +HI F E + +++ GL + R
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 119 NGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
+RDLKPEN+L+ + ++I+D GLA ++ V T Y APEV + + Y+
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV-INNEKYT 179
Query: 178 PAIDMWAVGAILAEL 192
+ D W +G ++ E+
Sbjct: 180 FSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 9 ELGDGTCGCVYKAF--NVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKLNHPNII 63
ELG G G V K ++ + VAVK +K + + LRE +++L++P I+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIV 59
Query: 64 KLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
++ + E + E E + ++ +E I + Q+ G+ ++ + H
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 124 RDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVST-----RWYRAPEVLLQSSSYS 177
RDL N LLVT KI+DFGL++ L + Y + + +WY APE + +S
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APEC-MNYYKFS 176
Query: 178 PAIDMWAVGAILAELFT 194
D+W+ G ++ E F+
Sbjct: 177 SKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
++++E +G+GT G VYK +V+T ++ A+K M EE +E+ L+K +H I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--QEINMLKKYSHHRNI 65
Query: 64 K--LKEVVREN-----NELFFIFEYMEHNLYH--IMRERQIPFSEGEIRSFMSQMLQGLA 114
+++N ++L+ + E+ I + E I ++L+GL+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLL- 171
H+H++ HRD+K +N+L+T N +K+ DFG++ +L ++ ++ T ++ APEV+
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 172 ---QSSSYSPAIDMWAVGAILAELFTLSP 197
++Y D+W++G E+ +P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
E+ +L ELG G+ G VY+ E VAVK + E L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSE---GEIRSFMSQMLQ- 111
++++L VV + + E M H +L +R + P +E G + +M+Q
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQM 124
Query: 112 ------GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE----YVS 160
G+A+++ + HRDL N +V +D +KI DFG+ R++ Y + +
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS 196
RW APE L+ ++ + DMW+ G +L E+ +L+
Sbjct: 185 VRWM-APES-LKDGVFTTSSDMWSFGVVLWEITSLA 218
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 25/252 (9%)
Query: 49 REVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQ 108
RE+ L+ ++H II L R + + + + +L+ + +R P + + +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRR 193
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVT---NDVLKIADFGLARELSSMPPYTE----YVST 161
+L+ LA++H G HRD+K EN+ + N VL DFG A +L P T + T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVL--GDFGAACKL-DAHPDTPQCYGWSGT 250
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPG---DSEIDQLYKVC-CILGA 217
+PE LL Y D+W+ G +L E+ + G S QL + C+
Sbjct: 251 LETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309
Query: 218 PDWTAFP--EATNISRLISISYSEIL--PINLSDIIPNA--SMEAIDLIWQLCSWDPLRR 271
P FP +TN+ + Y+ +L P + +I M+ LI ++ ++D R
Sbjct: 310 P--LEFPQNGSTNLCKHFK-QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFR 366
Query: 272 PTADQALQHPFF 283
P+A L P F
Sbjct: 367 PSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 82/303 (27%), Positives = 125/303 (41%), Gaps = 59/303 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR-EVKALRKLNHP 60
++Y I LG G G V A V E AVK + + + + EV L +
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 61 NIIKLKEVV---RENNE-----LFFIFEYMEH-NLYHIMRERQI---PFSEGEIRSFMSQ 108
+I+K E N + + +Y +L ++ R F E E Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 109 MLQGLAHMHRNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVS------- 160
+L + H+H HRD+K N LL +N ++K+ DFG S M Y VS
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG----FSKM--YAATVSDDVGRTF 205
Query: 161 --TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218
T +Y APE+ + YS DM+++G +L EL TL F G++ + ++K + G
Sbjct: 206 CGTPYYVAPEI-WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT--LAGRY 262
Query: 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
D P LP P+ S E +++ L S DP RRP++ + L
Sbjct: 263 D----P----------------LP-------PSISPEMQEIVTALLSSDPKRRPSSSKLL 295
Query: 279 QHP 281
P
Sbjct: 296 NMP 298
|
Length = 496 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKK----------MKRKFYFWEECMNLRE 50
M+RY I+ +G G G VY A++ VA+KK +K++F LRE
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRF--------LRE 52
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMR---ERQI---PFSEGE-I 102
K L HP I+ + + + + +++ Y+E + L +++ +++ +E +
Sbjct: 53 AKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 103 RSFMS---QMLQGLAHMHRNGYFHRDLKPENLLVT--NDVLKIADFGLAREL-------- 149
+F+S ++ + ++H G HRDLKP+N+L+ +V+ I D+G A
Sbjct: 113 GAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLL 171
Query: 150 -----------SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI 198
SSM + V T Y APE LL + S + D++A+G IL ++ TLS
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLS-- 228
Query: 199 FP 200
FP
Sbjct: 229 FP 230
|
Length = 932 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 81/332 (24%), Positives = 133/332 (40%), Gaps = 84/332 (25%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL----NHPNI 62
++ LG G G V A V+T + A+K +++K + VKA R + ++ +
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRN--QVAHVKAERDILAEADNEWV 63
Query: 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
++L ++ + L+F+ +Y+ + R F E R +++++ + +H+ G+
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 123 HRDLKPENLLVTND-VLKIADFGLAREL-----------------SSMPPYTEY------ 158
HRD+KP+N+L+ D +K+ DFGL SM E+
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 159 -------------------------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF 193
V T Y APEVLL+ + Y+ D W+VG IL E+
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 242
Query: 194 TLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNAS 253
P F + ++ KV I++ L I S
Sbjct: 243 VGQPPFLAQTPLETQMKV-----------------------INWQTSLHIPPQ---AKLS 276
Query: 254 MEAIDLIWQLCSW--DPLRRPTADQALQHPFF 283
EA DLI +LC D L + AD+ HPFF
Sbjct: 277 PEASDLIIKLCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 8 EELGDGTCGCV----YKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
+ELG G G V Y + + E VAVK +K++ + LRE + +L+HP I+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 64 KLKEVVRENNELFFIFEYMEHNLYH--IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+L V + L + E + + R+IP S+ ++ Q+ G+A++ +
Sbjct: 60 RLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSD--LKELAHQVAMGMAYLESKHF 116
Query: 122 FHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVLLQS 173
HRDL N LLV KI+DFG++R L Y +T +WY APE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAGRWPLKWY-APEC-INY 172
Query: 174 SSYSPAIDMWAVGAILAELFTL 195
+S D+W+ G L E F+
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 67/252 (26%), Positives = 101/252 (40%), Gaps = 62/252 (24%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEI----------------VAVKKMK-------RK 38
+ +E+LG+G G V+ + VAVK ++ R+
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 39 FYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPF 97
+ L+EVK L +L+ PNI +L V + L I EYME+ +L +++
Sbjct: 65 DF-------LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 98 SEGEIRSFMS----------QMLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLA 146
S S Q+ G+ ++ + HRDL N LV N +KIADFG++
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 147 RELSS-----------MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
R L S +P RW VLL ++ D+WA G L E+ TL
Sbjct: 178 RNLYSSDYYRVQGRAPLP-------IRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTL 228
Query: 196 SPIFPGDSEIDQ 207
P + DQ
Sbjct: 229 CREQPYEHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 72/295 (24%), Positives = 121/295 (41%), Gaps = 52/295 (17%)
Query: 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK--------ALRKL 57
++EELG G G V K +V T I+AVK+++ +N +E K ++R +
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-------VNSQEQKRLLMDLDISMRSV 57
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMR---ERQIPFSEGEIRSFMSQMLQGLA 114
+ P + + +++ E M+ +L + ++ + E + +++ L
Sbjct: 58 DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 115 HMHRN-GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL-- 170
++H HRD+KP N+L+ N +K+ DFG++ L T + Y APE +
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 177
Query: 171 -LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDW-TAFPEATN 228
L Y D+W++G + EL T FP DS W T F +
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGR--FPYDS----------------WKTPFQQLKQ 219
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ S LP S E D + + + RP + LQHPFF
Sbjct: 220 VVE----EPSPQLPAE------KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 8 EELGDGTCGCVYKAFNVETYEI-----VAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
+E+G+G G K E + V VK+++ E+ + L+EV+ R+LNHPN+
Sbjct: 1 DEIGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57
Query: 63 IKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQM----LQGLAHMH 117
++ E+ + E+ +L + +R + ++ + + +M GL +H
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 118 RNGYFHRDLKPENLLVTNDV-LKIADFGLA----RELSSMPPYTEYVSTRWYRAPEVL-- 170
+ + H DL N +T D+ +KI D+GLA E + V RW APE++
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEI 176
Query: 171 ----LQSSSYSPAIDMWAVGAILAELFTLS 196
L + ++W++G + ELFT +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 82/336 (24%), Positives = 136/336 (40%), Gaps = 90/336 (26%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREV---KALRKL----NH 59
++ LG G G V A V+T+ + A+K +++K + +N +V KA R + ++
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-----DVLNRNQVAHVKAERDILAEADN 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++KL ++ + L+F+ +Y+ + R F E R +++++ + +H+
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLAREL-----------------SSMPPYTEY--- 158
G+ HRD+KP+N+L+ D +K+ DFGL SM P +
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 159 ----------------------------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILA 190
V T Y APEVLL+ Y+ D W+VG IL
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239
Query: 191 ELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIP 250
E+ P F + + KV +W +L
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVI------NWENTLHIPPQVKL------------------ 275
Query: 251 NASMEAIDLIWQLC--SWDPLRRPTADQALQHPFFN 284
S EA+DLI +LC + + L R AD HPFF+
Sbjct: 276 --SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 39/139 (28%), Positives = 78/139 (56%), Gaps = 7/139 (5%)
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
NHP ++ L + + LFF+ E++ ++H+ R+R++P E R + +++ L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP--EEHARFYSAEISLALNF 111
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQS 173
+H G +RDLK +N+L+ + +K+ D+G+ +E + + + T Y APE+ L+
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-LRG 170
Query: 174 SSYSPAIDMWAVGAILAEL 192
Y ++D WA+G ++ E+
Sbjct: 171 EDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 18/224 (8%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNI 62
++I+E +G GT G VYK N + + AVK + EE E L+ L NHPN+
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE--AEYNILQSLPNHPNV 81
Query: 63 IKLKEVVRENN-----ELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+K + + + +L+ + E L + E I + L GL
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVSTRWYRAPEVLL 171
H+H N HRD+K N+L+T + +K+ DFG++ +L+S V T ++ APEV+
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 172 ----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
SY D+W++G EL P + L+K+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 7/190 (3%)
Query: 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEV 68
G+ GC+ E VA+ ++ + L E L + +H NI++L+ V
Sbjct: 17 RFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGV 74
Query: 69 VRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLK 127
+ N + + EYM + L +R+ + G++ + + G+ ++ GY H+ L
Sbjct: 75 ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA 134
Query: 128 PENLLVTND-VLKIADFGLARELSSMPPYTEY--VSTRWYRAPEVLLQSSSYSPAIDMWA 184
+LV +D V KI+ F +E S YT S + APE +Q +S A D+W+
Sbjct: 135 AHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA-IQYHHFSSASDVWS 193
Query: 185 VGAILAELFT 194
G ++ E+ +
Sbjct: 194 FGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 9/220 (4%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII 63
++ + ELG G G V+K + + I+A K + + +RE++ L + N P I+
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 64 KLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM-HRNGYF 122
+ E+ E+M+ + ++ E + +++GL ++ ++
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 123 HRDLKPENLLV-TNDVLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAI 180
HRD+KP N+LV + +K+ DFG++ +L SM +V TR Y +PE LQ + YS
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYSVQS 183
Query: 181 DMWAVGAILAEL-FTLSPIFPGDS-EIDQLYKVCCILGAP 218
D+W++G L E+ PI P D+ E++ ++ C + G P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFG-CPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 23/194 (11%)
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
++P ++ L + + LF + EY+ ++H+ R+R++P E R + +++ L
Sbjct: 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP--EEHARFYAAEICIALNF 111
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARE-LSSMPPYTEYVSTRWYRAPEVLLQS 173
+H G +RDLK +N+L+ D +K+ D+G+ +E L + + T Y APE+ L+
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI-LRG 170
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIF------PGDSEIDQLYKVCCILGAPDWTAFPEAT 227
Y ++D WA+G ++ E+ F P + D L++V IL P
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--ILEKP--------I 220
Query: 228 NISRLISISYSEIL 241
I R +S+ S +L
Sbjct: 221 RIPRFLSVKASHVL 234
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
E+ + ELG G+ G VY+ E VA+K + E L E +++
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMR--ERQIPFSEGEIRSFMSQMLQ-- 111
N ++++L VV + I E M +L +R ++ + + + +M+Q
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 112 -----GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE----YVST 161
G+A+++ N + HRDL N +V D +KI DFG+ R++ Y + +
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS 196
RW +PE L+ ++ D+W+ G +L E+ TL+
Sbjct: 186 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATLA 218
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 48/206 (23%)
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLAR-ELSSMPP--YTEY 158
R + ++ + L ++H G HRDLKP+NLL+T+ +K+ DFGL++ L S+ Y +
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 159 VS-------------TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI 205
+ T Y APEV+L+ Y +D WA+G IL E F GD+
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDT-- 220
Query: 206 DQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCS 265
PE ++IS +I + +P +A DLI +L
Sbjct: 221 ------------------PEEL-FGQVIS---DDIEWPEGDEALPA---DAQDLISRLLR 255
Query: 266 WDPLRR---PTADQALQHPFFNVETW 288
+PL R A + QH FF W
Sbjct: 256 QNPLERLGTGGAFEVKQHRFFLGLDW 281
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 7/202 (3%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
E + + LG G+ G V A + E + VA+K+ ++ ++ ++ E K L +N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HP + L ++ + L+ + E++ + R F + +Q++ ++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
+RDLKPENLL+ D +K+ DFG A+ + + YT T Y APE+LL + +
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-TYT-LCGTPEYIAPEILL-NVGHG 206
Query: 178 PAIDMWAVGAILAELFTLSPIF 199
A D W +G + E+ P F
Sbjct: 207 KAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 9 ELGDGTCGCVYKA-FNVETYEI-VAVKKMKR--KFYFWEECMNLREVKALRKLNHPNIIK 64
ELG G GCV K + + +I VA+K +K + +E M RE + + +L++P I++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM--REAEIMHQLDNPYIVR 59
Query: 65 LKEVVRENNELFFIFEYMEH---NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+ V E L + E N + ++ +I S + M Q+ G+ ++ +
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSN--VVELMHQVSMGMKYLEGKNF 116
Query: 122 FHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVST-----RWYRAPEVLLQSSS 175
HRDL N LLV KI+DFGL++ L + Y + S +WY APE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY-APECIN-FRK 174
Query: 176 YSPAIDMWAVGAILAELFT 194
+S D+W+ G + E F+
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 10 LGDGTCGCVYKAF-----NVETYEIVAVKKM-KRKFYFWEECMNL---REVKALRKLNHP 60
LG G G V+ A +V VK + K K +E + RE+ RKL+H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHK 68
Query: 61 NIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQI--------PFSEGEIRSFMSQMLQ 111
N+++L + RE + I EY + +L +R + P S + + +Q+
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST----RWYRA 166
G+ H+ + HRDL N LV++ +K++ L++++ + Y + + RW A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN-SEYYKLRNALIPLRWL-A 186
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFT 194
PE +Q +S D+W+ G ++ E+FT
Sbjct: 187 PEA-VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 26/172 (15%)
Query: 48 LREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGE----- 101
L+EVK L +L PNII+L V + + L I EYME+ +L + + E
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 102 -------------IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLAR 147
+ Q+ G+ ++ + HRDL N LV N +KIADFG++R
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 148 ELSSMPPY----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
L + Y + RW A E +L ++ A D+WA G L E+ L
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWM-AWECILM-GKFTTASDVWAFGVTLWEILML 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 89/335 (26%), Positives = 141/335 (42%), Gaps = 77/335 (22%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+R+KIL LG+GT G V +A++ + E AVK ++ N+ + K+
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR----------NVPKYTRDAKIE--- 175
Query: 62 IIKLKEVVRENN-----ELFFIFEYMEHNLYH---------------IMRERQIPFSEGE 101
I+ E VR+ + L I Y ++ H IM+ PFS
Sbjct: 176 -IQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRH 232
Query: 102 IRSFMSQMLQGLAHMHRNGYF-HRDLKPENLL----------VTNDVL-------KIADF 143
+ + Q L + H + H DLKPEN+L VTN L +I D
Sbjct: 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 144 G-LARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD 202
G E S T VSTR YR+PEV+L + + DMW++G I+ EL+T ++
Sbjct: 293 GGCCDERHSR---TAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 203 SEIDQLYKVCCILG--APDWTAFPEATNISRLISISYSEILPIN-------------LSD 247
++ L+ + LG +W T +RL+ S ++ P + +
Sbjct: 349 DNLEHLHLMEKTLGRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVRE 407
Query: 248 IIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+I + + DLI+ L +D +R A Q HP+
Sbjct: 408 VIRDDLL--CDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 1 MERYKILEELGDGTCGCVYKAFNV---ETYEI-VAVKKMKRKFYFWEECMNLREVKALRK 56
+ ++ LG G G VYK + E +I VA+K ++ + L E +
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
++HP++++L + ++++ I + M L +R + + ++ Q+ +G+++
Sbjct: 66 VDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 116 MHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEY------VSTRWYRAPE 168
+ HRDL N+LV T +KI DFGLA+ L EY V +W A E
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWM-ALE 181
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFT 194
+ Y+ D+W+ G + EL T
Sbjct: 182 S-ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 10 LGDGTCGCVYKAFNVETYEI---VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
+G G GCVY +++ AVK + R E L+E ++ +HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 67 EVVRENNEL-FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHR 124
+ + + YM+H +L + +R + ++ F Q+ +G+ ++ + HR
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 125 DLKPEN-LLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEV--------LLQSSS 175
DL N +L + +K+ADFGLAR++ EY S + ++ LQ+
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 176 YSPAIDMWAVGAILAELFT 194
++ D+W+ G +L EL T
Sbjct: 179 FTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVK--------KMKRKFYFWEECMNLREVKALRK 56
+ + +LG G G V K ++ T ++A K ++++ LRE++ + +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--------LRELQIMHE 59
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSE---GEIRSFMSQMLQG 112
P I+ N + E+M+ +L I ++ P G+I + + L
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTY 118
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
L ++HR HRD+KP N+LV + +K+ DFG++ EL + T +V T Y +PE +
Sbjct: 119 LYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPE-RI 174
Query: 172 QSSSYSPAIDMWAVGAILAEL------FTLSPI 198
Q Y+ D+W++G + EL F S I
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 12/145 (8%)
Query: 94 QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM 152
+ P + ++ + Q+ +G+ + HRDL N+L++ N+V+KI DFGLAR++
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 153 PPYTEYVSTRW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG---DSE 204
P Y S R + APE + Y+ D+W+ G +L E+F+L SP +PG + E
Sbjct: 228 PDYVRKGSARLPLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEE 285
Query: 205 IDQLYKVCCILGAPDWTAFPEATNI 229
Q K + AP+ PE I
Sbjct: 286 FCQRLKDGTRMRAPENAT-PEIYRI 309
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 5 KILEELGDGTCGCVYKA--FNV---ETYEIVAVKKMKRK--FYFWEECMNLREVKALR-K 56
+ +EELG+ G VYK F E + VA+K +K K EE + +R +
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE---FKHEAMMRSR 64
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSE----------------G 100
L HPNI+ L VV + L IF Y H+ H + P S+
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 101 EIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPY---- 155
+ ++Q+ G+ + + H+DL N+LV + + +KI+D GL RE+ + Y
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
+ RW +PE ++ +S D+W+ G +L E+F+
Sbjct: 185 NSLLPIRWM-SPEAIMY-GKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 73/297 (24%), Positives = 119/297 (40%), Gaps = 79/297 (26%)
Query: 2 ERYKILEELGDGTCGCVYKA--FNVE---TYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+R K+ + LG G G V +A F +E + VAVK +K E + E+K L
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH 66
Query: 57 L-NHPNIIKL-KEVVRENNELFFIFEYMEH-NLYHIMR---------------ERQIPFS 98
+ +H N++ L + L I EY + NL + +R +R++
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQK 126
Query: 99 EGEIRSFMS------------QMLQGLAHMHRNGY------------------------- 121
EG+ + S + L+ + +
Sbjct: 127 EGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGM 186
Query: 122 --------FHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW---YRAPEV 169
HRDL N+L++ N+V+KI DFGLAR++ P Y R + APE
Sbjct: 187 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG---DSEIDQLYKVCCILGAPDWT 221
+ Y+ D+W+ G +L E+F+L SP +PG D E + K + AP++
Sbjct: 247 IF-DKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQIDEEFCRRLKEGTRMRAPEYA 301
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 76/307 (24%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 2 ERYKILEELGDGTCG--CVYKAFNVETYEIVAVKKMKRKFYFWE-----ECMNLREVK-A 53
+ ++IL+ +G G G V K N ++ A+K + + WE E RE +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTG--QVYAMKILNK----WEMLKRAETACFREERDV 54
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEY-MEHNLYHIMR--ERQIPFSEGEIRSFMSQML 110
L + I L ++ N L+ + +Y + +L ++ E ++P E R ++++M+
Sbjct: 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP--EDMARFYLAEMV 112
Query: 111 QGLAHMHRNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSS--MPPYTEYVSTRWYRAP 167
+ +H+ GY HRD+KP+N LL N +++ADFG L + V T Y +P
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 168 EVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
E+L Y P D W++G + E+ F +S ++ K+
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------------ 220
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQL-CSWDP-LRRPTADQALQHP 281
+++ E + + S EA DLI +L CS + L R HP
Sbjct: 221 -----------MNHKEHF--QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267
Query: 282 FFNVETW 288
FF W
Sbjct: 268 FFEGIDW 274
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 64/248 (25%), Positives = 98/248 (39%), Gaps = 49/248 (19%)
Query: 50 EVKALRKLN-HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI------------ 95
E++ L KL HPNII L L+ EY H NL +R+ ++
Sbjct: 57 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116
Query: 96 ---PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSS 151
S ++ F + + +G+ ++ + + HRDL N+LV N V KIADFGL+R
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 152 MPPYTE-YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK 210
T + RW L S Y+ D+W+ G +L E+ +L
Sbjct: 177 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGT-----------P 223
Query: 211 VCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR 270
C + A + P+ + + P+N D E DL+ Q P
Sbjct: 224 YCGMTCAELYEKLPQGYRLEK----------PLNCDD-------EVYDLMRQCWREKPYE 266
Query: 271 RPTADQAL 278
RP+ Q L
Sbjct: 267 RPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 46/130 (35%), Positives = 70/130 (53%), Gaps = 18/130 (13%)
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW--- 163
Q+ +G+ + HRDL N+L++ N+V+KI DFGLAR++ P Y R
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQLYKVCCILG----- 216
+ APE + Y+ D+W+ G +L E+F+L SP +PG +ID+ + C L
Sbjct: 247 WMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPG-VKIDEEF--CRRLKEGTRM 301
Query: 217 -APDWTAFPE 225
APD+T PE
Sbjct: 302 RAPDYTT-PE 310
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 10 LGDGTCGCVYKA----FNVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64
LG G G VY+ + + E+ VAVK + +E L E + K NH NI++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 65 LKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQ-------GLAHM 116
L V E F + E M +L +RE + P E M +L G ++
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENR-PRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 117 HRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYTE----YVSTRWYRAPE 168
N + HRD+ N L+T V KIADFG+AR++ Y + + +W PE
Sbjct: 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM-PPE 191
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
L ++ D+W+ G +L E+F+L
Sbjct: 192 AFLD-GIFTSKTDVWSFGVLLWEIFSL 217
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 2 ERYKILEELGDGTCGCVYKA------FNVETYEIVAVKKMKRKFYFWEECMNLREVKALR 55
+R + + L +GT G ++ E E V VK +K + + L+E L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKE--EEVFVKTVKDHASEIQVTLLLQESCLLY 63
Query: 56 KLNHPNIIKLKEVVRENNEL-FFIFEYMEH-NLYHIMRE-RQIP------FSEGEIRSFM 106
L+H NI+ + V E+ E F ++ YM NL +++ R S ++
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPY----TEYVST 161
Q+ G++++H+ G H+D+ N ++ ++ +KI D L+R+L M + E
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+W A E L + YS A D+W+ G +L EL TL
Sbjct: 184 KWM-ALES-LVNKEYSSASDVWSFGVLLWELMTL 215
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAF-NVETYEIVAVKKMKRKFYFWEECMNLR-EVKALRKL-N 58
E K + +G+G G V +A + ++ A KM ++F + + E++ L KL +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI---------------PFSEGEI 102
HPNII L L+ EY + NL +R+ ++ + ++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLAR-ELSSMPPYTEYVS 160
F S + G+ ++ + HRDL N+LV N KIADFGL+R E + +
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
RW L S Y+ D+W+ G +L E+ +L
Sbjct: 182 VRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 71/326 (21%), Positives = 134/326 (41%), Gaps = 68/326 (20%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLR-EVKALRKLNHPN 61
++ L+ +G G G V +T I A+K +++ E+ ++R E L + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
++K+ ++ L+ I E++ + ++ SE + ++++ + + +H+ G+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 122 FHRDLKPENLLV-TNDVLKIADFGLA------------RELSSMPPYT------------ 156
HRD+KP+NLL+ +K++DFGL R L+ PP
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 157 ------------EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE 204
V T Y APEV +Q + Y+ D W++G I+ E+ P F ++
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 205 IDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLC 264
+ KV +W ++ + +PI S +A DLI + C
Sbjct: 242 QETYRKVM------NWKE-----------TLVFPPEVPI---------SEKAKDLILRFC 275
Query: 265 --SWDPLRRPTADQALQHPFFNVETW 288
S + + ++ HPFF W
Sbjct: 276 TDSENRIGSNGVEEIKSHPFFEGVDW 301
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 10 LGDGTCGCVYKAF---NVETYEIVAVKKMKRKFYF---WEECMNLREVKALRKLNHPNII 63
LG G G V +A +++ VAVK +K + EE LRE +++ +HPN+I
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEF--LREAACMKEFDHPNVI 64
Query: 64 KLKEVV---RENNEL---FFIFEYMEHNLYHI------MRERQIPFSEGEIRSFMSQMLQ 111
KL V R L I +M+H H + E + FM +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 112 GLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTE----YVSTRWYRA 166
G+ ++ + HRDL N ++ ++ + +ADFGL++++ S Y + + +W
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPG--DSEI 205
L + Y+ D+WA G + E+ T + G +SEI
Sbjct: 185 ES--LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 2 ERYKILEELGDGTCGCVYK-----------AFNVETYEIVAVKKMKRKFYFWEECMNLRE 50
E + +G+G G VY+ A V+T + ++ KF L+E
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF--------LQE 57
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFE-YMEHNLYHIMRERQIPFSEGEIRSFMSQM 109
+R+ +HP+I+KL V+ N ++ + E L ++ + + + Q+
Sbjct: 58 AYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 110 LQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVS---TRWYR 165
LA++ + HRD+ N+LV + D +K+ DFGL+R L Y +W
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM- 175
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTL 195
APE + ++ A D+W G + E+ L
Sbjct: 176 APES-INFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL---- 57
E + ++ +G G G V +T +I A+K + + F ++ L VKA R +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD--QLAHVKAERDVLAES 58
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
+ P ++ L ++ L+ I E++ M + FSE R +M++ + + +H
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLA 146
+ G+ HRD+KP+N+L+ +K++DFGL+
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 10 LGDGTCGCVYKAF-NVETYEIVAVKKMKRKFYFWEECMNLR-EVKALRKL-NHPNIIKLK 66
+G+G G V KA + + A K +++ ++ + E++ L KL +HPNII L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 67 EVVRENNELFFIFEYMEH-NLYHIMRERQI---------------PFSEGEIRSFMSQML 110
L+ EY H NL +R+ ++ S ++ F + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTNDVL-KIADFGLAR-ELSSMPPYTEYVSTRWYRAPE 168
+G+ ++ + + HRDL N+LV + + KIADFGL+R + + + RW
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 182
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
L S Y+ D+W+ G +L E+ +L
Sbjct: 183 --LNYSVYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 8 EELGDGTCGCVY--KAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKL 65
+E+G+G G V + + T V VK+++ E+ L E + R L H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 66 KEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQM----LQGLAHMHRNG 120
E + E+ +L +R + + + +M GL H+H+N
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 121 YFHRDLKPENLLVTNDV-LKIADFGLA----RELSSMPPYTEYVSTRWYRAPEVL----- 170
+ H DL N L+T D+ +KI D+GL+ +E + P +V RW APE++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHG 179
Query: 171 -LQSSSYSPAIDMWAVGAILAELFTL 195
L + ++W++G + ELF L
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFEL 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 39/289 (13%)
Query: 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-PNIIKL 65
L E+G G G V K + + I+AVK+++ E+ L ++ + + + P I+K
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 66 KEVVRENNELFFIFEYME---HNLYHIMRERQ---IPFSEGEIRSFMSQMLQGLAHMHRN 119
+ + + E M+ Y + E IP E + ++ L ++
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKEE 126
Query: 120 -GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS-- 175
HRD+KP N+L+ N +K+ DFG++ +L T R Y APE + S+
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y D+W++G L E+ T +P +S DQL +V + G P
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--VKGDP---------------- 228
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
PI + S ++ I D +RP + L+HPF
Sbjct: 229 -------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 10 LGDGTCGCVYKA-FNVE--TYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHPNIIKL 65
LG+G G V + + + + VAVK MK + + E L E ++ +HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 66 KEVVRENNEL------FFIFEYMEHNLYHI----MRERQIP--FSEGEIRSFMSQMLQGL 113
V E + L I +M+H H R +P + FM + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
++ + HRDL N ++ D+ + +ADFGL++++ S Y + R + P +
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ---GRIAKMPVKWIA 183
Query: 173 SSS-----YSPAIDMWAVGAILAELFT--LSPIFPG--DSEIDQL 208
S Y+ D+WA G + E+ T +P +PG + EI
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTP-YPGVENHEIYDY 227
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 10 LGDGTCGCVYKA-FNVETYEI-VAVKKMKRKFYFWEECMN-LREVKALRKLNHPNIIKLK 66
LG+G G V + N + + VAVK MK E + L E +++ +HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 67 EVVRENNEL------FFIFEYMEHN------LYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
V + E I +M+H LY + + + FM+ + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 115 HMHRNGYFHRDLKPEN-LLVTNDVLKIADFGLARELSSMPPYTE----YVSTRWYRAPEV 169
++ + HRDL N +L N + +ADFGL++++ + Y + + +W
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES- 185
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPI-FPG--DSEI 205
L Y+ D+W+ G + E+ T +PG +SEI
Sbjct: 186 -LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 14/143 (9%)
Query: 58 NHPNIIKLKEVVRENNELFFIFEYM-EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
++PN IKL V I +Y+ + +L+ +++ ++ SE E++ + Q+++ L +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDL 125
Query: 117 HRNGYFHRDLKPENLLVT--NDVLKIADFGLAREL---SSMPPYTEYVSTRWYRAPEVLL 171
H++ H D+K EN+L D + + D+GL + + S +Y S PE +
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFS------PEKIK 179
Query: 172 QSSSYSPAIDMWAVGAILAELFT 194
+Y + D WAVG + EL T
Sbjct: 180 -GHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 42/104 (40%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 102 IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS---MPPYTE 157
I+ M Q+L GL +HR G HRD+KPENLLVT D +KI DFG A ++ + P
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 158 YVSTRWYRAPE--VLLQSSSYSPAIDMWAVGAILAELFTLSPIF 199
+ R Y PE V+ QS +PA M A+ + A L+ +F
Sbjct: 371 MLDPR-YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413
|
Length = 507 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 22/226 (9%)
Query: 2 ERYKILEELGDGTCG--CVYKAFNVETYEIVAVKKMKRKFYFWE-----ECMNLREVK-A 53
E ++IL+ +G G G V K N + ++ A+K + + WE E RE +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNAD--KVFAMKILNK----WEMLKRAETACFREERDV 54
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEY-MEHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
L ++ I L ++ N L+ + +Y + +L ++ + + E R ++++M+
Sbjct: 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLAREL--SSMPPYTEYVSTRWYRAPEV 169
+ +H+ Y HRD+KP+N+L+ N +++ADFG +L + V T Y +PE+
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 170 LLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
L Y P D W++G + E+ F +S ++ K+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 55/236 (23%)
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
PN++ L + + + +F + ++ E L+ HI + IP E ++ + ++M+ L +H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP--EECVKRWAAEMVVALDALH 102
Query: 118 RNGYFHRDLKPENLLVTNDV--LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
R G RDL P N+L+ +D +++ F E+ Y APEV S
Sbjct: 103 REGIVCRDLNPNNILL-DDRGHIQLTYFSRWSEVE--DSCDGEAVENMYCAPEV-GGISE 158
Query: 176 YSPAIDMWAVGAILAELFT---LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
+ A D W++GAIL EL T L P + I+
Sbjct: 159 ETEACDWWSLGAILFELLTGKTLVECHP--------------------------SGINTH 192
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFF 283
+++ E + S EA L+ QL ++P R A + HPFF
Sbjct: 193 TTLNIPEWV-----------SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 40/199 (20%)
Query: 89 IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147
I+ E ++ ++ SF Q+ +G++ + HRDL N+L+T+ + KI DFGLAR
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
Query: 148 ELSSMPPYTEYVSTRW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS----PIFP 200
++ + Y + R + APE + Y+ D+W+ G +L E+F+L P P
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMP 321
Query: 201 GDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLI 260
DS+ ++ K + +P E P + DI+ +
Sbjct: 322 VDSKFYKMIKEGYRMLSP--------------------ECAPSEMYDIMKSC-------- 353
Query: 261 WQLCSWDPLRRPTADQALQ 279
W DPL+RPT Q +Q
Sbjct: 354 WDA---DPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 30 VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYH 88
V VK++K E+ L++ R L HPNI++ E +FEY E +L
Sbjct: 25 VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS 84
Query: 89 IMRERQIPFSEGEI---RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFG 144
+ + Q ++ + ++ G+ HMH++ + H DL N +T+D+ +K+ D+G
Sbjct: 85 YLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG 144
Query: 145 LA----RELSSMPPYTEYVSTRWYRAPEVL------LQSSSYSPAIDMWAVGAILAELF 193
+ +E + V RW APE++ L ++ + ++WA+G L ELF
Sbjct: 145 IGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 91 RERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149
E P ++ F SQ+ QG+ + HRD+ N+L+T+ V KI DFGLAR++
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 150 SSMPPYTEYVSTRW---YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG--- 201
+ Y + R + APE + Y+ D+W+ G +L E+F+L SP +PG
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSP-YPGILV 320
Query: 202 DSEIDQLYKVCCILGAPDWTAFPEATNI 229
+S+ ++ K + PD+ A PE +I
Sbjct: 321 NSKFYKMVKRGYQMSRPDF-APPEIYSI 347
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY----FWEECMNLREVKALRK 56
+E + I++ + G G VY ++ AVK +K+ + R+ AL K
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYM----EHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
P I+ L ++ N ++ + EY+ +L HI F E ++S++
Sbjct: 63 --SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALA 116
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147
L ++HR+G HRDLKP+N+L++N+ +K+ DFGL++
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 45/303 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-----ECMNLREVK-ALR 55
+ ++I++ +G G G V T I A+K + + WE E RE + L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK----WEMLKRAETACFREERNVLV 56
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEY-MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
+ I L ++ N L+ + +Y + +L ++ + + E R ++++M+ +
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 115 HMHRNGYFHRDLKPENLLV-TNDVLKIADFG--LARELSSMPPYTEYVSTRWYRAPEVLL 171
+H+ Y HRD+KP+N+L+ N +++ADFG L + V T Y +PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 172 QSS----SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
Y P D W++G + E+ F +S ++ K I+ + FP
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMNHEERFQFPSH- 232
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQL-CSWD-PLRRPTADQALQHPFFNV 285
I + S EA DLI +L CS + L + + +H FF
Sbjct: 233 ---------------------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271
Query: 286 ETW 288
W
Sbjct: 272 IDW 274
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 82/322 (25%), Positives = 129/322 (40%), Gaps = 60/322 (18%)
Query: 9 ELGDGTCG--CVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK-------LNH 59
E+G G C VY A + T +V V+ E C +KAL+ H
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITD-----LENC-TEEHLKALQNEVVLSHFFRH 58
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIP--FSEGEIRSFMSQMLQGLAHMH 117
PNI+ V + L+ I +M + + + + P SE I + + L+GL ++H
Sbjct: 59 PNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 118 RNGYFHRDLKPENLLVTNDVLKIADFGL------------ARELSSMPPYTEYVSTRWYR 165
+NGY HR++K ++L++ D L ++ GL A+ + P ++ V W
Sbjct: 119 QNGYIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WL- 175
Query: 166 APEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP----DW 220
+PE+L Q Y+ D+++VG EL T F L + + G P D
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK--LKGPPYSPLDI 233
Query: 221 TAFP------------------EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQ 262
T FP E+ + + SE L S A ++L Q
Sbjct: 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ 293
Query: 263 LCSWDPLRRPTADQALQHPFFN 284
DP +RP+A L H FF
Sbjct: 294 ---QDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 69/323 (21%), Positives = 133/323 (41%), Gaps = 63/323 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL---- 57
E ++ L+ +G G G V +T + A+K +++ +E + ++A R +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE--QVGHIRAERDILVEA 58
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
+ ++K+ ++ L+ I E++ + ++ +E E + ++++ + + +H
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118
Query: 118 RNGYFHRDLKPENLLV-TNDVLKIADFGLARELS-------------SMPPYTEY----- 158
+ G+ HRD+KP+NLL+ + +K++DFGL L S+P +
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 159 ------------------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFP 200
V T Y APEV +Q + Y+ D W++G I+ E+ P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 201 GDSEIDQLYKVCCILGAPDWTAFPEATNIS--------RLISISYSEILPINLSDIIPNA 252
++ + KV + + FP IS R I + +I N
Sbjct: 238 SETPQETYKKV---MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294
Query: 253 SMEAIDLIWQLCSWDPLR-RPTA 274
E +D W+ +R RP A
Sbjct: 295 FFEGVD-------WEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 101 EIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYV 159
++ SF Q+ +G+ + HRDL N+L+ ++KI DFGLAR++ Y
Sbjct: 238 DLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 160 ST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPG 201
ST +W APE + + Y+ D+W+ G +L E+F+L +PG
Sbjct: 298 STFLPVKWM-APESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 48/194 (24%), Positives = 77/194 (39%), Gaps = 41/194 (21%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC---------MNLREVKALRKLNHP 60
LG+G G VYKA +V + K Y ++ MN R +A
Sbjct: 140 LGEGAFGVVYKA------SLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 61 NIIKLKEVVRENN--ELFFIFEYM-EHNLYHIMRERQIPFS---------EGE------- 101
+ E V E + ++ Y E L +M+ ++ P++ +
Sbjct: 194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERE 253
Query: 102 ---IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPYT 156
I++ M Q+L L +H G HRD+KP+N++ + KI D G A +L Y
Sbjct: 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313
Query: 157 --EYVSTRWYRAPE 168
E++ Y APE
Sbjct: 314 PKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 105 FMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVL-KIADFGLARELSSMPPYTEYVST-- 161
F Q+ G+ + HRDL N+L+ L KI DFGLAR++ Y ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 162 --RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+W APE + + Y+ D+W+ G +L E+FTL
Sbjct: 304 PLKWM-APESIFNNL-YTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 4 YKILEELGDGTCGCVYKAFNV---ETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNH 59
+K ++ LG G G VYK + E +I VA+K+++ L E + +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
P++ +L + + + I + M L +RE + + ++ Q+ +G+ ++
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 119 NGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEY------VSTRWYRAPEVLL 171
HRDL N+LV +KI DFGLA+ L + EY V +W A E +L
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWM-ALESIL 184
Query: 172 QSSSYSPAIDMWAVGAILAELFTL 195
Y+ D+W+ G + EL T
Sbjct: 185 H-RIYTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 50 EVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN------LYHIMRERQIPFSEGEIR 103
E+ + NHPNI+ + +NEL+ + +M + H M SE I
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MSELAIA 104
Query: 104 SFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----------VLKIADFGL-ARELSSM 152
+ +L+ L ++H GY HR +K ++L++ D L + + G R +
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF 164
Query: 153 PPYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAEL 192
P Y+ V + +PEVL Q+ Y D+++VG EL
Sbjct: 165 PKYS--VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 1 MERYKILEELGDGTCGCVYKAFNV---ETYEI-VAVKKMKRKFYFWEECMNLREVKALRK 56
++R K+L G G G VYK V ET +I VA+K + + E +
Sbjct: 9 LKRVKVL---GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
++HP++++L V + + + M H L + E + + ++ Q+ +G+ +
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 116 MHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEY------VSTRWYRAPE 168
+ HRDL N+LV + + +KI DFGLAR L EY + +W A E
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKWM-ALE 181
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
+ ++ D+W+ G + EL T
Sbjct: 182 C-IHYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 41/203 (20%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK----ALRKLNHP 60
+ L+ LG G G V+K + + + + + +E+ A+ L+H
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I++L + L + + +L +R+ + + ++ Q+ +G+ ++ +
Sbjct: 70 YIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP------YTEY-VSTRWYRAPEVLL 171
HR+L N+L+ +D +++IADFG+A L P Y+E+ +W +L
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLL---YPDDKKYFYSEHKTPIKWMALESILF 185
Query: 172 QSSSYSPAIDMWAVGAILAELFT 194
Y+ D+W+ G + E+ +
Sbjct: 186 --GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 10/35 (28%), Positives = 18/35 (51%)
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLAR 147
+ +H+ G H DL N++++ + DFGL
Sbjct: 105 VGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 11/113 (9%)
Query: 90 MRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARE 148
+RE + ++ ++ Q+ +G++++ HRDL N+LV + + +KI DFGLAR
Sbjct: 99 VRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
Query: 149 LSSMPPYTEY------VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
L TEY V +W +L + ++ D+W+ G + EL T
Sbjct: 159 LDI--DETEYHADGGKVPIKWMALESILHRRFTHQS--DVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 33/197 (16%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV 69
+ G G YK +++ VK++ + E+ + KL HPNI+KL +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADMGKLQHPNIVKLIGLC 752
Query: 70 RENNELFFIFEYME-HNLYHIMR----ERQIPFSEGEIRSFMSQMLQGLAHMHRN----- 119
R + I EY+E NL ++R ER+ R + + L +H
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRNLSWERR--------RKIAIGIAKALRFLHCRCSPAV 804
Query: 120 --GYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
G L PE +++ D L+ ++S+ Y APE ++ +
Sbjct: 805 VVGN----LSPEKIII--DGKDEPHLRLSLPGLLCTDTKCFISSA-YVAPET-RETKDIT 856
Query: 178 PAIDMWAVGAILAELFT 194
D++ G IL EL T
Sbjct: 857 EKSDIYGFGLILIELLT 873
|
Length = 968 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 50 EVKALRKLNHPNIIKLK----EVVRENNELFFIFEYMEHNLYH--IMRERQIPFSEGEIR 103
E+K LR+++ NI+K+ ++V + L I EY + +E+ + F
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK--L 125
Query: 104 SFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST 161
+GL ++++ +++L + LVT + LKI GL + LSS PP+ V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-PPFKN-VNF 183
Query: 162 RWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFT 194
Y + ++L S Y+ D++++G +L E+FT
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 28/125 (22%)
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
Y APE+LL + PA+D WA+G L E T P F D Q+++ P W
Sbjct: 546 YLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPF-NDETPQQVFQNILNRDIP-W--- 599
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
PE E L +N + AI++ L + DP +R + QHP F
Sbjct: 600 PEG-----------EEKLSVN--------AQNAIEI---LLTMDPTKRAGLKELKQHPLF 637
Query: 284 NVETW 288
+ W
Sbjct: 638 HGVDW 642
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 13/35 (37%), Positives = 21/35 (60%)
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLAR 147
+ +H+ G H DL N++V +D L + DFGL +
Sbjct: 103 VGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 14/35 (40%), Positives = 21/35 (60%)
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLAR 147
+A +H+ G H DL N +V +D L + DFGL +
Sbjct: 441 VAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-T 134
F + E + N I + R ++ I++ M ML L ++H +G H D+KPEN++V
Sbjct: 103 FILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161
Query: 135 NDVLKIADFGLARELSSMPPYTEYV--STRWYR 165
N+ I D+G+A + EY +R
Sbjct: 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHR 194
|
Length = 294 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 11/32 (34%), Positives = 18/32 (56%)
Query: 116 MHRNGYFHRDLKPENLLVTNDVLKIADFGLAR 147
+H G H DL N++++ + + DFGLA
Sbjct: 111 LHSAGIIHGDLTTSNMILSGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 34/173 (19%), Positives = 57/173 (32%), Gaps = 30/173 (17%)
Query: 1 MERYKILE---ELGDGTCGCVYKAFNVETYEIVAVKK--------MKRKFY------FWE 43
+ R I E + G VY A VAVK + + Y F
Sbjct: 44 LSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRN 102
Query: 44 ECMNLR---------EVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ 94
N R E + L++ + + + NN L + E++ + R +
Sbjct: 103 SRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNNVL--VMEFIGDDGLPAPRLKD 160
Query: 95 IPFSEGEIRSFMSQMLQGLAHM-HRNGYFHRDLKPENLLVTNDVLKIADFGLA 146
+P E +++ + + G H DL N+LV + I D A
Sbjct: 161 VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 12/105 (11%)
Query: 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFG 144
+L I+ R P +E EI + Q L L +HR L + L+ G
Sbjct: 2 SLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------DG 54
Query: 145 LARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAIL 189
++ P + APEV +Q SY+ D++++G L
Sbjct: 55 ---SVAFKTPEQSRPDPYF-MAPEV-IQGQSYTEKADIYSLGITL 94
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 432 | |||
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.06 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.28 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.27 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.9 | |
| PLN02236 | 344 | choline kinase | 96.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.74 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.63 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.22 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.84 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.81 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.48 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 95.23 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.89 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.76 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.65 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.28 |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-81 Score=607.50 Aligned_cols=431 Identities=49% Similarity=0.826 Sum_probs=369.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCC-EEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENN-ELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~-~~~lV 78 (432)
|+||.++++||.|+||.||+|+.+.+|+.||||++++++..++++..+||++.|++|+ ||||++|++++.++. .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 6899999999999999999999999999999999999999999999999999999998 999999999998877 99999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||||+++|++.++.+++.|++..++.|++||++||+|+|++|+.|||+||+|||+. ++.+||+|||+|+.+...+++++
T Consensus 89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe 168 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE 168 (538)
T ss_pred HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcch
Confidence 99999999999999999999999999999999999999999999999999999999 67999999999999999999999
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
|+.|+||+|||++++...|+.++|||++|||++|+.+-+|+|+|.++.||+.+|++++|+|.++.|++.....+.+++.+
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~ 248 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF 248 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC----------hhhhhccCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHD----------PLELRLNNMGSK 307 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~~~~~----------~~~~~~~~~~~~ 307 (432)
++..+.++..+.++++.++.++|.+||.+||++||||.|+|+||||+.........+. |...........
T Consensus 249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~a~~~~~~~~~~~~p~~~~~~~~t~~ 328 (538)
T KOG0661|consen 249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSSARGSPKKALELAFPVASEPPVPTKE 328 (538)
T ss_pred CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccccccCCccccccccCCCCCCCCCCccc
Confidence 9999999999999999999999999999999999999999999999976543332221 000000001112
Q ss_pred CCCccCCCCCCCCCCccccCccccccC-ChhhhhccCC--ccccccccccCCCCCCCc-----ceeeeeccC-CCCCCCC
Q 014039 308 PNLELNLWDFGTEPDDCFLGLTLAVKP-SNLEMVHNVP--QGMQEDILFCSDLKDHSE-----QTVFWSLLS-PDQNRMR 378 (432)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~ 378 (432)
.+...+.+.|..++..++.+......| +.......+. +...++..++|+.++.-. .+++|.+.+ .+.+...
T Consensus 329 ~~~~~n~~~~~~~~~~~~~~~~~~~~~ks~~~~~~~~n~~~~~~~~~~l~~~v~~~~~~~~l~P~~~~~l~~~~~~s~~~ 408 (538)
T KOG0661|consen 329 GPIKKNTSKFLKQPKKSFPPLTSAQPPKSHASGEDRLNSESSTKLSELLNPGVNNDVPAISLRPSVRWPLTSSIKESDDS 408 (538)
T ss_pred cCcCcchhccccccccccCCcccccCccccccccCCccccccccccccccccccccCccccCCCCcCccccccccccccc
Confidence 345566788888888888888887775 3332233333 334457788898887555 556666433 5566665
Q ss_pred CCcccc--ccccccccCCC--CCCCCCCCCcccc-ccCCCCcCCccccccCCccc--cCCC
Q 014039 379 APVESS--LSLSFSSIQHP--STGVPQSAGYAIT-SLQPNLLDCPFLAVSSPLQQ--SHCL 432 (432)
Q Consensus 379 ~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~ 432 (432)
+..+.. +..|.+...+. +.+.+|+++++.. |.||++.+. |++.++|++| +|||
T Consensus 409 ~~~~~~~~~lps~~~l~~~~~~~g~~~~~~~~~~~p~~~s~~~~-~~~~~~~~~~~~s~~l 468 (538)
T KOG0661|consen 409 KELKNADQLLPSISRLDSYKPTSGSNQLSGATNSSPRQPSLKDR-EITEKSPFKQKHSHYL 468 (538)
T ss_pred cccccccccCCccccccccCCCCCCceecCccccCCcchhhhhc-cccccccccccccccC
Confidence 655544 34555555555 7788898888877 599999988 9999999999 9986
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-68 Score=498.95 Aligned_cols=299 Identities=36% Similarity=0.654 Sum_probs=269.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC---CEE--EE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN---NEL--FF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---~~~--~l 77 (432)
.|+..+++|.|+||.||+|...++++.||||++..+... ..+|+++|+.++|||||+|..+|... +.+ .+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 488899999999999999999999999999999765432 35899999999999999999888532 233 48
Q ss_pred EEecCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCC
Q 014039 78 IFEYMEHNLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSM 152 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~ 152 (432)
|||||+.++++.++.. +..++..+++.|++||++||+|||+.|||||||||+|||||. +.+||||||+|+.+..+
T Consensus 100 VleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 100 VLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 9999999999999853 567999999999999999999999999999999999999995 49999999999999999
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
+++.+|++|++|+|||++++...|+.++||||.||+++||+.|+++|+|++..+|+.+|++++|+|+.+++. .++.++
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~--~mn~~y 257 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK--SMNPNY 257 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh--hcCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999998764 456778
Q ss_pred hhccccccCCCCccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCChhhhhccCCCCCCCCc
Q 014039 233 ISISYSEILPINLSD-IIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELRLNNMGSKPNLE 311 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (432)
.+..++++++..+.+ .....++++.||+.++|+++|.+|.+|.|+|.||||++ ++++ ..++++....|+
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde-------lr~~-~~~l~~g~~lp~-- 327 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE-------LRDP-NTKLPNGRPLPP-- 327 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH-------hhCc-CccCcCCCcCCC--
Confidence 899999999999988 45789999999999999999999999999999999997 7777 577777775554
Q ss_pred cCCCCCCCC
Q 014039 312 LNLWDFGTE 320 (432)
Q Consensus 312 ~~~~~~~~~ 320 (432)
+|||+..
T Consensus 328 --lf~f~~~ 334 (364)
T KOG0658|consen 328 --LFNFKRA 334 (364)
T ss_pred --ccCchHH
Confidence 6888764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-68 Score=486.70 Aligned_cols=285 Identities=36% Similarity=0.622 Sum_probs=260.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHH-HHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE-CMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|+.+.++|+|+||+||+++++.||+.||||++......... ...+|||++|++|.|+|+|.|+++|.....++||+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 89999999999999999999999999999999999865543333 34679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecC-CCCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~-~~~~~~~ 157 (432)
|||+.++++.+......++++.++.|++|++.|+.|+|+++++||||||+||||+ +|.+||||||+|+.+. ++..++.
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9999999999998887899999999999999999999999999999999999998 4599999999999987 7788999
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
|+.|+||+|||++.+...|+.++||||+||+++||++|.|+|+|.++.||++.|.+.+|.........-..++.+....+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 99999999999999999999999999999999999999999999999999999999999876665555555666666777
Q ss_pred cccC-CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEIL-PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
|+.. +.++..-+++++.-+.||+++||..||++|++++|+|.||||++
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 7654 45666778899999999999999999999999999999999954
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-65 Score=461.27 Aligned_cols=283 Identities=45% Similarity=0.733 Sum_probs=260.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|..+++||+|+||+||+|++.+||+.||||+++.....+. ....+||++.|+.++|+||+.++++|...+.+.||+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5799999999999999999999999999999999986543322 334679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC-Ccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP-YTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~-~~~ 157 (432)
|||+.+|...++.+...++..+++.|+.++++||+|||+++|+||||||.|+|+++ |.+||+|||+|+.+..... ...
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99999999999999999999999999999999999999999999999999999985 5999999999998865433 334
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+.|+||+|||++++...|+..+||||+|||++||+.|.|.|+|+++.||+..|...+|+|..+.|++....+.+..+.
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~- 239 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ- 239 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999999988877
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+......+++.++.++.||+.+||.+||.+|+||.|+|+|+||..
T Consensus 240 -~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 240 -QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred -cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 33444555689999999999999999999999999999999999985
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-64 Score=473.95 Aligned_cols=282 Identities=42% Similarity=0.675 Sum_probs=253.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe-----CCEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE-----NNELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~~~~ 76 (432)
+|..++.||+|+||.|+.|.++.+|+.||||++.+.+... ...+.+||+++|+.++|+||+.+++++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4666899999999999999999999999999998766443 34456899999999999999999999854 46899
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC---C
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS---M 152 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~---~ 152 (432)
+|+|+|+.+|...++.+. .|++.+++.++|||++||+|+|+.|++||||||.|+|++.+ .+||||||+|+.... .
T Consensus 103 iV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999999888887776653 69999999999999999999999999999999999999977 999999999998863 4
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh-hhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE-ATNISR 231 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~-~~~~~~ 231 (432)
...++|+.|+||+|||+++....|+.++||||+|||++||++|+++|+|.+..+|+..|+.++|+|+.+.+.. .....+
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 5678999999999999999999999999999999999999999999999999999999999999998776543 222333
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
-+-...+..++.++..++++++++|+||+++||..||.+|+||+|+|+||||..
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 355678899999999999999999999999999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-62 Score=477.72 Aligned_cols=283 Identities=41% Similarity=0.701 Sum_probs=253.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN--NELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV 78 (432)
+.|+.+++||+|+||.||+|++..+|+.||+|++...... .......|||.+|++|+||||++|.++..+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 5688999999999999999999999999999999854422 2233457999999999999999999998765 789999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--CCC
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM--PPY 155 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~--~~~ 155 (432)
+|||+.+|...+...+-.|++.+++.||.||+.||+|||++||+|||||.+|||||++ .+||+|||+|+.+... .++
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~ 276 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY 276 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence 9999999999998888889999999999999999999999999999999999999965 9999999999976543 468
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
+..+.|.||+|||++++...|+.++|+||+||||+||+.|+|+|+|..+.+|+.+|.++.|.|....|+ ...++.+..+
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~ 355 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIF 355 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCccccc
Confidence 888999999999999999999999999999999999999999999999999999999999999999887 4445544444
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.-....+..+.+.+..++..+.+|+.+||..||++|.||.++|+|+||..
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 44455566777778899999999999999999999999999999999954
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-62 Score=455.77 Aligned_cols=285 Identities=43% Similarity=0.726 Sum_probs=259.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (432)
++.|+.+.+|++|+||+||+|+++.|++.||+|+++-+..... ....+|||.+|.+.+|||||.+.++... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4679999999999999999999999999999999985442211 2235799999999999999999998753 467999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCC-CCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~-~~~ 155 (432)
|||||+.++-..+.....+|...+++.++.|+++||+|||+++|+||||||+|+|++ .|.+||+|||+|+.++.. .++
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 999999999998888878999999999999999999999999999999999999997 569999999999998754 567
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
+..+.|.||+|||++++...|++++||||+|||++||+++.|+|+|.++.||+.+|.+.+|+|+...|+.....+.....
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 88899999999999999999999999999999999999999999999999999999999999999999988877777778
Q ss_pred cccccCCCCccccCCCC--CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNA--SMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~--s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.++..+...+...++.. +..+.+|+..+|.+||.+|.||.|+|+|+||.+
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 88888888888887665 499999999999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-59 Score=447.04 Aligned_cols=258 Identities=31% Similarity=0.481 Sum_probs=217.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch------HHHHHHHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW------EECMNLREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
+.|.+.+.||+|+||.|-+|..+.||+.||||++.+..... ......+|+++|++|+|||||+++++|+.....
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 46899999999999999999999999999999998644332 222246899999999999999999999999999
Q ss_pred EEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecC
Q 014039 76 FFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELS 150 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~ 150 (432)
|||||||+|+ |.+.+..+ +.+.+...+.+++||+.|+.|||++||+||||||+|||++++ .+||+|||+|+..+
T Consensus 252 YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred EEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 9999999875 55555544 579999999999999999999999999999999999999754 79999999999998
Q ss_pred CCCCCccccCCccccchhhhcCC--CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCCCCchhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY-KVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~-~i~~~~g~p~~~~~~~~~ 227 (432)
....+.+.|||+.|.|||++... ..|..++||||+||+||-+++|.+||.++.....+. +|.+ |.-.
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~--G~y~-------- 400 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK--GRYA-------- 400 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc--Cccc--------
Confidence 88888999999999999999633 245669999999999999999999998875543222 2211 1111
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+..+.+++.++++||++||..||++|||++|+|+||||+..
T Consensus 401 ----------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 401 ----------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ----------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 1113345789999999999999999999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-58 Score=436.22 Aligned_cols=285 Identities=43% Similarity=0.781 Sum_probs=255.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCc-ccccceEEEeCC-----
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPN-IIKLKEVVRENN----- 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~----- 73 (432)
|+.|+.+++||+|+||+||+|+++.+|+.||+|++.-.... .-.....||+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35688889999999999999999999999999999865432 22234579999999999999 999999997766
Q ss_pred -EEEEEEecCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeecccee
Q 014039 74 -ELFFIFEYMEHNLYHIMRERQ---IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARE 148 (432)
Q Consensus 74 -~~~lV~E~~~~~ll~~~~~~~---~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~ 148 (432)
.+|+||||++-++...+.... ..++...++.+++||+.||+|||++||+||||||+||||++ |.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 899999999999999888765 46888999999999999999999999999999999999985 5999999999998
Q ss_pred cC-CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 149 LS-SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 149 ~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
.. +...++..++|.||+|||++++...|++.+||||+|||++||++++++|+|.++.+|+.+|.+.+|+|....|+...
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 76 44557888999999999999999999999999999999999999999999999999999999999999999998877
Q ss_pred hhhhhhhccccccC-CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 228 NISRLISISYSEIL-PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 228 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+++.. .|+... +..+....++.++++.|++.+||+++|.+|.||+.+|+||||...
T Consensus 250 ~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 250 SLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 7777665 455554 677777778888999999999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=429.96 Aligned_cols=260 Identities=30% Similarity=0.476 Sum_probs=229.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.||+++.+.|++.+|+|+++++..... .....+|..+|.+++||+||+++..|++...+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 689999999999999999999999999999999987665433 344578999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceec-CCCCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLAREL-SSMPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~-~~~~~~~~ 157 (432)
||+.|+-+....++.+.++|..++.|+..|+.||.|||++||+||||||+|||++. |.++|+|||+|+.. ..+....+
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~t 184 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRT 184 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcccc
Confidence 99999877777777778999999999999999999999999999999999999995 59999999999954 44456677
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.|||+.|||||++. ...|+.++|+||||+++|||++|.+||.+++......+|.+.-
T Consensus 185 fcGT~eYmAPEil~-~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------------------- 241 (357)
T KOG0598|consen 185 FCGTPEYMAPEILL-GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------------------- 241 (357)
T ss_pred ccCCccccChHHHh-cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------------------
Confidence 89999999999996 5689999999999999999999999999999888877774311
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP----TADQALQHPFFNVETWVPY 291 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp----ta~elL~Hp~f~~~~~~~~ 291 (432)
+......++.+++|||+++|+.||++|. ++.++-+||||...+|...
T Consensus 242 -------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 242 -------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred -------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 1111224789999999999999999996 6899999999999999433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-57 Score=447.14 Aligned_cols=252 Identities=33% Similarity=0.508 Sum_probs=226.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+|+..+.||+|+|+.||.+++..+|+.||+|++.++... ....+..+||++.++|+|||||+++++|++.+.+|||+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 599999999999999999999999999999999874432 234456799999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
+|..+.+..+.+++++++|.+++.+++||+.||.|||+++|+|||||-.|++++++ +|||+|||+|..+... +...+.
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~Tl 178 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTL 178 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccccee
Confidence 99977666666677899999999999999999999999999999999999999998 9999999999998744 677889
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
||||.|.|||++. ...++..+||||+|||||-|+.|+|||...+-.+.+.+|.+. +
T Consensus 179 CGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------------~---- 234 (592)
T KOG0575|consen 179 CGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------------E---- 234 (592)
T ss_pred cCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------------C----
Confidence 9999999999996 778999999999999999999999999999888888887421 0
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..++..+|.+|+|||.+||+.||.+|||++++|.|+||+.
T Consensus 235 -------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 235 -------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 1123468999999999999999999999999999999954
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-56 Score=420.36 Aligned_cols=252 Identities=30% Similarity=0.396 Sum_probs=220.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC-EEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN-ELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 81 (432)
+.+.++.||+|+.|+||+++|+.|++.+|+|++...........+.||+++++..+||+||++|+.|..++ .++|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 56678899999999999999999999999999976555555666789999999999999999999999988 59999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+++.++.+....+.++|..+..++.+|++||.|||+ ++|+||||||+||||+ .|+|||||||.++.+... ...+++
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfv 238 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFV 238 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccccc
Confidence 9999888888877889999999999999999999995 8999999999999998 569999999999988765 668899
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD-----SEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~-----~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
||..|||||-+ .+..|+.++||||||..++||++|+.||... ...+.+..|+ .+.|+
T Consensus 239 GT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv--~~ppP--------------- 300 (364)
T KOG0581|consen 239 GTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV--DEPPP--------------- 300 (364)
T ss_pred ccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh--cCCCC---------------
Confidence 99999999999 4778999999999999999999999999875 2333333332 12222
Q ss_pred ccccccCCCCccccCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 235 ISYSEILPINLSDIIP-NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.++. .+|+++++||..||++||.+|+|+.|+|+|||++.
T Consensus 301 ------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 301 ------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred ------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 1223 38999999999999999999999999999999985
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-55 Score=440.87 Aligned_cols=278 Identities=39% Similarity=0.636 Sum_probs=233.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-C-----CcccccceEEEeCCEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-H-----PNIIKLKEVVRENNELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~~~~~~~~~~~ 76 (432)
+|++++.||+|+||.|.+|.+..|++.||||+++++.....+ ...|+.+|..|+ | -|+|+++++|...+++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q--~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQ--AQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHH--HHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 699999999999999999999999999999999977654333 346999999985 4 38999999999999999
Q ss_pred EEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---CeEEEeeeccceecCCC
Q 014039 77 FIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---DVLKIADFGLARELSSM 152 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~~lkL~DFG~a~~~~~~ 152 (432)
||+|.+..+|+++++.+ ...|+...++.++.||+.||.+||+.||||+||||||||+.+ ..|||+|||+|......
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 99999999999999875 357999999999999999999999999999999999999973 39999999999887653
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
. ..|+.+++|+|||+|+ +..|+.++||||||||++||.+|.|+|+|+++.||+..|++++|.|+...+.......++
T Consensus 345 -v-ytYiQSRfYRAPEVIL-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 345 -V-YTYIQSRFYRAPEVIL-GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred -c-eeeeeccccccchhhc-cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 3 3899999999999998 677999999999999999999999999999999999999999999987655443333322
Q ss_pred hhc-c-c--------------------------ccc-CC---CCccccCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 233 ISI-S-Y--------------------------SEI-LP---INLSDIIP-NASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 233 ~~~-~-~--------------------------~~~-~~---~~~~~~~~-~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+. . + ... .| ..+..... .....++|||++||.+||.+|+|+.|+|+
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 221 0 0 000 00 11111122 23446799999999999999999999999
Q ss_pred CCCCCC
Q 014039 280 HPFFNV 285 (432)
Q Consensus 280 Hp~f~~ 285 (432)
||||..
T Consensus 502 Hpfl~~ 507 (586)
T KOG0667|consen 502 HPFLTG 507 (586)
T ss_pred Cccccc
Confidence 999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-55 Score=427.96 Aligned_cols=258 Identities=33% Similarity=0.521 Sum_probs=228.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHH--HHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM--NLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~--~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++++.||+|+|++|++|+.+.+++.||||++.++....+... ..+|-.+|.+| +||.|++|+..|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 589999999999999999999999999999999987665443332 45899999999 899999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-- 154 (432)
+||+++ +|++.+.+. +.|++..++.|+.||+.||+|||++|||||||||+|||++.+ .+||+|||.|+.+.+...
T Consensus 153 Le~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred EEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 999985 577776665 589999999999999999999999999999999999999976 999999999987753211
Q ss_pred ------------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q 014039 155 ------------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTA 222 (432)
Q Consensus 155 ------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~ 222 (432)
..+++||..|.+||++. ....++++|||+||||+|+|+.|.|||.+.++.-..++|+.+-=
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y------ 304 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY------ 304 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc------
Confidence 15589999999999984 67789999999999999999999999999999999888865421
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~ 291 (432)
++.++++++++|||+++|..||.+|+|+.||.+||||.+.+|...
T Consensus 305 ------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 305 ------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred ------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 123467899999999999999999999999999999999999763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=424.68 Aligned_cols=283 Identities=28% Similarity=0.459 Sum_probs=234.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|+++++||+|+||.||+|+-+.||+.+|+|++++..-... ......|..+|...++|.||+||..|++...+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 4789999999999999999999999999999999987654322 22346799999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCC------
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSS------ 151 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~------ 151 (432)
|||++||....+..+.+.|++..++.|+.+++.|+..||+.|++||||||+|+||| .|.+||+|||+|..+..
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999987777777777999999999999999999999999999999999999999 46999999999953311
Q ss_pred ------------------CC----C--------------------CccccCCccccchhhhcCCCCCCcccceechHHHH
Q 014039 152 ------------------MP----P--------------------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAIL 189 (432)
Q Consensus 152 ------------------~~----~--------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il 189 (432)
.. . ..+.+|||.|+|||+++ +..|+..+|+|||||||
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWWSLGCIM 378 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHHHHHHHH
Confidence 00 0 13468999999999997 55699999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCC
Q 014039 190 AELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPL 269 (432)
Q Consensus 190 ~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~ 269 (432)
||||.|.|||.+++..+...+|+.--- .+.+|.. ..++.+|+|||.+||. ||+
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~-----------------~l~fP~~---------~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRE-----------------TLKFPEE---------VDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhh-----------------hccCCCc---------CcccHHHHHHHHHHhc-CHH
Confidence 999999999999999998888753211 1112211 2467899999999999 999
Q ss_pred CCCC---HHHHhcCCCCCCCCCCCCCCC-ChhhhhccCCCCCCCCc
Q 014039 270 RRPT---ADQALQHPFFNVETWVPYPLH-DPLELRLNNMGSKPNLE 311 (432)
Q Consensus 270 ~Rpt---a~elL~Hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 311 (432)
+|.. ++||.+||||+..+|....-. .|+.+.+++.....+|+
T Consensus 432 ~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFd 477 (550)
T KOG0605|consen 432 NRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFD 477 (550)
T ss_pred HhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccc
Confidence 9985 899999999999999654322 35555555555555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=397.16 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=229.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|+.++.||.|+||.|.+++++.+|..+|+|++.+.....- .....+|..+|+.+.||+++++++.+.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4789999999999999999999999999999999987654432 22346899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||++|+-+..+.++.+++++..++.|+.||+.||+|||+++|++|||||+|||+|. |.+||+|||+|+.+... +.+
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~T 200 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWT 200 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEE
Confidence 999998766666666668999999999999999999999999999999999999995 59999999999998764 677
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.||||.|+|||++ ..+.|+.++|+||||+++|||+.|.+||.+.++.....+|+.. . .
T Consensus 201 lCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--~-----------------v-- 258 (355)
T KOG0616|consen 201 LCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--K-----------------V-- 258 (355)
T ss_pred ecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--c-----------------c--
Confidence 8999999999998 4888999999999999999999999999999998888888631 1 1
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWVPYP 292 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~~~~ 292 (432)
..++.++++++|||+++|+.|-.+|. ...+|.+||||+..+|.+..
T Consensus 259 ---------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~ 309 (355)
T KOG0616|consen 259 ---------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL 309 (355)
T ss_pred ---------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence 12246899999999999999999994 57899999999999996553
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=410.95 Aligned_cols=283 Identities=36% Similarity=0.615 Sum_probs=245.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
|++|+++++||+|+||.||+|.+..+++.||+|+++............+|++++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 68999999999999999999999999999999999754433333445689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
|+++++.+.+...+..+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+++..... ......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~ 163 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence 99999888887766678999999999999999999999999999999999999854 9999999999765432 223445
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+...+|.|+...++.......+....++
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 78999999999876678999999999999999999999999999999999999999999988877665555555554555
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.....++....+.++.+++|||++||++||.+|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 544444445556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-54 Score=431.07 Aligned_cols=313 Identities=28% Similarity=0.419 Sum_probs=257.9
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|.++++||+|+||+|++|..+.+++.+|||.+++...... ......|.+++... +||.+++++.+|+++.++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 5789999999999999999999999999999999998764422 23346788888888 59999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecC-CCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~-~~~~~ 155 (432)
||||+.|+.+..++ +.+.|++..++.|+..|+.||.|||++||||||||-+|||+| +|.+||+|||+|+... .+..+
T Consensus 447 vmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred EEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 99999988743333 335799999999999999999999999999999999999999 5699999999999764 55567
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
.+.||||.|+|||++. ...|+.++|+|||||+|||||.|++||+|+++.+....|+.. .+
T Consensus 526 sTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~----------------- 585 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EV----------------- 585 (694)
T ss_pred ccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CC-----------------
Confidence 8899999999999984 778999999999999999999999999999999888887421 00
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC---CCCChhhhhccCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVPY---PLHDPLELRLNNMGSK 307 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~~---~~~~~~~~~~~~~~~~ 307 (432)
.++..+|.|++++++++|.+||++|.. +.+|.+||||+.++|... .+..|+.+.+.+..+.
T Consensus 586 -----------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~ 654 (694)
T KOG0694|consen 586 -----------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV 654 (694)
T ss_pred -----------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence 112358999999999999999999986 589999999999999544 3445665555554444
Q ss_pred CCCccCCCCCCCCCCccccCccccccCChhhhhccCCccccccccccCC
Q 014039 308 PNLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILFCSD 356 (432)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (432)
++++ -+|+.| .-.++|.+...+....|.++.+|.|...
T Consensus 655 snFd---~eFt~e--------~p~Lt~~~~~~l~~~~q~~F~~Fs~~~~ 692 (694)
T KOG0694|consen 655 SNFD---EEFTSE--------KPALTPSDPRPLTEEEQEAFRDFSFVAE 692 (694)
T ss_pred cccc---hhhhcC--------CCccCCCCccccchhhHHHhcCccccCC
Confidence 4432 233443 3347776666777788888899887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=405.15 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=222.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+.+|++.+.||+|+||+||+|+++.++..||||.+.++.... .......|+.+|+.++|||||.+++++.+.+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 368999999999999999999999999999999998776333 3344578999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-------eEEEeeeccceecCCC
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-------VLKIADFGLARELSSM 152 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-------~lkL~DFG~a~~~~~~ 152 (432)
|||.|+.+..+.++.+.++|..++.++.||+.||++||+++|+||||||+|||++.. .+||+|||+|+.+...
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999976666555555689999999999999999999999999999999999999742 6899999999999988
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
....+.||++.|||||++ ....|+.|+|+||+|+|+|+|++|.+||...+..+.+..+.+.-..
T Consensus 169 ~~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~--------------- 232 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI--------------- 232 (429)
T ss_pred hHHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc---------------
Confidence 878889999999999999 4788999999999999999999999999999887776654221100
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+....+....+|+..+|+.+|..|.+..+-+.|+++..
T Consensus 233 ------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 233 ------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 01112245667889999999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-54 Score=367.31 Aligned_cols=284 Identities=37% Similarity=0.634 Sum_probs=252.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|.+|.-.++||+|+||+||+|+++++++.||+|.++....... ....+||+-+|+.++|.|||+++++...+..+.+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 6789999999999999999999999999999999985443222 234679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-CCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP-PYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~-~~~~ 157 (432)
|||+.++-..+..-.+.++.+.++.++.|+++||.++|++++.|||+||+|+||+. |++|++|||+|+.++-.- -+..
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 99999999999988889999999999999999999999999999999999999985 599999999999876533 3455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.+.|.||++|.++++..-|++++|+||.|||++|+.. |.|+|+|.+-.||+.+|..++|+|..+.|+.....+.+....
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 6789999999999999999999999999999999986 999999999999999999999999999998877766665432
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
... ....+..+.++++...+||+.++|.-+|.+|++|+++|+||||..
T Consensus 241 ~yp-attswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 241 IYP-ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred Ccc-ccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 211 124566677888889999999999999999999999999999975
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=402.31 Aligned_cols=285 Identities=33% Similarity=0.561 Sum_probs=233.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|+++.+++.||+|++.............+|+++++.++||||+++++++.+....|+||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 68999999999999999999999999999999997544333333456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
+.+++.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++..... ......+
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 164 (303)
T cd07869 85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV 164 (303)
T ss_pred CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCc
Confidence 999999988877678999999999999999999999999999999999999985 49999999999765322 2334567
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE-IDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~-~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
+|+.|+|||++.+...++.++||||+||++|||++|.+||.+... .+++..+...++.+....++............+.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T cd07869 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT 244 (303)
T ss_pred ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccc
Confidence 899999999987667789999999999999999999999998654 4677777778888776655443322222211122
Q ss_pred ccCCCCccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 239 EILPINLSDIIP--NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 239 ~~~~~~~~~~~~--~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+..+...+. ..+.++.+||++||++||++|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 245 LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 122222222221 256789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=390.05 Aligned_cols=285 Identities=36% Similarity=0.631 Sum_probs=235.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe----EEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe-CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE----IVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE-NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~ 75 (432)
..|+.++.||+|+||.||+|..+.++. .+|||+++...... -.....||+.+++.+.||||+.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 479999999999999999997665543 58999998653322 12335699999999999999999999866 7889
Q ss_pred EEEEecCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-C----CeEEEeeeccc
Q 014039 76 FFIFEYMEHNLYHIMRER----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-N----DVLKIADFGLA 146 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~----~~lkL~DFG~a 146 (432)
++++||.+.+|+..+... .+.++...++.+++||+.|+.|||++.|+||||||.||||. + |.|||+|||+|
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 999999999999998742 35799999999999999999999999999999999999996 3 49999999999
Q ss_pred eecCCC-C---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC---------hHHHHHHHHH
Q 014039 147 RELSSM-P---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS---------EIDQLYKVCC 213 (432)
Q Consensus 147 ~~~~~~-~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~---------~~d~~~~i~~ 213 (432)
+.+... . .....+.|.||+|||++++...|+.++|||++|||++||++..|+|.+.. ..||+.+|++
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 987542 1 23456789999999999999999999999999999999999999998853 3689999999
Q ss_pred HhCCCCCCCchhhhhhhhhhh--cccc--ccCCCCcccc---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 214 ILGAPDWTAFPEATNISRLIS--ISYS--EILPINLSDI---IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
++|+|+...|+...+.+.+.. ..|+ ......+..+ ...-++.+.+|+.+||++||-+|.||+++|+|+||.+.
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 999999999987766665522 1111 1111112222 23356679999999999999999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=420.75 Aligned_cols=278 Identities=32% Similarity=0.570 Sum_probs=236.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC--------C
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN--------N 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--------~ 73 (432)
++|+++++||+|+||.||+|.+..+++.||||++..... ...+|+.+|+.++||||+++++++... .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 479999999999999999999999999999999865432 234799999999999999999886432 2
Q ss_pred EEEEEEecCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeecccee
Q 014039 74 ELFFIFEYMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARE 148 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~ 148 (432)
.+++||||+++++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 4679999999988776653 45679999999999999999999999999999999999999843 799999999998
Q ss_pred cCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
+........++||+.|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++.++++.+|.|..+.+.. .
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~--~ 298 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE--M 298 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH--h
Confidence 76655666788999999999987777899999999999999999999999999999999999999999987665432 1
Q ss_pred hhhhhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+....++...+..+...+ ...+.++++||++||++||.+|+|+.|+|+||||+..
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 233444555555555555444 3578999999999999999999999999999999864
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=397.43 Aligned_cols=285 Identities=36% Similarity=0.638 Sum_probs=245.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
|++|+++++||+|+||.||+|+++.+++.||+|++.............+|++++++++||||+++++++..++..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 68899999999999999999999999999999999754433333345689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
|+++++...+...+..+++..++.++.||+.||+|||++||+||||||+||+++++ .+||+|||+++...... .....
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 164 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccc
Confidence 99999988887776679999999999999999999999999999999999999855 99999999997654322 23345
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+...+|.+....++.......+....++
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence 78999999999876677899999999999999999999999999999999999999999887766654444444445555
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+..+....+.++.++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 55454555555678999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=403.31 Aligned_cols=253 Identities=32% Similarity=0.457 Sum_probs=219.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----hHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----WEECMNLREVKALRKLN-HPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~ 76 (432)
.+|++.+.||+|+||.|++|.+..+|+.||+|++.++... .......||+.+++.+. ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 5899999999999999999999999999999987764221 22334558999999998 999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceec-CCC
Q 014039 77 FIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLAREL-SSM 152 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~-~~~ 152 (432)
+||||+.| +|++.+.+ .+++.|.+++.+++||+.|++|||++||+||||||+|||++. +++||+|||++... ...
T Consensus 97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 99999986 78888877 668999999999999999999999999999999999999985 59999999999988 466
Q ss_pred CCCccccCCccccchhhhcCCC-CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSS-SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
......|||+.|+|||++.+.. ..+.++||||+|++||.|++|..||...+......+|.. |.
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--~~-------------- 239 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--GE-------------- 239 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--CC--------------
Confidence 6778899999999999997655 446999999999999999999999999776665555421 11
Q ss_pred hhhccccccCCCCccccCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~-s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. .++..+ |+++++||++||+.||.+|+|+.++++||||+.
T Consensus 240 ---~-----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 ---F-----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---c-----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 0 122344 999999999999999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-53 Score=377.41 Aligned_cols=258 Identities=32% Similarity=0.482 Sum_probs=224.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecc-cccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKR-KFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+.|++.++||+|+|++|+++.++.||+.+|+|++.. +......+.+.+|++|.+.|+||||++|.+.+...+..|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 468899999999999999999999999999999974 3333445567799999999999999999999999999999999
Q ss_pred cCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---C-eEEEeeeccceecCCCCCC
Q 014039 81 YMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---D-VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~-~lkL~DFG~a~~~~~~~~~ 155 (432)
+|.|+ +...+-.+ ..++|..+..+++||++||+|+|.+||+|||+||+|+|+-. + -+||||||+|..+..+...
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99985 44455444 46899999999999999999999999999999999999952 2 8999999999999987788
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+|||.|+|||++ +...|+..+|||+.|+|||-|+.|.+||.+++..+....|++.--..+
T Consensus 170 ~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~---------------- 232 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP---------------- 232 (355)
T ss_pred ccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC----------------
Confidence 889999999999998 577899999999999999999999999999988888877753211111
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
...++++++++++||++||..||.+|+||.|+|+|||+.+..
T Consensus 233 ----------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 233 ----------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred ----------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 123568999999999999999999999999999999998643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-52 Score=406.28 Aligned_cols=253 Identities=32% Similarity=0.501 Sum_probs=221.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|-+.+.||+|+||.||+|+.+.+.+.||||.+.+..... +.....+|++++++++|||||.+++.|++..++++|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 899999999999999999999999999999999998755444 4445679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~ 157 (432)
||+.|+|...+.. .+.++|+.++.+++|++.||.|||+++|.|||+||+|||++.+ .+|+||||+|+....+.. .++
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9999976666554 5589999999999999999999999999999999999999966 999999999998766433 355
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.-|||.|||||+.. +..|+..+|+||+|||+|||+.|+|||-..+-......|.+. |.
T Consensus 160 ikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v------------------ 217 (808)
T KOG0597|consen 160 IKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV------------------ 217 (808)
T ss_pred ccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC------------------
Confidence 67999999999984 888999999999999999999999999887665555555321 11
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+.+++.+++.||..+|.+||.+|.|-.+++.|||.++
T Consensus 218 ---------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 218 ---------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred ---------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 112368899999999999999999999999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=407.01 Aligned_cols=255 Identities=31% Similarity=0.474 Sum_probs=223.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
-|++++.||.|+-|.|-+|+|..||+.+|||++.+... ......+.+||-+|+.+.||||+++|++++++.++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 48999999999999999999999999999999986532 2233456799999999999999999999999999999999
Q ss_pred cCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccc
Q 014039 81 YMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
|++|| |++++..+ +++++.++.++++||+.|+.|+|..+|||||+||+|+|++. +++||+|||+|..-..+.-..+.
T Consensus 93 yv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred ecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 99865 55655554 58999999999999999999999999999999999999984 48999999999877777778889
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
||+|.|.|||++.+..+.+.++||||.|+|||.|++|..||.+++-...+.++.+ |.
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--G~--------------------- 228 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--GV--------------------- 228 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--Cc---------------------
Confidence 9999999999998888889999999999999999999999997766555555532 10
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
-+++.+++.+|.|||++||..||++|+|.+||++|||+...+-
T Consensus 229 -------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 229 -------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 1233578999999999999999999999999999999987654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=388.36 Aligned_cols=254 Identities=31% Similarity=0.452 Sum_probs=208.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC--EEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN--ELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV~E 80 (432)
+|...+.||+|+||.||++.++++|+.+|+|.+...... ......+|+++|++++|||||++++...... .++++||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 578889999999999999999999999999999866322 2334678999999999999999999854433 6889999
Q ss_pred cCCCcHHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCC----CC
Q 014039 81 YMEHNLYHI-MRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSS----MP 153 (432)
Q Consensus 81 ~~~~~ll~~-~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~----~~ 153 (432)
|++++.+.. +.+.++.|+|..++.+++||++||+|||++||+||||||+|||++. +.+||+|||+|+.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 998765554 4444448999999999999999999999999999999999999997 4999999999987763 12
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD-SEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~-~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......||+.|||||++..+.....++||||+||++.||+||.+||... ...+.+..|.. .
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~--------------- 238 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---E--------------- 238 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---c---------------
Confidence 2456789999999999965333345999999999999999999999873 33333333311 0
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+.++..++.++++||++||++||++||||+++|+|||.+.
T Consensus 239 ----------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 239 ----------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0112445678999999999999999999999999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=384.06 Aligned_cols=281 Identities=39% Similarity=0.665 Sum_probs=227.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++.+.||+|+||.||+|+++.+++.||+|++....... ......+|+++++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 58999999999999999999999999999999997543222 23345689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCcc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTE 157 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~ 157 (432)
|+++++++.+......+++..++.++.||+.||.|||+.||+||||||+||+++.+ .+||+|||+|+...... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 99999888887766679999999999999999999999999999999999999855 89999999998764322 2344
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+++.|+|||++. ...++.++||||+||++|||++|++||++.+..+.+..+....|..+...+.............+
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 67899999999985 45689999999999999999999999999998888888887777665433221111111111111
Q ss_pred cccC-CCC-ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEIL-PIN-LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~-~~~-~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
+... +.. .......++.++.+||++||++||++|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1100 000 011223478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=384.71 Aligned_cols=285 Identities=35% Similarity=0.623 Sum_probs=240.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+++|+++++||+|+||.||+|.+..+++.||+|.+.............+|+++++.++||||+++++++...+..|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999998754433333445689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
|+++++...+......+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||++....... .....
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence 99999988887766789999999999999999999999999999999999999865 99999999997654322 22345
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.+++.|+|||++.+...++.++|||||||++|||++|.+||.+.+..++...+...++.+....++.......+....++
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 67899999999876677899999999999999999999999999988898899888888877666544333333333344
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......+......++.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 33333333344578899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=381.14 Aligned_cols=278 Identities=35% Similarity=0.618 Sum_probs=229.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-CCeEEEEEEecccccch-HHHHHHHHHHHHHhc---CCCcccccceEEE-----e
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-TYEIVAVKKMKRKFYFW-EECMNLREVKALRKL---NHPNIIKLKEVVR-----E 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~-----~ 71 (432)
++|++++.||+|+||.||+|++.. ++..||+|++....... ......+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999864 57889999987543221 122345677777665 6999999999875 2
Q ss_pred CCEEEEEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 72 NNELFFIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 72 ~~~~~lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
...+++||||+++++.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4568999999999888887654 3468999999999999999999999999999999999999855 9999999999877
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
..........+|+.|+|||++. ...++.++||||+||++|||++|.+||.+.+..+.+.+++...+.|....++.....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCCcccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 6554455668999999999985 567899999999999999999999999999999999999998888776655443221
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
. ...+.......+..+.+.++..+.+||.+||+.||++|||+.|+|+||||
T Consensus 240 ~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 P---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred c---chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1 12233334445555667789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=389.55 Aligned_cols=284 Identities=39% Similarity=0.658 Sum_probs=228.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN-----NELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (432)
+|++.++||+|+||.||+|++..+|+.||||++...... .......+|+++++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998754322 2233467899999999999999999987532 3589
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-- 153 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-- 153 (432)
+||||+++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999998888777654 469999999999999999999999999999999999999865 99999999997643221
Q ss_pred --CCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh-
Q 014039 154 --PYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI- 229 (432)
Q Consensus 154 --~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~- 229 (432)
.....++|+.|+|||++.+. ..++.++||||+||++|||++|++||.+.+...++..+...+|.++...+......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 12456899999999998532 57899999999999999999999999999998888888888888765533221100
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
............+..+...++..++++.++|.+||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0000111222233344445567889999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=396.13 Aligned_cols=254 Identities=29% Similarity=0.544 Sum_probs=224.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.+|....+||+|+-|.||.|+...+++.||||++...... ....+++|+.+|+...|+|||++++.|...+++|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4688899999999999999999999999999999865543 334467999999999999999999999888999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-CCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP-PYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~-~~~~~~ 159 (432)
|+|+.+.++.... .|+|.++..+++.++.||+|||.+||+|||||.+|||++. |.+||+|||+|..+.... .-.+.+
T Consensus 352 m~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmV 430 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMV 430 (550)
T ss_pred cCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccccc
Confidence 9987666666554 5999999999999999999999999999999999999984 599999999998876554 556789
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
|||+|||||++ ....|++++||||||+++.||+-|+|||-.++....++.|. .-|+|....
T Consensus 431 GTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~lk~----------------- 491 (550)
T KOG0578|consen 431 GTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPKLKN----------------- 491 (550)
T ss_pred CCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCCcCC-----------------
Confidence 99999999998 47789999999999999999999999999999988888874 345544332
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+.+|++++|||.+||+.|+.+|++|.|+|+||||+.
T Consensus 492 ---------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 492 ---------PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ---------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 2468999999999999999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=375.56 Aligned_cols=243 Identities=30% Similarity=0.483 Sum_probs=203.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc-cchHHHHHHHHHHHHHhcCCCcccccce-EEEeCCE-EEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF-YFWEECMNLREVKALRKLNHPNIIKLKE-VVRENNE-LFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~~-~~lV 78 (432)
.+|+++++||+|+||+||++++..+|+.+|.|+++-.. ...+.+....|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35999999999999999999999999999999998332 2234445678999999999999999998 5555455 8999
Q ss_pred EecCCCc-HHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeccCCCCceeEeC-CeEEEeeeccceec
Q 014039 79 FEYMEHN-LYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMHR--NG--YFHRDLKPENLLVTN-DVLKIADFGLAREL 149 (432)
Q Consensus 79 ~E~~~~~-ll~~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~--~g--ivHrDlkP~NILl~~-~~lkL~DFG~a~~~ 149 (432)
||||+++ |...+. +.++.++|..+|+++.|+++||.++|+ .+ |+||||||.||++++ |.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999865 444443 345679999999999999999999999 45 999999999999995 59999999999988
Q ss_pred CCCC-CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 150 SSMP-PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 150 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
.... ...+++|||+||+||.+ ....|+.++||||+||++|||...++||.|++-...-.+|.+.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-------------- 243 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-------------- 243 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC--------------
Confidence 6543 35689999999999999 4788999999999999999999999999999766666666432
Q ss_pred hhhhhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCH
Q 014039 229 ISRLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTA 274 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta 274 (432)
+.++++ ...|.++..+|..|+..||+.||+.
T Consensus 244 ---------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 244 ---------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 111223 3578899999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.70 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=215.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++...... .......+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 5899999999999999999999999999999999754321 22334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++..... ....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence 999875444444444579999999999999999999999999999999999999854 9999999999876542 3346
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.. +.+
T Consensus 159 ~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~-------------------- 215 (291)
T cd05612 159 CGTPEYLAPEVIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKL-------------------- 215 (291)
T ss_pred cCChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCc--------------------
Confidence 7999999999984 56789999999999999999999999998877665555431 111
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVPY 291 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~~ 291 (432)
.+...++.++++||++||+.||.+|++ ++|+++||||+..+|...
T Consensus 216 --------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 265 (291)
T cd05612 216 --------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265 (291)
T ss_pred --------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHH
Confidence 112346889999999999999999995 999999999998877543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=391.65 Aligned_cols=284 Identities=33% Similarity=0.527 Sum_probs=231.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCC-----EEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENN-----ELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~ 76 (432)
+|+++++||+|+||.||+|.+..+|+.||||++...... .......+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999999999999998754322 23345678999999999999999999997765 789
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--C
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM--P 153 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~--~ 153 (432)
+||||+.+++...+... +.+++..++.++.||+.||.|||+.|++||||||+|||++++ .+||+|||+|+..... .
T Consensus 81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999998888776554 479999999999999999999999999999999999999865 9999999999865432 2
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
......++++|+|||++.+...++.++||||+||++|||++|.+||.+.+..+++..+...+|.++...+..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 23445789999999999766778999999999999999999999999999999999999999988865443221111110
Q ss_pred hccccccCC--CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 234 SISYSEILP--INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 234 ~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
....+...+ .....+....+.++.+||.+||++||++|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 001111111 011123345789999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=383.09 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=215.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++.+.||+|+||.||+|+++.+++.||+|++.+.... .......+|++++++++||||+++++++.+.+.+|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999999754321 1223456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||+.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+++..... ...
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 174 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--TFT 174 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--cce
Confidence 9999875544444445579999999999999999999999999999999999999855 9999999999876542 335
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.+.......+.. +.+
T Consensus 175 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~~------------------- 232 (329)
T PTZ00263 175 LCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--GRL------------------- 232 (329)
T ss_pred ecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCc-------------------
Confidence 68999999999985 56689999999999999999999999988876655544421 111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
.+...++.++.+||++||+.||.+|++ ++++++||||+..+|.
T Consensus 233 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 233 ---------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 111246788999999999999999997 7999999999986664
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=382.73 Aligned_cols=251 Identities=28% Similarity=0.399 Sum_probs=210.3
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|++..+|+.||+|++++.... .......+|++++++++||||+++++++.+.+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999864322 22334568999999999999999999999999999999999876
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCCccccCCcc
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRW 163 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~~~~~~t~~ 163 (432)
.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+... ........+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 555555555689999999999999999999999999999999999999855 99999999997643 2233445689999
Q ss_pred ccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCC
Q 014039 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPI 243 (432)
Q Consensus 164 y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (432)
|+|||++. ...|+.++||||+||++|||++|..||.+.+.......+.. +.+
T Consensus 161 y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~------------------------- 212 (323)
T cd05571 161 YLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEI------------------------- 212 (323)
T ss_pred ccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCC-------------------------
Confidence 99999984 66789999999999999999999999988766544443311 100
Q ss_pred CccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 244 NLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 244 ~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.+...++.++.+||++||+.||++|| ++.++++||||...+|.
T Consensus 213 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 213 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11235788999999999999999999 89999999999988774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=374.19 Aligned_cols=277 Identities=37% Similarity=0.640 Sum_probs=228.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhc---CCCcccccceEEEe-----CC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKL---NHPNIIKLKEVVRE-----NN 73 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~-----~~ 73 (432)
+|++++.||+|+||+||+|+++.+++.||+|.++....... .....+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875432211 12234667666655 79999999998754 34
Q ss_pred EEEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
.+++||||+.+++...+.... ..+++..++.++.||+.||.|||+.|++||||||+|||++++ .+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 589999999998888776543 358999999999999999999999999999999999999854 999999999987765
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
........+|..|+|||++. ...++.++||||+||++|+|++|.++|.+....+.+.++....+.+....++......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP- 238 (288)
T ss_pred cccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc-
Confidence 44455668899999999985 5668999999999999999999999999999999999999988887766554322111
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+....+..+....+.++.++.+||.+||++||++|||+.|++.||||
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 --RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred --ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11233333444555667789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=387.41 Aligned_cols=281 Identities=36% Similarity=0.559 Sum_probs=225.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------C
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------N 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~ 73 (432)
+++|++++.||+|+||.||+|.+..+|+.||+|++...... .......+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999999999999999999754322 2334456899999999999999999998643 3
Q ss_pred EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
.+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 5799999999998876642 48899999999999999999999999999999999999855 9999999999876554
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
.......+|+.|+|||++. +..++.++||||+||++|+|++|..||.+.+..++...++..+|.|............+.
T Consensus 177 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred ccCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 4456678999999999985 567899999999999999999999999999999999999888888775432221111110
Q ss_pred hhccccccCCCCcc------------ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLS------------DIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~------------~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+......+. ......+.++++||.+||++||++|||+.|+|+||||..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00001111111111 111235678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=384.98 Aligned_cols=281 Identities=35% Similarity=0.551 Sum_probs=225.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------C
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------N 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~ 73 (432)
+++|++++.||+|+||.||+|.+..+++.||||++...... .......+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999999999999999999764332 2334466899999999999999999987532 4
Q ss_pred EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
.+|+||||+++++...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 5799999999998887643 48899999999999999999999999999999999999855 9999999999876654
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
.......+|+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+...+++..+|.|..+.+.........
T Consensus 180 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 4455678999999999985 567899999999999999999999999999999999999998888765432221111110
Q ss_pred hhccccccCCCC------------ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPIN------------LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~------------~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+...... ........+.++++||.+||+.||++|||+.|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000011000000 01111234678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=371.51 Aligned_cols=265 Identities=27% Similarity=0.416 Sum_probs=222.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++..+||.|..++||+|+++.+++.||||++.-+.+......+.+|++.|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 57999999999999999999999999999999999877766666778999999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-----
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP----- 153 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~----- 153 (432)
|.+ ++++.+... ...|.|..+..+++++++||.|||.+|.+|||||+.||||+. |.|||+|||.+..+....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 986 566666543 345999999999999999999999999999999999999985 599999999876543221
Q ss_pred CCccccCCccccchhh-hcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEV-LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~-l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
.....+||++|||||+ +.....|+.|+||||||+...||++|..||....+...+-. .+-|.|+..... ....
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~t~-~~~~--- 259 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLLTS-GLDK--- 259 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCcccc-cCCh---
Confidence 1256789999999999 55567899999999999999999999999998887665543 455666533210 0000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
+-...++..++.+|..||++||++||||+++|+|+||+..
T Consensus 260 --------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 260 --------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred --------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0012456689999999999999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=380.56 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=214.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCC-eEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETY-EIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++++.||+|+||.||+|.+..++ ..||+|++.+.... .......+|+++++.++||||+++++++.+.+.+|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 368999999999999999999876654 78999998754321 223345689999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
||||+.++.+..+..+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++.... ...
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--~~~ 186 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTY 186 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--Ccc
Confidence 99999876555454455579999999999999999999999999999999999999854 999999999987653 234
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. +..++.++||||+||++|||++|.+||.+.+.......+... .
T Consensus 187 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~------------------- 244 (340)
T PTZ00426 187 TLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--I------------------- 244 (340)
T ss_pred eecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--C-------------------
Confidence 568999999999985 566899999999999999999999999988776555554210 0
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWVP 290 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~~ 290 (432)
..+.+.++.++.++|++||+.||++|+ +++++++||||++.+|..
T Consensus 245 ---------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 245 ---------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 011235688999999999999999995 899999999999888753
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=384.15 Aligned_cols=256 Identities=34% Similarity=0.541 Sum_probs=224.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 78 (432)
+.|++.+.||+|.||.||+++++.||+.+|+|.+.+...... .....+|+++|+++. |||||.++++|++...+|+|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 469999999999999999999999999999999987665433 245679999999997 99999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-----CeEEEeeeccceecCCC
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-----DVLKIADFGLARELSSM 152 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-----~~lkL~DFG~a~~~~~~ 152 (432)
||++.| .+++.+... .++|..+..++.||+.|++|||+.|++||||||+|+|+.. +.+|++|||+|......
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 999986 566666665 3999999999999999999999999999999999999962 27999999999998876
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......+||++|+|||++. ...|+..+||||+|+++|.|++|.+||.+++.......|.. |...+
T Consensus 193 ~~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--~~~~f------------ 257 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--GDFDF------------ 257 (382)
T ss_pred ceEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--CCCCC------------
Confidence 6778899999999999984 57899999999999999999999999999998777776532 22211
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+.|+.++..|++||++||..||.+|+||.++|+|||++..
T Consensus 258 ------------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 258 ------------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ------------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 123456789999999999999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=384.42 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=213.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||+||+|+++.+++.||+|++.+.... .......+|+.+++.++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999999754322 12234567999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
||++++.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999876555555455689999999999999999999999999999999999999854 99999999997543211
Q ss_pred -------------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC
Q 014039 154 -------------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD 202 (432)
Q Consensus 154 -------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~ 202 (432)
.....+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 012458999999999985 567899999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC---CCCHHHHhc
Q 014039 203 SEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR---RPTADQALQ 279 (432)
Q Consensus 203 ~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~---Rpta~elL~ 279 (432)
+..+...++....... .++. ...++.++++||.+|+. +|.+ ||+++|+++
T Consensus 240 ~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 240 TPQETYKKVMNWKETL-----------------IFPP---------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred CHHHHHHHHHcCcCcc-----------------cCCC---------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 8776666553211110 0110 11468899999999876 4554 589999999
Q ss_pred CCCCCCCCCCC
Q 014039 280 HPFFNVETWVP 290 (432)
Q Consensus 280 Hp~f~~~~~~~ 290 (432)
||||+..+|..
T Consensus 293 hp~f~~~~~~~ 303 (363)
T cd05628 293 NPFFEGVDWEH 303 (363)
T ss_pred CCCCCCCCHHH
Confidence 99999988854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=365.22 Aligned_cols=284 Identities=38% Similarity=0.633 Sum_probs=241.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc-cchHHHHHHHHHHHHHhcCCCcccccceEEEe--------C
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF-YFWEECMNLREVKALRKLNHPNIIKLKEVVRE--------N 72 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------~ 72 (432)
..|+-+.+||+|.||.||+|+++.+|+.||+|++.-+. ...-....+||+++|..|.|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35777889999999999999999999999999875311 11112335799999999999999999998743 3
Q ss_pred CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCC
Q 014039 73 NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSS 151 (432)
Q Consensus 73 ~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~ 151 (432)
..+|+||.+|+.+|...+......++..++++++.+++.||.|+|+..|+|||+||+|+||+. +.+||+|||+|+.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 458999999999999988887778999999999999999999999999999999999999997 5999999999987653
Q ss_pred C-----CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 152 M-----PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 152 ~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
. +.++..+.|.||++||.+++...|++++|||+.||||+||+++.|+|.++++..++..|..++|..+.+.|+..
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 2 22455677999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred hhhhhhhhccccccCC---CCccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 227 TNISRLISISYSEILP---INLSDIIP--NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~---~~~~~~~~--~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+.+-+..+..+.... ..+.+..+ .-.+++.||+.+||.+||.+|++++++|+|.||..
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 7777766664443222 22222222 13568999999999999999999999999999964
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=378.01 Aligned_cols=304 Identities=26% Similarity=0.415 Sum_probs=231.1
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++||+|+||.||+|++..+++.||+|++.+.... ........|.++++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999764321 2223355788888876 899999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... .......+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 6555444445579999999999999999999999999999999999999855 999999999976432 22334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|.+||.+.+..+....+.. +..
T Consensus 161 ~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~------------------------ 213 (321)
T cd05591 161 DYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDV------------------------ 213 (321)
T ss_pred cccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC------------------------
Confidence 999999884 66789999999999999999999999999887776665532 100
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCCCCCCCCCCC---ChhhhhccCCCCCCCCcc
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRP-------TADQALQHPFFNVETWVPYPLH---DPLELRLNNMGSKPNLEL 312 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-------ta~elL~Hp~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 312 (432)
.....++.++.+||++||+.||++|+ ++.++++||||...+|...... .+....... ..+.
T Consensus 214 ----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 284 (321)
T cd05591 214 ----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKT-----KRDV 284 (321)
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCC-----cchh
Confidence 01124678999999999999999999 8999999999998887533211 111111100 0011
Q ss_pred CCCCCCCCCCccccCccccccCChhhhhccCCccccccccc
Q 014039 313 NLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILF 353 (432)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (432)
+.++ .+ +.....-+.|+..++.+.+.+..++++++
T Consensus 285 ~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (321)
T cd05591 285 NNFD--QD----FTKEEPVLTPVDPAVIKQINQEEFRGFSF 319 (321)
T ss_pred hhcC--Cc----cccCccccCCCCccccccccccccCCCcc
Confidence 1111 10 11112235677777888888888888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=372.95 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=220.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+.|++++.||.|.-|+||+|+.+.++..+|+|++.+..... +..+...|.+||+.++||.++.||..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 46888999999999999999999999999999998765432 2234567999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecC------
Q 014039 80 EYMEHNLYHIMRER--QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELS------ 150 (432)
Q Consensus 80 E~~~~~ll~~~~~~--~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~------ 150 (432)
|||+|+.+..++++ ++.|++..++.|+..++.||+|||-.|||+|||||+||||.+ |.+-|+||.++....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 99998877777654 467999999999999999999999999999999999999974 599999999873210
Q ss_pred ----------------------------C-C----------------------CCCccccCCccccchhhhcCCCCCCcc
Q 014039 151 ----------------------------S-M----------------------PPYTEYVSTRWYRAPEVLLQSSSYSPA 179 (432)
Q Consensus 151 ----------------------------~-~----------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~ 179 (432)
. . ....+++||-.|.|||++. +...+.+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~-G~GHgsA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR-GEGHGSA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-cCCCCch
Confidence 0 0 0124578999999999994 6778999
Q ss_pred cceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHH
Q 014039 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDL 259 (432)
Q Consensus 180 ~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 259 (432)
+|+|+||+++|||+.|.-||+|.+..+.+..|+ +.+. .|+. .+.++..++||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv---~~~l----------------~Fp~---------~~~vs~~akDL 367 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV---GQPL----------------KFPE---------EPEVSSAAKDL 367 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh---cCCC----------------cCCC---------CCcchhHHHHH
Confidence 999999999999999999999999988877763 2221 1111 12567899999
Q ss_pred HHHhcccCCCCCCC----HHHHhcCCCCCCCCCC
Q 014039 260 IWQLCSWDPLRRPT----ADQALQHPFFNVETWV 289 (432)
Q Consensus 260 i~~~L~~dP~~Rpt----a~elL~Hp~f~~~~~~ 289 (432)
|+++|.+||++|.. |+||.+||||++.+|.
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999999998 9999999999999997
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=371.37 Aligned_cols=260 Identities=24% Similarity=0.320 Sum_probs=214.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|+..+.||+|+||.||+|.+..+|+.||+|++...... .......+|++++++++|+||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 489999999999999999999999999999998754322 222345689999999999999999999999999999999
Q ss_pred cCCCcHHH-HHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 81 YMEHNLYH-IMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 81 ~~~~~ll~-~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|++++.+. .+.. ....+++..++.++.||+.||+|||+.||+||||||+|||++++ .+||+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99876554 4433 23469999999999999999999999999999999999999854 999999999987655444556
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||..|+|||++. ...++.++||||+||++|||++|..||.+.........+.......
T Consensus 161 ~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 220 (285)
T cd05631 161 RVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED------------------- 220 (285)
T ss_pred CCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-------------------
Confidence 78999999999985 5678999999999999999999999998766533322222111110
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
...+...++.++.+||++||+.||.+|++ ++++++||||++.+|.
T Consensus 221 -------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 -------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred -------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 01123457889999999999999999997 8999999999987663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=383.35 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=214.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|++..+|+.||||++...... .......+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 5899999999999999999999999999999999754321 12233568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999876555555455579999999999999999999999999999999999999854 99999999997643211
Q ss_pred ----------------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCC
Q 014039 154 ----------------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIF 199 (432)
Q Consensus 154 ----------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF 199 (432)
.....+||+.|+|||++. ...++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011347999999999985 567899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHH
Q 014039 200 PGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT---ADQ 276 (432)
Q Consensus 200 ~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt---a~e 276 (432)
.+.+..+....++..... ..++. ...+++++.+||++||. +|.+|++ +.|
T Consensus 240 ~~~~~~~~~~~i~~~~~~-----------------~~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 240 CSDNPQETYRKIINWKET-----------------LQFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred CCCCHHHHHHHHHcCCCc-----------------cCCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 988876655554321000 00000 11468899999999997 9999998 999
Q ss_pred HhcCCCCCCCCCC
Q 014039 277 ALQHPFFNVETWV 289 (432)
Q Consensus 277 lL~Hp~f~~~~~~ 289 (432)
+++||||+..+|.
T Consensus 293 ll~h~~~~~~~~~ 305 (364)
T cd05599 293 IKSHPFFKGVDWE 305 (364)
T ss_pred HhcCCCcCCCCHH
Confidence 9999999988774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=379.66 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=215.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-------------HHHHHHHHHHHHHhcCCCcccccce
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------------EECMNLREVKALRKLNHPNIIKLKE 67 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------------~~~~~~~Ei~~l~~l~hpnIv~l~~ 67 (432)
+++|++++.||+|.||.|.+|++..+++.||||++.+..... ......+||.+|+++.|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 578999999999999999999999999999999996533211 1124568999999999999999999
Q ss_pred EEEe--CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeec
Q 014039 68 VVRE--NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFG 144 (432)
Q Consensus 68 ~~~~--~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG 144 (432)
+..+ .+.+|||+|||..+-..........+++.+++.|++.++.||+|||.+||+||||||+|+||++ |.+||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 9975 5789999999997665544443323999999999999999999999999999999999999985 599999999
Q ss_pred cceecCCC------CCCccccCCccccchhhhcCC---CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014039 145 LARELSSM------PPYTEYVSTRWYRAPEVLLQS---SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL 215 (432)
Q Consensus 145 ~a~~~~~~------~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~ 215 (432)
.+.....+ ......+|||.|+|||++.++ ...+.+.||||+|++||.|+.|+.||-++...+...+|+..-
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 99866322 223447899999999999763 345789999999999999999999999999998888885321
Q ss_pred CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 216 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..|+ ..+.+..+++|||.+||++||++|++..++..|||....
T Consensus 336 -------------------L~fP---------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 -------------------LEFP---------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -------------------ccCC---------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 0111 112467899999999999999999999999999999754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=382.64 Aligned_cols=280 Identities=36% Similarity=0.623 Sum_probs=229.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|++++.||+|+||.||+|.+..+++.||+|++...... .......+|+++|++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 6899999999999999999999999999999999764322 2223456899999999999999999987532 45
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
.|+++|++.+++...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+++....
T Consensus 95 ~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-- 170 (343)
T cd07878 95 VYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-- 170 (343)
T ss_pred EEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC--
Confidence 789999998877665543 369999999999999999999999999999999999999865 999999999987654
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
....+++|+.|+|||++.+...++.++||||+||++|+|++|..||++.+..+.+..+....|.+......... ...+.
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 34566899999999999766789999999999999999999999999999999999998888887654322110 00111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....++......+...+...++.+.+||.+||+.||++|||+.|+|+||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 11122333333444555677889999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=375.08 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=209.4
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754321 2233456788888877 799999999999999999999999997
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.... .......+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 6655555555679999999999999999999999999999999999999855 999999999976432 22334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|..||.+.+..+....+.. +.+
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~------------------------ 213 (320)
T cd05590 161 DYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEV------------------------ 213 (320)
T ss_pred cccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCC------------------------
Confidence 999999984 66789999999999999999999999998887666555431 100
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA------DQALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta------~elL~Hp~f~~~~~~ 289 (432)
.....++.++.+||++||+.||++|+++ +++++||||+..+|.
T Consensus 214 ----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 214 ----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 1123468899999999999999999998 999999999988774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.69 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=210.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.||+|.+..+++.||||++.+.... .......+|++++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 5899999999999999999999999999999998754321 22234568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---- 154 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---- 154 (432)
||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999875554444445679999999999999999999999999999999999999854 999999999964321000
Q ss_pred --------------------------------------------CccccCCccccchhhhcCCCCCCcccceechHHHHH
Q 014039 155 --------------------------------------------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILA 190 (432)
Q Consensus 155 --------------------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ 190 (432)
....+||+.|+|||++. ...++.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchhhh
Confidence 01357999999999985 567899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC
Q 014039 191 ELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR 270 (432)
Q Consensus 191 ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 270 (432)
||++|.+||.+.+..+....+....... .++. ...++.++.+||++||. +|.+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETL-----------------YFPD---------DIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCcc-----------------CCCC---------CCCCCHHHHHHHHHHhc-CHhh
Confidence 9999999999888766655553210000 0100 12468899999999998 7777
Q ss_pred C---CCHHHHhcCCCCCCCCCC
Q 014039 271 R---PTADQALQHPFFNVETWV 289 (432)
Q Consensus 271 R---pta~elL~Hp~f~~~~~~ 289 (432)
| +|+.|+++||||+..+|.
T Consensus 293 r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 293 RLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred cCCCCCHHHHhcCCCcCCCCHH
Confidence 5 599999999999987664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=376.91 Aligned_cols=263 Identities=30% Similarity=0.458 Sum_probs=218.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|++..+++.||+|++.+.... .......+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999754322 22334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.... .....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 999876566555555689999999999999999999999999999999999999865 999999999986654 34556
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.+..+....+......... +
T Consensus 159 ~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------------~ 220 (333)
T cd05600 159 VGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-----------------P 220 (333)
T ss_pred ccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC-----------------C
Confidence 8999999999985 558899999999999999999999999988876665554321110000 0
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
........++.++.+||.+||+.+|.+|+++.++++||||...+|.
T Consensus 221 -----~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 221 -----VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred -----CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 0000013578899999999999999999999999999999987664
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=381.17 Aligned_cols=281 Identities=35% Similarity=0.599 Sum_probs=225.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------C
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------N 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~ 73 (432)
+++|++++.||+|+||.||+|.+..+++.||+|++...... .......+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999999999999999999764432 2334456899999999999999999988543 3
Q ss_pred EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
..|+||||+++++...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999988877643 48899999999999999999999999999999999999855 9999999999876655
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-hhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-ISR 231 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~~~ 231 (432)
......++|+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+....++..++.+..+.+..... ...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred cccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 4456678999999999985 56789999999999999999999999999999999999988888776443221110 001
Q ss_pred hh-------hccccccCCCC----ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LI-------SISYSEILPIN----LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~-------~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+. ...++...+.. ........+.++++||.+||+.||++|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 10 01111110000 01112235678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=375.57 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=212.7
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCC-CcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNH-PNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~ 79 (432)
+|++++.||+|+||.||+|++..+++.||+|++.+.... .......+|++++..+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 699999999999999999999999999999999764321 223345689999999966 56888999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~~~ 157 (432)
||++++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999876555444445579999999999999999999999999999999999999855 99999999997542 2223345
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...++.++||||+||++|||++|.+||.+.+..+....+... .
T Consensus 161 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~-------------------- 217 (324)
T cd05587 161 FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--N-------------------- 217 (324)
T ss_pred ecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------------
Confidence 67999999999985 566899999999999999999999999988876666555311 0
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f~~~~~~ 289 (432)
..+...++.++.++|++||+.||.+|+++ .++++||||+..+|.
T Consensus 218 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 218 --------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred --------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01123578899999999999999999986 899999999988874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=366.39 Aligned_cols=279 Identities=47% Similarity=0.841 Sum_probs=234.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeC--CEEEEEEe
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVREN--NELFFIFE 80 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~~~~lV~E 80 (432)
|+++++||+|+||.||+|.+..+++.||+|+++............+|+.+++++ +|+||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 789999999999999999999999999999998654433444456899999999 599999999999877 88999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCCCccccC
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
|+.+++++.+..+...+++..++.++.||+.||.|||+.|++||||||+||+++++.+||+|||+++............+
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~ 160 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYIS 160 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCC
Confidence 99999999888766689999999999999999999999999999999999999999999999999988766555566778
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||++.....++.++||||+||++|||++|.+||++.+..+....+...+|.+..... ......+.....++..
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (282)
T cd07831 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL-KKFRKSRHMNYNFPSK 239 (282)
T ss_pred CcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH-HhhcccccccccCccc
Confidence 999999998766667899999999999999999999999999998888888888877664321 1111111122233333
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+....+.++.++++||.+||++||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 3333444455779999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=375.07 Aligned_cols=304 Identities=26% Similarity=0.411 Sum_probs=230.2
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|.+..+++.||+|++++.... .......+|+++++.+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999864321 2223346788999888 799999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.....+.+.+++..++.++.||+.||.|||+.||+||||||+|||++++ .+||+|||+++.... .......++++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 6555555555579999999999999999999999999999999999999855 999999999975322 22334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. +..++.++||||+||++|+|++|..||.+.+.......+.. +.
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--~~------------------------- 212 (318)
T cd05570 161 DYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--DE------------------------- 212 (318)
T ss_pred cccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CC-------------------------
Confidence 999999985 56789999999999999999999999988876555444321 00
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCCCCC---ChhhhhccCCCCCCCCccCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFFNVETWVPYPLH---DPLELRLNNMGSKPNLELNL 314 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 314 (432)
..+...++.++.+||++||+.||++|||+ .++++||||+..+|...... .|...... +..+...
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 284 (318)
T cd05570 213 ---VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIK-----GRFDVSN 284 (318)
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCC-----Ccchhhh
Confidence 01123568899999999999999999999 99999999998887432211 11111111 1111111
Q ss_pred CCCCCCCCccccCccccccCChhhhhccCCccccccccc
Q 014039 315 WDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILF 353 (432)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (432)
++.. +......+.|...+.++.+.|..+++|.|
T Consensus 285 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (318)
T cd05570 285 FDDE------FTKEKPVLTPPDEAIIRNIDQEEFRGFSY 317 (318)
T ss_pred cCch------hccCcccCCCCcccccccccccccCCCCC
Confidence 1111 11112234555666778888888888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=382.61 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=211.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
..|++++.||+|+||+||+|++..+++.||+|++.+.... .......+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3699999999999999999999999999999999764322 22334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
||++++.+..+..+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.+ .+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999876555444445579999999999999999999999999999999999999854 99999999986431100
Q ss_pred -------------------------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHH
Q 014039 154 -------------------------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILA 190 (432)
Q Consensus 154 -------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ 190 (432)
.....+||+.|+|||++. ...|+.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhHHH
Confidence 012457999999999985 567899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhccc--CC
Q 014039 191 ELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSW--DP 268 (432)
Q Consensus 191 ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~--dP 268 (432)
||++|.+||.+.+..+....++...+... ++ ....+++++++||.+||.. +|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~~---------~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLH-----------------IP---------PQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccC-----------------CC---------CCCCCCHHHHHHHHHHccCcccc
Confidence 99999999998776655544432111100 00 0125789999999996654 44
Q ss_pred CCCCCHHHHhcCCCCCCCCCCC
Q 014039 269 LRRPTADQALQHPFFNVETWVP 290 (432)
Q Consensus 269 ~~Rpta~elL~Hp~f~~~~~~~ 290 (432)
..|++++|+++||||+..+|..
T Consensus 294 ~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred cCCCCHHHHhcCcccCCCChhH
Confidence 5599999999999999877743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=383.33 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=212.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
.+|+++++||+|+||.||+|++..+++.||+|++.+.... .......+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999754321 22234568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC------
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM------ 152 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~------ 152 (432)
||++++.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|..+...
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999875444444444579999999999999999999999999999999999999854 9999999998533100
Q ss_pred ------------------------------------------CCCccccCCccccchhhhcCCCCCCcccceechHHHHH
Q 014039 153 ------------------------------------------PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILA 190 (432)
Q Consensus 153 ------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ 190 (432)
......+||+.|+|||++. ...|+.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHHHH
Confidence 0012357999999999985 567899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC
Q 014039 191 ELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR 270 (432)
Q Consensus 191 ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 270 (432)
||++|.+||.+.+..+...++........ + .....+++++.++|.+|+. +|.+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~---------p~~~~~s~~~~~li~~l~~-~p~~ 292 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLH-----------------I---------PPQAKLSPEASDLIIKLCR-GPED 292 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcC-----------------C---------CCcccCCHHHHHHHHHHcc-CHhH
Confidence 99999999998877665555432110000 0 0113578999999999874 9999
Q ss_pred CCC---HHHHhcCCCCCCCCCCC
Q 014039 271 RPT---ADQALQHPFFNVETWVP 290 (432)
Q Consensus 271 Rpt---a~elL~Hp~f~~~~~~~ 290 (432)
|++ ++|+++||||+..+|..
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcChHH
Confidence 997 99999999999887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=385.06 Aligned_cols=275 Identities=25% Similarity=0.366 Sum_probs=217.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|+.... ...+|+++|++++||||+++++++..+...++|||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~-------~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-------GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh-------hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4799999999999999999999999999999976532 246899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC--CCCccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM--PPYTEY 158 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~--~~~~~~ 158 (432)
+.++++..+... +.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+..... ......
T Consensus 165 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 165 YKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 998888877655 46899999999999999999999999999999999999985 49999999999754321 223456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCCCCchhh-hhhh
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD-------SEIDQLYKVCCILGAPDWTAFPEA-TNIS 230 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~-------~~~d~~~~i~~~~g~p~~~~~~~~-~~~~ 230 (432)
+||+.|+|||++. ...|+.++||||+||++|||++|..+|-+. ....++..++...|.++....... ....
T Consensus 244 ~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 244 AGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred cCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 8999999999985 567899999999999999999999776443 235677788888887664422111 1111
Q ss_pred hhh-hc-cccccCCC--CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLI-SI-SYSEILPI--NLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~-~~-~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
... .. ......+. ........++.++.+||.+||++||++||||.|+|+||||+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 111 00 00000000 000111235678999999999999999999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=375.29 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=205.2
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|++..+++.||+|++++..... ......+|+.+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999998654322 223356899999998 799999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec-CCCCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~-~~~~~~~~~~~t~ 162 (432)
+.+..+..+.+.+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+++.. .........+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 6555444445689999999999999999999999999999999999999855 9999999999753 2233345578999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE--------IDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~--------~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.|+|||++. ...++.++||||+||++|+|++|..||..... .+.+.+.+ ..
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------------~~ 219 (329)
T cd05588 161 NYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------------------LE 219 (329)
T ss_pred cccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------------------Hc
Confidence 999999985 56789999999999999999999999964221 11111110 00
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT------ADQALQHPFFNVETWVP 290 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt------a~elL~Hp~f~~~~~~~ 290 (432)
....+...++.++.++|++||+.||.+|+| ++++++||||...+|..
T Consensus 220 ---------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~ 272 (329)
T cd05588 220 ---------KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272 (329)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 001123457889999999999999999997 78999999999877743
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=366.83 Aligned_cols=283 Identities=36% Similarity=0.626 Sum_probs=233.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+++|++.+.||+|++|.||+|.++.+++.||+|.+.............+|++++++++|+||+++++++.+....|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999998754332222335689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
|+.+++.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.+ .+||+|||+++..... ......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccccc
Confidence 99998888777666689999999999999999999999999999999999999854 9999999998764321 112233
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS-EIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~-~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++..|+|||++.+...++.++||||+||++|+|++|.++|.+.. ..+++..+...++.+....++............+
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence 568889999998766778999999999999999999999998776 5677777888888877666655444433333333
Q ss_pred cccCCCCccccCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNAS--MEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s--~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+..+....+.++ .++.++|.+||+.||++|||+.|+++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 3333333434444555 899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=364.85 Aligned_cols=282 Identities=45% Similarity=0.774 Sum_probs=242.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|+||.||+|.+..+|+.||+|++..... ........+|+.++++++||||+++++++.+....|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999999999999999976543 22234467899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTEY 158 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~~ 158 (432)
+.+++.+.+......+++..++.++.||+.||.|||+.|++|+||||+||+++++ .++|+|||.+....... .....
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 9777877777666789999999999999999999999999999999999999854 99999999998765432 23456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++.+|+|||++.+...++.++||||+||+++||++|.++|.+......+..+...++.+....++.......+....++
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence 78999999999876667899999999999999999999999999999999999998888877666554444455555555
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
......+....++.+.++.+||.+||+.||++|||++++|+||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 5555556666778889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=369.20 Aligned_cols=285 Identities=40% Similarity=0.660 Sum_probs=234.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVREN--NELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 77 (432)
+++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+|+.++++++|+||+++++++.+. +.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 5789999999999999999999999999999999875432211 22345799999999999999999998654 56899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
||||+.+++.+.+......+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||.+...... ...
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence 99999998888877666689999999999999999999999999999999999999865 9999999999876543 223
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+++.|+|||++.+...++.++||||+||++|||++|.+||.+.+..+.+..+...++.+....++...........
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 34456888999999876677899999999999999999999999999999999999998888776555433322222222
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.........+...+...++++.+||++||++||++|||+.|+++||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 22222222233334457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=372.94 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=213.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+|++++.||+|+||.||+|++..+++.||+|++.+.... ........|..++..+ .|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999864322 1222345788888877 5899999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~ 157 (432)
||++++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.... ......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 999875444444444579999999999999999999999999999999999999865 999999999986432 223445
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...++.++||||+||++|||++|..||.+.+..+....+... ..
T Consensus 161 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~------------------- 218 (323)
T cd05616 161 FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NV------------------- 218 (323)
T ss_pred CCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------------
Confidence 68999999999985 567899999999999999999999999988876666555321 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFFNVETWVP 290 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f~~~~~~~ 290 (432)
.....++.++.+||.+||+.||++|+++ .++++||||+..+|..
T Consensus 219 ---------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 219 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 1123578899999999999999999984 8999999999888743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=379.46 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=216.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999999753221 12233568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC--CCc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~--~~~ 156 (432)
||++++.+..+..+. .+++..++.++.||+.||+|||+.||+||||||+|||++. +.+||+|||++....... ...
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 999876555554443 5899999999999999999999999999999999999985 499999999998764322 234
Q ss_pred cccCCccccchhhhcCC---CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQS---SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~---~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..+||+.|+|||++... ..++.++|||||||++|||++|.+||.+.+......++........
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 267 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT-------------- 267 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC--------------
Confidence 56799999999998643 3488999999999999999999999999887666665532111100
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~~~ 291 (432)
++ ....++.++.+||++||+.+|.+ |+|++|+++||||+...|...
T Consensus 268 ---~~---------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~~ 315 (370)
T cd05596 268 ---FP---------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFD 315 (370)
T ss_pred ---CC---------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhhH
Confidence 10 01247889999999999999988 999999999999998877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=366.47 Aligned_cols=279 Identities=38% Similarity=0.648 Sum_probs=228.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++++.||+|+||.||+|++..+|+.||+|++....... ......+|++++++++||||+++++++.+....|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 6999999999999999999999999999999997543221 122356799999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
+++++.+.+....+.+++..++.++.||++||.|||+.|++||||||+||+++++ .+||+|||+++..... .......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence 9999998887766789999999999999999999999999999999999999855 9999999999866432 2233456
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~p-F~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
++..|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+...++.+....++.......... ++
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 238 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP--YP 238 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc--cC
Confidence 789999999987666789999999999999999987655 677777788888888888776655543222222211 11
Q ss_pred cc-CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.. ....+....+.++.++.+||.+||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11 1112233446789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=363.27 Aligned_cols=280 Identities=39% Similarity=0.685 Sum_probs=230.2
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++++.||+|++|.||+|++..+++.||+|++....... ......+|+.++++++||||+++++++.+++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 6999999999999999999999999999999987543221 223456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 82 MEHNLYHIMRER--QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 82 ~~~~ll~~~~~~--~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
+.+++.+.+... +..+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||++...... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 998888777543 2579999999999999999999999999999999999999855 9999999999765432 22234
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+++.|+|||++.+...++.++||||+||++|+|++|.+||.+....+....+...++.+....++.......+ ...+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY-KNTF 239 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH-Hhhc
Confidence 467899999999876677899999999999999999999999999999998888888887765555433322221 1122
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
+.............++.++.+||++||+.||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 2222223333445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=376.38 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=216.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|++..+|+.||||++...... .......+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 5899999999999999999999999999999999754322 22334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
||++++.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999875444444444689999999999999999999999999999999999999865 99999999998665432
Q ss_pred -------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHH
Q 014039 154 -------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQL 208 (432)
Q Consensus 154 -------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~ 208 (432)
......||+.|+|||++. ...++.++|||||||++|||++|..||.+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 234567999999999985 557899999999999999999999999988876665
Q ss_pred HHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCC
Q 014039 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-ADQALQHPFFNVET 287 (432)
Q Consensus 209 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-a~elL~Hp~f~~~~ 287 (432)
.++....... .++ ....+++++.+||.+||. ||.+|++ ++|+++||||+..+
T Consensus 240 ~~i~~~~~~~-----------------~~p---------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 240 NKIINWKESL-----------------RFP---------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHHhccCCcc-----------------cCC---------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 5553211100 000 012368899999999998 9999999 99999999999877
Q ss_pred CCC
Q 014039 288 WVP 290 (432)
Q Consensus 288 ~~~ 290 (432)
|..
T Consensus 293 ~~~ 295 (350)
T cd05573 293 WEN 295 (350)
T ss_pred HHH
Confidence 743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=371.40 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=204.5
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|++..+++.||+|++++.... .......+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865322 2223356788888877 899999999999999999999999997
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++... ........+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 6555555555689999999999999999999999999999999999999855 99999999997642 223344568999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE--------IDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~--------~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.|+|||++. ...++.++||||+||++|||++|..||..... .+.+.+.+ ..
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------------------~~ 219 (329)
T cd05618 161 NYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------------------LE 219 (329)
T ss_pred cccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------------------hc
Confidence 999999985 56789999999999999999999999953211 11111110 00
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT------ADQALQHPFFNVETWV 289 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt------a~elL~Hp~f~~~~~~ 289 (432)
....++..++.++.+||++||+.||++|++ ++++++||||+..+|.
T Consensus 220 ---------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 220 ---------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 001233467889999999999999999998 4799999999998884
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=355.77 Aligned_cols=257 Identities=32% Similarity=0.499 Sum_probs=217.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc---hH----HHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF---WE----ECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~----~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|+-.+.||+|..++|.++.++.+|..+|+|++...... .. .....+|+.+|+++ +||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677888999999999999999999999999998632111 11 11235799999998 8999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 74 ELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
.+++|+|.|+. .|.+.+.+ .-.++|...+++|+||++|+.|||.++||||||||+|||++++ ++||+|||+|+.+..
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999985 55555544 4589999999999999999999999999999999999999987 999999999999999
Q ss_pred CCCCccccCCccccchhhhc-----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLL-----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
++.....||||.|.|||.+. +...|+..+|+|++|+|||-|+.|.|||-.....-.+..|++ |.-.+.
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--GkyqF~----- 248 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--GKYQFR----- 248 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--cccccC-----
Confidence 99999999999999999874 446799999999999999999999999977666555555543 211111
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
++-|.++|.+++|||++||+.||.+|.|++|+|+||||..
T Consensus 249 -------------------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 249 -------------------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -------------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 1224567889999999999999999999999999999953
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=369.73 Aligned_cols=274 Identities=35% Similarity=0.598 Sum_probs=212.4
Q ss_pred eeeEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEEEEecC
Q 014039 7 LEELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFFIFEYM 82 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 82 (432)
.++||+|+||+||+|+++ .+++.||+|.+...... ....+|+++|++++||||+++++++.. ...+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc---HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999976 46788999999754322 235689999999999999999998854 46789999999
Q ss_pred CCcHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-----CCeEEEeeeccceec
Q 014039 83 EHNLYHIMRER--------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-----NDVLKIADFGLAREL 149 (432)
Q Consensus 83 ~~~ll~~~~~~--------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-----~~~lkL~DFG~a~~~ 149 (432)
++++...+... ...+++..++.++.||+.||+|||++||+||||||+|||++ .+.+||+|||+|+..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 99888776532 23589999999999999999999999999999999999994 238999999999876
Q ss_pred CCCC----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhC
Q 014039 150 SSMP----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---------IDQLYKVCCILG 216 (432)
Q Consensus 150 ~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~---------~d~~~~i~~~~g 216 (432)
.... .....++|+.|+|||++.+...|+.++||||+||++|||++|.+||.+... .+++..+...+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 4321 234568899999999997767799999999999999999999999976543 467788888888
Q ss_pred CCCCCCchhhhhhhhhh-------hccccccCC-CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 217 APDWTAFPEATNISRLI-------SISYSEILP-INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 217 ~p~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.|....+.......... ...+..... ..+.......+.++.|||++||++||.+|+||+|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 87765543322111100 000000000 00001112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=363.16 Aligned_cols=260 Identities=29% Similarity=0.441 Sum_probs=228.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH--HHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC--MNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~--~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|+.+++||+|.||.|.+++.+.+++.+|||+++++....... ..+.|-++|+...||.+..|...|+.++++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 789999999999999999999999999999999999876554333 346899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecccee-cCCCCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARE-LSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~-~~~~~~~~ 156 (432)
|||+.|+-+....++.+.++|...+.|-..|+.||.|||+++||+||||.+|+|+|.+ .+||+|||+|+. +..+..+.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 9999988776666666789999999999999999999999999999999999999955 999999999985 44556778
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.+||||.|.|||++ ....|+.++|+|.+|++||||+||+.||...+.......|+.. ++.
T Consensus 327 TFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------------d~k 386 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------------DLK 386 (516)
T ss_pred cccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------------hcc
Confidence 89999999999998 5788999999999999999999999999887765555544311 112
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVPY 291 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~~ 291 (432)
| +..++++|+.|+..+|.+||.+|.. |.|+.+|+||...+|...
T Consensus 387 F-----------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 387 F-----------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred C-----------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 2 2478999999999999999999975 899999999999999543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=380.34 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=210.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
.+|++++.||+|+||.||+|++..+++.||+|++.+.... .......+|+++|++++|+||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999999754321 12233568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC------
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM------ 152 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~------ 152 (432)
||++++.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999876555444445579999999999999999999999999999999999999855 9999999998533100
Q ss_pred --------------------------------------CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh
Q 014039 153 --------------------------------------PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194 (432)
Q Consensus 153 --------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~ 194 (432)
......+||+.|+|||++. ...++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeeccceeeehhh
Confidence 0012357999999999984 6678999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC--
Q 014039 195 LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-- 272 (432)
Q Consensus 195 g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-- 272 (432)
|.+||.+.+..+....+....... .+ .....++.++.++|.+|+ .+|.+|+
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~---------~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTL-----------------HI---------PSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccc-----------------cC---------CCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 999999888766555442110000 00 011357889999999987 5999999
Q ss_pred -CHHHHhcCCCCCCCCCC
Q 014039 273 -TADQALQHPFFNVETWV 289 (432)
Q Consensus 273 -ta~elL~Hp~f~~~~~~ 289 (432)
|+.|+++||||+..+|.
T Consensus 293 ~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 293 NGADEIKAHPFFKGIDFA 310 (376)
T ss_pred CCHHHHhCCCCcCCCCHH
Confidence 99999999999986653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=371.90 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=209.5
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|++..+|+.||+|++.+.... .......+|+++++.++||||+++++++.+.+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999764322 22334568999999999999999999999999999999999876
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCcc
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRW 163 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~~ 163 (432)
.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.... .......+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 555555555679999999999999999999999999999999999999854 999999999976432 223345679999
Q ss_pred ccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCC
Q 014039 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPI 243 (432)
Q Consensus 164 y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (432)
|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+.. +.
T Consensus 161 y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~-------------------------- 211 (328)
T cd05593 161 YLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--ED-------------------------- 211 (328)
T ss_pred ccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CC--------------------------
Confidence 99999984 56789999999999999999999999988766544433310 00
Q ss_pred CccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 244 NLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 244 ~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
..+...++.++.+||++||+.||++|+ ++.|+++||||...+|.
T Consensus 212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 212 --IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred --ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 012235788999999999999999997 89999999999987764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=369.88 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=205.6
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|++..+++.||+|++.+..... ......+|+.++.++ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998654322 223356899999888 699999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++... ........+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 6555544445579999999999999999999999999999999999999855 99999999997632 233345578999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE------IDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~------~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.|+|||++. ...++.++|||||||++|||++|..||..... .+.+..++. ..
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~------------------- 218 (327)
T cd05617 161 NYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--EK------------------- 218 (327)
T ss_pred ccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--hC-------------------
Confidence 999999985 66789999999999999999999999964321 112221110 00
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA------DQALQHPFFNVETWVP 290 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta------~elL~Hp~f~~~~~~~ 290 (432)
...+...++.++.++|++||+.||++|+++ .++++||||+..+|..
T Consensus 219 --------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 219 --------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred --------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 011233578899999999999999999984 6999999999988753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.07 Aligned_cols=254 Identities=29% Similarity=0.416 Sum_probs=210.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHH---HhcCCCcccccceEEEeCCEEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKAL---RKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++++.||+|+||.||+|.+..+|+.||||++++.... .......+|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999754321 1223344565554 566899999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~ 156 (432)
|||+.++.+...... +.+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||+++.... .....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999998766555443 469999999999999999999999999999999999999855 999999999875432 22334
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+|++.|+|||++. +..++.++|||||||++|||++|..||.+.+..+....+... .+
T Consensus 160 ~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~------------------ 218 (324)
T cd05589 160 TFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EV------------------ 218 (324)
T ss_pred ccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC------------------
Confidence 568999999999985 567899999999999999999999999988876666554321 00
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.....++.++.+||++||+.||++|| ++.++++||||+..+|.
T Consensus 219 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 219 ----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 11235688999999999999999999 79999999999987664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=368.83 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=206.4
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++||+|+||.||+|++..+++.||+|+++..... ........|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999864321 1222345677777655 899999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.... .......+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 6555555455579999999999999999999999999999999999999855 999999999986533 23334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. +..++.++||||+||++|||++|..||.+.+..+....+.. ..+
T Consensus 161 ~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~------------------------ 213 (316)
T cd05592 161 DYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRP------------------------ 213 (316)
T ss_pred cccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC------------------------
Confidence 999999985 56689999999999999999999999998877555544421 000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-DQALQHPFFNVETWVP 290 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-~elL~Hp~f~~~~~~~ 290 (432)
.+...++.++.+||++||+.||++|+++ .++++||||...+|..
T Consensus 214 ----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05592 214 ----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWER 258 (316)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence 1123468899999999999999999986 5899999999887743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=346.10 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=220.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|.||.||+|+.++++-.||+|++.++.... -.....||+++...|+||||+++|++|.++..+||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 578999999999999999999999999999999998654321 123356899999999999999999999999999999
Q ss_pred EecCC-CcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCCC
Q 014039 79 FEYME-HNLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPY 155 (432)
Q Consensus 79 ~E~~~-~~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~~ 155 (432)
+||.+ |+++..+.. ..+++++...+.|++|++.||.|+|..+++||||||+|+|++ +|.+||+|||.+.... ...-
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR 179 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR 179 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence 99987 567777774 345799999999999999999999999999999999999998 5699999999997655 3455
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
.+.|||..|.+||+. ++..++..+|+|++|++.||++.|.+||...+..+...+|.++- .
T Consensus 180 ~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-------------------~ 239 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-------------------L 239 (281)
T ss_pred eeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-------------------c
Confidence 678999999999988 57889999999999999999999999999998777777764321 1
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+ +..++.++.|+|.+||.++|.+|.+..|++.|||+..
T Consensus 240 ~~-----------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 KF-----------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cC-----------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 11 2468999999999999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.89 Aligned_cols=248 Identities=28% Similarity=0.445 Sum_probs=206.3
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
||+|+||.||+|++..+++.||+|++.+... ........+|+.++++++||||+++++++.+.+..|+||||++++.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999999999999999975432 12233456899999999999999999999999999999999987655
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCcccc
Q 014039 88 HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYR 165 (432)
Q Consensus 88 ~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~~y~ 165 (432)
..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... .......+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 4444445579999999999999999999999999999999999999854 999999999976432 22334567999999
Q ss_pred chhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCc
Q 014039 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINL 245 (432)
Q Consensus 166 aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (432)
|||++. ...++.++||||+||++|||++|.+||.+.+.......+.. +.
T Consensus 161 aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~--~~---------------------------- 209 (312)
T cd05585 161 APELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--EP---------------------------- 209 (312)
T ss_pred CHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc--CC----------------------------
Confidence 999985 56789999999999999999999999998776554444321 00
Q ss_pred cccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCC
Q 014039 246 SDIIPNASMEAIDLIWQLCSWDPLRRP---TADQALQHPFFNVETW 288 (432)
Q Consensus 246 ~~~~~~~s~~~~dli~~~L~~dP~~Rp---ta~elL~Hp~f~~~~~ 288 (432)
..+...++.++.+||.+||+.||.+|+ ++.|+|+||||...+|
T Consensus 210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 012235788999999999999999997 5899999999997655
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=372.35 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=215.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++.+.||+|+||.||+|+++.+|+.||+|+++..... .......+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 5899999999999999999999999999999999865431 22334568999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--C
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--Y 155 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~ 155 (432)
||++++ |.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||+|..+..... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999764 555555554689999999999999999999999999999999999999854 999999999987654322 2
Q ss_pred ccccCCccccchhhhcC-----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQ-----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~-----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
...++|+.|+|||++.. ...++.++|||||||++|||++|..||.+.........++.....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------- 227 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF------------- 227 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc-------------
Confidence 23478999999999852 456789999999999999999999999888776665555321000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
..++ ..+.++.++.+||.+||+ ||.+|||++++++||||...+|.
T Consensus 228 ----~~~~---------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 228 ----LKFP---------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred ----cCCC---------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 0011 113578899999999998 99999999999999999987664
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=374.28 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=212.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999753221 12234568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
||++++.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|....... ...
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 999875444444433 58999999999999999999999999999999999999854 99999999998764322 224
Q ss_pred cccCCccccchhhhcCC---CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQS---SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~---~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..+||+.|+|||++.+. ..++.++||||+||++|||++|.+||.+.+......+++.......+
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 268 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF------------- 268 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC-------------
Confidence 56899999999998643 24789999999999999999999999988877666665432111110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWV 289 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~ 289 (432)
+. ...++..++++|.+||+.++.+ |+|+.|+++||||+...|.
T Consensus 269 ----p~---------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 269 ----PE---------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred ----CC---------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 00 0246889999999999866544 8899999999999986653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=370.45 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=209.8
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|++..+|+.||+|++...... .......+|+++++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999864322 22334568999999999999999999999999999999999987
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCcc
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRW 163 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~~ 163 (432)
.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+++.... .......+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 665555555689999999999999999999999999999999999999865 999999999976432 223345679999
Q ss_pred ccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCC
Q 014039 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPI 243 (432)
Q Consensus 164 y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (432)
|+|||++. ...++.++|||||||++|||++|..||.+.+.......+.. +.
T Consensus 161 y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~-------------------------- 211 (323)
T cd05595 161 YLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EE-------------------------- 211 (323)
T ss_pred cCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC--------------------------
Confidence 99999984 56789999999999999999999999988776555444321 00
Q ss_pred CccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 244 NLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 244 ~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
..+...+++++.+||++||+.||++|+ ++.++++||||....|.
T Consensus 212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 212 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 012235788999999999999999998 89999999999987664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=388.67 Aligned_cols=278 Identities=26% Similarity=0.363 Sum_probs=213.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC------CcccccceEEEeC-CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH------PNIIKLKEVVREN-NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~~~-~~ 74 (432)
++|+++++||+|+||+||+|.+..+++.||||+++..... .....+|+++++.+.| .+++++++++... ..
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY--TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh--HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 5799999999999999999999999999999999753221 1223457777777644 4588888888654 57
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-----------------
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND----------------- 136 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~----------------- 136 (432)
+|+|||++.+++++.+... +.+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 207 ~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 8999999988898887765 479999999999999999999998 599999999999999743
Q ss_pred eEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014039 137 VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG 216 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g 216 (432)
.+||+|||.+..... .....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+++..+...+|
T Consensus 286 ~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 286 RVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred eEEECCCCccccCcc--ccccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 399999998865332 345678999999999985 56799999999999999999999999999999999999999988
Q ss_pred CCCCCCchhh--hhhhhhhhcc---ccccCCCCccccC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 217 APDWTAFPEA--TNISRLISIS---YSEILPINLSDII-------PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 217 ~p~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~-------~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.++....... .....+.... .+...+..+..+. ...++.+.|||++||++||.+||||+|+|+||||.
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 7653311100 0000010000 0000000000000 01246788999999999999999999999999998
Q ss_pred C
Q 014039 285 V 285 (432)
Q Consensus 285 ~ 285 (432)
.
T Consensus 443 ~ 443 (467)
T PTZ00284 443 K 443 (467)
T ss_pred c
Confidence 5
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.65 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=213.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|.++.+++.||+|++...... .......+|+.++..++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999999753321 12234567999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP----- 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~----- 153 (432)
||++++.+..+..+.+.+++..++.++.||+.||+|||+.||+||||||+|||++. +.+||+|||+|+.+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99987655555444557999999999999999999999999999999999999985 499999999987543210
Q ss_pred -------------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC
Q 014039 154 -------------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD 202 (432)
Q Consensus 154 -------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~ 202 (432)
.....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCCCCC
Confidence 012457999999999985 667899999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhc
Q 014039 203 SEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT---ADQALQ 279 (432)
Q Consensus 203 ~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt---a~elL~ 279 (432)
+......+++..... ..++. ...++.++++||.+|+. ||.+|++ ++|+++
T Consensus 240 ~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 240 TPQETYRKVMNWKET-----------------LVFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CHHHHHHHHHcCCCc-----------------eecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 876655554321000 00110 01368899999999875 9999984 899999
Q ss_pred CCCCCCCCCCCC
Q 014039 280 HPFFNVETWVPY 291 (432)
Q Consensus 280 Hp~f~~~~~~~~ 291 (432)
||||+..+|...
T Consensus 293 hp~f~~~~~~~~ 304 (360)
T cd05627 293 HPFFEGVDWGHI 304 (360)
T ss_pred CCCCCCCCHHHH
Confidence 999999888543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.86 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=231.2
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
|.+.+.||+|.|++|.+|+|..||+.||+|++.+-... .....+..|++-|+.++|||||+||++..+...+|||+|+-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 88899999999999999999999999999999864432 23344678999999999999999999999999999999999
Q ss_pred CC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCCCCCcccc
Q 014039 83 EH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 83 ~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
++ +++++|++....+.|+.+++|+.||+.|+.|+|+..+|||||||+|+.+.+ |-|||+|||++..+.++...+..|
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsC 179 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSC 179 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhccc
Confidence 86 799999988888999999999999999999999999999999999999975 599999999999999999999999
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
|+..|.|||++++..+..+++||||||+|||-|+||++||...++.+.+..|+..-
T Consensus 180 GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK------------------------ 235 (864)
T KOG4717|consen 180 GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK------------------------ 235 (864)
T ss_pred chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc------------------------
Confidence 99999999999988888899999999999999999999999998888888775321
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
..++..++.+++|||..||+.||.+|.+.+||..|+|++..+-
T Consensus 236 ------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 236 ------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred ------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 1234578999999999999999999999999999999997653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=367.91 Aligned_cols=275 Identities=23% Similarity=0.317 Sum_probs=215.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|++..+|..+|+|.+...........+.+|+++|++++||||+++++++.+.+.+++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 68999999999999999999999999999999998654333344567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
++++.+..+......+++..++.++.||+.||.|||+. +|+||||||+|||++.+ .+||+|||++...... ......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 163 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 163 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCC
Confidence 99866665555555799999999999999999999986 69999999999999854 9999999999866432 334567
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh-------------
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA------------- 226 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~------------- 226 (432)
+|+.|+|||++. +..++.++|||||||++|||++|..||......+. . ..++.+........
T Consensus 164 g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 164 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-E---AIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred CCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-H---HHhcccccccccCCccccCcccccccc
Confidence 999999999985 56789999999999999999999999987665432 2 22333221110000
Q ss_pred ------------hhhhhhhhccccccCCCCcccc-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 227 ------------TNISRLISISYSEILPINLSDI-IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 227 ------------~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
......... +........ ...++.++++||++||++||++|||+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDY----IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccchhHHHHHHH----HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000000000 000000111 12468899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=369.01 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=207.6
Q ss_pred CeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc---hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF---WEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .......+|+++++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 57899999999753321 1223356799999999 599999999999999999
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP- 153 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~- 153 (432)
|+||||+.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999875444444444579999999999999999999999999999999999999855 99999999998653322
Q ss_pred -CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 154 -PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 154 -~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
.....+||+.|+|||++.+...++.++|||||||++|||++|..||...........+.....
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 224 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL---------------- 224 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh----------------
Confidence 233467999999999997556689999999999999999999999975433211111111000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.. -..+...++.++.+||.+||+.||++|| +++++++||||+..+|.
T Consensus 225 -~~---------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 225 -KC---------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred -cC---------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 00 0012235788999999999999999999 78999999999986654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=365.73 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=206.1
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|++..+++.||+|+++.... .........|..+++.. +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999986432 12223345688888765 999999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.........+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 5555444444579999999999999999999999999999999999999865 999999999976432 22334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|..||.+.+..+....+.. +.+
T Consensus 161 ~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~------------------------ 213 (316)
T cd05619 161 DYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNP------------------------ 213 (316)
T ss_pred cccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC------------------------
Confidence 999999985 56789999999999999999999999988776554444311 111
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD-QALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~-elL~Hp~f~~~~~~ 289 (432)
.+...++.++.+||.+||+.||++|+++. ++++||||+..+|.
T Consensus 214 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 214 ----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 01124678999999999999999999996 99999999998874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=366.44 Aligned_cols=317 Identities=24% Similarity=0.390 Sum_probs=262.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH--HHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC--MNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~--~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
.+|..+.+||+|+||.|.+|..+.+.+.+|||++++........ --+.|-++|... .-|.+++++.+|++-+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46889999999999999999999999999999998765332211 124678888777 578999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceec-CCCCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLAREL-SSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~-~~~~~~~ 156 (432)
|||+.|+.+-..+.+-+.+.|..+..|+..|+-||-+||++||++||||.+|||++. |.+||+|||+++.- -....+.
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTk 508 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTK 508 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCccee
Confidence 999998777666666668999999999999999999999999999999999999995 59999999999864 3445567
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
++||||.|+|||++. ...|+.++|+||+|++||||+.|++||.|+++.+....|.+.- .
T Consensus 509 TFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-------------------v- 567 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-------------------V- 567 (683)
T ss_pred eecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-------------------C-
Confidence 899999999999986 6789999999999999999999999999999988888775321 1
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCC---CCCChhhhhccCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFFNVETWVPY---PLHDPLELRLNNMGSKP 308 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f~~~~~~~~---~~~~~~~~~~~~~~~~~ 308 (432)
..++.+|.||.++++.+|.+.|.+|..+ .++-+||||+.++|... +...|..+++...+...
T Consensus 568 ----------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~e 637 (683)
T KOG0696|consen 568 ----------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAE 637 (683)
T ss_pred ----------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchh
Confidence 1234689999999999999999999875 79999999999999443 45556666655555545
Q ss_pred CCccCCCCCCCCCCccccCccccccCChhhhhccCCccccccccc-cCCCCCC
Q 014039 309 NLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILF-CSDLKDH 360 (432)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 360 (432)
|++. .|+.++.+ ++|.+..+..++.|..+++|+| .|.+..+
T Consensus 638 NFD~---~Ft~~~~~--------lTPpD~~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 638 NFDK---FFTREPTD--------LTPPDKLVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred hhhH---HHhcCCCC--------CCCchHHHHhcCchhhcCceeeeChhhcCC
Confidence 4432 24455444 8899999999999999999988 4666554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=375.04 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=221.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
.|+.++.||+|+||.||+|.+..+++.||||++.-+...++...+.+|+.+|.+++++||.++|+.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 47888999999999999999999999999999998877777777889999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-CCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP-PYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~-~~~~~~~ 160 (432)
.|+....+.+.+..+.|.++..++++++.||.|||+++.+|||||+.|||+.. +.+||+|||.+..+.... ...+++|
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvG 173 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVG 173 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccc
Confidence 98766666666667799999999999999999999999999999999999985 599999999998775433 2378899
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
|++|||||++. ...|+.++||||||++.+||++|.||+....+...+..| ++.
T Consensus 174 TPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------------------------pk~ 226 (467)
T KOG0201|consen 174 TPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------------------------PKS 226 (467)
T ss_pred cccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--------------------------cCC
Confidence 99999999995 778999999999999999999999999887763332222 222
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.|..+ -..+|+.+++|+..||++||+.||+|.++|+|+|++..
T Consensus 227 ~PP~L---~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 227 APPRL---DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred CCCcc---ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 22222 23689999999999999999999999999999999863
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=366.34 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=205.8
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|+++.+|+.||+|++++... .........|..++... +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999986432 12233345788888765 899999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+++.... .......+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 5554444445579999999999999999999999999999999999999865 999999999975422 22344568999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|..||.+.+.......+.. +.+
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~------------------------ 213 (316)
T cd05620 161 DYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTP------------------------ 213 (316)
T ss_pred CccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC------------------------
Confidence 999999985 56789999999999999999999999988776544443311 111
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-DQALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-~elL~Hp~f~~~~~~ 289 (432)
.+...++.++++||++||+.||++|+++ +++++||||+..+|.
T Consensus 214 ----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 214 ----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 1122468899999999999999999998 589999999987764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=372.88 Aligned_cols=275 Identities=24% Similarity=0.391 Sum_probs=214.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+|++++.||+|+||.||+|++..+++.||+|+..... ..+|+.++++++||||+++++++......|+|||++
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 6999999999999999999999999999999865433 246999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST 161 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t 161 (432)
.++++..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++............||
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt 219 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccccc
Confidence 999999888877789999999999999999999999999999999999999865 9999999999765444444566899
Q ss_pred ccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHHhCCCCCCCc--hhhhhh
Q 014039 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSE---------IDQLYKVCCILGAPDWTAF--PEATNI 229 (432)
Q Consensus 162 ~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~---------~d~~~~i~~~~g~p~~~~~--~~~~~~ 229 (432)
+.|+|||++. ...++.++|||||||++|||+++ .++|.+... ..++..++..+|..+.... +.....
T Consensus 220 ~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 298 (357)
T PHA03209 220 VETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298 (357)
T ss_pred ccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence 9999999985 56789999999999999999984 555554321 2345555555554432211 111111
Q ss_pred hhhhhccccccCCCCcccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 230 SRLISISYSEILPINLSDI--IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+....-....+...... ..+++.++.+||.+||++||.+||||.|+|+||||+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1111111000011000000 1256778999999999999999999999999999974
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=361.82 Aligned_cols=283 Identities=44% Similarity=0.747 Sum_probs=234.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVREN--NELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 77 (432)
+++|++.+.||.|+||.||+|.+..+++.+|+|+++....... .....+|++++++++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999999999999999975432211 22346899999999999999999998776 88999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
||||+.+++.+.+......+++..++.++.||+.||+|||+.|++|+||||+||+++++ .+||+|||++...... ...
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99999998888777665579999999999999999999999999999999999999865 9999999999876553 334
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+++.|+|||.+.+...++.++||||+||++++|++|.++|.+....+...++....+.|....++...........
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 45678899999999876666799999999999999999999999999999999999888888776655443333333222
Q ss_pred cccccCCCCccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 236 SYSEILPINLSDIIPN--ASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~--~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.+.......+...++. ++..+.++|++||+.||++|||+.|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 2222223333334444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=368.28 Aligned_cols=251 Identities=29% Similarity=0.395 Sum_probs=208.9
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|++..+|+.||+|++.+.... .......+|+++++.++||||+++++++.+.+.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999764322 22234568999999999999999999999999999999999987
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCCccccCCc
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTR 162 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~~~~~~t~ 162 (432)
.+.....+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++++ .+||+|||+++... ........+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 666555555689999999999999999999997 799999999999999865 99999999997643 223334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|..||.+.+.......+.. +..
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~--~~~------------------------ 213 (325)
T cd05594 161 EYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEI------------------------ 213 (325)
T ss_pred ccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--CCC------------------------
Confidence 999999984 56789999999999999999999999988766544443311 000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.+...+++++.+||++||++||++|+ ++.++++||||....|.
T Consensus 214 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 214 ----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11235788999999999999999997 89999999999986654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=363.58 Aligned_cols=251 Identities=31% Similarity=0.495 Sum_probs=221.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH--HHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC--MNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~--~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+|++.+.||+|+||.|-+|+....|+.||||.+++....++.. .+.|||+||..|+||||+.+|++|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 6999999999999999999999999999999999877655443 36799999999999999999999999999999999
Q ss_pred cCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 81 YMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
|..++ |++++.. .+.|+|.+++.+++||..|+.|+|+++++|||||.+|||+|.+ ++||+|||++..+.......++
T Consensus 134 YaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF 212 (668)
T KOG0611|consen 134 YASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF 212 (668)
T ss_pred ecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence 99865 5665554 4589999999999999999999999999999999999999965 9999999999998888888999
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
||+|.|.+||++.+..+-+..+|.||||++||-|+.|..||.|.+......+|-. |. +.
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~--Ga-------------------Yr 271 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR--GA-------------------YR 271 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--cc-------------------cc
Confidence 9999999999997666779999999999999999999999999887666655521 10 00
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
-+..+.++.-||+.||..||++|.|+.++-.|=|.+.
T Consensus 272 ----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 272 ----------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 1234668999999999999999999999999988863
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.42 Aligned_cols=282 Identities=36% Similarity=0.574 Sum_probs=227.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+|+.||+|.+.............+|+++++.++|+||+++++++.+....|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 57999999999999999999999999999999997554332333456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
+.++++..+......+++..++.++.||+.||.|||+.||+||||||+||+++.+ .+||+|||+++..... .......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 164 (291)
T cd07870 85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV 164 (291)
T ss_pred ccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCcc
Confidence 9999988877666678999999999999999999999999999999999999854 9999999999764332 2233446
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE-IDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~-~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
++..|+|||.+.+...++.++|||||||++|||++|.+||.+... .+++.++...+|.|....+......+.+....+.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07870 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244 (291)
T ss_pred ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcc
Confidence 789999999987666788999999999999999999999987654 4667777777787766554433333333322222
Q ss_pred ccCCCCccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EILPINLSDIIPN--ASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~~~~~~~~~~~--~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+..+..++.. .+.++.++|.+||+.||++|||+.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 245 PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2222222222222 36789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=356.97 Aligned_cols=260 Identities=26% Similarity=0.343 Sum_probs=214.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|++.++||+|+||+||+|.+..+++.||+|++........ .....+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999975432222 2335689999999999999999999999899999999
Q ss_pred cCCCcHHH-HHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 81 YMEHNLYH-IMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 81 ~~~~~ll~-~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|+.++.+. .+... ...+++..++.++.||+.||.|||+.|++||||||+||+++++ .++|+|||+++..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99876554 44332 3469999999999999999999999999999999999999865 999999999987755444455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+|++.|+|||++. ...++.++||||+||++|||++|..||.+.........+...+....
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 221 (285)
T cd05605 161 RVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ------------------ 221 (285)
T ss_pred ccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc------------------
Confidence 68999999999985 56689999999999999999999999988765444433322211100
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
......++..+.+||.+||+.||++|| +++++++||||...+|.
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 --------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred --------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 012235788999999999999999999 89999999999986664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=353.80 Aligned_cols=282 Identities=36% Similarity=0.634 Sum_probs=225.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|.++.+|+.||+|++...... .......+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5899999999999999999999999999999998754322 122335689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
|+++++++.+......+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99999888887766679999999999999999999999999999999999999854 99999999998765433 33455
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+...++...............+.....+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 78899999999876677899999999999999999999999999888888777666654322110000000000000111
Q ss_pred c-cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 E-ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~-~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
. .....+....+.++.++.+||.+||+.||++|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1 00111222345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=372.34 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=225.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCE-EEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNE-LFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~~lV 78 (432)
|++|+++++||+|+||.+++++++..+..+++|++.-.... ..+.....|+.+++++.|||||.+++.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 68999999999999999999999999999999999855433 333356789999999999999999999988887 9999
Q ss_pred EecCCCcHHH-HHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-C
Q 014039 79 FEYMEHNLYH-IMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-P 154 (432)
Q Consensus 79 ~E~~~~~ll~-~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~ 154 (432)
|+|++|+.+. .+... +.-++|+.+..|+.||+.||.|||+++|+|||||++||+++.+ .|||+|||+|+.+.... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999986554 44443 3679999999999999999999999999999999999999865 88999999999988765 6
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..+++||++|+.||++ .+..|+.++|||||||++|||++-++.|.+.+......+|......|
T Consensus 163 a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------------- 225 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------------- 225 (426)
T ss_pred hheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC----------------
Confidence 6789999999999988 58889999999999999999999999999999988888886544332
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+....+.+++.+|+.||+.+|+.||+|.++|.+|....
T Consensus 226 -------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 -------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 33467889999999999999999999999999998863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.34 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=212.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+|+..+.||+|+||.||+|+++.+|+.||+|++.+.... .......+|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 588999999999999999999999999999999754321 22233567888998885 578888999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||++++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 999876555555555579999999999999999999999999999999999999865 9999999999764322 22345
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...++.++||||+||++|||++|.+||.+.+.......+... ..
T Consensus 161 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~------------------- 218 (323)
T cd05615 161 FCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NV------------------- 218 (323)
T ss_pred ccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------------
Confidence 67999999999985 567899999999999999999999999988776555554321 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
.+...++.++.+++.+||+.||.+|++ ..++++||||...+|.
T Consensus 219 ---------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 219 ---------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred ---------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 112356889999999999999999997 5799999999998874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=362.12 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=213.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999999753221 12233567999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCC--
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPY-- 155 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~-- 155 (432)
||+.++ |.+.+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999764 55555554567999999999999999999999999999999999999975 49999999999776543222
Q ss_pred ccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+||+.|+|||++.. ...++.++||||+||++|||++|..||.+.+..+....+......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 226 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH-------------- 226 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc--------------
Confidence 23468999999999853 345788999999999999999999999988776665555321100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWVP 290 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~~ 290 (432)
..+......++.++++||++||..++++ |+++.++++||||...+|..
T Consensus 227 -----------~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 227 -----------FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred -----------ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 0011112347889999999999765544 78999999999999877644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.69 Aligned_cols=251 Identities=30% Similarity=0.506 Sum_probs=208.1
Q ss_pred eeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc---hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 7 LEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF---WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++.||+|+||.||+|++. .+++.||+|++++.... .......+|+++|+.++||||+++++++.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999864 57889999999754321 122334689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~ 158 (432)
|+.++.+.....+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.... .......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99986555555555679999999999999999999999999999999999999854 999999999975432 2233456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.+.......+.. +.
T Consensus 161 ~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--~~--------------------- 216 (323)
T cd05584 161 CGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GK--------------------- 216 (323)
T ss_pred CCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC---------------------
Confidence 7999999999985 56689999999999999999999999998877665555431 10
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETW 288 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~ 288 (432)
..+.+.+++++.+||++||+.||++|+ ++.++++||||...+|
T Consensus 217 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 217 -------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 012235688999999999999999999 8999999999987665
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.21 Aligned_cols=280 Identities=39% Similarity=0.696 Sum_probs=233.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+|+++++||.|++|.||+|++..+|+.||||+++............+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 69999999999999999999999999999999986543333344568999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 83 EHNLYHIMRERQ--IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 83 ~~~ll~~~~~~~--~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
++++.+.+.... ..+++..+..++.||+.||.|||+.|++||||||+||+++++ .+||+|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE 160 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence 998888776543 469999999999999999999999999999999999999865 9999999999765432 122345
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|++||++.+...++.++|+||+||++|+|++|.++|.+.+..+...++....+.|....+........+ ...++
T Consensus 161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (284)
T cd07836 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KPTFP 239 (284)
T ss_pred cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh-ccccc
Confidence 67899999999876667899999999999999999999999999988888888888887766554333322211 12333
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.........+.+..+.+++++|.+||+.||.+||++.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 333333344455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=356.05 Aligned_cols=280 Identities=41% Similarity=0.719 Sum_probs=231.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++++.||.|++|.||+|++..+|+.||||++....... ......+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5899999999999999999999999999999987543221 223456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 82 MEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 82 ~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
+.+++...+... ...+++..++.++.||+.||+|||+.|++||||+|+||+++++ .+||+|||++...... ......
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 988877776543 3578999999999999999999999999999999999999865 9999999999765432 223344
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|+|||++.+...++.++|||||||++|||++|..||.+.+..+...++.+.++.+....++.......+.. .++
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-SFP 239 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh-hcc
Confidence 6788999999887666678999999999999999999999999999999999998888876554433222222221 333
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
......+..+.+.++.+++++|.+||+.||++|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 333344445556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=341.69 Aligned_cols=278 Identities=29% Similarity=0.529 Sum_probs=228.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeC--CEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVREN--NELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~~~~l 77 (432)
.++|++++++|+|.|++||.|.+..+++.++||+++.-. ...+.||+.+|+.| +||||++|+++..+. ....|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 478999999999999999999999999999999997432 23467999999999 599999999998763 45679
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~~~ 155 (432)
|+||+.......+-. .|+...++.++++|+.||.|+|+.||+|||+||.|++|+.. .++|+|+|+|..+.++..+
T Consensus 113 iFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred HhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 999999876665543 58899999999999999999999999999999999999954 9999999999999998888
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh--hhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN--ISRL 232 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~--~~~~ 232 (432)
+-.+.+++|..||++..-..|+.+-|+|||||+++.|+.. .|.|.|.+..||+.+|.+++|+-....+-.... ....
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 8889999999999999889999999999999999999986 566789999999999999999854332211100 0000
Q ss_pred hhccccccCCCCccccCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIP-----NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~-----~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..-...+.....|..... -.+++++|||.++|.+|..+|+||.|++.||||..
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 000011112222322221 25799999999999999999999999999999974
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=354.51 Aligned_cols=280 Identities=65% Similarity=1.147 Sum_probs=244.2
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
|++.+.||+|++|+||+|....+++.||||++.............+|+..++++. |+||+++++++.+++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7899999999999999999999999999999876654444445568999999998 999999999999999999999999
Q ss_pred CCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccC
Q 014039 83 EHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
.+++++.+.... ..+++..+..++.||+.+|.|||++|++|+||+|+||+++++ .++|+|||.+.............+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS 160 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCC
Confidence 888888877654 478999999999999999999999999999999999999965 999999999987766555566788
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||++.+...++.++|+||+||+++||++|.++|++....++..++...++.+....+.............++..
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07830 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240 (283)
T ss_pred cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc
Confidence 99999999987677789999999999999999999999999999999999999999988777666555555555555555
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+....+..+.++.+||++||+.||++|||+.|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 5555555556668899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=355.65 Aligned_cols=285 Identities=38% Similarity=0.692 Sum_probs=232.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|++.+.||+|++|.||+|.+..+|+.||+|++...... .......+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999998654322 12233568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C-eEEEeeeccceecCCC-CCC
Q 014039 80 EYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 80 E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
||+++++.+.+.... ..+++..++.++.||+.||+|||++|++||||+|+||+++. + .+||+|||++...... ...
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 999988888776543 34688999999999999999999999999999999999984 3 7999999999765432 223
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+....+...++....+.|....+........+. .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK-S 239 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh-h
Confidence 445678999999998666678999999999999999999999999999888888888888887765554333222221 1
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.++...........+..+.++.++|.+||+.||++||++.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 112212222233345788999999999999999999999999999999863
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=368.14 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=212.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999998753221 12233568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
||++++.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+...... ...
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~ 201 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccccc
Confidence 999876555544443 58999999999999999999999999999999999999854 99999999998765322 224
Q ss_pred cccCCccccchhhhcCC---CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQS---SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~---~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..+||+.|+|||++... ..++.++|||||||++|||++|.+||.+.+......+|+.......
T Consensus 202 ~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 267 (371)
T cd05622 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-------------- 267 (371)
T ss_pred CcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc--------------
Confidence 56799999999998643 2488999999999999999999999998887666655532111110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWV 289 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~ 289 (432)
++ ....++.++++||.+||+.++.+ |++++|+++||||++..|.
T Consensus 268 ---~~---------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 268 ---FP---------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred ---CC---------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 00 11357889999999999844433 7899999999999886653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=366.18 Aligned_cols=251 Identities=26% Similarity=0.439 Sum_probs=203.7
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhc---CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKL---NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
||+|+||+||+|+++.+|+.||+|++.+..... ......+|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997543221 222334677777665 699999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.....+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 5544444445679999999999999999999999999999999999999855 999999999976432 23344568999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+.. +.. .++
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~-----------------~~~---- 217 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF--GKV-----------------RFP---- 217 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--CCC-----------------CCC----
Confidence 999999997666789999999999999999999999988776554444321 110 000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRP----TADQALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp----ta~elL~Hp~f~~~~~~ 289 (432)
...++.++.+||++||+.||.+|| ++.++++||||....|.
T Consensus 218 ------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~ 262 (330)
T cd05586 218 ------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD 262 (330)
T ss_pred ------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence 013688999999999999999998 79999999999987664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=354.56 Aligned_cols=281 Identities=40% Similarity=0.718 Sum_probs=229.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhc-CCCcccccceEEEeCCE-----
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKL-NHPNIIKLKEVVRENNE----- 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~----- 74 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 58999999999999999999999999999999987543221 223456899999999 56999999999876554
Q ss_pred EEEEEecCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C-eEEEeeecccee
Q 014039 75 LFFIFEYMEHNLYHIMRER----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D-VLKIADFGLARE 148 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~-~lkL~DFG~a~~ 148 (432)
.|+||||+++++.+.+... ...+++..++.++.||+.||.|||++|++||||||+||+++. + .+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999888877653 246899999999999999999999999999999999999986 4 999999999986
Q ss_pred cCCC-CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 149 LSSM-PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 149 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
+... .......+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+.++...++.+....++...
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 5432 222334678899999998766778999999999999999999999999999999988888888877766554333
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
....... ++...+..+....+.++.++.+||.+||+.||.+||++.|++.||||+
T Consensus 241 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHE--FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhh--cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 2222221 222233333444567899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=355.52 Aligned_cols=281 Identities=43% Similarity=0.720 Sum_probs=232.7
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc---h-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF---W-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+|++++.||+|+||.||+|.+..+|+.||+|++...... . ......+|++++++++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999765432 1 122345799999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~ 156 (432)
|||+.+++.+.+......+++..++.++.||++||.|||++|++|+||||+||+++.+ .+||+|||+++..... ....
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence 9999666766665544479999999999999999999999999999999999999855 9999999999876543 2233
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...+++.|+|||.+.+...++.++|+||+||++|||++|.++|.+.+..+.+.++...++.+....++.......+. .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 238 (298)
T cd07841 161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV--E 238 (298)
T ss_pred ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc--c
Confidence 44678899999998666678999999999999999999999999999988888888888877665554333222222 1
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+......+...+.++.+||.+||++||++|||+.|+++||||.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 2222333444556678899999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.44 Aligned_cols=283 Identities=39% Similarity=0.693 Sum_probs=230.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe--------
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE-------- 71 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-------- 71 (432)
+++|++.++||+|+||.||+|.++.+++.+|+|++....... ......+|+++++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999986543221 12234689999999999999999998743
Q ss_pred CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 72 NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 72 ~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
...+|+||||+.+++...+......+++..++.++.||++||+|||+.|++||||||+||+++++ .+||+|||+++...
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999999888887666689999999999999999999999999999999999999865 99999999997654
Q ss_pred CCCC------------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014039 151 SMPP------------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 151 ~~~~------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
.... .....+++.|+|||++.+...++.++||||+||++|||++|.++|.+.+.......+....+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3211 2234578889999998766678999999999999999999999999999999888888888877
Q ss_pred CCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....++.................+..+...+...+.++.+||.+||+.||.+|||+.|+++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 66555443333332221122222233333445677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=360.79 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=214.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.||+++++.+++.+|+|++.+.... .......+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999999653211 12223567899999999999999999999999999999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--C
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--Y 155 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~ 155 (432)
||+.+ ++.+.+.+....+++..++.++.||+.||+|||+.||+||||||+|||++.+ .+||+|||++..+..... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99976 4555655545679999999999999999999999999999999999999854 999999999976543222 2
Q ss_pred ccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+||+.|+|||++.. ...++.++|||||||++|||++|..||.+.+..+...++......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 226 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-------------- 226 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc--------------
Confidence 34579999999999852 356899999999999999999999999988877666655321000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWVP 290 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~~ 290 (432)
..+......++.++++||++||..++++ |++++|+++||||.+.+|..
T Consensus 227 -----------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 227 -----------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred -----------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 0011122457899999999999765554 68999999999999877743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=360.74 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=205.1
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHH-HHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVK-ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||+||+|+++.+|+.||+|++.+.... .......+|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999999999999999754322 12223345554 46778999999999999999999999999988
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.......+.+++..++.++.||+.||+|||+.||+||||||+|||++++ .+||+|||+++.... .......+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 6555555555689999999999999999999999999999999999999855 999999999975432 23344567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|.+||.+.+..+....+... .
T Consensus 161 ~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~------------------------- 212 (325)
T cd05604 161 EYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--P------------------------- 212 (325)
T ss_pred hhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--C-------------------------
Confidence 999999984 567899999999999999999999999887765554444210 0
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFFNVETW 288 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta----~elL~Hp~f~~~~~ 288 (432)
..+.+..+.++.++|++||+.||.+||++ .++++||||+...|
T Consensus 213 ---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 ---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 01123578899999999999999999987 59999999998766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=361.64 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=205.5
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHH-HHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVK-ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||+||+|++..+|+.||+|++.+.... .......+|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754321 12223345554 56778999999999999999999999999988
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.....+.+.+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+++.... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 6555555555689999999999999999999999999999999999999855 999999999976432 22344567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++|||||||++|||++|.+||.+.+..+....+.. .+
T Consensus 161 ~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~------------------------ 212 (323)
T cd05575 161 EYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN---KP------------------------ 212 (323)
T ss_pred hhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc---CC------------------------
Confidence 999999985 56789999999999999999999999998776555444421 00
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta----~elL~Hp~f~~~~~~ 289 (432)
..+.+.++.++.++|++||+.||.+||++ .|+++||||...+|.
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 213 ---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 01224568899999999999999999998 699999999886653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=368.85 Aligned_cols=254 Identities=29% Similarity=0.391 Sum_probs=205.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+.+++||+|+||.||+|++..+++.||||++...........+.+|+++++.++|+||+++++++.+.+.+|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 46889999999999999999999999999999997554333344567999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
+.++.+.. .....+..+..++.||+.||+|||++||+||||||+|||++++ .+||+|||+++..... ......+
T Consensus 154 ~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 229 (353)
T PLN00034 154 MDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229 (353)
T ss_pred CCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccc
Confidence 99876542 2346788899999999999999999999999999999999865 9999999999876532 2334568
Q ss_pred CCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 160 STRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 160 ~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
||..|+|||++.. ...++.++|||||||++|||++|+.||......+....+......
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------------------ 291 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS------------------ 291 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc------------------
Confidence 9999999998742 234467999999999999999999999754332222111111000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
........++.++++||.+||+.||++|||+.|+|+||||..
T Consensus 292 --------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 292 --------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred --------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 001122357889999999999999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=362.96 Aligned_cols=282 Identities=37% Similarity=0.623 Sum_probs=227.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN-----NELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (432)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+|++++++++|+||+++++++... ...|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 58999999999999999999999999999999987433322334456899999999999999999987543 4589
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~- 154 (432)
+|+||+++++.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++++ .+||+|||+++.......
T Consensus 85 lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 85 IVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 9999999988876643 369999999999999999999999999999999999999865 999999999987543221
Q ss_pred ---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-hh
Q 014039 155 ---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-IS 230 (432)
Q Consensus 155 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~~ 230 (432)
....++++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+...+...+...++.+..+.+..... ..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 23457899999999987667789999999999999999999999999998888888888888876654321110 00
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+......+......+....++.+.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 0011111222223333344567889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=355.46 Aligned_cols=283 Identities=37% Similarity=0.624 Sum_probs=224.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeC-------
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVREN------- 72 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------- 72 (432)
+++|+++++||+|+||.||+|.+..+++.||+|++....... ......+|++++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 578999999999999999999999999999999986543221 122345799999999999999999988653
Q ss_pred -CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 73 -NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 73 -~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
...|+||||+.+++.+.+......+++.+++.++.||+.||.|||++|++|+||||+||+++.+ .+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 3469999999999888887766679999999999999999999999999999999999999865 99999999997664
Q ss_pred CCCC-----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 151 SMPP-----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 151 ~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
.... .....++..|+|||++.+...++.++||||+||++|||++|.++|.+.+.......+....|..+...++.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 22346788899999987666688999999999999999999999999988888877877777766554433
Q ss_pred hhhhhhhhhccccccCCCCccc-c-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 226 ATNISRLISISYSEILPINLSD-I-IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~-~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
......+....++......... + ....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 3222222122222211111111 1 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=350.35 Aligned_cols=313 Identities=23% Similarity=0.376 Sum_probs=251.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHH--HHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE--CMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~--~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|.++++||+|+|+.|.++++++|.+.+|+|+++++...+.+ .....|..+..+- +||.+|-++.+|++++.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46899999999999999999999999999999999876543322 2245677777776 89999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeecccee-cCCCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARE-LSSMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~-~~~~~~~ 155 (432)
|.||++|+.+-....+++.++|++++.|...|+.||.|||++||++||||.+|+|++ +|.+||+|+|+++. +.++..+
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 999999987777777777899999999999999999999999999999999999999 56999999999986 4566677
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPG-------DSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~-------~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
.++||||.|.|||++ ++..|+.++|+|+||++|+||+.|+.||.- .+..|.+.+++-
T Consensus 409 stfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--------------- 472 (593)
T KOG0695|consen 409 STFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--------------- 472 (593)
T ss_pred ccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh---------------
Confidence 889999999999987 688899999999999999999999999952 233344443320
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCCCCCCCCC---Chhhh
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT------ADQALQHPFFNVETWVPYPLH---DPLEL 299 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt------a~elL~Hp~f~~~~~~~~~~~---~~~~~ 299 (432)
+ .--.++..+|-.+..+++..|++||.+|.. .+++..|+||+.++|...+.. .|..+
T Consensus 473 -----e---------kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p 538 (593)
T KOG0695|consen 473 -----E---------KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQP 538 (593)
T ss_pred -----h---------hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCC
Confidence 0 011234567888999999999999999976 589999999999999655433 23322
Q ss_pred hccCCCCCCCCccCCCCCCCCCCccccCccccccCChhhhhccCCcccccccccc
Q 014039 300 RLNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILFC 354 (432)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (432)
.........+ ..-.|+.|+ ..++|.+.+.++++.|.++++|.|.
T Consensus 539 ~i~~d~~l~~---fd~qft~e~--------~qltpdd~d~i~ridqsefegfeyi 582 (593)
T KOG0695|consen 539 QITDDYGLDN---FDTQFTSEP--------VQLTPDDEDAIKRIDQSEFEGFEYI 582 (593)
T ss_pred ccccccCccc---cccccccCC--------cccCCCCHHHHHhcchhhcCcceec
Confidence 2222111111 112344443 3489999999999999999999664
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=351.48 Aligned_cols=282 Identities=37% Similarity=0.633 Sum_probs=227.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+++++||+|+||.||+|.+..+++.||+|++....... ......+|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 58999999999999999999999999999999987543322 23345689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
|+.+++++.+......+++..++.++.||+.||+|||+.|++|+||+|+||+++++ .+||+|||++...... ......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 99998888777666679999999999999999999999999999999999999865 9999999999875432 233456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|+|||++.+...++.++||||+||++|||++|.++|.+.+..+....+....+.....................+
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 78999999999876667889999999999999999999999999888888888777665432211100000000111111
Q ss_pred ccC-CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EIL-PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
... ........+.++..+.+|+.+||+.||++||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 111 112223345788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=356.89 Aligned_cols=274 Identities=34% Similarity=0.594 Sum_probs=210.4
Q ss_pred eeeEeecCceEEEEEEEcC--CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE--eCCEEEEEEecC
Q 014039 7 LEELGDGTCGCVYKAFNVE--TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR--ENNELFFIFEYM 82 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~ 82 (432)
..+||+|+||.||+|+++. ++..||+|.+...... ....+|++++++++||||+++++++. .+..+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS---MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc---HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3589999999999998654 6688999998754322 23568999999999999999999884 356789999999
Q ss_pred CCcHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-----CCeEEEeeeccceec
Q 014039 83 EHNLYHIMRER--------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-----NDVLKIADFGLAREL 149 (432)
Q Consensus 83 ~~~ll~~~~~~--------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-----~~~lkL~DFG~a~~~ 149 (432)
++++.+.+... ...+++..++.++.||+.||.|||+.||+||||||+|||+. ++.+||+|||+|+..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 99988876532 23589999999999999999999999999999999999994 238999999999876
Q ss_pred CCCC----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhC
Q 014039 150 SSMP----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---------IDQLYKVCCILG 216 (432)
Q Consensus 150 ~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~---------~d~~~~i~~~~g 216 (432)
.... ......+|+.|+|||++.+...++.++||||+||++|||++|.+||.+... .+++.++...+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 4322 223457899999999997667789999999999999999999999976432 456777888888
Q ss_pred CCCCCCchhhhhhhhhhhcc--c--cccCCCC----ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 217 APDWTAFPEATNISRLISIS--Y--SEILPIN----LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~--~--~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.+....+........+.... + ....... ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 77665553322111111100 0 0000000 011112356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=358.70 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=213.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+++++.+++.||+|++.+.... .......+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999999753221 12233557899999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-- 155 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~-- 155 (432)
||+.|+ |.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999865 555555545679999999999999999999999999999999999999854 9999999999876543222
Q ss_pred ccccCCccccchhhhcCC----CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQS----SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~----~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+||+.|+|||++.+. ..++.++||||+||++|||++|..||.+.+..+...++.......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 227 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF------------- 227 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-------------
Confidence 235799999999998532 457899999999999999999999999887766555543211000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWVP 290 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~~ 290 (432)
.+......++.++++||.+||..++++ |++++++++||||+..+|..
T Consensus 228 ------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 228 ------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred ------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 111122357889999999999976655 46899999999999877643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=351.18 Aligned_cols=280 Identities=50% Similarity=0.863 Sum_probs=241.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
|++.+.||.|++|.||+|.+..+++.+|+|++...... .......+|++++++++|+||+++++++.+.+..|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 78899999999999999999999999999998765433 22344568999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~ 160 (432)
++++...+..+...+++..++.++.||+.||.|||+.|++|+||||+||+++++ .+||+|||.+....... ......+
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 160 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence 999988888766789999999999999999999999999999999999999864 99999999998775543 3344578
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||.+.+...++.++|+||+||++|+|++|+++|++.+..++..++...++.+....+.............++..
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 88999999987655789999999999999999999999999999999999998888887666655444344444555555
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.......+.+.++.++.+||.+||+.||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 5555555667789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=357.90 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=204.3
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHH-HHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVK-ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|++..+++.||+|++.+.... .......+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754321 12223345554 67888999999999999999999999999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+.....+.+.+++..++.++.||+.||.|||+.||+||||||+||+++.+ .+||+|||+++.... .......+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 6555444455679999999999999999999999999999999999999854 999999999976422 22334567999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++|||||||++|||++|.+||.+.+.......+.. .+
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~------------------------ 212 (321)
T cd05603 161 EYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---KP------------------------ 212 (321)
T ss_pred ccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---CC------------------------
Confidence 999999984 56789999999999999999999999988776544444321 10
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta----~elL~Hp~f~~~~~~ 289 (432)
..+.+..+.++.++|.+||+.||.+|+++ .|+++|+||...+|.
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 213 ---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 01223567899999999999999999976 599999999987764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=367.46 Aligned_cols=278 Identities=24% Similarity=0.358 Sum_probs=220.1
Q ss_pred CeeEeeeEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+|++++.||+|+||.||+|... .+++.||+|.+..... ..+|+++|++++||||+++++++.....+|+|||
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~------~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKT------PGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccccc------HHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 6999999999999999999754 4567899999875432 3579999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---Cc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YT 156 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~ 156 (432)
++.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+....... ..
T Consensus 167 ~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 167 KYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred hcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence 99999888874 44579999999999999999999999999999999999999865 999999999976654322 23
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCCCCchhhh-h-hhh
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS---EIDQLYKVCCILGAPDWTAFPEAT-N-ISR 231 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~---~~d~~~~i~~~~g~p~~~~~~~~~-~-~~~ 231 (432)
..+||+.|+|||++. ...|+.++||||+||++|||++|..||.+.. ..+++..++..++..+........ . ...
T Consensus 246 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 246 GWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred ccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence 467999999999984 5678999999999999999999999997753 456777788777765543221110 0 011
Q ss_pred hhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
+.........+....+.+ ..++.++.+||++||++||++|||+.|+|.||||....|
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 111112222222222222 246788999999999999999999999999999986443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=346.20 Aligned_cols=255 Identities=31% Similarity=0.443 Sum_probs=211.1
Q ss_pred CCeeEee-eEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe----CCEE
Q 014039 2 ERYKILE-ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE----NNEL 75 (432)
Q Consensus 2 ~~Y~~~~-~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~~~ 75 (432)
++|.+.. +||-|-.|.|..+.++.|++.+|+|++.... +..||+++.-.. .|||||.++++|+. ..++
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 5677765 7999999999999999999999999987543 245788877666 79999999999854 4678
Q ss_pred EEEEecCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceec
Q 014039 76 FFIFEYMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLAREL 149 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~ 149 (432)
.+|||.|+|+ |+..+..+ .+.++|.++..++.||..|+.|||+.+|.||||||+|+|.... .+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 8999999875 66666554 3469999999999999999999999999999999999999732 8999999999988
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCCCCchh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI----DQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~----d~~~~i~~~~g~p~~~~~~~ 225 (432)
.......+.|.||+|.|||++ +...|+...|+||+|+|||-|++|.|||...... +...+|. .|.
T Consensus 215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~--~gq-------- 283 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR--TGQ-------- 283 (400)
T ss_pred CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh--ccC--------
Confidence 766677888999999999998 6778999999999999999999999999887642 2222221 111
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
..|| .+-|..+|.+++|+|+++|..+|.+|.|+.|+++|||+....-+
T Consensus 284 ---------y~FP-------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 284 ---------YEFP-------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred ---------ccCC-------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 1121 12345689999999999999999999999999999999875543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=359.39 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=206.0
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHH-HHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVK-ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||+||+|++..+++.||+|++.+.... .......+|.. +++.++||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999754321 12223334444 56778999999999999999999999999998
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~~~~~t~ 162 (432)
+.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+|+.... .......+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 6555555555679999999999999999999999999999999999999855 999999999976432 23345568999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++. ...++.++||||+||++|||++|.+||.+.+..+....+... +
T Consensus 161 ~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------------------ 212 (325)
T cd05602 161 EYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------------------ 212 (325)
T ss_pred cccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C------------------------
Confidence 999999985 567899999999999999999999999988776655544210 0
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCHH----HHhcCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD----QALQHPFFNVETWV 289 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~----elL~Hp~f~~~~~~ 289 (432)
..+.+.++.++.++|++||+.||.+|+++. ++++|+||...+|.
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 213 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred ---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 012246788999999999999999999876 99999999987764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=360.96 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=208.1
Q ss_pred eeeEeecCceEEEEEEE---cCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 7 LEELGDGTCGCVYKAFN---VETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~---~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
++.||+|+||.||++++ ..+|+.||+|++.+.... .......+|+++|++++||||+++++++.+.+.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 46899999999999976 467899999999764322 22334568999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~~ 160 (432)
.++.+.....+...+++..++.++.||+.||+|||+.||+||||||+|||++++ .+||+|||+++..... ......+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 865444444445579999999999999999999999999999999999999855 9999999999865443 23445679
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
|+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 161 ~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~------------------------- 214 (318)
T cd05582 161 TVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK------------------------- 214 (318)
T ss_pred ChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 99999999985 5678999999999999999999999999887766655542100
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
..+...++.++.+||++||+.||++||+ +.++++||||...+|.
T Consensus 215 -----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 215 -----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 0112356889999999999999999999 6789999999986653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=362.46 Aligned_cols=280 Identities=35% Similarity=0.578 Sum_probs=223.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++.+.... .......+|+.++++++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 5799999999999999999999999999999998754322 2233456899999999999999999988543 35
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
.|+||||+.+++.+.+... +++..++.++.||+.||+|||+.|++||||||+||+++.+ .+||+|||+++......
T Consensus 96 ~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 96 VYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 7999999999888876543 8999999999999999999999999999999999999865 99999999998776544
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
......+++.|+|||++. ...++.++||||+||++|+|++|..||.+.+..++..+++..+|.|...............
T Consensus 173 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 173 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred CCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 445567899999999985 5678999999999999999999999999999999999999989987654222111100000
Q ss_pred hccccccCCCCcccc-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDI-------------IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~-------------~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+......+..+ ....+.++++||.+||+.||++|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000000000111111 1235667999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=351.97 Aligned_cols=253 Identities=26% Similarity=0.323 Sum_probs=204.4
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
||+|+||+||++.++.+++.||+|++....... ......+|+++++.++|+||+++.+++......|+||||++++.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999999999999997543221 123346799999999999999999999999999999999987655
Q ss_pred HHHH-H---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccCC
Q 014039 88 HIMR-E---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVST 161 (432)
Q Consensus 88 ~~~~-~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~t 161 (432)
.... . ....+++..++.++.||+.||+|||++||+||||||+||+++++ .+||+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 4333 2 33569999999999999999999999999999999999999854 99999999998765432 23446789
Q ss_pred ccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 162 ~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
+.|+|||++. ...++.++||||+||++|||++|..||...........+....-..
T Consensus 161 ~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------- 216 (280)
T cd05608 161 PGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------------- 216 (280)
T ss_pred cCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----------------------
Confidence 9999999985 5678999999999999999999999998765432222221110000
Q ss_pred CCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 242 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
...+...++.++.+++.+||+.||++|+ +++++++||||+...|.
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012245788999999999999999999 89999999999986664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=349.28 Aligned_cols=282 Identities=41% Similarity=0.689 Sum_probs=228.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++.+.||+|+||.||+|.+..+++.||+|+++...... ......+|++++++++|+||+++++++.+.+..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 58999999999999999999999999999999987543222 23346789999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCcc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTE 157 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~ 157 (432)
|++++++..+..+...+++..++.++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||.+....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 99999988877766679999999999999999999999999999999999999865 99999999998765443 4456
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
+.++.+|+|||++.+...++.++|+||+||++|+|++|.++|.+.+..+.+..+...++...............+....+
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 78899999999997655889999999999999999999999999988888888777776544332211111111111111
Q ss_pred cccC-CCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEIL-PINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~-~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
+... +..+...+ ..++.++++||++||+.+|++|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1111 11111112 2358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=360.11 Aligned_cols=282 Identities=39% Similarity=0.661 Sum_probs=228.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN-----NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~ 75 (432)
++|++.+.||+|+||+||+|++..+++.||||++...... .......+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5899999999999999999999999999999998754322 2233456899999999999999999987543 358
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-C
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-P 153 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~ 153 (432)
|+|+||+.+++.+.+... +.+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||+++..... .
T Consensus 85 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 999999998887776654 579999999999999999999999999999999999999855 9999999999876443 2
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh--hhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE--ATNISR 231 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~--~~~~~~ 231 (432)
....+.++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+....|.+..+.+.. .....+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 334567899999999987656789999999999999999999999999988888888888888876554321 011111
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+.. ..+...........+.++.++.+||++||+.||++|||+.|+++||||..
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 244 YIR-SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHH-hcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 111 11111222233445678999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.52 Aligned_cols=275 Identities=22% Similarity=0.340 Sum_probs=212.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.+|.+.+.||+|+||.||+|.+..+++.||+|..... ...+|+++|++++|+|||++++++...+..++|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3699999999999999999999999999999975432 135899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---Ccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YTE 157 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~~ 157 (432)
+.++++..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....... ...
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 9999999887766689999999999999999999999999999999999999864 999999999987643221 224
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCC-CCCCCC------hHHHHHHHHHHhCCCCCC--Cchhhhh
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSP-IFPGDS------EIDQLYKVCCILGAPDWT--AFPEATN 228 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~-pF~~~~------~~d~~~~i~~~~g~p~~~--~~~~~~~ 228 (432)
.+||+.|+|||++. +..++.++|||||||++|||++|.. +|.... ..+++.++++..+..... .......
T Consensus 322 ~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 322 IAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred cCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 57999999999985 5678999999999999999998764 444321 234566666554432211 1100000
Q ss_pred hhhhhh----ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 229 ISRLIS----ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 229 ~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+.. ...+......+.. +..++.++.+||++||++||.+|||+.|+|+||||+.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 011110 0111111111111 1256778999999999999999999999999999974
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=358.09 Aligned_cols=282 Identities=22% Similarity=0.300 Sum_probs=211.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||.||+|.+..++..+|+|.+...........+.+|++++++++||||+++++++.+++..|+||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 68999999999999999999999999999999987654333344567999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
+.++.+..+..+.+.+++..++.++.||+.||.|||+. +++||||||+|||++. +.+||+|||++...... ......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 163 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 163 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCC
Confidence 98755554444455799999999999999999999975 7999999999999985 48999999999765432 234467
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCCCCCchhhhhh-hhhhhcc-
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVC-CILGAPDWTAFPEATNI-SRLISIS- 236 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~-~~~g~p~~~~~~~~~~~-~~~~~~~- 236 (432)
++..|+|||++. +..++.++|+||+||++|+|++|..||......+....+. ...|.+........... .......
T Consensus 164 ~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 164 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 899999999985 5678999999999999999999999998765533322111 11111111110000000 0000000
Q ss_pred ------------ccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 ------------YSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ------------~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...........+. ...+.++.+||.+||++||++|||+.|+++||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 0000000001111 236789999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=346.17 Aligned_cols=256 Identities=38% Similarity=0.589 Sum_probs=211.9
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH-HHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC-MNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
|++++.||+|+||+||+|++..+++.||+|++.......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999998765443332 3356999999999999999999999999999999999
Q ss_pred CC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceec-CCCCCCcccc
Q 014039 83 EH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLAREL-SSMPPYTEYV 159 (432)
Q Consensus 83 ~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~-~~~~~~~~~~ 159 (432)
.+ ++.+.+. ..+.+++..++.++.||++||++||+.|++|+||||+||++++ +.++|+|||.+... ..........
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 98 5666655 4447999999999999999999999999999999999999995 49999999999864 3334456678
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
++..|+|||++.....++.++||||+||++++|++|..||......+....+.......... ...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~~~- 224 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------------SSQ- 224 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------------HTT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------------ccc-
Confidence 99999999998546789999999999999999999999999885555555543332211000 000
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.......++.++|++||+.||++|||+.++++||||
T Consensus 225 --------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 --------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=359.21 Aligned_cols=265 Identities=28% Similarity=0.367 Sum_probs=229.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++.|..-++||+|+||.||-++.+.||+.+|+|++.+++.... +...++|.++|.+++.+.||.+-..|++.+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4578889999999999999999999999999999976654432 33457899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC
Q 014039 79 FEYMEHNLYHIMRERQI--PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~--~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~ 155 (432)
+..|.|+.+...+.+-+ .|++..++.|+.+|+.||.+||+.+||+||+||+|||+|+. .+.|+|+|+|..+..+.+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999988887766543 79999999999999999999999999999999999999864 9999999999999999888
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||..|||||++. +..|+.++|+|||||++|||+.|+.||....+.+...++-+..-.-
T Consensus 344 ~~rvGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----------------- 405 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----------------- 405 (591)
T ss_pred ccccCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----------------
Confidence 8889999999999995 5559999999999999999999999998877665554442221110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVPYP 292 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~~~ 292 (432)
-.++..++|+++++|.+.+|++||++|.. ++++.+||||+..+|...+
T Consensus 406 ---------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 406 ---------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE 458 (591)
T ss_pred ---------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence 11233578999999999999999999985 6899999999999995544
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=358.56 Aligned_cols=282 Identities=42% Similarity=0.728 Sum_probs=231.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe----CCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE----NNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~ 76 (432)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .......+|+.+|++++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 4799999999999999999999999999999999764432 223345689999999999999999998753 35789
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~- 154 (432)
+||||+.+++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++++ .+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999998877766654 4469999999999999999999999999999999999999865 999999999976543211
Q ss_pred ----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh--h
Q 014039 155 ----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT--N 228 (432)
Q Consensus 155 ----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~--~ 228 (432)
....+++.+|+|||.+.+...++.++||||+||++|||++|.+||.+.+...++..+...+|.|+...+.... .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 1345789999999998665678999999999999999999999999999999999999999988765442211 1
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+.. ..++......+..+.+..+.++.++|++||+.||++|||+++++.||||+.
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 244 VRKYI-QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred HHHHH-hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 11111 123334444455556778999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.74 Aligned_cols=283 Identities=39% Similarity=0.687 Sum_probs=228.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCC------
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENN------ 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------ 73 (432)
+++|++.+.||+|+||.||+|.++.+|+.||+|+++..... .......+|+++++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 36899999999999999999999999999999999754321 12234568999999999999999999886544
Q ss_pred ----EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 74 ----ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 74 ----~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
.+|+|+||+++++...+......+++..++.++.||+.||.|||+.||+||||||+||+++++ .+||+|||.+..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 789999999998888877665679999999999999999999999999999999999999865 999999999987
Q ss_pred cCCCC--CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 149 LSSMP--PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 149 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
..... ......++..|+|||++.+...++.++||||+||+++||++|+++|...+..+.+..+....+.+....++..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 64432 2233456788999999865566899999999999999999999999999988888888888887765544433
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.....+............+...+..++..+.++|.+||+.||++|||+.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 222221111111111112222344578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=357.33 Aligned_cols=281 Identities=42% Similarity=0.694 Sum_probs=235.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-chHHHHHHHHHHHHHhcCCCcccccceEEEeCC-----EEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNIIKLKEVVRENN-----ELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~ 76 (432)
+|++.+.||.|+||.||+|++..+++.||||++..... ........+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986542 233345678999999999999999999987664 789
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-- 153 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-- 153 (432)
+||||+++++.+.+... ..+++..++.++.||+.||+|||+.||+||||||+||+++++ .++|+|||.+.......
T Consensus 81 lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999998777766554 489999999999999999999999999999999999999865 99999999998775542
Q ss_pred --CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh--hhhh
Q 014039 154 --PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE--ATNI 229 (432)
Q Consensus 154 --~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~--~~~~ 229 (432)
......++++|+|||++.+...++.++|+||+||++|+|++|.+||.+.+..+....+....|.+....+.. ....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 244567899999999987655889999999999999999999999999999999999999988887654431 1111
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+. .......+..+....+.++.++.+||.+||++||++|||+++++.||||+.
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 240 RNYL-KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hhHH-hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 1111 113333444555566778999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.52 Aligned_cols=279 Identities=41% Similarity=0.748 Sum_probs=229.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
|++.+.||.|++|.||+|.+..+|..||+|++....... ......+|+++++.++||||+++++++.+.+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 788999999999999999999999999999987543221 1233568999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 83 EHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 83 ~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
++++.+.+.... ..+++..++.++.||+.||+|||+.|++||||+|+||+++++ .++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 160 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence 888877766543 368999999999999999999999999999999999999865 9999999999765432 2223346
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
++..|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+.++.+..+.|....+........+.. .++.
T Consensus 161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (283)
T cd07835 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-TFPK 239 (283)
T ss_pred cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh-hccc
Confidence 688999999887666789999999999999999999999999999888888888888877655433322222211 2222
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
..........+.++.++.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 23333344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=346.14 Aligned_cols=280 Identities=41% Similarity=0.735 Sum_probs=229.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEEEEe
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN--NELFFIFE 80 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~E 80 (432)
|++.+.||.|+||.||+|.+..+++.+|+|++...... .......+|+++++.++|+|++++++++.+. +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78999999999999999999999999999999865411 2223456899999999999999999999887 88999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCcc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTE 157 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~ 157 (432)
|+++++...+......+++..++.++.||+.||+|||+.|++|+||||+||+++++ .+||+|||.+....... ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99998888777665689999999999999999999999999999999999999865 99999999998765432 2334
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||.+.+...++.++|||||||+++||++|.+||.+....+.+..+....+.++...++.............
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 46788999999887666789999999999999999999999999998888888888888877665543332211111111
Q ss_pred cccCCCCccccCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~-s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+..+...+... +.++.++|++||+.||.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 111122222333343 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=344.13 Aligned_cols=281 Identities=31% Similarity=0.523 Sum_probs=232.4
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEEEEE
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN-----NELFFI 78 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~lV 78 (432)
+--+.||-|+||+||.+.+..+|+.||+|++..-+.. ...+...+|+++|..++|.|++..+++.+.. .++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999999999999999999765433 2334467999999999999999999887543 457899
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--CCC
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM--PPY 155 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~--~~~ 155 (432)
+|+|..+|...+-.-+ .++.++++-++|||++||+|||+.||.||||||.|+|++.+ .+||||||+|+..... ..+
T Consensus 136 TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 9999988888776544 79999999999999999999999999999999999999988 9999999999976543 345
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
+..+.|-+|+|||++.+...|+.++||||+|||+.||+..+.+|...++.+|+..|..++|+|..+.+....+-.+..-.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 66788999999999999999999999999999999999999999999999999999999999998866543322221111
Q ss_pred cccccCCCCccccC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 236 SYSEILPINLSDII-----PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 236 ~~~~~~~~~~~~~~-----~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.-+ .++..+..++ ..-..++.+++.+||..||++|.+.++++.|+|..+.+
T Consensus 295 R~~-~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 295 RAG-LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ccC-CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 111 1111222222 23456889999999999999999999999999998643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=347.18 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=202.1
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
||+|+||.||+++++.+|+.||+|++...... ........|++++++++||||+++++++.+....|+||||+.++.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999753322 1223345799999999999999999999999999999999987544
Q ss_pred -HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCccc
Q 014039 88 -HIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWY 164 (432)
Q Consensus 88 -~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y 164 (432)
..+... ...+++..+..++.||+.||+|||+.|++||||||+||+++++ .+||+|||++.............++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 444332 3368999999999999999999999999999999999999865 8999999999877654444556789999
Q ss_pred cchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCC
Q 014039 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244 (432)
Q Consensus 165 ~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (432)
+|||++. ...++.++|+||+||++|||++|..||.+.........+.... ... .
T Consensus 161 ~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~--------~ 214 (277)
T cd05607 161 MAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT-----------------LED--------E 214 (277)
T ss_pred cCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh-----------------hcc--------c
Confidence 9999985 4559999999999999999999999997654321111111100 000 0
Q ss_pred ccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 014039 245 LSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFFNVETW 288 (432)
Q Consensus 245 ~~~~~~~~s~~~~dli~~~L~~dP~~Rpta----~elL~Hp~f~~~~~ 288 (432)
.......++.++.+||++||++||++||++ ++++.||||+..+|
T Consensus 215 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 215 VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 000113578899999999999999999999 77889999998766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=346.88 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=208.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|+..+.||+|+||.||+|.+..+++.||+|++........ .....+|+.+++.++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999875432222 2335689999999999999999999999999999999
Q ss_pred cCCCcHH-HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 81 YMEHNLY-HIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 81 ~~~~~ll-~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|+.++.+ +.+... ...+++..+..++.|++.||.|||+.||+||||||+||+++.+ .++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9987544 444332 3469999999999999999999999999999999999999865 999999999987655444455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..|+..|+|||++. ...++.++||||+||++|+|++|.+||.+..................
T Consensus 161 ~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------ 221 (285)
T cd05630 161 RVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ------------------ 221 (285)
T ss_pred CCCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh------------------
Confidence 68999999999985 56689999999999999999999999987543211111110000000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETW 288 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~ 288 (432)
......+++++.+||++||+.||++||| ++|+++||||+..+|
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 222 --------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred --------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 0112357889999999999999999999 999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=354.34 Aligned_cols=281 Identities=38% Similarity=0.656 Sum_probs=230.9
Q ss_pred CCeeE-eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-------------HHHHHHHHHHHHhcCCCcccccce
Q 014039 2 ERYKI-LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-------------ECMNLREVKALRKLNHPNIIKLKE 67 (432)
Q Consensus 2 ~~Y~~-~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-------------~~~~~~Ei~~l~~l~hpnIv~l~~ 67 (432)
++|.. .+.||.|+||+||+|.+..+++.||+|++........ .....+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46765 4679999999999999999999999999875432210 113468999999999999999999
Q ss_pred EEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 68 VVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 68 ~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
++...+..|+||||+.+++.+.+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.+ .+||+|||.+
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 99999999999999999888777654 469999999999999999999999999999999999999865 9999999999
Q ss_pred eecCC---------------CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014039 147 RELSS---------------MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211 (432)
Q Consensus 147 ~~~~~---------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i 211 (432)
..... ........++..|+|||.+.+...++.++|+||+||++|||++|.+||.+.+..+.+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 76541 111223456888999999876667899999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 212 CCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 212 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...++.|....++.......+.. +....+.......+..+.++.++|.+||+.||++|||++|+|.||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHhCCCchhhCcchhhcccccc--cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 99999887766654433332221 1122233334445677899999999999999999999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=345.96 Aligned_cols=278 Identities=36% Similarity=0.576 Sum_probs=231.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe------CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE------NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~ 74 (432)
.||.-++.+|.|+- .|..|.+.-+++.||+|++...+... ......||+..|..++|+||++++.+|.. ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47888999999998 89999999999999999997664332 23346799999999999999999999853 356
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+|||+|..++-..+.- .++-+.++.+++|++.|++|||+.||+||||||+||+++.+ .+||+|||+|+.-...-
T Consensus 96 ~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence 899999999999888773 47788999999999999999999999999999999999966 99999999998876665
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.++.|+.|++|+|||++++-. |...+||||+|||+.||++|..+|+|.+..||..++.+.+|+|....+.+.....+.+
T Consensus 173 ~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred ccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 678899999999999997554 9999999999999999999999999999999999999999999977554333222222
Q ss_pred hccccccCCCCccccCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 234 SISYSEILPINLSDIIP------------NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~------------~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
-...++.....+.+.++ .-+..++|++.+||..||++|.+++++|+||||+
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 22222222222222222 2345789999999999999999999999999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=351.51 Aligned_cols=278 Identities=32% Similarity=0.540 Sum_probs=223.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-C-C----cccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-H-P----NIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-h-p----nIv~l~~~~~~~~~~ 75 (432)
+||++++.+|+|+||.|.++.+.++++.||||+++.-....+ ..+-|+++|+++. + | -+|.+.++|+..++.
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYre--Aa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYRE--AALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhh--HHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 589999999999999999999999999999999985432222 2345999999993 2 3 277888889999999
Q ss_pred EEEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC------------------
Q 014039 76 FFIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND------------------ 136 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~------------------ 136 (432)
|||+|.++-++.+.+..+ -.+++..+++.+.+||++++++||+.+++|.||||+|||+.+.
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999999999999999874 4689999999999999999999999999999999999998421
Q ss_pred ---eEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014039 137 ---VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 137 ---~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~ 213 (432)
.+||+|||.|+.-.. .....+.|+.|+|||+++ +-.++...||||+||||+|+.+|..+|++.++.+++.-+..
T Consensus 247 ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred CCcceEEEecCCcceecc--CcceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 489999999987554 346778999999999997 67799999999999999999999999999999999988889
Q ss_pred HhCCCCCCCchhhhhhhhhhh---cccccc-----------CCCCccccCCCC---CHHHHHHHHHhcccCCCCCCCHHH
Q 014039 214 ILGAPDWTAFPEATNISRLIS---ISYSEI-----------LPINLSDIIPNA---SMEAIDLIWQLCSWDPLRRPTADQ 276 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~---s~~~~dli~~~L~~dP~~Rpta~e 276 (432)
++|..+...+... ...++.. ..++.. .+.++..+.... ..++.|||++||.+||.+|+|+.|
T Consensus 324 IlGp~P~~mi~r~-~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 324 ILGPIPSRMIKKT-RKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred hhCCCcHHHhhhh-hhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 9996665433222 1112111 111111 111122222222 235789999999999999999999
Q ss_pred HhcCCCCCC
Q 014039 277 ALQHPFFNV 285 (432)
Q Consensus 277 lL~Hp~f~~ 285 (432)
+|.||||+.
T Consensus 403 AL~HpFF~~ 411 (415)
T KOG0671|consen 403 ALSHPFFAR 411 (415)
T ss_pred HhcCHHhhc
Confidence 999999985
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=343.70 Aligned_cols=279 Identities=44% Similarity=0.769 Sum_probs=236.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
|++.+.||+|.+|.||+|++..+++.||+|++...... .......+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 78889999999999999999999999999999865311 12233567999999999999999999999989999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~ 160 (432)
++++.+.+......+++..++.++.||+.||.|||+.|++||||+|+||+++++ .+||+|||.++...... ......+
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence 998888777664579999999999999999999999999999999999999864 99999999998764432 3344566
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||.+.+...++.++|+||+||+++||++|.++|.+.+..+.+.++...++.+....+....... .....++..
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (282)
T cd07829 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPKF 239 (282)
T ss_pred CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-ccccccccc
Confidence 8889999998766588999999999999999999999999999999999999988888766555443333 233444444
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
........++..+.++.++|++||+.||++||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 4445555566778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.09 Aligned_cols=248 Identities=29% Similarity=0.356 Sum_probs=204.8
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCC-EEEEEEec
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENN-ELFFIFEY 81 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 81 (432)
..+...||+|+||+||+|....+. .||+|++........ ...+.+|+.+|++++|||||++++++.+.. .++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 345567999999999999765432 299999986554333 445779999999999999999999998876 79999999
Q ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCceeEeCC--eEEEeeeccceecCCC-CCC
Q 014039 82 MEHNLYHIMRER--QIPFSEGEIRSFMSQMLQGLAHMHRNG-YFHRDLKPENLLVTND--VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 82 ~~~~ll~~~~~~--~~~l~~~~~~~i~~qIl~aL~~LH~~g-ivHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~-~~~ 155 (432)
|+++.+..+... .+.++...+..++.||++|+.|||+++ ||||||||+|||++.+ ++||||||+++..... ...
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~ 201 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSM 201 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccc
Confidence 998766665544 678999999999999999999999999 9999999999999965 9999999999877654 344
Q ss_pred ccccCCccccchhhhcC-CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQ-SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~-~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
+...||..|||||++.+ ...|+.++||||||+++|||++|..||.+.........+.....+|.
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--------------- 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--------------- 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Confidence 55799999999999954 46899999999999999999999999999998554444432221221
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+...+++.+..|+.+|++.||.+||+..+++.-
T Consensus 267 -------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~ 299 (362)
T KOG0192|consen 267 -------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSR 299 (362)
T ss_pred -------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence 223478899999999999999999999888753
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=349.84 Aligned_cols=281 Identities=36% Similarity=0.621 Sum_probs=219.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcC--CCeEEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVE--TYEIVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVREN--NELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~ 76 (432)
+|++.++||+|+||.||+|.+.. +++.||+|.+..... ........+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 899999999986331 11123356899999999999999999999887 8899
Q ss_pred EEEecCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-----CeEEEeeeccce
Q 014039 77 FIFEYMEHNLYHIMRER----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-----DVLKIADFGLAR 147 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-----~~lkL~DFG~a~ 147 (432)
+||||+++++.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||+++. +.+||+|||+++
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999999888766532 237899999999999999999999999999999999999986 389999999998
Q ss_pred ecCCCC----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH---------HHHHHHHHH
Q 014039 148 ELSSMP----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---------DQLYKVCCI 214 (432)
Q Consensus 148 ~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~---------d~~~~i~~~ 214 (432)
...... .....+++..|+|||++.+...++.++|||||||++++|++|.+||.+.... +.+.+++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 654322 1234577899999999876677899999999999999999999999876543 456677777
Q ss_pred hCCCCCCCchhhhhhhhhhhc-cccccCC---CCccc---cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 215 LGAPDWTAFPEATNISRLISI-SYSEILP---INLSD---IIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~---~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
++.+....+........+... ....... ..+.. .....+.++.++|.+||+.||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 777665444322222111110 0000000 00101 112577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=338.27 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=208.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW----EECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+.|++.+.||+|++|.||+|.+..+++.||+|.+....... ......+|++++++++||||+++++++.++..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999999999999987543221 22345689999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~- 155 (432)
|+||++++.+.......+.+++..++.+++||+.||.|||+.|++||||+|+||+++++ .++|+|||.++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999876555444444579999999999999999999999999999999999999865 9999999999765432111
Q ss_pred ---ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 156 ---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 156 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
....++..|+|||++. +..++.++||||+||++|||++|.+||.+.+.......+.....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------- 224 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT---------------- 224 (263)
T ss_pred ccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC----------------
Confidence 3456888999999985 45689999999999999999999999987665544433311000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+...++.++.++|++||+.+|.+|||+.|+++||||
T Consensus 225 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 011223578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.62 Aligned_cols=280 Identities=25% Similarity=0.380 Sum_probs=227.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.|.+++++.|++.||+|++.+-.-. ....-+..|..+|..-+.+=|++++..|+++.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 5799999999999999999999999999999999862211 12233456888898889999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCC--CC
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMP--PY 155 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~--~~ 155 (432)
|||+|| ++..+.+.. ++++..++.|+..|+.||+-||+.|+|||||||+|||+| .|.+||+|||.|-.+..+. ..
T Consensus 155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 999875 555554544 899999999999999999999999999999999999999 5699999999998775332 24
Q ss_pred ccccCCccccchhhhc---CC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLL---QS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~---~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+|||.|.+||++. ++ +.|+...|+||+|+++|||+.|.-||..++-.+...+|+..-.
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~--------------- 298 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE--------------- 298 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh---------------
Confidence 5679999999999984 23 6799999999999999999999999999999999999864311
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCCCC-CCChhhhhccCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT---ADQALQHPFFNVETWVPYP-LHDPLELRLNNMGSK 307 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt---a~elL~Hp~f~~~~~~~~~-~~~~~~~~~~~~~~~ 307 (432)
.+.||.. ..+|.+++|||++++. +|+.|.+ ++++..||||.+++|.... ...|.-+.+++....
T Consensus 299 --~l~FP~~---------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DT 366 (1317)
T KOG0612|consen 299 --SLSFPDE---------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDT 366 (1317)
T ss_pred --hcCCCcc---------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcc
Confidence 1122211 1489999999999998 8899998 9999999999999994321 122333334444444
Q ss_pred CC
Q 014039 308 PN 309 (432)
Q Consensus 308 ~~ 309 (432)
+|
T Consensus 367 sn 368 (1317)
T KOG0612|consen 367 SN 368 (1317)
T ss_pred cc
Confidence 44
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.27 Aligned_cols=259 Identities=26% Similarity=0.362 Sum_probs=213.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|+..+.||+|+||+||+|.+..+++.||+|++....... ......+|+++|+.++|+||+.+.+.+.+++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999987543221 22335689999999999999999999999999999999
Q ss_pred cCCCcHHHH-HHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 81 YMEHNLYHI-MRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 81 ~~~~~ll~~-~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|+.++.+.. +.. ....+++..+..++.|++.||.|||+.||+||||||+||+++++ .+||+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 999765544 333 23469999999999999999999999999999999999999865 999999999987655444455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..|+..|+|||++. ...++.++|+||+||++|+|++|..||.+.........+........
T Consensus 161 ~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------------------ 221 (285)
T cd05632 161 RVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------------------ 221 (285)
T ss_pred CCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------------------
Confidence 68999999999985 56789999999999999999999999988766544444322111110
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETW 288 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~ 288 (432)
..+...++.++.+|+.+||+.||++||+ +.++++|+||+...|
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 222 --------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred --------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 0122357889999999999999999999 899999999997554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=358.52 Aligned_cols=250 Identities=31% Similarity=0.466 Sum_probs=218.9
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
.++||.|.||+||-|+++++|+-||||++.+.+.. ..+....+|+.||+++.||.||.+--.|++.+.+++|||-+.|+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36899999999999999999999999999875543 33444568999999999999999999999999999999999999
Q ss_pred HHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCCCCCccccC
Q 014039 86 LYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 86 ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
.++.+.. ..+.|++...+.++.||+.||+|||-+||+|+||||+|||+.+. .+||||||+|+.++......+.+|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 9998875 45689999999999999999999999999999999999999743 899999999999998877888999
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
||.|.|||++ +.+.|...-||||+|+|+|--++|..||..+.++ ||++...-. +|
T Consensus 729 TPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM----------------------yP- 784 (888)
T KOG4236|consen 729 TPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM----------------------YP- 784 (888)
T ss_pred CccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc----------------------cC-
Confidence 9999999999 5788999999999999999999999999876553 444432111 11
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
+ +-|..++++|+|||..+|+..-++|.|.++.|.|||+++.
T Consensus 785 --p----~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 785 --P----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --C----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 1 2234679999999999999999999999999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.06 Aligned_cols=281 Identities=37% Similarity=0.602 Sum_probs=218.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC---------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN--------- 72 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--------- 72 (432)
.+|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 589999999999999999999999999999999876543 2333456899999999999999999876543
Q ss_pred -----CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C-eEEEeeecc
Q 014039 73 -----NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D-VLKIADFGL 145 (432)
Q Consensus 73 -----~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~-~lkL~DFG~ 145 (432)
...|+||||+++++.+.+.. +.+++..++.++.||+.||.|||+.|++||||||+||+++. + .+||+|||.
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 35789999999877666543 36999999999999999999999999999999999999973 3 799999999
Q ss_pred ceecCCCC----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMP----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++...... ......++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 97653321 12234678899999988766778999999999999999999999999988877777665543332221
Q ss_pred Cchhh-hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 222 AFPEA-TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 222 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..... ........ ........+.....+.++.++++||++||+.||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 242 DRNELLNVIPSFVR-NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred Hhhhhhhhhhhhhh-hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 11100 00000000 001111122333445788999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.79 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=208.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHH-HHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKA-LRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|+++.+|+.||||+++............+|+.+ ++.++||||+++++++..++..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5899999999999999999999999999999999865544444455567665 566799999999999999999999999
Q ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC
Q 014039 81 YMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~ 155 (432)
|+++++.+.+.. .+..+++..++.++.||+.||+|||++ +++||||||+||+++.+ .+||+|||++.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999987776654 345799999999999999999999997 99999999999999855 9999999999876543333
Q ss_pred ccccCCccccchhhhcCC---CCCCcccceechHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQS---SSYSPAIDMWAVGAILAELFTLSPIFPGD-SEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~---~~~~~~~DiWSlG~il~ell~g~~pF~~~-~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
....++..|+|||++.+. ..++.++|+||+||++|+|++|..||... ...+.+..+.. +....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~----------- 227 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSPQ----------- 227 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCCC-----------
Confidence 335688899999988532 45788999999999999999999999653 22233332211 00000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
+ ....++.++.++|.+||+.+|++||++.++++||||....
T Consensus 228 -----~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 228 -----L----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -----C----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 0 0124678999999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=348.69 Aligned_cols=282 Identities=43% Similarity=0.675 Sum_probs=227.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCC--CeEEEEEEecccccc-hHHHHHHHHHHHHHhc-CCCcccccceEEEe----CCE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVET--YEIVAVKKMKRKFYF-WEECMNLREVKALRKL-NHPNIIKLKEVVRE----NNE 74 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~~ 74 (432)
+|++.+.||+|+||.||+|.+..+ +..||+|++...... .......+|+++++++ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 699999999999999999999888 899999998754322 1233456899999999 69999999987532 245
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+++||+.+++...+.. ...+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||.++......
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999999888777754 4479999999999999999999999999999999999999865 99999999998664322
Q ss_pred -----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 154 -----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 154 -----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
......++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+.+..++..+|.++...+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 123457899999999987667789999999999999999999999999999999999999999877543322111
Q ss_pred h-hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 229 I-SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 229 ~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. ...............+....+..+.++.+||.+||+.||++|||+.|++.||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 0 01111122222333444455677899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.32 Aligned_cols=277 Identities=23% Similarity=0.312 Sum_probs=211.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+..++..+|+|.+.............+|++++++++||||+++++++.+++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 57999999999999999999999999999999987654333334467899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
++++.+..+..+.+.+++..++.++.||+.||.|||+ .|++||||||+|||++++ .+||+|||++...... .....+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 159 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 159 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCC
Confidence 9876555555555689999999999999999999997 599999999999999865 8999999998765432 234567
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCCCCc-----------hhhh
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG-APDWTAF-----------PEAT 227 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g-~p~~~~~-----------~~~~ 227 (432)
+++.|+|||++. +..++.++|+||+||++|+|++|..||...+..+.. .+..... ....... ....
T Consensus 160 ~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 160 GTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCcCccChhHhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchh
Confidence 899999999884 566899999999999999999999999876543322 2211100 0000000 0000
Q ss_pred hhhhhhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.............. ..+. ..++.++.+||.+||+.||++|||+.|+++||||..
T Consensus 238 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 238 AIFELLDYIVNEPP----PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hHHHHHHHHhcCCC----ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000000000 0111 236889999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.85 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=218.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
-|+++..||.|+||.||+|.++.++-..|.|++..+. ..+....+-||.||...+||+||+|++.|...+.++|+.|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4788999999999999999999999999999987543 234445678999999999999999999999899999999999
Q ss_pred CCcHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceec-CCCCCCcccc
Q 014039 83 EHNLYHIMR-ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLAREL-SSMPPYTEYV 159 (432)
Q Consensus 83 ~~~ll~~~~-~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~-~~~~~~~~~~ 159 (432)
+||-.+.++ .-++.|++.+++.+++|++.||.|||+++|+|||||..|||++ +|.++|+|||.+... .......+++
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 998666554 5577899999999999999999999999999999999999998 669999999987543 3444567899
Q ss_pred CCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 160 STRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 160 ~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
|||||||||++. ...+|++++||||||+.|.||..+.||....+....+.+|.+- .|+--
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPTL-------------- 255 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPTL-------------- 255 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCcc--------------
Confidence 999999999974 4578999999999999999999999999988888877776431 11100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
--+.+.+.++.||+++||.+||..||+++++|+||||.+.
T Consensus 256 -----------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 256 -----------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -----------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0123577889999999999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=346.04 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=214.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
|.++++||+|+||.||+|.|+++|..+|||++..+. ..+.+.+|+.+|++.+.|+||++|+.|-.+..++||||||+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 667899999999999999999999999999998654 34557789999999999999999999999999999999997
Q ss_pred -CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC-CCCccccC
Q 014039 84 -HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-PPYTEYVS 160 (432)
Q Consensus 84 -~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-~~~~~~~~ 160 (432)
|+..+.++.++++|+|.++..+++..+.||.|||...-+|||||..|||++. |..||+|||.|..+.+. ...++.+|
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcccc
Confidence 5677777888899999999999999999999999999999999999999985 59999999999876543 34467899
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
||.|||||++. .-.|+.++||||||+...||..|+|||.+-.+...+.- +--.|+
T Consensus 192 TPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---IPT~PP--------------------- 246 (502)
T KOG0574|consen 192 TPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---IPTKPP--------------------- 246 (502)
T ss_pred CcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---ccCCCC---------------------
Confidence 99999999994 56799999999999999999999999987665322111 111111
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+ +.+...|.++.|||++||.+.|++|.||.++++|||+++.
T Consensus 247 --PTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 247 --PTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred --CCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 111 1123468899999999999999999999999999999864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=338.52 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=214.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .......+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 5899999999999999999999999999999998754322 12334568999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||++++ +.+.+.. .+.+++..++.++.||+.||.|||+.|++|+||+|.||+++.+ .+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 999654 5555444 4579999999999999999999999999999999999999855 9999999999876543 344
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+. .+.+
T Consensus 158 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~------------------- 215 (290)
T cd05580 158 LCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKV------------------- 215 (290)
T ss_pred CCCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCc-------------------
Confidence 57899999999885 5568899999999999999999999998877544444432 1111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWVPY 291 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~~~ 291 (432)
.+....+..+.++|++||+.||.+|+ +++|+++||||+...|...
T Consensus 216 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 216 ---------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred ---------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 11234578999999999999999999 9999999999998777443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.20 Aligned_cols=279 Identities=22% Similarity=0.235 Sum_probs=204.7
Q ss_pred eEeeeEeec--CceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 5 KILEELGDG--TCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 5 ~~~~~IG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+++++||+| +|++||++.++.+|+.||+|++........ .....+|+++++.++||||+++++++.+++..|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 778999999999999999999986543322 23456799999999999999999999999999999999
Q ss_pred CCCcHHH-HHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 82 MEHNLYH-IMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 82 ~~~~ll~-~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
++++.+. .+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .++++||+.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9875554 44332 3469999999999999999999999999999999999999854 99999998764432110
Q ss_pred ---CCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCC--------
Q 014039 154 ---PYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT-------- 221 (432)
Q Consensus 154 ---~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~-------- 221 (432)
......++..|+|||++.+. ..|+.++||||+||++|||++|..||.+........... .+..+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 238 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCccccccccchhh
Confidence 01223567789999998643 468999999999999999999999998766544333322 1211100
Q ss_pred -Cchhhhh----hhhhhh-----ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 222 -AFPEATN----ISRLIS-----ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 222 -~~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+..... ...... ...+.............+++++.+||++||++||++|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0000000 000000 000000011111223356889999999999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=364.47 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=209.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCC-CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVET-YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.|.+.+.||+|+||.||+|.+..+ ++.||+|++..... .......+|+++|+.++||||+++++++...+.+||||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 499999999999999999998877 78899998754432 2233456799999999999999999999999999999999
Q ss_pred CCCc-HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---
Q 014039 82 MEHN-LYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--- 153 (432)
Q Consensus 82 ~~~~-ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--- 153 (432)
++++ |.+.+.. ...++++..+..++.||+.||.|||++||+||||||+|||++++ .+||+|||+|+.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 9865 4444432 34579999999999999999999999999999999999999855 99999999998765432
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+||+.|+|||++. ...++.++||||+||++|||++|..||.+.+..+.+..+.. |..
T Consensus 227 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~--------------- 288 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--GKY--------------- 288 (478)
T ss_pred cccccCCCccccCHhHhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC---------------
Confidence 234567999999999884 56789999999999999999999999988877665555432 110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......++.++.+||.+||+.||++||++++++.|+|++.
T Consensus 289 ------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 289 ------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 0112356789999999999999999999999999999964
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=349.70 Aligned_cols=280 Identities=38% Similarity=0.617 Sum_probs=223.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.+..... ......+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 68999999999999999999999999999999987543222 123356899999999999999999998643 35
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+|+||+..++.... +..+++..++.++.||+.||+|||+.|++||||||+||+++.+ .+||+|||+++....
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence 6899999987655443 3368999999999999999999999999999999999999865 999999999976543
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh-hhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI-SRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~-~~~ 232 (432)
......++..|+|||++.+...++.++||||+||++|||++|+.||.+.+..+.+..++...|.+........... ...
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 2345678899999999866567899999999999999999999999999888888888887776543321111100 000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....+......+...++..+.++.+||++||+.||.+||+++|++.||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 011122222333444456788999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=342.41 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=215.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ......+|+++++.++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 58999999999999999999999999999999998654332 3334668999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---
Q 014039 80 EYMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--- 153 (432)
Q Consensus 80 E~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--- 153 (432)
||+.++ +.+.+... +..+++..++.++.||+.||+|||+.|++|+||||+||+++.+ .++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999875 54444432 3579999999999999999999999999999999999999854 99999999987543211
Q ss_pred ---------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHH
Q 014039 154 ---------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID 206 (432)
Q Consensus 154 ---------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d 206 (432)
.....+|+..|+|||++. +..++.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 112346888999999985 5568999999999999999999999999887766
Q ss_pred HHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCC
Q 014039 207 QLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT----ADQALQHPF 282 (432)
Q Consensus 207 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt----a~elL~Hp~ 282 (432)
....+... .+. ++ .....+.++.++|.+||+.||++||| ++|+|+|||
T Consensus 240 ~~~~~~~~--~~~-----------------~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 240 TFSNILKK--EVT-----------------FP---------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHhcC--Ccc-----------------CC---------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 55554210 000 00 01126889999999999999999999 999999999
Q ss_pred CCCCCCCCCCC
Q 014039 283 FNVETWVPYPL 293 (432)
Q Consensus 283 f~~~~~~~~~~ 293 (432)
|+...|....+
T Consensus 292 ~~~~~~~~~~~ 302 (316)
T cd05574 292 FRGVNWALIRH 302 (316)
T ss_pred hhcCChhhccc
Confidence 99988865544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=347.64 Aligned_cols=280 Identities=36% Similarity=0.608 Sum_probs=224.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|++++.||+|+||.||+|.+..+++.||+|++.+.... .......+|++++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 6899999999999999999999999999999999764322 2233456899999999999999999988542 45
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
.|++++++.+++.+.+.. +.+++..++.++.||++||+|||+.|++||||||+||+++++ .+||+|||+++....
T Consensus 97 ~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-- 172 (345)
T cd07877 97 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 172 (345)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc--
Confidence 789999987777665543 359999999999999999999999999999999999999865 999999999986543
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-hhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-ISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~~~~ 232 (432)
......+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+....+..+....+.+.......... ..+.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 334567899999999986656789999999999999999999999999888888888887777665443221110 0111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+......+.......++++++||.+||+.||.+|+++.++++||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 11112222333334444467889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=339.19 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=209.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|.+.............+|++++++++|+||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 58999999999999999999999999999999987654333344567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 82 MEHNLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 82 ~~~~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
++++.+..+... ...+++..++.++.||+.||.|||+ .|++||||||+||+++.+ .+||+|||.+..+... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccc
Confidence 998655555443 2379999999999999999999997 599999999999999865 9999999999766432 233
Q ss_pred cccCCccccchhhhcCC-----CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQS-----SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~-----~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+++.|+|||.+.+. ..++.++||||+||++|+|++|..||...........+.......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 226 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD------------- 226 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-------------
Confidence 45688899999988533 236889999999999999999999997655433322221111111
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+.+.++.++.+||.+||+.+|++||++.++++||||...
T Consensus 227 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 227 -------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred -------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 112234578899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.63 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=207.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||.||+|.+..+++.||+|.+.............+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 57999999999999999999999999999999997654433444567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccC
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
++++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.+ .+||+|||++...... .....++
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVG 155 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCC
Confidence 998776543 257899999999999999999999999999999999999865 9999999999876542 3345689
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ---LYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
+..|+|||++. ...++.++|+||+||++|+|++|..||......+. ..............
T Consensus 156 ~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 218 (279)
T cd06619 156 TNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP---------------- 218 (279)
T ss_pred ChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC----------------
Confidence 99999999885 55689999999999999999999999965322110 00111111100000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.......++++.++|.+||+.||++||+++|+++||||...
T Consensus 219 --------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 219 --------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00112467899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=357.05 Aligned_cols=280 Identities=25% Similarity=0.367 Sum_probs=236.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
.+.+.+..||-|+||.|=+++.......+|+|.+++....+. +.....|.++|.....|.||++|..|.++..+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 466788899999999999998777666799999987665433 334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
|-|-|+-+-.+.+.++.|++...+.|+.++++|++|||++||++|||||+|++++. |.+||.|||+|+.+..+..+-++
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeee
Confidence 98866544444444558999999999999999999999999999999999999985 59999999999999999999999
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
||||.|.|||+++ ++..+.++|.||||+++|||++|.|||.+.++.-..+.|++.+....
T Consensus 580 cGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------------------- 639 (732)
T KOG0614|consen 580 CGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------------------- 639 (732)
T ss_pred cCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-------------------
Confidence 9999999999997 67789999999999999999999999999999988888875443221
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCC---CCChhhhhccCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVPYP---LHDPLELRLNNMGSKPNL 310 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 310 (432)
++..++..+.+||++++..+|.+|.. +.||.+|-||.+.+|.... +..|..+.+.+....++|
T Consensus 640 ---------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~F 710 (732)
T KOG0614|consen 640 ---------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNF 710 (732)
T ss_pred ---------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhc
Confidence 22467889999999999999999986 8999999999999996543 334554444454444443
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=378.56 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=210.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (432)
+++|++++.||+|+||+||+|+++.+++.||+|++...... .....+.+|+.+|++++|||||+++++|.+ ...+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 47899999999999999999999999999999998754332 233456789999999999999999998854 467899
Q ss_pred EEecCCC-cHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeccCCCCceeEeCC----------
Q 014039 78 IFEYMEH-NLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRN-------GYFHRDLKPENLLVTND---------- 136 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~-------givHrDlkP~NILl~~~---------- 136 (432)
||||+++ +|.+.+.. ..+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999986 55555543 235799999999999999999999985 49999999999999632
Q ss_pred --------eEEEeeeccceecCCCCCCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHH
Q 014039 137 --------VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ 207 (432)
Q Consensus 137 --------~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~ 207 (432)
.+||+|||++..+.........++|+.|+|||++.+. ..++.++||||||||+|||++|..||.......+
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 4899999999877654444566899999999998643 4589999999999999999999999987766555
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
+...+.. .+.. .....+.++.+||.+||+.+|.+||++.|+|.|+||+..
T Consensus 252 li~~lk~--~p~l---------------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LISELKR--GPDL---------------------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhc--CCCC---------------------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 4433211 0100 012457899999999999999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=349.86 Aligned_cols=280 Identities=36% Similarity=0.626 Sum_probs=225.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCE------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNE------ 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~------ 74 (432)
++|++.+.||+|+||.||+|++..+++.||+|++....... ......+|+.++++++|+||+++.+++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 57999999999999999999999999999999987543222 22345689999999999999999988765443
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
.|+|+||+++++.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++++ .+||+|||++.....
T Consensus 95 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~-- 170 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-- 170 (343)
T ss_pred EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc--
Confidence 899999998887776654 369999999999999999999999999999999999999865 999999999987644
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-hhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-ISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~~~~ 232 (432)
....+.++..|+|||++.+...++.++||||+||++|+|++|.+||++....+.+..+....+.++...+..... ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 244567899999999986556789999999999999999999999999988888888888877665432211100 0000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+......+...+...+.++.+||++||+.||++|||+.|+++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 01112222223334445567899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=332.23 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=211.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||.|+||+||+|.+..++..+|+|++.............+|+++++.++|+||+++++.+...+..|+|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 58999999999999999999999999999999997655444455677999999999999999999999999999999999
Q ss_pred CCCcHHH-HHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---
Q 014039 82 MEHNLYH-IMRER--QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--- 154 (432)
Q Consensus 82 ~~~~ll~-~~~~~--~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--- 154 (432)
++++.+. .+... ...+++..++.++.||+.||+|||+.|++||||||+||+++++ .+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9875444 44432 2468999999999999999999999999999999999999865 999999999976654322
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
....+++..|+|||++.....++.++|+||+||++++|++|..||...+......++... .++ .+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--~~--------- 227 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP--SL--------- 227 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC--Cc---------
Confidence 134468899999999865557899999999999999999999999877665444443211 000 00
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....-...++.++.++|.+||+.||++|||+.++++||||
T Consensus 228 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 -----------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000023578899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.00 Aligned_cols=256 Identities=28% Similarity=0.425 Sum_probs=205.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEec-ccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~-~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|+++++||.|+-+.||++.....+ .||+|++. ..+......-..+|+..|.+| +|.+|++|++|-..++.+|||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 5999999999999999999866554 46666554 444433444567899999999 79999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCC---Ccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPP---YTE 157 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~---~~~ 157 (432)
|-+.+|...+.++...++...++.|.+|++.|+.++|.+||||.||||.|+|+-.|.+||+|||+|..+..... ..+
T Consensus 441 ~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kds 520 (677)
T KOG0596|consen 441 CGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDS 520 (677)
T ss_pred cccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeecc
Confidence 99999999999887777777999999999999999999999999999999999999999999999988765432 356
Q ss_pred ccCCccccchhhhcCC----------CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 158 YVSTRWYRAPEVLLQS----------SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~----------~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
.+||..||+||.+... -..+.++||||||||||+|+.|++||..-.. +..++ ..+-.|.-
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl-~aI~~P~~------- 590 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKL-HAITDPNH------- 590 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHH-HhhcCCCc-------
Confidence 7999999999998421 1256799999999999999999999955432 22222 11122211
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+.|+.+.. ..+++++++.||++||.+|||+.|+|+|||+..
T Consensus 591 ------~Iefp~~~~----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 591 ------EIEFPDIPE----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ------cccccCCCC----------chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 122333221 224999999999999999999999999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=326.94 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=223.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++.+.+..||.|+.|+|++++.+.+|...|+|.+.+.....+..++++.+.++..- ++|+||+.+++|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34556788999999999999999999999999999887777777888899887766 69999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
.|..-....++.-.++++|..+-++.+.++.||.||.+ +||+|||+||+|||+|+ |++||||||++..+.+....+..
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs 251 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS 251 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccc
Confidence 99877666666667789999999999999999999995 49999999999999995 69999999999988887888888
Q ss_pred cCCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 159 VSTRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGD-SEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 159 ~~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~-~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
.|.+.|||||-+- ....|+.++||||||+.++||+||+.||++. .+.+.+.+++. ..|+.- +
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L--~----------- 316 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLL--P----------- 316 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCC--C-----------
Confidence 9999999999884 2357999999999999999999999999985 45677777754 222211 0
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
--.++|+++.+|+..||++|+.+||.-.++|+|||+...
T Consensus 317 ------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 317 ------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 012489999999999999999999999999999999754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=338.17 Aligned_cols=260 Identities=30% Similarity=0.428 Sum_probs=211.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||.||+|++..+++.+|+|.+..... .......+|+++++.++|+||+++++++..++..|+||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 469999999999999999999999999999999875432 2334456899999999999999999999999999999999
Q ss_pred CCCcHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC-CCCccc
Q 014039 82 MEHNLYHIM-RERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 82 ~~~~ll~~~-~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
++++.+..+ .+....+++..++.++.||+.||.|||+.|++||||||+||+++. +.+||+|||++...... ......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 170 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF 170 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccccee
Confidence 998766544 444567999999999999999999999999999999999999984 49999999998764332 223455
Q ss_pred cCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 159 VSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 159 ~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.++..|+|||++. ....++.++|+|||||++|||++|.+||...+......++.. +.++.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~-------------- 234 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPT-------------- 234 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--CCCcc--------------
Confidence 7889999999885 234578899999999999999999999987665443333211 00000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
......++.++.++|++||+.||++||++.|+++||||...+|.
T Consensus 235 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 235 -----------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred -----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 01123567889999999999999999999999999999876554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=348.23 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=196.0
Q ss_pred CCeeEeeeEeecCceEEEEEEE-----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe-CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE-NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (432)
++|++.++||+|+||.||+|.+ ..+++.||+|+++............+|+.+|+.+ +||||+++++++.. ++.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 5899999999999999999975 2456789999998654444445577899999999 89999999998865 456
Q ss_pred EEEEEecCCCc-HHHHHHHc------------------------------------------------------------
Q 014039 75 LFFIFEYMEHN-LYHIMRER------------------------------------------------------------ 93 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~------------------------------------------------------------ 93 (432)
+|+||||++++ |.+.+...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 89999999865 44444432
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---CccccCCccccchh
Q 014039 94 -QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPE 168 (432)
Q Consensus 94 -~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE 168 (432)
..++++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++....... .....++..|+|||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 1247888999999999999999999999999999999999855 999999999986543221 12334567899999
Q ss_pred hhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccc
Q 014039 169 VLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSD 247 (432)
Q Consensus 169 ~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (432)
++. ...++.++|||||||++|||++ |.+||.+....+.....+.. |.. ..
T Consensus 247 ~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~---------------------------~~ 297 (338)
T cd05102 247 SIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR---------------------------MR 297 (338)
T ss_pred Hhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC---------------------------CC
Confidence 985 5678999999999999999997 99999886544333322110 000 01
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 248 IIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 248 ~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
....+++++.+||.+||+.||++|||+.|+++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=363.53 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=209.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCC-------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENN------- 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------- 73 (432)
++|++.+.||+|+||+||+|++..+|+.||||++...... .......+|+..+..++|+||+++++.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 5899999999999999999999999999999999765433 23344668999999999999999988764321
Q ss_pred -EEEEEEecCCC-cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 74 -ELFFIFEYMEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 74 -~~~lV~E~~~~-~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
.+++||||+.+ +|.+.+..+ ...+++..++.++.||+.||+|||+.||+||||||+|||++.+ .+||+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 36899999986 455555432 3579999999999999999999999999999999999999855 99999999998
Q ss_pred ecCCC---CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 148 ELSSM---PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 148 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
.+... ......+||+.|+|||++. ...|+.++|||||||++|||++|..||.+.+..+.+..+.. +.
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~--~~------- 261 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA--GR------- 261 (496)
T ss_pred eccccccccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC-------
Confidence 76432 2234568999999999985 56789999999999999999999999998876555544421 10
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+.+.+++++.+||.+||+.||.+||++.++++|||++.
T Consensus 262 --------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 --------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 01123467889999999999999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.27 Aligned_cols=252 Identities=31% Similarity=0.471 Sum_probs=220.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
|.-++.||.|+||-||-|++..+.+.||||++.-.... .+...+++|+..|+++.|||++.+.++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55678899999999999999999999999999744332 3445578999999999999999999999998999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccccC
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
|-|+-.+.+.-..++|.+.++..|..+.+.||+|||+.+.||||||..|||+++ |.|||+|||.|.... +.++++|
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAnsFvG 184 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANSFVG 184 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhcccC
Confidence 999888888777789999999999999999999999999999999999999985 599999999997654 4678999
Q ss_pred Cccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 161 TRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 161 t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
||+|||||+|+ ..+.|+-++||||||++..||.-.+||.-..+....++.|.+. ..|...
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLq----------------- 246 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQ----------------- 246 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCC-----------------
Confidence 99999999996 4567999999999999999999999999898888888887532 111111
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
-...|..++.|+..||++-|.+|||++++|.|+|+...
T Consensus 247 ----------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 ----------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred ----------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 13467889999999999999999999999999999753
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=366.66 Aligned_cols=283 Identities=23% Similarity=0.352 Sum_probs=206.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC-eEEEEEEe--------------cccc--cchHHHHHHHHHHHHHhcCCCcccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY-EIVAVKKM--------------KRKF--YFWEECMNLREVKALRKLNHPNIIK 64 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~-~~vAiK~i--------------~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~ 64 (432)
++|+++++||+|+||+||+|..+... +.+++|.+ .+.. .......+.+|+++|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 58999999999999999998765432 22232211 1100 0111223468999999999999999
Q ss_pred cceEEEeCCEEEEEEecCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 65 LKEVVRENNELFFIFEYMEHNLYHIMRERQ----IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 65 l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~----~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
+++++.+.+..|+|+|++.++++..+.... .......++.++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999888775432 234567788999999999999999999999999999999854 999
Q ss_pred EeeeccceecCCCCC--CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCC-CCC--CChHHHHHHHHHH
Q 014039 140 IADFGLARELSSMPP--YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPG--DSEIDQLYKVCCI 214 (432)
Q Consensus 140 L~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~p-F~~--~~~~d~~~~i~~~ 214 (432)
|+|||+|+.+..... ....+||..|+|||++. ...|+.++|||||||++|||++|..+ |.+ .....++.+++..
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999987754322 23467999999999985 56789999999999999999998754 432 2455677777766
Q ss_pred hCCCCCCCchh-hhhhhhhhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 215 LGAPDWTAFPE-ATNISRLISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 215 ~g~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
++....+ ++. ......++........+..+.... ..++.++.++|.+||++||.+||||.|+|+||||...
T Consensus 387 ~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 387 LSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 6544322 221 111111211111111111222222 1367789999999999999999999999999999864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=346.54 Aligned_cols=280 Identities=35% Similarity=0.604 Sum_probs=222.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCC------E
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENN------E 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~ 74 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+|+++|+.++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 58999999999999999999999999999999986543322 2234568999999999999999999986543 4
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+++||||+++++...+.. ..+++..++.++.||+.||+|||+.||+||||||+||+++++ .+||+|||++.....
T Consensus 95 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-- 170 (343)
T cd07880 95 FYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-- 170 (343)
T ss_pred EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc--
Confidence 689999997666655543 369999999999999999999999999999999999999854 999999999986543
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+.+..+...+++...+.++........ .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07880 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250 (343)
T ss_pred CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence 23445789999999998655668999999999999999999999999998888888887766655422111000 00001
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+...+..+..+.+.++.++.++|.+||+.||++|||+.++++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 11112222233334455678999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.47 Aligned_cols=276 Identities=40% Similarity=0.677 Sum_probs=222.4
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhc---CCCcccccceEEEeCCE-----
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKL---NHPNIIKLKEVVRENNE----- 74 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~----- 74 (432)
|++.+.||+|+||.||+|+++.+++.||+|+++....... .....+|+.+++++ +|+||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975433211 22344677777666 69999999999987665
Q ss_pred EEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
.+++|||+.+++.+.+.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||.+......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999988877766543 369999999999999999999999999999999999999865 9999999999887655
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
.......++..|+|||++. ...++.++|+||+||++|+|++|.++|.+.+..+...++....+.+....++.... .
T Consensus 161 ~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 236 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS---L 236 (287)
T ss_pred cccccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc---c
Confidence 4445566888999999985 55689999999999999999999999999999999988887776654333221110 0
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....++...........+..+.++.++|.+||+.||++||++.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 011122222333344445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=334.14 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=210.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||.|+||.||+|.+..+++.||+|.+.............+|+++++.++|+||+++++++.+....|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 58999999999999999999999999999999997654333444567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
++++.+..+.... ++++..++.++.||+.||.|||+.|++||||+|+||+++++ .++|+|||+++..... .......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 9875554444433 79999999999999999999999999999999999999865 9999999999887643 2334557
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
++..|+|||.+. +..++.++||||+||++|+|++|.+||.+.+.......+... .+
T Consensus 160 ~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~--------------------- 215 (274)
T cd06609 160 GTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NP--------------------- 215 (274)
T ss_pred CCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc--CC---------------------
Confidence 888999999985 455899999999999999999999999876654433332110 00
Q ss_pred cCCCCccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPN-ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+... ++.++.++|.+||..||++|||++++++||||..
T Consensus 216 ------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 216 ------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 011112 6788999999999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=332.45 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=204.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|++..+++.||+|++...... ......+|+.++++++||||+++++++...+..|+||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 5799999999999999999999999999999998754322 223456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~ 159 (432)
++++.+..+....+++++..+..++.|++.||.|||+.||+||||||+||+++++ .+||+|||++....... ......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI 167 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccc
Confidence 9976555544445579999999999999999999999999999999999999855 89999999998764322 234457
Q ss_pred CCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
++..|+|||.+. ....++.++|+||+||++|||++|.+||......+....+... .+
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~---------------------~~ 226 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS---------------------NF 226 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC---------------------CC
Confidence 889999999874 2345788999999999999999999998655433222111000 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~ 282 (432)
. +..+ .....++.++.+||++||+.||++|||++++++|+|
T Consensus 227 ~---~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 227 Q---PPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred C---CCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0 0000 011246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=346.58 Aligned_cols=281 Identities=39% Similarity=0.726 Sum_probs=227.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhc-CCCcccccceEEEe--CCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKL-NHPNIIKLKEVVRE--NNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--~~~~~l 77 (432)
++|++.+.||+|+||.||+|.+..+|+.+|+|++...... .......+|+.+++++ +||||+++++++.. ....|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 5799999999999999999999999999999998653322 2233456899999999 99999999998864 346899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--- 153 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--- 153 (432)
||||+++++...+... .+++..++.++.||+.||.|||+.||+||||||+||+++++ .+||+|||.+.......
T Consensus 87 v~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 87 VFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred EecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 9999998877766543 68999999999999999999999999999999999999865 99999999998654321
Q ss_pred ---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-h
Q 014039 154 ---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-I 229 (432)
Q Consensus 154 ---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~ 229 (432)
....+.++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+...++....+.+....+..... .
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 233467899999999987667789999999999999999999999999999999999888888776543321110 0
Q ss_pred h-hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 230 S-RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. .... ..............+.++.++.++|.+||+.||++|||+.++++||||+.
T Consensus 245 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 245 AATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0 0111 12222223334455668999999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.70 Aligned_cols=251 Identities=25% Similarity=0.446 Sum_probs=206.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe-CCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE-NNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E 80 (432)
+|++++.||+|++|.||+|.++.+++.||+|++...... .......+|++++++++|+|++++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 599999999999999999999999999999999754432 223345689999999999999999988764 456899999
Q ss_pred cCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCc
Q 014039 81 YMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYT 156 (432)
Q Consensus 81 ~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~ 156 (432)
|++++ +.+.+... ...+++.+++.++.||+.||++||+.|++||||||+||+++++ .++|+|||++...... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99864 55555543 4469999999999999999999999999999999999999865 8999999999876432 2233
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...+++.|+|||++. ...++.++|+||+||++++|++|..||.+.+.......+.. +..
T Consensus 161 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--~~~------------------ 219 (257)
T cd08223 161 TLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--GKL------------------ 219 (257)
T ss_pred cccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCC------------------
Confidence 456889999999885 56788999999999999999999999987766554444321 110
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
..+....+.++.+||.+||+.||++|||+.++++||||
T Consensus 220 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=332.58 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=205.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|++..+++.||+|+++.... .......+|+.+++.++||||+++++++...+..|+||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 478999999999999999999999999999999875432 2223456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
++++.+..+....+.+++..++.++.||+.||.|||+.|++|+||||+||+++.+ .+||+|||++...... .......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI 167 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccccc
Confidence 9976555555555589999999999999999999999999999999999999854 9999999999765432 2234567
Q ss_pred CCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
|+..|+|||++. ....++.++|+||+||++|+|++|.+||...........+.. +...
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~~------------------ 227 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNFQ------------------ 227 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCCC------------------
Confidence 899999999874 244588999999999999999999999876554333322211 0000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~ 282 (432)
+..... ...++..+.++|++||+.||++|||++++++|||
T Consensus 228 ----~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 228 ----PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 1146778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=354.51 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=208.7
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH-
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY- 87 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll- 87 (432)
+||+|+||+||-|+++.|....|||.+..+.. ...+-...||.+.++|.|.|||++++.+..++.+-|.||-++|+.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 69999999999999999999999999975432 2333456899999999999999999999999999999999997644
Q ss_pred HHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe--CCeEEEeeeccceecCCCCCC-ccccCCc
Q 014039 88 HIMRERQIPF--SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT--NDVLKIADFGLARELSSMPPY-TEYVSTR 162 (432)
Q Consensus 88 ~~~~~~~~~l--~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~--~~~lkL~DFG~a~~~~~~~~~-~~~~~t~ 162 (432)
..++.+-+++ .|..+..|..||++||.|||++.|||||||-+|+||+ .|.+||+|||.++.+..-.+. .++.||.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 5556666788 8889999999999999999999999999999999998 679999999999988665554 4578999
Q ss_pred cccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 163 WYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ-LYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 163 ~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
.|||||+|-++ ..|+.++|||||||.+.||.||+|||-....... +.+ ..+.+.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk------------------------VGmyKv 796 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK------------------------VGMYKV 796 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh------------------------hcceec
Confidence 99999999644 5799999999999999999999999965433211 111 111111
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
-++++..++.+++.||.+|+..||.+||+|.++|+.||++..
T Consensus 797 ----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 797 ----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 113445689999999999999999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=332.97 Aligned_cols=255 Identities=31% Similarity=0.435 Sum_probs=210.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
-|++++.||.|+||.||+|.+..++..+++|.+..... .......+|+++++.++||||+++++++...+..|+||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 47889999999999999999999999999999865432 23344568999999999999999999999999999999999
Q ss_pred CCcHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 83 EHNLYHIM-RERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 83 ~~~ll~~~-~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
+++.+..+ .....++++..++.++.||+.||.|||+.|++||||||+||+++.+ .+||+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 98766554 4445679999999999999999999999999999999999999854 9999999999765332 2234457
Q ss_pred CCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 160 STRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 160 ~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
++..|+|||++. ....++.++||||+||++|||++|.+||.+.+..+....+.... ++..
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~-------------- 228 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPTL-------------- 228 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--CCCC--------------
Confidence 899999999874 23457889999999999999999999998877666555543211 1000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....++.++.+||.+||+.||++||+++++++||||..
T Consensus 229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 229 -----------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 011246789999999999999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.36 Aligned_cols=261 Identities=27% Similarity=0.388 Sum_probs=211.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|.+..+++.||+|.+...... .......+|+++++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999998765321 22334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
||++|+.+..+....+.+++..++.++.|++.||.|||+.|++||||||+||+++++ .+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999986555555555689999999999999999999999999999999999999865 99999999986421100
Q ss_pred -----------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q 014039 154 -----------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTA 222 (432)
Q Consensus 154 -----------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~ 222 (432)
......++..|+|||.+. ...++.++|+|||||++|||++|..||.+....+....+.. +...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-- 235 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--DDIEW-- 235 (305)
T ss_pred ccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCC--
Confidence 011235788899999985 46689999999999999999999999988766544443321 11000
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCC
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT---ADQALQHPFFNVETWVP 290 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt---a~elL~Hp~f~~~~~~~ 290 (432)
+ .....++.++.++|++||+.||++||+ +.++|+||||...+|..
T Consensus 236 ---------------~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 236 ---------------P--------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ---------------C--------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 0 011246889999999999999999998 89999999998877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=326.56 Aligned_cols=255 Identities=31% Similarity=0.453 Sum_probs=209.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||.|+||.||+|.+..+++.+|+|++...... ......+|++++++++||||+++++++.+.+.+|++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 6899999999999999999999999999999999765432 344567899999999999999999999999999999999
Q ss_pred CCCcHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 82 MEHNLYHIMR-ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 82 ~~~~ll~~~~-~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
++++.+..+. .....+++..++.++.|++.||+|||++|++|+||||+||+++++ .+||+|||.+....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 9986555544 443689999999999999999999999999999999999999865 89999999997654322 23445
Q ss_pred cCCccccchhhhcCC--CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 159 VSTRWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~--~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.++..|+|||.+... ..++.++|+||+||++|+|++|.+||.+.+.......+...--.+..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 225 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK---------------- 225 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc----------------
Confidence 788899999988533 26889999999999999999999999887765544433211000000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~ 282 (432)
.......+.++.+||++||+.||.+|||+.+++.|+|
T Consensus 226 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ---------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0011245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.81 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=210.2
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... .......+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999999754322 2334467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCCCCcc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~~~~~ 157 (432)
+++ ++.+.+... ...+++..++.++.|++.||+|||++|++|+||||+||+++++ .+||+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 987 455555543 3458999999999999999999999999999999999999843 789999999988765544455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||.+. ...++.++|+||+||++++|++|..+|.+.+.......+... .
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~--~-------------------- 217 (256)
T cd08220 161 VVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG--T-------------------- 217 (256)
T ss_pred cccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc--C--------------------
Confidence 67899999999885 566889999999999999999999999887655444433210 0
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+...++.++.++|.+||+.||++|||+.|+++||||
T Consensus 218 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 -------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 011223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=336.11 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=209.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+..+.||+|+||.||++.+..+++.||+|++.............+|+.++.++. |+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 567888999999999999999999999999999986544444555678999999995 9999999999988889999999
Q ss_pred cCCCcHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 81 YMEHNLYHIMR----ERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 81 ~~~~~ll~~~~----~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
|+..++.+... .....+++..+..++.|++.||+|||+. |++||||||+||+++.+ .+||+|||+++.+.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 99876554332 2345799999999999999999999975 99999999999999855 899999999987654444
Q ss_pred CccccCCccccchhhhcCC--CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCCCCchhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG-APDWTAFPEATNISR 231 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~--~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g-~p~~~~~~~~~~~~~ 231 (432)
.....+++.|+|||++.+. ..++.++||||+||++|+|++|.+||..... ....+.+... .++..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~---------- 231 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL---------- 231 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC----------
Confidence 4455788999999998654 3789999999999999999999999976542 1111111111 11000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.......++.++.+||++||+.||++|||++++++||||+...
T Consensus 232 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 232 -------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred -------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 0011135788999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.12 Aligned_cols=254 Identities=27% Similarity=0.366 Sum_probs=200.3
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHH---hcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALR---KLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
.||+|+||.||+|.+..+++.+|+|.+.+.... .......+|..+++ ..+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998754322 11222334444433 3479999999999998899999999999
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCc
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR 162 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~ 162 (432)
++.+.......+.+++..++.++.||+.||.|||+.|++||||||+|||++++ .+||+|||++....... .....++.
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 76665555555679999999999999999999999999999999999999855 99999999997664432 23457899
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||.+..+..++.++||||+||++|+|++|..||.+....+... +......
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~------------------------- 213 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT------------------------- 213 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc-------------------------
Confidence 99999998656678999999999999999999999997654322111 1000000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWVP 290 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~~ 290 (432)
....+.+.++.++.++|++||+.||++|+ |+.|+++||||+..+|..
T Consensus 214 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 214 -VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred -CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 00112345788999999999999999999 699999999999877644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=328.66 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=206.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--------HHHHHHHHHHHHhcCCCcccccceEEEeCCE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--------ECMNLREVKALRKLNHPNIIKLKEVVRENNE 74 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 74 (432)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+........ .....+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 58899999999999999999999999999999875432211 1235689999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
.++||||++++.+..+....+.+++..++.++.||+.||.|||++|++||||+|+||+++++ .+||+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999876555555555679999999999999999999999999999999999999865 89999999998765211
Q ss_pred -------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 154 -------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 154 -------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
......++..|+|||.+. ...++.++|+||+||++|+|++|..||.+.........+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~--------- 227 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---N--------- 227 (267)
T ss_pred ccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---c---------
Confidence 112345788999999885 55688999999999999999999999987665444333211 0
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+...++.++.++|++||+.||.+||++.|+++||||
T Consensus 228 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 -----------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0011223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.05 Aligned_cols=257 Identities=31% Similarity=0.439 Sum_probs=210.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||.|+||.||+|.+..+++.+|+|.+..... .......+|++++++++|+||+++++++.+....|+||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 579999999999999999999999999999999875432 2333466899999999999999999999999999999999
Q ss_pred CCCcHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 82 MEHNLYHIM-RERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 82 ~~~~ll~~~-~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
++++.+..+ ...+..+++..++.++.|++.||.|||+.||+|+||||+||+++.+ .++|+|||++...... ......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccccee
Confidence 998655544 4445679999999999999999999999999999999999999854 9999999998765332 223345
Q ss_pred cCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 159 VSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 159 ~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.++..|+|||++. ....++.++|+||+||++|+|++|.+||.+.+.......+.. +.++.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~-------------- 227 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SEPPT-------------- 227 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CCCCC--------------
Confidence 7899999999975 234578899999999999999999999988766544433311 11100
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
......++.++.++|.+||+.||++||++.++++||||...
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 -----------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00113467899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.81 Aligned_cols=279 Identities=35% Similarity=0.600 Sum_probs=225.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe-CCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE-NNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~ 79 (432)
++|++++.||.|+||.||+|.+..+++.||+|++.+.... .......+|+++++.++||||+++++++.. ....|+||
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 5799999999999999999999999999999998653322 223345689999999999999999999865 56789999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||+++++...+.. .++++..+..++.||+.||+|||+.|++||||+|+||+++++ .+||+|||.+..... .....
T Consensus 90 e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~~ 165 (328)
T cd07856 90 ELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGY 165 (328)
T ss_pred ehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCCC
Confidence 9998877665543 368999999999999999999999999999999999999865 899999999976533 23456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh--hhhhhhcc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN--ISRLISIS 236 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~--~~~~~~~~ 236 (432)
.++..|+|||.+.+...++.++||||+||++|+|++|.++|++.........+...+|.++.+....... ..++. ..
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 244 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV-QS 244 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH-hh
Confidence 7888999999886657789999999999999999999999999988888888888888876443221100 00110 11
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+...+.+.....+.++.++.++|++||+.+|++|||+++++.||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 2222233334445678899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.76 Aligned_cols=254 Identities=26% Similarity=0.499 Sum_probs=209.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.+|++++.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++|+||+++++.+......|+||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 5899999999999999999999999999999999765433 234456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~ 159 (432)
++++.+..+... ..+++.++..++.||+.||.|||+.||+||||||+||+++.+ .+||+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 177 (296)
T cd06654 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177 (296)
T ss_pred cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCccc
Confidence 987655544443 368999999999999999999999999999999999999855 89999999987654322 223357
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
+++.|+|||.+. ...++.++||||+||++|+|++|.+||......+....+.. .+.+..
T Consensus 178 ~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~------------------- 236 (296)
T cd06654 178 GTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL------------------- 236 (296)
T ss_pred CCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCC-------------------
Confidence 889999999885 56678999999999999999999999988776554433211 111110
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....++..+.++|.+||+.||++|||+.|+++||||..
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred -------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 112346788999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=327.95 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=206.5
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
||.|+||.||+|.+..+++.||+|++.+.... .....+.+|+++++.++||||+++++++.+....|+||||++++.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999765432 2334467899999999999999999999999999999999987555
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCccccc
Q 014039 88 HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRA 166 (432)
Q Consensus 88 ~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y~a 166 (432)
..+..+...+++..++.++.||+.||+|||++|++|+||||+||+++++ .+||+|||++.............++..|+|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 5444444579999999999999999999999999999999999999865 999999999987765433445678999999
Q ss_pred hhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCC
Q 014039 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS--EIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244 (432)
Q Consensus 167 PE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~--~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (432)
||.+. ...++.++|+||+||++|+|++|..||.... ..+...++......+
T Consensus 161 PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------- 213 (262)
T cd05572 161 PEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL-------------------------- 213 (262)
T ss_pred hhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC--------------------------
Confidence 99874 5668999999999999999999999998776 333333322100000
Q ss_pred ccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 245 LSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 245 ~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
......+.++.++|.+||+.||++|++ +.|+++||||+..+|.
T Consensus 214 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 214 --EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred --CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 111234789999999999999999999 9999999999987774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.09 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=202.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe------CCEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE------NNEL 75 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~------~~~~ 75 (432)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ......+|+.+++++ +|+||+++++++.. ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 68999999999999999999999999999999875432 233456899999998 79999999999864 2468
Q ss_pred EEEEecCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 76 FFIFEYMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
|+||||++++ +.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++++ .+||+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999875 44444442 3468999999999999999999999999999999999999865 8999999999866432
Q ss_pred -CCCccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
.......++..|+|||++.. ...++.++||||+||++|||++|..||...........+.. .+
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~--------- 232 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP--------- 232 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC---------
Confidence 22344678999999999853 34588899999999999999999999976554433322210 00
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
........++.++.+||.+||+.||.+|||+.|+++||||
T Consensus 233 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ----------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000113467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=328.29 Aligned_cols=256 Identities=28% Similarity=0.426 Sum_probs=207.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+|+..+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999987543211 12345689999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCC--
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMP-- 153 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~-- 153 (432)
||||+.++.+..+..+.+++++..++.++.||+.||.|||++|++|+||||+||+++.+ .+||+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 99999986666555555689999999999999999999999999999999999999743 79999999997664321
Q ss_pred ---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 154 ---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 ---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
......++..|+|||++. ...++.++|+||+||++++|++|..||...........+.+..-.
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 226 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA------------- 226 (268)
T ss_pred CCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-------------
Confidence 122346788999999985 567899999999999999999999999765443332222111000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.....+....++++.++|.+||+.||++||++.|+++||||+
T Consensus 227 ------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000122235788999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=323.38 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=209.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... ........+|+++++.++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58999999999999999999999999999999875432 23344567899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~ 157 (432)
+++ ++.+.+... ...+++..++.++.||+.||.|||+.|++|+||||+||+++++ .+||+|||+++....... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 986 555555443 4579999999999999999999999999999999999999965 999999999987654322 234
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||++. ...++.++|+|||||++++|++|..||...+..+....+.. +.
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~-------------------- 217 (256)
T cd08529 161 IVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--GV-------------------- 217 (256)
T ss_pred cccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CC--------------------
Confidence 56889999999985 55689999999999999999999999988876554444321 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+...++.++.++|.+||+.+|++||++.++++|||+
T Consensus 218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 011112467889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=328.02 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=205.2
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-----hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-----WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+...... .....+.+|++++++++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 689999999999999999986 57889999998754321 112335689999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-----
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS----- 151 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~----- 151 (432)
||||++++.++.+..+..++++..++.++.||+.||+|||+.|++|+||+|+||+++++ .+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999886666555555579999999999999999999999999999999999999854 999999999876432
Q ss_pred --CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 152 --MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 152 --~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
........++..|+|||++. ...++.++|+||+||++|+|++|..||...+.......+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 226 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL------------ 226 (265)
T ss_pred cccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC------------
Confidence 11223456889999999984 566899999999999999999999999876654433332111000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+...++.++.++|++||+.+|++||++.|+++||||
T Consensus 227 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ---------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=324.46 Aligned_cols=253 Identities=31% Similarity=0.485 Sum_probs=209.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+|+..+.||+|+||.||+|.+..+++.|++|.+...... .....+.+|+++++.++|+||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999989999999998653311 1233466899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
+||++++.+..+..+...+++..++.++.||+.||+|||+.|++|+||+|+||+++.+ .+||+|||.+...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 9999875555554445579999999999999999999999999999999999999855 999999999987655443455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||.+.....++.++|+||+||++|+|++|.+||......+...++....
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------------------- 218 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK---------------------- 218 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc----------------------
Confidence 6789999999998544448999999999999999999999998776544443332100
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+...++.++.++|++||+.+|++||++.+++.|||+
T Consensus 219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0111234578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.83 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=209.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.... .......+|++++++++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 599999999999999999999999999999999754322 233456789999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+.++.+........++++..+..++.||++||.|||++|++|+||+|+||+++++ .++|+|||.+.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99876555555444689999999999999999999999999999999999999865 99999999998766544445567
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE--IDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~--~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
++..|+|||++. ...++.++|+||+||++|+|++|..||...+. .+...... ...
T Consensus 161 ~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~------------------- 217 (258)
T cd05578 161 GTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---ETA------------------- 217 (258)
T ss_pred CChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh---ccc-------------------
Confidence 888999999985 45589999999999999999999999987764 22222211 100
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA--DQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta--~elL~Hp~f 283 (432)
.....+..+.++.++|.+||+.||.+||++ .|+++||||
T Consensus 218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 -------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 011223567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.09 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=220.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
..|.++++||+|.|+.|.+|++.-++..||||.+.+...... .....+|+++|+.++|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 469999999999999999999999999999999987654433 3446799999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+.++.+.....+.+.+.+..++.++.|+++|++|||+++|||||||.+|||++.+ ++||+|||++..+.......++|
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~c 215 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFC 215 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccC
Confidence 99876555555555578889999999999999999999999999999999999988 79999999999998888889999
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
|++.|.|||++.+....+..+|+||+|+++|-|++|..||.|..-.....+.+ ...
T Consensus 216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl---------------------~gk--- 271 (596)
T KOG0586|consen 216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL---------------------RGK--- 271 (596)
T ss_pred CCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe---------------------eee---
Confidence 99999999999877878999999999999999999999999876433222110 000
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
-.+.-.++.++.++|+++|..+|.+|++++++++|.|...
T Consensus 272 ------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 272 ------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred ------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 0122347889999999999999999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.92 Aligned_cols=264 Identities=28% Similarity=0.417 Sum_probs=208.8
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCCc-
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEHN- 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~~- 85 (432)
+.||+|+||.|--+....+|..||+|++.+. ....+.+..||++++.+. +|+||++|+++|+++..+|||||-|.|+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4799999999999999999999999999877 445666778999999998 7999999999999999999999999875
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C---eEEEeeeccceecCCC--------C
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D---VLKIADFGLARELSSM--------P 153 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~---~lkL~DFG~a~~~~~~--------~ 153 (432)
++..|.+ ++.|+|.++.+++..|+.||+|||++||.|||+||+|||-.. + -+|||||.+......+ +
T Consensus 163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 5555554 458999999999999999999999999999999999999863 3 7999999988654321 2
Q ss_pred CCccccCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
...+.+|+..|||||+.. +...|+.+.|.||||+|+|-|++|.+||.|....|=-.. -|.+... .+...+
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd----rGe~Cr~--CQ~~LF 315 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD----RGEVCRV--CQNKLF 315 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc----CCCccHH--HHHHHH
Confidence 345678999999999863 456899999999999999999999999998654221000 0000000 000001
Q ss_pred hhhhh--ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 230 SRLIS--ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 230 ~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+.+ ..|| .+-|..+|.+++|+|+.+|..|+..|.+|.++++|||++..
T Consensus 316 esIQEGkYeFP-------dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 316 ESIQEGKYEFP-------DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHhccCCcCC-------hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 11111 1122 12345789999999999999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=344.69 Aligned_cols=242 Identities=31% Similarity=0.446 Sum_probs=203.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
+++++.||+|.||+||+|....+. .||+|.++..... ...+.+|+++|++|+|+|||++++++..+..+|||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 456789999999999999875543 5999999875432 2335699999999999999999999999889999999998
Q ss_pred -CcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccC
Q 014039 84 -HNLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 84 -~~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
|+|++.++. .+..+...+...|+.||++|++||+++++|||||-..||||+++ .+||+|||+|+...+ ..+....+
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~ 363 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEG 363 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCC
Confidence 568888886 56689999999999999999999999999999999999999977 999999999994443 33333333
Q ss_pred C---ccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 161 T---RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 161 t---~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
. ..|.|||.+. ...++.++||||||++|+||+| |+.|+++.+..+.+..+.+....|.
T Consensus 364 ~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~----------------- 425 (468)
T KOG0197|consen 364 GKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR----------------- 425 (468)
T ss_pred CCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-----------------
Confidence 3 3499999995 6679999999999999999998 9999999999998888754332222
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
++.+++++.+++..|+..+|++|||.+.+..
T Consensus 426 ------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 426 ------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred ------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 2478999999999999999999999886653
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=332.34 Aligned_cols=254 Identities=26% Similarity=0.501 Sum_probs=212.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||.|+||.||+|.+..+|+.||+|.+...... ......+|+.+++.++||||+++++++......|+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4699999999999999999999999999999998754332 233456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~~~ 159 (432)
+.++.+..+.... .+++.++..++.||+.||+|||+.|++||||||+||+++.+ .+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence 9887666655543 68999999999999999999999999999999999999854 999999999886544322 23356
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
++..|+|||.+. ...++.++|+||+||++|+|++|.+||.+.+..+....+.. .+.+..
T Consensus 177 ~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-~~~~~~------------------- 235 (296)
T cd06655 177 GTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL------------------- 235 (296)
T ss_pred CCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCccc-------------------
Confidence 888999999884 56688999999999999999999999998877665544321 111110
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+++.+.+||++||..||++|||+.+++.||||+.
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 236 -------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 112357789999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=330.18 Aligned_cols=255 Identities=28% Similarity=0.381 Sum_probs=202.4
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHH---HHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLRE---VKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
.||+|+||.||+|.+..+++.||+|.+.+..... .......| ++.++...||||+++++++.+.+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987643221 11112233 344555689999999999999999999999999
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCc
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR 162 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~ 162 (432)
|+.+.....+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.+ .+||+|||++....... ....+++.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence 87666665556689999999999999999999999999999999999999855 99999999997664432 23457899
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||++.++..++.++||||+||++|+|++|..||.+....+...........
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------- 214 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------------------------- 214 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-------------------------
Confidence 9999999876667899999999999999999999999876432221110000000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWVPY 291 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~~~ 291 (432)
...+....+.++.++|++||..||.+|+ ++.++++||||+..+|...
T Consensus 215 --~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 215 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 0012234688999999999999999999 9999999999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=326.48 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=201.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----hHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----WEECMNLREVKALRKLNHPNIIKLKEVVRE--NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (432)
.+|+..+.||+|+||.||+|.+..++..||+|++...... .......+|++++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999999999999999998643321 122345689999999999999999998865 3678
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-- 152 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-- 152 (432)
+++|||++++.+.......+.+++..++.++.||+.||+|||+.|++||||||+||+++.+ .+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999875444444444579999999999999999999999999999999999999865 8999999999765321
Q ss_pred --CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 153 --PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 153 --~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.......++..|+|||.+. ...++.++|+||+||++|||++|.+||...........+. ..+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~---~~~~~---------- 227 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTN---------- 227 (266)
T ss_pred cCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh---cCCCC----------
Confidence 1122345788999999985 5668999999999999999999999998765443333221 11110
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
..+...++..+.++| +||..+|++||+++|+++||||+
T Consensus 228 ---------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 ---------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 011234677889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.67 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=210.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|+.++.||.|+||.||.+++..+++.+++|++...... .......+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999998755432 2334466899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCcc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~ 157 (432)
+++ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++++ .+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 986 565555543 4568999999999999999999999999999999999999865 89999999998764432 2344
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+++.|+|||++. +..++.++|+||+||+++||++|..+|.+....+....+.. |...
T Consensus 161 ~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~------------------ 219 (256)
T cd08221 161 VVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT------------------ 219 (256)
T ss_pred cCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC------------------
Confidence 57899999999985 45588999999999999999999999988776665555421 1110
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.....++.++.++|.+||+.||++||++.|+|+|+|+
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 ---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 1113568899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=324.25 Aligned_cols=251 Identities=30% Similarity=0.476 Sum_probs=207.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||.||+|.+..+++.+|+|.+..... .....+|++++++++|+||+++++++.+....|+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 679999999999999999999999999999999875432 34567899999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
++++ +.+.+...+..+++..++.++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||++....... .....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 9875 545555556689999999999999999999999999999999999999855 89999999998765432 22334
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|+|||++. +..++.++||||+||++++|++|.+||...........+.. ...
T Consensus 160 ~~~~~y~~PE~~~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~------------------- 216 (256)
T cd06612 160 IGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPP------------------- 216 (256)
T ss_pred cCCccccCHHHHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCC-------------------
Confidence 5788999999984 55789999999999999999999999987655433222100 000
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
........++.++.++|.+||+.||++|||+.|+|+||||
T Consensus 217 -----~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 217 -----PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0001112467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.79 Aligned_cols=280 Identities=29% Similarity=0.476 Sum_probs=228.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC------CcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH------PNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~~~~~~ 75 (432)
.+|.+....|+|-|++|..|.+..-|..||||+|.+..... ..-++|+++|++|+. -|+++|+..|...+++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 47999999999999999999999989999999998765422 223589999999942 4899999999999999
Q ss_pred EEEEecCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCC
Q 014039 76 FFIFEYMEHNLYHIMRERQI--PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSS 151 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~--~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~ 151 (432)
|||||-+.-+|-+.+.+.+. .|....++.|++|++.||..|..+||+|.||||+||||+++ .+||||||.|.....
T Consensus 510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 99999999999998887643 58888999999999999999999999999999999999976 999999999988776
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
+ ..+.|..++.|+|||+|+ +-.|+..+|+||+||+||||.||+.+|+|....+.+...+.+-|..+...+....-...
T Consensus 590 n-eitPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 590 N-EITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred c-cccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 4 457788999999999997 66799999999999999999999999999999999999999999877554432221111
Q ss_pred hhh----cccc---------------ccCC-CCccccC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 232 LIS----ISYS---------------EILP-INLSDII----------PNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 232 ~~~----~~~~---------------~~~~-~~~~~~~----------~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
..+ +.+. ..+| ..+...+ +..-..+++||.+||..||++|.|+.++|.||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 111 1111 1111 0110000 11223578999999999999999999999999
Q ss_pred CCCC
Q 014039 282 FFNV 285 (432)
Q Consensus 282 ~f~~ 285 (432)
||.+
T Consensus 748 Fi~~ 751 (752)
T KOG0670|consen 748 FITE 751 (752)
T ss_pred cccC
Confidence 9974
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=333.58 Aligned_cols=255 Identities=27% Similarity=0.505 Sum_probs=209.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++|+||+++++++......|+||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 5799999999999999999999999999999999754432 234456899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~~~ 159 (432)
++++.+..+..+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ .+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 176 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCccc
Confidence 987655555443 368999999999999999999999999999999999999854 999999999987644322 23457
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
+++.|+|||.+. ...++.++|+||+||++|+|++|.+||.+.+....+..+. ..+.+..
T Consensus 177 ~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~------------------- 235 (297)
T cd06656 177 GTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPEL------------------- 235 (297)
T ss_pred CCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-cCCCCCC-------------------
Confidence 889999999885 5668899999999999999999999998766533322211 0111110
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....++..+.+||.+||+.||++||+++++++||||+..
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 236 -------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 1123467889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=326.93 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=201.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.++ ..+..||+|.++..........+.+|++++++++||||+++++++..++..|+|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46999999999999999999765 456789999998664444444567899999999999999999999999999999
Q ss_pred EecCCCcHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEHNLYHIM-RERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~-~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||++++.++.+ ......+++..++.++.||+.||+|||++|++||||||+|||++.+ .+|++|||.+..........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence 999998766654 4445579999999999999999999999999999999999999865 89999999876543221111
Q ss_pred --cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 --EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 --~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
...++..|+|||++. ...++.++||||+||++|||++ |.+||.+.+..+.+..+......
T Consensus 165 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 227 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---------------- 227 (266)
T ss_pred ccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----------------
Confidence 223457899999884 5678999999999999999775 99999888776655544211000
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.....++..+.+++.+||+.+|++||+++++++
T Consensus 228 -------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 -------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=327.85 Aligned_cols=253 Identities=30% Similarity=0.455 Sum_probs=208.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.............+|++++++++||||+++++++...+.+|+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 57999999999999999999999999999999998765444455567899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
+++ ++.+.+......+++..++.++.||+.||+|||+ .|++|+||||+||+++++ .+||+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcc
Confidence 995 4555554444689999999999999999999999 999999999999999865 999999999876543221 226
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS-----EIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~-----~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.++..|+|||.+. +..++.++||||+||++++|++|..||.... ..+....+. ..+.
T Consensus 160 ~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~-------------- 221 (265)
T cd06605 160 VGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV---NEPP-------------- 221 (265)
T ss_pred cCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh---cCCC--------------
Confidence 7888999999984 5678999999999999999999999997653 112222111 1100
Q ss_pred hccccccCCCCccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDIIPN-ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+... ++.++.++|.+||..||++|||+.|++.||||+.
T Consensus 222 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 222 ------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 011112 6889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=332.51 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=211.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+..+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4699999999999999999999999999999998643322 22234678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||+.+++.+.+....+.+++..+..++.||+.||.|||+.|++||||+|+||+++.+ .+||+|||++..... ....
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---~~~~ 171 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSF 171 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---CCCc
Confidence 999999988887666689999999999999999999999999999999999999855 999999999976543 2345
Q ss_pred cCCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 159 VSTRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 159 ~~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.++..|+|||++. ....++.++||||+||++|||++|.+||.+.+.......+.. +.++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----------------- 232 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSP----------------- 232 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCCC-----------------
Confidence 7888999999875 245688999999999999999999999988776554443311 0000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. .....++.++.++|.+||+.||++||++.+++.||||..
T Consensus 233 --~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 233 --T-------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --C-------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0 001235778999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=329.06 Aligned_cols=253 Identities=29% Similarity=0.348 Sum_probs=203.5
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
||+|+||+||+|.+..+|+.||+|.+...... .......+|+++|++++||||+++++++...+..|+||||++++.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998754321 2233346899999999999999999999999999999999987544
Q ss_pred H-HHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCccc
Q 014039 88 H-IMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWY 164 (432)
Q Consensus 88 ~-~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y 164 (432)
. .+.... ..+++..++.++.||+.||.|||+.|++||||+|+||+++++ .+||+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 4 444432 369999999999999999999999999999999999999865 9999999999876544444456778899
Q ss_pred cchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCC
Q 014039 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244 (432)
Q Consensus 165 ~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (432)
+|||.+. +..++.++||||+||++|+|++|..||.+.........+....- ..
T Consensus 161 ~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~~ 213 (277)
T cd05577 161 MAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--------------------------EM 213 (277)
T ss_pred CCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--------------------------cc
Confidence 9999985 44589999999999999999999999977654222111111000 00
Q ss_pred ccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 245 LSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 245 ~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.....+.+++++.++|++||+.||++|| ++.++++||||...+|.
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 0112235688999999999999999999 99999999999987764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.79 Aligned_cols=257 Identities=32% Similarity=0.476 Sum_probs=204.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch---------HHHHHHHHHHHHHhcCCCcccccceEEEeCC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW---------EECMNLREVKALRKLNHPNIIKLKEVVRENN 73 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 73 (432)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.++...... ....+.+|+++++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999999999999999886422110 1123457999999999999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
..++||||++++.+.....+.+.+++..++.++.||+.||.|||+.|++||||+|+||+++.+ .+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999876554444444689999999999999999999999999999999999999854 9999999999765421
Q ss_pred C---CCccccCCccccchhhhcCCC-CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 153 P---PYTEYVSTRWYRAPEVLLQSS-SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 153 ~---~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
. ......++..|+|||++.... .++.++|+||+||++++|++|..||..........++......+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 231 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP---------- 231 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC----------
Confidence 1 123346788999999986443 48999999999999999999999997665544333321100000
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.........++.++.++|.+||+.||++|||++++|+||||
T Consensus 232 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 --------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00011224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.96 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=203.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----hHHHHHHHHHHHHHhcCCCcccccceEEEe--CCE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----WEECMNLREVKALRKLNHPNIIKLKEVVRE--NNE 74 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~ 74 (432)
+++|++.+.||+|+||.||+|.+..+++.||||++...... .......+|+++++++.||||+++++++.+ ...
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 46899999999999999999999999999999998643211 122345689999999999999999998865 356
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM- 152 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~- 152 (432)
+|++|||++++.+.....+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.+ .+||+|||.+......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 88999999876555444444578999999999999999999999999999999999999865 9999999999765321
Q ss_pred ---CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 153 ---PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 153 ---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.......++..|+|||++. ...++.++|+|||||++|||++|..||.+........++ ...+..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~--------- 227 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPTN--------- 227 (265)
T ss_pred ccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCCCC---------
Confidence 1223456888999999985 566899999999999999999999999876544433322 111110
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
..+....+..+.++|++||. +|++||+++|+++|||++
T Consensus 228 ----------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 ----------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 01123567789999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=328.43 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=201.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEE------eCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVR------ENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~------~~~~ 74 (432)
..|++.+.||.|+||.||+|.+..+++.+|+|.+..... ......+|+.+++++ +|+||+++++++. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 468999999999999999999999999999999865432 223456799999998 7999999999884 2467
Q ss_pred EEEEEecCCCc-HHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 75 LFFIFEYMEHN-LYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
+|++|||++++ +.+.+.. ....+++..++.++.||+.||+|||+.||+|+||||+||+++++ .++|+|||++.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 89999999875 5444443 23468999999999999999999999999999999999999865 899999999876542
Q ss_pred C-CCCccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 152 M-PPYTEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 152 ~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
. .......+++.|+|||++.. ...++.++|+||+||++|||++|.+||...........+.. ...
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~------- 243 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP------- 243 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCC-------
Confidence 2 22344678999999998853 34678899999999999999999999977654333322110 000
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.......++.++.+||++||+.||.+|||+.|+|+||||
T Consensus 244 ------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 ------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000113568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.25 Aligned_cols=280 Identities=28% Similarity=0.466 Sum_probs=218.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-----C---CcccccceEEEe--
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-----H---PNIIKLKEVVRE-- 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-----h---pnIv~l~~~~~~-- 71 (432)
.||-+.++||+|.|++||+|.+..+.++||+|+.+..... ....+.||++|+++. | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY--tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY--TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH--HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4899999999999999999999999999999999854322 223468999999982 2 369999999964
Q ss_pred --CCEEEEEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-----------
Q 014039 72 --NNELFFIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND----------- 136 (432)
Q Consensus 72 --~~~~~lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~----------- 136 (432)
..++|||+|+++.+|+..|+.. -+.++...++.|++||+.||.|||.. ||+|.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a 235 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA 235 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence 5689999999999999999864 35699999999999999999999965 99999999999995311
Q ss_pred --------------------------------------------------------------------------------
Q 014039 137 -------------------------------------------------------------------------------- 136 (432)
Q Consensus 137 -------------------------------------------------------------------------------- 136 (432)
T Consensus 236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~ 315 (590)
T KOG1290|consen 236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST 315 (590)
T ss_pred ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence
Q ss_pred ----------------------------------------------------------------------------eEEE
Q 014039 137 ----------------------------------------------------------------------------VLKI 140 (432)
Q Consensus 137 ----------------------------------------------------------------------------~lkL 140 (432)
.|||
T Consensus 316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI 395 (590)
T KOG1290|consen 316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI 395 (590)
T ss_pred hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence 1345
Q ss_pred eeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC------ChHHHHHHHHHH
Q 014039 141 ADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD------SEIDQLYKVCCI 214 (432)
Q Consensus 141 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~------~~~d~~~~i~~~ 214 (432)
+|||.|+.+.. .++.-+.|+.|+|||+++ +..|++.+||||++|+++||+||..+|.-. .+.|.++.|+++
T Consensus 396 aDlGNACW~~k--hFT~DIQTRQYRapEVll-GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL 472 (590)
T KOG1290|consen 396 ADLGNACWVHK--HFTEDIQTRQYRAPEVLL-GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL 472 (590)
T ss_pred eeccchhhhhh--hhchhhhhhhccCcceee-cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence 55555544332 345567799999999998 567999999999999999999999999643 467899999999
Q ss_pred hCCCCCCCchhhhhhhhhhhc-----cccccCCCCccccC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014039 215 LGAPDWTAFPEATNISRLISI-----SYSEILPINLSDII-------PNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~ 282 (432)
+|..++.-.....-...+.+. .+...++-++.+++ ..-..++.|||.-||+.+|++|+||.++|+|||
T Consensus 473 LG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPw 552 (590)
T KOG1290|consen 473 LGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPW 552 (590)
T ss_pred HhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcc
Confidence 999887644322222222221 22233333333332 123456789999999999999999999999999
Q ss_pred CCCC
Q 014039 283 FNVE 286 (432)
Q Consensus 283 f~~~ 286 (432)
++..
T Consensus 553 Ln~~ 556 (590)
T KOG1290|consen 553 LNPV 556 (590)
T ss_pred ccCC
Confidence 9863
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.00 Aligned_cols=256 Identities=30% Similarity=0.414 Sum_probs=211.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|++|.||+|.+..+++.||+|++.............+|++++++++|+||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 57999999999999999999999999999999998665433445567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-ccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-TEY 158 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~-~~~ 158 (432)
++++.+..+......+++..++.++.||++||.|||+ .|++||||+|+||+++.+ .++|+|||.+......... ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9965555444444689999999999999999999999 999999999999999865 9999999999876543332 255
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE--IDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~--~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.++..|+|||.+. ...++.++|+|||||++|+|++|..||..... ..+..+. ......
T Consensus 161 ~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~----------------- 220 (264)
T cd06623 161 VGTVTYMSPERIQ-GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--ICDGPP----------------- 220 (264)
T ss_pred eecccccCHhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH--HhcCCC-----------------
Confidence 7889999999884 56789999999999999999999999987752 2221111 111100
Q ss_pred ccccCCCCccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 237 YSEILPINLSDIIPN-ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+... ++..+.++|.+||..+|++|||+.|+++||||+..
T Consensus 221 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 221 ---------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 011223 67899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.21 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=209.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC---CCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN---HPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~ 79 (432)
.|++++.||+|+||.||+|.+..+++.||+|.+.............+|+++++++. |||++++++++.++...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58999999999999999999999999999999876544334445668999999986 999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~ 157 (432)
||++++.+..+...+ .+++..+..++.||+.||.|||+.|++|+||+|+||+++++ .++|+|||.+....... ....
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 999886555555443 79999999999999999999999999999999999999854 99999999998765432 2334
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||.+.++..++.++|+||+||++|+|++|.+||.+.........+.. .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~-------------------- 217 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---S-------------------- 217 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---C--------------------
Confidence 57889999999986666789999999999999999999999987654332221100 0
Q ss_pred cccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
....+. ...+.++.++|.+||+.||++||++.|+++|+||++.
T Consensus 218 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 ------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred ------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 000111 1267899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=320.45 Aligned_cols=251 Identities=27% Similarity=0.508 Sum_probs=208.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|+||.||++.+..+|+.||+|++...... .......+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 699999999999999999999999999999998754322 2333467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~ 157 (432)
+.+ ++.+.+... ...+++..+..++.||+.||.|||++|++|+||+|+||+++.+ .++|+|||.+........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 976 566665543 3368999999999999999999999999999999999999854 999999999987644322 223
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||++. +..++.++|+||+||++++|++|..||......+...+++. +..
T Consensus 161 ~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~------------------- 218 (256)
T cd08218 161 CIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY------------------- 218 (256)
T ss_pred ccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC-------------------
Confidence 46788899999985 55688999999999999999999999987766655544421 110
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
......++.++.++|++||+.+|++||++.|+++||||
T Consensus 219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 --------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred --------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 01123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.69 Aligned_cols=253 Identities=30% Similarity=0.449 Sum_probs=203.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC------E
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN------E 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~------~ 74 (432)
++|++.+.||.|+||.||+|.++.+++.+++|++..... ....+.+|+.+++++ +|+||+++++++.+.. .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 689999999999999999999999999999999875543 234467899999999 7999999999986543 4
Q ss_pred EEEEEecCCCcHHH-HHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 75 LFFIFEYMEHNLYH-IMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 75 ~~lV~E~~~~~ll~-~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
+|+||||++++.+. .+.. .+..+++..++.++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 89999999975444 3332 24579999999999999999999999999999999999999855 9999999999765
Q ss_pred CCC-CCCccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 150 SSM-PPYTEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 150 ~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
... .......++..|+|||++.. ...++.++||||+||++|+|++|.+||.+........++... .+.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----- 236 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN--PPP----- 236 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc--CCC-----
Confidence 432 22234568899999998743 245788999999999999999999999876555444443210 000
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.+ ......+.++.+||++||+.||++|||+.|+++|||+
T Consensus 237 -------------------~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 -------------------TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -------------------CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00 0012367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=329.63 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=208.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|.+..+|..||+|++.............+|+++++.++||||+++++++...+.+|+||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57999999999999999999999999999999987654433444567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
++++.+..+....+.+++..++.++.|++.||.|||+ .|++||||||+||+++++ .++|+|||++...... ......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~ 163 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFV 163 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccc
Confidence 9987666665555689999999999999999999997 699999999999999865 9999999998765332 223457
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ----LYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~----~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
++..|+|||++. ...++.++||||+||++|+|++|..||......+. ...+.... .....
T Consensus 164 ~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~- 227 (284)
T cd06620 164 GTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL--------------QQIVQ- 227 (284)
T ss_pred cCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH--------------HHHhh-
Confidence 899999999985 45789999999999999999999999987654211 00000000 00000
Q ss_pred cccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. ....+. ..++.++.+||.+||+.||++|||+.|+++|+||..
T Consensus 228 ---~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 228 ---E----PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ---c----cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 000011 126778999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=327.24 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=209.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
.|+.++.||.|+||.||+|.+..++..||+|.+.............+|+++++.++|+||+++++++.+....|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 58889999999999999999999999999999876544444455678999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~ 160 (432)
+++.+..+... +++++..+..++.|++.||+|||+.|++|+||+|+||+++.+ .++|+|||++....... ......+
T Consensus 85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (277)
T cd06640 85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccC
Confidence 87554444443 368999999999999999999999999999999999999865 89999999997764432 2234568
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||++. ...++.++|+|||||++|||++|.+||.+.........+.. +.
T Consensus 164 ~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~----------------------- 217 (277)
T cd06640 164 TPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NN----------------------- 217 (277)
T ss_pred cccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CC-----------------------
Confidence 88999999885 55689999999999999999999999987665433322100 00
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+...++.++.++|.+||+.+|++||++.++++|+||...
T Consensus 218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 218 ----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 011223467789999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=332.11 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=208.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
.|.....||+|+||.||++.+..+++.||||++..... .......+|+.+++.++|+||+++++.+...+..|+||||+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 35567789999999999999999999999999865432 23334668999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~~ 160 (432)
+++.+..+...+ .+++..++.++.||+.||+|||++||+||||||+||+++++ .+||+|||++...... .......+
T Consensus 102 ~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 102 EGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence 987766665543 68999999999999999999999999999999999999865 9999999998755322 22344678
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||.+. ...++.++|+||+||++|||++|..||.+.+.......+...+... .
T Consensus 181 ~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~--- 238 (292)
T cd06658 181 TPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------V--- 238 (292)
T ss_pred CccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------------c---
Confidence 99999999884 5678999999999999999999999998877655444432111000 0
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......+..+.++|.+||+.||.+|||++|+++||||+.
T Consensus 239 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 239 ------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred ------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 001246778999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.00 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=201.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEE-----eCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVR-----ENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~-----~~~~~ 75 (432)
++|++++.||+|+||.||+|.+..+++.+|+|++..... ......+|+.+++.+ +||||+++++++. ..+..
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 689999999999999999999999999999998865322 223355799999999 7999999999873 34678
Q ss_pred EEEEecCCCcHHH-HHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 76 FFIFEYMEHNLYH-IMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 76 ~lV~E~~~~~ll~-~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
|+||||++++.+. .+. .....+++..++.++.||+.||.|||+.+++||||||+||+++.+ .+||+|||+++...
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 9999999875444 333 234578999999999999999999999999999999999999865 89999999998764
Q ss_pred CCC-CCccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 151 SMP-PYTEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 151 ~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
... ......+++.|+|||++.. ...++.++||||+||++|||++|..||.+......+..+.. +.+.
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~--~~~~------ 247 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR--NPPP------ 247 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc--cCCC------
Confidence 322 2234578999999998742 24578999999999999999999999987665443322210 0000
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
. .......+.++.+||.+||+.||++|||+.|+++|+||
T Consensus 248 ------------------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 ------------------T-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ------------------c-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 00112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=325.44 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=202.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeC-----CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVREN-----NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~-----~~~ 75 (432)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... ......+|+.+++++ +|||++++++++... +..
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 579999999999999999999999999999999875432 223345799999999 899999999998643 468
Q ss_pred EEEEecCCCcHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 76 FFIFEYMEHNLYHIMR----ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~----~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
|+||||++++.+..+. ..+..+++..++.++.|++.||.|||+.|++||||||+||+++++ .+||+|||++....
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 9999999875444333 234579999999999999999999999999999999999999865 89999999998654
Q ss_pred CCC-CCccccCCccccchhhhcCCC----CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 151 SMP-PYTEYVSTRWYRAPEVLLQSS----SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 151 ~~~-~~~~~~~t~~y~aPE~l~~~~----~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
... ......++..|+|||++.... .++.++||||+||++|||++|.+||........+.++.. .+...
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~---- 252 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPT---- 252 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCC----
Confidence 322 123456888999999875332 368899999999999999999999987766544443311 10000
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
+ ......+.++.+||.+||+.||++||++.|+++||||+
T Consensus 253 -------------------~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 -------------------L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------------C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 00124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.32 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=201.7
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHH-hcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALR-KLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
++.||.|+||.||+|.+..+|+.||+|.+.+..... .......|..++. ..+|+||+++++++...+.+|+||||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 367999999999999999999999999987543221 1122334555444 4589999999999999999999999998
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCc
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR 162 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~ 162 (432)
++.+..+....+.+++..++.++.||+.||.|||+.|++||||+|+||+++++ .+||+|||+++.... .....++.
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 86666665555689999999999999999999999999999999999999865 999999999976543 23456888
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+.......+.. +...+.
T Consensus 158 ~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--------------------- 213 (260)
T cd05611 158 DYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS--RRINWP--------------------- 213 (260)
T ss_pred CccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--cccCCC---------------------
Confidence 9999999864 4589999999999999999999999988766544443321 111000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTA---DQALQHPFFNVETW 288 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta---~elL~Hp~f~~~~~ 288 (432)
......++.++.++|.+||+.||++||++ +|+|+||||...+|
T Consensus 214 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 214 ---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 01123578899999999999999999955 79999999998777
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=319.25 Aligned_cols=248 Identities=31% Similarity=0.503 Sum_probs=206.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+|++.+.||+|+||.||++.+..+++.+|+|.++............+|+.+++.++|+||+++++.+.+++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 69999999999999999999999999999999875443334445668999999999999999999999999999999999
Q ss_pred CC-cHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 83 EH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 83 ~~-~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
++ ++.+.+.. ....+++..++.++.||+.||.|||++|++|+||||+||+++++ .++|+|||.+....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 86 56665554 34568999999999999999999999999999999999999855 99999999998764422 23446
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|+|||++. ...++.++|+||+||++|+|++|..||...+.......+.. +.
T Consensus 161 ~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~~--------------------- 216 (255)
T cd08219 161 VGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GS--------------------- 216 (255)
T ss_pred cCCccccCHHHHc-cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--CC---------------------
Confidence 7899999999884 56689999999999999999999999988766554444321 10
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+...++.++.+||++||+.||++|||+.++++-
T Consensus 217 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 ------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001123467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=319.73 Aligned_cols=251 Identities=31% Similarity=0.509 Sum_probs=206.2
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEE--eCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVR--ENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV~ 79 (432)
+|++++.||.|+||.||+|.+..+++.||+|.+...... .......+|+++++.++|+||+++++++. .....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 699999999999999999999999999999998754432 23344668999999999999999999875 346789999
Q ss_pred ecCCCc-HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 80 EYMEHN-LYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMH-----RNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 80 E~~~~~-ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH-----~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
||++++ +.+.+... ..++++..++.++.||+.||+||| +.+++|+||||+||+++++ .+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999864 55555432 467999999999999999999999 8999999999999999865 9999999999877
Q ss_pred CCCCC-CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 150 SSMPP-YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 150 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
..... .....++..|+|||++. ...++.++|+|||||++++|++|..||.+.+.......+.. +
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~------------ 225 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE--G------------ 225 (265)
T ss_pred cCCcccccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--C------------
Confidence 55433 34567899999999985 45688999999999999999999999988764433332211 0
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+....+.++.+++.+||+.+|++||++.++++|||+
T Consensus 226 ---------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ---------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0112223577899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=318.46 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=206.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... .....+.+|+++++.++|+||+++++++.+.+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999999865443 2344567899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-----
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----- 155 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~----- 155 (432)
++++.+..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9976666555555578999999999999999999999999999999999999865 9999999999876543221
Q ss_pred ccccCCccccchhhhcCCC--CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSS--SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~--~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
....++..|+|||++.... .++.++||||+||++++|++|..||.+..........+.. +..+ .+
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--~~---------- 227 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--PI---------- 227 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC--CC----------
Confidence 1346788999999985432 3789999999999999999999999765432222211110 1100 00
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.....++.++.+||.+||+.+|.+|||+.|++.|||+
T Consensus 228 -------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 228 -------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0112457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=327.36 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=209.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|++.+.||+|+||.||+|.+..+++.||+|.++............+|+.++.+. +|+||+++++++.+....|++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 368999999999999999999999999999999998654444444556788777666 5999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||+.+.+...+......+++..+..++.||+.||+|||+ .||+||||+|+||+++++ .+||+|||++..+........
T Consensus 94 e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (296)
T cd06618 94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR 173 (296)
T ss_pred eccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccC
Confidence 999887777776656689999999999999999999997 599999999999999855 999999999987654433444
Q ss_pred ccCCccccchhhhcCC---CCCCcccceechHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 158 YVSTRWYRAPEVLLQS---SSYSPAIDMWAVGAILAELFTLSPIFPGDSE-IDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~---~~~~~~~DiWSlG~il~ell~g~~pF~~~~~-~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..++..|+|||.+.+. ..++.++|||||||++|+|++|..||..... .+.+.++.. ....
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~------------- 237 (296)
T cd06618 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPP------------- 237 (296)
T ss_pred CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCCC-------------
Confidence 5678899999998533 3478899999999999999999999976433 223322211 1000
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. + .....++.++.+||.+||+.||++||++.++++||||..
T Consensus 238 -----~-----~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 238 -----S-----L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred -----C-----C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0 0 001136788999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=326.23 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=204.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.++||+|+||.||+|.++. .+..||+|.+.............+|+.+++.++||||+++++++.+....|
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 589999999999999999997652 355799999875543334445678999999999999999999999888999
Q ss_pred EEEecCCC-cHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 77 FIFEYMEH-NLYHIMRERQ---------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~---------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
+||||+++ +|.+.+.... ..++...+..++.||+.||.|||++|++||||||+||+++++ .+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 99999986 5555554321 235677889999999999999999999999999999999865 999999999
Q ss_pred ceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++....... .....++..|+|||.+. ...++.++|+||+||++|||++ |.+||.+....+....+.. -+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~~~--- 240 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-GGYL--- 240 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC---
Confidence 986543221 12224466799999885 5668999999999999999998 7899988776554443321 0000
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCCCC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ------HPFFNVETW 288 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~------Hp~f~~~~~ 288 (432)
......+.++.+++.+||+.||++|||+.++++ ||||+..+|
T Consensus 241 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 241 -------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 111245788999999999999999999999987 999998877
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=328.21 Aligned_cols=255 Identities=26% Similarity=0.311 Sum_probs=196.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC----------------CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCccccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE----------------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKL 65 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l 65 (432)
++|++.++||+|+||.||+|.+.. ++..||+|.+.............+|+++|++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 479999999999999999997532 3457999999865444444557799999999999999999
Q ss_pred ceEEEeCCEEEEEEecCCCc-HHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 014039 66 KEVVRENNELFFIFEYMEHN-LYHIMRERQ------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL 126 (432)
Q Consensus 66 ~~~~~~~~~~~lV~E~~~~~-ll~~~~~~~------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDl 126 (432)
++++.+.+..|+||||+.++ +.+.+.... ..+++..+..++.||+.||.|||+.||+||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl 164 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 99999989999999999865 544443321 24677889999999999999999999999999
Q ss_pred CCCceeEeCC-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh--CCCCCC
Q 014039 127 KPENLLVTND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT--LSPIFP 200 (432)
Q Consensus 127 kP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~--g~~pF~ 200 (432)
||+|||++.+ .+||+|||+++.+..... .....++..|+|||++. ...++.++|||||||++|||++ +..||.
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 9999999865 899999999986643221 22334577899999985 5568999999999999999986 567777
Q ss_pred CCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 201 GDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 201 ~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
+.+..+.+..+...+...... ......+.++.++.+||.+||+.||++|||+.|+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQGRQ----------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCHHHHHHHHHHHhhhcccc----------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 766554444332211100000 000112356789999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.21 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCC-----eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETY-----EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
+++|++.+.||+|+||.||+|.+...+ ..||+|.+.............+|+++++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357999999999999999999876555 679999987654433444567899999999999999999999988899
Q ss_pred EEEEecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eE
Q 014039 76 FFIFEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VL 138 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~l 138 (432)
|++|||+++ ++.+.+.... ..+++..+..++.||+.||.|||++|++||||||+||+++++ .+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999986 4555554321 458899999999999999999999999999999999999866 89
Q ss_pred EEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014039 139 KIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCI 214 (432)
Q Consensus 139 kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~ 214 (432)
||+|||+++...... ......+++.|+|||.+. ...++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~- 241 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS- 241 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999998654322 123345678899999885 5668999999999999999998 9999988776554444321
Q ss_pred hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 215 LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+. .......++.++.+|+++||+.||.+||++.|++++
T Consensus 242 -~~---------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 -RQ---------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -CC---------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 011224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.25 Aligned_cols=250 Identities=29% Similarity=0.410 Sum_probs=199.1
Q ss_pred CCeeEeeeEeecCceEEEEEEE-----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.++||+|+||.||+|.. ..++..||+|+++............+|+++|+.+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 3567789999997655444455567899999999 899999999999999999
Q ss_pred EEEEecCCC-cHHHHHHHcC------------------------------------------------------------
Q 014039 76 FFIFEYMEH-NLYHIMRERQ------------------------------------------------------------ 94 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~------------------------------------------------------------ 94 (432)
|+||||+++ +|.+.+....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999986 4555554321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC---c
Q 014039 95 --------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---T 156 (432)
Q Consensus 95 --------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~---~ 156 (432)
..+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 247888999999999999999999999999999999999866 8999999999876443211 1
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |.+||.+........+.+..--.
T Consensus 275 ~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------ 335 (375)
T cd05104 275 NARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR------------------ 335 (375)
T ss_pred CCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc------------------
Confidence 223456799999985 5678999999999999999998 89999876654444433211000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......+.++.+||.+||+.||++|||+.|+++.
T Consensus 336 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 ----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.68 Aligned_cols=249 Identities=28% Similarity=0.379 Sum_probs=197.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-----CeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-----YEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.+.||+|+||.||+|++..+ +..||+|+++............+|+++++.+ +|+||+++++++...+.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4699999999999999999986443 4579999998655444445567899999999 899999999999999999
Q ss_pred EEEEecCCCc-HHHHHHHc-------------------------------------------------------------
Q 014039 76 FFIFEYMEHN-LYHIMRER------------------------------------------------------------- 93 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~------------------------------------------------------------- 93 (432)
|+||||++++ +.+.+...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999864 55544321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC---ccccCC
Q 014039 94 --------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVST 161 (432)
Q Consensus 94 --------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~---~~~~~t 161 (432)
..++++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+++........ ....++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 1247889999999999999999999999999999999999865 8999999999876432211 122345
Q ss_pred ccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 162 ~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
..|+|||++. ...++.++||||+||++|||++ |..||.+.........++.....+
T Consensus 278 ~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~---------------------- 334 (374)
T cd05106 278 VKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM---------------------- 334 (374)
T ss_pred cceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc----------------------
Confidence 6799999985 5678999999999999999997 999998765444333332110000
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++++.++|.+||+.||++|||+.++++
T Consensus 335 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=319.56 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=204.4
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
||.|+||.||+|.+..+|+.+|+|.+...... .......+|++++++++||||+++++.+......|++|||+.++.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999998754332 2333466899999999999999999999999999999999987555
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---------CCcc
Q 014039 88 HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP---------PYTE 157 (432)
Q Consensus 88 ~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~---------~~~~ 157 (432)
..+..+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 4444444479999999999999999999999999999999999999865 99999999987654321 2234
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..++..|+|||.+. ...++.++|+|||||++|+|++|..||......+....+.. +...+..
T Consensus 161 ~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--------------- 222 (265)
T cd05579 161 IVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPE--------------- 222 (265)
T ss_pred cccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCc---------------
Confidence 56788999999985 44588999999999999999999999988776554444321 1111100
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA---DQALQHPFFNVETW 288 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta---~elL~Hp~f~~~~~ 288 (432)
....+.++.++|++||+.+|++|||+ .++|+||||+..+|
T Consensus 223 -----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 223 -----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred -----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 01247899999999999999999999 99999999998877
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=327.15 Aligned_cols=253 Identities=30% Similarity=0.438 Sum_probs=211.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|...++||+|+||.||+|++..+++.||+|++...... .....+.+|+++++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 366778999999999999999999999999998754322 222345689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+.+++++.+.....++++..+..++.||+.||.|||+.|++|+||+|+||+++++ .+||+|||++..... .....
T Consensus 102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~ 178 (313)
T cd06633 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV 178 (313)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcc
Confidence 99999988887767789999999999999999999999999999999999999864 899999999865332 33567
Q ss_pred CCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
++..|+|||++. ....++.++||||+||++|+|++|.+||.+.+.......+... ..+.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~------------------ 239 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT------------------ 239 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCC------------------
Confidence 889999999974 2356888999999999999999999999887766655544211 0000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....++..+.+||.+||+++|.+||++.+++.||||...
T Consensus 240 ---------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 240 ---------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0112456789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=347.80 Aligned_cols=251 Identities=30% Similarity=0.410 Sum_probs=212.3
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc---cchHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEEEE
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF---YFWEECMNLREVKALRKLNHPNIIKLKEVVREN--NELFFIF 79 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 79 (432)
+...+||+|+|-+||+|.|..+|..||.-.++... ......++..|+.+|+.|+||||+++|++|.+. ..+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999999999999987665322 122345677999999999999999999999764 4578999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeccCCCCceeEeCC--eEEEeeeccceecCCCCCC
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN--GYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~--givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~~~ 155 (432)
|.|.+|.++.++++.+.+....++.|++||++||.|||++ -|+|||||.+||+|+.+ .|||+|+|+|...... ..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-HA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-cc
Confidence 9999888888888777899999999999999999999999 49999999999999854 9999999999877653 34
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+|||.|||||++ ...|+..+||||||++|+||+|+..||.......|+++-+. -|
T Consensus 202 ksvIGTPEFMAPEmY--EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SG------------------- 259 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMY--EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SG------------------- 259 (632)
T ss_pred ceeccCccccChHHH--hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cC-------------------
Confidence 558999999999998 47899999999999999999999999999888888776431 11
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
++|..+.++ -.+++++||.+||.. .++|+||.|+|+||||+..
T Consensus 260 ----iKP~sl~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 260 ----IKPAALSKV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----CCHHHhhcc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 222222222 367999999999999 9999999999999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=341.49 Aligned_cols=259 Identities=29% Similarity=0.517 Sum_probs=211.7
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHH--HHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM--NLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~--~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
|..++.||-|+||+|.+++..+|...||+|.+.+.......+. ...|..||..-+.+-||+||..|++++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 7788999999999999999999999999999987654433322 35799999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCC--------
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSS-------- 151 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~-------- 151 (432)
++|+ +..++++. +-|.|..++.|+..+..|+++.|+.|+|||||||+|||||. |.+||+|||+|..+.-
T Consensus 711 IPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9875 55555554 47999999999999999999999999999999999999995 5999999999964420
Q ss_pred -C--------CC--------------------------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCC
Q 014039 152 -M--------PP--------------------------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS 196 (432)
Q Consensus 152 -~--------~~--------------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~ 196 (432)
+ ++ ..+.+||+.|+|||++. ...|+...|+||.|+|||||+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHhhCC
Confidence 0 00 13467999999999996 677999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---
Q 014039 197 PIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT--- 273 (432)
Q Consensus 197 ~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt--- 273 (432)
+||-.....+.-.+++ .| .+++.+.+ -.++|.++.++|.+++. +++.|..
T Consensus 869 ~pf~~~tp~~tq~kv~------nw---------~~~l~~~~-----------~~~ls~e~~~li~kLc~-sad~RLGkng 921 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVI------NW---------RNFLHIPY-----------QGNLSKEALDLIQKLCC-SADSRLGKNG 921 (1034)
T ss_pred CCccCCCCCcceeeee------eh---------hhcccccc-----------ccccCHHHHHHHHHHhc-Chhhhhcccc
Confidence 9998877654433332 11 11111111 14689999999999776 8889975
Q ss_pred HHHHhcCCCCCCCCCCCC
Q 014039 274 ADQALQHPFFNVETWVPY 291 (432)
Q Consensus 274 a~elL~Hp~f~~~~~~~~ 291 (432)
++|+..||||+.++|...
T Consensus 922 ~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 922 ADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred hhhhhcCccccccchHhh
Confidence 788999999999999763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=324.38 Aligned_cols=241 Identities=20% Similarity=0.235 Sum_probs=195.6
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEe----CCEEEEEEec
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRE----NNELFFIFEY 81 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 81 (432)
..||+|++|.||+|.. +|+.||+|++........ .....+|+++|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999976 788999999976433221 2335689999999999999999999876 4578999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
++++.+..+....+.+++.....++.|++.||.|||+. +++||||||+|||++++ .+||+|||+++..... ....+
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccccc
Confidence 99875555555556799999999999999999999984 99999999999999865 9999999999866442 23457
Q ss_pred CCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
++..|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+....+...-..+
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------- 241 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------------- 241 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------------
Confidence 88999999998532 578999999999999999999999999887655544442211110
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+...++.++.+||.+||+.||++|||+.|+++.
T Consensus 242 --------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 242 --------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred --------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0112468899999999999999999999999863
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=327.66 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=206.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
.|+.++.||+|+||.||+|.+..+++.||+|.+.............+|++++++++||||+++++++..++..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 47788999999999999999999999999999875543334445678999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-CccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~~~~ 160 (432)
+++.+..+... +.+++..++.++.||+.||.|||++|++|+||+|+||+++++ .+||+|||++........ .....+
T Consensus 85 ~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (277)
T cd06642 85 GGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163 (277)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccC
Confidence 97655555443 468999999999999999999999999999999999999855 999999999987654321 223467
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||.+. ...++.++|+||+||++|||++|.+||...........+.. +.
T Consensus 164 ~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~----------------------- 217 (277)
T cd06642 164 TPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NS----------------------- 217 (277)
T ss_pred cccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc--CC-----------------------
Confidence 88999999985 56789999999999999999999999976554332221100 00
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+...++.++.++|.+||+.+|++||++.++++||||..
T Consensus 218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 ----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00112246788999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.76 Aligned_cols=259 Identities=29% Similarity=0.379 Sum_probs=203.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~ 79 (432)
++|+..+.||.|++|.||+|.+..+++.+|+|.+.............+|++++++++||||+++++++.+ .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5799999999999999999999999999999999865443344556789999999999999999998854 45789999
Q ss_pred ecCCCc-HHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 80 EYMEHN-LYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 80 E~~~~~-ll~~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
||++++ |.+.+. .....+++..+..++.||+.||+|||+.|++|+||+|+||+++++ .++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 999875 433332 334568999999999999999999999999999999999999855 99999999987654322
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE-----IDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~-----~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.....++..|+|||.+. ...++.++||||+||++|+|++|..||..... .+....+ .......
T Consensus 160 ~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~------- 227 (287)
T cd06621 160 AGTFTGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPE------- 227 (287)
T ss_pred cccccCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchh-------
Confidence 23456788999999884 66789999999999999999999999987632 1111111 1100000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
... . ...-...++++.+||.+||+.||++|||+.|+++||||..
T Consensus 228 -------~~~----~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 228 -------LKD----E-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -------hcc----C-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000 0 0000124678999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=328.52 Aligned_cols=250 Identities=28% Similarity=0.356 Sum_probs=197.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeE--EEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEI--VAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++.+.||+|+||.||+|.+..++.. +|+|.++..........+.+|+.++.++ +|+||+++++++.+.+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999998887754 5777776443333444566899999999 89999999999999999999
Q ss_pred EEecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEE
Q 014039 78 IFEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKI 140 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL 140 (432)
||||+++ ++.+.+...+ ..+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 9999986 4555554321 258899999999999999999999999999999999999855 9999
Q ss_pred eeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014039 141 ADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPD 219 (432)
Q Consensus 141 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~ 219 (432)
+|||+++.............+..|+|||.+. ...++.++|||||||++|||++ |.+||.+.+..+....+. ....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~ 241 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---QGYR 241 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh---cCCc
Confidence 9999996543221122223456799999884 5668999999999999999998 999998776554433321 0000
Q ss_pred CCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 220 WTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. .....++.++.+||.+||+.+|++||++++++++
T Consensus 242 ~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 242 L--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0112467889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.84 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=208.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
|+....||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++||||+++++++..++..|+||||++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 55567899999999999999999999999998654322 23446689999999999999999999999999999999999
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccCC
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVST 161 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~t 161 (432)
++.+..+... ..+++..++.++.||+.||.|||+.|++||||||+||+++.+ .+||+|||++....... .....+++
T Consensus 102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 180 (297)
T cd06659 102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180 (297)
T ss_pred CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence 8666655544 368999999999999999999999999999999999999855 99999999997654322 23456789
Q ss_pred ccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 162 ~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
..|+|||++. ...++.++|+||+||++|||++|.+||...+..+.+..+. +.+.
T Consensus 181 ~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~---------------------- 234 (297)
T cd06659 181 PYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DSPP---------------------- 234 (297)
T ss_pred ccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---ccCC----------------------
Confidence 9999999985 5568999999999999999999999998877655544331 1100
Q ss_pred CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 242 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
........++.++.++|++||+.+|++||++.++++||||...
T Consensus 235 --~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 235 --PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred --CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 0001123567889999999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=315.96 Aligned_cols=251 Identities=33% Similarity=0.581 Sum_probs=206.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|+||.||+|.++.+|..+|+|.+...... .......+|+++++.++|+||+++++.+.+.+..|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 699999999999999999999999999999998754322 2233456899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCCC-Cc
Q 014039 82 MEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPP-YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~~-~~ 156 (432)
+++ ++.+.+.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++++ .+||+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 986 4555554432 358999999999999999999999999999999999999865 579999999977654322 22
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...+++.|+|||++. ...++.++|+||+||+++||++|..||.+.+..+....+.. +
T Consensus 161 ~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-------------------- 217 (257)
T cd08225 161 TCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ--G-------------------- 217 (257)
T ss_pred ccCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--c--------------------
Confidence 346888999999884 45688999999999999999999999987665444333211 0
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+.+..+.++.++|++||+.+|++|||+.|+++||||
T Consensus 218 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 218 -------YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0111234567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=320.93 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=207.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
|++++.||+|+||.||+|.+..+++.||+|.+...........+.+|++++++++||||+++++++.++...|+||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 78899999999999999999999999999998754433344456789999999999999999999999999999999999
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-CccccCC
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTEYVST 161 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~~~~t 161 (432)
++.+..+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++++ .++|+|||++........ .....++
T Consensus 86 ~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (277)
T cd06641 86 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 164 (277)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCC
Confidence 7655555444 368999999999999999999999999999999999999865 899999999976644221 2335688
Q ss_pred ccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 162 ~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
..|+|||.+. ...++.++|+||+||++|+|++|..||...........+.. +.
T Consensus 165 ~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~------------------------ 217 (277)
T cd06641 165 PFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--NN------------------------ 217 (277)
T ss_pred ccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--CC------------------------
Confidence 8999999884 55678899999999999999999999987655433333210 00
Q ss_pred CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 242 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+...++.++.++|.+||+.+|++||++.++++||||..
T Consensus 218 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 218 ---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 01122356789999999999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.51 Aligned_cols=252 Identities=30% Similarity=0.432 Sum_probs=210.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|+..+.||+|+||.||+|++..++..+|+|++...... .....+.+|+++++.++|+|++++++++.+....|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 478889999999999999999999999999998754322 222346689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+.|++++.+.....++++..+..++.||+.||.|||+.|++||||+|+||+++++ .+||+|||++..... .....
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~ 182 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFV 182 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccccc
Confidence 99999888877666789999999999999999999999999999999999999864 999999999875543 23457
Q ss_pred CCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
+++.|+|||.+. ....++.++||||+||++|||++|.+||.+.........+..... +.
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~------------------ 243 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PT------------------ 243 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-CC------------------
Confidence 889999999974 235688999999999999999999999987766555554432111 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......+..+.+||.+||+.+|.+||++.++++|+|+..
T Consensus 244 ---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 ---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 001245778999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=326.19 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=209.7
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.|+..+.||+|+||.||+|+++.+++.+|+|.+..... ........+|+++++.++|+|++++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 57788999999999999999999999999999864321 1223345689999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+.+++.+.+.....++++..++.++.|++.||.|||+.|++||||||+||+++.+ .+||+|||++..... .....
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~~~ 172 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFV 172 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---ccccc
Confidence 99998888877666679999999999999999999999999999999999999865 899999999976543 23457
Q ss_pred CCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
+++.|+|||.+.+ ...++.++|||||||++|+|++|..||.+....+....+... ..+.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~------------------ 233 (308)
T cd06634 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPA------------------ 233 (308)
T ss_pred CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-CCCC------------------
Confidence 8899999999752 345788999999999999999999999776655544433210 0000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......+.++.+||++||+.+|++||++.++++|||+..
T Consensus 234 ---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 001246778999999999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=316.40 Aligned_cols=250 Identities=29% Similarity=0.397 Sum_probs=199.5
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
....||+|+||.||+|.+..++..||+|.+..... .......+|+++++.++|+||+++++++...+..++|+||++++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 45689999999999999999999999999875542 23334678999999999999999999999999999999999865
Q ss_pred -HHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCCC-CCcccc
Q 014039 86 -LYHIMRERQIPF--SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSMP-PYTEYV 159 (432)
Q Consensus 86 -ll~~~~~~~~~l--~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~-~~~~~~ 159 (432)
|.+.+......+ ++..+..++.||+.||+|||++||+||||||+||+++. +.+||+|||.+....... ......
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 170 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence 555555544456 88899999999999999999999999999999999974 489999999997654322 233456
Q ss_pred CCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
++..|+|||.+.+. ..++.++|+||+||++|+|++|.+||................+
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------- 228 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK---------------------- 228 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc----------------------
Confidence 78899999998543 3488999999999999999999999975432211110000000
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+...++.++.+|+++||+.+|++|||+.|+++||||
T Consensus 229 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 -----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0011234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.19 Aligned_cols=246 Identities=28% Similarity=0.378 Sum_probs=199.2
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccce-EEE---e---CCE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKE-VVR---E---NNE 74 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~-~~~---~---~~~ 74 (432)
++++.++|.+|+|+.||+|++...|..||+|++... .........+|+++|++| +|+|||.+++ ... . .-+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 578999999999999999999999899999999766 344455567999999999 5999999999 332 1 236
Q ss_pred EEEEEecCC-CcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 75 LFFIFEYME-HNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 75 ~~lV~E~~~-~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
++|+||||. |+|.+.+..+ ...|+|.++.+|++|+++|+.+||... |||||||-|||||+.+ ..||||||.|...
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 789999999 5899988754 335999999999999999999999997 9999999999999855 8999999999754
Q ss_pred CCCCCC----------ccccCCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014039 150 SSMPPY----------TEYVSTRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA 217 (432)
Q Consensus 150 ~~~~~~----------~~~~~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~ 217 (432)
...... ....-|+.|||||+|. ++...+.|+|||+|||+||.|+....||.+......+.-
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng------- 269 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG------- 269 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec-------
Confidence 332211 1234689999999973 566789999999999999999999999976543211110
Q ss_pred CCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
.+.+| .+++++..+.+||+.||+.||++||++.|++++-
T Consensus 270 ----------------~Y~~P---------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 270 ----------------NYSFP---------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ----------------cccCC---------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 01121 1257889999999999999999999999998773
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=319.89 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=195.3
Q ss_pred CCeeEeeeE--eecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEEL--GDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~I--G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.+ |+|+||.||++.++.+++.+|+|.+....... .|+.....+ +|+||+++++++...+..|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 467777776 99999999999999999999999987543211 133333323 799999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCCCC
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~~~ 155 (432)
|||+++ +|.+.+... +.+++..++.++.||+.||.|||+.|++||||||+||+++.+ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999986 455555444 489999999999999999999999999999999999999854 7999999999876532
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ-LYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~-~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....++..|+|||++. ...++.++|+||+||++|+|++|..||......+. ...+.....
T Consensus 164 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 224 (267)
T PHA03390 164 SCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ------------------ 224 (267)
T ss_pred ccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc------------------
Confidence 2346889999999985 56689999999999999999999999986543221 111111000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-ADQALQHPFFNV 285 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-a~elL~Hp~f~~ 285 (432)
......+.+++.+.+||.+||+.||.+|++ ++|+|+||||++
T Consensus 225 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 225 ---------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ---------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 001122368899999999999999999996 599999999963
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=306.66 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=199.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE-----eCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR-----ENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-----~~~~~~ 76 (432)
+||++.+.||+|+|+-||++++..+++.||+|++.... ..+....++|++..++++||||++++++.. .....|
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 58999999999999999999999999999999998766 345556789999999999999999988752 245689
Q ss_pred EEEecCC-CcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeC-CeEEEeeeccceec
Q 014039 77 FIFEYME-HNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTN-DVLKIADFGLAREL 149 (432)
Q Consensus 77 lV~E~~~-~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~-~~lkL~DFG~a~~~ 149 (432)
|+++|+. |++++.+.. ++..++|.++..|+.+|++||.+||+.. ++||||||.|||+.+ +..+|.|||+++..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999986 668887764 3447999999999999999999999998 999999999999986 69999999999754
Q ss_pred CCC----------CCCccccCCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014039 150 SSM----------PPYTEYVSTRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA 217 (432)
Q Consensus 150 ~~~----------~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~ 217 (432)
.-. +...+.-+|..|+|||++.- ....+.++|||||||++|+|+.|..||...-. .-|.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------~GgS 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------QGGS 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------cCCe
Confidence 321 11234568999999999842 23468899999999999999999999943211 0000
Q ss_pred CCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.. +. ..+ -.+.+|.. ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus 251 la---LA--v~n---~q~s~P~~---------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LA---LA--VQN---AQISIPNS---------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EE---Ee--eec---cccccCCC---------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00 00 000 00111111 2378899999999999999999999999976
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.03 Aligned_cols=251 Identities=32% Similarity=0.522 Sum_probs=208.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+|++.+.||+|++|.||+|.+..+++.+++|++..... .......+|++++++++|+||+++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 58999999999999999999999999999999976543 23445678999999999999999999999999999999999
Q ss_pred CCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccC
Q 014039 83 EHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 83 ~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
+++ +.+.+......+++..+..++.|++.||++||+.|++||||+|+||+++++ .++|+|||.+.............+
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 964 555444443679999999999999999999999999999999999999855 999999999987765433455678
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+.. ...+...
T Consensus 160 ~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~------------------- 218 (253)
T cd05122 160 TPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLR------------------- 218 (253)
T ss_pred CCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcC-------------------
Confidence 89999999985 45589999999999999999999999987765444433221 1100000
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~ 282 (432)
....++.++.++|++||+.||++|||+.|+++|||
T Consensus 219 -------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 219 -------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.64 Aligned_cols=251 Identities=32% Similarity=0.532 Sum_probs=209.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|+||.||+|.+..+++.||+|++...... .......+|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 699999999999999999999999999999999765432 3344567899999999999999999999988999999999
Q ss_pred CCC-cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-CC
Q 014039 82 MEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP-PY 155 (432)
Q Consensus 82 ~~~-~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~-~~ 155 (432)
+++ ++.+.+... ...+++..+..++.||+.||.|||+.|++|+||+|+||++++ +.++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 987 455555543 368999999999999999999999999999999999999996 499999999998765432 23
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+++.|+|||.+. ...++.++|+||+|+++++|++|..||...+..+....+... .
T Consensus 161 ~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----~---------------- 219 (258)
T cd08215 161 KTVVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG----Q---------------- 219 (258)
T ss_pred cceeeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC----C----------------
Confidence 3457889999999874 556899999999999999999999999877654433332110 0
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+...++.++.++|.+||..+|++|||+.|+|+||||
T Consensus 220 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011122567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=357.28 Aligned_cols=147 Identities=27% Similarity=0.435 Sum_probs=128.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|+++++||+|+||.||+|.+..+++.||||++....... ......+|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 689999999999999999999999999999999997543221 223456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
|||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999875444444445579999999999999999999999999999999999999854 99999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.45 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=205.7
Q ss_pred CeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc---hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF---WEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
+|++.+.||.|+||.||+|.+. .+|+.||+|.+...... .......+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999998753321 1223346799999999 699999999999999999
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP- 153 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~- 153 (432)
|+||||++++.+.........+++..+..++.||+.||.|||+.|++||||||+|||++++ .+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999975444444444579999999999999999999999999999999999999855 99999999998764422
Q ss_pred -CCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 154 -PYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 154 -~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
......++..|+|||.+... ..++.++||||+||++|+|++|..||...........+.......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------------- 227 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------------
Confidence 22345689999999998643 357889999999999999999999997543322222221111000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETW 288 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~ 288 (432)
.....+.++..+.+++++||+.||++|+ +++++++||||+..+|
T Consensus 228 -------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 228 -------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0011234678899999999999999997 8999999999998776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.33 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=206.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+|...+.||+|++|.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 45667899999999999999999999999999864332 23334678999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~ 160 (432)
.++.+..+... +++++..++.++.||+.||+|||++|++||||+|+||+++.+ .++|+|||.+....... ......+
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence 87655554444 469999999999999999999999999999999999999865 99999999887654322 2234568
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
+..|+|||.+. ...++.++|+||+||++|+|++|..||.+.+.......+... .++.
T Consensus 178 ~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~-------------------- 234 (285)
T cd06648 178 TPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPPK-------------------- 234 (285)
T ss_pred CccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCCC--------------------
Confidence 99999999985 456899999999999999999999999887665554443211 0000
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......++.++.+||.+||+.+|++|||+.++++||||+.
T Consensus 235 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 235 -----LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred -----CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 0011236789999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.26 Aligned_cols=249 Identities=26% Similarity=0.318 Sum_probs=198.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe--EEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE--IVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|....++. .+++|.++............+|+++++++ +||||+++++++.+.+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999887765 46888877433333344567899999999 799999999999998999999
Q ss_pred EecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEe
Q 014039 79 FEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIA 141 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~ 141 (432)
|||+++ ++.+.+.... ..+++..++.++.||+.||+|||++|++||||||+|||++++ .+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999986 5555554321 258899999999999999999999999999999999999865 99999
Q ss_pred eeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCC
Q 014039 142 DFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDW 220 (432)
Q Consensus 142 DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~ 220 (432)
|||++..............+..|+|||.+. ...++.++|||||||++|||++ |..||.+....+...++.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~---- 236 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---- 236 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----
Confidence 999986543221122223345699999885 5668999999999999999997 9999988776555444321100
Q ss_pred CCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.+||.+||+.||.+|||++++++.
T Consensus 237 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 -------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=323.35 Aligned_cols=255 Identities=27% Similarity=0.512 Sum_probs=208.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||++.+..++..||+|.+..... .......+|+.+++.++||||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 579999999999999999999999999999999864332 2234467899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~~~ 159 (432)
++++.+..+..+. .+++..+..++.||+.||.|||++|++||||||+||+++.+ .+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 176 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccccc
Confidence 9876555554433 58899999999999999999999999999999999999865 899999999876544322 23346
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
+++.|+|||.+. ...++.++|+||+||++|+|++|..||...+..++...+. ..+.+..
T Consensus 177 ~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~------------------- 235 (293)
T cd06647 177 GTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPEL------------------- 235 (293)
T ss_pred CChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-cCCCCCC-------------------
Confidence 888999999885 4568999999999999999999999998876654433221 0111110
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....++.++.++|++||+.+|++||++.+++.|+||+..
T Consensus 236 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 236 -------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 0112467789999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=325.84 Aligned_cols=276 Identities=21% Similarity=0.227 Sum_probs=199.4
Q ss_pred eeEeec--CceEEEEEEEcCCCeEEEEEEecccc-cchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDG--TCGCVYKAFNVETYEIVAVKKMKRKF-YFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
.+||+| ++|.||.+++..+++.||+|++.... .......+.+|+++++.++|+||+++++++.+.+..|++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 344544 55677778778899999999998652 233344567899999999999999999999999999999999997
Q ss_pred cHHHHH-HHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC-------
Q 014039 85 NLYHIM-RER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP------- 154 (432)
Q Consensus 85 ~ll~~~-~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~------- 154 (432)
+.+..+ ... ...+++..++.+++||+.||+|||++||+||||||+||+++. +.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 655444 432 346899999999999999999999999999999999999985 5999999999875532211
Q ss_pred -CccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCC----chhhhh
Q 014039 155 -YTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTA----FPEATN 228 (432)
Q Consensus 155 -~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~----~~~~~~ 228 (432)
.....++..|+|||++... ..|+.++||||+||+++||++|..||..........+. ..|...... .+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCccccccCchhhhcC
Confidence 1234567789999998543 46899999999999999999999999887655443322 222211100 000000
Q ss_pred hhhh--hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 229 ISRL--ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 229 ~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.... .....+.............++.++.+||.+||++||++|||+.|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0000 00000000000001112235678999999999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.53 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=198.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeE----EEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEI----VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
.+|++.+.||+|+||.||+|++..+++. ||+|+++............+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 5799999999999999999998766654 8999987544333444567899999999999999999998764 4679
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~ 155 (432)
|+||+.+ ++.+.+......+++..+..++.||+.||+|||+.||+||||||+|||++++ .+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 9999975 5667776666678999999999999999999999999999999999999865 9999999999876543222
Q ss_pred ---ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 ---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
....++..|+|||++. ...++.++|||||||++|||++ |..||.+....+. ..++.....+
T Consensus 166 ~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~------------- 230 (316)
T cd05108 166 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL------------- 230 (316)
T ss_pred eeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC-------------
Confidence 1223456799999985 5678999999999999999997 9999987665432 2222110000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+.++.++.+++.+||+.||++||++.+++.+
T Consensus 231 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0113467789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=320.27 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=200.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|.+.+.||+|+||.||+|.+.. +++.||+|+++............+|+++|+.++|+||+++++++......|
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 578999999999999999998753 467899999976544334456778999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEe
Q 014039 77 FIFEYMEHN-LYHIMRER-------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIA 141 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~-------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~ 141 (432)
+||||++++ +.+.+... ...+++..+..++.||+.||.|||++|++||||||+||+++.+ .+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 999999875 44444432 1348899999999999999999999999999999999999855 99999
Q ss_pred eeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014039 142 DFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGA 217 (432)
Q Consensus 142 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~ 217 (432)
|||+++...... ......++..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.. |.
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~--~~ 241 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ--GR 241 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC
Confidence 999997653321 123345677899999985 5678999999999999999998 9999987766554444321 10
Q ss_pred CCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......++.++.++|.+||+.||++||++.|+++
T Consensus 242 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 ---------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred ---------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=331.34 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=196.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe-CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE-NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (432)
++|++.+.||+|+||.||+|... .+++.||+|++.............+|+++++++ +|+||+++++++.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 48999999999999999999743 356789999997654433444567899999999 89999999998754 567
Q ss_pred EEEEEecCCCc-HHHHHHHc------------------------------------------------------------
Q 014039 75 LFFIFEYMEHN-LYHIMRER------------------------------------------------------------ 93 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~------------------------------------------------------------ 93 (432)
++++|||++++ +.+.+...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999875 44444321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---CccccCCccccchhh
Q 014039 94 QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEV 169 (432)
Q Consensus 94 ~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~ 169 (432)
..++++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.+..... .....++..|+|||+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 1268899999999999999999999999999999999999854 999999999987643221 223345678999999
Q ss_pred hcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCcccc
Q 014039 170 LLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDI 248 (432)
Q Consensus 170 l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (432)
+. ...++.++||||+||++|||++ |..||.+....+.+...+.. +.. ...
T Consensus 247 ~~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~ 297 (337)
T cd05054 247 IF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTR---------------------------MRA 297 (337)
T ss_pred hc-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cCC---------------------------CCC
Confidence 85 5678999999999999999997 99999876544433332210 000 001
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 249 IPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 249 ~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....++++.+++.+||+.+|++||++.|+++|
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.76 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=200.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEE----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFN----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
+++|++.+.||+|+||.||+|.. ..++..+|+|.+...........+.+|+++++.++||||+++++++......|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 46899999999999999999985 34667899999986544333345678999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eE
Q 014039 77 FIFEYMEHN-LYHIMRER----------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VL 138 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~----------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~l 138 (432)
+||||++++ +.+.+..+ ...+++..+..++.||+.||.|||++|++||||||+|||++++ .+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 999999865 54444322 1247889999999999999999999999999999999999866 89
Q ss_pred EEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014039 139 KIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCI 214 (432)
Q Consensus 139 kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~ 214 (432)
||+|||+++...... ......++..|+|||.+. ...++.++|+|||||++|||++ |.+||.+.+..+....+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 241 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK- 241 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999998754322 122334567799999885 4568999999999999999998 9999988766444333311
Q ss_pred hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 215 LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+. .......++.++.+++.+||+.||.+||++.+++++
T Consensus 242 -~~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 -RQ---------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -CC---------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00 001223567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.33 Aligned_cols=241 Identities=30% Similarity=0.484 Sum_probs=204.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+.|++...+|.|+|+.|..+.+..++...++|++.+.... ..+|+.++... +||||+++.+++.+..+.|+|||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5689999999999999999999999999999999876321 23677666665 89999999999999999999999
Q ss_pred cCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe--CCeEEEeeeccceecCCCCCCcc
Q 014039 81 YMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT--NDVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~--~~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
.+.|+ +++.++... .+ ..++..|+.||+.|+.|||++|++||||||+|||++ .+.++|||||.++.+... ...
T Consensus 397 ~l~g~ell~ri~~~~-~~-~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-EF-CSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDT 472 (612)
T ss_pred hccccHHHHHHHhcc-hh-HHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcc
Confidence 99876 555554433 33 377888999999999999999999999999999994 448999999999987764 445
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.|-|..|.|||++. ...|+.++||||||++||+|++|+.||...... ..|...++.+.+.
T Consensus 473 p~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s---------------- 532 (612)
T KOG0603|consen 473 PALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS---------------- 532 (612)
T ss_pred cchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----------------
Confidence 57789999999985 788999999999999999999999999877665 3344444544432
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
..+|.+|+|||++||+.||.+|+++.+++.||||
T Consensus 533 ------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 2689999999999999999999999999999999
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=313.62 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=203.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc----cchHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF----YFWEECMNLREVKALRKLNHPNIIKLKEVVREN--NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 75 (432)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885321 112233456899999999999999999998653 568
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-- 152 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-- 152 (432)
+++|||++++.+.......+.+++..++.++.||+.||.|||+.|++|+||||+||+++++ .++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999875444444444469999999999999999999999999999999999999865 8999999999865321
Q ss_pred --CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 153 --PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 153 --~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.......++..|+|||++. ...++.++|+|||||++|+|++|.+||.+........++ ...+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCCC---------
Confidence 1223456889999999885 456889999999999999999999999876554443332 2221111
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.+...++.++.++|.+||+ +|.+||++.++++|||.
T Consensus 229 ----------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ----------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1234678899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=329.69 Aligned_cols=279 Identities=23% Similarity=0.242 Sum_probs=200.2
Q ss_pred eeeEeec--CceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 7 LEELGDG--TCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 7 ~~~IG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
...||+| +||+||+|++..+|+.||+|++........ ...+.+|+.+++.++||||+++++++...+..|+||||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3467777 999999999999999999999875543332 3445689999999999999999999999999999999998
Q ss_pred C-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CC----
Q 014039 84 H-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PY---- 155 (432)
Q Consensus 84 ~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~---- 155 (432)
+ ++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||+++++ .+|++||+.+....... ..
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 6 455444433 2358999999999999999999999999999999999999855 99999998654332110 00
Q ss_pred ---ccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 ---TEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ---~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
....++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+.........++......++...........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 012345669999998644 4578999999999999999999999988776555444332111111110000000000
Q ss_pred hhh-----------cccc-----ccCCCCc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LIS-----------ISYS-----EILPINL-SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~~-----------~~~~-----~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
... .... ......+ ......++.++.+||++||++||++|||++|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000 0000 0000000 0112346788999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.42 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=203.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc----cchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF----YFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+|.+.+.||+|+||.||+|.+..++..+++|.++... .........+|+++++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998887777777765422 122333456799999999999999999999888899999
Q ss_pred EecCCCcHHH-HHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCC
Q 014039 79 FEYMEHNLYH-IMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPP 154 (432)
Q Consensus 79 ~E~~~~~ll~-~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~ 154 (432)
|||++++.+. .+.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++++.+||+|||.++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence 9999875444 3432 34579999999999999999999999999999999999999988999999999977643322
Q ss_pred -CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 -YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 -~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+++.|+|||.+. ...++.++|+||+|+++++|++|..+|.+.........+.. +..
T Consensus 161 ~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~--------------- 222 (260)
T cd08222 161 LATTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT--------------- 222 (260)
T ss_pred cccCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC---------------
Confidence 23456788999999874 56688899999999999999999999987665444433321 110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
......++.++.++|.+||+.||++||++.|+++||||
T Consensus 223 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 ------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.89 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=193.6
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc-H
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-L 86 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~-l 86 (432)
+.||+|+||.||+|.++.+++.+|+|.+.............+|+++++.++||||+++++++...+..|+||||+.++ +
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999999999999999999876544344455678999999999999999999999999999999999875 5
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc---cccCCc
Q 014039 87 YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT---EYVSTR 162 (432)
Q Consensus 87 l~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~---~~~~t~ 162 (432)
.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+.......... ....+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 55555555579999999999999999999999999999999999999865 89999999997654321110 112235
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
.|+|||.+. ...++.++||||+||++|||++ |.+||......+....+.... .
T Consensus 161 ~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~------------------------ 214 (252)
T cd05084 161 KWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-R------------------------ 214 (252)
T ss_pred eecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-C------------------------
Confidence 699999884 5668999999999999999997 899997665544333221100 0
Q ss_pred CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 242 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......+.++.+|+.+||+.||++|||+.++++
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 ----LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.56 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=197.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.+.||+|+||.||+|.+. .++..||+|++.............+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 57999999999999999999864 3457799999865433333444678999999999999999999999889999
Q ss_pred EEEecCCCc-HHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 77 FIFEYMEHN-LYHIMRERQ---------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~~---------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
+||||++++ +.+.+.... ..++...+..++.|++.||+|||+.|++||||||+||+++++ .+||+|||+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 999999865 444444322 235778899999999999999999999999999999999965 999999999
Q ss_pred ceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++....... .....++..|+|||.+. ...++.++|||||||++|||++ |.+||.+....+....+... +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~---- 239 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GL---- 239 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc----
Confidence 976533211 11234567899999985 5668999999999999999998 78999887665444333210 00
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.++|.+||+.||++|||+.|++++
T Consensus 240 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 ------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.93 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=199.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.............+|+.+++.++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 469999999999999999999987 788899999875544334445678999999999999999999998888899
Q ss_pred EEEecCCCc-HHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeecc
Q 014039 77 FIFEYMEHN-LYHIMRERQ------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~~------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~ 145 (432)
+||||+.++ +.+.+...+ ..+++..+..++.||+.||.|||++|++||||||+||+++.+ .+||+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 999999765 555554432 258999999999999999999999999999999999999743 699999999
Q ss_pred ceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++....... ......+..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.. .+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~--- 240 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRL--- 240 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCcC---
Confidence 987633211 11223356799999985 5668999999999999999996 9999988766544332211 0000
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+++.+||+.||++|||+.++++|
T Consensus 241 -------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 -------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=308.57 Aligned_cols=251 Identities=33% Similarity=0.554 Sum_probs=209.7
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... .......+|++++++++|+|++++++++.+.+..|++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 699999999999999999999999999999999865432 2333467899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~~~ 159 (432)
++++.+..+......+++..++.++.|++.||.|||+.|++||||||+||+++++ .++|+|||.+........ .....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 9876555554444689999999999999999999999999999999999999864 999999999987754332 23456
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
++..|+|||... ...++.++|+||+|+++++|++|..||...........+.. +
T Consensus 161 ~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~----------------------- 214 (254)
T cd06627 161 GTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--D----------------------- 214 (254)
T ss_pred cchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--c-----------------------
Confidence 888999999885 44589999999999999999999999987665444333210 0
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+.+.++.++.++|.+||+.+|++|||+.+++.||||
T Consensus 215 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 ----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0011224568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=314.05 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=200.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++.+.||+|+||.||+|++..+++.||||++..... ........+|+++++.++||||+++++++.+.+..++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 4789999999999999999999999999999998864322 22233456899999999999999999999999999999
Q ss_pred EecCCCcHHH-HHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 79 FEYMEHNLYH-IMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 79 ~E~~~~~ll~-~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
|||++++.+. .+. .....+++..+..++.||+.||.|||++|++|+||||+||+++.+ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999975444 332 234468999999999999999999999999999999999999855 89999999998765422
Q ss_pred C-CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 154 P-YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 154 ~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
. .....++..|+|||.+. ...++.++|+||+||++|||++|..||...... ......+...+.++.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL----------- 228 (267)
T ss_pred HHHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-----------
Confidence 1 22356888999999885 556889999999999999999999998665321 122221111111110
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.++.++|.+||+.+|++||++.++++.
T Consensus 229 ----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 ----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=308.86 Aligned_cols=252 Identities=35% Similarity=0.513 Sum_probs=207.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN--NELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 79 (432)
+|...+.||+|++|.||+|.+..+++.|++|++...... .......+|++++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 589999999999999999999999999999998755432 2334567899999999999999999999887 8899999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---C
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---Y 155 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~ 155 (432)
||++++.+..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++++ .+||+|||.+........ .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 999765555444444489999999999999999999999999999999999999964 999999999988766543 3
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....++..|+|||.+. ...++.++|+|||||++++|++|..||...... .....+ ..
T Consensus 161 ~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~------------------ 218 (260)
T cd06606 161 GSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI---GS------------------ 218 (260)
T ss_pred cCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc---cc------------------
Confidence 4567888999999884 455899999999999999999999999877621 111111 00
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
......+....+.++.++|.+||+.||++||++.|++.||||
T Consensus 219 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 001112233568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.33 Aligned_cols=250 Identities=32% Similarity=0.515 Sum_probs=206.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+|+++++++. |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5899999999999999999999999999999998764322 22334568999999998 99999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--- 153 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--- 153 (432)
||++.+ ++.+.+.. .+.+++..++.++.||+.||.|||+.|++|+||||+||+++.+ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999965 45555544 4579999999999999999999999999999999999999864 99999999997654322
Q ss_pred ------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014039 154 ------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL 215 (432)
Q Consensus 154 ------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~ 215 (432)
......++..|+|||++. ...++.++|+|||||++++|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 112345788999999885 4568999999999999999999999998877544433332100
Q ss_pred CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 014039 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFF 283 (432)
Q Consensus 216 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta----~elL~Hp~f 283 (432)
..+...+++.+.+||.+||+.||++||++ +|+++||||
T Consensus 239 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 ------------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ------------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 01123457899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=318.92 Aligned_cols=249 Identities=30% Similarity=0.431 Sum_probs=199.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-----CeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-----YEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.+.||+|+||.||+|.+... ...+|+|.+.............+|+++++++ +|+||+++++++...+.+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 5799999999999999999987643 3789999988654433444567899999999 899999999999999999
Q ss_pred EEEEecCCCc-HHHHHHH---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eE
Q 014039 76 FFIFEYMEHN-LYHIMRE---------------RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VL 138 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~---------------~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~l 138 (432)
+++|||+.++ +...+.. ..+.+++..+..++.||+.||+|||+.||+||||||+||+++++ .+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence 9999999865 4444432 13468999999999999999999999999999999999999855 99
Q ss_pred EEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014039 139 KIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCI 214 (432)
Q Consensus 139 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~ 214 (432)
||+|||+++.+..... .....++..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+..
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 249 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE- 249 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc-
Confidence 9999999987654221 12223456799999874 6678999999999999999997 9999988766554433211
Q ss_pred hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 215 LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+. ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 250 -~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 250 -GY---------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -CC---------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00 001123567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=310.11 Aligned_cols=250 Identities=32% Similarity=0.513 Sum_probs=207.2
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.++||+|+||.||++++..+++.+|+|++...... .......+|+++++.++|+||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 699999999999999999999999999999999764432 2333456899999999999999999999998999999999
Q ss_pred CCCc-HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 82 MEHN-LYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 82 ~~~~-ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
+++. +...+.. ....+++..++.++.||+.||+|||+.|++|+||+|.||+++++ .+||+|||+++..... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 9875 4444433 13568999999999999999999999999999999999999865 9999999999876554 333
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...++..|+|||.+. ...++.++|+||+|+++++|++|..||...+.......+.. +
T Consensus 160 ~~~~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-------------------- 216 (256)
T cd08530 160 TQIGTPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--G-------------------- 216 (256)
T ss_pred cccCCccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C--------------------
Confidence 456889999999984 56788999999999999999999999988765443333211 0
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
....+....+.+++++|.+||+.+|++|||+.|+++||++
T Consensus 217 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 -------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0111223567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=313.54 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=201.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.+..+ ...||+|++.............+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5799999999999999999988644 4579999987655444445567899999999999999999999999999999
Q ss_pred EecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCC
Q 014039 79 FEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
|||++++ +.+.+....+.+++..+..++.|++.||.|||++||+||||||+||+++++ .+||+|||+++..... ...
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999875 555555555679999999999999999999999999999999999999865 8999999999877521 111
Q ss_pred c--cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 156 T--EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 156 ~--~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
. ...++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+......
T Consensus 164 ~~~~~~~~~~y~~Pe~~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 227 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL--------------- 227 (266)
T ss_pred eccCCCCCccccChhhhc-cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 1 123456799999884 5678999999999999999998 99999776655444333211000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+|+.+||+.+|++||++.|++++
T Consensus 228 --------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 --------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=312.87 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=200.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.+|.+.+.||+|+||.||+|.++.+++.||+|++..... ......+|+++++.++|+||+++++++...+.+++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 368999999999999999999999999999999875432 334467899999999999999999999998999999999
Q ss_pred CCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--c
Q 014039 82 MEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--T 156 (432)
Q Consensus 82 ~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~ 156 (432)
++++ +.+.+... ...+++..++.++.|++.||+|||++|++||||||+||+++++ .+||+|||++......... .
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9865 55555443 3468999999999999999999999999999999999999865 9999999999876542211 1
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+..|+|||.+. ...++.++|||||||++|||++ |..||++....+....+....
T Consensus 164 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------- 222 (263)
T cd05052 164 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------------- 222 (263)
T ss_pred CCCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------------------
Confidence 122356799999884 5678999999999999999998 999998876544433321100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. ......++.++.++|.+||+.||++|||+.++++.
T Consensus 223 --~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 --R-------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred --C-------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0 01123578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=318.69 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=200.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC----------------eEEEEEEecccccchHHHHHHHHHHHHHhcCCCccccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY----------------EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKL 65 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l 65 (432)
++|++++.||+|+||.||+|.+..++ ..||+|.+.............+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 58999999999999999999876544 55899998865544444556789999999999999999
Q ss_pred ceEEEeCCEEEEEEecCCCc-HHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe
Q 014039 66 KEVVRENNELFFIFEYMEHN-LYHIMRERQ----------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT 134 (432)
Q Consensus 66 ~~~~~~~~~~~lV~E~~~~~-ll~~~~~~~----------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~ 134 (432)
++++..++..+++||++.++ +.+.+.... ..+++..++.++.||+.||+|||+.|++||||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence 99999989999999999865 444444332 2689999999999999999999999999999999999998
Q ss_pred CC-eEEEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh--CCCCCCCCChHHHH
Q 014039 135 ND-VLKIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT--LSPIFPGDSEIDQL 208 (432)
Q Consensus 135 ~~-~lkL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~--g~~pF~~~~~~d~~ 208 (432)
++ .++|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |..||......+.+
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 65 99999999998654322 123345677899999985 4568999999999999999998 67788766655544
Q ss_pred HHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 209 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+......... .........++.++.++|.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 244 ENAGHFFRDDGR----------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred HHHHhccccccc----------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 443221111000 00001123567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.42 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=199.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
.+|++.+.||+|+||.||+|.+.. .+..||+|++...........+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 568899999999999999998754 357899999986543333344668999999999999999999999989999
Q ss_pred EEEecCCCcHHH-HHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 77 FIFEYMEHNLYH-IMRER---------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 77 lV~E~~~~~ll~-~~~~~---------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
+++||+.++.+. .+..+ ...+++..++.++.|++.||.|||++|++||||||+||+++++ .+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 999999865444 44211 2358889999999999999999999999999999999999865 899
Q ss_pred EeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014039 140 IADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCIL 215 (432)
Q Consensus 140 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~ 215 (432)
|+|||+++....... .....+++.|+|||.+. ...++.++||||+||++|||++ |.+||.+....+....+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986643222 12334567899999985 4568999999999999999998 889998877665554442110
Q ss_pred CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 216 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+...++.++.+|+.+||+.+|++||++.+++..
T Consensus 244 -----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 -----------------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred -----------------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 001223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=311.58 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=198.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|..+. +..+|+|.+...... .....+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 579999999999999999998754 457999988754332 23456799999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--cc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--TE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~~ 157 (432)
+++ ++.+.+......+++..++.++.||+.||+|||+.|++||||||+||+++++ .+||+|||.++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 986 4655555555578999999999999999999999999999999999999865 8999999999865432211 12
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||++. ...++.++|+||+||++|||++ |++||.+.+..+....+.. +...
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~--~~~~----------------- 220 (256)
T cd05114 161 AKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR--GFRL----------------- 220 (256)
T ss_pred CCCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--CCCC-----------------
Confidence 23456799999984 5678999999999999999999 9999988876665555422 1000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.+++.+||+.||++||+++++++
T Consensus 221 ----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001124678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=315.47 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=198.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe----EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE----IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|+++++||+|+||+||+|.+..+++ .||+|++.............+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 579999999999999999999877776 4899998765544445556789999999999999999998865 45789
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~ 155 (432)
++||+++ ++.+.+....+.+++..+..++.||+.||+|||++|++||||||+|||++++ .+||+|||+++........
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 9999975 6766666656679999999999999999999999999999999999999754 8999999999876543221
Q ss_pred ---ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 ---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
....++..|+|||.+. ...++.++|||||||++|||++ |.+||.+....+....+ .....+
T Consensus 166 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~------------- 230 (279)
T cd05109 166 YHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERL------------- 230 (279)
T ss_pred eecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC-------------
Confidence 1223456799999985 5668999999999999999998 99999776554332222 110000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.++|.+||+.||++||++.++++.
T Consensus 231 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 231 ---------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123567899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.47 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=206.3
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+...+||+|+||.||+|.+..+++.||+|++..... .......+|+.+++.++|+||+++++++...+..|+||||+++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334679999999999999999999999999864332 2334467899999999999999999999999999999999998
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~~t~ 162 (432)
+.+..+.... .+++..++.++.||+.||+|||+.|++|+||+|+||+++.+ .++|+|||++....... ......+++
T Consensus 102 ~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 102 GALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred CcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 7666665543 68999999999999999999999999999999999999865 89999999987654322 234457889
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
.|+|||.+. ...++.++|+||+||++|+|++|.+||.+.........+.... +.
T Consensus 181 ~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~----------------------- 234 (292)
T cd06657 181 YWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP----------------------- 234 (292)
T ss_pred cccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cc-----------------------
Confidence 999999884 5667899999999999999999999998876655443332110 00
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+. ....++.++.++|.+||+.||.+||++.++++||||..
T Consensus 235 -~~~-~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 235 -KLK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275 (292)
T ss_pred -ccC-CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence 000 11346788999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=351.62 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=198.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|+++++||+|+||.||+|.+..+|+.||+|++...... .......+|++++++++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999999754322 2233467899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccc
Q 014039 79 FEYMEHNLYHIMRER-----------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLA 146 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~-----------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a 146 (432)
|||++|+.+..+... ...++...+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999987544443321 124566778899999999999999999999999999999985 49999999999
Q ss_pred eecCCC-------------------CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHH
Q 014039 147 RELSSM-------------------PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ 207 (432)
Q Consensus 147 ~~~~~~-------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~ 207 (432)
+..... ......+||+.|+|||++. +..++.++||||+||++|||++|.+||.+......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 865211 0112357999999999985 56789999999999999999999999987554322
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.... ....|. .. .....+++.+.+++.+||+.||++|++..+.+.+
T Consensus 240 ~~~~--~i~~P~------------------------~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRD--VILSPI------------------------EV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hccChh------------------------hc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2110 000000 00 0013577889999999999999999887666544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=311.15 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=198.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||.||+|.+. ++..||+|.+..... ......+|+.+++.++|+||+++++++.+.+..|++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 68999999999999999999865 456799999875432 234466899999999999999999999988999999999
Q ss_pred CCC-cHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Cc
Q 014039 82 MEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~ 156 (432)
+++ ++.+.+.. ....+++..++.++.||+.||+|||+.|++||||||+||+++++ .+||+|||++........ ..
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 976 55555543 24568999999999999999999999999999999999999865 899999999987654221 12
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 163 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------ 223 (261)
T cd05072 163 GAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------------------ 223 (261)
T ss_pred CCccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 234566799999884 5668899999999999999998 99999887766555444211100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.....++.++.++|.+||+.||++||+++++++
T Consensus 224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 -----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.37 Aligned_cols=254 Identities=31% Similarity=0.424 Sum_probs=212.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
|+....+||.|.||.||-|.+..||+..|+|-++-.... .......+|..++..++|||+|++|++-.+...+||.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 456678999999999999999999999999998743322 1222356899999999999999999999888999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCC-----CC
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMP-----PY 155 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~-----~~ 155 (432)
|.++.+..+...++-.+|...+.|..|++.||+|||+.|||||||||+||+++ +|.+|++|||.|..+.... ..
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99988888888777889999999999999999999999999999999999998 5599999999998876532 23
Q ss_pred ccccCCccccchhhhcCCC--CCCcccceechHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSS--SYSPAIDMWAVGAILAELFTLSPIFPGDSE-IDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~--~~~~~~DiWSlG~il~ell~g~~pF~~~~~-~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
..+.||+-|||||++.+.. ...-++|||||||++.||+||+.||...+. +..+++. |...-
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V----~~gh~------------ 1459 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV----AAGHK------------ 1459 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH----hccCC------------
Confidence 5678999999999997554 567799999999999999999999976543 3333333 21111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+.++.++|.+.+|||.+||+.||.+|.++.|+|+|-|-+.
T Consensus 1460 -------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1460 -------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred -------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 1223458999999999999999999999999999998764
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=313.72 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=199.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-----CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-----YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.+.||+|+||.||+|.+... +..||+|.+.............+|+++++.++|+||+++++++......|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 6899999999999999999987643 47899999875544344445678999999999999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 77 FIFEYMEH-NLYHIMRER---------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~---------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
+||||+++ ++.+.+... ...+++..+..++.||+.||.|||+.|++||||||+||+++.+ .+||+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 99999985 555555432 1246788999999999999999999999999999999999865 999999999
Q ss_pred ceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++...... ......++..|+|||.+. ...++.++|||||||++|||++ |.+||.+.+.......+. .+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~--~~~---- 238 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI--DGG---- 238 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh--cCC----
Confidence 97654322 122335677899999884 5668999999999999999998 999998877654443331 010
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.++|.+||+.+|++|||+.++++.
T Consensus 239 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 239 -----------------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred -----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 001123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=310.81 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=198.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.... +..+|+|.+...... .....+|++++++++||||+++++++......|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 579999999999999999997654 345999998754332 23457899999999999999999999988889999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--cc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--TE 157 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~~ 157 (432)
+.++ +.+.+......+++..++.++.||+.||+|||+.|++|+||||+||+++++ .+||+|||.++........ ..
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9865 555555545579999999999999999999999999999999999999865 8999999999866443211 12
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+......
T Consensus 161 ~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 220 (256)
T cd05113 161 SKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------------------- 220 (256)
T ss_pred CccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-------------------
Confidence 23456799999984 4568999999999999999998 99999877765544444221100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......+.++.+++.+||+.||.+||++.+++++
T Consensus 221 ----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=331.34 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=196.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 75 (432)
++|++++.||+|+||.||+|.+.. ++..||+|++.............+|+++|++++ ||||+++++++.+.+.+
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 468899999999999999998643 345799999976544444456779999999995 99999999999999999
Q ss_pred EEEEecCCCc-HHHHHHHc-------------------------------------------------------------
Q 014039 76 FFIFEYMEHN-LYHIMRER------------------------------------------------------------- 93 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~------------------------------------------------------------- 93 (432)
||||||++++ |.+.+...
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999864 44444321
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eE
Q 014039 94 ----------------------------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VL 138 (432)
Q Consensus 94 ----------------------------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~l 138 (432)
...+++..+..++.||+.||+|||+.||+||||||+|||++++ .+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 1247888899999999999999999999999999999999866 89
Q ss_pred EEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014039 139 KIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCI 214 (432)
Q Consensus 139 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~ 214 (432)
||+|||+++....... .....++..|+|||++. ...++.++|||||||++|||++ |..||++....+.....+..
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 9999999987643222 22345677899999885 5668999999999999999997 99999876543333322211
Q ss_pred hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 215 LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
-..+ .....++.++.++|.+||+.||++|||+.++.+.
T Consensus 356 ~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 356 GYRM----------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred CCCC----------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 0000 0113567899999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=315.11 Aligned_cols=257 Identities=31% Similarity=0.538 Sum_probs=210.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+.|++.+.||+|++|.||+|.+..++..||+|++..... ......+|+++++.++|+||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 468899999999999999999998899999999976543 334456899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCccc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~ 158 (432)
+++ ++.+.+......+++..+..++.||+.||.|||+.|++|+||+|+||+++++ .++|+|||.+....... .....
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 995 5555555544479999999999999999999999999999999999999855 99999999987654321 22334
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.++..|+|||.+. ...++.++|+|||||++|+|++|..||.+.+.......+.. .+.+...
T Consensus 177 ~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~----------------- 237 (286)
T cd06614 177 VGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLK----------------- 237 (286)
T ss_pred cCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCCCc-----------------
Confidence 5788999999885 56689999999999999999999999988766554443321 1111100
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
....++.++.+||++||+.+|.+|||+.++++|+||....|
T Consensus 238 ---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 238 ---------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred ---------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 01236788999999999999999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=311.98 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=200.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
.+|++.+.||+|+||.||+|.++.+++ .||+|.+...........+.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 579999999999999999999887664 59999987654433445567899999999999999999999998999999
Q ss_pred EecCCCcHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEHNLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll-~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||++++.+ +.+....+.+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999987544 4555555679999999999999999999999999999999999999865 99999999987654322111
Q ss_pred cc---c---CCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 157 EY---V---STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 157 ~~---~---~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.+ . .+..|+|||.+. ...++.++||||+||++|||++ |..||.+.+..+....+......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~------------ 230 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL------------ 230 (269)
T ss_pred ccccccCCCcceeecCHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence 11 1 134699999884 5678999999999999999886 99999887766554444211000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+++.+||+.+|++||++.+++..
T Consensus 231 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 231 -----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred -----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=315.65 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=197.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|.+.+.||+|+||.||++.+. .++..+|+|.+..... .......+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 36999999999999999999853 3566799999875432 23334678999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEee
Q 014039 77 FIFEYMEHN-LYHIMRERQ------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIAD 142 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~~------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~D 142 (432)
+||||++++ +.+.+...+ ..+++..++.++.||+.||+|||++|++||||||+||+++++ .+||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 999999865 555554322 248999999999999999999999999999999999999865 899999
Q ss_pred eccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014039 143 FGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 143 FG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
||+++....... .....++..|+|||++. ...++.++|||||||++|+|++ |.+||.+....+....+.. +..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~--~~~ 240 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ--GRV 240 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CCc
Confidence 999986543221 12234567899999884 5678999999999999999998 9999988776555444421 110
Q ss_pred CCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 ---------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111246789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.03 Aligned_cols=243 Identities=30% Similarity=0.444 Sum_probs=201.5
Q ss_pred eeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|.+... +..||+|.+.............+|++.++.++|+||+++++++.+...+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999998866 8899999998765544345567899999999999999999999999999999999965
Q ss_pred -cHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC--
Q 014039 85 -NLYHIMRER--------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-- 152 (432)
Q Consensus 85 -~ll~~~~~~--------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-- 152 (432)
++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||++++ +.+||+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 566665554 368999999999999999999999999999999999999997 49999999999876543
Q ss_pred -CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.......++..|+|||.+. ...++.++||||+||++|+|++ |..||.+....+....+.. +.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~------------- 224 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GY------------- 224 (262)
T ss_pred cccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC-------------
Confidence 2233456788899999885 4478999999999999999999 6999988866555444321 00
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.++|.+||+.||++|||+.|+++|
T Consensus 225 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.83 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=199.4
Q ss_pred CCeeEeeeEeecCceEEEEEEE-----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.+.||+|+||.||+|.+ ..++..||+|.++............+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4789999999999999999975 3456689999987654333444567899999999 799999999999999999
Q ss_pred EEEEecCCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
|+||||+.+ ++.+.+.... ..+++.++..++.||+.||.|||+.|++|+||||+|||++.+ .+||+|||+++.....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 999999986 4555554433 348999999999999999999999999999999999999865 8999999999866432
Q ss_pred CC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 153 PP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 153 ~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
.. .....++..|+|||.+. ...++.++||||+||++|||++ |.+||.+....+...+.+.. +..
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~~~---------- 262 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-GYR---------- 262 (302)
T ss_pred CceeecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-CCc----------
Confidence 21 12234567899999885 5568999999999999999998 99999887665544443211 000
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......+.++.+|+.+||+.+|++|||+.|+++
T Consensus 263 -----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 -----------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011245789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=311.53 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=199.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.++.++. .+|+|.++............+|+.++++++||||+++++++.+++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 479999999999999999999875543 79999987654433444567899999999999999999999998999999
Q ss_pred EecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-
Q 014039 79 FEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~- 155 (432)
|||++++ +.+.+....+.+++..+..++.||+.||.|||+.|++||||||+|||++++ .+||+|||.+.........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999875 555555555678999999999999999999999999999999999999865 9999999999876543211
Q ss_pred ---ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 ---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
....++..|+|||.+. ...++.++|+||+||++||+++ |..||.+....+....+......
T Consensus 164 ~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 228 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-------------- 228 (267)
T ss_pred eecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC--------------
Confidence 1112345799999985 5668999999999999999886 99999887665554444211100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.....++.++.+++.+||+.+|++||++.++++
T Consensus 229 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ---------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.69 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=194.5
Q ss_pred eeEeeeEeecCceEEEEEEEcC---CCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCC------
Q 014039 4 YKILEELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENN------ 73 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------ 73 (432)
|++.+.||+|+||.||+|.+.. ++..||+|+++...... ......+|++.++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 34789999998654332 2334678999999999999999999875543
Q ss_pred EEEEEEecCCCcHH-HHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 74 ELFFIFEYMEHNLY-HIMRER-----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 74 ~~~lV~E~~~~~ll-~~~~~~-----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
..+++|||+.++.+ ..+... ...+++..++.++.||+.||.|||+.|++||||||+||+++++ .+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 37899999987544 443221 2368999999999999999999999999999999999999866 9999999999
Q ss_pred eecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCC
Q 014039 147 RELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTA 222 (432)
Q Consensus 147 ~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~ 222 (432)
+....... ......+..|+|||.+ ....++.++||||+||++|||++ |.+||.+....+....+.. +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~----- 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH--GN----- 232 (273)
T ss_pred eeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CC-----
Confidence 87643221 1122345679999987 46678999999999999999999 9999988766544333211 00
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.++|.+||+.||++|||+.|++++
T Consensus 233 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 ----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.13 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=203.7
Q ss_pred CeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc---hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF---WEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
+|++.+.||+|+||.||+|++. .+++.||+|.+++.... .......+|+++++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 46788999998754321 1223356899999999 699999999999999999
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
|+||||+.++.+.........+++..++.++.|+++||.|||+.|++||||||.||+++.+ .++|+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 9999999875444444444579999999999999999999999999999999999999855 899999999976543322
Q ss_pred --CccccCCccccchhhhcCCC-CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSS-SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~-~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....++..|+|||.+.+.. ..+.++|+||+||++|||++|..||...........+.+..-
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------------- 225 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--------------- 225 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH---------------
Confidence 12346889999999985433 368899999999999999999999975433222122111000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT---ADQALQHPFFNVETWV 289 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt---a~elL~Hp~f~~~~~~ 289 (432)
.. .......++.++.++|.+||+.||++||| +.++|+||||+..+|.
T Consensus 226 --~~---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 226 --KS---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred --cc---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 00 00122346788999999999999999998 5788999999988774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.11 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=200.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++.+.||+|+||.||+|.+..+++.+|+|++...... .......+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 57899999999999999999999999999999988753322 2233456899999999999999999999999999999
Q ss_pred EecCCCc-HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 79 FEYMEHN-LYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
|||+.++ +.+.+.. ....+++..++.++.||+.||.|||++|++|+||||+||+++.+ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999875 4444432 24468999999999999999999999999999999999999855 99999999997764432
Q ss_pred C-CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 154 P-YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 154 ~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
. .....++..|+|||.+. ...++.++|+||+||++|+|++|..||.+..... ..+.+....
T Consensus 161 ~~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~--------------- 222 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQ--------------- 222 (267)
T ss_pred cccccccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhc---------------
Confidence 2 23457889999999884 5668899999999999999999999997654321 111110000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..++. ......+.++.++|.+||+.||++|||+.++++
T Consensus 223 --~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 223 --CDYPP-------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred --CCCCC-------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00000 011246789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=309.05 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=200.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|+..+.||+|+||.||+|.++.++. .+|+|++.............+|++++++++|+||+++.+++.+.+..|+|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468999999999999999999876654 79999987654333445567899999999999999999999999999999
Q ss_pred EecCCCcHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-
Q 014039 79 FEYMEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155 (432)
Q Consensus 79 ~E~~~~~ll~-~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~- 155 (432)
|||++++.++ .+....+.+++..+..++.|++.||+|||+.|++||||||+||+++++ .+||+|||++.........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999876554 444445679999999999999999999999999999999999999865 8999999999866432211
Q ss_pred -c--cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 -T--EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 -~--~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
. ....+..|+|||++. ...++.++||||+||++|||++ |..||...+..+....+......|
T Consensus 165 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 230 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP------------- 230 (268)
T ss_pred eeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-------------
Confidence 1 112345699999885 5668999999999999999997 999998877665555543211100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....++.++.+++.+||+.||++||++.++++.
T Consensus 231 ----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 231 ----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012457789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.81 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=198.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.+.... .....+|+++++.++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46899999999999999999876 4567999998754332 22356799999999999999999999998999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--cc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--TE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~~ 157 (432)
+++ ++.+.+..+...+++..++.++.||+.||+|||+.|++||||||+||+++++ .+||+|||.++........ ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 976 4666666555578999999999999999999999999999999999999855 8999999999865432211 11
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||.+. ...++.++||||+||++|+|++ |.+||.+.+..+....+.....
T Consensus 161 ~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 219 (256)
T cd05059 161 TKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-------------------- 219 (256)
T ss_pred CCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--------------------
Confidence 12334699999885 5678999999999999999998 8999987766554443321100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.+++.+||+.+|++|||+.|+++.
T Consensus 220 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ---------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01113468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=311.18 Aligned_cols=248 Identities=20% Similarity=0.272 Sum_probs=194.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeE----EEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEI----VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++++.||+|+||+||+|....+++. +++|++.............+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 5799999999999999999998877764 677777543322223345678889999999999999998754 45788
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~- 154 (432)
++||+++ ++.+.+....+.+++..+..++.||+.||.|||+.|++||||||+|||++++ .+||+|||.++.......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999985 6666666666689999999999999999999999999999999999999866 899999999987643221
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....++..|+|||.+. ...++.++|||||||++|||++ |..||.+....... .++. .|...
T Consensus 166 ~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~-~~~~~------------ 230 (279)
T cd05111 166 YFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLE-KGERL------------ 230 (279)
T ss_pred cccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH-CCCcC------------
Confidence 22345667899999985 5568999999999999999998 99999887653322 2211 00000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+++.+|+..||++|||+.|+++.
T Consensus 231 ---------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 231 ---------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011356788999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=306.08 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=197.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|++|.||+|.+.. ++.||+|.++.... ......+|++++++++|+||+++++++...+..|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 479999999999999999998654 46799999875432 233456899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 82 MEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
+.+ ++.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++++ .+||+|||+++...... ....
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 161 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAR 161 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cccc
Confidence 965 5666655432 468999999999999999999999999999999999999865 89999999998765321 1112
Q ss_pred cC---CccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 159 VS---TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 159 ~~---t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.+ +..|+|||.+. ...++.++|+|||||++|||++ |+.||.+.........+......
T Consensus 162 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------- 223 (261)
T cd05068 162 EGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------------- 223 (261)
T ss_pred CCCcCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 22 34799999884 5678999999999999999999 99999887765554443211000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.+++.+||+.||++||++.++++
T Consensus 224 ------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.95 Aligned_cols=255 Identities=27% Similarity=0.350 Sum_probs=197.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC--------------eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccce
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY--------------EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKE 67 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~ 67 (432)
++|++.+.||+|+||.||+|++..++ ..||+|++.............+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 48999999999999999999875433 3589999976544334445678999999999999999999
Q ss_pred EEEeCCEEEEEEecCCCc-HHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC
Q 014039 68 VVRENNELFFIFEYMEHN-LYHIMRERQ-----------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN 135 (432)
Q Consensus 68 ~~~~~~~~~lV~E~~~~~-ll~~~~~~~-----------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~ 135 (432)
++...+..++||||+.++ +.+.+.... ..+++..+..++.||+.||.|||+.|++||||||+||++++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 999999999999999875 444443221 13688899999999999999999999999999999999986
Q ss_pred C-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh--CCCCCCCCChHHHHH
Q 014039 136 D-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT--LSPIFPGDSEIDQLY 209 (432)
Q Consensus 136 ~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~--g~~pF~~~~~~d~~~ 209 (432)
+ .+||+|||++........ .....++..|+|||.+. ...++.++|+|||||++|+|++ |..||...+..+...
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 6 899999999976543221 12234467899999885 5568999999999999999988 677887766655444
Q ss_pred HHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 210 KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 210 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+.......... ......+..+..+.+||.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 244 NTGEFFRNQGRQ----------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHhhhhcccc----------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 432211100000 000112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.06 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=195.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||.||+|++..++ .||+|++...... .....+|+++++.++||||+++++++.+ ...|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 57999999999999999999887665 5999999764432 2345689999999999999999988754 557999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--c
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--T 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~ 156 (432)
+++ ++.+.+... ...+++..+..++.|++.||+|||+.|++||||||+||+++++ .+||+|||.++........ .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 986 555555543 3458999999999999999999999999999999999999865 8999999999876543221 1
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|+|||||++|||++ |.+||.+....+....+.. +.+
T Consensus 162 ~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~--~~~----------------- 221 (262)
T cd05071 162 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--GYR----------------- 221 (262)
T ss_pred CCcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc--CCC-----------------
Confidence 234566799999884 5668999999999999999999 8999988766554443321 000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
. .....++.++.++|.+||+.||++||++.++++
T Consensus 222 -~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 -M---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -C---------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 011246788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=307.05 Aligned_cols=242 Identities=22% Similarity=0.314 Sum_probs=191.7
Q ss_pred eeEeecCceEEEEEEE--cCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFN--VETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|.. ..++..+|+|+++...... ......+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 3689999999999964 5678899999987544322 23345689999999999999999998754 467899999997
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC----Ccccc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YTEYV 159 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~----~~~~~ 159 (432)
+.+..+....+.+++..+..++.||+.||+|||++|++||||||+||+++++ .+||+|||+++....... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 6554444444579999999999999999999999999999999999999866 899999999987644322 11223
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
++..|+|||.+. ...++.++|||||||++|||++ |.+||.+....+....+.. +.
T Consensus 160 ~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~--~~--------------------- 215 (257)
T cd05116 160 WPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES--GE--------------------- 215 (257)
T ss_pred CCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--CC---------------------
Confidence 457899999884 5678999999999999999997 9999988776555444321 00
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+...++.++.++|.+||+.||++||++++|.+.
T Consensus 216 ------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 216 ------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHH
Confidence 001223578899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=306.97 Aligned_cols=244 Identities=28% Similarity=0.404 Sum_probs=195.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||.||+|.+. ++..+|+|.+...... .....+|+.++++++|+||+++++++.. ...|++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 68999999999999999999765 4556999998764432 2346789999999999999999998754 568999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--c
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--T 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~ 156 (432)
+++ ++.+.+... ...+++..++.++.||+.||+|||+.|++||||||+||+++++ .+||+|||.+......... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 986 555555443 3468999999999999999999999999999999999999876 8999999999876543211 1
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||.+. ...++.++|||||||++|+|++ |.+||.+.+..+....+.... .+
T Consensus 162 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~----------------- 222 (260)
T cd05070 162 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RM----------------- 222 (260)
T ss_pred CCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC-----------------
Confidence 223456799999884 5668999999999999999999 999998877666555442110 00
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.+|+.+||+.||++|||++++.+
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 -----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=314.05 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=198.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-------CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-------ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|++.+.||+|+||.||+|++. ..+..||+|.+.............+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 47999999999999999999753 234579999987654444445567899999999 8999999999999999
Q ss_pred EEEEEEecCCCc-HHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEHN-LYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~~-ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
..|+||||+.++ +.+.+.... ..++...+..++.||+.||.|||++|++||||||+||+++++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 999999999865 555554321 247888899999999999999999999999999999999854
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||.++....... .....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999999987643221 22234567899999884 5678999999999999999998 889998876655444331
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. +.. ......++.++.+||.+||+.+|++|||+.|+++.
T Consensus 254 ~--~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 254 E--GHR---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred c--CCc---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1 000 01123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=315.22 Aligned_cols=249 Identities=29% Similarity=0.401 Sum_probs=197.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-------CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-------ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|.+.++||+|+||.||+|++. .....+|+|.++............+|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 47999999999999999999864 235579999987654434444567899999999 6999999999999889
Q ss_pred EEEEEEecCCCc-HHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEHN-LYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~~-ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
..|+||||++++ +.+.+.... ..++...+..++.||+.||.|||++|++||||||+|||++++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 999999999865 555554321 358899999999999999999999999999999999999855
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||.++....... .....++..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999986643211 11122345799999985 5678999999999999999998 899998876655444332
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. +.. ......++.++.++|.+||+.||++|||+.|+++.
T Consensus 251 ~--~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 251 E--GHR---------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred c--CCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 000 01123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.16 Aligned_cols=262 Identities=27% Similarity=0.348 Sum_probs=194.3
Q ss_pred CCe-eEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCE
Q 014039 2 ERY-KILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNE 74 (432)
Q Consensus 2 ~~Y-~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~ 74 (432)
+|| ++++.||+|+||+||++. ...++..||+|.+.............+|++++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 566 999999999999998865 3457888999999765433334456689999999999999999998764 346
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+||||+.++.+..+.... .+++..++.++.|++.||+|||++|++||||||+||+++++ .+||+|||+++......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 89999999876555554443 59999999999999999999999999999999999999865 89999999998765422
Q ss_pred C----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 P----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
. .....++..|+|||.+. ...++.++|||||||++|||++|..||...... ...+. +. ....... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~---~~-~~~~~~~-~~~ 233 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMI---GP-KQGQMTV-VRL 233 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhh---cc-cccccch-hhh
Confidence 1 12234566799999884 566899999999999999999999988654321 11111 00 0000000 000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
...... .........++.++.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 234 IELLER-------GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhc-------CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000 0001123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.01 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=201.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||.|+||.||+|.+.. ++.+|+|.+...... ......+|+++++.++|+||+++++++.+....++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 468999999999999999999888 888999998765431 233456899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccc
Q 014039 82 MEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~ 157 (432)
+++ ++.+.+.. .+..+++..++.++.||+.||.|||++|++||||||+||+++++ .+||+|||.+........ ...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~ 163 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence 987 56565554 24568999999999999999999999999999999999999866 999999999976643211 122
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||.+. ...++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 164 ~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 223 (261)
T cd05148 164 KKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------------- 223 (261)
T ss_pred CCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-------------------
Confidence 33456799999885 5678999999999999999998 89999887765555544311100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.....++.++.++|.+||+.||.+|||+.++++
T Consensus 224 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=315.36 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=197.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-------CCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-------TYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|.+.+.||+|+||.||+|++.. ++..+|+|.+.............+|+++++.+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999998643 33569999998654333444567899999999 7999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
..|+||||+++ ++.+.+..+. ..++...+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 99999999986 5555554432 248889999999999999999999999999999999999855
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||.++....... .....++..|+|||++. ...++.++|+||+||++|||++ |.+||.+....+....+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 899999999976543221 11123446799999885 5668999999999999999998 889997766543333221
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. +. .......++.++.+||.+||..+|++|||+.+++++
T Consensus 257 ~--~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 E--GH---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred c--CC---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0 00 001123567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.79 Aligned_cols=242 Identities=34% Similarity=0.523 Sum_probs=199.8
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC-cH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NL 86 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~-~l 86 (432)
||.|+||.||++.+..+++.+|+|.+.+..... ......+|++++++++|+||+++++.+.++...|+||||+++ ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999999899999999987654322 233466899999999999999999999999999999999965 55
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccccCCccc
Q 014039 87 YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYVSTRWY 164 (432)
Q Consensus 87 l~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~~t~~y 164 (432)
.+.+.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++++ .++|+|||.+...... .......++..|
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 555544 4479999999999999999999999999999999999999865 9999999999876543 233456788899
Q ss_pred cchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCC
Q 014039 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPIN 244 (432)
Q Consensus 165 ~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (432)
+|||.+. ....+.++|+|||||++|+|++|..||...+.......+.. +..
T Consensus 160 ~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~-------------------------- 210 (250)
T cd05123 160 LAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL-------------------------- 210 (250)
T ss_pred cChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC--------------------------
Confidence 9999885 45578899999999999999999999987765333333321 110
Q ss_pred ccccCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 014039 245 LSDIIPNASMEAIDLIWQLCSWDPLRRPTA---DQALQHPFF 283 (432)
Q Consensus 245 ~~~~~~~~s~~~~dli~~~L~~dP~~Rpta---~elL~Hp~f 283 (432)
.+....+.++.++|++||..||++||++ +++++||||
T Consensus 211 --~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 --RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1122457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=304.36 Aligned_cols=249 Identities=31% Similarity=0.484 Sum_probs=199.9
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
.++|++.+.||+|+||.||+|.+..+|+.||+|.++..... .......+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 47899999999999999999999999999999998743222 2234567899999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 79 FEYMEH-NLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
|||+++ ++...+.. ....+++..++.++.||+.||.|||+.|++||||||+||+++.+ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999986 45555443 23468999999999999999999999999999999999999854 99999999997654322
Q ss_pred -CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 154 -PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI--DQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 -~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~--d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
......++..|+|||.+. ...++.++|+||+||++|+|++|..||.+.... +....+.. +
T Consensus 161 ~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-------------- 223 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--C-------------- 223 (267)
T ss_pred cccceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--C--------------
Confidence 223456888999999885 566899999999999999999999999665421 11111100 0
Q ss_pred hhhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 231 RLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+ .... +..+.++.++|.+||..+|++|||+.++++
T Consensus 224 -----~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 -----DY--------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----CC--------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 0111 246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.28 Aligned_cols=247 Identities=28% Similarity=0.382 Sum_probs=195.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.............+|+++++.++||||+++++.+...+..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 3356889988765543344456789999999999999999999999899999
Q ss_pred EEecCCCcHHH-HHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE
Q 014039 78 IFEYMEHNLYH-IMRER-----------------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV 133 (432)
Q Consensus 78 V~E~~~~~ll~-~~~~~-----------------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl 133 (432)
+|||+.++.+. .+... ...+++..+..++.|++.||.|||+.|++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999865444 43321 1357889999999999999999999999999999999999
Q ss_pred eCC-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHH
Q 014039 134 TND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQL 208 (432)
Q Consensus 134 ~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~ 208 (432)
+++ .+||+|||+++....... .....++..|+|||.+. ...++.++|||||||+++||++ |..||.+.......
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 865 999999999976533221 12234566899999884 5668999999999999999998 99999887654433
Q ss_pred HHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 209 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..+..... ......++.++.+|+.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYR-----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCC-----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 32210000 0112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=308.67 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=192.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCe--EEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe------CCE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYE--IVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE------NNE 74 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~--~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~ 74 (432)
|.+.+.||+|+||.||+|.+..++. .+|+|.++..... .......+|+++++.++|+||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999887775 5899998764322 223445689999999999999999997632 134
Q ss_pred EEEEEecCCCc-HHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 75 LFFIFEYMEHN-LYHIMRE-----RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~-----~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
.+++|||+.++ +.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++++ .+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999864 4444432 22358999999999999999999999999999999999999865 89999999998
Q ss_pred ecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q 014039 148 ELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAF 223 (432)
Q Consensus 148 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~ 223 (432)
....... .....+++.|+|||.+. ...++.++||||+||++|||++ |.+||.+....+....+.. +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~~----- 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ--GNR----- 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--CCC-----
Confidence 7654321 12234567899999884 5678999999999999999999 8999988766443333211 000
Q ss_pred hhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 ----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.56 Aligned_cols=236 Identities=29% Similarity=0.431 Sum_probs=199.0
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcH
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNL 86 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~l 86 (432)
++-||.|+.|-||+|+. .++.||||+++.-. ..+|+.|++|+||||+.++++|.....+|||||||..+-
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 45699999999999964 56889999987432 368999999999999999999999999999999998664
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCCCccccCCcccc
Q 014039 87 YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRWYR 165 (432)
Q Consensus 87 l~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~ 165 (432)
+..+.+.+.+++......|..+|+.|+.|||.+.|||||||.-||||. ++.|||+|||.++.+.......+++||..||
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWM 278 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWM 278 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhh
Confidence 444555556899999999999999999999999999999999999998 5599999999999988877778899999999
Q ss_pred chhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCc
Q 014039 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINL 245 (432)
Q Consensus 166 aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (432)
|||+| +....+.|+|||||||+||||+||..||.+-+....+. ..|... +.
T Consensus 279 APEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGsNs-------------L~----------- 329 (904)
T KOG4721|consen 279 APEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGSNS-------------LH----------- 329 (904)
T ss_pred CHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchheeEE----eccCCc-------------cc-----------
Confidence 99999 57889999999999999999999999997654322111 111100 00
Q ss_pred cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 246 SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 246 ~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
-.++..++..++-||++||+-.|..||+..++|.|=
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 023356888899999999999999999999999993
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=305.04 Aligned_cols=243 Identities=27% Similarity=0.375 Sum_probs=195.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEE-EeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV-RENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV~ 79 (432)
+++|++.+.||+|+||.||+|.. .|..+|+|.++.... .....+|+.++++++|+|++++++++ .+.+..|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 46899999999999999999965 477899999875432 23456899999999999999999875 4556789999
Q ss_pred ecCCC-cHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 80 EYMEH-NLYHIMRERQI-PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~-~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
||+++ ++.+.+..... .+++..+..++.||+.||+|||++|++||||||+||+++++ .+||+|||+++...... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence 99986 56666655433 48999999999999999999999999999999999999855 99999999998654422 2
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++||||+||++|||++ |.+||......+....+... .
T Consensus 158 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~--~------------------ 216 (256)
T cd05082 158 TGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--Y------------------ 216 (256)
T ss_pred CCccceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--C------------------
Confidence 334567899999884 6678999999999999999997 99999876654443333110 0
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 217 ---------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 001223578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.00 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=197.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|.+.++||+|+||.||+|... .++..+|+|.+..... .......+|+++++.++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46889999999999999999743 3567899998875432 23345678999999999999999999999989999
Q ss_pred EEEecCCCc-HHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEE
Q 014039 77 FIFEYMEHN-LYHIMRERQ--------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKI 140 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~~--------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL 140 (432)
++|||++++ +.+.+.... ..+++..++.++.||+.||+|||+.|++||||||+|||++++ .+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 999999865 555544322 248899999999999999999999999999999999999865 8999
Q ss_pred eeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014039 141 ADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILG 216 (432)
Q Consensus 141 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g 216 (432)
+|||+++....... .....+++.|+|||.+. ...++.++|||||||++|||++ |.+||......+....+.. +
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~ 240 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ--G 240 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc--C
Confidence 99999976543221 12234567899999885 5668999999999999999998 9999987776555444321 1
Q ss_pred CCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+. .....+++++.+||.+||+.||++||++.|+++
T Consensus 241 ~~~---------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 241 REL---------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ccC---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 111356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.69 Aligned_cols=245 Identities=33% Similarity=0.471 Sum_probs=193.7
Q ss_pred eEeeeEeecCceEEEEEEEc----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 5 KILEELGDGTCGCVYKAFNV----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++.+.||.|+||.||+|... ..+..|+||.++..........+.+|++.+++++||||+++++++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999987 45677999999765444445667899999999999999999999998888999999
Q ss_pred cCCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---
Q 014039 81 YMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--- 154 (432)
Q Consensus 81 ~~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--- 154 (432)
|+++ +|.+.+... ...+++..+..++.||+.||.|||+++++|+||+++||+++.+ .+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9985 566666665 5689999999999999999999999999999999999999955 999999999987732211
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.........|+|||.+. ...++.++||||||+++|||++ |..||.+.+..+....+.+ +..
T Consensus 162 ~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~--~~~--------------- 223 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ--GQR--------------- 223 (259)
T ss_dssp STTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT--TEE---------------
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--ccc---------------
Confidence 23345677899999985 4558999999999999999999 7899988866655554421 000
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++..+.++|.+||..||++|||+.++++
T Consensus 224 ------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 ------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0112357889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.64 Aligned_cols=242 Identities=29% Similarity=0.380 Sum_probs=190.5
Q ss_pred eeEeecCceEEEEEEEcCCCe--EEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETYE--IVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|+||.||+|++..++. .+|+|.++............+|+++++++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999988775 46888887543333444567899999999 899999999999998999999999986
Q ss_pred -cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 85 -NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 85 -~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
++.+.+.... ..+++..++.++.||+.||+|||++|++||||||+||+++++ .+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 5555554422 247899999999999999999999999999999999999865 99999999986
Q ss_pred ecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 148 ELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
.............+..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.. +
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~--~---------- 227 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--G---------- 227 (270)
T ss_pred ccchhhhccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--C----------
Confidence 433221112223356799999884 6678999999999999999996 9999987665444333210 0
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
. .......++.++.+++.+||+.||.+|||+.++++
T Consensus 228 ----------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ----------Y-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ----------C-------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 00112246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=303.77 Aligned_cols=243 Identities=28% Similarity=0.395 Sum_probs=198.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||.|+||.||+|.. .|+.||+|++..... ......+|+.+++.++|+||+++++++.+.+..|+||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 5799999999999999999976 478899999986543 344567899999999999999999999988999999999
Q ss_pred CCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 82 MEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
+++ ++.+.+.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.++..... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--~~~~ 159 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--QDSG 159 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--cccC
Confidence 986 5655555443 268999999999999999999999999999999999999855 8999999999876432 2233
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+..|+|||.+. ...++.++|+||+||+++||++ |..||......+....+... +
T Consensus 160 ~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------------~ 216 (256)
T cd05039 160 KLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------------Y 216 (256)
T ss_pred CCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------------C
Confidence 4456799999884 5568899999999999999997 99999877655443332110 0
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. ......+++++.++|++||+.+|++|||+.|+++.
T Consensus 217 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 217 R-------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred C-------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0 01123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=304.52 Aligned_cols=240 Identities=24% Similarity=0.366 Sum_probs=190.6
Q ss_pred eeEeecCceEEEEEEEcCCC---eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVETY---EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++||+|+||.||+|....++ ..+|+|.+.............+|+++++.++|+||+++++++.. ...++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 47999999999999876554 78999999866543344556789999999999999999998764 467999999986
Q ss_pred c-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-ccc---
Q 014039 85 N-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-TEY--- 158 (432)
Q Consensus 85 ~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~-~~~--- 158 (432)
+ +.+.+... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ .+||+|||.++........ ...
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 4 55555444 479999999999999999999999999999999999999865 8999999999876443221 111
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++..|+|||.+. ...++.++|||||||++|+|++ |.+||...+..+....+... .+
T Consensus 159 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~~------------------- 216 (257)
T cd05060 159 RWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ER------------------- 216 (257)
T ss_pred cccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--Cc-------------------
Confidence 1235699999884 5678999999999999999997 99999877665443333110 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++..+.++|.+||+.||++||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 --------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=310.25 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=197.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
.+|.+.+.||+|+||.||+|++. .++..+++|.+..... .......+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 46999999999999999999854 3456689998865432 22334668999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 77 FIFEYMEHN-LYHIMRER---------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~---------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
+||||++++ +.+.+... .+.+++..++.++.||+.||+|||++|++||||||+||+++++ .+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999865 44444432 1348999999999999999999999999999999999999865 999
Q ss_pred EeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014039 140 IADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCIL 215 (432)
Q Consensus 140 L~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~ 215 (432)
|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |.+||...+..+....+..
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-- 240 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-- 240 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC--
Confidence 99999997654322 123345678899999885 5678999999999999999998 9999987766554333210
Q ss_pred CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 216 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+.. ......++.++.+++.+||+.||++|||+.++++.
T Consensus 241 ~~~---------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 241 GRV---------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCC---------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 100 01112467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=310.38 Aligned_cols=248 Identities=29% Similarity=0.442 Sum_probs=197.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|.+. .++..||+|++...........+.+|++++++++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 57999999999999999999875 3678899999876543333444678999999999999999999999888999
Q ss_pred EEEecCCC-cHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe
Q 014039 77 FIFEYMEH-NLYHIMRERQ---------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT 134 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~---------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~ 134 (432)
+||||+++ ++.+.+.... ..+++..++.++.||+.||+|||++|++||||||+||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 99999986 5555554321 2478889999999999999999999999999999999998
Q ss_pred CC-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHH
Q 014039 135 ND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLY 209 (432)
Q Consensus 135 ~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~ 209 (432)
++ .+||+|||++..+..... ......+..|+|||.+. ...++.++|||||||++|||++ |..||.+....+...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 55 999999999976543221 12234456799999885 5678999999999999999997 888887776654443
Q ss_pred HHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 210 KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 210 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+.. +. .......++.++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~--~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 244 YVRD--GN---------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHhc--CC---------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 3311 00 00112356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=302.90 Aligned_cols=246 Identities=32% Similarity=0.448 Sum_probs=200.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCC----eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETY----EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++.+.||.|+||.||+|.+...+ ..||+|++.............+|+.+++.++|+||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467889999999999999998766 8899999976544334455678999999999999999999999989999999
Q ss_pred ecCCCc-HHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 80 EYMEHN-LYHIMRERQIP-FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~-l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
||++++ +.+.+...... +++..+..++.||+.||+|||+.|++|+||||+||+++++ .++|+|||.++.........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999875 55555443333 9999999999999999999999999999999999999976 89999999998765432222
Q ss_pred --cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 --EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 --~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
...++..|+|||.+ ....++.++|+||+||++++|++ |.+||.+.+..+....+... .
T Consensus 161 ~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~--~---------------- 221 (258)
T smart00219 161 KKGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG--Y---------------- 221 (258)
T ss_pred cccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--C----------------
Confidence 12366789999988 56778999999999999999998 89999886665554443210 0
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
........+.++.+++.+||+.||++|||+.|+++
T Consensus 222 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 -----------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 00112246889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.28 Aligned_cols=249 Identities=28% Similarity=0.390 Sum_probs=197.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-------CeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-------YEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
.+|++++.||+|+||.||+|++... +..||+|.++............+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 3699999999999999999986432 2368999887554333445567899999999 8999999999999888
Q ss_pred EEEEEEecCCCc-HHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEHN-LYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~~-ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
.+|++|||++++ +.+.+..+. ..++...+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 999999999864 555554321 247788899999999999999999999999999999999855
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+++....... .....++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999987654321 12223346799999985 5678999999999999999998 899998877655444331
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. +. .......++.++.+||.+||+.+|++|||+.|++++
T Consensus 251 ~--~~---------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 251 E--GH---------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred c--CC---------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1 00 001123567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.52 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=193.9
Q ss_pred CCeeEeeeEeecCceEEEEEEE-----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe-CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE-NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (432)
++|++++.||+|+||.||+|.+ ..+++.||+|+++............+|+.+|.++ +||||+++++++.. ...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5899999999999999999984 3567889999997654444444567899999999 68999999998754 456
Q ss_pred EEEEEecCCCc-HHHHHHHcC-----------------------------------------------------------
Q 014039 75 LFFIFEYMEHN-LYHIMRERQ----------------------------------------------------------- 94 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~~----------------------------------------------------------- 94 (432)
+++||||++++ |.+.+....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 88999999865 444443321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---CccccCCcc
Q 014039 95 -------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YTEYVSTRW 163 (432)
Q Consensus 95 -------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~ 163 (432)
..++...+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++........ .....++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 236788889999999999999999999999999999999854 999999999986533221 112334567
Q ss_pred ccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 164 y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
|+|||.+. ...++.++|||||||++|+|++ |..||.+..........+.. +..
T Consensus 247 y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~------------------------ 300 (343)
T cd05103 247 WMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTR------------------------ 300 (343)
T ss_pred eECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cCC------------------------
Confidence 99999985 5678999999999999999996 99999876543332222110 000
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++++.+++.+||+.||++|||+.|+++|
T Consensus 301 ---~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112356789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=306.78 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=199.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe----EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE----IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++.+.||+|+||.||+|.++.+|+ .+|+|.+.............+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 579999999999999999999877665 5899988765543344456789999999999999999999877 78899
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~ 155 (432)
||||+.+ ++.+.+......+++..+..++.||+.||+|||++|++||||||+||+++++ .+||+|||.++........
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 9999975 5666666656679999999999999999999999999999999999999854 9999999999876543221
Q ss_pred cc---ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TE---YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~---~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.. ..++..|+|||.+. ...++.++|+||+||++|||++ |..||.+....+....+.. +..
T Consensus 166 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~------------- 229 (279)
T cd05057 166 YHAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--GER------------- 229 (279)
T ss_pred eecCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC--CCC-------------
Confidence 11 12346799999884 5678999999999999999998 9999988776554443321 100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......+.++.+++.+||..||++||++.++++
T Consensus 230 --------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 --------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0111246778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=303.62 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=195.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||.||+|... +++.||+|.+...... .....+|+.++++++|+||+++++++. .+..|++|||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 57999999999999999999865 4677999998754432 234568999999999999999998874 4568999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Cc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~ 156 (432)
+.+ ++.+.+... +..+++..+..++.|++.||+|||+.|++||||||+||+++++ .++|+|||.+........ ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 976 566655443 4578999999999999999999999999999999999999865 899999999987653221 12
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |.+||.+.+..+....+......
T Consensus 162 ~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 222 (260)
T cd05067 162 GAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------------------ 222 (260)
T ss_pred CCcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC------------------
Confidence 234566799999884 5668999999999999999998 99999887765544443211100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.++|.+||+.+|++|||++++++
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=303.74 Aligned_cols=241 Identities=22% Similarity=0.333 Sum_probs=191.0
Q ss_pred eEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc-
Q 014039 9 ELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN- 85 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~- 85 (432)
.||+|+||.||+|.+. .++..||+|++.............+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999765 45667999998765433334456789999999999999999998764 5689999999865
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC----ccccC
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----TEYVS 160 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~----~~~~~ 160 (432)
+.+.+......+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++......... ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 555555455679999999999999999999999999999999999999866 8999999999765433221 11123
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
+..|+|||.+. ...++.++|||||||++|||++ |.+||.+....+....+.. |..
T Consensus 161 ~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~--------------------- 216 (257)
T cd05115 161 PLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ--GKR--------------------- 216 (257)
T ss_pred CcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC--CCC---------------------
Confidence 46799999885 5568999999999999999996 9999988776655443321 100
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++++.++|.+||+.||++||++.++++.
T Consensus 217 ------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 217 ------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123568899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=304.91 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=198.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|.+.+.||+|+||.||+|.+... ...||||...............+|+++++.++||||+++++++.+ ...|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4689999999999999999987544 346899998765543344456789999999999999999998875 457899
Q ss_pred EecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-
Q 014039 79 FEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~- 155 (432)
|||++++ +.+.+......+++..++.++.||+.||+|||+.|++||||||+||+++.+ .+||+|||+++........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 9999864 555555545568999999999999999999999999999999999999864 9999999999876543221
Q ss_pred -ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 156 -TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 156 -~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
....++..|+|||.+. ...++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 165 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------------------ 225 (270)
T cd05056 165 ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE------------------ 225 (270)
T ss_pred cCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 1223345799999874 5678999999999999999986 999998887765554432100
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.++.++.++|.+||..+|++|||+.++++.
T Consensus 226 -----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 226 -----------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001224578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.78 Aligned_cols=246 Identities=28% Similarity=0.387 Sum_probs=199.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.++|++.++||+|+||.||+|.+.. +..+|+|.+...... .....+|++++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3689999999999999999998754 567999998754432 2346689999999999999999999998889999999
Q ss_pred cCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--C
Q 014039 81 YMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--Y 155 (432)
Q Consensus 81 ~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~ 155 (432)
|++++ +.+.+... +..+++..+..++.||+.||.|||++|++|+||||+||+++++ .+||+|||.+........ .
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 99864 55555443 2468999999999999999999999999999999999999865 999999999987653211 1
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.....+..|+|||.+. +..++.++|+||+||++|+|++ |..||.+......+..+......
T Consensus 162 ~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------- 223 (261)
T cd05034 162 EGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------------- 223 (261)
T ss_pred hccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 1223456799999885 5668999999999999999998 99999887766655554221110
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.+++.+||+.+|++||+++++++
T Consensus 224 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011235778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.83 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=195.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC----------------CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCccccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE----------------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKL 65 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l 65 (432)
++|++.++||+|+||.||+|.+.. ++..+|+|++.............+|+++|+.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 479999999999999999986432 3457999999865443344456789999999999999999
Q ss_pred ceEEEeCCEEEEEEecCCC-cHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe
Q 014039 66 KEVVRENNELFFIFEYMEH-NLYHIMRERQ----------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT 134 (432)
Q Consensus 66 ~~~~~~~~~~~lV~E~~~~-~ll~~~~~~~----------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~ 134 (432)
++++...+..|+||||+.+ ++.+.+.... ..+++..+..++.||+.||+|||+.|++||||||+|||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 9999999999999999986 5555554422 2477889999999999999999999999999999999998
Q ss_pred CC-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh--CCCCCCCCChHHHH
Q 014039 135 ND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT--LSPIFPGDSEIDQL 208 (432)
Q Consensus 135 ~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~--g~~pF~~~~~~d~~ 208 (432)
.+ .+||+|||+++.+..... ......+..|+|||... ...++.++|+|||||++|||++ |..||...+..+..
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 55 999999999986543221 12233467799999875 4568999999999999999998 77888776654433
Q ss_pred HHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 209 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......... ... .........++..+.+|+.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~-----------------~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 244 ENTGEFFRD-----------------QGR-----QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHhh-----------------ccc-----cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 322111000 000 0000112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=301.43 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=195.0
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc-H
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-L 86 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~-l 86 (432)
++||+|+||.||+|.+.. ++.||+|++.............+|++++++++|+||+++++++.+....|+||||+.++ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999887 89999999886554434455678999999999999999999999999999999999765 5
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC---ccccCCc
Q 014039 87 YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVSTR 162 (432)
Q Consensus 87 l~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~---~~~~~t~ 162 (432)
.+.+......+++..+..++.|++.||+|||++|++||||||+||+++.+ .+||+|||.+......... .....+.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 55555555678999999999999999999999999999999999999855 9999999999765422111 1122355
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
.|+|||.+. ...++.++|+|||||++|||++ |..||.+.........+....+.
T Consensus 160 ~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~------------------------ 214 (251)
T cd05041 160 KWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM------------------------ 214 (251)
T ss_pred ccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC------------------------
Confidence 699999885 5578999999999999999998 89999887654443333110000
Q ss_pred CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 242 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+++.+||+.+|.+|||+.|+++.
T Consensus 215 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 215 -----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0112467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=307.52 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=195.6
Q ss_pred CeeEeeeEeecCceEEEEEEE----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFN----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN--NELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~ 76 (432)
-|++++.||+|+||.||+|+. ..+++.||+|.+.............+|+++++.++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 378999999999999999974 4678899999987554333334567899999999999999999998764 5689
Q ss_pred EEEecCCCcHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 77 FIFEYMEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 77 lV~E~~~~~ll~-~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
+||||++++.+. .+......+++..+..++.||+.||+|||++|++||||||+||+++++ .+||+|||+++.+.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 999999875554 444444568999999999999999999999999999999999999865 899999999987654321
Q ss_pred ----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 155 ----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 155 ----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....++..|+|||++. ...++.++|||||||++|||+++..++.... .. .....+..... .......
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~--~~---~~~~~~~~~~~-~~~~~~~- 236 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPM--TL---FLKMIGPTHGQ-MTVTRLV- 236 (284)
T ss_pred ceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCcccc--ch---hhhhccccccc-ccHHHHH-
Confidence 12345667899999885 4568999999999999999999876543221 11 11111211111 1000000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..... .........++.++.+||.+||+.||++|||+.+++++
T Consensus 237 ~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEE-------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHc-------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000 00112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.24 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=197.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe-CCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE-NNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~ 76 (432)
++|++.+.||+|+||.||+|.+.. ++..|++|++.............+|++++++++|+||+++++++.. ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 579999999999999999999876 3578999998755444445556789999999999999999998755 56788
Q ss_pred EEEecCCC-cHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 77 FIFEYMEH-NLYHIMRERQ-------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~-------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
+++||+++ ++.+.+.... ..+++..++.++.||+.||+|||+.|++||||||+||+++++ .+||+|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999985 4555544321 458999999999999999999999999999999999999865 99999999998
Q ss_pred ecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q 014039 148 ELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAF 223 (432)
Q Consensus 148 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~ 223 (432)
.+..... .....++..|+|||++. ...++.++||||+||++||+++ |.+||.+.+..+....+.. +. .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~-~---- 237 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD--GY-R---- 237 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc--CC-C----
Confidence 6643221 12234566799999885 5668999999999999999998 9999988766543332211 00 0
Q ss_pred hhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
. .....++.++.+++.+||+.||++|||+.++++
T Consensus 238 -------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 -------------L---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=334.94 Aligned_cols=276 Identities=22% Similarity=0.340 Sum_probs=185.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCC----CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceE------EE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVET----YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEV------VR 70 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~------~~ 70 (432)
.++|++.++||+|+||.||+|.+..+ +..||+|++..... .+. ... +.++...+.+++.+... ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~-~~~--e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEI-WMN--ERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHH-HHH--HHHHhhchhhHHHHHHhhhcccccc
Confidence 36899999999999999999999998 99999999864321 111 111 11222223333333222 13
Q ss_pred eCCEEEEEEecCCCc-HHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 014039 71 ENNELFFIFEYMEHN-LYHIMRERQIP-------------------FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPEN 130 (432)
Q Consensus 71 ~~~~~~lV~E~~~~~-ll~~~~~~~~~-------------------l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~N 130 (432)
.....++||||++++ +.+.+...... ..+..++.++.||+.||+|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 456789999999875 44444332211 1234577899999999999999999999999999
Q ss_pred eeEeC--CeEEEeeeccceecCCC--CCCccccCCccccchhhhcCCC---------------------CCCcccceech
Q 014039 131 LLVTN--DVLKIADFGLARELSSM--PPYTEYVSTRWYRAPEVLLQSS---------------------SYSPAIDMWAV 185 (432)
Q Consensus 131 ILl~~--~~lkL~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~l~~~~---------------------~~~~~~DiWSl 185 (432)
||+++ +.+||+|||+|+.+... .....+++|+.|+|||.+.... .++.++||||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 48999999999865432 2234678999999999764221 24456799999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcc
Q 014039 186 GAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCS 265 (432)
Q Consensus 186 G~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 265 (432)
||++|||+++. |+..+...++.+++...+... ..| ............ ....++......++.|||++||+
T Consensus 366 GviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~-~~~------~~~~~~~~~~~~-~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 366 GLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDL-VAW------RKLVEPRASPDL-RRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcH-HHH------HHhhccccchhh-hhhhhhccccchHHHHHHHHHcc
Confidence 99999999854 555555556665554433211 000 000000000000 00011222345567899999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014039 266 WDPLRRPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 266 ~dP~~Rpta~elL~Hp~f~~~~~~~~ 291 (432)
+||++|||+.|+|+||||+...+...
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDREGLLGL 461 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCCCcccc
Confidence 99999999999999999998776543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.30 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=193.5
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc-H
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-L 86 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~-l 86 (432)
++||+|+||.||+|... ++..+|+|++.............+|+++++.++||||+++++++...+..++||||++++ +
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999854 678899999876544333445678999999999999999999999989999999999864 5
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC--ccccCCcc
Q 014039 87 YHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--TEYVSTRW 163 (432)
Q Consensus 87 l~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~--~~~~~t~~ 163 (432)
.+.+......+++..+..++.|++.||.|||++|++||||||+||+++++ .+||+|||++......... ....++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 55555555578999999999999999999999999999999999999865 8999999999764332111 11233567
Q ss_pred ccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC
Q 014039 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILP 242 (432)
Q Consensus 164 y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (432)
|+|||++. ...++.++||||+||++|+|++ |..||.+.........+....
T Consensus 160 y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------------------------- 211 (250)
T cd05085 160 WTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------------------------- 211 (250)
T ss_pred ccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence 99999884 5668999999999999999998 999998876654443331100
Q ss_pred CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 243 INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 243 ~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+++.+||+.+|++||++.|+++.
T Consensus 212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 001123567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.88 Aligned_cols=199 Identities=32% Similarity=0.513 Sum_probs=176.8
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC------CEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN------NELFF 77 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~~~l 77 (432)
+...+.||+|+||.||+++++.+|+.||||..+............+|+++|++|+|+|||++.++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 566788999999999999999999999999998766555666677999999999999999999986543 34679
Q ss_pred EEecCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---C--eEEEeeeccceec
Q 014039 78 IFEYMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---D--VLKIADFGLAREL 149 (432)
Q Consensus 78 V~E~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~--~lkL~DFG~a~~~ 149 (432)
|||||.|+.++...+ +...|+|.++..++..+..||.|||++|||||||||.||++-. | .-||||||.|+.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999876666554 2346999999999999999999999999999999999999963 3 6899999999999
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD 202 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~ 202 (432)
.++....+.+||+.|.+||++.+.+.|+.-+|.||+||++|+++||..||-..
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999999999999999965688999999999999999999999999654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=317.50 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=213.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH------HHHHHHHHHHhcCCCcccccceEEE-eCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC------MNLREVKALRKLNHPNIIKLKEVVR-ENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~------~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~ 74 (432)
++|-++..||+|+|+.||+|.+....++||+|+-.....+.++. ...||.+|.+.|+||.||++|++|. +...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 47888999999999999999999999999999876444433332 2358999999999999999999995 6677
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeccCCCCceeEeCC----eEEEeeecccee
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN--GYFHRDLKPENLLVTND----VLKIADFGLARE 148 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~--givHrDlkP~NILl~~~----~lkL~DFG~a~~ 148 (432)
+|-|+|||+|+.++++.+..+-++|.+++.|+.||+.||.||... -|+|-||||.|||+.+| .+||+|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 899999999999999988888999999999999999999999977 69999999999999765 899999999987
Q ss_pred cCCCC--------CCccccCCccccchhhhcC---CCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Q 014039 149 LSSMP--------PYTEYVSTRWYRAPEVLLQ---SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILG 216 (432)
Q Consensus 149 ~~~~~--------~~~~~~~t~~y~aPE~l~~---~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g 216 (432)
..+.. .+....||-||++||.+.- .+..+.++||||+|+|+|.++.|+.||..+... +.+..
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe------ 696 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE------ 696 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh------
Confidence 75422 2345679999999999863 356799999999999999999999999665332 22221
Q ss_pred CCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+.+.+..+..||.. +-++.++.+||++||++--+.|....++-.||||..
T Consensus 697 ----------NTIlkAtEVqFP~K---------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 697 ----------NTILKATEVQFPPK---------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ----------hchhcceeccCCCC---------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11122223334321 358999999999999999999999999999999974
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=322.52 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=198.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 75 (432)
++|.+.++||+|+||.||+|++. .+++.||+|+++............+|+++|.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46788899999999999999853 4567899999986544433445678999999997 99999999999998999
Q ss_pred EEEEecCCCc-HHHHHHHcC------------------------------------------------------------
Q 014039 76 FFIFEYMEHN-LYHIMRERQ------------------------------------------------------------ 94 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~~------------------------------------------------------------ 94 (432)
++||||+.++ |.+.+...+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999864 555543321
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 95 -------------------------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 95 -------------------------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
..+++..+..++.||+.||.|||+.|++||||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 136777889999999999999999999999999999999865
Q ss_pred eEEEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+++...... ......++..|+|||.+. ...++.++||||+||++|||++ |..||......+.....+
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 89999999998654322 122345678899999985 5668999999999999999998 889998766555444332
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.. |.. ......++.++.+||.+||+.+|++||+++|+++.
T Consensus 356 ~~-~~~---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 356 KR-GYR---------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred Hc-CCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 000 01123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.76 Aligned_cols=255 Identities=33% Similarity=0.441 Sum_probs=200.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe----------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE---------- 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---------- 71 (432)
.+|+.++.||+|+||.||+++++-+|+.||||+|..........++.||+..|.+|+|||||+++..|-+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4678899999999999999999999999999999877644455567899999999999999977543200
Q ss_pred ---------------------------------------------C----------------------------------
Q 014039 72 ---------------------------------------------N---------------------------------- 72 (432)
Q Consensus 72 ---------------------------------------------~---------------------------------- 72 (432)
.
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CEEEEEEecCCCcHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHCCC
Q 014039 73 ------------------------------NELFFIFEYMEHNLYHIMRERQIPF-SEGEIRSFMSQMLQGLAHMHRNGY 121 (432)
Q Consensus 73 ------------------------------~~~~lV~E~~~~~ll~~~~~~~~~l-~~~~~~~i~~qIl~aL~~LH~~gi 121 (432)
..+||-||||+.++++.+.+++... .....+++++||++||.|+|+.||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 1268999999999999888876554 577899999999999999999999
Q ss_pred eeccCCCCceeEeCC-eEEEeeeccceecC-------------------CCCCCccccCCccccchhhhcCCC--CCCcc
Q 014039 122 FHRDLKPENLLVTND-VLKIADFGLARELS-------------------SMPPYTEYVSTRWYRAPEVLLQSS--SYSPA 179 (432)
Q Consensus 122 vHrDlkP~NILl~~~-~lkL~DFG~a~~~~-------------------~~~~~~~~~~t~~y~aPE~l~~~~--~~~~~ 179 (432)
|||||||.||+++++ .|||+|||+|+... .....++.+||-.|+|||++.+.. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999965 99999999998621 011346789999999999996555 69999
Q ss_pred cceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHH
Q 014039 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDL 259 (432)
Q Consensus 180 ~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 259 (432)
+||||||+|++||+. ||...-+ ...++..+..+... .+ ..++.+.-+....+
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsME---Ra~iL~~LR~g~iP---------------------~~-~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSME---RASILTNLRKGSIP---------------------EP-ADFFDPEHPEEASL 850 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHH---HHHHHHhcccCCCC---------------------CC-cccccccchHHHHH
Confidence 999999999999986 3543221 12222222221111 11 22233444567899
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 260 IWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 260 i~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
|+.||+.||++||||.|+|++.||.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhccCCC
Confidence 9999999999999999999999997
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=305.20 Aligned_cols=238 Identities=19% Similarity=0.241 Sum_probs=187.0
Q ss_pred eeEeecCceEEEEEEEcC------------CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 8 EELGDGTCGCVYKAFNVE------------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~------------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
+.||+|+||.||+|+... ....+|+|.+..... .......+|+.+++.++||||+++++++.++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999997432 233588888765432 2233456789999999999999999999988889
Q ss_pred EEEEecCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--------eEEEeeeccc
Q 014039 76 FFIFEYMEHNLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--------VLKIADFGLA 146 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--------~lkL~DFG~a 146 (432)
++||||++++.++.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ .+|++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 99999999876665554 45579999999999999999999999999999999999999743 3899999998
Q ss_pred eecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 147 RELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF-TLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell-~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
...... ....++..|+|||.+.....++.++|||||||++|||+ .|..||.+....+... +.. .
T Consensus 160 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~---~-------- 224 (262)
T cd05077 160 ITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE---G-------- 224 (262)
T ss_pred ccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh---c--------
Confidence 765432 34567888999998865677999999999999999998 5888887654332211 100 0
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+ ......+.++.+||.+||+.||.+||++.+++++
T Consensus 225 ----------~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 ----------QC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------Cc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 0112345689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.34 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=188.4
Q ss_pred eeEeecCceEEEEEEEcC--CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVE--TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|.... ....+|+|.+.............+|+++++.++|+||+++++.+.+....|+||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999996433 456788888765443333344678999999999999999999999989999999999875
Q ss_pred -HHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---CCc
Q 014039 86 -LYHIMRERQ----IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP---PYT 156 (432)
Q Consensus 86 -ll~~~~~~~----~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~---~~~ 156 (432)
+.+.+.... ...++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 444444432 234678889999999999999999999999999999999865 99999999987543221 112
Q ss_pred cccCCccccchhhhcC------CCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQ------SSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~------~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
...++..|+|||++.. ...++.++||||+||++|||++ |.+||......+.+..++..... .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~---------- 229 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI-K---------- 229 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc-c----------
Confidence 2345677999998742 3457889999999999999999 88899887766655544321110 0
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+...++....+++..|+ .||++|||++|+++-
T Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 230 -------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred -------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 0001122357788899999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=306.59 Aligned_cols=238 Identities=18% Similarity=0.243 Sum_probs=187.5
Q ss_pred eeEeecCceEEEEEEEcCCCeE-------EEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 8 EELGDGTCGCVYKAFNVETYEI-------VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+.||+|+||.||+|.+...+.. +|+|.+..... .......+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 4689999999999998765544 78888754332 222345679999999999999999999999889999999
Q ss_pred cCCCcHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC---------eEEEeeeccceecC
Q 014039 81 YMEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND---------VLKIADFGLARELS 150 (432)
Q Consensus 81 ~~~~~ll~-~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~---------~lkL~DFG~a~~~~ 150 (432)
|++++.++ .+..++..+++..+..++.||+.||+|||++||+||||||+||+++.+ .+|++|||.+....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99876554 444445568999999999999999999999999999999999999754 27999999987654
Q ss_pred CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
. .....++..|+|||++.+...++.++||||+||++|||++| .+||...+........ +..
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~----~~~----------- 221 (258)
T cd05078 160 P---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY----EDR----------- 221 (258)
T ss_pred C---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH----Hcc-----------
Confidence 3 23356788999999997656789999999999999999998 5666655443322211 000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+....+.++.+||.+||+.||++|||++++++.
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 ----------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 01122356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=299.92 Aligned_cols=245 Identities=27% Similarity=0.385 Sum_probs=196.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ......+|+++++.++|+||+++++++.+ ...|++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4789999999999999999997654 45699998875432 23346689999999999999999999877 77899999
Q ss_pred cCCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--C
Q 014039 81 YMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--Y 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~ 155 (432)
|+++ ++.+.+... ...+++..+..++.||+.||.|||+.|++||||||+||+++.+ .+||+|||.+........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 9985 666666543 4468889999999999999999999999999999999999866 999999999986643221 1
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....++..|+|||++. ...++.++|+|||||++|+|++ |.+||.+.+..+....+......
T Consensus 161 ~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------- 222 (260)
T cd05073 161 EGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----------------- 222 (260)
T ss_pred cCCcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------
Confidence 1223456799999984 5668999999999999999998 99999987765555443211000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.+++.+||+.||++||++.++++
T Consensus 223 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 112356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=300.85 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=195.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+..++ .+|+|++...... .....+|+++++.++|+|++++++++.. +..|+||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc--HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 57999999999999999999876654 5899988654322 2345689999999999999999988754 567899999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Cc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~ 156 (432)
+.+ ++.+.+... ...+++..+..++.||+.||.|||+.|++|+||||+||+++++ .+||+|||.++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 986 566666543 3458999999999999999999999999999999999999865 899999999986643221 12
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||.+. ...++.++|||||||++|||++ |.+||.+....+....+.... .+
T Consensus 162 ~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----------------- 222 (260)
T cd05069 162 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM----------------- 222 (260)
T ss_pred CCccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-----------------
Confidence 234566799999885 5668999999999999999999 999998877655544432110 00
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+..+.+++++||+.||++||+++++++
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=301.89 Aligned_cols=227 Identities=25% Similarity=0.364 Sum_probs=183.8
Q ss_pred cCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc-HHHHHH
Q 014039 13 GTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMR 91 (432)
Q Consensus 13 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~-ll~~~~ 91 (432)
|.+|.||+|++..+++.||+|++..... ..+|...+....||||+++++++.+....|+||||++++ +.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 8999999999999999999999976432 224555556667999999999999999999999999875 555554
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCccccchhhh
Q 014039 92 ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170 (432)
Q Consensus 92 ~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l 170 (432)
. ...+++..+..++.||+.||.|||+.|++||||||+||+++.+ .++++|||.+...... .....++..|+|||.+
T Consensus 78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 78 K-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVG 154 (237)
T ss_pred H-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCccc
Confidence 4 3469999999999999999999999999999999999999855 8999999988765442 2344567789999987
Q ss_pred cCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCC
Q 014039 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIP 250 (432)
Q Consensus 171 ~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (432)
. ...++.++|+||+||++|||++|..+|....... . .... ..+.+
T Consensus 155 ~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~---------~~~~-----------~~~~~ 199 (237)
T cd05576 155 G-ISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------N---------THTT-----------LNIPE 199 (237)
T ss_pred C-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------c---------cccc-----------cCCcc
Confidence 4 5668899999999999999999998774322100 0 0000 01223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 014039 251 NASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFF 283 (432)
Q Consensus 251 ~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f 283 (432)
.++.++.++|++||+.||++|+++ +|+++||||
T Consensus 200 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 200 WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 578899999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.23 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=212.0
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHh-cCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK-LNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
-+..||.|+||+|++..++.+|+..|+|++.......+...++.|.....+ -++||||++|+..-.++..||-||+|+-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 356799999999999999999999999999877665666677788875544 5899999999999888999999999998
Q ss_pred cHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccc
Q 014039 85 NLYHIMRE----RQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 85 ~ll~~~~~----~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
++-...+. ....++|+.+-.+....+.||.||.+. .|+|||+||+|||++. |.+||||||++..+...-..+--
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d 227 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD 227 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence 75544432 344799999999999999999999965 8999999999999994 69999999999887765555667
Q ss_pred cCCccccchhhhcCCC-CCCcccceechHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 159 VSTRWYRAPEVLLQSS-SYSPAIDMWAVGAILAELFTLSPIFPGDS-EIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~-~~~~~~DiWSlG~il~ell~g~~pF~~~~-~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.|.+.|+|||-+.... .|+.++|+||||+.|||++||..|+++=+ -.+|+..+ +.|.|+.-..+..
T Consensus 228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V--v~gdpp~l~~~~~---------- 295 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV--VIGDPPILLFDKE---------- 295 (361)
T ss_pred cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH--HcCCCCeecCccc----------
Confidence 8999999999986444 49999999999999999999999997743 34555444 4565553322111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
--+.+..++.+|..||.+|-+.||...+++++||+...
T Consensus 296 ------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 296 ------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 01478899999999999999999999999999999753
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.93 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=197.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.+|++.+.||+|+||.||+|.+.. +..+|+|++...... .....+|++++++++||||+++++++......|+||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 579999999999999999998754 667999998754432 23356899999999999999999999998999999999
Q ss_pred CCCcHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Ccc
Q 014039 82 MEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTE 157 (432)
Q Consensus 82 ~~~~ll~-~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~~ 157 (432)
+.++.+. .+......++++.++.++.|++.||+|||+.|++||||||+||+++.+ .+||+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9875444 444445578999999999999999999999999999999999999855 899999999986543221 112
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||.+. ...++.++||||+||++|||++ |..||...........+....
T Consensus 161 ~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------------- 218 (256)
T cd05112 161 TKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--------------------- 218 (256)
T ss_pred CccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---------------------
Confidence 23456799999885 5678999999999999999998 999998776654444331100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.. ......+.++.+|+++||+.+|++|||+.|++++
T Consensus 219 -~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -RL-------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -CC-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 0012357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.71 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=197.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|+.+. +.+.|++|.+.............+|++++++++|+||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 579999999999999999999754 346799998875443323445678999999999999999999999888999
Q ss_pred EEEecCCCcHHH-HHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 77 FIFEYMEHNLYH-IMRERQ--------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 77 lV~E~~~~~ll~-~~~~~~--------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
+||||++++.+. .+.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.+ .++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 999999865444 444332 168999999999999999999999999999999999999855 8999999998
Q ss_pred eecCCCC--CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q 014039 147 RELSSMP--PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAF 223 (432)
Q Consensus 147 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~ 223 (432)
+...... ......++..|+|||.+. ...++.++||||+||++|+|++ |..||.+....+....+.. +...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--~~~~~--- 238 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--GKLEL--- 238 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc--CCcCC---
Confidence 7543221 223345677799999885 4567899999999999999998 8889977655443333210 11100
Q ss_pred hhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++..+.++|.+||+.||++|||+.|++.+
T Consensus 239 -----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 -----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.50 Aligned_cols=242 Identities=26% Similarity=0.331 Sum_probs=195.6
Q ss_pred eeEeecCceEEEEEEEcC-CCe--EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNVE-TYE--IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
+.||+|++|.||+|.+.. +++ .||||.+...........+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998765 333 5899999876543344456789999999999999999999988 889999999975
Q ss_pred -cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC----Ccc
Q 014039 85 -NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YTE 157 (432)
Q Consensus 85 -~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~----~~~ 157 (432)
++.+.+.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+ .+||+|||+++.+..... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 5666666544 578999999999999999999999999999999999999855 999999999987644221 112
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||.+. ...++.++|||||||++|||++ |..||.+.+..+....+.......
T Consensus 160 ~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 220 (257)
T cd05040 160 LKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL------------------ 220 (257)
T ss_pred CCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC------------------
Confidence 34667899999874 6678999999999999999998 999998877766555543210000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++.+++.+||+.+|++|||+.++++
T Consensus 221 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ----------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.41 Aligned_cols=237 Identities=18% Similarity=0.197 Sum_probs=186.0
Q ss_pred eEeecCceEEEEEEEcCC------------------------CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccc
Q 014039 9 ELGDGTCGCVYKAFNVET------------------------YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 64 (432)
.||+|+||.||+|....+ ...||+|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 689999999999975321 23488888864432 22234567899999999999999
Q ss_pred cceEEEeCCEEEEEEecCCCcHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-------
Q 014039 65 LKEVVRENNELFFIFEYMEHNLYHIMR-ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND------- 136 (432)
Q Consensus 65 l~~~~~~~~~~~lV~E~~~~~ll~~~~-~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~------- 136 (432)
+++++.+.+..++||||++++.++.+. ...+.+++..+..++.||++||+|||++||+||||||+|||++..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 999999999999999999987666554 445679999999999999999999999999999999999999732
Q ss_pred -eEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHH-hCCCCCCCCChHHHHHHHHHH
Q 014039 137 -VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF-TLSPIFPGDSEIDQLYKVCCI 214 (432)
Q Consensus 137 -~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell-~g~~pF~~~~~~d~~~~i~~~ 214 (432)
.+|++|||.+...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+....+...
T Consensus 161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 237 (274)
T cd05076 161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK 237 (274)
T ss_pred ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhc
Confidence 4899999998654332 23357788999999866677899999999999999985 699999876543322111000
Q ss_pred hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 215 LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. ......++++.++|.+||+.+|++|||+.+++++
T Consensus 238 --------------------~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 238 --------------------H-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred --------------------c-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 0 0111245689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.43 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=196.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe----EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE----IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|+..+.||+|+||.||+|.+..+|+ .+|+|.+.............+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 578999999999999999999887776 46888887544333333467899999999999999999988654 4679
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC-
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~- 154 (432)
++||+++ ++.+.+......+++..+..++.||+.||.|||++||+||||||+||++++ +.+||+|||+++.......
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 9999985 566666665557899999999999999999999999999999999999975 4899999999987653322
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....++..|+|||.+. ...++.++|||||||++|||++ |..||.+....+. ..++.....+
T Consensus 166 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~------------- 230 (303)
T cd05110 166 YNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL------------- 230 (303)
T ss_pred cccCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC-------------
Confidence 22334567899999884 5678999999999999999997 8999987654332 2222110000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+.++.++.+++.+|+..||++||+++++++.
T Consensus 231 ---------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ---------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112457789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=300.64 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=187.7
Q ss_pred eeEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|... .++..+|+|++...........+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999754 4567799999876554444445678999999999999999999999888899999999865
Q ss_pred HH-HHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---Cc
Q 014039 86 LY-HIMRER----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YT 156 (432)
Q Consensus 86 ll-~~~~~~----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~ 156 (432)
.+ +.+... ....++..++.++.|++.||+|||+.|++||||||+||+++.+ .+||+|||.++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 44 444432 2245677888999999999999999999999999999999866 999999999975432211 12
Q ss_pred cccCCccccchhhhcCC------CCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQS------SSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~------~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
...++..|+|||++.+. ..++.++||||+||++|||++ |..||+.....+....... +...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~---------- 228 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--EQQL---------- 228 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh--cccC----------
Confidence 34567889999998432 236889999999999999996 9999987665544332211 1000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+ ....+....+..+.+++++|+ .+|++|||++|++.
T Consensus 229 ------~~------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 ------KL------PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ------CC------CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 001111245778999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=298.89 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=187.9
Q ss_pred eeEeecCceEEEEEEEcC---CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE-eCCEEEEEEecCC
Q 014039 8 EELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR-ENNELFFIFEYME 83 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~E~~~ 83 (432)
+.||+|+||.||+|.+.. .+..||||++.............+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 345799999865433333445668999999999999999999764 4566889999998
Q ss_pred C-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----CCc
Q 014039 84 H-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-----PYT 156 (432)
Q Consensus 84 ~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-----~~~ 156 (432)
+ ++.+.+......+++..+..++.||+.||+|||+.|++||||||+|||++++ .+||+|||+++...... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 6 5555555545567888889999999999999999999999999999999865 99999999997653311 112
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||.+. ...++.++|||||||++|||++ |.++|...+..+....+.. +.+.
T Consensus 161 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~~~---------------- 221 (262)
T cd05058 161 GAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRL---------------- 221 (262)
T ss_pred cCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCCC----------------
Confidence 334567899999885 5678999999999999999999 5788877665543333211 0000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++..+.+++.+||+.+|++||++.|+++.
T Consensus 222 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 222 -----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0012356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=300.82 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=194.3
Q ss_pred CCeeEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (432)
++|++++.||+|+||.||+|. +..+++.||+|++..... .....+.+|++++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 469999999999999999997 456788999999875432 233445689999999999999999998643 4568
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
++||||+++ ++.+.+......+++..++.++.||+.||+|||++|++||||||+||+++++ .+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 999999986 5555555555579999999999999999999999999999999999999865 89999999998764432
Q ss_pred CC----ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 PY----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.. ....++..|+|||++. ...++.++||||+||+++||++|..++...... .....+......... ...
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~ 235 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDKQGQMIV-YHL 235 (284)
T ss_pred cceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-----hhhhcccccccccch-HHH
Confidence 21 1122345699999884 567899999999999999999988766443221 111112211100000 000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....... ........++.++.+||.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 236 IELLKNN-------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHhcC-------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0000000 0011234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=297.63 Aligned_cols=241 Identities=27% Similarity=0.382 Sum_probs=193.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||++. .+++.||+|++.... ......+|+.+++.++||||+++++++..+ ..|+||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 579999999999999999985 578889999987543 223456899999999999999999998654 47999999
Q ss_pred CCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 82 MEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
+.+ ++.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ .+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 157 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNS 157 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCC
Confidence 986 5666665443 358999999999999999999999999999999999999864 9999999999765432 2233
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+..|+|||.+. ...++.++|+|||||++|||++ |.+||.+.+..+....+... +
T Consensus 158 ~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------------~ 214 (254)
T cd05083 158 KLPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG----------------------Y 214 (254)
T ss_pred CCCceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC----------------------C
Confidence 4456799999884 5678999999999999999997 99999887765443332110 0
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. ......++.++.++|.+||+.+|++||+++++++.
T Consensus 215 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 215 R-------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred C-------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.42 Aligned_cols=235 Identities=21% Similarity=0.254 Sum_probs=184.5
Q ss_pred eeEeecCceEEEEEEEcCCC----------eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 8 EELGDGTCGCVYKAFNVETY----------EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+.||+|+||.||+|.+..++ ..+++|.+...... .....+|++++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999998777 34788877654322 4456789999999999999999999877 77899
Q ss_pred EEecCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--------eEEEeeecccee
Q 014039 78 IFEYMEHNLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--------VLKIADFGLARE 148 (432)
Q Consensus 78 V~E~~~~~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--------~lkL~DFG~a~~ 148 (432)
||||++++.++.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999766555544 34379999999999999999999999999999999999999854 499999999987
Q ss_pred cCCCCCCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
... .....++..|+|||++... ..++.++||||+||++++|++ |..||...+........ . ...
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~---~~~------- 223 (259)
T cd05037 158 VLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-Q---DQH------- 223 (259)
T ss_pred ccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-h---cCC-------
Confidence 544 2234567789999998644 478999999999999999999 57777665432221111 0 000
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
........++.++|.+||+.+|++|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 --------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000112268899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=300.68 Aligned_cols=242 Identities=29% Similarity=0.410 Sum_probs=191.7
Q ss_pred eeEeecCceEEEEEEEcCCC------eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 8 EELGDGTCGCVYKAFNVETY------EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+.||+|+||.||+|++...+ +.+|+|.+.............+|+++++.++||||+++++++.+....|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46899999999999876544 789999987554333444567899999999999999999999988899999999
Q ss_pred CCC-cHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC------eEEEeeecccee
Q 014039 82 MEH-NLYHIMRER------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND------VLKIADFGLARE 148 (432)
Q Consensus 82 ~~~-~ll~~~~~~------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~------~lkL~DFG~a~~ 148 (432)
+++ ++.+.+... ...+++..+..++.||+.||+|||+.|++|+||||+||+++++ .+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 986 555555432 2347889999999999999999999999999999999999853 699999999976
Q ss_pred cCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 149 LSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 149 ~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
...... .....++..|+|||.+. ...++.++|||||||++|||++ |..||+.....+....+.. .+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~------- 231 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGR------- 231 (269)
T ss_pred cccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCc-------
Confidence 543211 12234567899999885 5668999999999999999998 9999987766554333210 000
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++.++.++|.+||+.+|.+||+++++++
T Consensus 232 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 ---------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=298.82 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=200.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcC-CCeEEEEEEecccc---------cchHHHHHHHHHHHHHh-cCCCcccccceEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVE-TYEIVAVKKMKRKF---------YFWEECMNLREVKALRK-LNHPNIIKLKEVVRE 71 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~---------~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~ 71 (432)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .........+|++++++ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48999999999999999999987 78899999886322 11122334578888876 699999999999999
Q ss_pred CCEEEEEEecCCCc-HHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 72 NNELFFIFEYMEHN-LYHIM---RERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 72 ~~~~~lV~E~~~~~-ll~~~---~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
++..++||||++++ +.+.+ ......+++..++.++.|++.||.|||+ .|++|+||||+||+++++ .+||+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999874 44443 2345579999999999999999999996 789999999999999865 899999999
Q ss_pred ceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 146 ARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 146 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
+.............++..|+|||.+. ...++.++|+|||||++|+|++|.+||...........+......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 233 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL------ 233 (269)
T ss_pred eeecccccccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC------
Confidence 98766544445567889999999985 55689999999999999999999999977665544443321111000
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.++.++|.+||+.||++||++.|+.++
T Consensus 234 ----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 ----------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ----------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012457899999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.53 Aligned_cols=252 Identities=19% Similarity=0.214 Sum_probs=187.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccch--HH--------HHHHHHHHHHHhcCCCcccccceE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFW--EE--------CMNLREVKALRKLNHPNIIKLKEV 68 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~--~~--------~~~~~Ei~~l~~l~hpnIv~l~~~ 68 (432)
++|++.+.||+|+||.||+|.+..+ +..+|+|+........ +. .....+...++.++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998877 6677777654222111 10 011234445566789999999987
Q ss_pred EEeCC----EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeee
Q 014039 69 VRENN----ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADF 143 (432)
Q Consensus 69 ~~~~~----~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DF 143 (432)
+.... ..++++|++..++.+.+... ...++..++.++.||+.||+|||+.||+||||||+|||++.+ .+||+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65432 34688998887776655443 357889999999999999999999999999999999999854 9999999
Q ss_pred ccceecCCCC--------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH--
Q 014039 144 GLARELSSMP--------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC-- 213 (432)
Q Consensus 144 G~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~-- 213 (432)
|+|+.+.... ......||+.|+|||++. +..++.++||||+||++|||++|.+||.+............
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 9998764221 123356999999999884 66789999999999999999999999988743332222111
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
...... . .. ...+.++.++.++++.|++.+|++||+..++++
T Consensus 250 ~~~~~~--------------~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 250 FIKRLH--------------E---GK-------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhh--------------h---hh-------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000 0 00 012356789999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=312.54 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=192.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC-EEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN-ELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 81 (432)
+|.-.+.||+|+||.||+|....+ ..||||++....... ...+.+|+.++.+++|||+|+|+|||.+.+ +.+||+||
T Consensus 76 ~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 76 NFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred CCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 456668999999999999986554 889999887654331 334789999999999999999999999888 59999999
Q ss_pred CCCc-HHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCceeEeCC-eEEEeeeccceecCC-CCC
Q 014039 82 MEHN-LYHIMRERQI-PFSEGEIRSFMSQMLQGLAHMHRNG---YFHRDLKPENLLVTND-VLKIADFGLARELSS-MPP 154 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~-~l~~~~~~~i~~qIl~aL~~LH~~g---ivHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~ 154 (432)
|+.+ |.+.+..... ++++....+|+.++++||+|||+.. |+|||||++|||+|++ +.||+|||+|+.... ...
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc
Confidence 9864 5555554444 8999999999999999999999864 9999999999999977 999999999966554 222
Q ss_pred Cccc-cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHhCCCCCCCchhhhhhh
Q 014039 155 YTEY-VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ--LYKVC-CILGAPDWTAFPEATNIS 230 (432)
Q Consensus 155 ~~~~-~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~--~~~i~-~~~g~p~~~~~~~~~~~~ 230 (432)
.... .||..|+|||.+. ....+.++||||||++|+||++|+.+......... +..+. ..+...
T Consensus 234 ~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~------------ 300 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG------------ 300 (361)
T ss_pred eeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc------------
Confidence 2223 8999999999884 46789999999999999999999987765331111 22211 111111
Q ss_pred hhhhccccccCCCCcc-ccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLS-DIIP--NASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~-~~~~--~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+.++....+. .-.+ ..-..+..+..+|++.+|.+||++.|+++.
T Consensus 301 -----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 301 -----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred -----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 11111111111 0000 112236788899999999999999997543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=320.07 Aligned_cols=248 Identities=27% Similarity=0.324 Sum_probs=199.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+..+...||+|.||+||+|++-. .||||+++......+ .+.+.+|+.++++-+|.||+=+.|++..... .||+-+
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 45678899999999999997644 399999987665544 3446789999999999999999999988776 999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec---CCCCCCc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL---SSMPPYT 156 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~---~~~~~~~ 156 (432)
|+|+ |+..+......|.....+.|+.||++|+.|||.++|+|||||..||++.++ .|||+|||+|..- .......
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 9985 555555555679999999999999999999999999999999999999985 9999999999643 2333344
Q ss_pred cccCCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..-|...|||||++.. ...|++.+|||||||++|||++|..||.... .||+.- ..|..
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIif---mVGrG---------------- 608 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQIIF---MVGRG---------------- 608 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheEE---Eeccc----------------
Confidence 4567788999999853 3579999999999999999999999998444 333211 11211
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..-..+..+..+++.++++|+..|+.+++++||...+||.
T Consensus 609 -----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 -----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 0011223344578889999999999999999999999887
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.02 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=200.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCe---E-EEEEEecccc--cchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYE---I-VAVKKMKRKF--YFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~---~-vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
+-.+.++||+|+||.||+|..+..+. . ||+|..+.+. .......+.+|+++|++++|||||++||+...+..+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34567899999999999998765422 3 8999988532 3344455789999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 77 FIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
+|||+|.|+ |.+.+++..+.++..+...++++.+.||+|||+++++||||-..|+|++.+ .+||+|||+++.-..-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 999999875 556666666679999999999999999999999999999999999999976 779999999976542111
Q ss_pred Ccccc-CCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 155 YTEYV-STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 155 ~~~~~-~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
....+ -...|+|||.+. ...|+.++||||+||++||+++ |..||++....+...+|....-..
T Consensus 318 ~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~-------------- 382 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM-------------- 382 (474)
T ss_pred ccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC--------------
Confidence 11112 345699999995 5589999999999999999999 899999999988887773211100
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+.++..++.+|+..||++|||+.++.+
T Consensus 383 --------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 --------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111256778899999999999999999988875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.42 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=186.5
Q ss_pred eeEeecCceEEEEEEEcCC--CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVET--YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+.||+|+||.||+|..... ...+++|.+.............+|+.+++.++||||+++++.+.+....|+||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 34567777765443334455778999999999999999999999988999999999865
Q ss_pred -HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---CCCcc
Q 014039 86 -LYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---PPYTE 157 (432)
Q Consensus 86 -ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---~~~~~ 157 (432)
|.+.+... ...+++..++.++.||+.||+|||+.|++||||||+|||++.+ .+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 44455432 2346778889999999999999999999999999999999855 9999999998643221 11234
Q ss_pred ccCCccccchhhhcC------CCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 158 YVSTRWYRAPEVLLQ------SSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~------~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.+++..|+|||++.. ...++.++||||+||++|||++ |.+||...+..+....++..-....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------- 229 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL----------- 229 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc-----------
Confidence 567889999998742 1245789999999999999996 6778887776655555432111000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.-..+...++..+.+++..|+ .+|++||+++++++
T Consensus 230 -------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 230 -------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 001112346788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.14 Aligned_cols=247 Identities=30% Similarity=0.456 Sum_probs=206.3
Q ss_pred CeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+-+..+.||+|+||.||+|+.- .....||||.++.......++.+.||+++|..|+|||||+|+|++..++.+|+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3456789999999999999753 34567999999988776677788999999999999999999999999999999
Q ss_pred EEecCC-CcHHHHHHHcC---------CC----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEee
Q 014039 78 IFEYME-HNLYHIMRERQ---------IP----FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIAD 142 (432)
Q Consensus 78 V~E~~~-~~ll~~~~~~~---------~~----l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~D 142 (432)
|+|||. |+|.++++... .+ |+..+...++.||+.|+.||-++.+|||||-..|+||.++ .|||+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecc
Confidence 999998 56666766431 23 8899999999999999999999999999999999999998 999999
Q ss_pred eccceecCCCCCCc---cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014039 143 FGLARELSSMPPYT---EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 143 FG~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
||+++.+-..+=+. ...-...|||||.|+ ...|++++||||+||+|||+++ |.-|+.|.+..+.++.|..
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~----- 720 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA----- 720 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-----
Confidence 99998754322111 112234699999996 6679999999999999999998 8899999998888777632
Q ss_pred CCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..+-+.+.+++.++.+|+..|++..|.+||+..||-.
T Consensus 721 ------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 721 ------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred ------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1112334589999999999999999999999988743
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=295.95 Aligned_cols=264 Identities=28% Similarity=0.384 Sum_probs=196.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEc----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (432)
++|++.+.||+|+||.||+|... .+++.+|+|++...........+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46889999999999999999864 45889999999865443234456789999999999999999999876 5678
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
++||||+++ ++.+.+......+++..+..++.||+.||+|||+.|++|+||||+||+++.+ .+||+|||.+.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 999999976 5555555554469999999999999999999999999999999999999865 99999999998765321
Q ss_pred CC----ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 PY----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.. ....++..|+|||.+. ...++.++|||||||+++||++|..||....... ....|....... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~--~~~~ 235 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQMI--VTRL 235 (284)
T ss_pred cceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccccc--HHHH
Confidence 11 1223456699999885 5578999999999999999999998886543211 011111100000 0000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......... ......++.++.+|+.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 236 LELLKEGER-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred HHHHHcCCc-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 000000000 01123466889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=295.19 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=191.4
Q ss_pred eeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCC------
Q 014039 4 YKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENN------ 73 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------ 73 (432)
|++.++||+|+||.||+|... .+++.||||++..+.... ......+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 778899999999999999864 467899999997654332 3334678999999999999999999875421
Q ss_pred EEEEEEecCCCcHH-HHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 74 ELFFIFEYMEHNLY-HIMRER-----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 74 ~~~lV~E~~~~~ll-~~~~~~-----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
..++++||+.++.+ ..+... ...+++..++.++.||+.||+|||+.||+||||||+||+++++ .+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788999986544 443221 1257899999999999999999999999999999999999865 9999999999
Q ss_pred eecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCC
Q 014039 147 RELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTA 222 (432)
Q Consensus 147 ~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~ 222 (432)
+....... .....++..|++||.+. ...++.++|||||||++|||++ |.+||.+....+....+.. +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~~---- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK--GNR---- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CCc----
Confidence 86643221 12234456799999884 5668899999999999999999 8999987766443333321 000
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....+..+.++.+++.+||+.+|++|||+.|++++
T Consensus 234 -----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 -----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.19 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=211.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe-----CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE-----NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-----~~~~ 75 (432)
+.|+++.+||.|.+|.||+++++.++..+|+|++......+++ +.-|.++|+.. .|||++.+|++|.. .+.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deE--iE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEE--IELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHH--HHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 4589999999999999999999999999999999876654444 34588999988 79999999999843 5789
Q ss_pred EEEEecCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 76 FFIFEYMEHNLYHIMRE--RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~--~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
|||||||.|+..-++.+ .+..+.|+.+..+++.+++||.+||.+.++|||||-.|||++.+ .|||+|||.+..+...
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 99999998765544433 25689999999999999999999999999999999999999855 9999999999877543
Q ss_pred -CCCccccCCccccchhhhcCC----CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQS----SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
....+.+|||+|||||++... ..|+..+|+||||++..||.-|.||+-+..+.-.+.+|- ..|+..
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPPk------ 247 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPK------ 247 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCcc------
Confidence 345678999999999999643 357889999999999999999999998887765555441 111111
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+ .-+.+.+.++.|||+.||.+|-.+||+..++|+|||+.+
T Consensus 248 -----------------L-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 -----------------L-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -----------------c-cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 0 112457889999999999999999999999999999984
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=301.44 Aligned_cols=278 Identities=31% Similarity=0.541 Sum_probs=214.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC---CCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+.|..+++||.|+|++||+|.+.. ..+.||+|.+..-.. -..+.+|+++|..+ .+.||+++.+++..++.+.+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 568999999999999999999887 789999999975432 22367899999999 79999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCC---
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSM--- 152 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~--- 152 (432)
|+||++..-...+.. .++..+++.|++.++.||.++|++||+||||||+|+|.+. +.-.|+|||+|......
T Consensus 113 vlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred EecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 999999876665554 3678899999999999999999999999999999999985 48899999999621100
Q ss_pred ------------C------------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHH
Q 014039 153 ------------P------------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILA 190 (432)
Q Consensus 153 ------------~------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ 190 (432)
. ......||+.|+|||++++....++++||||.|+|+.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0 0122468999999999999999999999999999999
Q ss_pred HHHhCCCCC-CCCChHHHHHHHHHHhCCCCCCC---------chhhhhhhhh--hhcccccc-----CC-----CCcccc
Q 014039 191 ELFTLSPIF-PGDSEIDQLYKVCCILGAPDWTA---------FPEATNISRL--ISISYSEI-----LP-----INLSDI 248 (432)
Q Consensus 191 ell~g~~pF-~~~~~~d~~~~i~~~~g~p~~~~---------~~~~~~~~~~--~~~~~~~~-----~~-----~~~~~~ 248 (432)
-++++..|| ...++.+.+.+|+..+|.-.-.. +.+..+.... ....|... .+ ......
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 999987665 66778888999888887522110 0000000000 00111111 11 111112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 249 IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 249 ~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+..+.||+.+||..||.+|.||+|+|.||||..
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 2345668999999999999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.57 Aligned_cols=247 Identities=29% Similarity=0.444 Sum_probs=206.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCC-----eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETY-----EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
.-++.+.||+|+||.||.|...... ..||+|.+++.....+...+++|..+|+.++|||||++++++-+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3467889999999999999865432 24999999988777777778999999999999999999999998999999
Q ss_pred EEecCCC-cHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 78 IFEYMEH-NLYHIMRER------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
++|||.| +|+.++++. ...++..+...++.||++|..||+++++|||||-..|+|++.. .+||+|||+|+.+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 9999986 577777765 4569999999999999999999999999999999999999976 9999999999955
Q ss_pred CCCCCCcc---ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 150 SSMPPYTE---YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 150 ~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
...+-+.. ..-...|||||.+. ...++.++||||||+++||+++ |..||++.+..+.+.-.... |.
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-gR-------- 922 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-GR-------- 922 (1025)
T ss_pred hhchheeccCccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-Cc--------
Confidence 43221111 11124699999985 5889999999999999999998 99999999988876644221 10
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
+ +.++.++..+.+++.+|++.+|++||+...|++
T Consensus 923 -----------L---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 -----------L---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------c---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0 123478889999999999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.80 Aligned_cols=242 Identities=43% Similarity=0.674 Sum_probs=198.3
Q ss_pred CceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC-cHHHHHHH
Q 014039 14 TCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRE 92 (432)
Q Consensus 14 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~-~ll~~~~~ 92 (432)
+||.||+|.+..+|+.+|+|++.............+|++.+++++|+||+++++++......++++|++++ ++...+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999999999999998654433244567899999999999999999999998999999999998 55555544
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCccccchhhhc
Q 014039 93 RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171 (432)
Q Consensus 93 ~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~ 171 (432)
. ..++...+..++.+++.+|.+||+.|++|+||+|.||+++++ .++|+|||.+.............++..|++||.+.
T Consensus 81 ~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 81 R-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred c-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 3 348999999999999999999999999999999999999865 99999999998876654556678899999999885
Q ss_pred CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCC
Q 014039 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPN 251 (432)
Q Consensus 172 ~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (432)
...++.++||||+|+++++|++|..||......+...+.+ ....... ......
T Consensus 160 -~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~-----------------------~~~~~~ 212 (244)
T smart00220 160 -GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI---GKPKPPF-----------------------PPPEWK 212 (244)
T ss_pred -cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---hccCCCC-----------------------cccccc
Confidence 5667889999999999999999999998744333333321 1111110 000111
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 252 ASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 252 ~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
++.++.+++.+||..||++||++.++++||||
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 67789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.14 Aligned_cols=267 Identities=21% Similarity=0.326 Sum_probs=182.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc----------------CCCeEEEEEEecccccchH-------------HHHHHHHHH
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV----------------ETYEIVAVKKMKRKFYFWE-------------ECMNLREVK 52 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~----------------~~~~~vAiK~i~~~~~~~~-------------~~~~~~Ei~ 52 (432)
++|++.++||+|+||+||+|... ..++.||||++........ ......|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999999752 3456799999864322110 111235777
Q ss_pred HHHhcCCCcc-----cccceEEEe--------CCEEEEEEecCCCcHH-HHHHHcC-----------------------C
Q 014039 53 ALRKLNHPNI-----IKLKEVVRE--------NNELFFIFEYMEHNLY-HIMRERQ-----------------------I 95 (432)
Q Consensus 53 ~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~~ll-~~~~~~~-----------------------~ 95 (432)
++.++.|.++ +++++++.. .+..+|||||++++.+ +.+.... .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7787766544 667776642 3568999999987544 4333211 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc--ccCCccccchhhhcC
Q 014039 96 PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE--YVSTRWYRAPEVLLQ 172 (432)
Q Consensus 96 ~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~--~~~t~~y~aPE~l~~ 172 (432)
.+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++.......... ..+|+.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 24567789999999999999999999999999999999865 999999999976544332222 234789999999853
Q ss_pred CCC-------------------CC--cccceechHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 173 SSS-------------------YS--PAIDMWAVGAILAELFTLSP-IFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 173 ~~~-------------------~~--~~~DiWSlG~il~ell~g~~-pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
... |+ .+.||||+||++|+|++|.. +|.+........+. .. ....
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~~----------~~~~ 451 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---YD----------NDLN 451 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---cc----------chHH
Confidence 221 22 24799999999999999875 66543222111100 00 0000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDP---LRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP---~~Rpta~elL~Hp~f~~ 285 (432)
.+... ......+ ..+...+.+++|||.+||..+| .+|+|++|+|+||||..
T Consensus 452 ~~r~~---~~~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 452 RWRMY---KGQKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHhh---cccCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00000 0001111 1345678999999999999876 68999999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=305.91 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=201.4
Q ss_pred EeeeEeecCceEEEEEEEcC--CC--eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 6 ILEELGDGTCGCVYKAFNVE--TY--EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~--~~--~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+.++||.|.||.||+|.... .| -.||||..+.+...+....++.|..+|++++||||++|+|++.+. ..+||||+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 45689999999999997532 23 348999999877777888899999999999999999999999874 57999999
Q ss_pred CC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 82 ME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
++ |.|-.++..+...++......|++||+.||+|||+.++|||||-..||||... -|||+|||+++.+....-+....
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 98 55666677777789999999999999999999999999999999999999865 89999999999887755444433
Q ss_pred CC--ccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 160 ST--RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 160 ~t--~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
|- .-|||||.+ ....++.++|||.||++|||++. |..||.|-...|.+-.|.+.
T Consensus 552 ~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG---------------------- 608 (974)
T KOG4257|consen 552 GKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG---------------------- 608 (974)
T ss_pred cccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC----------------------
Confidence 32 359999998 57889999999999999999776 99999998777665444211
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL 278 (432)
.-.+.++++++.+..|+.+|+.+||.+||+..|+.
T Consensus 609 -------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 609 -------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 11124568999999999999999999999975543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.26 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=216.8
Q ss_pred eeEeeeEeecCceEEEEEEEcCCC---eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 4 YKILEELGDGTCGCVYKAFNVETY---EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
-++.++||.|.||+|++|+.+..| ..||||.++.......+..++.|+.||-+++||||++|.++......+.||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 467889999999999999988666 44999999988877777789999999999999999999999999999999999
Q ss_pred cCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-Ccc
Q 014039 81 YMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-YTE 157 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-~~~ 157 (432)
||+.+ |-.+++.+.+.|+..++..+++.|+.|++||-+.|+|||||-..||||+.+ .+|++|||+++.+.++.+ ..+
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 99865 445667777889999999999999999999999999999999999999998 999999999998866542 222
Q ss_pred ccC---CccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 158 YVS---TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 158 ~~~---t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..| ...|.|||.|. ...++.++||||+|++|||.|+ |..||-+.++.|.+..|.+.++.|+.-
T Consensus 791 t~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm------------ 857 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM------------ 857 (996)
T ss_pred ccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC------------
Confidence 222 24699999995 6789999999999999999776 999999999999999998877766643
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.++..+..|+..|+++|-.+||...||+.+
T Consensus 858 -----------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 858 -----------------DCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 578889999999999999999999999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.54 Aligned_cols=241 Identities=30% Similarity=0.479 Sum_probs=188.0
Q ss_pred eeeEeecCce-EEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCCC
Q 014039 7 LEELGDGTCG-CVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 7 ~~~IG~G~fg-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
.+.+|.|+-| .||+|.. .|+.||+|.+..... ....||++.|+.- +|||||++++.-.+....||..|.|.+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHhH----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 3568899887 6899954 678999999876543 2356999999998 799999999999999999999999999
Q ss_pred cHHHHHHHc--CCCC-CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----C--eEEEeeeccceecCCCCC-
Q 014039 85 NLYHIMRER--QIPF-SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----D--VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 85 ~ll~~~~~~--~~~l-~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~--~lkL~DFG~a~~~~~~~~- 154 (432)
+|.+.+... ...+ .....+.++.|++.||++||+.+||||||||+||||+. + .++|+|||+++.+..+..
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999988763 1111 11456889999999999999999999999999999974 2 899999999998865432
Q ss_pred ---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 155 ---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 155 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....||-.|+|||++. ...-+.++||+|+||++|..++| ..||...-..+. .|+ .|.....
T Consensus 668 ~~r~s~~sGt~GW~APE~L~-~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl--~~~~~L~--------- 733 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLR-EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NIL--TGNYTLV--------- 733 (903)
T ss_pred hhcccCCCCcccccCHHHHh-ccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhh--cCcccee---------
Confidence 34567999999999995 44457799999999999988775 899955432111 110 1111100
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
.+-+....+|.|||.+||++||..||+|.++|.||||
T Consensus 734 ----------------~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 734 ----------------HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred ----------------eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 1111112289999999999999999999999999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.03 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=208.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcC-CCe--EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVE-TYE--IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+.++.+.||+|.||+|++|.... +|+ .||+|.++..........+++|+.+|.+|+|+|+++||++..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44567889999999999998753 333 3899999876655555668899999999999999999999987 6678999
Q ss_pred ecCCC-cHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCc
Q 014039 80 EYMEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 80 E~~~~-~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~ 156 (432)
|++++ +|++.+++ ....|.......|+.||+.|+.||.++++|||||-..|+|+-. ..|||||||+.+.+..++.+.
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99985 68888877 4567899999999999999999999999999999999999974 599999999999998766554
Q ss_pred cccC----CccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 157 EYVS----TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 157 ~~~~----t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+ ...|+|||.+ +...++.++|+|++||.+|||++ |..||.|....+.+.+|-. |.
T Consensus 270 vm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--~e-------------- 332 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--GE-------------- 332 (1039)
T ss_pred EecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--cc--------------
Confidence 3322 2359999998 57789999999999999999998 8999999999888887621 00
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.-.-.+.++.++.+++.+|+..+|.+|||...|.+.-+..
T Consensus 333 -------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 333 -------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred -------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 0112346899999999999999999999998887654443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.58 Aligned_cols=208 Identities=24% Similarity=0.389 Sum_probs=179.9
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEecCC
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
..+..||+|+||.|-+.++..+|...|+|.+.......+..+.++|+.+..+. .+|.+|.+|+.+.....++|.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 34567999999999999999999999999998766666667788999877665 89999999999999999999999999
Q ss_pred CcHHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEe-CCeEEEeeeccceecCCCCCCccc
Q 014039 84 HNLYHIM---RERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 84 ~~ll~~~---~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
.++-.+. ..+++.++|..+-+++..++.||.|||++ .++|||+||+||||+ .|++|+||||.+..+.+.-..+..
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d 208 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD 208 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence 8755544 45678999999999999999999999987 999999999999999 459999999999888765555556
Q ss_pred cCCccccchhhhc---CCCCCCcccceechHHHHHHHHhCCCCCCC-CChHHHHHHHH
Q 014039 159 VSTRWYRAPEVLL---QSSSYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVC 212 (432)
Q Consensus 159 ~~t~~y~aPE~l~---~~~~~~~~~DiWSlG~il~ell~g~~pF~~-~~~~d~~~~i~ 212 (432)
.|...|+|||.+. ....|+-++||||||+.+.||.+++.||+. .++..|+.++.
T Consensus 209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 7888999999984 334799999999999999999999999864 57777777764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=288.34 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=201.3
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
..+..+||-|.||.||.|..++..-.||+|.++.+.- +...++.|+.+|+.+.|||+|+|+++|..+..+|||+|||.
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 3456789999999999999999999999999986543 45567899999999999999999999999999999999986
Q ss_pred -CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccC
Q 014039 84 -HNLYHIMRERQI-PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 84 -~~ll~~~~~~~~-~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
|+|+++++...+ -++.-.+..++.||..|+.||..+++|||||-..|+||.++ .||++|||+++.... ..++.-.|
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTYTAHAG 425 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTYTAHAG 425 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC-CceecccC
Confidence 789999987543 46677778999999999999999999999999999999977 999999999987654 23333333
Q ss_pred ---CccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 161 ---TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 161 ---t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..-|.|||-+. ...++.++|||+||++|||+.| |-.||+|-+.......+.+.+ ...
T Consensus 426 AKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------------------RM~ 486 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------------------RMD 486 (1157)
T ss_pred ccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc------------------ccc
Confidence 34599999884 5567999999999999999998 889999987654443332211 111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
-+..|++.+.+|++.|++++|.+||+.+|+-+
T Consensus 487 -----------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 487 -----------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -----------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 12478999999999999999999999887644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=284.80 Aligned_cols=254 Identities=27% Similarity=0.366 Sum_probs=203.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+..+.++||+|.||+|.++.. ..+..||+|+++..........+.+|+++|.+|+||||+.|+++|..++.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 346788999999999999974 3468899999998887777777889999999999999999999999999999999999
Q ss_pred CCc-HHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC---c
Q 014039 83 EHN-LYHIMRERQIP-FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---T 156 (432)
Q Consensus 83 ~~~-ll~~~~~~~~~-l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~---~ 156 (432)
+.+ +..++....-+ +.......++.||+.|++||.+.++|||||.+.|+|++.+ ++||+|||+++.+-.++-+ .
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 865 44555544323 3555667799999999999999999999999999999977 9999999999976443322 2
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF--TLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell--~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..+-...|||+|.++ ...+++++|+|++|+.+||++ +...||....+.+........+..+.....
T Consensus 698 r~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~----------- 765 (807)
T KOG1094|consen 698 RAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV----------- 765 (807)
T ss_pred ceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-----------
Confidence 234457799999997 556899999999999999976 477888777776665555444443332211
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...++-++.++.+++-+|+.+|-.+||+.+++-.|
T Consensus 766 -----------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 766 -----------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred -----------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 11224578899999999999999999999998654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=318.16 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=184.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
.|+..+.||+|+||.||+|+++.++..||+|++...... ..+|+++|++++|||||++++++.+....|+||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 455677899999999999999999999999998753321 235789999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH---RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH---~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
+++.+..+.+ .+++..+..++.||++||+||| +.+|+||||||+||+++.+ ..+++ ||.+..... ....
T Consensus 766 ~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~ 838 (968)
T PLN00113 766 EGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKC 838 (968)
T ss_pred CCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCc
Confidence 8765555543 3889999999999999999999 6699999999999999866 55554 665544322 1234
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+|+.|+|||++. ...|+.++||||+||++|||++|+.||...... ..+.+.....-.. .....+.+...
T Consensus 839 ~~t~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 909 (968)
T PLN00113 839 FISSAYVAPETRE-TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD--------CHLDMWIDPSI 909 (968)
T ss_pred cccccccCccccc-CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc--------cchhheeCccc
Confidence 7889999999884 667999999999999999999999998543211 1111111100000 00000000000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. . . .........++.+++.+|++.||++|||+.|+++.
T Consensus 910 ~---~-~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 R---G-D-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred c---C-C-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0 0 0 00011223467899999999999999999999876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=291.68 Aligned_cols=258 Identities=29% Similarity=0.428 Sum_probs=216.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++.++|.|+||.||+|+++.+++..|+|+++-... +.......|+-+++..+|||||.+++.+.....+++.|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 589999999999999999999999999999999986542 2333456899999999999999999999988999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
|+|+.++.+..-.++++|.++..+.+..++||+|||+.|-+|||||-.|||+++ +.+|+.|||.+..+... ....+++
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksfi 173 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFI 173 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhccc
Confidence 999988888888889999999999999999999999999999999999999974 59999999998766432 3456789
Q ss_pred CCccccchhhh--cCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVL--LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l--~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
||++|||||+- .+...|....|||++|+...|+.--++|-........+..+-+-.-.|+
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------------------ 235 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------------------ 235 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC------------------
Confidence 99999999985 3556899999999999999999988888766665544443321111111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+.+ ..+.++-+.+|++.+|.++|.+|||++.+|.|||...
T Consensus 236 ------~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 ------TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------cccC-CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 0000 1245778899999999999999999999999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=285.12 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=199.3
Q ss_pred eEeeeEeecCceEEEEEEEc----C---CCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEE
Q 014039 5 KILEELGDGTCGCVYKAFNV----E---TYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~----~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 76 (432)
++.+.||+|+||.|++|.-. . ....||+|.++......+...+..|+++|+.+ .|+||+.+.+++...+.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 46679999999999999743 1 14569999999877766667788999999999 6999999999999899999
Q ss_pred EEEecCC-CcHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 77 FIFEYME-HNLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 77 lV~E~~~-~~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
+|+||+. |+++..++.++ ..++..+...+++||+.|++||++.+++||||-..|||+.++ .+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 9999997 57777777765 348999999999999999999999999999999999999987 999
Q ss_pred EeeeccceecCCCCCCcc--ccC--CccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014039 140 IADFGLARELSSMPPYTE--YVS--TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCI 214 (432)
Q Consensus 140 L~DFG~a~~~~~~~~~~~--~~~--t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~ 214 (432)
|+|||+|+.......+.. ..+ ...|||||.+. ...|+.++||||+|++|||+++ |..|+++-.....+.+.++
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~- 536 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK- 536 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhc-cCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh-
Confidence 999999997655443321 122 22399999996 4889999999999999999998 8899988552222222111
Q ss_pred hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 215 LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 215 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
... -.+.+..++.++.++++.|++.+|++||+..++.+.
T Consensus 537 --~G~-------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 537 --EGN-------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred --cCC-------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 100 011234689999999999999999999999888753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=272.38 Aligned_cols=197 Identities=28% Similarity=0.464 Sum_probs=171.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH-------HHHHHHHHHHhcC---CCcccccceEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC-------MNLREVKALRKLN---HPNIIKLKEVVRE 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-------~~~~Ei~~l~~l~---hpnIv~l~~~~~~ 71 (432)
.+|..++.+|.|+||.|++|.++++...|+||.+.+++...... ..-.||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46999999999999999999999999999999998766432211 1236999999996 9999999999999
Q ss_pred CCEEEEEEecCCC--cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeecccee
Q 014039 72 NNELFFIFEYMEH--NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARE 148 (432)
Q Consensus 72 ~~~~~lV~E~~~~--~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~ 148 (432)
++.+||+||--.. +|.+.+. ....++|.+++.+++|++.|+++||+.||+|||||-+|+.++. |-+||+|||.|..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999998764 4555554 4457999999999999999999999999999999999999985 5999999999966
Q ss_pred cCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCC
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFP 200 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~ 200 (432)
... .+...++||..|.|||++-+..+.+..-|||++|++||-++....||.
T Consensus 720 ~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 544 567889999999999999777777999999999999999998887774
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=275.83 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=199.8
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeE----EEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEI----VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+..++||.|+||+||+|.....|+. ||||++...........+++|+-+|.+++|||+++|++++.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999987655554 78888876655556667889999999999999999999997755 789999
Q ss_pred cCC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCCCccc
Q 014039 81 YME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 81 ~~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||+ |.|++.++..+..+-......|.+||++|+.|||+++++||||-..||||. .+.+||.|||+|+.+.....-...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 998 568899888888999999999999999999999999999999999999998 469999999999988765432222
Q ss_pred c---CCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 159 V---STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 159 ~---~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
. -.+-|+|-|.+ ....|+.++||||+||.+||+|| |..|+.+....+.-..+. .+.+
T Consensus 858 ~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----~geR-------------- 918 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----KGER-------------- 918 (1177)
T ss_pred cccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----cccc--------------
Confidence 2 23458999988 47889999999999999999998 888888877654433321 1110
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
-.-++.++.++.-++.+||..|+..||+++++-+
T Consensus 919 -----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 -----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0123568999999999999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-30 Score=236.77 Aligned_cols=211 Identities=43% Similarity=0.637 Sum_probs=181.3
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC-cHHH
Q 014039 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYH 88 (432)
Q Consensus 10 IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~-~ll~ 88 (432)
||+|++|.||++.+..+++.+++|+..............+|++.++.+.|++|+++++++......+++||++++ ++..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999998889999999998665432334567899999999999999999999988999999999995 5555
Q ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCCC-CCccccCCcccc
Q 014039 89 IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSMP-PYTEYVSTRWYR 165 (432)
Q Consensus 89 ~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~-~~~~~~~t~~y~ 165 (432)
.+......++...++.++.+++++|.+||+.|++|+||+|.||+++. +.++|+|||.+....... ......+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 55444356899999999999999999999999999999999999997 599999999998765432 134456788899
Q ss_pred chhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCc
Q 014039 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINL 245 (432)
Q Consensus 166 aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (432)
+||.+.....++.+.|+|++|+++++|
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------------- 187 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------------- 187 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------------
Confidence 999985433788999999999999998
Q ss_pred cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 246 SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 246 ~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
..+.+++.+||+.||++||++.++++|+
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1577999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=258.00 Aligned_cols=257 Identities=28% Similarity=0.345 Sum_probs=181.4
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHh--cCCCcccccceEEEeC----CEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK--LNHPNIIKLKEVVREN----NELFF 77 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~----~~~~l 77 (432)
-++...||+|.||.||+|+. +++.||||++.... .+....|.+|.+. +.|+||+++++.-+.. .+++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhc--cCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 45678899999999999965 55899999987432 2334556666665 4899999999886543 47899
Q ss_pred EEecCC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 78 IFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN---------GYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 78 V~E~~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~---------givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
|+||.+ |+|.+.+..+ .+++....+++..+++||+|||+. .|+|||||..||||.+| ++-|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999998 5566666554 699999999999999999999963 59999999999999977 9999999999
Q ss_pred eecCCCCC---CccccCCccccchhhhcCCCCCC-----cccceechHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCC
Q 014039 147 RELSSMPP---YTEYVSTRWYRAPEVLLQSSSYS-----PAIDMWAVGAILAELFTLSPIFP-GDSEIDQLYKVCCILGA 217 (432)
Q Consensus 147 ~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~-----~~~DiWSlG~il~ell~g~~pF~-~~~~~d~~~~i~~~~g~ 217 (432)
..+....+ ....+||+.|||||++.+.-+.. .++||||+|.+|+||++....+. +..+.-++---.++--.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 98865433 34478999999999996655554 47899999999999999876653 22211111111111112
Q ss_pred CCCCCchhhhhhhhhhhccccccCCCCccccC-C-CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014039 218 PDWTAFPEATNISRLISISYSEILPINLSDII-P-NASMEAIDLIWQLCSWDPLRRPTADQA 277 (432)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~s~~~~dli~~~L~~dP~~Rpta~el 277 (432)
|..+++.. .....+. ...+...+ . ..-..+++.+..|+..||+.|.||.=+
T Consensus 444 Pt~e~mq~-----~VV~kK~----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 444 PTLEEMQE-----LVVRKKQ----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCHHHHHH-----HHHhhcc----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 22222110 0001111 11111111 1 123457899999999999999998543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=235.62 Aligned_cols=202 Identities=40% Similarity=0.621 Sum_probs=172.2
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
|.+.+.||.|++|.||++.+..+++.+|+|.+.............+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999998999999999865443234456689999999999999999999998889999999999
Q ss_pred C-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCcccc
Q 014039 84 H-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTEYV 159 (432)
Q Consensus 84 ~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~~~ 159 (432)
+ ++.+.+......+++..+..++.|++.+|.+||+.|++|+||+|.||+++.+ .++|+|||.+....... ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 8 5555554443228999999999999999999999999999999999999964 99999999998876543 334567
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCC-CChH
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPG-DSEI 205 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~-~~~~ 205 (432)
++..|++||.+.....++.++|+|++||++++|++|..||.+ .+..
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 888999999875456778899999999999999999999977 3443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.32 Aligned_cols=198 Identities=19% Similarity=0.239 Sum_probs=148.0
Q ss_pred hcCC-CcccccceEE-------EeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q 014039 56 KLNH-PNIIKLKEVV-------RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLK 127 (432)
Q Consensus 56 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlk 127 (432)
.+.| +||++++++| .....++++||+++++|.+.+......+++.+++.+++||++||+|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5788888877 2234678899999999988887656679999999999999999999999999999999
Q ss_pred CCceeEeC--------------------CeEEEeeeccceecCCCC-----------------CCccccCCccccchhhh
Q 014039 128 PENLLVTN--------------------DVLKIADFGLARELSSMP-----------------PYTEYVSTRWYRAPEVL 170 (432)
Q Consensus 128 P~NILl~~--------------------~~lkL~DFG~a~~~~~~~-----------------~~~~~~~t~~y~aPE~l 170 (432)
|+||||+. +.+|++|||+++...... .....++|++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999952 157777777776432100 01124689999999998
Q ss_pred cCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCC
Q 014039 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIP 250 (432)
Q Consensus 171 ~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (432)
. ...|+.++|||||||+||||++|.+++..... ....+.... .++ ...
T Consensus 188 ~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~----------------------------~~~ 235 (793)
T PLN00181 188 N-GSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPP----------------------------QIL 235 (793)
T ss_pred c-cCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cCh----------------------------hhh
Confidence 5 56689999999999999999999887653221 111111000 000 000
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 251 NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 251 ~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+++.+++.+||+.||.+||++.|+|+||||..
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 12346779999999999999999999999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=239.96 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=193.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceE-EEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEV-VRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~-~~~~~~~~lV~ 79 (432)
+.|.+.+.||+|-||.+-++.|+.++..+++|.+.+... ....+.||..---.| .|.||+.-|++ |++.+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 569999999999999999999999999999999987654 344456776654445 58999998886 57777788999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CC--eEEEeeeccceecCCCCCC
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-ND--VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~--~lkL~DFG~a~~~~~~~~~ 155 (432)
||++- +|...+... .+-|...++++.|++.|+.|||++++||||||.+||||- .+ .+||||||..+..+..-..
T Consensus 102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 99985 454444443 488999999999999999999999999999999999995 34 9999999999876653322
Q ss_pred ccccCCccccchhhhcCC----CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCCCCchhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQS----SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY-KVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~----~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~-~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.. .+..|.+||+...- -...+..|+|.||+|+|.+++|.+||....-.|+.+ +.++
T Consensus 180 ~~--~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~----------------- 240 (378)
T KOG1345|consen 180 LE--YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ----------------- 240 (378)
T ss_pred hh--hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-----------------
Confidence 22 34568999987422 234778999999999999999999997544333221 1111
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR---PTADQALQHPFFN 284 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R---pta~elL~Hp~f~ 284 (432)
+.+.+-..+++.+..+++.+..+.++-|..++++| .++.+....-|..
T Consensus 241 ------w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 241 ------WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ------HhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 11222234556677899999999999999999999 4555555555543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=238.40 Aligned_cols=245 Identities=28% Similarity=0.389 Sum_probs=176.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHh--cCCCcccccceEEEeC----CEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK--LNHPNIIKLKEVVREN----NELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~----~~~~ 76 (432)
+-.+++.||+|.||+||+|.. -|+.||+|++... ++....||.++.+. |+|+||+.+++.-..+ .++|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccc--cCCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 457899999999999999955 5788999998643 22334577777766 4999999998764222 4689
Q ss_pred EEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 77 FIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN--------GYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~--------givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
||++|.+. +|++++.. ..++.+...++++.++.||++||.. .|.|||||..||||.++ .+-|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999985 56665554 3799999999999999999999953 49999999999999855 9999999999
Q ss_pred eecCCC-----CCCccccCCccccchhhhcCCCCC-----CcccceechHHHHHHHHhC----------CCCCCC----C
Q 014039 147 RELSSM-----PPYTEYVSTRWYRAPEVLLQSSSY-----SPAIDMWAVGAILAELFTL----------SPIFPG----D 202 (432)
Q Consensus 147 ~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~-----~~~~DiWSlG~il~ell~g----------~~pF~~----~ 202 (432)
-..... .+.+..+||..|||||++...-+. -..+||||||.|+||++.. ++||.+ +
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 765443 234667999999999998533221 1268999999999999853 455543 2
Q ss_pred ChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 203 SEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPN--ASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 203 ~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
...+++.+++++- .....+++.+.. .=.....+++.|+..+|.-|.||--+.+
T Consensus 444 Ps~eeMrkVVCv~------------------------~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQ------------------------KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCHHHHhcceeec------------------------ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 2233333332211 111111111111 1124568899999999999999866653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=216.89 Aligned_cols=165 Identities=25% Similarity=0.309 Sum_probs=126.8
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCc
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR 162 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~ 162 (432)
|+|.+.+..+++++++.+++.++.||+.||.|||+.+ ||+|||++.+ .+|+ ||+++..... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 5677777766678999999999999999999999999 9999999865 8888 9999876542 237899
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY-KVCCILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
.|+|||++. ...|+.++||||+||++|||++|.+||.......... .+............
T Consensus 69 ~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 129 (176)
T smart00750 69 YFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR------------------ 129 (176)
T ss_pred cccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc------------------
Confidence 999999985 5678999999999999999999999997765433322 22211111000000
Q ss_pred CCCccccCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 242 PINLSDIIPNAS--MEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 242 ~~~~~~~~~~~s--~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
......+ .++.++|++||+.||.+||++.|+++|+|+.
T Consensus 130 -----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 -----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred -----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0001122 2689999999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-26 Score=219.18 Aligned_cols=258 Identities=34% Similarity=0.520 Sum_probs=206.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCC-cccccceEEEeCCEEEEEEe
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHP-NIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lV~E 80 (432)
|++.+.||.|+||.||++.+. ..+++|.+........ .....+|+++++.+.|+ +|+++++++......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 7799999987655443 55577999999999888 79999999987777899999
Q ss_pred cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCC--
Q 014039 81 YMEHNLYHIMRERQI---PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMP-- 153 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~---~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~-- 153 (432)
++.++.+..+..... .+++..+..++.|++.++.|+|+.|++|||+||+||+++.. .++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999865555444432 69999999999999999999999999999999999999965 69999999998655432
Q ss_pred -----CCccccCCccccchhhhcCC--CCCCcccceechHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC-CCCC
Q 014039 154 -----PYTEYVSTRWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTLSPIFPGDSE---IDQLYKVCCILGAP-DWTA 222 (432)
Q Consensus 154 -----~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiWSlG~il~ell~g~~pF~~~~~---~d~~~~i~~~~g~p-~~~~ 222 (432)
.....++|..|+|||.+... ..++...|+||+|+++++++.|..||..... .......+...+.+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 34677899999999999653 6789999999999999999999999888764 44444444433332 0000
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..... .......+.+++.+++..+|..|.++.+...++|...
T Consensus 239 ~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSN---------------------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccc---------------------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 00000 0122357899999999999999999999999977654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=255.80 Aligned_cols=261 Identities=26% Similarity=0.310 Sum_probs=196.5
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEeccc----ccchHHH-HHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRK----FYFWEEC-MNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~-~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
...+.+|.|++|.|+.+......+.++.|..... ....... ....|.-+-..+.|+|++.....+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999999999988777777777765421 1111111 1345777777889999988877766655555559
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-----C
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-----P 153 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-----~ 153 (432)
|||++++...+... +.+...++..++.||+.||+|||+.||.|||+|++|++++.+ .+||+|||.+....-. .
T Consensus 401 E~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999666555544 468999999999999999999999999999999999999966 9999999999765432 2
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+|+..|+|||++.+.......+||||.|++++.|++|+.||.-....++...-. .+.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--~~~---------------- 541 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--NYS---------------- 541 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--ccc----------------
Confidence 24567899999999999766666778999999999999999999997665544332000 000
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
-..........++..++.+.+.+|.+||+.||.+|.|+++|++.+||+.+.
T Consensus 542 ---~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 542 ---DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ---cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 000111222234445777889999999999999999999999999998754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=226.89 Aligned_cols=172 Identities=20% Similarity=0.283 Sum_probs=130.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcC-CCeEEEEEEecccc----cchHHHHHHHHHHHHHhcCCCcccc-cceEEEeCCE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVE-TYEIVAVKKMKRKF----YFWEECMNLREVKALRKLNHPNIIK-LKEVVRENNE 74 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~~ 74 (432)
+++|++.+.||+|+||+||+|+++. +++.+|||++.... .......+.+|+++|++++|+||+. +++ .+.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence 4689999999999999999999876 78888999875331 1122344679999999999999985 443 246
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCceeEeC-CeEEEeeeccceecCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL-KPENLLVTN-DVLKIADFGLARELSSM 152 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDl-kP~NILl~~-~~lkL~DFG~a~~~~~~ 152 (432)
.|+||||++|+.+.... ... ...++.|+++||.|||++||+|||| ||+|||++. +.+||+|||+|+.+...
T Consensus 93 ~~LVmE~~~G~~L~~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 93 DGLVRGWTEGVPLHLAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred cEEEEEccCCCCHHHhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 79999999987665321 111 1568899999999999999999999 999999975 48999999999876542
Q ss_pred CC---------CccccCCccccchhhhcCC-----CCCCccccee
Q 014039 153 PP---------YTEYVSTRWYRAPEVLLQS-----SSYSPAIDMW 183 (432)
Q Consensus 153 ~~---------~~~~~~t~~y~aPE~l~~~-----~~~~~~~DiW 183 (432)
.. .....+++.|.|||.+... ...+...|-|
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 21 1344677889999987421 2233446666
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=218.38 Aligned_cols=248 Identities=21% Similarity=0.251 Sum_probs=191.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC-----eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE-eCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY-----EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR-ENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~ 75 (432)
+|++....+-+|.||.||.|..++.. +.|-+|.++......+...++.|--.+..+.|||+..+.++.. +....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 35667778889999999999765432 2356777777665555556778999999999999999999874 45667
Q ss_pred EEEEecCCC-cHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 76 FFIFEYMEH-NLYHIMRE-------RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~-------~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
++++.++.- +|-.++.. ..+.++..++..++.|++.|++|||++|++|.||-..|.+|++. .+||+|=.++
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence 788888874 55555541 12357788889999999999999999999999999999999988 9999999999
Q ss_pred eecCCCCCC---ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCC
Q 014039 147 RELSSMPPY---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTA 222 (432)
Q Consensus 147 ~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~ 222 (432)
+.+.+..-. ...-....||+||.+. ...|+.++|+||||++||||++ |+.|+..-++.+...-+.+.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-------- 514 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-------- 514 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--------
Confidence 987653211 0111234599999984 7789999999999999999998 88888887776654433211
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
++... +-+++.++..++.-|+..+|++||+.+|+..
T Consensus 515 ----------yRlaQ-----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ----------YRLAQ-----------PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------ceecC-----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 00001 1278999999999999999999999998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-25 Score=214.87 Aligned_cols=251 Identities=23% Similarity=0.234 Sum_probs=192.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCC-eEEEEEEecccccchHHHHHHHHHHHHHhcC----CCcccccceEE-EeCCEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETY-EIVAVKKMKRKFYFWEECMNLREVKALRKLN----HPNIIKLKEVV-RENNELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~----hpnIv~l~~~~-~~~~~~~ 76 (432)
+|++.+.||+|+||.||++.+..++ +.+|+|........... ....|+.++..+. ..++..+++.. .....-|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988775 67888887754332222 3456888888886 36899999988 4777889
Q ss_pred EEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC------CeEEEeeeccce--
Q 014039 77 FIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN------DVLKIADFGLAR-- 147 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~------~~lkL~DFG~a~-- 147 (432)
+||+.++.+|.+...... +.++...+..++.|++.+|.+||+.|++||||||+|+++.. ..+.|.|||+|+
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 999999999999876554 78999999999999999999999999999999999999973 269999999998
Q ss_pred ecCCC--------CC-CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014039 148 ELSSM--------PP-YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 148 ~~~~~--------~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
.+... .. .....||..|+++.+.. +...+.+.|+||++.++.||+.|..||.+....+...+..+....-
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 32111 11 22355999999999884 6678999999999999999999999998776544433332211110
Q ss_pred CCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
... ......+.+..++...+-..+...+|....+.+.
T Consensus 257 ~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 LTD-------------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccc-------------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 000 0112344567777777777888999987777655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-27 Score=239.01 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=199.7
Q ss_pred eEeecCceEEEEEE---EcCCCeEEEEEEecccccchHHH-HHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEecCC
Q 014039 9 ELGDGTCGCVYKAF---NVETYEIVAVKKMKRKFYFWEEC-MNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 9 ~IG~G~fg~V~~a~---~~~~~~~vAiK~i~~~~~~~~~~-~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
++|+|+||.|++++ -...|..+|+|+.++........ ....|..++...+ ||.+|++...++.++.+|+++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999874 34567789999987654332211 2345888888885 9999999999999999999999999
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccccCCc
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTR 162 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~~~t~ 162 (432)
|+.+-........+.+..++.+...++-+++++|+.||+|||+|++||+++. |.+|+.|||+++........ |||.
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~ 157 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY 157 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence 8766555555567899999999999999999999999999999999999994 58999999999877653332 9999
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCCCCchhhhhhhhhhhccccccC
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC-ILGAPDWTAFPEATNISRLISISYSEIL 241 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (432)
.|||||++. ....++|+||+|++++||++|..+|.+ +....|.+ .++
T Consensus 158 eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~------------------------- 205 (612)
T KOG0603|consen 158 EYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE------------------------- 205 (612)
T ss_pred hhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC-------------------------
Confidence 999999984 578999999999999999999999988 55555533 111
Q ss_pred CCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 014039 242 PINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVPY 291 (432)
Q Consensus 242 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~~ 291 (432)
.+..++.++.+++.+++..+|..|.. +.|+++|+||+.++|...
T Consensus 206 ------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l 254 (612)
T KOG0603|consen 206 ------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL 254 (612)
T ss_pred ------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence 12356789999999999999999986 489999999999999743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=200.82 Aligned_cols=207 Identities=24% Similarity=0.311 Sum_probs=174.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.+|+++++||.|+||.+|+|.+..+|+.||||.-...... .....|.++.+.|. ...|..++.+..+...-.+|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 5799999999999999999999999999999997755432 22467999999995 5788888888888888899999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceecCCCC---
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARELSSMP--- 153 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~~~~~--- 153 (432)
....+|.+.+.-..+.++...+..++-|++.-++|+|.++++||||||+|+|..= +.+.++|||+|+.+.+..
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 9999999988777778999999999999999999999999999999999999973 389999999998775432
Q ss_pred -----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014039 154 -----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 154 -----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~ 212 (432)
......||..|.+--... +...+...|+=|+|.+|..+..|..||.|.......++..
T Consensus 172 HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred cCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 124467899998876654 3445788999999999999999999999987766555543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=201.65 Aligned_cols=199 Identities=22% Similarity=0.290 Sum_probs=172.7
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.|+++++||+|+||+.|+|++.-+++.||||.-.++..... ...|.+..+.| ..++|...|.+....-+-.||+|+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ---LrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ---LRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcch---HHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 59999999999999999999999999999999766543322 34578888887 689999999887777777899999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe------CCeEEEeeeccceecCCCC--
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT------NDVLKIADFGLARELSSMP-- 153 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~------~~~lkL~DFG~a~~~~~~~-- 153 (432)
++.+|.+.+.-.++.|+...+..++.|++.-++|+|++.+|+|||||+|+||. .+.+.|+|||+|+.+.+..
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 99999999988888999999999999999999999999999999999999996 2389999999999876532
Q ss_pred ------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH
Q 014039 154 ------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI 205 (432)
Q Consensus 154 ------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~ 205 (432)
...+..||..||+--..+ +..-+...|+=|||-+++..+-|..||.|....
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 245678999999987776 456788999999999999999999999986543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=231.54 Aligned_cols=223 Identities=29% Similarity=0.396 Sum_probs=173.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+.++.|..|+||-||+++|+.+...+|+ ++.++.. ++|- ++...+.|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccch------hhhc--cccccCCccee------------------
Confidence 4789999999999999999999999999999 5554432 1221 44444666666
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-------
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP------- 153 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~------- 153 (432)
|+-. .+.+.-++++..- +.+++|||+.||+|||+||+|++|+. |.+|++|||+.+......
T Consensus 136 --gDc~-tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 136 --GDCA-TLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred --chhh-hhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 2222 2223334565443 77999999999999999999999984 799999999986532110
Q ss_pred ---------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 154 ---------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 154 ---------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
.-...|||+.|+|||+++ ...|+..+|+|++|+|+||.+-|..||.|+...+.+...+......+..
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVil-rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--- 280 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--- 280 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhh-hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---
Confidence 013458999999999997 5679999999999999999999999999999888777765544332222
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP---TADQALQHPFFNVETWVP 290 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp---ta~elL~Hp~f~~~~~~~ 290 (432)
-....+|+.++|.++|+.+|..|. .+.++.+|+||+.-+|..
T Consensus 281 ------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ 325 (1205)
T KOG0606|consen 281 ------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS 325 (1205)
T ss_pred ------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence 124678999999999999999995 589999999999999963
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=194.93 Aligned_cols=141 Identities=21% Similarity=0.281 Sum_probs=111.2
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-------------------------HHHHHHHHHHHHhcCCCc
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-------------------------ECMNLREVKALRKLNHPN 61 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-------------------------~~~~~~Ei~~l~~l~hpn 61 (432)
.+.||+|+||.||+|.+. +|+.||+|+++....... .....+|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999987 899999999975422100 011235999999998888
Q ss_pred ccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCceeEeCCeEEE
Q 014039 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM-HRNGYFHRDLKPENLLVTNDVLKI 140 (432)
Q Consensus 62 Iv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~L-H~~givHrDlkP~NILl~~~~lkL 140 (432)
+.....+... ..+|||||++|+.+.......+.+++..+..++.||+.+|.++ |+.||+||||||+|||++++.++|
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~L 158 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYI 158 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEE
Confidence 7554433322 2389999999865543323345799999999999999999999 799999999999999999889999
Q ss_pred eeeccceecC
Q 014039 141 ADFGLARELS 150 (432)
Q Consensus 141 ~DFG~a~~~~ 150 (432)
+|||+|....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05147 159 IDVSQSVEHD 168 (190)
T ss_pred EEccccccCC
Confidence 9999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=191.33 Aligned_cols=170 Identities=15% Similarity=0.141 Sum_probs=130.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHH--H------HHHHHHHHHhcCCCcccccceEEEeC-
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC--M------NLREVKALRKLNHPNIIKLKEVVREN- 72 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~--~------~~~Ei~~l~~l~hpnIv~l~~~~~~~- 72 (432)
++|++++.+|.|+||.||++.. ++..+|+|.+..+....+.. . ..+|++.+.++.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4799999999999999999755 46679999997554332221 1 35899999999999999998886532
Q ss_pred -------CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeecc
Q 014039 73 -------NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGL 145 (432)
Q Consensus 73 -------~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~ 145 (432)
+..+|||||++|..+..+. .+++ ....+|+.+|..||+.|++|||+||+||+++++.++|+|||.
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg~ 180 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLSG 180 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECCC
Confidence 3578999999986554442 2333 245699999999999999999999999999866699999998
Q ss_pred ceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHH
Q 014039 146 ARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF 193 (432)
Q Consensus 146 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell 193 (432)
........ |-+.+.....|+.++|+|+||+.+.-..
T Consensus 181 ~~~~~e~~------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 181 KRCTAQRK------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccchh------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 87653321 1222333556778999999999987764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=200.80 Aligned_cols=201 Identities=24% Similarity=0.390 Sum_probs=148.8
Q ss_pred CCCcccccceEEEe---------------------------CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHH
Q 014039 58 NHPNIIKLKEVVRE---------------------------NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQML 110 (432)
Q Consensus 58 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl 110 (432)
.|||||++...|.+ ...+|+||..++++|...+-.+. .+....+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence 59999998776632 24589999999999998887664 67888899999999
Q ss_pred HHHHHHHHCCCeeccCCCCceeEe--CC---eEEEeeeccceecCC---C----CCCccccCCccccchhhhcCCCC---
Q 014039 111 QGLAHMHRNGYFHRDLKPENLLVT--ND---VLKIADFGLARELSS---M----PPYTEYVSTRWYRAPEVLLQSSS--- 175 (432)
Q Consensus 111 ~aL~~LH~~givHrDlkP~NILl~--~~---~lkL~DFG~a~~~~~---~----~~~~~~~~t~~y~aPE~l~~~~~--- 175 (432)
+|+.|||++||.|||+|.+|||+. ++ .+.|+|||.|-.-.. . ......-|...-||||+..--..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999995 33 899999998843221 1 11233456677899998731111
Q ss_pred --CCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCC
Q 014039 176 --YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNAS 253 (432)
Q Consensus 176 --~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 253 (432)
--.++|.|+.|.+.||+++...||.+..+... .. ..|. ...+..+...++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--------~~------------r~Yq--------e~qLPalp~~vp 483 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--------DT------------RTYQ--------ESQLPALPSRVP 483 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchhee--------ch------------hhhh--------hhhCCCCcccCC
Confidence 12378999999999999999999987433110 00 0111 112334556789
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 014039 254 MEAIDLIWQLCSWDPLRRPT---ADQALQHPFFNVETW 288 (432)
Q Consensus 254 ~~~~dli~~~L~~dP~~Rpt---a~elL~Hp~f~~~~~ 288 (432)
+.+++++..+|+.||+||++ |+.+|+---+...+|
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 99999999999999999998 466776655555544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=225.36 Aligned_cols=245 Identities=28% Similarity=0.416 Sum_probs=179.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch---HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW---EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+|...+.||.+.|=.|.+|++.+ |. |++|++-+..... .....++|++ ....++||++.+..+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 47788999999999999998755 33 8899987655332 2233445666 55569999999988877777889999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceec--CCCCC--
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLAREL--SSMPP-- 154 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~--~~~~~-- 154 (432)
+|+..+|++.+..+. .+.+-+.+.|+.||+.||.-+|+.||||+|||.+||||+. +-+.|+||..-+.. ..+.+
T Consensus 101 qyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999999999887654 5788889999999999999999999999999999999985 68999999977643 12111
Q ss_pred CccccC----CccccchhhhcCCC----------CCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014039 155 YTEYVS----TRWYRAPEVLLQSS----------SYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPD 219 (432)
Q Consensus 155 ~~~~~~----t~~y~aPE~l~~~~----------~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~ 219 (432)
+.-+.. --+|.|||-+.... ..+++.||||+||+++||++ |+|+|.- .|+-+.. -|.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr--~~~-- 251 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYR--SGN-- 251 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHh--ccC--
Confidence 111222 23599999885422 25678999999999999998 7999942 1211110 000
Q ss_pred CCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 220 WTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+ .+ . +.++ -+...+.+|..|++.||++|.+|++.|+-
T Consensus 252 -~~~~-e~----~------------Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 -ADDP-EQ----L------------LEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -ccCH-HH----H------------HHhC---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000 00 0 0000 13368899999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=183.98 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=112.8
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----------------------hH---HHHHHHHHHHHHhcCCC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----------------------WE---ECMNLREVKALRKLNHP 60 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----------------------~~---~~~~~~Ei~~l~~l~hp 60 (432)
+.+.||+|+||.||+|.+. +|+.||||+++..... .. .....+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998754211 00 11234789999999999
Q ss_pred cccccceEEEeCCEEEEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCCeE
Q 014039 61 NIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTNDVL 138 (432)
Q Consensus 61 nIv~l~~~~~~~~~~~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~~l 138 (432)
+|.....+.... .||||||++|+ +...... ...+++..+..++.|++.+|.++|+ .||+||||||+||+++++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCE
Confidence 886655544332 48999999986 3333233 3468899999999999999999999 99999999999999997799
Q ss_pred EEeeeccceecCC
Q 014039 139 KIADFGLARELSS 151 (432)
Q Consensus 139 kL~DFG~a~~~~~ 151 (432)
+|+|||+|.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=189.88 Aligned_cols=232 Identities=21% Similarity=0.222 Sum_probs=145.5
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCC----------CcccccceEE--
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNH----------PNIIKLKEVV-- 69 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~~-- 69 (432)
+...+.||.|+++.||.+.+.+||+.+|+|+....... .......+|.-....+.+ -.++...+..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 46678999999999999999999999999998643322 122223334333333211 1222222222
Q ss_pred -------EeC---C-----EEEEEEecCCCcHHHHHH---HcCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 014039 70 -------REN---N-----ELFFIFEYMEHNLYHIMR---ERQIP---FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKP 128 (432)
Q Consensus 70 -------~~~---~-----~~~lV~E~~~~~ll~~~~---~~~~~---l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP 128 (432)
... + ..+++|+-+.+++...+. ..... +.......+..|+++.+++||+.|++|+||||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 111 1 236789999988776643 22211 22222345569999999999999999999999
Q ss_pred CceeEeC-CeEEEeeeccceecCCCCCCccccCCccccchhhhcCC-------CCCCcccceechHHHHHHHHhCCCCCC
Q 014039 129 ENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS-------SSYSPAIDMWAVGAILAELFTLSPIFP 200 (432)
Q Consensus 129 ~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiWSlG~il~ell~g~~pF~ 200 (432)
+|++++. |.++|+||+.....+..... ...+..|.+||+.... ..++.+.|.|+||+++|.|+||..||.
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999995 59999999988776542221 3455779999987432 357889999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCC
Q 014039 201 GDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR 271 (432)
Q Consensus 201 ~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 271 (432)
....... +. ..+.... +++..+++||++||++||.+|
T Consensus 252 ~~~~~~~----------~~-----------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEAD----------PE-----------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGST----------SG-----------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCcccc----------cc-----------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 6543100 00 0122233 678899999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=175.23 Aligned_cols=188 Identities=20% Similarity=0.163 Sum_probs=137.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH---HHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
..+...|++|.||+|+++.. .+..++.+.+........ ...+.+|+++|++| ++++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999998854 667788777764432211 22456899999999 45889999886 4569999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDL-KPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDl-kP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||+.|..+...... . ...++.|++.+|.++|++||+|||| ||+|||++.+ .++|+|||+|...........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99998766432211 1 2357889999999999999999999 7999999854 899999999986554321100
Q ss_pred --------------ccCCccccchhhhcCCCCCC-cccceechHHHHHHHHhCCCCCCCCCh
Q 014039 158 --------------YVSTRWYRAPEVLLQSSSYS-PAIDMWAVGAILAELFTLSPIFPGDSE 204 (432)
Q Consensus 158 --------------~~~t~~y~aPE~l~~~~~~~-~~~DiWSlG~il~ell~g~~pF~~~~~ 204 (432)
...++.|++|+.-.--...+ ...++++.|+-+|+++|+..++-++.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 12467788888643222233 567899999999999999988766543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=175.66 Aligned_cols=146 Identities=18% Similarity=0.195 Sum_probs=112.0
Q ss_pred eeEeeeEeecCceEEEEEE-EcCCCeEEEEEEecccccc--------------------h---HHHHHHHHHHHHHhcCC
Q 014039 4 YKILEELGDGTCGCVYKAF-NVETYEIVAVKKMKRKFYF--------------------W---EECMNLREVKALRKLNH 59 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~-~~~~~~~vAiK~i~~~~~~--------------------~---~~~~~~~Ei~~l~~l~h 59 (432)
|++.+.||+|+||.||+|. +..+|+.||+|++...... . ......+|+++++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7889999999999999998 7789999999998743210 0 01123579999999965
Q ss_pred CcccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCceeEeCCeE
Q 014039 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG-YFHRDLKPENLLVTNDVL 138 (432)
Q Consensus 60 pnIv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g-ivHrDlkP~NILl~~~~l 138 (432)
. .+.+..++... ..++||||++|..+.........+....+..++.||+.+|.+||+.| ++||||||+||+++++.+
T Consensus 110 ~-~i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i 187 (237)
T smart00090 110 A-GVPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKV 187 (237)
T ss_pred c-CCCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCE
Confidence 3 33333333222 35899999999655443323345677778899999999999999999 999999999999997799
Q ss_pred EEeeeccceecCC
Q 014039 139 KIADFGLARELSS 151 (432)
Q Consensus 139 kL~DFG~a~~~~~ 151 (432)
+|+|||.|.....
T Consensus 188 ~LiDFg~a~~~~~ 200 (237)
T smart00090 188 VIIDVSQSVELDH 200 (237)
T ss_pred EEEEChhhhccCC
Confidence 9999999875443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7e-20 Score=168.09 Aligned_cols=134 Identities=19% Similarity=0.205 Sum_probs=103.3
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-----CCCcccccceEEEeCC---EEE
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-----NHPNIIKLKEVVRENN---ELF 76 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~---~~~ 76 (432)
.-.+.||+|+||.||. +..++.. +||++...... ......+|+++++.+ +||||++++++++++. .++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999995 7777766 69998754322 234467999999999 6799999999998763 444
Q ss_pred -EEEecCC--C-cHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeccCCCCceeEeC---C--eEEEeeeccc
Q 014039 77 -FIFEYME--H-NLYHIMRERQIPFSEGEIRSFMSQMLQGL-AHMHRNGYFHRDLKPENLLVTN---D--VLKIADFGLA 146 (432)
Q Consensus 77 -lV~E~~~--~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL-~~LH~~givHrDlkP~NILl~~---~--~lkL~DFG~a 146 (432)
+||||.+ + +|.+.+. +. .+++. ..++.|++.++ +|||+++|+||||||+|||++. + .++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~-~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAE-QC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHH-cc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899944 4 5555554 33 46666 46688888888 9999999999999999999972 2 7999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=197.21 Aligned_cols=189 Identities=23% Similarity=0.357 Sum_probs=152.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC---CCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN---HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV 78 (432)
++|.|-+.||+|+||.||+|.+.. |+.||+|+-+....+.- . ==.+++.+|+ -+.|..+...+...+..+||
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-Y---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-Y---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-e---ehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 579999999999999999999877 99999999876543311 1 1134444454 34566666666666777899
Q ss_pred EecCC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--------eEEEeeeccceec
Q 014039 79 FEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--------VLKIADFGLAREL 149 (432)
Q Consensus 79 ~E~~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--------~lkL~DFG~a~~~ 149 (432)
+||.+ |+|++.+- ..+.+++..+..++.|+++.++.||..+|||+||||+|+||... .++|+|||.+..+
T Consensus 773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99998 45666655 55689999999999999999999999999999999999999521 7999999999765
Q ss_pred C---CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCC
Q 014039 150 S---SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSP 197 (432)
Q Consensus 150 ~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~ 197 (432)
. ++......++|-.+-.+|+. .+..+++.+|.|+++.+++-|+.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3 33345667889999999987 57889999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-19 Score=160.96 Aligned_cols=136 Identities=16% Similarity=0.204 Sum_probs=110.7
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-------HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++.||+|++|.||+|.. .|..+++|+........ ......+|++++..+.|++|.....++.+....++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999976 67789999866433211 1123468999999999999988877777777889999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeecccee
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARE 148 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~ 148 (432)
||++|..+..+..... . ....++.+|+.+|.++|+.|++|+|++|.|||++++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 9999865555544332 2 788999999999999999999999999999999977999999999865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-20 Score=195.62 Aligned_cols=259 Identities=23% Similarity=0.285 Sum_probs=200.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-CCeEEEEEEecccc-cchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-TYEIVAVKKMKRKF-YFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 78 (432)
..|.+.+.||+|+|+.|-++.... +...+|.|.+.... ..........|..+-+.+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 468899999999999999987744 44557777776443 1122222345777777786 99999999999999999999
Q ss_pred EecCCCcHHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCceeEe-CC-eEEEeeeccceecCC-C
Q 014039 79 FEYMEHNLYHIMR-ERQI-PFSEGEIRSFMSQMLQGLAHMH-RNGYFHRDLKPENLLVT-ND-VLKIADFGLARELSS-M 152 (432)
Q Consensus 79 ~E~~~~~ll~~~~-~~~~-~l~~~~~~~i~~qIl~aL~~LH-~~givHrDlkP~NILl~-~~-~lkL~DFG~a~~~~~-~ 152 (432)
+|+..|+.+.... .... .++......++.|+..+|.|+| ..++.|||+||+|.+++ ++ .+|+.|||+|..+.. .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9998775444333 3333 6788899999999999999999 99999999999999998 45 799999999987755 2
Q ss_pred C---CCccccC-CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 153 P---PYTEYVS-TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 153 ~---~~~~~~~-t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
. .....+| ++.|.|||...+........|+||.|+++.-+++|..++......+..+.
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------------------ 241 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------------------ 241 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce------------------
Confidence 1 2345678 99999999997666789999999999999999999988765544331110
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+.......-...+..++..+.+++.++|..+|+.|.+.+++..++|+..
T Consensus 242 -------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 242 -------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------eecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 01111111122345678889999999999999999999999999999976
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-19 Score=178.85 Aligned_cols=176 Identities=29% Similarity=0.403 Sum_probs=130.6
Q ss_pred CEEEEEEecCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 73 NELFFIFEYMEHNLYHIMRERQ---IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 73 ~~~~lV~E~~~~~ll~~~~~~~---~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
.++||.|++|..+.+..+..+. ..-+....+.++.|+..|++| +|.+|||+||.||+...+ .+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3578999999976666665432 345667889999999999999 999999999999999755 899999999987
Q ss_pred cCCCC-------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 149 LSSMP-------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 149 ~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
..... ..+..+||.+||+||.+. +..|+.++||||||.|++|++. .|....+ .+ ++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~---~f~T~~e-----r~----~t---- 468 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLI---QFSTQFE-----RI----AT---- 468 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHH---HhccHHH-----HH----Hh----
Confidence 76554 467789999999999994 7789999999999999999987 1111110 00 00
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
+..+....+++.+.--.++..+|+.+||...|.+||++.+.--|.|.
T Consensus 469 ---------------~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 469 ---------------LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ---------------hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 00000011111111123467799999999999999988888777764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=155.34 Aligned_cols=132 Identities=18% Similarity=0.236 Sum_probs=103.3
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecccccch-------HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.||+|+||.||+|. .+|..+++|+........ ......+|+++++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 38999999999997 456789999865432111 123345899999999888776665555666677999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceec
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLAREL 149 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~ 149 (432)
++|..+......... .++.|++.+|.+||+.|++|+|++|.||+++++.++++|||+++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcCC
Confidence 998655544433211 8899999999999999999999999999999779999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-18 Score=154.97 Aligned_cols=137 Identities=20% Similarity=0.239 Sum_probs=104.8
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch---------------------HHHHHHHHHHHHHhcCCCc-
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW---------------------EECMNLREVKALRKLNHPN- 61 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~~Ei~~l~~l~hpn- 61 (432)
|.+.+.||+|+||.||+|... +|+.||+|++....... ......+|..++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999874 79999999876432110 0112357899999997774
Q ss_pred -ccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 62 -IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 62 -Iv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
+...++ ....++||||++|..+..+.. ......++.+|+.++.++|+.||+||||||+||+++++ .++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 333332 245689999999866554322 13467889999999999999999999999999999854 999
Q ss_pred EeeeccceecCC
Q 014039 140 IADFGLARELSS 151 (432)
Q Consensus 140 L~DFG~a~~~~~ 151 (432)
|+|||.|.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=175.52 Aligned_cols=136 Identities=18% Similarity=0.195 Sum_probs=106.4
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEec-ccccch------HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFW------EECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~-~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
|...+.||+|+||+||+|..... .+++|+.. +..... ......+|+++++.++|++++....+..+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 45678999999999999976443 34444432 211111 1233568999999999999998877777777789
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceec
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLAREL 149 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~ 149 (432)
+||||++|+.+..... ....++.||+.+|.+||+.|++||||||+|||++++.++|+|||+|+..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCcccccC
Confidence 9999999865554432 3577999999999999999999999999999998889999999999764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.4e-18 Score=154.12 Aligned_cols=239 Identities=21% Similarity=0.284 Sum_probs=174.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
..++.+|.+..-|+.|+|+...+ -++.|++...... .....+..|.-.|+-+.||||..+++.+.....+.++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34566788889999999976443 4566776533222 12223567888899999999999999999999999999999
Q ss_pred CC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeCC---eEEEeeeccceecCCCCCC
Q 014039 83 EH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTND---VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 83 ~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~~---~lkL~DFG~a~~~~~~~~~ 155 (432)
+- +|+..+.... --.+..++.+++..|++|++|||+.. |.---|....++|+++ .+..+|--++.. .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------E 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------c
Confidence 95 4555554332 24677789999999999999999874 3344688899999987 444455433321 1
Q ss_pred ccccCCccccchhhhcCCCCC--CcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSY--SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~--~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
....-+|.|++||.+.+.... -.++|+|||+++++||.|...||..-++.+---+|. +-|.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-legl---------------- 406 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-LEGL---------------- 406 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-hccc----------------
Confidence 123457889999999654433 347999999999999999999998888766544431 0000
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL 278 (432)
-..++++++.....|++-|++.||.+||..+.+.
T Consensus 407 -----------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 -----------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 0135578899999999999999999999876654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=147.65 Aligned_cols=134 Identities=23% Similarity=0.308 Sum_probs=97.9
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHH-----------------------HHHHHHHHHhcCCCc--
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM-----------------------NLREVKALRKLNHPN-- 61 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~-----------------------~~~Ei~~l~~l~hpn-- 61 (432)
.+.||+|+||.||+|.+. +|+.||||++........... ...|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999876 789999999875322111100 124666666664332
Q ss_pred ccccceEEEeCCEEEEEEecCCCc-----HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeC
Q 014039 62 IIKLKEVVRENNELFFIFEYMEHN-----LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTN 135 (432)
Q Consensus 62 Iv~l~~~~~~~~~~~lV~E~~~~~-----ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~ 135 (432)
+.+++++ ...++||||++++ .+.... . ...++.++.+++.++.++|. .||+||||||+||++++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~ 150 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDD 150 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEEC
Confidence 3333332 2358999999983 222211 1 16788999999999999999 99999999999999997
Q ss_pred CeEEEeeeccceecCC
Q 014039 136 DVLKIADFGLARELSS 151 (432)
Q Consensus 136 ~~lkL~DFG~a~~~~~ 151 (432)
+.++|+|||.|.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 7999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=165.20 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=151.0
Q ss_pred HHhcCCCcccccceEEEeCCEEEEEEecCC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eeccCCCCce
Q 014039 54 LRKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY-FHRDLKPENL 131 (432)
Q Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~gi-vHrDlkP~NI 131 (432)
|+.+.|.|+.++++.+.+....++|.+||. |++.+.+......++......+++.|+.||.|||+--| +|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999998 55666666656778888999999999999999998755 9999999999
Q ss_pred eEeCC-eEEEeeeccceecCCC---CCCccccCCccccchhhhcCCC--C----CCcccceechHHHHHHHHhCCCCCCC
Q 014039 132 LVTND-VLKIADFGLARELSSM---PPYTEYVSTRWYRAPEVLLQSS--S----YSPAIDMWAVGAILAELFTLSPIFPG 201 (432)
Q Consensus 132 Ll~~~-~lkL~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~--~----~~~~~DiWSlG~il~ell~g~~pF~~ 201 (432)
+++.. .+||+|||+....... .......-..-|.|||++.... . -+.+.||||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99998 9999999998766421 1111222344589999985431 1 46789999999999999999999987
Q ss_pred CChHHHHHHHHH-Hh--CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 014039 202 DSEIDQLYKVCC-IL--GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278 (432)
Q Consensus 202 ~~~~d~~~~i~~-~~--g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL 278 (432)
........+++. +. |..+.. |.+ .. .....+++..++++|+..+|.+||+++++-
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~r----------------P~i-----~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFR----------------PSI-----EL-LNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcC----------------cch-----hh-hhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 433222122221 11 111110 000 00 013445799999999999999999998876
Q ss_pred c
Q 014039 279 Q 279 (432)
Q Consensus 279 ~ 279 (432)
.
T Consensus 219 ~ 219 (484)
T KOG1023|consen 219 S 219 (484)
T ss_pred h
Confidence 5
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.2e-17 Score=163.42 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=198.4
Q ss_pred eeEeeeEee--cCceEEEEEEE--cCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 4 YKILEELGD--GTCGCVYKAFN--VETYEIVAVKKMKRKFYF-WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 4 Y~~~~~IG~--G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+.+...+|. |.+|.||.+.. ..++..+|+|+-+..... ......++|+...+.+ .|+|.++.+..++..+.+|+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 456778999 99999999998 899999999986543321 1223346888888888 59999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ----GLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSS 151 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~----aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~ 151 (432)
-+|++...+.........-+++..++..+.+..+ ||.++|+.+++|-|+||+||+...+ .++++|||+...+..
T Consensus 196 qtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~ 275 (524)
T KOG0601|consen 196 QTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD 275 (524)
T ss_pred eeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccC
Confidence 9999998888877766666999999999999999 9999999999999999999999865 899999999988876
Q ss_pred CCCC------ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 152 MPPY------TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 152 ~~~~------~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
.... ....+...|++||+. ..-++.+.||+++|-+.++-.++..++..... ..|..+.
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------------~~W~~~r- 339 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKN-------------SSWSQLR- 339 (524)
T ss_pred CccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCC-------------CCccccc-
Confidence 5422 122567779999987 56789999999999999999888766543310 1111111
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+.+ --.++..+.+.++...+..|++.+|..|+++..+++|+++..
T Consensus 340 -----~~~----------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 340 -----QGY----------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -----ccc----------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 000 001223456677778999999999999999999999999974
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-15 Score=141.90 Aligned_cols=134 Identities=18% Similarity=0.193 Sum_probs=98.0
Q ss_pred eeEe-ecCceEEEEEEEcCCCeEEEEEEeccccc------------chHHHHHHHHHHHHHhcCCCcc--cccceEEEe-
Q 014039 8 EELG-DGTCGCVYKAFNVETYEIVAVKKMKRKFY------------FWEECMNLREVKALRKLNHPNI--IKLKEVVRE- 71 (432)
Q Consensus 8 ~~IG-~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------------~~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~- 71 (432)
..|| .|+.|+||.+... +..+++|...+... ........+|++++..|.|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888899988653 67799998753211 1122345689999999988775 566665433
Q ss_pred CCE---EEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 72 NNE---LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 72 ~~~---~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
... .++|||+++| ..+..+... ..+++.. +.||+.+|.+||++||+||||||+|||++.+ .++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 222 3599999996 344444333 3566553 5789999999999999999999999999854 8999999988
Q ss_pred ee
Q 014039 147 RE 148 (432)
Q Consensus 147 ~~ 148 (432)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 65
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.6e-16 Score=131.88 Aligned_cols=131 Identities=24% Similarity=0.271 Sum_probs=108.5
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC--CcccccceEEEeCCEEEEEEecCC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH--PNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
+++.||.|.++.||++.... ..+++|....... .....+|+.+++.+.+ .++++++.+....+..+++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 46789999999999998744 6799999865543 3345689999999966 588888888877788999999998
Q ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCceeEeC-CeEEEeeecccee
Q 014039 84 HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN---GYFHRDLKPENLLVTN-DVLKIADFGLARE 148 (432)
Q Consensus 84 ~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~---givHrDlkP~NILl~~-~~lkL~DFG~a~~ 148 (432)
+..+..+ +......++.+++.+|++||.. +++|+|++|.||++++ +.++++|||.+..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8654432 5566778899999999999985 7999999999999997 5999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.2e-16 Score=163.70 Aligned_cols=265 Identities=22% Similarity=0.257 Sum_probs=195.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+.+.+++.+-+|+++.++.+.-..+|...++|.......... .....++-.++-...+|.++.....+.-....+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 567788889999999999998888887788877653221100 111122333333334566665544444556789999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCC------
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM------ 152 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~------ 152 (432)
+|..++.+....+..++.+++-.+.++..+..++++||+..+.|||++|.|+|+. .+..++.|||........
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 9998754444444555788889999999999999999999999999999999997 458999999844322110
Q ss_pred --------------------------CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHH
Q 014039 153 --------------------------PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID 206 (432)
Q Consensus 153 --------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d 206 (432)
.......+|+.|.|||..+ +...+.++|+|++|++++|.++|.++|.......
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0123356899999999986 5667899999999999999999999999888765
Q ss_pred HHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCC
Q 014039 207 QLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD---QALQHPFF 283 (432)
Q Consensus 207 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~---elL~Hp~f 283 (432)
....|.. +. .++.......+.++.+++.++|..+|.+|..+. ++-.|+||
T Consensus 1043 ~f~ni~~--~~-------------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~ 1095 (1205)
T KOG0606|consen 1043 IFENILN--RD-------------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFF 1095 (1205)
T ss_pred hhhcccc--CC-------------------------CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCcc
Confidence 5444321 11 223333446788999999999999999999887 99999999
Q ss_pred CCCCCCCCCCC
Q 014039 284 NVETWVPYPLH 294 (432)
Q Consensus 284 ~~~~~~~~~~~ 294 (432)
+..+|......
T Consensus 1096 ~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1096 QDVDWENLALQ 1106 (1205)
T ss_pred CCCCccccccc
Confidence 99999766443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-13 Score=124.30 Aligned_cols=140 Identities=13% Similarity=0.177 Sum_probs=101.5
Q ss_pred eeeEeecCceEEEEEEEcC------CCeEEEEEEeccccc---------------------chHHHH----HHHHHHHHH
Q 014039 7 LEELGDGTCGCVYKAFNVE------TYEIVAVKKMKRKFY---------------------FWEECM----NLREVKALR 55 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~---------------------~~~~~~----~~~Ei~~l~ 55 (432)
..+||.|.-+.||.|.... .+..+|+|+.+.... ...... ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999997643 357899998642100 001111 237999999
Q ss_pred hcCC--CcccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCcee
Q 014039 56 KLNH--PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM-HRNGYFHRDLKPENLL 132 (432)
Q Consensus 56 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~L-H~~givHrDlkP~NIL 132 (432)
++.. -++.+++++ ..-+|||||++++.+..-.-+...+++..+..+..|++.+|..| |+.|++|+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9843 345555654 45589999998742211111122466677788899999999999 8999999999999999
Q ss_pred EeCCeEEEeeeccceecC
Q 014039 133 VTNDVLKIADFGLARELS 150 (432)
Q Consensus 133 l~~~~lkL~DFG~a~~~~ 150 (432)
+.++.+.|+|||.|....
T Consensus 158 ~~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EECCcEEEEECCCceeCC
Confidence 998999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-13 Score=138.71 Aligned_cols=180 Identities=21% Similarity=0.286 Sum_probs=134.4
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYME 83 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 83 (432)
|++ ...+-+..+.+-.|..+.++.+|.+...+.... .......+-++.|+.++||||+++++.++.++.+|||+|.+.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR 92 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence 444 333334444322567788899999999886654 223345678999999999999999999999999999999986
Q ss_pred C--cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC-Cccc
Q 014039 84 H--NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-RNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP-YTEY 158 (432)
Q Consensus 84 ~--~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH-~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~-~~~~ 158 (432)
. ..++. +....+..-++||+.||.||| +++++|++|.-+.|+|+. |..||++|..+........ ...+
T Consensus 93 Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~ 165 (690)
T KOG1243|consen 93 PLETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL 165 (690)
T ss_pred cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc
Confidence 4 22221 337788999999999999998 679999999999999995 5999999999876554332 2222
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhC
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g 195 (432)
.---.|..|+.+... +...|.|.|||+++|++.|
T Consensus 166 ~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 222336777765321 2578999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.8e-14 Score=140.72 Aligned_cols=250 Identities=21% Similarity=0.252 Sum_probs=187.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-CCCeEEEEEEecccccchH-HHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-ETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
.+|-.+..||.|.|+.|+..... .++..|++|.+.+...... ...-+.|+.+...+ .|.+++.++..|......|+=
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 35778999999999999987655 7888899999886654433 33346788888887 599999999988888888899
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~~~~ 156 (432)
.|||.+.....-..-...+.+...+++..|++.++.++|+..++|+|+||+||++.+ ...+++|||.+..+.- ....
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-~~~~ 423 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-SSGV 423 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-eccc
Confidence 999987655544433346889999999999999999999999999999999999987 5899999999975321 1111
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..-.++.|-..|++.....+..++|++|||.-+.+.+++.++-......-. |.
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~------------------------ 476 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IR------------------------ 476 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCccccccee---ee------------------------
Confidence 222344442466676788899999999999999999998775433221100 00
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......+....++..+.+.+...|+..|+.+.++..|.=|..
T Consensus 477 ------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 477 ------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000111234467889999999999999999999999876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.2e-13 Score=119.60 Aligned_cols=127 Identities=17% Similarity=0.125 Sum_probs=94.6
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCccc-ccceEEEeCCEEEEEEecCCCc
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNII-KLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
++.|+.|.++.||++... ++.|++|....... ......+|+++++.+.+.+++ +++.+.. ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 578899999999999764 77899999765432 112245789999988654443 4544432 3347999999986
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeccCCCCceeEeCCeEEEeeeccce
Q 014039 86 LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY-----FHRDLKPENLLVTNDVLKIADFGLAR 147 (432)
Q Consensus 86 ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~gi-----vHrDlkP~NILl~~~~lkL~DFG~a~ 147 (432)
.+... ......++.+++++|+.||+.++ +|+|++|.||+++++.++++|||.|.
T Consensus 77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 44321 11124567899999999999985 99999999999998899999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-13 Score=142.33 Aligned_cols=141 Identities=24% Similarity=0.354 Sum_probs=94.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----------------------------h----H-H-----
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----------------------------W----E-E----- 44 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----------------------------~----~-~----- 44 (432)
.|+. +.||.|++|.||+|+.+.+|+.||||+.+..... . + .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 7899999999999999988999999998743100 0 0 0
Q ss_pred -HHHHHHHHHHHhc----CCCcccccceEEEe-CCEEEEEEecCCCcHHHHH---HHcCC---CCCHHHHHHHHHHHHHH
Q 014039 45 -CMNLREVKALRKL----NHPNIIKLKEVVRE-NNELFFIFEYMEHNLYHIM---RERQI---PFSEGEIRSFMSQMLQG 112 (432)
Q Consensus 45 -~~~~~Ei~~l~~l----~hpnIv~l~~~~~~-~~~~~lV~E~~~~~ll~~~---~~~~~---~l~~~~~~~i~~qIl~a 112 (432)
....+|+..+.++ .+.+.+.+-.++.+ .+..+|||||++|.-+..+ ...+. .+.+..+..++.||+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 1123444444444 23333444444422 4456799999998644432 22221 355555666666665
Q ss_pred HHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecCC
Q 014039 113 LAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS 151 (432)
Q Consensus 113 L~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~~ 151 (432)
..|++|+|+||.||+++.+ .++++|||++..+..
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5899999999999999843 799999999987754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=133.76 Aligned_cols=140 Identities=23% Similarity=0.293 Sum_probs=92.7
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccch---------------------------------------HHHHHH
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW---------------------------------------EECMNL 48 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---------------------------------------~~~~~~ 48 (432)
+.||.|++|.||+|+.+ +|+.||||+.+...... .+....
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 68999999985431000 001123
Q ss_pred HHHHHHHhc----CCCcccccceEE-EeCCEEEEEEecCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHH-HHHHHHHCCC
Q 014039 49 REVKALRKL----NHPNIIKLKEVV-RENNELFFIFEYMEHNLYHIMRE-RQIPFSEGEIRSFMSQMLQ-GLAHMHRNGY 121 (432)
Q Consensus 49 ~Ei~~l~~l----~hpnIv~l~~~~-~~~~~~~lV~E~~~~~ll~~~~~-~~~~l~~~~~~~i~~qIl~-aL~~LH~~gi 121 (432)
+|.+.+.++ .+.+-+.+-.++ ...+..+|||||++|..+..+.. ...... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 466666665 222223332333 23445689999999865443332 111222 3445666665 4788999999
Q ss_pred eeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 122 FHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 122 vHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
+|+|+||.||+++++ .++++|||++..+..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999755 999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-13 Score=128.59 Aligned_cols=199 Identities=20% Similarity=0.292 Sum_probs=133.5
Q ss_pred HHHHhcCCCcccccceEEEe-----CCEEEEEEecCCCc-HHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 014039 52 KALRKLNHPNIIKLKEVVRE-----NNELFFIFEYMEHN-LYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRN--G 120 (432)
Q Consensus 52 ~~l~~l~hpnIv~l~~~~~~-----~~~~~lV~E~~~~~-ll~~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~~--g 120 (432)
..|-++.|.|||+++.|+.+ ..+..+++|||..+ +-..++ ..+..+.....++|+.||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 44555679999999999854 35678999999864 333333 3456788999999999999999999998 5
Q ss_pred CeeccCCCCceeEeCC-eEEEeeeccceecCC------CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHH
Q 014039 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS------MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELF 193 (432)
Q Consensus 121 ivHrDlkP~NILl~~~-~lkL~DFG~a~~~~~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell 193 (432)
|+|+++....|++..+ -+|++--.-. .... ........+-++|.|||.= ...+.+.++|||++|....||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHH
Confidence 9999999999999854 5665421111 1100 0011222355778999853 2345677999999999999998
Q ss_pred hCCCC-CCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC
Q 014039 194 TLSPI-FPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP 272 (432)
Q Consensus 194 ~g~~p-F~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp 272 (432)
.|..- -.+++....-..|..+ ++.--..--+++|.+||+-.|..||
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~---------------------------------i~~len~lqr~~i~kcl~~eP~~rp 323 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV---------------------------------IIGLENGLQRGSITKCLEGEPNGRP 323 (458)
T ss_pred HheeccCCCcceeehhhhhhhh---------------------------------eeeccCccccCcCcccccCCCCCCc
Confidence 76542 1122211111111000 0000111235889999999999999
Q ss_pred CHHHHhcCCCCCC
Q 014039 273 TADQALQHPFFNV 285 (432)
Q Consensus 273 ta~elL~Hp~f~~ 285 (432)
+|.+++.||-.-+
T Consensus 324 ~ar~llfHpllfe 336 (458)
T KOG1266|consen 324 DARLLLFHPLLFE 336 (458)
T ss_pred chhhhhcCceeee
Confidence 9999999997744
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.4e-11 Score=104.15 Aligned_cols=132 Identities=19% Similarity=0.239 Sum_probs=94.7
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-------HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-------ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
..+++|+-+.++.+.. -|..+++|.-..+.+-.. .....+|.+++.++.--.|....=+..+...-.|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999954 333466665443332211 1223579999998854444443333445556679999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeecccee
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARE 148 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~ 148 (432)
|++|.++....... . -.++..+=.-+.-||.+||+|+||.++||++.++.+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 99999888655443 1 3456666677788999999999999999999999999999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=101.90 Aligned_cols=141 Identities=20% Similarity=0.208 Sum_probs=104.3
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-------HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
.+..|-+|+-+.|+++ ...|+.+.||.-..+.+-. ...+..+|+++|.++.--.|....-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4667889999999998 5578888888754333221 122346799999888544555544455566666799
Q ss_pred EecCCC--cHHHHHHHcCCCCCHHHH-HHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeecccee
Q 014039 79 FEYMEH--NLYHIMRERQIPFSEGEI-RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARE 148 (432)
Q Consensus 79 ~E~~~~--~ll~~~~~~~~~l~~~~~-~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~ 148 (432)
|||++| ++-+.+......-.++.. ..++.+|=+.+.-||.++|||+||..+||++..+ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999998 677777654333333333 7899999999999999999999999999999743 569999999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.8e-10 Score=113.45 Aligned_cols=211 Identities=21% Similarity=0.262 Sum_probs=153.4
Q ss_pred eEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE----eCCEEEEEEecCCC--cHHHH
Q 014039 16 GCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR----ENNELFFIFEYMEH--NLYHI 89 (432)
Q Consensus 16 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~~--~ll~~ 89 (432)
.+.|++....+|..|++|++...+... ..+...-+++++++.|.|||++.++|. .+..+++|++|.++ +|++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 578999999999999999994322211 111234588899999999999999886 34668899999986 57776
Q ss_pred HHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 90 MRE--------------RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 90 ~~~--------------~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
+-. .+...+|+.+|.|+.||..||.++|+.|+..+-|.|.+||++.+ +++|...|....+...+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~- 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP- 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence 532 12357899999999999999999999999999999999999988 99998888876665432
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
. |.+. --.+-|.=.||.+++.|.+|..--...+. .+-..
T Consensus 448 ----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~~s~------------------------ 486 (655)
T KOG3741|consen 448 ----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDS-TQSSH------------------------ 486 (655)
T ss_pred ----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccc-hHHHH------------------------
Confidence 0 1121 12345777999999999998642111111 11110
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+..+.+..+.+++++|.-+...++++ -++.+++.|
T Consensus 487 ----------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ----------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ----------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11123457888999999999999886 677777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=106.53 Aligned_cols=140 Identities=19% Similarity=0.246 Sum_probs=101.3
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC--CcccccceEEEeC---CEEEEEEec
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH--PNIIKLKEVVREN---NELFFIFEY 81 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~---~~~~lV~E~ 81 (432)
++.||.|..+.||++.... |+.+++|...............+|.++++.+.+ .++.+++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999997643 578999998654322122345689999999965 3456677665543 356899999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR------------------------------------------- 118 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~------------------------------------------- 118 (432)
++|..+...... ..+++.....++.+++++|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998644432211 346777777778888888888773
Q ss_pred -------------CCCeeccCCCCceeEeC--C-eEEEeeecccee
Q 014039 119 -------------NGYFHRDLKPENLLVTN--D-VLKIADFGLARE 148 (432)
Q Consensus 119 -------------~givHrDlkP~NILl~~--~-~lkL~DFG~a~~ 148 (432)
..++|+|++|.||++++ + .+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999987 4 689999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=97.74 Aligned_cols=127 Identities=24% Similarity=0.342 Sum_probs=82.9
Q ss_pred EEEEEEEcCCCeEEEEEEeccccc----------------------c---hHHHHHHHHHHHHHhcCCC--cccccceEE
Q 014039 17 CVYKAFNVETYEIVAVKKMKRKFY----------------------F---WEECMNLREVKALRKLNHP--NIIKLKEVV 69 (432)
Q Consensus 17 ~V~~a~~~~~~~~vAiK~i~~~~~----------------------~---~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~ 69 (432)
.||.|.. ..|+.+|+|+.+.... . .......+|.++|.++..- ++.+++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4888876 4567899998642110 0 0112235899999999655 45556544
Q ss_pred EeCCEEEEEEecCC--CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeccCCCCceeEeCCeEEEeeeccc
Q 014039 70 RENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH-MHRNGYFHRDLKPENLLVTNDVLKIADFGLA 146 (432)
Q Consensus 70 ~~~~~~~lV~E~~~--~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~-LH~~givHrDlkP~NILl~~~~lkL~DFG~a 146 (432)
.. -+|||||++ |..+..+.... ++......++.+++..+.. +|+.||+|+|+.+.|||++++.+.|+|||.|
T Consensus 79 -~~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~qa 153 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQA 153 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTTE
T ss_pred -eC--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCcc
Confidence 22 369999999 65554444332 2245567788888885555 5799999999999999999999999999999
Q ss_pred eecC
Q 014039 147 RELS 150 (432)
Q Consensus 147 ~~~~ 150 (432)
....
T Consensus 154 v~~~ 157 (188)
T PF01163_consen 154 VDSS 157 (188)
T ss_dssp EETT
T ss_pred eecC
Confidence 7654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.5e-10 Score=119.25 Aligned_cols=152 Identities=24% Similarity=0.364 Sum_probs=113.2
Q ss_pred HHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-----Cc-----cccCCccccchhhhcCCCCC
Q 014039 109 MLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-----YT-----EYVSTRWYRAPEVLLQSSSY 176 (432)
Q Consensus 109 Il~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-----~~-----~~~~t~~y~aPE~l~~~~~~ 176 (432)
...||.|+|.. ++||++|.|++|.++.+ ..||+.|+++........ +. .......|.|||.+.. ..-
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccc
Confidence 33899999955 99999999999999965 999999999865544111 11 1123556999999964 667
Q ss_pred CcccceechHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHH
Q 014039 177 SPAIDMWAVGAILAELF-TLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASME 255 (432)
Q Consensus 177 ~~~~DiWSlG~il~ell-~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 255 (432)
+.++|++|+||++|.+. .|.++|.+.........-....+... .....+++.|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--------------------------~~~s~~~p~e 240 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--------------------------FGYSNNLPSE 240 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc--------------------------ccccccCcHH
Confidence 99999999999999999 78888877654333222111111100 0111468899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 256 AIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 256 ~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
+++=|.++|..|+..||++.+++.-|||....
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-08 Score=96.55 Aligned_cols=131 Identities=16% Similarity=0.066 Sum_probs=90.2
Q ss_pred eEEEEEEEcCCCeEEEEEEecccccch----------HHHHHHHHHHHHHhcCCCcc--cccceEEEe-----CCEEEEE
Q 014039 16 GCVYKAFNVETYEIVAVKKMKRKFYFW----------EECMNLREVKALRKLNHPNI--IKLKEVVRE-----NNELFFI 78 (432)
Q Consensus 16 g~V~~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~-----~~~~~lV 78 (432)
..|++.. -.|+.|.||......... ......+|.+.+.++..-+| ..+..+... ....+||
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3455553 356789999764322110 01124588888888743333 334445432 2357899
Q ss_pred EecCCCc--HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--------CeEEEeeeccce
Q 014039 79 FEYMEHN--LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--------DVLKIADFGLAR 147 (432)
Q Consensus 79 ~E~~~~~--ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--------~~lkL~DFG~a~ 147 (432)
||++++. +.+.+... ..+.++.....++.+++..+.-||..||+|+|+++.|||++. ..+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999984 44444321 235667788899999999999999999999999999999974 289999999885
Q ss_pred e
Q 014039 148 E 148 (432)
Q Consensus 148 ~ 148 (432)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.1e-09 Score=97.00 Aligned_cols=136 Identities=26% Similarity=0.280 Sum_probs=100.6
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc------------------c---chHHHHHHHHHHHHHhcCCC--c
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF------------------Y---FWEECMNLREVKALRKLNHP--N 61 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------------~---~~~~~~~~~Ei~~l~~l~hp--n 61 (432)
.+..+||-|.-+.||.|.+. .|..+|+|.=+-.. . ........+|.++|.+|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46788999999999999875 57789999632110 0 11223356899999999544 5
Q ss_pred ccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEE
Q 014039 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKI 140 (432)
Q Consensus 62 Iv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL 140 (432)
|.+.++. +...+|||+++|..+...+ ++.+....++..|++-+.-+-..|++|+|+++-||+++++ .+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 6666654 6678999999996554332 2355566677777777777778999999999999999976 9999
Q ss_pred eeeccceecC
Q 014039 141 ADFGLARELS 150 (432)
Q Consensus 141 ~DFG~a~~~~ 150 (432)
+||-.+....
T Consensus 244 IDwPQ~v~~~ 253 (304)
T COG0478 244 IDWPQAVPIS 253 (304)
T ss_pred EeCcccccCC
Confidence 9999886544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.1e-08 Score=90.20 Aligned_cols=103 Identities=20% Similarity=0.340 Sum_probs=77.6
Q ss_pred HHHHHHHHHHhcCCCc--ccccceEEEeC----CEEEEEEecCCCc--HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014039 46 MNLREVKALRKLNHPN--IIKLKEVVREN----NELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117 (432)
Q Consensus 46 ~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~----~~~~lV~E~~~~~--ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH 117 (432)
...+|...+..|..-. +.+.+.+.+.. ...+||+|++++. +.+.+.... ..+......++.+++..++-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHH
Confidence 4567888877774333 44455555432 3458999999873 444444322 3677788999999999999999
Q ss_pred HCCCeeccCCCCceeEeCC----eEEEeeeccceec
Q 014039 118 RNGYFHRDLKPENLLVTND----VLKIADFGLAREL 149 (432)
Q Consensus 118 ~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~ 149 (432)
.+||+|+|+++.|||++.+ .+.++||+-++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999865 5999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.9e-07 Score=91.46 Aligned_cols=254 Identities=15% Similarity=0.080 Sum_probs=153.7
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceE-----E-EeCC-EEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEV-----V-RENN-ELFF 77 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~-----~-~~~~-~~~l 77 (432)
..+.||+|+-+.+|-.-. -+. .+.|+.......... +.+..|... +||-+-.-+.+ + -+.+ .+-+
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecch--hhc-hhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 356799999999987522 222 355777654432221 223444444 56644331111 1 1222 3678
Q ss_pred EEecCCCc--HHHHHHH--cC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 78 IFEYMEHN--LYHIMRE--RQ---IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 78 V~E~~~~~--ll~~~~~--~~---~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
+|..+.|- ...++.. ++ ....+....++.+.|+.+.+.||..|.+-+|++++|+||.++ .+.|.|=..-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 99998873 3333221 11 236677889999999999999999999999999999999865 8888775443332
Q ss_pred CCCCCCccccCCccccchhhhc----CCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
..+..+...+|...|.+||.-. -+-.-+...|.|.||+++++++.| +.||.|-... ...|+.-+-.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~---------~~ap~p~E~~ 238 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI---------SDAPNPLETD 238 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc---------CCCCCcchhh
Confidence 3334455568999999999742 123346789999999999998886 9999874321 0111111100
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccC--CCCCCCHH
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWD--PLRRPTAD 275 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--P~~Rpta~ 275 (432)
.....--+....-...++.+..--+.-+++++..|..+|+... +.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 0000000001111222233333333457888999999999754 56899974
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-07 Score=88.07 Aligned_cols=140 Identities=17% Similarity=0.236 Sum_probs=96.6
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-------------------HH----HHHHHHHHHHHhcC--CC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------------------EE----CMNLREVKALRKLN--HP 60 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------~~----~~~~~Ei~~l~~l~--hp 60 (432)
+...|..|..+.||+|.. .++..+|+|+.+.....- .. ....+|...|+++. +=
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345777899999999964 557889999875322110 00 11246888888873 33
Q ss_pred cccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCCeEE
Q 014039 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTNDVLK 139 (432)
Q Consensus 61 nIv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~~lk 139 (432)
.+.+.+.+. .-.|||||++......=+-+.-++...+...+..++++.+.-|-. .|+||+||+.-|||+.++.+.
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~ 206 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPY 206 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEE
Confidence 444445442 336999999864111100111234444788888999999888877 899999999999999999999
Q ss_pred EeeeccceecC
Q 014039 140 IADFGLARELS 150 (432)
Q Consensus 140 L~DFG~a~~~~ 150 (432)
|+|||.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999997654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.5e-09 Score=110.74 Aligned_cols=243 Identities=16% Similarity=0.125 Sum_probs=167.8
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc-ccccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN-IIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~ 82 (432)
|....-.++|+++.+++.+...+...+ .+.+.... ...-++++|.+++||| .+..++-++.+...+++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~l------~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQTL------SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccch------hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 344455788999999999877666655 66665441 1234899999999999 666666667777888999999
Q ss_pred CCc--HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCCCccccC
Q 014039 83 EHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVS 160 (432)
Q Consensus 83 ~~~--ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~~~~~~~ 160 (432)
.++ ...........+-+-+.....+.-+++|+++|+.--+||| ||+..++..|..||+.+..+..........+
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~ 392 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIG 392 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCC
Confidence 875 2221111111233444556666777899999998778999 9999999999999999988877656677899
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
++.++|||+.. ...+....|.|++|.-..+|.-|.+|-...- .+.. ..|..+ +......
T Consensus 393 ~~~~~~pev~~-~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p--------~s~~L~~------ 451 (829)
T KOG0576|consen 393 TPEPLAPEVIQ-ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGP--------NSPMLTD------ 451 (829)
T ss_pred CCCCCCchhhc-ccccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCC--------Cccccch------
Confidence 99999999884 6678999999999988778877777654410 0000 001111 0000000
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..-+... .-.++...|+..-|..|+.+..++-|.+|+.
T Consensus 452 -~~aw~~~------~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 452 -KSAWSPV------FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred -hhhcCcc------cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 0000111 1126788999999999999999999999985
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.7e-07 Score=81.79 Aligned_cols=137 Identities=18% Similarity=0.269 Sum_probs=89.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHH--------HHHHHHHHHhc---CCCcccccceEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM--------NLREVKALRKL---NHPNIIKLKEVVR 70 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~--------~~~Ei~~l~~l---~hpnIv~l~~~~~ 70 (432)
.+|++++++-......|.+. .-.|+.+++|....+..-.++.. ..+++..+.++ +....+.++-+.+
T Consensus 31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35778888877777777666 34567788998765432222111 13455545444 3334444443332
Q ss_pred e-----CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeecc
Q 014039 71 E-----NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGL 145 (432)
Q Consensus 71 ~-----~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~ 145 (432)
. ....+|+|||++|.-+..+. .+++ .+...|.+++.-||+.|++|+|..|.|++++++.++++||+.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~ 180 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQG 180 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcc
Confidence 2 23456899999995443221 1333 244567778999999999999999999999999999999986
Q ss_pred cee
Q 014039 146 ARE 148 (432)
Q Consensus 146 a~~ 148 (432)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.8e-06 Score=78.66 Aligned_cols=136 Identities=14% Similarity=0.157 Sum_probs=95.9
Q ss_pred eecCceEEEEEEEcCCCeEEEEEEeccccc-----chHHHHHHHHHHHHHhcCCCc--ccccceEEE---e--CCEEEEE
Q 014039 11 GDGTCGCVYKAFNVETYEIVAVKKMKRKFY-----FWEECMNLREVKALRKLNHPN--IIKLKEVVR---E--NNELFFI 78 (432)
Q Consensus 11 G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~---~--~~~~~lV 78 (432)
|+|+-+.|+.... .|+.+-+|.-...-. ......+.+|...+++|..-+ +.++. ++. . ...-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888998754 333677887652111 123445678999988884322 44444 222 1 2235799
Q ss_pred EecCCC--cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CC--eEEEeeeccceec
Q 014039 79 FEYMEH--NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-ND--VLKIADFGLAREL 149 (432)
Q Consensus 79 ~E~~~~--~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~--~lkL~DFG~a~~~ 149 (432)
+|-+++ +|.+.+... -.+.++.....++.+++.+++-||+.|+.|+|+-+.||+++ ++ .++++||.-++..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 999985 555555442 22567888899999999999999999999999999999997 44 5999999977643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.8e-06 Score=77.67 Aligned_cols=78 Identities=17% Similarity=0.164 Sum_probs=53.4
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCC--cccccceEEE---eCCEEEEEEec
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP--NIIKLKEVVR---ENNELFFIFEY 81 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~---~~~~~~lV~E~ 81 (432)
++.|+.|..+.||+..... ..+++|..... .......+|..+++.+... .+.+++.... .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999997755 37889997654 2333456788888888432 3556665432 34457899999
Q ss_pred CCCcHHHH
Q 014039 82 MEHNLYHI 89 (432)
Q Consensus 82 ~~~~ll~~ 89 (432)
++|..+..
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 99854333
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.4e-06 Score=79.63 Aligned_cols=133 Identities=18% Similarity=0.190 Sum_probs=81.6
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc--ccccceEEEeCCEEEEEEecCCCc
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN--IIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
..||.|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 24457788876433 1223568999999985333 466777777778888999999984
Q ss_pred H-H---------------HHHHH-----cC---CCCCHHH-HHHHHHHH----------HH-HHHHHH----HCCCeecc
Q 014039 86 L-Y---------------HIMRE-----RQ---IPFSEGE-IRSFMSQM----------LQ-GLAHMH----RNGYFHRD 125 (432)
Q Consensus 86 l-l---------------~~~~~-----~~---~~l~~~~-~~~i~~qI----------l~-aL~~LH----~~givHrD 125 (432)
. . ..+-. .. ....... ...+..++ .. ...+|. ...+||+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 1 1 00000 00 0011110 01111111 11 112222 12578999
Q ss_pred CCCCceeEeCCeEEEeeeccce
Q 014039 126 LKPENLLVTNDVLKIADFGLAR 147 (432)
Q Consensus 126 lkP~NILl~~~~lkL~DFG~a~ 147 (432)
+.|.||+++++.+.|+||+.|.
T Consensus 160 ~~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCCcEEEechhcC
Confidence 9999999997679999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.6e-06 Score=89.54 Aligned_cols=138 Identities=22% Similarity=0.348 Sum_probs=86.5
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc---------------------------------------hHHHHHH
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF---------------------------------------WEECMNL 48 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------------------------------------~~~~~~~ 48 (432)
..|+.++-|.||+|+.+. |+.||||+....-.. ..+....
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 468899999999998655 999999986422100 0011123
Q ss_pred HHHHHHHhc-----CCCcccccceEEEeCCEEEEEEecCCCc-HHH--HHHHcCCCCCHHHHHHHHHHHHHH-HHHHHHC
Q 014039 49 REVKALRKL-----NHPNIIKLKEVVRENNELFFIFEYMEHN-LYH--IMRERQIPFSEGEIRSFMSQMLQG-LAHMHRN 119 (432)
Q Consensus 49 ~Ei~~l~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~~~-ll~--~~~~~~~~l~~~~~~~i~~qIl~a-L~~LH~~ 119 (432)
+|...+.++ +.++|.--.=+++-.+.-.|+|||++|. +.+ .+... .++... ++..++++ +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhc
Confidence 566666665 2343332222333445668999999994 222 23332 344332 33333332 3334458
Q ss_pred CCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 120 givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
|++|.|.+|.||+++.+ .+.+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999865 999999999977654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.6e-06 Score=91.00 Aligned_cols=198 Identities=21% Similarity=0.207 Sum_probs=138.2
Q ss_pred HHHHHHHhcCCCcccccceEEEeCC----EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 014039 49 REVKALRKLNHPNIIKLKEVVRENN----ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHR 124 (432)
Q Consensus 49 ~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHr 124 (432)
-|+..+.+..|+|++.++.+..... ...+..|++....+..+...-+.++...++.+..+++.||+|+|+....|.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v 310 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHV 310 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcccee
Confidence 4677778889999999988864322 123455777765555555555689999999999999999999999966666
Q ss_pred cCCCC---ceeEeC-CeEEEe--eeccceecCCCCCCccccCCccccchhhhcCCCCCCc--ccceechHHHHHHHHhCC
Q 014039 125 DLKPE---NLLVTN-DVLKIA--DFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSP--AIDMWAVGAILAELFTLS 196 (432)
Q Consensus 125 DlkP~---NILl~~-~~lkL~--DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~--~~DiWSlG~il~ell~g~ 196 (432)
-+... +--++. +.+.+. ||+..+.+...........+..+.|+|... ...+.. ..|+|.+|.....+..|.
T Consensus 311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~-~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLK-ENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred EEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccc-cccchhhhhhHHHHHHHHHhhhhhcC
Confidence 55544 222232 255555 999888877665555666777888998774 333333 369999999999998866
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCH-HHHHHHHHhcccCCCCCCCHH
Q 014039 197 PIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASM-EAIDLIWQLCSWDPLRRPTAD 275 (432)
Q Consensus 197 ~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~dli~~~L~~dP~~Rpta~ 275 (432)
.+-.-.. .. ..+.+..+. +..+++.+|+.-++++|+++.
T Consensus 390 ~i~~~~~---~~-------------------------------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 390 DISEKSA---VP-------------------------------------VSLLDVLSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred ccccccc---ch-------------------------------------hhhhccccchhhhhhhhhhcchhhhhccchh
Confidence 4321100 00 001111121 678999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 014039 276 QALQHPFFNVET 287 (432)
Q Consensus 276 elL~Hp~f~~~~ 287 (432)
+++.|+|.+...
T Consensus 430 ~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 430 ELLTHPFLRFPT 441 (1351)
T ss_pred hhhhchhccccc
Confidence 999999997643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.5e-06 Score=90.94 Aligned_cols=80 Identities=19% Similarity=0.257 Sum_probs=55.9
Q ss_pred EeeeEeecCceEEEEEEEcCCC--eEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcc--cccceEEEeC---CEEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETY--EIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNI--IKLKEVVREN---NELFF 77 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnI--v~l~~~~~~~---~~~~l 77 (432)
-++.++.|.+..+|+......+ ..+++|+..............+|.++|+.+. |.+| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998765432 4577887654332222334668999999995 6665 6667766553 46789
Q ss_pred EEecCCCc
Q 014039 78 IFEYMEHN 85 (432)
Q Consensus 78 V~E~~~~~ 85 (432)
||||++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999985
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.5e-06 Score=76.65 Aligned_cols=73 Identities=12% Similarity=0.072 Sum_probs=49.2
Q ss_pred eEeecCc-eEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEecCCCcH
Q 014039 9 ELGDGTC-GCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFEYMEHNL 86 (432)
Q Consensus 9 ~IG~G~f-g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~~l 86 (432)
.|-.|.. +.||+.... +..+.+|...... .....+|+++++.+. +--+.+++++....+..++|||+++|..
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 789999643 3567888876542 122457999998883 4345567777766667889999999853
Q ss_pred H
Q 014039 87 Y 87 (432)
Q Consensus 87 l 87 (432)
+
T Consensus 79 l 79 (244)
T cd05150 79 A 79 (244)
T ss_pred H
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=8.9e-06 Score=83.96 Aligned_cols=138 Identities=22% Similarity=0.310 Sum_probs=87.1
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccc-----------------------------h-------HHHHHHHHH
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-----------------------------W-------EECMNLREV 51 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----------------------------~-------~~~~~~~Ei 51 (432)
+.||.-+.|.|++|+.+. |+.||+|+-+..-.. + .+..+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468899999999998766 999999975422110 0 011123455
Q ss_pred HHHHhc----CCCcc---cccceEE-EeCCEEEEEEecCCC---cHHHHHHHcCCCCCHHHHHHHHHHHHHH-HHHHHHC
Q 014039 52 KALRKL----NHPNI---IKLKEVV-RENNELFFIFEYMEH---NLYHIMRERQIPFSEGEIRSFMSQMLQG-LAHMHRN 119 (432)
Q Consensus 52 ~~l~~l----~hpnI---v~l~~~~-~~~~~~~lV~E~~~~---~ll~~~~~~~~~l~~~~~~~i~~qIl~a-L~~LH~~ 119 (432)
+...++ .|-+. |.+-.++ .-...-.|+||||+| +.++.+.+.+ ++...+.. .+.++ +.-|-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~---~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILN---KLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHH---HHHHHHHHHHHhc
Confidence 544443 34441 1122222 223455899999998 4666666654 55554433 33333 2233467
Q ss_pred CCeeccCCCCceeEeC-----CeEEEeeeccceecCC
Q 014039 120 GYFHRDLKPENLLVTN-----DVLKIADFGLARELSS 151 (432)
Q Consensus 120 givHrDlkP~NILl~~-----~~lkL~DFG~a~~~~~ 151 (432)
|++|+|=.|.||++.. ..+.+-|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999982 2899999999977654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=5e-05 Score=68.77 Aligned_cols=126 Identities=24% Similarity=0.291 Sum_probs=87.1
Q ss_pred CCeeEeeeEeecCc-eEEEEEEEcCCCeEEEEEEecc---c-------ccch----------HHHHHHHHHHHHHhc---
Q 014039 2 ERYKILEELGDGTC-GCVYKAFNVETYEIVAVKKMKR---K-------FYFW----------EECMNLREVKALRKL--- 57 (432)
Q Consensus 2 ~~Y~~~~~IG~G~f-g~V~~a~~~~~~~~vAiK~i~~---~-------~~~~----------~~~~~~~Ei~~l~~l--- 57 (432)
.+++.++.||.|.- |.||+++. .|+.||+|..+. . .... ...-+..|.++.-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 36889999999999 99999965 567999999321 0 0000 001134566666655
Q ss_pred CCCcc--cccceEEEeC------------------CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014039 58 NHPNI--IKLKEVVREN------------------NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117 (432)
Q Consensus 58 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH 117 (432)
++.++ |+++++..=. ....||.||++..- .++.. -+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 55666 8898886211 12348888887643 23333 3456777788899
Q ss_pred HCCCeeccCCCCceeEeCCeEEEeeeccc
Q 014039 118 RNGYFHRDLKPENLLVTNDVLKIADFGLA 146 (432)
Q Consensus 118 ~~givHrDlkP~NILl~~~~lkL~DFG~a 146 (432)
+.||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----CCEEEecccC
Confidence 999999999999987 4589999965
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.6e-05 Score=68.59 Aligned_cols=128 Identities=23% Similarity=0.217 Sum_probs=86.2
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccc-cceEEEeCCEEEEEEecCCC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK-LKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~~~~lV~E~~~~ 84 (432)
..+.||+|.+|.||++.. .|..+|+|+-..+.. ...+..|+++|..+.-.++.. +|.+-. -.+.|||+.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 456799999999999954 455789998765543 334567999999987666554 444422 2455999998
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC--CceeEeCCeEEEeeeccceec
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKP--ENLLVTNDVLKIADFGLAREL 149 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP--~NILl~~~~lkL~DFG~a~~~ 149 (432)
--+....... + ++-+..+++.-.-|-..||-|..|.- .||+++++.+.|+||..|+..
T Consensus 97 ~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 4333322211 2 33344555665556677999998863 466666669999999999743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00018 Score=65.38 Aligned_cols=130 Identities=20% Similarity=0.229 Sum_probs=88.2
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccc---------------cchHHHHHHHHHHHHHhcC------CCccccc
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF---------------YFWEECMNLREVKALRKLN------HPNIIKL 65 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~Ei~~l~~l~------hpnIv~l 65 (432)
...||+|+.-.||.- . .....+||++.... .........+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999999975 2 23346789887654 0011223345666555554 7899999
Q ss_pred ceEEEeCCEEEEEEecCC---C----cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---
Q 014039 66 KEVVRENNELFFIFEYME---H----NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--- 135 (432)
Q Consensus 66 ~~~~~~~~~~~lV~E~~~---~----~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--- 135 (432)
+|+.+++-..-+|+|.+. | +|.+.+ ..+ .+++ .+... +-+-.+||-+.+|+.+|++|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~-~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL-KEG-GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH-HcC-CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999988999999864 2 344444 333 4665 33333 344456788999999999999999962
Q ss_pred C--eEEEee-ecc
Q 014039 136 D--VLKIAD-FGL 145 (432)
Q Consensus 136 ~--~lkL~D-FG~ 145 (432)
+ .+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 2 578887 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00031 Score=70.63 Aligned_cols=76 Identities=18% Similarity=0.135 Sum_probs=51.9
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccc----c--chHHHHHHHHHHHHHhcC---CCcccccceEEEeCCEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF----Y--FWEECMNLREVKALRKLN---HPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~--~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l 77 (432)
.+.||.|.+..||++....+++.++||.-.... . .........|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 467999999999999986554679999854110 0 112234456888888762 2456677766 4455689
Q ss_pred EEecCCC
Q 014039 78 IFEYMEH 84 (432)
Q Consensus 78 V~E~~~~ 84 (432)
|||++++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999975
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.1e-05 Score=69.67 Aligned_cols=28 Identities=43% Similarity=0.688 Sum_probs=24.6
Q ss_pred CCeeccCCCCceeEeCCe-EEEeeeccce
Q 014039 120 GYFHRDLKPENLLVTNDV-LKIADFGLAR 147 (432)
Q Consensus 120 givHrDlkP~NILl~~~~-lkL~DFG~a~ 147 (432)
++||+|+.+.||+++++. .-|+||+.|.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 589999999999999875 4699999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00012 Score=71.46 Aligned_cols=142 Identities=20% Similarity=0.262 Sum_probs=97.7
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEeccc--------ccc-------------hHH----HHHHHHHHHHHhcCCC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRK--------FYF-------------WEE----CMNLREVKALRKLNHP 60 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------~~~-------------~~~----~~~~~Ei~~l~~l~hp 60 (432)
+-.+|..|.-+.||.|. ..+|+.+|||+.+.+ .+. ..+ .....|++.|+++...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44678899999999996 455777999987521 110 011 1124688888888666
Q ss_pred cccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCceeEeCCeEE
Q 014039 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-RNGYFHRDLKPENLLVTNDVLK 139 (432)
Q Consensus 61 nIv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH-~~givHrDlkP~NILl~~~~lk 139 (432)
.|....-+... ...|||+|++..-...=+-+.-.++...+..+-.|++.-+.-|- .+++||.||.--|+|+.+|.+.
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~ly 304 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKLY 304 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEEE
Confidence 65443333332 33799999985322221222335777788887777777777664 6799999999999999999999
Q ss_pred EeeeccceecC
Q 014039 140 IADFGLARELS 150 (432)
Q Consensus 140 L~DFG~a~~~~ 150 (432)
|+|.+.+....
T Consensus 305 iIDVSQSVE~D 315 (520)
T KOG2270|consen 305 IIDVSQSVEHD 315 (520)
T ss_pred EEEccccccCC
Confidence 99999885443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00027 Score=65.93 Aligned_cols=73 Identities=21% Similarity=0.230 Sum_probs=46.1
Q ss_pred eeeEeecCceEEEEEEEcC-CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc-ccccceEEEeCCEEEEEEecCCC
Q 014039 7 LEELGDGTCGCVYKAFNVE-TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN-IIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++.|..|-...||+..... .++.|++|+....... .....+|+.+++.+...+ ..++++... + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 5677888889999986543 3567889976543211 112347888888884333 344444332 2 379999987
Q ss_pred c
Q 014039 85 N 85 (432)
Q Consensus 85 ~ 85 (432)
.
T Consensus 77 ~ 77 (235)
T cd05157 77 R 77 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00017 Score=68.40 Aligned_cols=133 Identities=19% Similarity=0.213 Sum_probs=75.8
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcc-cccceEEEeCCEEEEEEecCCCcHH
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI-IKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
.+..|-.+.+|+.. .+++.+++|......... .....+|.++++.+....+ .+++... . -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 34567788999886 456678888765432111 0123578889988854333 3344332 2 2689999988432
Q ss_pred H-----------HH----HH--c----CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCeeccCCC
Q 014039 88 H-----------IM----RE--R----QIPFSE-GEIRSFMSQM---------LQGLAHMHR--------NGYFHRDLKP 128 (432)
Q Consensus 88 ~-----------~~----~~--~----~~~l~~-~~~~~i~~qI---------l~aL~~LH~--------~givHrDlkP 128 (432)
. .+ .+ . ..+++. ..+..+..++ ...+..+-. ..+||+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 1 11 10 0 111221 1222322222 111222222 2589999999
Q ss_pred CceeEeCCeEEEeeecccee
Q 014039 129 ENLLVTNDVLKIADFGLARE 148 (432)
Q Consensus 129 ~NILl~~~~lkL~DFG~a~~ 148 (432)
.||+++++.+.|+||+.|..
T Consensus 156 ~Nil~~~~~~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQGLKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCCCEEEeccccCc
Confidence 99999987789999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00047 Score=66.67 Aligned_cols=135 Identities=16% Similarity=0.129 Sum_probs=78.1
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCC--cccccce------EEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP--NIIKLKE------VVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~------~~~~~~~~~lV 78 (432)
++.|..|....+|+... .+..+++|+... . .......|+++++.+... .+.+++. +....+..++|
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 55677788789999854 334688898764 1 122345678888777322 2444433 12334567899
Q ss_pred EecCCCcHHH--------HH-------HHcCCCCC--------HHHHH------------HHHHHHHHHHHHHHH-----
Q 014039 79 FEYMEHNLYH--------IM-------RERQIPFS--------EGEIR------------SFMSQMLQGLAHMHR----- 118 (432)
Q Consensus 79 ~E~~~~~ll~--------~~-------~~~~~~l~--------~~~~~------------~i~~qIl~aL~~LH~----- 118 (432)
+|+++|.... .+ ......+. ..... .....+..++.++.+
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9999873210 01 00000000 00000 011123334445443
Q ss_pred --CCCeeccCCCCceeEeCCe-EEEeeeccce
Q 014039 119 --NGYFHRDLKPENLLVTNDV-LKIADFGLAR 147 (432)
Q Consensus 119 --~givHrDlkP~NILl~~~~-lkL~DFG~a~ 147 (432)
.++||+|+.|.||+++++. +.|+||+.|.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4799999999999999875 5799999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=63.88 Aligned_cols=136 Identities=14% Similarity=0.121 Sum_probs=76.6
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc--ccccceE------EEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN--IIKLKEV------VRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~~lV 78 (432)
++.++.|....||++.. .+| .+++|+...... ......|++++..|.... +.+++.. ....+..+++
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 56677887789999864 334 577887754321 112345677777763222 3343331 1234667899
Q ss_pred EecCCCcH-----HHHH----------HHcCCCC--------CHHH-----HH----------HHHHHHHHHHHHHHH--
Q 014039 79 FEYMEHNL-----YHIM----------RERQIPF--------SEGE-----IR----------SFMSQMLQGLAHMHR-- 118 (432)
Q Consensus 79 ~E~~~~~l-----l~~~----------~~~~~~l--------~~~~-----~~----------~i~~qIl~aL~~LH~-- 118 (432)
+||++|.. .... ......+ .... .. .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 99998731 1111 0000011 0000 00 011123334555542
Q ss_pred -----CCCeeccCCCCceeEeCCe-EEEeeeccce
Q 014039 119 -----NGYFHRDLKPENLLVTNDV-LKIADFGLAR 147 (432)
Q Consensus 119 -----~givHrDlkP~NILl~~~~-lkL~DFG~a~ 147 (432)
.++||+|+++.||+++++. +.|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5899999999999998774 5899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0026 Score=62.27 Aligned_cols=29 Identities=38% Similarity=0.519 Sum_probs=25.5
Q ss_pred CCCeeccCCCCceeEeCCeE-EEeeeccce
Q 014039 119 NGYFHRDLKPENLLVTNDVL-KIADFGLAR 147 (432)
Q Consensus 119 ~givHrDlkP~NILl~~~~l-kL~DFG~a~ 147 (432)
.|+||+|+.|.||+++++.+ -|+||+.|.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 38999999999999997754 799999884
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=1.6e-05 Score=88.69 Aligned_cols=208 Identities=15% Similarity=0.076 Sum_probs=137.3
Q ss_pred HHHHHHHHhcCCCcccccceEEE--eCCEEEEEEecCCCc-HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC--
Q 014039 48 LREVKALRKLNHPNIIKLKEVVR--ENNELFFIFEYMEHN-LYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRN-- 119 (432)
Q Consensus 48 ~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~~~-ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~-- 119 (432)
..|..-++...|+++...+.-.. ++.+.|..++|+.++ +...+.+. ..++...-+.....+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34555666678998887665543 345678999998754 55555543 23455555555555557777777754
Q ss_pred ---CCeeccCCCCceeEeCC-eEEEeeeccceec-CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh
Q 014039 120 ---GYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194 (432)
Q Consensus 120 ---givHrDlkP~NILl~~~-~lkL~DFG~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~ 194 (432)
--+|+++|+-|.+|..+ .+|++++|+.+.. ..........++++|+++++.. .-.++.++|+|..||-+|+.-.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhc
Confidence 26899999999999876 8999999999933 3333445678899999999873 4457778999999999999988
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 014039 195 LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA 274 (432)
Q Consensus 195 g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta 274 (432)
|.++|. ..+..+++ |... +...+.. ..-.+.++-.....+|-+.-..||.-
T Consensus 1436 ~n~~fi-----~flq~~Lk--giid-----------n~tf~sI-----------e~l~pgdaNve~~~~Ll~K~~~rp~q 1486 (2724)
T KOG1826|consen 1436 GNAYFI-----FFLQPALK--GIID-----------NHTFFSI-----------EKLKPGDANVEALHRLLWKYMERPGQ 1486 (2724)
T ss_pred ccHHHH-----HHHHHHHc--Cccc-----------ccccccc-----------cccCCCcccHHHHHHHHHHhhhcchh
Confidence 777662 22222211 1110 0001111 11123344455555666666799999
Q ss_pred HHHhcCCCCCC
Q 014039 275 DQALQHPFFNV 285 (432)
Q Consensus 275 ~elL~Hp~f~~ 285 (432)
...+.-+.|..
T Consensus 1487 ~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1487 YISLSRDHFAV 1497 (2724)
T ss_pred hhhcccccccc
Confidence 99999988864
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00051 Score=69.73 Aligned_cols=172 Identities=19% Similarity=0.285 Sum_probs=113.1
Q ss_pred HHHHHHHHHHhcCCCcccccceEEEeC-CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 014039 46 MNLREVKALRKLNHPNIIKLKEVVREN-NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHR 124 (432)
Q Consensus 46 ~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHr 124 (432)
.++--.++++.+.|+|...++++-+.. ....+|||++..++.+..+.+. +-..... .+|+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~~~- 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGVLH- 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------ccccce-
Confidence 345667889999999999998887543 4578999999999998877653 2211111 122222
Q ss_pred cCCCCceeEeCCeEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh
Q 014039 125 DLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE 204 (432)
Q Consensus 125 DlkP~NILl~~~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~ 204 (432)
.|+ ++.+| -++ . + | |- ..+.++||||+|.++.|+..|..+++....
T Consensus 91 ----~~~------~~~td-~~~----t------~-----~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~ 136 (725)
T KOG1093|consen 91 ----LNI------IYITD-HFL----T------K-----Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELTE 136 (725)
T ss_pred ----ehh------hhccc-ccc----c------c-----C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence 122 23333 000 0 0 0 11 112499999999999999999999988888
Q ss_pred HHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 205 IDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 205 ~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.+++..+.+..-.+. +.....+.. .+.-.++....+++.+|+-..|..||...++++|+-|.
T Consensus 137 s~~l~~i~k~~~~d~-~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 137 SEYLEILLKYYTDDQ-ELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred HHHHHHHHHhccCch-hHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence 888777765443322 211111110 01123566788999999999999999999999999998
Q ss_pred CC
Q 014039 285 VE 286 (432)
Q Consensus 285 ~~ 286 (432)
+.
T Consensus 199 ev 200 (725)
T KOG1093|consen 199 EV 200 (725)
T ss_pred HH
Confidence 64
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00077 Score=60.89 Aligned_cols=97 Identities=23% Similarity=0.292 Sum_probs=75.6
Q ss_pred HHHHHHHHhcCC-CcccccceEEEeCCEEEEEEecCCCc-HHHH---HHHcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 014039 48 LREVKALRKLNH-PNIIKLKEVVRENNELFFIFEYMEHN-LYHI---MRERQIPFSEGEIRSFMSQMLQGLAHMHR---N 119 (432)
Q Consensus 48 ~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~~~-ll~~---~~~~~~~l~~~~~~~i~~qIl~aL~~LH~---~ 119 (432)
..|.-+|+.+.+ +++.+++|+|-. ++|+||.+.+ ++.. +... ..-++....+++.++++.+.+++. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999965 699999999843 5688999853 3321 1111 235788999999999999999997 3
Q ss_pred CCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 120 GYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 120 givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
.+.-.|++++|+-++++ .+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 57778999999999965 9999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=62.84 Aligned_cols=73 Identities=19% Similarity=0.190 Sum_probs=46.1
Q ss_pred eeeEeecCceEEEEEEEcC------CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcc-cccceEEEeCCEEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVE------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI-IKLKEVVRENNELFFIF 79 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~ 79 (432)
++.+..|--..||+..... +++.+++|+...... ......+|.++++.+...++ .+++.++. + .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 4567777778999987543 257888999665321 12234578888888843333 34555443 2 3588
Q ss_pred ecCCCc
Q 014039 80 EYMEHN 85 (432)
Q Consensus 80 E~~~~~ 85 (432)
||++|.
T Consensus 77 e~i~G~ 82 (302)
T cd05156 77 EFIPSR 82 (302)
T ss_pred heeCCC
Confidence 988773
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0033 Score=62.22 Aligned_cols=74 Identities=19% Similarity=0.235 Sum_probs=48.0
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecc------cccchHHHHHHHHHHHHHhcC--CC-cccccceEEEeCCEEEEEE
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKR------KFYFWEECMNLREVKALRKLN--HP-NIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~------~~~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lV~ 79 (432)
.||.|....||++.+..+++.++||.-.. ........+...|...|+... .| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999765446799997541 111122233446888887763 34 45555544 445567999
Q ss_pred ecCCC
Q 014039 80 EYMEH 84 (432)
Q Consensus 80 E~~~~ 84 (432)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0053 Score=59.82 Aligned_cols=138 Identities=21% Similarity=0.232 Sum_probs=77.7
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC--CcccccceEEEeCC--EEEEEEec
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH--PNIIKLKEVVRENN--ELFFIFEY 81 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~--~~~lV~E~ 81 (432)
+++.+-.|.--.+|.... +++.+++.+-.............+|..+|+.+.- --+...++++.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~--~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD--TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEec--CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 344443333334444433 3777888832223344445556789999998843 22333455555444 67899999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHH-HHHHHHHHHHH------------------------------------------
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMS-QMLQGLAHMHR------------------------------------------ 118 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~-qIl~aL~~LH~------------------------------------------ 118 (432)
+.|..... .. .+...-..++. .+.+.|+-||+
T Consensus 107 veGe~~~~---~~--~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 107 VEGEVVWS---AL--PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred ecceeccC---cC--CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99831100 00 00000011222 33333333332
Q ss_pred --------C--------CCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 119 --------N--------GYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 119 --------~--------givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
+ .++|+|+++.||+++++ -+-+.||+.+..-.
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 2 48999999999999976 78899999986543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0052 Score=61.56 Aligned_cols=76 Identities=17% Similarity=0.149 Sum_probs=49.9
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecc----ccc-chHHHHHHHHHHHHHhcC--CC-cccccceEEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKR----KFY-FWEECMNLREVKALRKLN--HP-NIIKLKEVVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~-~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lV 78 (432)
++.||.|.-..||++.+...++.|+||.-.. ... .....+...|.+.|+.+. .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999998754456799997531 111 122334456888888763 34 45556544 44455789
Q ss_pred EecCCC
Q 014039 79 FEYMEH 84 (432)
Q Consensus 79 ~E~~~~ 84 (432)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.016 Score=56.32 Aligned_cols=29 Identities=24% Similarity=0.568 Sum_probs=26.2
Q ss_pred CCCeeccCCCCceeEeCCeEEEeeeccce
Q 014039 119 NGYFHRDLKPENLLVTNDVLKIADFGLAR 147 (432)
Q Consensus 119 ~givHrDlkP~NILl~~~~lkL~DFG~a~ 147 (432)
.++||+|+.+.||+++++.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence 47899999999999998888999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0078 Score=59.74 Aligned_cols=135 Identities=13% Similarity=0.177 Sum_probs=76.4
Q ss_pred eeeEeecCceEEEEEEEcC----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcc-cccceEEEeCCEEEEEEec
Q 014039 7 LEELGDGTCGCVYKAFNVE----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI-IKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~ 81 (432)
+..|-.|-.-.+|++.... +++.|++|+...... ......+|..+++.+..-++ .++++.+.. + .|.||
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ef 114 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEF 114 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEe
Confidence 4455557778999986432 346788998764321 11123468889888854333 345665533 2 57888
Q ss_pred CCCcHHH-----------HH----HH--c-C---C--CCCHHHHHHHHHHHH-----------------HHHHHHH----
Q 014039 82 MEHNLYH-----------IM----RE--R-Q---I--PFSEGEIRSFMSQML-----------------QGLAHMH---- 117 (432)
Q Consensus 82 ~~~~ll~-----------~~----~~--~-~---~--~l~~~~~~~i~~qIl-----------------~aL~~LH---- 117 (432)
+++..+. .+ .+ . . . ......+..+..++. ..+..|.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 8763211 11 00 0 0 0 111223333332221 1121221
Q ss_pred ----HCCCeeccCCCCceeEeC--CeEEEeeeccce
Q 014039 118 ----RNGYFHRDLKPENLLVTN--DVLKIADFGLAR 147 (432)
Q Consensus 118 ----~~givHrDlkP~NILl~~--~~lkL~DFG~a~ 147 (432)
...+||+|+++.|||+++ +.+.++||..|.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 226899999999999985 379999999885
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0015 Score=63.04 Aligned_cols=136 Identities=15% Similarity=0.222 Sum_probs=89.0
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecc----------cc---------cc--hHHHHHHHHHHHHHhcC-CCc
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKR----------KF---------YF--WEECMNLREVKALRKLN-HPN 61 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~----------~~---------~~--~~~~~~~~Ei~~l~~l~-hpn 61 (432)
|.+++.||-|.-+.||.+-+.. |...++|.-.. ++ .+ ..+....+|...|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4568899999999999997643 66778885321 11 10 11223457889998883 332
Q ss_pred -ccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 62 -IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 62 -Iv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
|.+.++ .+..++|||++.|=-+..++. ...+..+...+..-+--|-.+|+||+|..-=||+|+++ .++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 334443 356789999998732222221 11223344445555666788999999999999999854 899
Q ss_pred EeeeccceecC
Q 014039 140 IADFGLARELS 150 (432)
Q Consensus 140 L~DFG~a~~~~ 150 (432)
++||-.+....
T Consensus 243 vIDFPQmvS~s 253 (465)
T KOG2268|consen 243 VIDFPQMVSTS 253 (465)
T ss_pred EeechHhhccC
Confidence 99999775443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.013 Score=56.36 Aligned_cols=29 Identities=28% Similarity=0.463 Sum_probs=24.8
Q ss_pred CCeeccCCCCceeEeC-C-eEEEeeecccee
Q 014039 120 GYFHRDLKPENLLVTN-D-VLKIADFGLARE 148 (432)
Q Consensus 120 givHrDlkP~NILl~~-~-~lkL~DFG~a~~ 148 (432)
.+||+|++|.||++++ + ..-|+||+.|..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987 5 457999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.016 Score=57.11 Aligned_cols=73 Identities=21% Similarity=0.211 Sum_probs=43.8
Q ss_pred eeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcc-cccceEEEeCCEEEEEEecC
Q 014039 7 LEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI-IKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 82 (432)
++.|..|-...+|+...... +..|++|+...... ......+|..+++.+..-++ .++++++. ++ +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence 34555577778898865432 23788888754321 11223478889988854444 35565552 33 588888
Q ss_pred CCc
Q 014039 83 EHN 85 (432)
Q Consensus 83 ~~~ 85 (432)
+|.
T Consensus 93 ~g~ 95 (330)
T PLN02421 93 NAR 95 (330)
T ss_pred cCC
Confidence 764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.03 Score=56.48 Aligned_cols=75 Identities=19% Similarity=0.200 Sum_probs=49.7
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--c----hHHHHHHHHHHHHHhcC---CCcccccceEEEeCCEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--F----WEECMNLREVKALRKLN---HPNIIKLKEVVRENNELF 76 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~----~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~ 76 (432)
..+.||.|.-..||+..+. +..++||.-..... . ....+...|.+.|+.+. ..++.+++.+..+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 3567899999999998763 34588997651111 0 12233446777777663 2467778877664 457
Q ss_pred EEEecCCC
Q 014039 77 FIFEYMEH 84 (432)
Q Consensus 77 lV~E~~~~ 84 (432)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.015 Score=58.56 Aligned_cols=29 Identities=31% Similarity=0.329 Sum_probs=26.1
Q ss_pred CCCeeccCCCCceeEeCCeEEEeeeccce
Q 014039 119 NGYFHRDLKPENLLVTNDVLKIADFGLAR 147 (432)
Q Consensus 119 ~givHrDlkP~NILl~~~~lkL~DFG~a~ 147 (432)
..+||.|+-+.||+.+++.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEecccc
Confidence 46899999999999988899999998774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.084 Score=51.47 Aligned_cols=29 Identities=17% Similarity=0.075 Sum_probs=25.8
Q ss_pred CCeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 120 GYFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 120 givHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
++||+|+.+.|+|++++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 79999999999999765 889999998854
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.071 Score=51.78 Aligned_cols=103 Identities=11% Similarity=0.093 Sum_probs=70.3
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC---CcccccceEEEe---CCEEEEEEe
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH---PNIIKLKEVVRE---NNELFFIFE 80 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~---~~~~~lV~E 80 (432)
.+.||.|..+.||...... + .+.+|..+... ......+|...|+.|.- -.+.++++++.+ .+..+||||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 5679999999999985432 3 46667643311 11235689999988842 357777877654 366899999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~ 119 (432)
+++|...... .........+..+++++|+-||+.
T Consensus 94 ~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9998544321 133445667778899999999975
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.021 Score=52.31 Aligned_cols=29 Identities=34% Similarity=0.626 Sum_probs=19.9
Q ss_pred CCeeccCCCCceeE--eCCeEEEeeecccee
Q 014039 120 GYFHRDLKPENLLV--TNDVLKIADFGLARE 148 (432)
Q Consensus 120 givHrDlkP~NILl--~~~~lkL~DFG~a~~ 148 (432)
.+||+|+.|.|||+ .++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 59999999999999 566999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.039 Score=54.30 Aligned_cols=86 Identities=23% Similarity=0.296 Sum_probs=61.9
Q ss_pred CCCcccccceEE-EeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeC
Q 014039 58 NHPNIIKLKEVV-RENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTN 135 (432)
Q Consensus 58 ~hpnIv~l~~~~-~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~ 135 (432)
..++..+.+-+- .+....|++|++-.+.+... . --..+++..++.+.+..++-+.+. .+-|||+.-.||||++
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdhgt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~ 357 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDHGTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDE 357 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecCCceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeec
Confidence 344444444333 23345678888877655432 1 234677888888888888777765 7899999999999999
Q ss_pred CeEEEeeecccee
Q 014039 136 DVLKIADFGLARE 148 (432)
Q Consensus 136 ~~lkL~DFG~a~~ 148 (432)
|+|.|+||-+|+.
T Consensus 358 GnvtLIDfklsRl 370 (488)
T COG5072 358 GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEeeeeec
Confidence 9999999999983
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.0037 Score=63.46 Aligned_cols=70 Identities=29% Similarity=0.307 Sum_probs=61.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 71 (432)
++++.+.++|.|+||+|+.+.++..+..+|||.+..+.........++|...+..+.|++++++...|..
T Consensus 49 ~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 49 NDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred ccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence 5678899999999999999999988889999999877766666777899999999999999998877753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.37 Score=54.81 Aligned_cols=29 Identities=34% Similarity=0.468 Sum_probs=24.6
Q ss_pred CCCeeccCCCCceeEeCC---eE-EEeeeccce
Q 014039 119 NGYFHRDLKPENLLVTND---VL-KIADFGLAR 147 (432)
Q Consensus 119 ~givHrDlkP~NILl~~~---~l-kL~DFG~a~ 147 (432)
.++||+|+.+.|||++.+ .+ -|+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 479999999999999865 44 499999885
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.22 Score=48.13 Aligned_cols=74 Identities=19% Similarity=0.191 Sum_probs=45.2
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc---CCCcccccceEEEeCCEEEEEEecC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL---NHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
-.+.|+.|.-..+|+.. .+++.+.+|+-.... ...+..|.+-|+.| .--.+.+++.+....+..+|||||+
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 45678889999999985 677788899876322 12244677777777 3445777888887777779999998
Q ss_pred CCc
Q 014039 83 EHN 85 (432)
Q Consensus 83 ~~~ 85 (432)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 743
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.3 Score=50.15 Aligned_cols=28 Identities=32% Similarity=0.615 Sum_probs=25.3
Q ss_pred CCeeccCCCCceeEeCCeEEEeeeccce
Q 014039 120 GYFHRDLKPENLLVTNDVLKIADFGLAR 147 (432)
Q Consensus 120 givHrDlkP~NILl~~~~lkL~DFG~a~ 147 (432)
.+||.|+-+.|||.+++.++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKCLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCCEEEEeecccc
Confidence 5899999999999988889999999774
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.23 Score=49.83 Aligned_cols=58 Identities=19% Similarity=0.376 Sum_probs=41.3
Q ss_pred EEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCceeEe
Q 014039 75 LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-RNGYFHRDLKPENLLVT 134 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH-~~givHrDlkP~NILl~ 134 (432)
..|+-+|+.| ++...+...+ .+|..+++++.-..+||.-+- -.+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3455567776 5556555443 567777777777777765544 45899999999999995
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.22 Score=45.88 Aligned_cols=100 Identities=18% Similarity=0.281 Sum_probs=61.3
Q ss_pred EEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHH
Q 014039 30 VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQM 109 (432)
Q Consensus 30 vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qI 109 (432)
..+|++..............+.+++.++ ..|+++..- +.-.+-++.|+|..- +-++ ..++..=
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~---------~i~~----~N~i~ag 150 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKI---------KINF----SNFITAG 150 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCc---------ccch----hHHHHHh
Confidence 4566665433322233345677777766 457777622 233455999998531 0111 1222233
Q ss_pred HHHHHHHHH--CCCeeccCCCCceeEeC-CeEEEeeeccc
Q 014039 110 LQGLAHMHR--NGYFHRDLKPENLLVTN-DVLKIADFGLA 146 (432)
Q Consensus 110 l~aL~~LH~--~givHrDlkP~NILl~~-~~lkL~DFG~a 146 (432)
+.+|.-.|+ .+.+|+|-.|+||+-+. |.+||.|=+..
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 567788884 37999999999999985 59999986643
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.35 Score=46.58 Aligned_cols=28 Identities=36% Similarity=0.487 Sum_probs=23.8
Q ss_pred CeeccCCCCceeEeCC------eEEEeeecccee
Q 014039 121 YFHRDLKPENLLVTND------VLKIADFGLARE 148 (432)
Q Consensus 121 ivHrDlkP~NILl~~~------~lkL~DFG~a~~ 148 (432)
++|+|++..|||+..+ .+++.||-.++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 8999999999999632 699999998853
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 432 | ||||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-56 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-56 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-56 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-56 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-56 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-56 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-56 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-56 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-55 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-55 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-55 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-55 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-55 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-55 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-55 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-55 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-55 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-55 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-55 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-55 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-55 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-55 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-55 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-55 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-55 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-55 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-55 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-55 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-55 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-55 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-55 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-55 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-55 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-55 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-55 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-54 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-54 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-50 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-50 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-50 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-50 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-49 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-47 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-47 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-47 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-47 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-46 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-46 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-46 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-46 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-46 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-46 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-46 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-46 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-46 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-46 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-46 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-46 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-46 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-46 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-46 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-46 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-46 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-46 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-46 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-46 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-46 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-46 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-46 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-46 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-45 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-45 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-45 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-43 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-43 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-43 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-43 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-43 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-43 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-43 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-43 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-43 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-43 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-43 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-43 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-43 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-43 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-43 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-43 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-43 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-43 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-43 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-43 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-43 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-42 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-42 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-42 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-42 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-42 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-42 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-42 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-42 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-42 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-42 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-42 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-42 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-42 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-42 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-42 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-42 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-42 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-42 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-42 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-42 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-42 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-42 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-42 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-42 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-42 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-42 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-42 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-42 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-42 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-42 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-42 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-42 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-42 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-42 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-42 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-42 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-42 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-42 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-42 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-42 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-42 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-42 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-42 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-42 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-42 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-42 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-41 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-41 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-41 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-41 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-41 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-41 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-41 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-40 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-40 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-40 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-40 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-40 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-40 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-39 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-39 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-39 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-39 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-39 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-39 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-39 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-39 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-39 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-39 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-39 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-39 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-39 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-39 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-39 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-39 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-39 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-39 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-39 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-39 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-39 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-39 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-39 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-39 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-39 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-39 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-39 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-39 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-39 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-39 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-39 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-39 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-39 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-38 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-38 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-38 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-38 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-38 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-38 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-38 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-38 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-38 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-38 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-37 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-37 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-37 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-36 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-36 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-36 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-36 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-33 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-33 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-32 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-31 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-28 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-26 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-26 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-26 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-26 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-26 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-26 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-26 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-26 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-25 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-25 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-24 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-24 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-24 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-24 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-23 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-23 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-23 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-22 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-22 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-22 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-22 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-20 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-20 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-20 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-18 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-18 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-18 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-09 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-09 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 |
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 432 | |||
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-141 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-137 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-122 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-121 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-120 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-119 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-119 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-118 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-118 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-115 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-114 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-113 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-113 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-112 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-110 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-105 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-102 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-101 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-101 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-100 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-100 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-100 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-99 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-99 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-99 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-69 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-68 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-67 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-67 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 8e-67 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 8e-67 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-66 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-66 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-66 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-65 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-63 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-63 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 6e-63 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-63 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-62 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-62 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-62 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-62 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-62 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-62 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 7e-62 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-61 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-61 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-61 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-61 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-61 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-61 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-61 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-60 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-60 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-60 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-60 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-60 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-60 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-59 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-59 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-59 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-59 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-59 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-59 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-59 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-58 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-58 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-58 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-58 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-58 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-58 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-58 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-56 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-56 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-56 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-55 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-55 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-55 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-55 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-54 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-54 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-54 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-53 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-53 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-53 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-52 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-51 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-50 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-50 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-50 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-49 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-48 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-48 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-48 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-48 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-47 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-47 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-47 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-46 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-46 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-46 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-46 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-45 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-45 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-44 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-44 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-44 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-44 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-43 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-43 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-42 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-42 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-42 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-42 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-42 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-41 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-41 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-41 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-41 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-40 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-40 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-39 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-39 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-39 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-39 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-39 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 6e-39 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-37 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-37 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-37 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-37 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-36 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-35 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-35 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-35 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-34 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-34 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-34 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-34 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-34 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-34 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-33 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-33 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-33 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-33 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-32 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-32 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-32 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-32 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-32 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-32 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-31 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-31 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-31 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-31 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-31 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-31 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-31 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-30 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-30 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-30 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-30 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-30 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-30 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-30 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-30 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-30 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-30 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-30 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-29 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-29 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-29 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-29 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-29 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-29 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-29 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-29 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-29 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 9e-29 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-28 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-28 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-28 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-28 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-28 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-28 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-28 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-28 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-28 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-27 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-27 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-27 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-27 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-27 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-27 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-27 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-27 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-27 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-27 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-26 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-26 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-26 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-26 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-26 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-26 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-25 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-25 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-25 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-25 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-24 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-24 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-24 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-24 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-21 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-20 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-19 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-19 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-19 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-17 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-15 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-15 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-14 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 |
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 405 bits (1042), Expect = e-141
Identities = 101/288 (35%), Positives = 158/288 (54%), Gaps = 4/288 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNH 59
ME+Y+ + ++G+G+ G V+K N +T +IVA+KK + + LRE++ L++L H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
PN++ L EV R L +FEY +H + H + Q E ++S Q LQ + H++
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+KPEN+L+T V+K+ DFG AR L+ Y + V+TRWYR+PE+L+ + Y
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
P +D+WA+G + AEL + P++PG S++DQLY + LG + +
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 238 SEILP-INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ L PN S A+ L+ DP R T +Q L HP+F
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-137
Identities = 100/305 (32%), Positives = 160/305 (52%), Gaps = 7/305 (2%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNH 59
ME+Y+ L +G+G+ G V K N +T IVA+KK + + +RE+K L++L H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
N++ L EV ++ + +FE+++H + + ++ ++ Q++ G+ H +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+KPEN+LV+ V+K+ DFG AR L++ Y + V+TRWYRAPE+L+ Y
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
A+D+WA+G ++ E+F P+FPGDS+IDQLY + LG +
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 238 SEILP-INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
EI L P S IDL + DP +RP + L H FF ++ +
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD---GFAERFS 320
Query: 297 LELRL 301
EL+L
Sbjct: 321 QELQL 325
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-122
Identities = 116/311 (37%), Positives = 172/311 (55%), Gaps = 24/311 (7%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE----CMNLREVKALRK 56
+RY+ L+ LG+G VYKA + T +IVA+KK+K + LRE+K L++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
L+HPNII L + + + +F++ME +L I+++ + + I+++M LQGL ++
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSS 174
H++ HRDLKP NLL+ + VLK+ADFGLA+ S YT V TRWYRAPE+L +
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 188
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP------DWTAFPEATN 228
Y +DMWAVG ILAEL P PGDS++DQL ++ LG P D + P+
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-- 246
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+++ I L I A + +DLI L ++P R TA QAL+ +F+
Sbjct: 247 ------VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR-- 298
Query: 289 VPYPLHDPLEL 299
P P +L
Sbjct: 299 -PGPT-PGCQL 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-121
Identities = 106/304 (34%), Positives = 163/304 (53%), Gaps = 8/304 (2%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE---CMNLREVKALRKL 57
ME Y L++LG+GT VYK + T +VA+K+++ + EE C +REV L+ L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDL 57
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H NI+ L +++ L +FEY++ +L + + + ++ F+ Q+L+GLA+ H
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSS 175
R HRDLKP+NLL+ LK+ADFGLAR S Y V T WYR P++LL S+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
YS IDMW VG I E+ T P+FPG + +QL+ + ILG P +P + +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHD 295
+Y + L P + DL+ +L ++ R +A+ A++HPFF + L D
Sbjct: 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD 297
Query: 296 PLEL 299
+
Sbjct: 298 TTSI 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-120
Identities = 111/289 (38%), Positives = 177/289 (61%), Gaps = 8/289 (2%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKL 57
ME+Y+ LE++G+GT G VYKA + IVA+K+++ +E + +RE+ L++L
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAE--DEGIPSTAIREISLLKEL 76
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
+HPNI+ L +V+ L +FE+ME +L ++ E + + +I+ ++ Q+L+G+AH H
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSS 175
++ HRDLKP+NLL+ +D LK+ADFGLAR + YT V T WYRAP+VL+ S
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
YS ++D+W++G I AE+ T P+FPG ++ DQL K+ ILG P+ +P+ +
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
++ S IIP E IDL+ + +DP +R +A A+ HP+F
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-119
Identities = 109/289 (37%), Positives = 166/289 (57%), Gaps = 9/289 (3%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKL 57
ME+Y LE++G+GT G VYKA N E A+KK++ +E + +RE+ L++L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR--LEKEDEGIPSTTIREISILKEL 57
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H NI+KL +V+ L +FE+++ +L ++ + +SF+ Q+L G+A+ H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSS 175
HRDLKP+NLL+ + LKIADFGLAR + YT + T WYRAP+VL+ S
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
YS ID+W+VG I AE+ +P+FPG SE DQL ++ ILG P+ +P T +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYDP 236
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+++ P+ + IDL+ ++ DP +R TA QAL+H +F
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-118
Identities = 104/290 (35%), Positives = 168/290 (57%), Gaps = 9/290 (3%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKL 57
M++Y+ LE++G+GT G V+KA N ET+EIVA+K+++ +E + LRE+ L++L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKEL 58
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H NI++L +V+ + +L +FE+ + +L ++SF+ Q+L+GL H
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSS 175
HRDLKP+NLL+ + LK+A+FGLAR + Y+ V T WYR P+VL +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 176 YSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
YS +IDMW+ G I AEL P+FPG+ DQL ++ +LG P +P T +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+L +++P + DL+ L +P++R +A++ALQHP+F+
Sbjct: 239 YPMYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-118
Identities = 102/331 (30%), Positives = 171/331 (51%), Gaps = 31/331 (9%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
Y + +G+G+ G VY+A ++ E+VA+KK+ + ++ RE++ +RKL+H N
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 108
Query: 62 IIKLKEVVRENNE------LFFIFEYMEHNLYHIMRER---QIPFSEGEIRSFMSQMLQG 112
I++L+ + E L + +Y+ +Y + R + ++ +M Q+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 113 LAHMHRNGYFHRDLKPENLLV--TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
LA++H G HRD+KP+NLL+ VLK+ DFG A++L P Y+ +R+YRAPE++
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
++ Y+ +ID+W+ G +LAEL PIFPGDS +DQL ++ +LG P E
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--P 286
Query: 231 RLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289
+ +I + + P EAI L +L + P R T +A H FF+
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD----- 341
Query: 290 PYPLHDPLELRLNNMGSKPNLELNLWDFGTE 320
L DP ++L N P L++F T+
Sbjct: 342 --ELRDP-NVKLPNGRDTP----ALFNFTTQ 365
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-115
Identities = 105/322 (32%), Positives = 170/322 (52%), Gaps = 28/322 (8%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
Y + +G+G+ G V++A VE+ E VA+KK+ + ++ RE++ +R + HP
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-----DKRFKNRELQIMRIVKHP 92
Query: 61 NIIKLKEVVRENNE------LFFIFEYMEHNLYHIMR---ERQIPFSEGEIRSFMSQMLQ 111
N++ LK N + L + EY+ +Y R + + I+ +M Q+L+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 112 GLAHMHRNGYFHRDLKPENLLV--TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
LA++H G HRD+KP+NLL+ + VLK+ DFG A+ L + P Y+ +R+YRAPE+
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+ +++Y+ ID+W+ G ++AEL P+FPG+S IDQL ++ +LG P
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN-- 270
Query: 230 SRLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+ + +I P S + P +AIDLI +L + P R TA +AL HPFF+
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD---- 326
Query: 289 VPYPLHDPLELRLNNMGSKPNL 310
L E R+ N P L
Sbjct: 327 ---ELRTG-EARMPNGRELPPL 344
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-114
Identities = 107/313 (34%), Positives = 161/313 (51%), Gaps = 28/313 (8%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE-----CMNLREVKALR 55
+ +Y+ L ++G GT G V+KA + +T + VA+KK+ E LRE+K L+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL----MENEKEGFPITALREIKILQ 71
Query: 56 KLNHPNIIKLKEVVREN--------NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
L H N++ L E+ R ++ +F++ EH+L ++ + F+ EI+ M
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-----SMPPYTEYVST 161
+L GL ++HRN HRD+K N+L+T D VLK+ADFGLAR S YT V T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221
WYR PE+LL Y P ID+W G I+AE++T SPI G++E QL + + G+
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 222 AFPEATNISRLISISYSEILPINLSDIIPNASM--EAIDLIWQLCSWDPLRRPTADQALQ 279
+P N + + + D + A+DLI +L DP +R +D AL
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 280 HPFFNVETWVPYP 292
H FF + P P
Sbjct: 312 HDFFWSD---PMP 321
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-113
Identities = 105/299 (35%), Positives = 166/299 (55%), Gaps = 19/299 (6%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE---CMNLREVKALRKL 57
++K LE+LG+GT VYK N T VA+K++K EE +RE+ +++L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD---SEEGTPSTAIREISLMKEL 60
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQI-----PFSEGEIRSFMSQMLQG 112
H NI++L +V+ N+L +FE+M+++L M R + ++ F Q+LQG
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVL 170
LA H N HRDLKP+NLL+ LK+ DFGLAR + ++ V T WYRAP+VL
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
+ S +YS +ID+W+ G ILAE+ T P+FPG ++ +QL + I+G P+ + +P T +
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 231 RLISISYSEILPINLSDIIPNASM-----EAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ + + P +L ++ + +D + L +P R +A QAL HP+F
Sbjct: 241 -KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-113
Identities = 115/295 (38%), Positives = 175/295 (59%), Gaps = 15/295 (5%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKL 57
++RY+ + +LG+GT G VYKA + T E VA+K+++ EE + +REV L++L
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKEL 90
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H NII+LK V+ N+ L IFEY E++L M ++ S I+SF+ Q++ G+ H
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 118 RNGYFHRDLKPENLLVTND------VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVL 170
HRDLKP+NLL++ VLKI DFGLAR + +T + T WYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
L S YS ++D+W++ I AE+ +P+FPGDSEIDQL+K+ +LG PD T +P T +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 231 RLISISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
S+ + L ++ E +DL+ + DP++R +A AL+HP+F+
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-112
Identities = 103/300 (34%), Positives = 160/300 (53%), Gaps = 22/300 (7%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN------LREVKAL 54
RY+ + E+G G G VYKA + + VA+K ++ +REV L
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALL 65
Query: 55 RKLN---HPNIIKLKEVVRENNE-----LFFIFEYMEHNLYHIMRERQIP-FSEGEIRSF 105
R+L HPN+++L +V + + +FE+++ +L + + P I+
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWY 164
M Q L+GL +H N HRDLKPEN+LVT+ +K+ADFGLAR S T V T WY
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
RAPEVLLQS+ Y+ +DMW+VG I AE+F P+F G+SE DQL K+ ++G P +P
Sbjct: 186 RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
L ++ P + ++P L+ ++ +++P +R +A +ALQH + +
Sbjct: 245 R---DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-110
Identities = 103/310 (33%), Positives = 166/310 (53%), Gaps = 23/310 (7%)
Query: 1 MERYKILEELGDGTCGCVYKAFNV-ETYEIVAVKKMKRKFYFWEECMN---LREVKALRK 56
++Y+ + E+G+G G V+KA ++ VA+K+++ EE M +REV LR
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRH 67
Query: 57 LN---HPNIIKLKEVV-----RENNELFFIFEYMEHNLYHIMRE-RQIPFSEGEIRSFMS 107
L HPN+++L +V +L +FE+++ +L + + + I+ M
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRA 166
Q+L+GL +H + HRDLKP+N+LVT+ +K+ADFGLAR S T V T WYRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
PEVLLQSS Y+ +D+W+VG I AE+F P+F G S++DQL K+ ++G P +P
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
+ R S S + + + DL+ + +++P +R +A AL HP+F
Sbjct: 247 VALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD- 302
Query: 287 TWVPYPLHDP 296
+ +
Sbjct: 303 --LERCKENL 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-105
Identities = 91/315 (28%), Positives = 160/315 (50%), Gaps = 26/315 (8%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----------LREV 51
Y + + G+ G V + E VA+K++ LRE+
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 52 KALRKLNHPNIIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFM 106
+ L +HPNI+ L+++ ++L+ + E M +L ++ +++I S I+ FM
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYR 165
+L GL +H G HRDL P N+L+ ++ + I DF LARE ++ T YV+ RWYR
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP--DWTAF 223
APE+++Q ++ +DMW+ G ++AE+F +F G + +QL K+ ++G P +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ + + S S + + ++P A A+DLI ++ ++P RR + +QAL+HP+F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 284 NVETWVPYPLHDPLE 298
L DPL+
Sbjct: 321 E-------SLFDPLD 328
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-102
Identities = 104/336 (30%), Positives = 172/336 (51%), Gaps = 45/336 (13%)
Query: 2 ERYKIL-EELGDGTCGCVYKAFN--VETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN 58
+ ++ ++G GT G VYKA + + A+K+++ RE+ LR+L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELK 76
Query: 59 HPNIIKLKEVVRENNE--LFFIFEYMEHNLYHIMR--------ERQIPFSEGEIRSFMSQ 108
HPN+I L++V + + ++ +F+Y EH+L+HI++ ++ + G ++S + Q
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS-MPPYTEY---V 159
+L G+ ++H N HRDLKP N+LV + +KIAD G AR +S + P + V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---------DQLYK 210
T WYRAPE+LL + Y+ AID+WA+G I AEL T PIF E DQL +
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 211 VCCILGAP---DW---TAFPEATNISRLISIS--YSEILPINLSDIIPNASMEAIDLIWQ 262
+ ++G P DW PE + + + + + L + +A L+ +
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316
Query: 263 LCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLE 298
L + DP++R T++QA+Q P+F + P P D
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLED---PLPTSDVFA 349
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-101
Identities = 109/310 (35%), Positives = 155/310 (50%), Gaps = 33/310 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM-NLREVKALRKLNHP 60
+ Y +G G G V A + + E VA+KK+ R F RE+ L+ + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 61 NIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N+I L +V + + + +M+ +L IM FSE +I+ + QML+GL
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLK 140
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
++H G HRDLKP NL V D LKI DFGLAR T YV TRWYRAPEV+L
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSW 198
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y+ +D+W+VG I+AE+ T +F G +DQL ++ + G P + +L
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG------TEFVQKLN 252
Query: 234 S---ISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
SY + LP + + + P AS +A DL+ ++ D +R TA QAL HPFF
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE-- 310
Query: 287 TWVPYPLHDP 296
P DP
Sbjct: 311 -----PFRDP 315
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-101
Identities = 103/339 (30%), Positives = 163/339 (48%), Gaps = 41/339 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM--KRKFYFWEECMNLREVKALRKLN 58
M+R+++ G GT G V T VA+KK+ +F E L+ ++ L L+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 59 HPNIIKLKEVVRENNE-------LFFIFEYMEHNLYHIMR---ERQIPFSEGEIRSFMSQ 108
HPNI++L+ E L + EY+ L+ R RQ+ I+ F+ Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 109 MLQGLAHMHRN--GYFHRDLKPENLLV--TNDVLKIADFGLARELSSMPPYTEYVSTRWY 164
+++ + +H HRD+KP N+LV + LK+ DFG A++LS P Y+ +R+Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP---DWT 221
RAPE++ + Y+ A+D+W+VG I AE+ PIF GD+ QL+++ +LG P
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 222 AF-PEATNIS--RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
P T++ I +S + D + EA DL+ L + P R +AL
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFS----DHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313
Query: 279 QHPFFNVETWVPYPLHDPLELRLNNMGSKPNLELNLWDF 317
HP+F+ LHDP +L N P +L+ F
Sbjct: 314 CHPYFD-------ELHDP-ATKLPNNKDLP---EDLFRF 341
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 102/323 (31%), Positives = 163/323 (50%), Gaps = 46/323 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM--------KRKFYFWEECMNLREVKA 53
RY L+ LG G G V+ A + + + VA+KK+ K LRE+K
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---------LREIKI 61
Query: 54 LRKLNHPNIIKLKEVVR--------------ENNELFFIFEYMEHNLYHIMRERQIPFSE 99
+R+L+H NI+K+ E++ E N ++ + EYME +L +++ + P E
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLE 119
Query: 100 GEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV--TNDVLKIADFGLAR----ELSSMP 153
R FM Q+L+GL ++H HRDLKP NL + + VLKI DFGLAR S
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213
+E + T+WYR+P +LL ++Y+ AIDMWA G I AE+ T +F G E++Q+ +
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
+ E ++ + + L+ ++P S EA+D + Q+ ++ P+ R T
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
Query: 274 ADQALQHPFFNVETWVPYPLHDP 296
A++AL HP+ + P
Sbjct: 300 AEEALSHPYMS-------IYSFP 315
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-100
Identities = 109/328 (33%), Positives = 164/328 (50%), Gaps = 56/328 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM---------KRKFYFWEECMNLREVK 52
+++ LG+G G V A + T EIVA+KK+ R LRE+K
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR---------TLREIK 61
Query: 53 ALRKLNHPNIIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMS 107
L+ H NII + + R NE++ I E M+ +L+ ++ + S+ I+ F+
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIY 119
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----------- 155
Q L+ + +H + HRDLKP NLL+ ++ LK+ DFGLAR +
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL 215
E+V+TRWYRAPEV+L S+ YS A+D+W+ G ILAELF PIFPG QL + I+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239
Query: 216 GAPDWTAFPEATNISRLIS---ISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDP 268
G P + + + S Y + LP L + P + + IDL+ ++ +DP
Sbjct: 240 GTPH----SDND-LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 269 LRRPTADQALQHPFFNVETWVPYPLHDP 296
+R TA +AL+HP+ HDP
Sbjct: 295 AKRITAKEALEHPYLQ-------TYHDP 315
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 84/312 (26%), Positives = 153/312 (49%), Gaps = 33/312 (10%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
+ Y+++ +LG G V++A N+ E V VK +K ++ RE+K L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGG 90
Query: 60 PNIIKLKEVVR--ENNELFFIFEY-MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
PNII L ++V+ + +FE+ + + + ++ +IR +M ++L+ L +
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 117 HRNGYFHRDLKPENLLV--TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
H G HRD+KP N+++ + L++ D+GLA Y V++R+++ PE+L+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 175 SYSPAIDMWAVGAILAEL-FTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y ++DMW++G +LA + F P F G DQL ++ +LG D + + NI
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL-- 264
Query: 234 SISYSEILP----INLSDIIPN-----ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+++IL + + S EA+D + +L +D R TA +A++HP+F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF- 323
Query: 285 VETWVPYPLHDP 296
Y +
Sbjct: 324 ------YTVVKD 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 1e-99
Identities = 108/316 (34%), Positives = 172/316 (54%), Gaps = 40/316 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
RY L +G+G G V A++ VA+KK+ +E LRE+K L +
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRF 82
Query: 58 NHPNIIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
H NII + +++R + +++ + + ME +LY +++ + S I F+ Q+L+G
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRG 140
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----TEYVSTRWYRAP 167
L ++H HRDLKP NLL+ LKI DFGLAR + TEYV+TRWYRAP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
E++L S Y+ +ID+W+VG ILAE+ + PIFPG +DQL + ILG+P
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS------QE 254
Query: 228 NISRLIS---ISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+++ +I+ +Y LP + + + PNA +A+DL+ ++ +++P +R +QAL H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 281 PFFNVETWVPYPLHDP 296
P+ +DP
Sbjct: 315 PYLE-------QYYDP 323
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 2e-99
Identities = 92/368 (25%), Positives = 167/368 (45%), Gaps = 62/368 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
++Y + + LG G+ G V + F++E+ + A+KK+ + + RE+ ++ L+H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHV 60
Query: 61 NIIKLKEVVREN--------------------------------------NELFFIFEYM 82
NIIKL + L I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 83 EHNLYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV--TNDV 137
L+ +++ I ++ Q+ + + +H G HRD+KP+NLLV ++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 138 LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSP 197
LK+ DFG A++L P Y+ +R+YRAPE++L ++ Y+P+ID+W++G + EL P
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 198 IFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNAS-MEA 256
+F G++ IDQL ++ I+G P + + + + I+P + A
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 257 IDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDPLELRLNNMGSKPNLEL---- 312
IDL+ Q+ ++P R +A+ HPFF+ L + E + N + P+
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFD-------HLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 313 NLWDFGTE 320
L++F
Sbjct: 352 QLFNFSPY 359
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 4e-99
Identities = 107/310 (34%), Positives = 159/310 (51%), Gaps = 32/310 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM-NLREVKALRKLNHP 60
Y+ L+ +G G G V A + T VA+KK+ R F RE++ L+ + H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 61 NIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N+I L +V + + + + +M +L +M+ E I+ + QML+GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
++H G HRDLKP NL V D LKI DFGLAR+ T YV TRWYRAPEV+L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNW 200
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
Y+ +D+W+VG I+AE+ T +F G +DQL ++ + G P A + RL
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP------AEFVQRLQ 254
Query: 234 S---ISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
S +Y + LP + + I+ NAS A++L+ ++ D +R TA +AL HP+F
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE-- 312
Query: 287 TWVPYPLHDP 296
LHD
Sbjct: 313 -----SLHDT 317
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 2e-98
Identities = 107/313 (34%), Positives = 168/313 (53%), Gaps = 38/313 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
ERY+ L +G G G V AF+ +T VAVKK+ R F + ++ RE++ L+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHM 85
Query: 58 NHPNIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
H N+I L +V E N+++ + M +L +I++ + ++ ++ + Q+L+
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILR 143
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
GL ++H HRDLKP NL V D LKI DFGLAR + T YV+TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIM 201
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
L Y+ +D+W+VG I+AEL T +FPG IDQL + ++G P A +
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG------AELLK 255
Query: 231 RLIS---ISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
++ S +Y + L +N +++ A+ A+DL+ ++ D +R TA QAL H +F
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 284 NVETWVPYPLHDP 296
HDP
Sbjct: 316 A-------QYHDP 321
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 2e-97
Identities = 101/368 (27%), Positives = 166/368 (45%), Gaps = 87/368 (23%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
+RY+I +G G+ G V +A++ +VA+KK+ R F E+ ++ LRE+ L +L
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRL 109
Query: 58 NHPNIIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
NH +++K+ ++V + +EL+ + E + + + R +E I++ + +L G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV-YLTELHIKTLLYNLLVG 168
Query: 113 LAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----------------- 154
+ ++H G HRDLKP N LV D +K+ DFGLAR +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 155 -----------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS------- 196
T +V TRWYRAPE++L +Y+ AID+W++G I AEL +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 197 ----PIFPGDS--------------------EIDQLYKVCCILGAPDWTAFPEATNISRL 232
P+FPG S DQL + ILG P
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED-- 346
Query: 233 ISISYSEILP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+ Y I P +L++ P +S +AI L+ ++ ++P +R T ++ L HPFF
Sbjct: 347 -AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK---- 401
Query: 289 VPYPLHDP 296
+
Sbjct: 402 ---EVRIA 406
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 3e-95
Identities = 100/321 (31%), Positives = 154/321 (47%), Gaps = 37/321 (11%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRK 56
++RY+ L+ +G G G V A++ VA+KK+ R F + + RE+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 80
Query: 57 LNHPNIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQML 110
+NH NII L V E +++ + E M+ NL +++ + + QML
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQML 137
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
G+ H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPEV
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+L Y +D+W+VG I+ E+ +FPG IDQ KV LG P +
Sbjct: 198 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 230 SRLISISYSEILPINLSDIIPNASM------------EAIDLIWQLCSWDPLRRPTADQA 277
R + + + + P+ +A DL+ ++ D +R + D+A
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 278 LQHPFFNVETWVPYPLHDPLE 298
LQHP+ N +DP E
Sbjct: 317 LQHPYIN-------VWYDPSE 330
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 4e-94
Identities = 101/320 (31%), Positives = 154/320 (48%), Gaps = 37/320 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
+RY+ L+ +G G G V A++ VA+KK+ R F + + RE+ ++ +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCV 118
Query: 58 NHPNIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
NH NII L V E +++ + E M+ NL +++ + + QML
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLC 175
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
G+ H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPEV+
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
L Y +D+W+VG I+ E+ +FPG IDQ KV LG P +
Sbjct: 236 L-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 231 RLISISYSEILPINLSDIIPNASM------------EAIDLIWQLCSWDPLRRPTADQAL 278
R + + + + P++ +A DL+ ++ DP +R + D AL
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 279 QHPFFNVETWVPYPLHDPLE 298
QHP+ N +DP E
Sbjct: 355 QHPYIN-------VWYDPAE 367
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 1e-93
Identities = 101/360 (28%), Positives = 163/360 (45%), Gaps = 79/360 (21%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECM-NLREVKALRKLNHP 60
+ Y I +G G+ G VY A++ T + VA+KK+ R F +C LRE+ L +L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 61 NIIKLKEVVR-----ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
II+L +++ + +EL+ + E + +L + + +E I++ + +L G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI-FLTEEHIKTILYNLLLGENF 144
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY------------------- 155
+H +G HRDLKP N L+ D +K+ DFGLAR ++S
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 156 ----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS-----------PIFP 200
T +V TRWYRAPE++L +Y+ +ID+W+ G I AEL + P+FP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 201 GDSE-----------------IDQLYKVCCILGAPDWTAFPEATNISRLIS---ISYSEI 240
G S DQL + I+G P ++ + I Y ++
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT------EDDLKNINKPEVIKYIKL 318
Query: 241 LP----INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
P INL P+ S + I+L+ + ++P +R T DQAL HP+ +
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK-------DVRKK 371
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 5e-93
Identities = 101/342 (29%), Positives = 174/342 (50%), Gaps = 59/342 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
+Y+++++LG G G V+K+ + T E+VAVKK+ F + + RE+ L +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTEL 65
Query: 58 N-HPNIIKLKEVVR--ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
+ H NI+ L V+R + +++ +F+YME +L+ ++R + + Q+++ +
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIK 123
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY------------------ 155
++H G HRD+KP N+L+ + +K+ADFGL+R ++
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 156 ----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
T+YV+TRWYRAPE+LL S+ Y+ IDMW++G IL E+ PIFPG S ++QL ++
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 212 CCILGAPDW---------------TAFPEATNISRLISISYSEILPINLSDIIPNA--SM 254
++ P + E I + L I P A +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 255 EAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
EA+DL+ +L ++P +R +A+ AL+HPF + H+P
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVS-------IFHNP 338
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 7e-69
Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 47/304 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
Y IL+++G G V++ N E +I A+K + + + ++ E+ L KL
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQ 84
Query: 59 HPN--IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
+ II+L + + ++ + E +L +++++ E +S+ ML+ + +
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 143
Query: 117 HRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVS---TRWYRAPEVLLQS 173
H++G H DLKP N L+ + +LK+ DFG+A ++ S T Y PE +
Sbjct: 144 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 174 SS----------YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
SS SP D+W++G IL + F
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------------------- 244
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
IS+L +I I DI + D++ DP +R + + L HP+
Sbjct: 245 ----QISKLHAIIDPNH-EIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 284 NVET 287
++T
Sbjct: 297 QIQT 300
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-68
Identities = 95/320 (29%), Positives = 150/320 (46%), Gaps = 44/320 (13%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH--- 59
RY++L+ +G G+ G V KA++ + ++ VA+K ++ + F + E++ L L
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE--EIRILEHLRKQDK 155
Query: 60 ---PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAH 115
N+I + E N + FE + NLY ++++ + FS +R F +LQ L
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 116 MHRNGYFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
+H+N H DLKPEN+L+ +K+ DFG + YT Y+ +R+YRAPEV+L
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYT-YIQSRFYRAPEVILG 273
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPD------------- 219
+ Y IDMW++G ILAEL T P+ PG+ E DQL + +LG P
Sbjct: 274 AR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332
Query: 220 -----------WTAFPEATNISRLISISYSEILPINLSDIIPNASMEA-----IDLIWQL 263
T + + + ++ S NA +D + Q
Sbjct: 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 264 CSWDPLRRPTADQALQHPFF 283
WDP R T QAL+HP+
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-67
Identities = 69/303 (22%), Positives = 125/303 (41%), Gaps = 47/303 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
Y IL+++G G V++ N E +I A+K + + + ++ E+ L KL
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQ 66
Query: 60 PN--IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
+ II+L + + ++ + E +L +++++ E +S+ ML+ + +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH 125
Query: 118 RNGYFHRDLKPENLLVTNDVLKIADFGLARELSS---MPPYTEYVSTRWYRAPEVLLQSS 174
++G H DLKP N L+ + +LK+ DFG+A ++ V T Y PE + S
Sbjct: 126 QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 175 S----------YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
S SP D+W++G IL + F
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------------------- 225
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
IS+L +I I DI + D++ DP +R + + L HP+
Sbjct: 226 ---QISKLHAIIDPNH-EIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
Query: 285 VET 287
++T
Sbjct: 279 IQT 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-67
Identities = 64/286 (22%), Positives = 104/286 (36%), Gaps = 36/286 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKL-N 58
+ ++ L LG G+ G V+K + E + AVK+ F ++ L EV + K+
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HP ++L++ E L+ E +L E ++ ++ L LAH+H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
G H D+KP N+ + K+ DFGL EL + Y APE+L SY
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYG 233
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
A D++++G + E+ +L
Sbjct: 234 TAADVFSLGLTILEVACNME------------------------LPHGGEGWQQLRQGYL 269
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
LS E ++ + DP R TA+ L P
Sbjct: 270 PPEFTAGLSS-------ELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 8e-67
Identities = 100/328 (30%), Positives = 146/328 (44%), Gaps = 51/328 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP- 60
+RY+I +G G+ G V KA++ E VA+K +K K F + EV+ L +N
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI--EVRLLELMNKHD 111
Query: 61 -----NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLA 114
I+ LK N L +FE + +NLY ++R S R F QM L
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 115 HMHRN--GYFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
+ H DLKPEN+L+ N +KI DFG + +L +Y+ +R+YR+PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQSRFYRSPEV 229
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP----------- 218
LL Y AIDMW++G IL E+ T P+F G +E+DQ+ K+ +LG P
Sbjct: 230 LL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 219 --------DWTAFPEATNISRL-----ISISYSEILPINLSDIIPNASMEA--------- 256
D T + T + + IL + + E+
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 257 -IDLIWQLCSWDPLRRPTADQALQHPFF 283
DLI ++ +DP R ALQH FF
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 8e-67
Identities = 79/319 (24%), Positives = 119/319 (37%), Gaps = 64/319 (20%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
++ + LG G G V KA N A+KK++ EE ++ L EV L LNH
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNH 61
Query: 60 PNIIKLKEVVRENNE-------------LFFIFEYME-HNLYHIMRERQIPFSEGEIRSF 105
+++ E LF EY E LY ++ + E
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPY--------- 155
Q+L+ L+++H G HRDLKP N+ + + +KI DFGLA+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 156 ------TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY 209
T + T Y A EVL + Y+ IDM+++G I E+ + P G E +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTG-MERVNIL 238
Query: 210 KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPL 269
K R +SI + N +I L DP
Sbjct: 239 KKL------------------RSVSIEFPPDFDDNKMK-------VEKKIIRLLIDHDPN 273
Query: 270 RRPTADQALQHPFFNVETW 288
+RP A L + V+
Sbjct: 274 KRPGARTLLNSGWLPVKHQ 292
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-66
Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 37/289 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
ME+Y L+++G+G+ G + E +K++ +E REV L + H
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
PNI++ +E EN L+ + +Y E +L+ I ++ + F E +I + Q+ L H+H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 118 RNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQSSS 175
HRD+K +N+ +T + +++ DFG+AR L+S + T +Y +PE+ ++
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKP 201
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS- 234
Y+ D+WA+G +L EL TL F EA ++ L+
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAF-------------------------EAGSMKNLVLK 236
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
I P++ + S + L+ QL +P RP+ + L+ F
Sbjct: 237 IISGSFPPVS-----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-66
Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 26/303 (8%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ + + LG G V++ + +T ++ A+K + + +RE + L+KLNH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 62 IIKLKEVV--RENNELFFIFEYMEH-NLYH--IMRERQIPFSEGEIRSFMSQMLQGLAHM 116
I+KL + I E+ +LY E E + ++ G+ H+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 117 HRNGYFHRDLKPENLLVT-----NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL- 170
NG HR++KP N++ V K+ DFG AREL + T Y P++
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 171 ------LQSSSYSPAIDMWAVGAILAELFTLSPIF----PGDSEIDQLYKVCCILGAPDW 220
Y +D+W++G T S F + +YK+ I G P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITGKPSG 246
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+ I S + +LS + ++ + D + DQ
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 281 PFF 283
Sbjct: 304 TSD 306
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 9e-66
Identities = 68/304 (22%), Positives = 124/304 (40%), Gaps = 47/304 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
Y IL+++G G V++ N E +I A+K + + + ++ E+ L KL
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQ 112
Query: 59 HPN--IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
+ II+L + + ++ + E +L +++++ E +S+ ML+ + +
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 171
Query: 117 HRNGYFHRDLKPENLLVTNDVLKIADFGLARELSS---MPPYTEYVSTRWYRAPEVLLQS 173
H++G H DLKP N L+ + +LK+ DFG+A ++ V Y PE +
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 174 SS----------YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
SS SP D+W++G IL + F
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------------------- 272
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
IS+L +I I DI + D++ DP +R + + L HP+
Sbjct: 273 ----QISKLHAIIDPN-HEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 284 NVET 287
++T
Sbjct: 325 QIQT 328
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-65
Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 44/294 (14%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPN 61
+ + LG G G + + VAVK++ + + + + REV+ LR+ + HPN
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPN 79
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+I+ ++ + E L + ++ E + + Q GLAH+H
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139
Query: 122 FHRDLKPENLLVTND------VLKIADFGLAREL----SSMPPYTEYVSTRWYRAPEVLL 171
HRDLKP N+L++ I+DFGL ++L S + T + APE+L
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 172 QSSS--YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+ + +D+++ G + + + G S Q +LGA +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---LLGACSLDCLHPEKHE 256
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
A +LI ++ + DP +RP+A L+HPFF
Sbjct: 257 DV-----------------------IARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 90/288 (31%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNHP 60
ERY I+ LG G+ G V K + T + AVK + K + LREV+ L+KL+HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+KL E++ +++ + + E L+ + +R+ FSE + + Q+ G+ +MH++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH 140
Query: 120 GYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
HRDLKPEN+L+ + +KI DFGL+ + + T +Y APEVL +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--T 198
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
Y D+W+ G IL L + +P F G +E D L +V G F
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA---FD----------- 242
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S +A DLI ++ ++ P R TA Q L+HP+
Sbjct: 243 ----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-63
Identities = 81/317 (25%), Positives = 131/317 (41%), Gaps = 45/317 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
+ Y I EELG G V K T A K +K++ REV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ H N+I L +V ++ I E + E L+ + +++ SE E SF+ Q+L G+
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGE--LFDFLAQKES-LSEEEATSFIKQILDGV 128
Query: 114 AHMHRNGYFHRDLKPENLLVTN-----DVLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
++H H DLKPEN+++ + +K+ DFGLA E+ + T + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
++ DMW++G I L + SP F GD++ + L + + D F
Sbjct: 189 IVNY-EPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANI--TSVSYD---FD--- 238
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
+ + S A D I +L + +R T +AL+HP+
Sbjct: 239 ------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 288 WVPYPLHDPLELRLNNM 304
+ + L N
Sbjct: 281 NQQAMVRRESVVNLENF 297
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 6e-63
Identities = 75/336 (22%), Positives = 135/336 (40%), Gaps = 65/336 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-- 59
+ ++ ++GDGT G V +++ + AVK ++ + E L+K+ +
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK--IEADILKKIQNDD 92
Query: 60 ---PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAH 115
NI+K + + IFE + +LY I+ F +I+ + ++L+ L +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 116 MHRNGYFHRDLKPENLLVTNDV--------------------------LKIADFGLAREL 149
+ + H DLKPEN+L+ + +K+ DFG
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG----- 207
Query: 150 SSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID 206
+ + ++TR YRAPEV+L + + DMW+ G +LAEL+T S +F ++
Sbjct: 208 CATFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
Query: 207 QLYKVCCILGAP-------------------DWTAFPEATNISRLISISYSEILPINLSD 247
L + I+ D N S + SI + + L
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP-LYK 325
Query: 248 IIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
II + D ++ + DP RP+ + L+H F
Sbjct: 326 IIKHELF--CDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-63
Identities = 85/303 (28%), Positives = 131/303 (43%), Gaps = 53/303 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMN------LREVKAL 54
+ Y + + LG G CG V AF +T + VA++ + KRKF E++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+KLNHP IIK+K + + + + E ME L+ + + E + + QML +
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAV 252
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
++H NG HRDLKPEN+L+++ ++KI DFG ++ L T Y APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 170 LLQSS--SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA------PDWT 221
L+ Y+ A+D W++G IL + P F L I W
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ--ITSGKYNFIPEVW- 369
Query: 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
S +A+DL+ +L DP R T ++AL+HP
Sbjct: 370 ----------------------------AEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 282 FFN 284
+
Sbjct: 402 WLQ 404
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 71/302 (23%), Positives = 115/302 (38%), Gaps = 59/302 (19%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+K +E +G G G V+KA + + +K++K E+ REVKAL KL+H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE--REVKALAKLDHV 64
Query: 61 NIIKLKE----------------VVRENNELFFIFEYMEH-NLYHIMRERQ-IPFSEGEI 102
NI+ + LF E+ + L + +R+ +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST 161
Q+ +G+ ++H +RDLKP N+ + +KI DFGL L + T T
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221
Y +PE + S Y +D++A+G ILAEL + T
Sbjct: 185 LRYMSPEQ-ISSQDYGKEVDLYALGLILAELLHVCD-----------------------T 220
Query: 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
AF + + L S+I + L+ +L S P RP + L+
Sbjct: 221 AFETSKFFTDLRDGIISDIF-----------DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
Query: 282 FF 283
Sbjct: 270 TV 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 88/301 (29%), Positives = 142/301 (47%), Gaps = 38/301 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNHP 60
+ Y + EELG G V + + T A K + +K + RE + RKL HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 61 NIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
NI++L + ++E + + +F+ + E L+ + R+ +SE + + Q+L+ +A+ H
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGE--LFEDIVAREF-YSEADASHCIQQILESIAYCH 122
Query: 118 RNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
NG HR+LKPENLL+ + +K+ADFGLA E++ + + T Y +PEVL +
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
YS +D+WA G IL L P F + + ++ GA D +P
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYD---YP--------- 227
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPL 293
S + EA LI + + +P +R TADQAL+ P+ V +
Sbjct: 228 ------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275
Query: 294 H 294
H
Sbjct: 276 H 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-62
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 35/285 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E+Y I E+LG G G V++ + + K +K K ++ + +E+ L H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 62 IIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ L E EL IFE++ +++ + +E EI S++ Q+ + L +H +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 121 YFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
H D++PEN++ +KI +FG AR+L + + Y APEV S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVS 181
Query: 178 PAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
A DMW++G ++ L + ++P F ++ + + + F
Sbjct: 182 TATDMWSLGTLVYVLLSGINP-FLAETNQQIIENI--MNAEYT---FD------------ 223
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281
+ S+EA+D + +L + R TA +ALQHP
Sbjct: 224 ---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 83/317 (26%), Positives = 131/317 (41%), Gaps = 45/317 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
+ Y I EELG G V K T A K +K++ REV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ HPNII L +V ++ I E + E L+ + +++ SE E SF+ Q+L G+
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGE--LFDFLAQKES-LSEEEATSFIKQILDGV 128
Query: 114 AHMHRNGYFHRDLKPENLLVTN-----DVLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
++H H DLKPEN+++ + +K+ DFGLA E+ + T + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
++ DMW++G I L + SP F GD++ + L + + D F
Sbjct: 189 IVNY-EPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANI--TAVSYD---FD--- 238
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
+ S A D I +L + +R T +AL+HP+
Sbjct: 239 ------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 288 WVPYPLHDPLELRLNNM 304
+ + L N
Sbjct: 281 TQQAMVRRESVVNLENF 297
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-62
Identities = 87/331 (26%), Positives = 142/331 (42%), Gaps = 59/331 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVET-YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
RY+I++ LG+G G V + + + VAVK +K + E E++ L LN
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR--SEIQVLEHLNTT 71
Query: 61 ------NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGL 113
+++ E + + +FE + + Y ++E +PF IR Q+ + +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 114 AHMHRNGYFHRDLKPENLLVTND--------------------VLKIADFGLARELSSM- 152
+H N H DLKPEN+L +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-----SATY 186
Query: 153 ---PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY 209
T VSTR YRAPEV+L +S D+W++G IL E + +FP + L
Sbjct: 187 DDEHHST-LVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 210 KVCCILGAP----------------DWTAFPEATNISRLISISYSEILPINLSDIIPNAS 253
+ ILG D + E ++ R +S + + LS + +
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 254 MEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ DLI ++ +DP +R T +AL+HPFF+
Sbjct: 305 L--FDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-62
Identities = 83/306 (27%), Positives = 130/306 (42%), Gaps = 59/306 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-------REVKAL 54
+ Y + + LG G CG V AF +T + VA+K + ++ + E++ L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+KLNHP IIK+K + + + + E ME L+ + + E + + QML +
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAV 127
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
++H NG HRDLKPEN+L+++ ++KI DFG ++ L T Y APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 170 LLQSS--SYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGA------P 218
L+ Y+ A+D W++G I LF P F L I
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQ--ITSGKYNFIPE 242
Query: 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
W S +A+DL+ +L DP R T ++AL
Sbjct: 243 VW-----------------------------AEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 279 QHPFFN 284
+HP+
Sbjct: 274 RHPWLQ 279
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 7e-62
Identities = 77/330 (23%), Positives = 134/330 (40%), Gaps = 59/330 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAF-NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
ERY+I+ LG+GT G V + + VA+K ++ + E E+ L+K+
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR--LEINVLKKIKEK 76
Query: 61 ------NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGL 113
+ + + + + FE + N + ++E P+ +R Q+ L
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV--------------------LKIADFGLA----REL 149
+H N H DLKPEN+L N +++ADFG A
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY 209
++ V+TR YR PEV+L ++ D+W++G IL E + +F + L
Sbjct: 197 TT------IVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 210 KVCCILGAP----------------DWTAFPEATNISRLISISYSEILPINLSDIIPNAS 253
+ ILG + E ++ R + + + L D + +
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 254 MEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ DL+ ++ +DP +R T +AL HPFF
Sbjct: 310 L--FDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-61
Identities = 87/304 (28%), Positives = 142/304 (46%), Gaps = 40/304 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNHP 60
+ Y + EELG G V + + T A K + +K + RE + RKL HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI++L + ++E + + +F+ + L+ + R+ +SE + + Q+L+ +A+ H N
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSN 147
Query: 120 GYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
G HR+LKPENLL+ + +K+ADFGLA E++ + + T Y +PEVL +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP- 206
Query: 176 YSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
YS +D+WA G IL + L P F + + ++ GA D +P
Sbjct: 207 YSKPVDIWACGVIL---YILLVGYPPFWDEDQHRLYAQIKA--GAYD---YP-------- 250
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYP 292
S + EA LI + + +P +R TADQAL+ P+ V
Sbjct: 251 -------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 297
Query: 293 LHDP 296
+H
Sbjct: 298 IHRQ 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ Y ILEELG G G V++ T + K + + + E+ + +L+HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 109
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+I L + + E+ I E++ L+ + SE E+ ++M Q +GL HMH +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 121 YFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
H D+KPEN++ +KI DFGLA +L+ +T + APE++ +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVG 228
Query: 178 PAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
DMWA+G + L + LSP F G+ +++ L V + F
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNV--KRCDWE---FD------------ 270
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
D + S EA D I L +P +R T AL+HP+ +
Sbjct: 271 ---------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 45/297 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
+ Y++ EELG G V K T + A K +K++ REV LR+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ HPNII L ++ ++ I E + E L+ + E++ +E E F+ Q+L G+
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGE--LFDFLAEKES-LTEDEATQFLKQILDGV 121
Query: 114 AHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
++H H DLKPEN+++ + +K+ DFG+A ++ + + T + APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
++ DMW++G I L + SP F G+++ + L + D F
Sbjct: 182 IVNY-EPLGLEADMWSIGVITYILLSGASP-FLGETKQETLTNI--SAVNYD---FD--- 231
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ N S A D I +L DP RR T Q+L+H +
Sbjct: 232 ------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-61
Identities = 64/300 (21%), Positives = 113/300 (37%), Gaps = 26/300 (8%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ + + LG G V++ + +T ++ A+K + + +RE + L+KLNH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 62 IIKLKEVV--RENNELFFIFEYMEH-NLYHIM--RERQIPFSEGEIRSFMSQMLQGLAHM 116
I+KL + I E+ +LY ++ E E + ++ G+ H+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 117 HRNGYFHRDLKPENLLVT-----NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL- 170
NG HR++KP N++ V K+ DFG AREL + T Y P++
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 171 ------LQSSSYSPAIDMWAVGAILAELFTLSPIF----PGDSEIDQLYKVCCILGAPDW 220
Y +D+W++G T S F + +YK+ I G P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITGKPSG 246
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+ I S + +LS + ++ + D + DQ
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-61
Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 45/317 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
+ Y EELG G V K T A K +K++ REV L++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ HPN+I L EV ++ I E + E L+ + E++ +E E F+ Q+L G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGE--LFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 AHMHRNGYFHRDLKPENLLVTN-----DVLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
++H H DLKPEN+++ + +KI DFGLA ++ + T + APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
++ DMW++G I L + SP F GD++ + L V + F
Sbjct: 188 IVNY-EPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANV--SAVNYE---FE--- 237
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
+ N S A D I +L DP +R T +LQHP+ +
Sbjct: 238 ------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 288 WVPYPLHDPLELRLNNM 304
+ +
Sbjct: 280 TQQALSRKASAVNMEKF 296
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-61
Identities = 87/288 (30%), Positives = 134/288 (46%), Gaps = 35/288 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNHP 60
E Y+ +++LG G G V + T+ A+K + K L EV L+ L+HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 61 NIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+KL + + + + E + L+ + R F+E + + Q+L G+ ++H++
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 120 GYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
HRDLKPENLL+ + ++KI DFGL+ + E + T +Y APEVL +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--K 213
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
Y D+W++G IL L P F G ++ + L KV G F
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYT---FD----------- 257
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S N S A DLI Q+ +D RR +A QAL+HP+
Sbjct: 258 ----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 6e-61
Identities = 92/311 (29%), Positives = 141/311 (45%), Gaps = 37/311 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNL-REVKALRKLNH 59
+RYK LG G+ G V + T + AVK + KR+ + +L REV+ L++L+H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 60 PNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNI+KL E + + + E L+ + R+ FSE + + Q+L G+ +MH+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHK 144
Query: 119 NGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
N HRDLKPENLL+ + ++I DFGL+ + + + T +Y APEVL
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-- 202
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
+Y D+W+ G IL L + P F G +E D L KV G F
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYT---FE---------- 247
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLH 294
S A DLI ++ ++ P R +A AL H + T +
Sbjct: 248 -----------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVD 296
Query: 295 DPL-ELRLNNM 304
P + + N+
Sbjct: 297 VPSLDNAILNI 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-60
Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNH 59
E Y++L +G G+ G K +I+ K++ E L EV LR+L H
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 60 PNIIKLKE--VVRENNELFFIFEYMEH-NLYHI---MRERQIPFSEGEIRSFMSQMLQGL 113
PNI++ + + R N L+ + EY E +L + + + E + M+Q+ L
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 114 AHMHRNGYF-----HRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRA 166
HR HRDLKP N+ + +K+ DFGLAR L+ + + +V T +Y +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
PE + SY+ D+W++G +L EL L P F A
Sbjct: 185 PEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPF-------------------------TA 218
Query: 227 TNISRLIS-ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ L I + I S E ++I ++ + RP+ ++ L++P
Sbjct: 219 FSQKELAGKIREGKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-60
Identities = 77/336 (22%), Positives = 129/336 (38%), Gaps = 79/336 (23%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL----REVKALRKL 57
++Y + +G G+ G V A +T I A+K M + ++ EV+ ++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 58 NHPNIIKLKEVVRENNELFFIFEYME---------------------------------- 83
+HPNI +L EV + + + E
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 84 ------HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136
+++ E I + M Q+ L ++H G HRD+KPEN L + +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 137 --VLKIADFGLARELSSMPP-----YTEYVSTRWYRAPEVLLQSS-SYSPAIDMWAVGAI 188
+K+ DFGL++E + T T ++ APEVL ++ SY P D W+ G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 189 LAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDI 248
L L + FPG ++ D + +V + F +
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQV--LNKKLC---FE---------------------NPN 299
Query: 249 IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
S A DL+ L + + R A +ALQHP+ +
Sbjct: 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-60
Identities = 89/310 (28%), Positives = 134/310 (43%), Gaps = 49/310 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVK---KMKRKFYFWEECMNL-----REVKA 53
E Y+ E LG G V + + T + AVK + EE L +EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 54 LRKLN-HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
LRK++ HPNII+LK+ N F +F+ M+ L+ + E+ SE E R M +L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 135
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
+ +H+ HRDLKPEN+L+ +D +K+ DFG + +L E T Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 171 LQSSS-----YSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGAPDWTA 222
S + Y +DMW+ G I ++TL SP F ++ L + + G
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVI---MYTLLAGSPPFWHRKQMLMLRMI--MSGNYQ--- 247
Query: 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
F S + S DL+ + P +R TA++AL HPF
Sbjct: 248 FG---------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286
Query: 283 FNVETWVPYP 292
F
Sbjct: 287 FQQYVVEEVR 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-60
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEEC--MNLREVKALRKLN 58
+ ++I +++G G VY+A + VA+KK++ + ++E+ L++LN
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIM---RERQIPFSEGEIRSFMSQMLQGLA 114
HPN+IK E+NEL + E + +L ++ ++++ E + + Q+ L
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQ 172
HMH HRD+KP N+ +T V+K+ D GL R SS V T +Y +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IH 209
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDS-EIDQLYKVCCILGAPDWTAFPEATNISR 231
+ Y+ D+W++G +L E+ L F GD + L K +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------------------K 249
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
+ Y + + S+ E L+ + DP +RP
Sbjct: 250 IEQCDYPPLPSDHYSE-------ELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-60
Identities = 88/288 (30%), Positives = 141/288 (48%), Gaps = 35/288 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHP 60
ERY I+ LG G+ G V K + T + AVK + + ++ + REV+ L+KL+HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 61 NIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+KL E++ +++ + + E L+ + +R+ FSE + + Q+ G+ +MH++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH 140
Query: 120 GYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
HRDLKPEN+L+ + +KI DFGL+ + + T +Y APEVL +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--T 198
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
Y D+W+ G IL L + +P F G +E D L +V G F
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA---FD----------- 242
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S +A DLI ++ ++ P R TA Q L+HP+
Sbjct: 243 ----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 5e-60
Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 20/296 (6%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
+++ E LG G G V + + +T E VA+K+ +++ E++ ++KLNHPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 63 IKLKEV------VRENNELFFIFEYMEH-NLYHIM--RERQIPFSEGEIRSFMSQMLQGL 113
+ +EV + N+ EY E +L + E EG IR+ +S + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
++H N HRDLKPEN+++ + KI D G A+EL TE+V T Y APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
L+ Y+ +D W+ G + E T F + + Q + + ++
Sbjct: 195 -LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSNEHIVVYDDL 250
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+ + S P +LS I + + + + W +R T Q F
Sbjct: 251 TGAVKFSSVLPTPNHLSGI---LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 79/290 (27%), Positives = 123/290 (42%), Gaps = 37/290 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ + +LG G G V+ + +K + + E++ L+ L+HPN
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 62 IIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIP---FSEGEIRSFMSQMLQGLAHMH 117
IIK+ EV + + ++ + E E L + Q SEG + M QM+ LA+ H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 118 RNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
H+DLKPEN+L + +KI DFGLA S T T Y APEV +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
+ D+W+ G ++ L T F G S + K P+ +
Sbjct: 201 -DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPN---YA--------- 245
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
E P+ + +A+DL+ Q+ + DP RRP+A Q L H +F
Sbjct: 246 ----VECRPL---------TPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-59
Identities = 78/325 (24%), Positives = 137/325 (42%), Gaps = 49/325 (15%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN---- 58
RY ++ +LG G V+ A ++ VA+K ++ + E E+K L+++N
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDADN 77
Query: 59 -------HPNIIKLKE--VVRENNE--LFFIFEYMEHNLYHIMRE-RQIPFSEGEIRSFM 106
+I+KL + + N + +FE + NL ++++ ++
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 107 SQMLQGLAHMHRN-GYFHRDLKPENLLVT-------NDVLKIADFGLARELSSMPPYTEY 158
Q+L GL +MHR G H D+KPEN+L+ +KIAD G A YT
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNS 195
Query: 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS------EIDQLYKVC 212
+ TR YR+PEVLL + + D+W+ ++ EL T +F D + D + ++
Sbjct: 196 IQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 213 CILGAPD-------------WTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDL 259
+LG + + NIS+L ++L + + E D
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDF 313
Query: 260 IWQLCSWDPLRRPTADQALQHPFFN 284
+ + DP +R A + HP+
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 39/289 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ Y + +G G+ G V A T A KK+ + F + +E++ ++ L+HPN
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLDHPN 67
Query: 62 IIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
II+L E +N +++ + E E L+ + ++ F E + M +L +A+ H+
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE--LFERVVHKR-VFRESDAARIMKDVLSAVAYCHK 124
Query: 119 NGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
HRDLKPEN L D LK+ DFGLA V T +Y +P+VL
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-- 182
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y P D W+ G ++ L P F ++ + + K+ G FP
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFT---FP---------- 227
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
N S +A LI +L + P +R T+ QAL+H +F
Sbjct: 228 -----------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-59
Identities = 90/328 (27%), Positives = 139/328 (42%), Gaps = 50/328 (15%)
Query: 2 ERYKI--LEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLN 58
Y + E LG G G V+K T +A K + R EE E+ + +L+
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK--NEISVMNQLD 144
Query: 59 HPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
H N+I+L + N++ + EY++ L+ + + +E + FM Q+ +G+ HMH
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 118 RNGYFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
+ H DLKPEN+L N +KI DFGLAR T + APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-D 263
Query: 175 SYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
S DMW+VG I L + LSP F GD++ + L + + D
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP-FLGDNDAETLNNI--LACRWD---LE--------- 308
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV-PYP 292
+ + S EA + I +L + R +A +AL+HP W+ +
Sbjct: 309 ------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP------WLSDHK 350
Query: 293 LHDPLELRLNNMGSKPNLELNLWDFGTE 320
LH L + K N + DF T+
Sbjct: 351 LHSRLSAQK-----KKNRGSDAQDFVTK 373
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 6e-59
Identities = 80/316 (25%), Positives = 137/316 (43%), Gaps = 57/316 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ + +E LG G V+ T ++ A+K +K+ F + E+ L+K+ H N
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHEN 67
Query: 62 IIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
I+ L+++ + + + + E L+ + ER + ++E + + Q+L + ++H
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE--LFDRILERGV-YTEKDASLVIQQVLSAVKYLHE 124
Query: 119 NGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
NG HRDLKPENLL + I DFGL++ + + T Y APEVL Q
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQ-K 182
Query: 175 SYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGA------PDWTAFPE 225
YS A+D W++G I + L P F ++E +L++ I P W
Sbjct: 183 PYSKAVDCWSIGVI---TYILLCGYPPFYEETE-SKLFEK--IKEGYYEFESPFW----- 231
Query: 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
+ S A D I L DP R T ++AL HP+ +
Sbjct: 232 ------------------------DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
Query: 286 ETWVPYPLHDPLELRL 301
T + ++ + L++
Sbjct: 268 NTALHRDIYPSVSLQI 283
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 6e-59
Identities = 85/309 (27%), Positives = 127/309 (41%), Gaps = 37/309 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ Y I EELG G G V++ T A K + +E + +E++ + L HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHPT 215
Query: 62 IIKLKEVVRENNELFFIFEYME-HNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ L + ++NE+ I+E+M L+ + E SE E +M Q+ +GL HMH N
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 120 GYFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
Y H DLKPEN++ T + LK+ DFGL L T + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPV 333
Query: 177 SPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
DMW+VG + L + LSP F G+++ + L V +
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNV--KSCDWN---MD----------- 376
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHD 295
S + D I +L DP R T QAL+HP+
Sbjct: 377 ----------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 296 PLELRLNNM 304
P R +
Sbjct: 427 PSS-RYTKI 434
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-59
Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 2 ERYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNH 59
Y + +ELG G V + + T + A K +K++ + + E+ L
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 60 -PNIIKLKEVVRENNELFFIFEYMEH-NLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHM 116
P +I L EV +E+ I EY ++ + E SE ++ + Q+L+G+ ++
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 117 HRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
H+N H DLKP+N+L+++ +KI DFG++R++ E + T Y APE+L
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207
Query: 173 SSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ A DMW +G I L T SP F G+ + + D +
Sbjct: 208 -DPITTATDMWNIGIIAYMLLTHTSP-FVGEDNQETYLNI--SQVNVD---YS------- 253
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ + S A D I L +P +RPTA+ L H +
Sbjct: 254 --------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-58
Identities = 67/307 (21%), Positives = 115/307 (37%), Gaps = 61/307 (19%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKL-NH 59
+ LE++G G G V+K I A+K+ K+ + N LREV A L H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI---PFSEGEIRSFMSQMLQGLAH 115
++++ E++ + EY +L + E F E E++ + Q+ +GL +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 116 MHRNGYFHRDLKPENLLVTND--------------------VLKIADFGLARELSSMPPY 155
+H H D+KP N+ ++ + KI D G +SS P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQ 188
Query: 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL 215
E + A EVL ++ ++ P D++A+ + P+ DQ ++
Sbjct: 189 VE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHE----- 239
Query: 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD 275
I L I S E +L+ + DP RRP+A
Sbjct: 240 ------------------------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
Query: 276 QALQHPF 282
++H
Sbjct: 276 ALVKHSV 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 82/315 (26%), Positives = 127/315 (40%), Gaps = 63/315 (20%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHP 60
+ LG G+ G V VAVK+M F + L E+K L + +HP
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHP 69
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIM------RERQIPFSEGEIRSFMSQMLQGLA 114
N+I+ + L+ E NL ++ E E S + Q+ G+A
Sbjct: 70 NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 115 HMHRNGYFHRDLKPENLLVT--------------NDVLKIADFGLAREL-----SSMPPY 155
H+H HRDLKP+N+LV+ N + I+DFGL ++L S
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 156 TEYVSTRWYRAPEVLLQSSS------YSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQL 208
T +RAPE+L +S++ + +ID++++G + + + F +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248
Query: 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDP 268
NI R I +S L + EA DLI Q+ DP
Sbjct: 249 -------------------NIIRGI---FS--LDEMKCLHDRSLIAEATDLISQMIDHDP 284
Query: 269 LRRPTADQALQHPFF 283
L+RPTA + L+HP F
Sbjct: 285 LKRPTAMKVLRHPLF 299
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-58
Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 45/307 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHP 60
E Y++ EELG G V + V + A + K + L RE + R L HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 61 NIIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
NI++L + + E + IF+ + E L+ + R+ +SE + + Q+L+ + H H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGE--LFEDIVARE-YYSEADASHCIQQILEAVLHCH 127
Query: 118 RNGYFHRDLKPENLLVTND----VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQ 172
+ G HR+LKPENLL+ + +K+ADFGLA E+ + + T Y +PEVL +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 173 SSSYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
Y +D+WA G I L+ L P F + + ++ GA D FP
Sbjct: 188 -DPYGKPVDLWACGVI---LYILLVGYPPFWDEDQHRLYQQIK--AGAYD---FP----- 233
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289
S + EA DLI ++ + +P +R TA +AL+HP+ + + V
Sbjct: 234 ----------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV 277
Query: 290 PYPLHDP 296
+H
Sbjct: 278 ASCMHRQ 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-58
Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 49/312 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL----REVKALRKL 57
+ Y++ E +G G V + N ET + AVK + + ++ RE L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRE--RQIPFSEGEIRSFMSQMLQGL 113
HP+I++L E + L+ +FE+M+ + I++ +SE +M Q+L+ L
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELS-SMPPYTEYVSTRWYRAPE 168
+ H N HRD+KP +L+ + +K+ FG+A +L S V T + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCIL-GAPDWTAFP 224
V+ + Y +D+W G I LF L F G E +L++ I+ G
Sbjct: 204 VVKR-EPYGKPVDVWGCGVI---LFILLSGCLPFYGTKE--RLFE--GIIKGKYK---MN 252
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ S A DL+ ++ DP R T +AL HP+
Sbjct: 253 ---------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
Query: 285 VETWVPYPLHDP 296
Y +H P
Sbjct: 292 ERDRYAYKIHLP 303
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-58
Identities = 90/300 (30%), Positives = 133/300 (44%), Gaps = 48/300 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMN------LREVKAL 54
++Y + +G G V + + T AVK M E + RE L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 55 RKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
R++ HP+II L + ++ +F +F+ M L+ + E+ SE E RS M +L+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEA 212
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
++ +H N HRDLKPEN+L+ +++ ++++DFG + L E T Y APE+L
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 172 QSSS-----YSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGAPDWTAF 223
S Y +D+WA G I LFTL SP F +I L + + G F
Sbjct: 273 CSMDETHPGYGKEVDLWACGVI---LFTLLAGSPPFWHRRQILMLRMI--MEGQYQ---F 324
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S + S DLI +L DP R TA+QALQHPFF
Sbjct: 325 S---------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-58
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 61/312 (19%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+ ++ ++ LG G G V++A N A+K+++ +REVKAL KL HP
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 61 NIIKLKEVVRENNE------------LFFIFEYMEH-NLYHIMRERQI--PFSEGEIRSF 105
I++ E N L+ + NL M R
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSS------------- 151
Q+ + + +H G HRDLKP N+ T +DV+K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211
+T V T+ Y +PE + +SYS +D++++G IL EL L P F E +
Sbjct: 184 YARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFEL--LYP-FSTQMERVRTLT- 238
Query: 212 CCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR 271
++ + + ++ + S P+ R
Sbjct: 239 ---------------------------DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER 271
Query: 272 PTADQALQHPFF 283
P A +++ F
Sbjct: 272 PEAINIIENAVF 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 8e-58
Identities = 84/321 (26%), Positives = 135/321 (42%), Gaps = 47/321 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVK-----KMKRKFYFWEECMN-------LR 49
E Y + +LG G G V + A+K + + Y +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 50 EVKALRKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQ 108
E+ L+ L+HPNIIKL +V + + + E+ E L+ + R F E + + M Q
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQ 154
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWY 164
+L G+ ++H++ HRD+KPEN+L+ N +KI DFGL+ S + + T +Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
APEVL + Y+ D+W+ G I+ L P F G ++ D + KV G F
Sbjct: 215 IAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE--KGKYY---FD 267
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ N S EA +LI + ++D +R TA++AL +
Sbjct: 268 ---------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
Query: 285 VETWVPYPLHDPL-ELRLNNM 304
L+NM
Sbjct: 307 KYANNINKSDQKTLCGALSNM 327
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-56
Identities = 86/293 (29%), Positives = 134/293 (45%), Gaps = 45/293 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ +++ ELG G VY+ T + A+K +K+ ++ + E+ L +L+HPN
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPN 109
Query: 62 IIKLKEVVRENNELFFIFEYM---EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
IIKLKE+ E+ + E + E L+ + E+ +SE + + Q+L+ +A++H
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGE--LFDRIVEKG-YYSERDAADAVKQILEAVAYLHE 166
Query: 119 NGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
NG HRDLKPENLL LKIADFGL++ + T Y APE+L
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225
Query: 175 SYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+Y P +DMW+VG I + L F + +++ + F
Sbjct: 226 AYGPEVDMWSVGII---TYILLCGFEPFYDERGDQFMFR-RILNCEYY---FI------- 271
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
S S+ A DL+ +L DP +R T QALQHP+
Sbjct: 272 --------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 75/318 (23%), Positives = 123/318 (38%), Gaps = 72/318 (22%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVK----------KMKRKFYFWEECMNLRE 50
RY LG G ++ + +T E+ A K + K E
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--------ME 65
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQM 109
+ R L H +++ +N+ +F + E L + + R+ +E E R ++ Q+
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQI 124
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM----------PPYTEY 158
+ G ++HRN HRDLK NL + + +KI DFGLA ++ P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI-- 182
Query: 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218
APEV L +S +D+W++G I+ L P F S + + Y
Sbjct: 183 -------APEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL-------- 225
Query: 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
R+ YS +P +++ A LI ++ DP RPT ++ L
Sbjct: 226 ------------RIKKNEYS--IPKHINP-------VAASLIQKMLQTDPTARPTINELL 264
Query: 279 QHPFFNVETWVPYPLHDP 296
FF ++P L
Sbjct: 265 NDEFFT-SGYIPARLPIT 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-56
Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 70/306 (22%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVK----------KMKRKFYFWEECMNLRE 50
+E +K+ LG G+ VY+A ++ T VA+K M ++ E
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ--------NE 61
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQM 109
VK +L HP+I++L ++N ++ + E + + ++ R PFSE E R FM Q+
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM----------PPYTEY 158
+ G+ ++H +G HRDL NLL+T N +KIADFGLA +L P Y
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI-- 179
Query: 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218
+PE+ S++ D+W++G + L P F +
Sbjct: 180 -------SPEI-ATRSAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLN-------- 222
Query: 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
+++ Y +P LS EA DLI QL +P R + L
Sbjct: 223 ------------KVVLADYE--MPSFLSI-------EAKDLIHQLLRRNPADRLSLSSVL 261
Query: 279 QHPFFN 284
HPF +
Sbjct: 262 DHPFMS 267
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 75/319 (23%), Positives = 132/319 (41%), Gaps = 59/319 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHP 60
+ Y++ E++G G+ + + T AVK + + + E++ L + HP
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIEILLRYGQHP 76
Query: 61 NIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
NII LK+V + ++ + E M+ L I+R++ FSE E + + + + + ++H
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHA 134
Query: 119 NGYFHRDLKPENLLVTN-----DVLKIADFGLARELSSM-PPYTEYVSTRWYRAPEVLLQ 172
G HRDLKP N+L + + ++I DFG A++L + T + APEVL +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 173 SSSYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGA------PDWTAF 223
Y A D+W++G + L+T+ F + + I W
Sbjct: 195 -QGYDAACDIWSLGVL---LYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW--- 247
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ S A DL+ ++ DP +R TA L+HP+
Sbjct: 248 --------------------------NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
Query: 284 NVETWVP-YPLHDPLELRL 301
+P Y L+ L
Sbjct: 282 VHWDQLPQYQLNRQDAPHL 300
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 76/335 (22%), Positives = 126/335 (37%), Gaps = 78/335 (23%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVK----------KMKRKFYFWEECMNLRE 50
RY LG G ++ + +T E+ A K + K E
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--------ME 91
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQM 109
+ R L H +++ +N+ +F + E L + + R+ +E E R ++ Q+
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQI 150
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSM----------PPYTEY 158
+ G ++HRN HRDLK NL + + +KI DFGLA ++ P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI-- 208
Query: 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218
APEV L +S +D+W++G I+ L P F S + + Y
Sbjct: 209 -------APEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL-------- 251
Query: 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
R+ YS +P +++ A LI ++ DP RPT ++ L
Sbjct: 252 ------------RIKKNEYS--IPKHINP-------VAASLIQKMLQTDPTARPTINELL 290
Query: 279 QHPFFNVETWVPYPLHDPLELRLNNMGSKPNLELN 313
FF + P L + + P +
Sbjct: 291 NDEFFTSG-------YIPARLPITCLTIPPRFSIA 318
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-55
Identities = 58/307 (18%), Positives = 105/307 (34%), Gaps = 57/307 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKLN 58
+ Y +++LG+G V + A+K++ E+ RE R N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFN 84
Query: 59 HPNIIKLKEVVRE----NNELFFIFEYMEH-NLYHIMRERQI---PFSEGEIRSFMSQML 110
HPNI++L +E + + + + L++ + + +E +I + +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 111 QGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE----------YV 159
+GL +H GY HRDLKP N+L+ + D G + +
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 160 STRWYRAPEVLLQSSSYSP---AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG 216
T YRAPE L S+ D+W++G +L + + +
Sbjct: 205 CTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------ 257
Query: 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ 276
+ S +P + P S L+ + + DP +RP
Sbjct: 258 --------------LAVQNQLS--IPQS-----PRHSSALWQLLNSMMTVDPHQRPHIPL 296
Query: 277 ALQHPFF 283
L
Sbjct: 297 LLSQLEA 303
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-55
Identities = 83/334 (24%), Positives = 130/334 (38%), Gaps = 64/334 (19%)
Query: 2 ERYKIL---EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL- 57
+ Y + + LG+G+ K + ++ + AVK + ++ E +E+ AL+
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCE 63
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
HPNI+KL EV + F + E + I +++ FSE E M +++ ++H
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSH 121
Query: 116 MHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSM-PPYTEYVSTRWYRAPEVL 170
MH G HRDLKPENLL T++ +KI DFG AR P T Y APE+L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 171 LQSSSYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGA---------- 217
Q + Y + D+W++G I L+T+ F I+
Sbjct: 182 NQ-NGYDESCDLWSLGVI---LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277
W N S EA DLI L + DP +R
Sbjct: 238 EAW-----------------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
Query: 278 LQHPFFNVETWVP-YPLHDPLELRLNNMGSKPNL 310
+ + + + PL P L + +
Sbjct: 269 RYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCV 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 184 bits (467), Expect = 3e-54
Identities = 43/318 (13%), Positives = 91/318 (28%), Gaps = 59/318 (18%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHP 60
+ K++E L G V+ +VE E A+K + A +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 61 NIIKLKEVVR--------------------------ENNELFFIFEYMEHNLYHIMR--- 91
+ + ++ R + +L +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 92 ---ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147
+ + +Q+++ A++ G H P+NL + D L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 148 ELSSMPPYTEYVSTRWYRAPEVLLQSSS-YSPAIDMWAVGAILAELFTLSPIFPGDSEID 206
++ + Y E L S++ ++ A++ W +G + ++ L F +
Sbjct: 243 KVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 207 QLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSW 266
+ L P + LI + ++
Sbjct: 301 KGSWKRPSLRVPGTDSLA---------------------FGSCTPLPDFVKTLIGRFLNF 339
Query: 267 DPLRRPTADQALQHPFFN 284
D RR +A++ P F
Sbjct: 340 DRRRRLLPLEAMETPEFL 357
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-54
Identities = 82/327 (25%), Positives = 129/327 (39%), Gaps = 66/327 (20%)
Query: 2 ERYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
+ YK+ + LG G G V + FN T E A+K ++ + REV+ +
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKAR--REVELHWRASQC 114
Query: 60 PNIIKLKEV----VRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
P+I+++ +V L + E ++ I F+E E M + + +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
++H HRD+KPENLL T+ +LK+ DFG A+E +S T T +Y APEV
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTL---SPIFPGDSEID---QLYKVCCILGA------ 217
L Y + DMW++G I ++ L P F + + + I
Sbjct: 235 LGP-EKYDKSCDMWSLGVI---MYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPN 288
Query: 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277
P+W S E LI L +P +R T +
Sbjct: 289 PEW-----------------------------SEVSEEVKMLIRNLLKTEPTQRMTITEF 319
Query: 278 LQHPFFNVETWVP-YPLHDPLELRLNN 303
+ HP+ T VP PLH L+ +
Sbjct: 320 MNHPWIMQSTKVPQTPLHTSRVLKEDK 346
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-54
Identities = 82/324 (25%), Positives = 123/324 (37%), Gaps = 61/324 (18%)
Query: 2 ERYKILEE-LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
+ Y++ ++ LG G G V + F+ T + A+K + +EV +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGG 81
Query: 60 PNIIKLKEV----VRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
P+I+ + +V L I E ME I F+E E M + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
+H + HRD+KPENLL T+ VLK+ DFG A+E + T +Y APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEV 200
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---IDQLYKVCCILGA------PDW 220
L Y + DMW++G I+ L P F ++ + + I P+W
Sbjct: 201 LGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--RIRLGQYGFPNPEW 257
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
S +A LI L DP R T Q + H
Sbjct: 258 -----------------------------SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288
Query: 281 PFFNVETWVP-YPLHDPLELRLNN 303
P+ N VP PLH L+ +
Sbjct: 289 PWINQSMVVPQTPLHTARVLQEDK 312
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 71/305 (23%), Positives = 132/305 (43%), Gaps = 49/305 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKL 57
+E ++I LG G G VY A ++ I+A+K + + + + REV+ L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 66
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
HPNI++L + ++ I EY +Y +++ F E ++++++ L++
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 117 HRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYT-----EYVSTRWYRAPEVL 170
H HRD+KPENLL+ LKIADFG + S +Y+ PE+
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEM- 178
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
++ + +D+W++G + E P F ++ + YK
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYK-------------------- 217
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
R+ + ++ P +++ A DLI +L +P +RP + L+HP+ + P
Sbjct: 218 RISRVEFT--FPDFVTE-------GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268
Query: 291 YPLHD 295
+
Sbjct: 269 SNCQN 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-53
Identities = 60/306 (19%), Positives = 114/306 (37%), Gaps = 46/306 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+ +G G+ G V++ + +T AVKK++ E + E+ A L+ P
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I+ L VRE + E +E +L ++++ E ++ Q L+GL ++H
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTR 169
Query: 120 GYFHRDLKPENLLVTND--VLKIADFGLARELS------SMPPYTEYVSTRWYRAPEVLL 171
H D+K +N+L+++D + DFG A L S+ T + APEV++
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+D+W+ ++ + G WT +
Sbjct: 230 G-KPCDAKVDIWSSCCMMLHMLN---------------------GCHPWTQYFRGPLC-L 266
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291
I+ I I P+ + I + +P+ R +A + + ++
Sbjct: 267 KIASEPPPIREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE--VG 319
Query: 292 PLHDPL 297
L P
Sbjct: 320 GLKSPW 325
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-53
Identities = 85/326 (26%), Positives = 134/326 (41%), Gaps = 49/326 (15%)
Query: 2 ERYKILEE-LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
+ Y++ E+ LG+G V N+ T + AVK ++++ + REV+ L + H
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQGH 70
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
N+++L E E + + +FE M L HI + R F+E E + + L +H
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLH 128
Query: 118 RNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRW--------YR 165
G HRDLKPEN+L + +KI DF L + + + Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 166 APEVL----LQSSSYSPAIDMWAVGAILAELFTL---SPIFPGDSEIDQLYKVCCILGAP 218
APEV+ ++S Y D+W++G I L+ L P F G D
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVI---LYILLSGYPPFVGRCGSD-----------C 234
Query: 219 DWTAFPEATNISRLISISYSEILPINL---SDIIPNASMEAIDLIWQLCSWDPLRRPTAD 275
W ++ + I + S A DLI +L D +R +A
Sbjct: 235 GWDRGEACPACQNML---FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
Query: 276 QALQHPFFNVETWVPY-PLHDPLELR 300
Q LQHP+ V+ P L P+ L+
Sbjct: 292 QVLQHPW--VQGCAPENTLPTPMVLQ 315
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 55/322 (17%), Positives = 116/322 (36%), Gaps = 50/322 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL------------ 48
+ Y+I+ L G + + + A+KK ++ +
Sbjct: 30 INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 49 ----REVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI-------P 96
E++ + + + + + ++ +E++ I+EYME+ ++ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 97 FSEGEIRSFMSQMLQGLAHMH-RNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPP 154
I+ + +L +++H HRD+KP N+L+ N +K++DFG + +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 155 YT-----EYVSTRWYRAPEVLLQSSSYS-PAIDMWAVGAILAELFTLSPIFPGDSEIDQL 208
E++ PE SSY+ +D+W++G L +F F + +L
Sbjct: 208 KGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDP 268
+ I +P N + + S E ID + +P
Sbjct: 262 FNN--IRTKN--IEYPLDRNHFL------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311
Query: 269 LRRPTADQALQHPFFNVETWVP 290
R T++ AL+H +
Sbjct: 312 AERITSEDALKHEWLADTNIED 333
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 39/282 (13%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPNIIKLKE 67
LG GT G VY ++ +A+K++ + E+ + L H NI++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 68 VVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGE--IRSFMSQMLQGLAHMHRNGYFHR 124
EN + E + +L ++R + P + E I + Q+L+GL ++H N HR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 125 DLKPENLLVTND--VLKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQSSS-YSPAI 180
D+K +N+L+ VLKI+DFG ++ L+ + P TE + T Y APE++ + Y A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 181 DMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240
D+W++G + E+ T G P + E + + ++
Sbjct: 207 DIWSLGCTIIEMAT---------------------GKPPFYELGEPQAA--MFKVGMFKV 243
Query: 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
P +I + S EA I + DP +R A+ L F
Sbjct: 244 HP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
++ + I LG G G VY A + I+A+K + + E + RE++ L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
HPNI+++ + ++ + E+ LY +++ F E +FM ++ L + H
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH 131
Query: 118 RNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYT-----EYVSTRWYRAPEVLL 171
HRD+KPENLL+ LKIADFG + S+ T +Y+ PE++
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMI- 184
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ ++ +D+W G + E P F + ++ R
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD-SPSHTETHR--------------------R 223
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
++++ P LSD + DLI +L + P +R ++HP+
Sbjct: 224 IVNVDLK--FPPFLSD-------GSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-50
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 39/293 (13%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLR-EVKALRKLNHPNI 62
K E+G G+ VYK + ET VA +++ + E + E + L+ L HPNI
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 63 IKL----KEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
++ + V+ + + E M +R +RS+ Q+L+GL +H
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 119 NGYF--HRDLKPENLLVT--NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
HRDLK +N+ +T +KI D GLA + + T + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EE 204
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y ++D++A G + E+ T + Q+Y+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------------------------ 240
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
S + P + + E ++I + R + L H FF ET
Sbjct: 241 RVTSGVKPASFDKVA---IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 53/318 (16%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNL----REVKALRKL 57
+Y++ LG G G VY V VA+K + K + W E N EV L+K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 58 NH--PNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ +I+L + + I E E L+ + ER E RSF Q+L+ +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAV 162
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV--LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
H H G HRD+K EN+L+ + LK+ DFG L YT++ TR Y PE +
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 221
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ + +W++G +L ++ F D EI + +
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-----GQVFFRQR----------- 265
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291
S E LI + P RPT ++ HP+ + +P
Sbjct: 266 --------------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ-DVLLPQ 304
Query: 292 PLHDPLELRLNNMGSKPN 309
E+ L+++ P+
Sbjct: 305 ETA---EIHLHSLSPGPS 319
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 81/329 (24%), Positives = 143/329 (43%), Gaps = 54/329 (16%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL---REVKALRKLNH 59
+Y + + LG+G+ G V + + ET AVK +K+K +E++ LR+L H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 60 PNIIKLKEVVR--ENNELFFIFEYMEHNLY----HIMRERQIPFSEGEIRSFMSQMLQGL 113
N+I+L +V+ E +++ + EY + + +R F + + Q++ GL
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGL 122
Query: 114 AHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTR----WYRAPE 168
++H G H+D+KP NLL+T LKI+ G+A E + T ++ PE
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADDTCRTSQGSPAFQPPE 181
Query: 169 VLLQSSSYS-PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
+ ++S +D+W+ G L + T F GD+ I +L++
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFE----------------- 223
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN--- 284
NI + Y+ +P + DL+ + ++P +R + Q QH +F
Sbjct: 224 NIGKGS---YA--IPGDCGP-------PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
Query: 285 --VETWVPYPLHDPLELRLNNMGSKPNLE 311
E VP P + R +M P LE
Sbjct: 272 PPAEAPVPIPPSPDTKDRWRSMTVVPYLE 300
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 71/318 (22%), Positives = 115/318 (36%), Gaps = 62/318 (19%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNL----REVKALRKL 57
Y++ LG G G V+ + VA+K + + + W + EV L K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 58 N----HPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQ 111
HP +I+L + + E L+ + E+ P EG R F Q++
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVA 150
Query: 112 GLAHMHRNGYFHRDLKPENLLV---TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
+ H H G HRD+K EN+L+ K+ DFG L PYT++ TR Y PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDE-PYTDFDGTRVYSPPE 208
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
+ + ++ +W++G +L ++ F D EI + L P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE-----AELHFPAHV------- 256
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV--- 285
S + LI + + P RP+ ++ L P+
Sbjct: 257 ------------------------SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292
Query: 286 ------ETWVPYPLHDPL 297
P PL L
Sbjct: 293 DVPLNPSKGGPAPLAWSL 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 46/303 (15%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNHPN 61
Y++L+ +G G V A ++ T VA+K + K + REV+ ++ LNHPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+KL EV+ L+ I EY ++ + E E RS Q++ + + H+
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 121 YFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRDLK ENLL+ D+ +KIADFG + E + + Y APE+ P
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
+D+W++G I L+TL V L P F + N+ L
Sbjct: 195 VDVWSLGVI---LYTL---------------VSGSL--P----F-DGQNLKEL----RER 225
Query: 240 IL------PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPL 293
+L P +S + +L+ + +P++R T +Q ++ + N
Sbjct: 226 VLRGKYRIPFYMST-------DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
Query: 294 HDP 296
Sbjct: 279 PFV 281
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-48
Identities = 73/324 (22%), Positives = 117/324 (36%), Gaps = 81/324 (25%)
Query: 2 ERYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
+ YK+ + LG G G V + FN T E A+K ++ + REV+ +
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKAR--REVELHWRASQC 70
Query: 60 PNIIKLKEV----VRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
P+I+++ +V L + E ++ I F+E E M + + +
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 114 AHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
++H HRD+KPENLL T+ +LK+ DFG A E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKET 170
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---DQLYKVCCILGA------PDW 220
+ Y + DMW++G I+ L P F + + + I P+W
Sbjct: 171 TGE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW 226
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
S E LI L +P +R T + + H
Sbjct: 227 -----------------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257
Query: 281 PFFNVETWVP-YPLHDPLELRLNN 303
P+ T VP PLH L+ +
Sbjct: 258 PWIMQSTKVPQTPLHTSRVLKEDK 281
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 80/315 (25%), Positives = 133/315 (42%), Gaps = 64/315 (20%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVK-----KMKRKFYFWEECMNL--------- 48
+Y + +E+G G+ G V A+N A+K K+ R+ F
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 49 -----------REVKALRKLNHPNIIKLKEVVRENNE--LFFIFEYMEH-NLYHIMRERQ 94
+E+ L+KL+HPN++KL EV+ + NE L+ +FE + + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK- 132
Query: 95 IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMP 153
P SE + R + +++G+ ++H HRD+KP NLLV + +KIADFG++ E
Sbjct: 133 -PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 154 PYTE-YVSTRWYRAPEVLL-QSSSYS-PAIDMWAVGAIL-AELFTLSPIFPGDSEIDQLY 209
V T + APE L +S A+D+WA+G L +F P F + I L+
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP-FMDER-IMCLH 249
Query: 210 KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPL 269
I FP+ +I+ + DLI ++ +P
Sbjct: 250 SK--IKSQA--LEFPDQPDIAE-----------------------DLKDLITRMLDKNPE 282
Query: 270 RRPTADQALQHPFFN 284
R + HP+
Sbjct: 283 SRIVVPEIKLHPWVT 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNH 59
+E + +++ LG+G G V A N T E VAVK + ++ E + +E+ + LNH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
N++K RE N + EY L+ + E + + F Q++ G+ ++H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTR----WYRAPEVLLQS 173
G HRD+KPENLL+ D LKI+DFGLA + ++ Y APE+L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY--KVCCILGAPDWTAFPEATNISR 231
++ +D+W+ G +L + + S+ Q Y W
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-------- 234
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ L+ ++ +P R T + ++N
Sbjct: 235 ---------------------DSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 47/313 (15%), Positives = 105/313 (33%), Gaps = 44/313 (14%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+ + LG+G VY+A + + + +K K WE + + ++ L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-WEFYIGTQLMERLKP 123
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI----PFSEGEIRSFMSQMLQ 111
+K N + E + L + + + +G + SF +ML
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 112 GLAHMHRNGYFHRDLKPENLLVTNDV------------LKIADFGLARELSSMPPYTEYV 159
+ +H H D+KP+N ++ N L + D G + ++ P T +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 160 S---TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG 216
+ T ++ E+L ++ ID + V A + + + + + + +
Sbjct: 244 AKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE------ 296
Query: 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLC-SWDPLRRPTAD 275
RL + + +I + ++DL+ Q
Sbjct: 297 ----------GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
Query: 276 QALQHPFFNVETW 288
+AL++ +
Sbjct: 347 RALRNRLIVLLLE 359
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-47
Identities = 74/337 (21%), Positives = 120/337 (35%), Gaps = 65/337 (19%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKL-NHP 60
R ++ L +G VY+A +V + A+K++ + + +EV ++KL HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII--QEVCFMKKLSGHP 86
Query: 61 NIIKL-------KEVVRENNELFFIF-EYMEHNLYHIM--RERQIPFSEGEIRSFMSQML 110
NI++ KE F + E + L + E + P S + Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 111 QGLAHMHRNG--YFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRW---- 163
+ + HMHR HRDLK ENLL++ +K+ DFG A +S P Y+ R
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 164 ---------YRAPEV--LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVC 212
YR PE+ L + D+WA+G I LY +C
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI-------------------LYLLC 247
Query: 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP 272
F E R+++ YS +P + LI + +P R
Sbjct: 248 FRQ-----HPF-EDGAKLRIVNGKYS--IPPH-----DTQYTVFHSLIRAMLQVNPEERL 294
Query: 273 TADQALQHPFFNVETWVPYPLHDPLELRLNNMGSKPN 309
+ + + P+ L G +
Sbjct: 295 SIAEVVHQLQEIAAA-RNVNPKSPITELLEQNGGYGS 330
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 55/311 (17%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVK---KMKRKFYFWEECMNL----REVKA 53
++Y + LG G G V+ A + E + V VK K K W E L E+
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEY----MEHNLY-HIMRERQIPFSEGEIRSFMSQ 108
L ++ H NIIK+ ++ + E ++ L+ I R + E Q
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD--LFAFIDRHPR--LDEPLASYIFRQ 138
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRWYRAP 167
++ + ++ HRD+K EN+++ + +K+ DFG A L + + T Y AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
EVL+ + P ++MW++G L+TL V P F E
Sbjct: 199 EVLMGNPYRGPELEMWSLGVT---LYTL---------------VFEEN--P----FCE-- 232
Query: 228 NISRLISISYSEILPINLSDIIPN-ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
E + + P S E + L+ L P RR T ++ + P+
Sbjct: 233 ---------LEETVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
Query: 287 TWVPYPLHDPL 297
+ + +
Sbjct: 282 VNLADYTWEEV 292
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 74/325 (22%), Positives = 135/325 (41%), Gaps = 43/325 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNLREVKALRKLNH 59
+E + +++ LG+G G V A N T E VAVK + ++ E + +E+ + LNH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHN-LY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
N++K RE N + EY L+ I E I E + + F Q++ G+ ++H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 118 RNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTR----WYRAPEVLLQ 172
G HRD+KPENLL+ D LKI+DFGLA + ++ Y APE+L +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR- 231
++ +D+W+ G + L + + L P + + ++ +
Sbjct: 182 REFHAEPVDVWSCGIV---LTAM---------------LAGEL--P----WDQPSDSCQE 217
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF--NVETWV 289
+ I + L+ ++ +P R T + ++ ++
Sbjct: 218 YSDWKEKKTYLNPWKKI----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
Query: 290 PYPLHDPLELRLNNMGSKPNLELNL 314
P + + G +++ NL
Sbjct: 274 KRPRVTSGGVSESPSGFSKHIQSNL 298
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 44/328 (13%), Positives = 88/328 (26%), Gaps = 83/328 (25%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL--REVKALRKL--- 57
LG +A + ET E V + EV LR L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 58 ----------------------NHPNIIKLKEVVRENN--ELFFIFEYMEHNLYHIMRE- 92
+I+++ R+ FF++ M+ NL
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 93 -----RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146
Q+++ LA +H G H L+P ++++ + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 147 RELSSMPPYTEYVSTRWYRAPEVL----------LQSSSYSPAIDMWAVGAILAELFTLS 196
+ +R + PE+ + + + + D WA+G ++ ++
Sbjct: 254 VRDGA---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 197 PIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEA 256
D+ + + F NI +
Sbjct: 311 LPITKDAALGGSEWI-----------FRSCKNIPQ-----------------------PV 336
Query: 257 IDLIWQLCSWDPLRRPTADQALQHPFFN 284
L+ + R QA++ P +
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 53/299 (17%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
+ Y + + LG GT G V + T VAVK + R+ + + RE++ L+
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
HP+IIKL +V+ + F + EY+ L+ + + E E R Q+L + + H
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH 128
Query: 118 RNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTR----WYRAPEVLLQ 172
R+ HRDLKPEN+L+ + KIADFG LS+M E++ T Y APEV +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFG----LSNMMSDGEFLRTSCGSPNYAAPEV-IS 183
Query: 173 SSSYS-PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA----PDWTAFPEAT 227
Y+ P +D+W+ G IL L + F + + L+K I G P++
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFK--KIRGGVFYIPEYL------ 234
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
+ L+ + DPL+R T +H +F +
Sbjct: 235 -------------------------NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 68/314 (21%), Positives = 127/314 (40%), Gaps = 28/314 (8%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+ ++ + ELG G G V+K + + ++A K + + +RE++ L + N P
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 61 NIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I+ + E+ E+M+ +L ++++ E + +++GL ++
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK 150
Query: 120 GY-FHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+KP N+LV + +K+ DFG++ +L + +V TR Y +PE LQ + YS
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPER-LQGTHYS 208
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
D+W++G L E+ P + C + P R ++
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 238 SEILP----INLSDIIPNA----------SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ P L D I N S+E D + + +P R Q + H F
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 284 --------NVETWV 289
+ W+
Sbjct: 329 KRSDAEEVDFAGWL 342
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 86/312 (27%), Positives = 122/312 (39%), Gaps = 53/312 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVK------KMKRKFYFWEECMNLREVKAL 54
+RY ++++G G G + T E+VAVK + RE+
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--------REIINH 70
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
R L HPNI++ KEV+ L I EY LY + FSE E R F Q+L G+
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGV 129
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV---LKIADFGL-ARELSSMPPYTEYVSTRWYRAPEV 169
++ H HRDLK EN L+ LKI DFG + P + V T Y APEV
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEV 188
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
LL+ D+W+ G L + + + P F E
Sbjct: 189 LLRQEYDGKIADVWSCGVTL---YVM---------------LVGAY--P----F-EDPEE 223
Query: 230 SRLISISYSEILPINLSDIIPNA---SMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
R + IL + S IP+ S E LI ++ DP R + + H +F
Sbjct: 224 PRDYRKTIQRILSVKYS--IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
Query: 287 TWVPYPLHDPLE 298
+P L +
Sbjct: 282 --LPADLMNESN 291
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 85/298 (28%), Positives = 139/298 (46%), Gaps = 56/298 (18%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNL-REVKALRKLNHP 60
Y I E LG+G+ G V A + +T + VA+K + ++ + M + RE+ L+ L HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
+IIKL +V+ ++ + EY L+ +I+ ++ +E E R F Q++ + + HR+
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH 127
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRW-----YRAPEVLLQS 173
HRDLKPENLL+ N +KIADFG LS++ ++ T Y APEV +
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFG----LSNIMTDGNFLKT-SCGSPNYAAPEV-ING 181
Query: 174 SSYS-PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA----PDWTAFPEATN 228
Y+ P +D+W+ G +L + F + I L+K + PD+
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFK--KVNSCVYVMPDFL------- 231
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
S A LI ++ DP++R T + + P+FNV
Sbjct: 232 ------------------------SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-44
Identities = 62/318 (19%), Positives = 111/318 (34%), Gaps = 41/318 (12%)
Query: 2 ERYKILEELGDGTC--GCVYKAFNVETYEIVAVKKMKRKFYFWEECMN------LREVKA 53
Y++L +G G V A T E V V+++ E C N E+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-----LEACSNEMVTFLQGELHV 79
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI-PFSEGEIRSFMSQMLQ 111
+ NHPNI+ + +NEL+ + +M + + ++ + +E I + +L+
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS--------MPPYTEYVSTR 162
L ++H GY HR +K ++L++ D + ++ + S V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 163 WYRAPEVLLQSSS-YSPAIDMWAVG--AI-LAE----LFTLSP---IF------PGDSEI 205
+ +PEVL Q+ Y D+++VG A LA + +
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 206 DQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCS 265
+ +P + + S S S + Q
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 266 WDPLRRPTADQALQHPFF 283
+P RP+A L H FF
Sbjct: 320 RNPDARPSASTLLNHSFF 337
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-44
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 50/294 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL--REVKALRKLNH 59
+ + L E+G G+ G VY A +V E+VA+KKM E +EV+ L+KL H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
PN I+ + + + + EY + ++ + P E EI + LQGLA++H +
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL--QSSSY 176
HRD+K N+L++ ++K+ DFG A ++ +V T ++ APEV+L Y
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 230
Query: 177 SPAIDMWAVG--AI-LAE----LFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
+D+W++G I LAE LF ++ +
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAM-----------SA------------------ 261
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
L I+ +E L + S + + P RPT++ L+H F
Sbjct: 262 --LYHIAQNE--SPALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 40/279 (14%)
Query: 5 KILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPN 61
+ + +G G+ G VYK ++ + VAVK + + + EV LRK H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVN 81
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ L + ++ E +LYH + + F ++ Q +G+ ++H
Sbjct: 82 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 121 YFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTR-WYR--APEVLLQSSS- 175
HRDLK N+ + ++ +KI DFGLA E S ++ APEV+ S
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 176 -YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
YS D++A G +L EL T + + DQ+ ++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--------------------- 239
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
L +LS + N L+ + RP+
Sbjct: 240 ---RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 75/305 (24%), Positives = 135/305 (44%), Gaps = 51/305 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
+ Y++ E +G G V A+ E VA+K++ E+C L+E++A+ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-----LEKCQTSMDELLKEIQAMSQ 69
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI-------PFSEGEIRSFMSQ 108
+HPNI+ +EL+ + + + ++ I++ E I + + +
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 109 MLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE------YVST 161
+L+GL ++H+NG HRD+K N+L+ D ++IADFG++ L++ T +V T
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILA-ELFTLSPIFPGDSEIDQLYKVCCILGAPDW 220
+ APEV+ Q Y D+W+ G I A EL T + + + + KV
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFG-ITAIELATGAAPY---HKYPPM-KVL-------- 236
Query: 221 TAFPEATNISRLISISYSEIL--PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQAL 278
L + L + +++ +I DP +RPTA + L
Sbjct: 237 ----------MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 279 QHPFF 283
+H FF
Sbjct: 287 RHKFF 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 82/298 (27%), Positives = 140/298 (46%), Gaps = 53/298 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHP 60
E ++I+ ELGDG G VYKA N ET + A K ++ K E+ + E++ L +HP
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHP 76
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I+KL + +L+ + E+ + IM E +E +I+ QML+ L +H
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLL----QS 173
HRDLK N+L+T + +++ADFG++ + + ++ T ++ APEV++ +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 174 SSYSPAIDMWAVG--AI-LAE----LFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
+ Y D+W++G I +A+ L+P+ +V
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----------RV--------------- 230
Query: 227 TNISRLISISYSEILPINLSDIIPNA-SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
L+ I+ S+ P L P+ S+E D + +P RP+A Q L+HPF
Sbjct: 231 -----LLKIAKSD--PPTLLT--PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 54/287 (18%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKR-KFYFWEECMN--LREVKALRKLNH 59
+ E +G G G VY+A + + VAVK + + + +E K L H
Sbjct: 10 TLEEIIGIGGFGKVYRA----FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
PNII L+ V + L + E+ L ++ ++IP + ++ Q+ +G+ ++H
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPD--ILVNWAVQIARGMNYLHD 123
Query: 119 NGYF---HRDLKPENLLV---------TNDVLKIADFGLARELSSMPPYTEYVSTRWYRA 166
HRDLK N+L+ +N +LKI DFGLARE + + W A
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MA 182
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
PEV +++S +S D+W+ G +L EL T F G + Y V A
Sbjct: 183 PEV-IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV--------------A 227
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
N L I L+ + DP RP+
Sbjct: 228 MNKLAL--------------PIPSTCPEPFAKLMEDCWNPDPHSRPS 260
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 84/312 (26%), Positives = 136/312 (43%), Gaps = 57/312 (18%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMNL-REVKALRKLN 58
+ Y + + LG GT G V + T VAVK + ++K + + RE++ L+
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHN-LY-HIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
HP+IIKL +V+ +++F + EY+ L+ +I + ++ E E R Q+L G+ +
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD--EKESRRLFQQILSGVDYC 132
Query: 117 HRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVSTRW-----YRAPEVL 170
HR+ HRDLKPEN+L+ + KIADFG LS+M E++ T Y APEV+
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFG----LSNMMSDGEFLRT-SCGSPNYAAPEVI 187
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA----PDWTAFPEA 226
P +D+W+ G IL L + F D + L+K I P +
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFK--KICDGIFYTPQYL----- 239
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
+ I L+ + DP++R T +H +F +
Sbjct: 240 --------------------------NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
Query: 287 TWVPYPLHDPLE 298
+P L
Sbjct: 274 --LPKYLFPEDP 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-42
Identities = 83/299 (27%), Positives = 141/299 (47%), Gaps = 62/299 (20%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + +LE+LG+G+ G VYKA + ET +IVA+K++ + +E + E+ +++ + P+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIK--EISIMQQCDSPH 85
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
++K +N +L+ + EY ++ I+R R +E EI + + L+GL ++H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K N+L+ + K+ADFG+A +L+ M + T ++ APEV+ + Y+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNC 204
Query: 179 AIDMWAVG--AI-LAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
D+W++G AI +AE G P P
Sbjct: 205 VADIWSLGITAIEMAE------------------------GKP-----P----------- 224
Query: 236 SYSEILPINLSDIIPNA-----------SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
Y++I P+ +IP S D + Q P +R TA Q LQHPF
Sbjct: 225 -YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 49/328 (14%), Positives = 90/328 (27%), Gaps = 79/328 (24%)
Query: 2 ERYKIL---EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRK 56
ER + L LG +A + ET E V + EV LR
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 57 L----------NHPNIIKLKEVVRENN-----------------ELFFIFEYMEHNLYHI 89
L H I ++V++ FF++ M+ NL
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 90 MRE------RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIAD 142
Q+++ LA +H G H L+P ++++ + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 143 FGLAREL--SSMPPYTEYVSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLS 196
F S++ P + A +L + + A D W +G + ++
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 197 PIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEA 256
D+ + + F NI +
Sbjct: 315 LPNTDDAALGGSEWI-----------FRSCKNIPQ-----------------------PV 340
Query: 257 IDLIWQLCSWDPLRRPTADQALQHPFFN 284
L+ + R QA++ P +
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 72/289 (24%), Positives = 113/289 (39%), Gaps = 52/289 (17%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPNI 62
E LG G G K + ET E++ +K++ R F EE L+EVK +R L HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 63 IKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
+K V+ ++ L FI EY++ L I++ + + SF + G+A++H
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 122 FHRDLKPENLLVT-NDVLKIADFGLARELSSMP----------------PYTEYVSTRWY 164
HRDL N LV N + +ADFGLAR + YT + W
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
APE+ + SY +D+++ G +L E+ P + +
Sbjct: 190 -APEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL------- 240
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
PN + + C DP +RP+
Sbjct: 241 ------DR--------------YCPPNCPPSFFPITVRCCDLDPEKRPS 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 23/215 (10%)
Query: 5 KILEELGDGTCGCVYKAF-NVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNHPN 61
+I E +G G G VY + E VA++ + + E+ + REV A R+ H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIE-RDNEDQLKAFKREVMAYRQTRHEN 90
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
++ L I + LY ++R+ +I + R ++++G+ ++H G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 121 YFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEY----VSTRWYR--APEVLLQSS 174
H+DLK +N+ N + I DFGL + + W APE++ Q S
Sbjct: 151 ILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 175 S--------YSPAIDMWAVGAILAELFTLSPIFPG 201
+S D++A+G I EL F
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + LE++G G+ G V+K + T ++VA+K + + E +E+ L + + P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+ K ++ +L+ I EY+ + ++ P E +I + + ++L+GL ++H
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK 139
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K N+L++ +K+ADFG+A +L+ +V T ++ APEV+ Q S+Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDS 198
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
D+W++G EL P P +S
Sbjct: 199 KADIWSLGITAIELARGEP--P------------------------------------HS 220
Query: 239 EILPINLSDIIPNA---------SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
E+ P+ + +IP S + + + +P RPTA + L+H F
Sbjct: 221 ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-41
Identities = 73/286 (25%), Positives = 134/286 (46%), Gaps = 36/286 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKLNHP 60
++Y E++G G G VY A +V T + VA+++M ++ E +N E+ +R+ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN--EILVMRENKNP 77
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+ + +EL+ + EY+ +L ++ E EG+I + + LQ L +H N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN 135
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+K +N+L+ D +K+ DFG +++ + V T ++ APEV+ + +Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG 194
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
P +D+W++G + E+ P + ++ + LY + PE N +L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT-PELQNPEKL----- 242
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S D + + D +R +A + LQH F
Sbjct: 243 ---------------SAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK-RKFYFWEECMNLREVKALRKLNHP 60
++G+G+ G V A + VAVK M RK E N EV +R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN--EVVIMRDYQHF 102
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
N++++ + EL+ + E+++ L I+ + +E +I + +LQ LA++H
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ 160
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYS 177
G HRD+K +++L+T D +K++DFG ++S +P V T ++ APEV+ + S Y+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
+D+W++G ++ E+ P + DS + + ++ D P+ N ++
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------RDSPP-PKLKNSHKV----- 267
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S D + ++ DP R TA + L HPF
Sbjct: 268 ---------------SPVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 49/286 (17%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
++ E +G G G V KA + + VA+K+++ + E + E++ L ++NHPNI
Sbjct: 11 EVEEVVGRGAFGVVCKA----KWRAKDVAIKQIESES---ERKAFIVELRQLSRVNHPNI 63
Query: 63 IKLKEVVRENNELFFIFEYMEH-NLYHIMR--ERQIPFSEGEIRSFMSQMLQGLAHMHR- 118
+KL + + EY E +LY+++ E ++ S+ Q QG+A++H
Sbjct: 64 VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 119 --NGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
HRDLKP NLL+ VLKI DFG A ++ + T + + APEV + S
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEV-FEGS 178
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
+YS D+++ G IL E+ T F +G P + N +R
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAFRIMWAVHNGTRP-- 223
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+I N L+ + S DP +RP+ ++ ++
Sbjct: 224 ------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 50/294 (17%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN------LREVKALRKLN 58
+ +++G G G V+K V+ +VA+K + E M REV + LN
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
HPNI+KL ++ N + E++ +LYH + ++ P M + G+ +M
Sbjct: 82 HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 118 RNGYF--HRDLKPENLLVTND------VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
HRDL+ N+ + + K+ADFGL+++ + + + APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPET 197
Query: 170 LL-QSSSYSPAIDMWAVGAILAELFTLSPIFPG--DSEIDQLYKVCCILGAPDWTAFPEA 226
+ + SY+ D ++ IL + T F +I + +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--------------R 243
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
R I + ++I S DP +RP ++
Sbjct: 244 EEGLRP--------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKRKFYFWEECMN--LREVKALRKLNHP 60
I E++G G+ G V++A + VAVK + + F E +N LREV +++L HP
Sbjct: 40 NIKEKIGAGSFGTVHRA----EWHGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHP 94
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMR--ERQIPFSEGEIRSFMSQMLQGLAHMH 117
NI+ V + L + EY+ +LY ++ + E S + +G+ ++H
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 118 RNGYF--HRDLKPENLLVT-NDVLKIADFGLARELSSMPPY-TEYVSTRWYRAPEVLLQS 173
HR+LK NLLV +K+ DFGL+R +S T + APEV L+
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV-LRD 213
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
+ D+++ G IL EL TL + + + V RL
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV--------------GFKCKRL- 258
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+I N + + +I + +P +RP+ +
Sbjct: 259 -------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 67/305 (21%), Positives = 120/305 (39%), Gaps = 43/305 (14%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
+ + L E+G GTCG V+K +T ++AVK+M+R E L ++ + K +
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-R 118
P I++ N ++F E M + + Q P E + +++ L ++ +
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL----LQS 173
+G HRD+KP N+L+ +K+ DFG++ L Y APE +
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
Y D+W++G L EL T + ++ + L KV P P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL--QEEP-----PLLPG---- 252
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF--------N 284
+ +S + + + D +RP ++ L+H F +
Sbjct: 253 -HMGFSG---------------DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 285 VETWV 289
V +W
Sbjct: 297 VASWF 301
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 70/306 (22%), Positives = 131/306 (42%), Gaps = 63/306 (20%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHP 60
++++E +G+GT G VYK +V+T ++ A+K M EE E+ L+K +H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ--EINMLKKYSHHR 81
Query: 61 NIIKL------KEVVRENNELFFIFEYME----HNLYHIMRERQIPFSEGEIRSFMSQML 110
NI K +++L+ + E+ +L + E I ++L
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKEEWIAYICREIL 139
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPE 168
+GL+H+H++ HRD+K +N+L+T + +K+ DFG++ +L + ++ T ++ APE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
Query: 169 VLLQS----SSYSPAIDMWAVG--AI-LAE----LFTLSPIFPGDSEIDQLYKVCCILGA 217
V+ ++Y D+W++G AI +AE L + P+ +
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----------RA------ 242
Query: 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277
L I + L S + I + +RP +Q
Sbjct: 243 --------------LFLIPRNP--APRLKS--KKWSKKFQSFIESCLVKNHSQRPATEQL 284
Query: 278 LQHPFF 283
++HPF
Sbjct: 285 MKHPFI 290
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-39
Identities = 50/258 (19%), Positives = 91/258 (35%), Gaps = 49/258 (18%)
Query: 43 EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER--QIPFSE 99
+++ + + N + + L+ + NL M R
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 100 GEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSS------- 151
G Q+ + + +H G HRDLKP N+ T +DV+K+ DFGL +
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 152 ------MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI 205
+T V T+ Y +PE + ++YS +D++++G IL EL
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYSHKVDIFSLGLILFEL------------- 269
Query: 206 DQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCS 265
+F R+I+ + P+ + P ++ + S
Sbjct: 270 --------------LYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH----MMVQDMLS 311
Query: 266 WDPLRRPTADQALQHPFF 283
P RP A +++ F
Sbjct: 312 PSPTERPEATDIIENAIF 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 66/307 (21%), Positives = 121/307 (39%), Gaps = 46/307 (14%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK-ALRKLNH 59
+ + + ELG G G V K +V + +I+AVK+++ E+ L ++ ++R ++
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 60 PNIIKLKEVVRENNELFFIFEYME---HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
P + + +++ E M+ Y + ++ E + +++ L H+
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 117 HRNGYF-HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL---L 171
H HRD+KP N+L+ +K+ DFG++ L + Y APE + L
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEATNIS 230
YS D+W++G + EL L + + QL ++ P
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEP------------ 230
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF------- 283
L S E +D Q + RPT + +QHPFF
Sbjct: 231 -----------SPQLPA--DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
Query: 284 -NVETWV 289
+V ++V
Sbjct: 278 TDVASFV 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 53/289 (18%), Positives = 97/289 (33%), Gaps = 50/289 (17%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKRKFYFWEECMN--LREVKALRKLNHP 60
L +L + G ++K + + VK +K + + E LR +HP
Sbjct: 13 NFLTKLNENHSGELWKG----RWQGNDIVVKVLKVR-DWSTRKSRDFNEECPRLRIFSHP 67
Query: 61 NIIKLKEVVRE--NNELFFIFEYMEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHM 116
N++ + + I +M + +LY+++ E + + F M +G+A +
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 117 HRNGYF--HRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL-- 171
H L ++++ + +I+ + S + W APE L
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAPAWV-APEALQKK 183
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ + DMW+ +L EL T F S ++ KV A R
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--------------ALEGLR 229
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
I P S L+ + DP +RP D +
Sbjct: 230 P--------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 70/308 (22%), Positives = 121/308 (39%), Gaps = 44/308 (14%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NH 59
E K L E+G G G V K + + +I+AVK+++ E+ L ++ + + +
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 60 PNIIKLKEVVRENNELFFIFEYM----EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
P I++ + + + E M + ++ E + ++ L H
Sbjct: 81 PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 116 MHRNGY-FHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
+ N HRD+KP N+L+ +K+ DFG++ +L T R Y APE + S
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 174 S---SYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEATNI 229
+ Y D+W++G L EL T +P +S DQL +V + G P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDP----------- 247
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF------ 283
P + S I+ + + D +RP + L+HPF
Sbjct: 248 ------------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295
Query: 284 --NVETWV 289
V +V
Sbjct: 296 AVEVACYV 303
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 49/300 (16%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRKLNHP 60
+K + LG+G+ V A + T A+K ++++ E + RE + +L+HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLDHP 90
Query: 61 NIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
+KL +++ +L+F Y + L +I + F E R + ++++ L ++H
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 119 NGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTE---YVSTRWYRAPEVLLQSS 174
G HRDLKPEN+L+ D+ ++I DFG A+ LS +V T Y +PE+ L
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEK 207
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
S + D+WA+G I+ +L P F +E +++ I+ FP
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQ--KIIKLE--YDFP---------- 252
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA------LQHPFFNVETW 288
+A DL+ +L D +R ++ HPFF TW
Sbjct: 253 ---------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 26/224 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK----------RKFYFWEECMNLREV 51
ERYKI+++LG G VY A + VA+K + ++F REV
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE--------REV 62
Query: 52 KALRKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQML 110
+L+H NI+ + +V E++ + + EY+E L + P S +F +Q+L
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQIL 121
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE---YVSTRWYRA 166
G+ H H HRD+KP+N+L+ ++ LKI DFG+A+ LS T+ + T Y +
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFS 180
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK 210
PE + + D++++G +L E+ P F G++ + K
Sbjct: 181 PE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 61/303 (20%), Positives = 105/303 (34%), Gaps = 46/303 (15%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKR--KFYFWEECMNLREVKALRKLNHP 60
++++++G G G V+ + E VAVK + ++ E E+ + H
Sbjct: 40 QMVKQIGKGRYGEVWMG----KWRGEKVAVKVFFTTEEASWFRE----TEIYQTVLMRHE 91
Query: 61 NIIKLKEVVRENN----ELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
NI+ + +L+ I +Y E+ +LY ++ + + + GL H
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS--MLKLAYSSVSGLCH 149
Query: 116 MHRNGYF--------HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS-----T 161
+H + HRDLK +N+LV + IAD GLA + S + T
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 162 RWYRAPEVL-----LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILG 216
+ Y PEVL DM++ G IL E+ E Y
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH------ 263
Query: 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ 276
D + R I + L+ + + +P R TA +
Sbjct: 264 --DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 277 ALQ 279
+
Sbjct: 322 VKK 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 57/276 (20%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKR--KFYFWEECMNLREVKALRKLNHP 60
+LE +G G G V++ ++ E VAVK + ++ E E+ L H
Sbjct: 11 TLLECVGKGRYGEVWRG----SWQGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHE 62
Query: 61 NIIKL----KEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
NI+ + +L+ I Y E +LY ++ + + + GLAH
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS--CLRIVLSIASGLAH 120
Query: 116 MHRNGYF--------HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS-----T 161
+H + HRDLK +N+LV + IAD GLA S + + T
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 162 RWYRAPEVL-----LQSSSYSPAIDMWAVGAILAELFTLSPIF--------------PGD 202
+ Y APEVL + +D+WA G +L E+ P D
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 203 SEIDQLYKVCCILGA-----PDWTAFPEATNISRLI 233
+ + KV C+ W + P T++++L+
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 57/276 (20%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKR--KFYFWEECMNLREVKALRKLNHP 60
+ E +G G G V++ + E VAVK + ++ E E+ L H
Sbjct: 45 VLQESIGKGRFGEVWRG----KWRGEEVAVKIFSSREERSWFRE----AEIYQTVMLRHE 96
Query: 61 NIIKLKEVVRENN----ELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
NI+ ++N +L+ + +Y EH +L+ + + + GLAH
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--MIKLALSTASGLAH 154
Query: 116 MHRNGYF--------HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS-----T 161
+H HRDLK +N+LV + IAD GLA S + T
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 162 RWYRAPEVL-----LQSSSYSPAIDMWAVGAILAELFTLSPIF--------------PGD 202
+ Y APEVL ++ D++A+G + E+ I P D
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 203 SEIDQLYKVCCILGA-----PDWTAFPEATNISRLI 233
++++ KV C W + +++++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 45/290 (15%)
Query: 5 KILEELGDGTCGCVYKA----FNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALR 55
K L++LG G G V T E+VAVKK++ RE++ L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ------HSTEEHLRDFEREIEILK 66
Query: 56 KLNHPNIIKLKEVVRENNE--LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
L H NI+K K V L I EY+ + +L +++ + ++ + SQ+ +G
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RWY 164
+ ++ Y HRDL N+LV + +KI DFGL + L + + WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWY 184
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
APE L + S +S A D+W+ G +L ELFT + + ++G
Sbjct: 185 -APESLTE-SKFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFMRMIGNDKQ---G 234
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLC-SWDPLRRPT 273
+ + + + LP P+ + I +I C + + +RP+
Sbjct: 235 QMIVFHLIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPS 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 5 KILEELGDGTCGCVYKA----FNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALR 55
K L++LG G G V T E+VAVKK++ RE++ L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ------HSTEEHLRDFEREIEILK 97
Query: 56 KLNHPNIIKLKEVVRENNE--LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
L H NI+K K V L I EY+ + +L +++ + ++ + SQ+ +G
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RWY 164
+ ++ Y HRDL N+LV + +KI DFGL + L Y Y WY
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWY 215
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
APE L + S +S A D+W+ G +L ELFT
Sbjct: 216 -APESLTE-SKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 40/242 (16%)
Query: 2 ERYKILEELGDGTCGCVYKA----FNVETYEIVAVKKMK--------RKFYFWEECMNLR 49
K + +LG+G G V T E VAVK +K +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL--------KK 72
Query: 50 EVKALRKLNHPNIIKLKEVVRENNE--LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFM 106
E++ LR L H NI+K K + E+ + I E++ +L + + + + + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST---- 161
Q+ +G+ ++ Y HRDL N+LV ++ +KI DFGL + + + Y Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRD 190
Query: 162 ---RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218
WY APE L+Q S + A D+W+ G L EL T DS+ + ++G
Sbjct: 191 SPVFWY-APECLMQ-SKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243
Query: 219 DW 220
Sbjct: 244 HG 245
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 78/296 (26%), Positives = 120/296 (40%), Gaps = 53/296 (17%)
Query: 2 ERYKILEELGDGTCGCVYKA----FNVETYEIVAVKKMK--------RKFYFWEECMNLR 49
K + +LG+G G V N T E+VAVK +K + +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW--------KQ 82
Query: 50 EVKALRKLNHPNIIKLKEVVRENNE--LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFM 106
E+ LR L H +IIK K + L + EY+ +L + I ++ + F
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFA 140
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST---- 161
Q+ +G+A++H Y HRDL N+L+ ND ++KI DFGLA+ + Y Y
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGD 198
Query: 162 ---RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218
WY APE L + + A D+W+ G L EL T DS K ++G
Sbjct: 199 SPVFWY-APECLKE-YKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIA 251
Query: 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLC-SWDPLRRPT 273
+ T + + E LP P+ + + + C + RPT
Sbjct: 252 ----QGQMTVLRLTELLERGERLP------RPDKCPAEVYHLMKNCWETEASFRPT 297
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 73/301 (24%), Positives = 118/301 (39%), Gaps = 43/301 (14%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLN 58
++ LG G G V T ++ A KK+++K E M L E + L K+N
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 59 HPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
++ L + L + M +HI Q F E + +++ GL +
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 117 HRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
HR +RDLKPEN+L+ + ++I+D GLA + V T Y APEV+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ER 361
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSE---IDQLYKVCCILGAPDWTAFPEATNISRL 232
Y+ + D WA+G +L E+ F + +++ ++ + P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKEVP-------------- 405
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNVET 287
YSE S +A L QL DP R +A + +HP F
Sbjct: 406 --EEYSERF-----------SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
Query: 288 W 288
+
Sbjct: 453 F 453
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 42/301 (13%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64
++LE G GCV+KA + E VAVK + + N EV +L + H NI++
Sbjct: 27 QLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQ 82
Query: 65 L----KEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
K + +L+ I + E +L ++ + ++E + M +GLA++H +
Sbjct: 83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE--LCHIAETMARGLAYLHED 140
Query: 120 GYF----------HRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVSTRWYR 165
HRD+K +N+L+ N+ IADFGLA + + V TR Y
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 166 APEVL----LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221
APEVL IDM+A+G +L EL + G + L P
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML---------PFEE 251
Query: 222 AFPEATNISRLISISYSEIL-PINLSDIIPNASMEAIDLIWQLCSW--DPLRRPTADQAL 278
+ ++ + + + P+ +A M + + C W D R +A
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC-WDHDAEARLSAGCVG 310
Query: 279 Q 279
+
Sbjct: 311 E 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 8e-34
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 3 RYKILEELGDGTCGCVYKAFNVE-TYEIVAVKKMK--------RKFYFWEECMNLREVKA 53
+Y++ + G G +Y A + V +K + + E +
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMA--------MAERQF 132
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEY--ME----HNLYHIMRERQIPFSEGEIRSFMS 107
L ++ HP+I+++ V + Y ME +L + E +++
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLL 189
Query: 108 QMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAP 167
++L L+++H G + DLKPEN+++T + LK+ D G ++S + T ++AP
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS---FGYLYGTPGFQAP 246
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS 203
E++ + A D++ VG LA L P G
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 73/303 (24%), Positives = 128/303 (42%), Gaps = 53/303 (17%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF--------YFWEECMNLREVKALR 55
Y++++ +G G G V + T ++ A+K + + +FWEE R++ +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDI--MA 124
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N P +++L +++ L+ + EYM +L ++M E R + ++++ L
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALD 182
Query: 115 HMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEY--VSTRWYRAPEVLL 171
+H G+ HRD+KP+N+L+ LK+ADFG +++ V T Y +PEVL
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 172 Q---SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
Y D W+VG L E+ F DS Y I+ + FP+ +
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYS--KIMNHKNSLTFPDDND 299
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR---PTADQALQHPFFNV 285
IS+ EA +LI + D R ++ +H FF
Sbjct: 300 ISK-----------------------EAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 335
Query: 286 ETW 288
+ W
Sbjct: 336 DQW 338
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 73/307 (23%), Positives = 119/307 (38%), Gaps = 55/307 (17%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF--------YFWEECMNLREVKALR 55
++IL+ +G G V +T ++ A+K M + F EE R+V L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE----RDV--LV 116
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ I +L ++ N L+ + EY L + + + R ++++++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAI 175
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEY--VSTRWYRAPEVL 170
+HR GY HRD+KP+N+L+ +++ADFG +L + V T Y +PE+L
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 171 LQ------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
+ SY P D WA+G E+F F DS + Y I+ + + P
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AETYG--KIVHYKEHLSLP 292
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR---PTADQALQHP 281
EA D I +L P R A HP
Sbjct: 293 LVD----------------------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329
Query: 282 FFNVETW 288
FF W
Sbjct: 330 FFFGLDW 336
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 5 KILEELGDGTCGCVYKA----FNVETYEIVAVKKMK-------RKFYFWEECMNLREVKA 53
K + +LG G G V T +VAVK+++ R F RE++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--------QREIQI 77
Query: 54 LRKLNHPNIIKLKEVVRENNE--LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQML 110
L+ L+ I+K + V L + EY+ L ++ + + + SQ+
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 111 QGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------R 162
+G+ ++ HRDL N+LV + +KIADFGLA+ L Y YV
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--YVVREPGQSPIF 195
Query: 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
WY APE L + +S D+W+ G +L ELFT
Sbjct: 196 WY-APESLSD-NIFSRQSDVWSFGVVLYELFTY 226
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK----------RKFYFWEECMNLREV 51
+RY++ E LG G V+ A ++ + VAVK ++ +F RE
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR--------REA 63
Query: 52 KALRKLNHPNIIKLKEVVRENNEL----FFIFEYME-HNLYHIMRERQIPFSEGEIRSFM 106
+ LNHP I+ + + + + EY++ L I+ P + +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVI 122
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTE---YVST 161
+ Q L H+NG HRD+KP N++++ +K+ DFG+AR ++ S T+ + T
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK 210
Y +PE + S D++++G +L E+ T P F GDS + Y+
Sbjct: 183 AQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 1e-32
Identities = 73/303 (24%), Positives = 124/303 (40%), Gaps = 47/303 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLN 58
M + + +G G G VY +T ++ A+K + +K E + L E L ++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 59 ---HPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
P I+ + ++L FI + M YH+ + FSE ++R + ++++ GL
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 305
Query: 114 AHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
HMH +RDLKP N+L+ ++I+D GLA + S P+ V T Y APEVL +
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQK 364
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID--QLYKVCCILGAPDWTAFPEATNIS 230
+Y + D +++G +L +L F D ++ ++ L
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMA------------ 410
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNV 285
+ + S E L+ L D RR A + + PFF
Sbjct: 411 ----VELPDSF-----------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
Query: 286 ETW 288
W
Sbjct: 456 LDW 458
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 51/307 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF--------YFWEECMNLREVK 52
E ++IL+ +G G G V ++ A+K + + F EE R+V
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE----RDV- 127
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQML 110
L + I L +++N L+ + +Y L + + E R ++++M+
Sbjct: 128 -LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMV 185
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEY--VSTRWYRAP 167
+ +H+ Y HRD+KP+N+L+ + +++ADFG +L V T Y +P
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 168 EVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAF 223
E+L Y P D W++G + E+ F +S + Y I+ + F
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYG--KIMNHKERFQF 302
Query: 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHP 281
P + + S A DLI +L R + + +HP
Sbjct: 303 P----------------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340
Query: 282 FFNVETW 288
FF+ W
Sbjct: 341 FFSGIDW 347
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMK----------RKFYFWEECMNLREVK 52
Y++ +G G G VY+A + IVA+K M + RE +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRM--------QREAR 86
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
+L P+++ + + + +L+ + +L ++R + P + + + Q+
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGS 145
Query: 112 GLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTE---YVSTRWYRAP 167
L H G HRD+KPEN+LV+ +D + DFG+A + T+ V T +Y AP
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAP 204
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS 203
E S + D++A+ +L E T SP + GD
Sbjct: 205 E-RFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRK 56
E +L+ELG G G V + + VAVK +K E M+ +E + + K
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIK------EGSMSEDEFFQEAQTMMK 59
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
L+HP ++K V + ++ + EY+ + L + +R ++ + +G+A
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 116 MHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAP 167
+ + + HRDL N LV + +K++DFG+ R + +YVS+ +W AP
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-AP 174
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTL 195
EV YS D+WA G ++ E+F+L
Sbjct: 175 EVFHY-FKYSSKSDVWAFGILMWEVFSL 201
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKLNHP 60
L+ELG G G V Y+ VA+K +K E M+ + E K + L+H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK------EGSMSEDEFIEEAKVMMNLSHE 79
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
+++L V + +F I EYM + L + +RE + F ++ + + + ++
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVLL 171
+ HRDL N LV V+K++DFGL+R + EY S+ RW PEVL+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLM 194
Query: 172 QSSSYSPAIDMWAVGAILAELFTL 195
S +S D+WA G ++ E+++L
Sbjct: 195 Y-SKFSSKSDIWAFGVLMWEIYSL 217
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN------LREVKALRKLN 58
+ E++G G G V+ +VAVK + E L+E + L++ +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR------ETLPPDLKAKFLQEARILKQYS 170
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
HPNI++L V + ++ + E ++ + +R + + G+ ++
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 118 RNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST--------RWYRAPE 168
HRDL N LVT +VLKI+DFG++RE + Y ++ +W APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWT-APE 285
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
L YS D+W+ G +L E F+L
Sbjct: 286 ALNY-GRYSSESDVWSFGILLWETFSL 311
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
++E+G G G V+ + + + VA+K ++ E M+ + E + + KL
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIR------EGAMSEEDFIEEAEVMMKL 60
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
+HP +++L V E + + E+MEH L +R ++ F+ + + +G+A++
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 117 HRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPE 168
HRDL N LV N V+K++DFG+ R + +Y S+ +W +PE
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPE 175
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
V S YS D+W+ G ++ E+F+
Sbjct: 176 VFSF-SRYSSKSDVWSFGVLMWEVFSE 201
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 5 KILEELGDGTCGCVYKAF---NVETYEI-VAVKKMKRKFYFWEECMN------LREVKAL 54
K ++ LG G G VYK E +I VA+K+++ E L E +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR------EATSPKANKEILDEAYVM 71
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+++P++ +L + + + I + M L +RE + + ++ Q+ +G+
Sbjct: 72 ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 114 AHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST----RWYRAPE 168
++ HRDL N+LV T +KI DFGLA+ L + +W A E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTL 195
+ Y+ D+W+ G + EL T
Sbjct: 190 S-ILHRIYTHQSDVWSYGVTVWELMTF 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 74/304 (24%), Positives = 117/304 (38%), Gaps = 46/304 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLN 58
+ + LG G G V+ T ++ A KK+ +K + E K L K++
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 59 HPNIIKLKEVVRENNELFFIFEYME--HNLYHI--MRERQIPFSEGEIRSFMSQMLQGLA 114
I+ L +L + M YHI + E F E + +Q++ GL
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 115 HMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQ 172
H+H+ +RDLKPEN+L+ +D ++I+D GLA EL + T+ Y T + APE+ L
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL-LL 362
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---IDQLYKVCCILGAPDWTAFPEATNI 229
Y ++D +A+G L E+ F E +L + +L
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--VLEQA----------- 409
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFN 284
P S + D L DP +R + D HP F
Sbjct: 410 ---------VTYPDKFSP-------ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
Query: 285 VETW 288
+W
Sbjct: 454 DISW 457
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 70/308 (22%), Positives = 134/308 (43%), Gaps = 65/308 (21%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREV-------KA 53
++++ ++ LG G+ G V + E+ A+K + + ++ + L+++ +
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
L+ +N P ++KL+ ++N+ L+ + EY+ H+ R + FSE R + +Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVL 152
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT-----EYVSTRWYR 165
++H +RDLKPENLL+ +++ DFG A+ + +T E +
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEAL------ 205
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225
APE+ + S Y+ A+D WA+G ++ E+ P F D I Q+Y+ I+ FP
Sbjct: 206 APEI-ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEK--IVSGK--VRFP- 258
Query: 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQH 280
+ S + DL+ L D +R + H
Sbjct: 259 ------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
Query: 281 PFFNVETW 288
+F W
Sbjct: 295 KWFATTDW 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 45/225 (20%)
Query: 5 KILEELGDGTCGCVYKAFNVETY--EIVAVKKMKR--KFYFWEECMNLREVKALRKLNHP 60
K+LE +G G G VYK + VAVK + F E + + + + H
Sbjct: 16 KLLELIGRGRYGAVYKG----SLDERPVAVKVFSFANRQNFINE----KNIYRVPLMEHD 67
Query: 61 NIIKL-----KEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
NI + + E + EY + +L + + + +GLA
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS--SCRLAHSVTRGLA 125
Query: 115 HMH---------RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY------ 158
++H + HRDL N+LV ND I+DFGL+ L+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 159 ---VSTRWYRAPEVL------LQSSSYSPAIDMWAVGAILAELFT 194
V T Y APEVL S +DM+A+G I E+F
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 5 KILEELGDGTCGCVYKA---FNVETYEIVAVKKMKRKFYFWEECMN------LREVKALR 55
I + +G G G V + VA+K +K L E +
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK------AGYTERQRRDFLSEASIMG 105
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
+ +HPNII+L+ VV + EYME+ +L +R F+ ++ + + G+
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 115 HMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST------RWYRAP 167
++ GY HRDL N+LV +N V K++DFGL+R L P Y +T RW AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWT-AP 223
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTL 195
E + ++S A D+W+ G ++ E+
Sbjct: 224 EAIAF-RTFSSASDVWSFGVVMWEVLAY 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 2 ERYKILEELGDGTCGCVYKA---FNVETYEIVAVKKMKRKFYFWEECMN------LREVK 52
I + +G G G V + VA+K +K L E
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK------VGYTEKQRRDFLGEAS 98
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
+ + +HPNII+L+ VV ++ + + EYME+ +L +R+ F+ ++ + +
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 112 GLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST------RWY 164
G+ ++ GY HRDL N+L+ N V K++DFGL R L P Y + RW
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKIPIRWT 217
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+PE + ++ A D+W+ G +L E+ +
Sbjct: 218 -SPEA-IAYRKFTSASDVWSYGIVLWEVMSY 246
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAF---NVETYEI-VAVKKMKRKFYFWEECMN------LREV 51
+ +G G G VYK + E+ VA+K +K L E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK------AGYTEKQRVDFLGEA 97
Query: 52 KALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQML 110
+ + +H NII+L+ V+ + + I EYME+ L +RE+ FS ++ + +
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 111 QGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST------RW 163
G+ ++ Y HRDL N+LV +N V K++DFGL+R L P Y ++ RW
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRW 216
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
APE + ++ A D+W+ G ++ E+ T
Sbjct: 217 T-APEAISY-RKFTSASDVWSFGIVMWEVMTY 246
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
+ +LG G G VY+ + VAVK +K E+ M L+E ++++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEI 66
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAH 115
HPN+++L V + I E+M + NL +RE + S + +Q+ + +
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 116 MHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAP 167
+ + + HRDL N LV N ++K+ADFGL+R ++ Y + +W AP
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-AP 181
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG 201
E L + +S D+WA G +L E+ T SP +PG
Sbjct: 182 ESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 35/213 (16%), Positives = 80/213 (37%), Gaps = 31/213 (14%)
Query: 5 KILEELGDGTCGCVYKA------FNVETYEI-VAVKKMKRKFYFWEECMN-----LREVK 52
E LG GT ++K + +E V +K + + N
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD------KAHRNYSESFFEAAS 64
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
+ KL+H +++ V +E + E+++ +L +++ + + Q+
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND---------VLKIADFGLARELSSMPPYTEYVSTR 162
+ + N H ++ +N+L+ + +K++D G++ + E +
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--P 182
Query: 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
W PE + + + A D W+ G L E+ +
Sbjct: 183 WV-PPECIENPKNLNLATDKWSFGTTLWEICSG 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 5 KILEELGDGTCGCVYKA--FNVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E +G G GCVY + + +I AVK + R E L E ++ +HPN
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 62 IIKLKEVV-RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ L + R + YM+H +L + +R + ++ F Q+ +G+ ++
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST------RWYRAPEVLLQ 172
+ HRDL N ++ +K+ADFGLAR++ Y+ + T +W A E LQ
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALES-LQ 205
Query: 173 SSSYSPAIDMWAVGAILAELFTL 195
+ ++ D+W+ G +L EL T
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTR 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 69/308 (22%), Positives = 131/308 (42%), Gaps = 65/308 (21%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREV-------KA 53
++ ++IL LG G+ G V+ + A+K +K+ E + L++V
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLM 59
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
L + HP II++ ++ ++F I +Y+E + + ++ F + + +++
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCL 117
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT-----EYVSTRWYR 165
L ++H +RDLKPEN+L+ + +KI DFG A+ + + YT +Y+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCGTPDYI------ 170
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225
APEV + + Y+ +ID W+ G ++ E+ F + + Y+ IL A FP
Sbjct: 171 APEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYE--KILNAE--LRFP- 223
Query: 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQH 280
P + + DL+ +L + D +R + H
Sbjct: 224 ------------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259
Query: 281 PFFNVETW 288
P+F W
Sbjct: 260 PWFKEVVW 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 62/298 (20%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREV-------KALRKLN 58
IL +G G+ G V +T ++ A+K M + ++C+ EV + ++ L
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQIMQGLE 73
Query: 59 HPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
HP ++ L ++ ++F + + + YH+ + F E ++ F+ +++ L ++
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYL 131
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
HRD+KP+N+L+ + I DF +A L T T+ Y APE+
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 176 --YSPAIDMWAVGAILAELFT-LSPIFPGDSE-IDQLYKVCCILGAPDWTAFPEATNISR 231
YS A+D W++G EL P S ++ +P
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTV--VTYP------- 240
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-PTADQALQHPFFNVETW 288
S E + L+ +L +P +R P+ N W
Sbjct: 241 ------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 5 KILEELGDGTCGCVYKAF---NVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
+ L+ LG G G V+K E+ +I V +K ++ K + A+ L+H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
+I++L + + L + +Y+ +L +R+ + + ++ Q+ +G+ ++ +
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST----RWYRAPEVLLQSS 174
G HR+L N+L+ + +++ADFG+A L Y +W A E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALES-IHFG 192
Query: 175 SYSPAIDMWAVGAILAELFTL 195
Y+ D+W+ G + EL T
Sbjct: 193 KYTHQSDVWSYGVTVWELMTF 213
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRKL 57
+ +LG G G VY+ + VAVK +K E+ M L+E ++++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEI 273
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAH 115
HPN+++L V + I E+M + NL +RE S + +Q+ + +
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 116 MHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAP 167
+ + + HR+L N LV N ++K+ADFGL+R ++ Y + +W AP
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-AP 388
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTL 195
E L + +S D+WA G +L E+ T
Sbjct: 389 ESLAY-NKFSIKSDVWAFGVLLWEIATY 415
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 71/368 (19%), Positives = 135/368 (36%), Gaps = 93/368 (25%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL---- 57
RY ++ +LG G V+ +++++ + VA+K +K ++ E + E++ L+ +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL--DEIRLLKSVRNSD 94
Query: 58 -NHPNIIKLKEVVRENNELFFI-----------FEYMEHNLYHIMRE-RQIPFSEGEIRS 104
N PN +E+V + + F I FE + H+L + + ++
Sbjct: 95 PNDPN----REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 105 FMSQMLQGLAHMHR-NGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPY-------- 155
+ Q+LQGL ++H H D+KPEN+L++ + I
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 156 ----------------------------------------TEYVSTRWYRAPEVLLQSSS 175
TE + TR YR+ EVL+ S
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG-SG 269
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPG------DSEIDQLYKVCCILGAP--DWTAFPEAT 227
Y+ D+W+ + EL T +F + D + + +LG + +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 228 -----------NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ 276
+I++L E+L + + D + + P +R TA +
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKY-EWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 277 ALQHPFFN 284
L+HP+ N
Sbjct: 389 CLRHPWLN 396
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 5 KILEELGDGTCGCVYKA-FNVETYEI--VAVKKMKRKFYFWEECMN--------LREVKA 53
++LE+LGDG+ G V + ++ + + VAVK +K + ++ +REV A
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK------PDVLSQPEAMDDFIREVNA 74
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQG 112
+ L+H N+I+L VV + + E +L +R+ Q F G + + Q+ +G
Sbjct: 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 113 LAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RWY 164
+ ++ + HRDL NLL+ T D++KI DFGL R L + YV W
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 191
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
APE L ++S A D W G L E+FT
Sbjct: 192 -APESLKT-RTFSHASDTWMFGVTLWEMFTY 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 71/306 (23%), Positives = 138/306 (45%), Gaps = 56/306 (18%)
Query: 1 MERYKILEELGDGTCGCVY---KAFNVETYEIVAVKKMKRKFYFW---EECMNLREVKAL 54
++++L+ LG G+ G V+ K + ++ A+K +K+ R++ L
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--L 80
Query: 55 RKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQG 112
++NHP I+KL + +L+ I +++ + +E F+E +++ +++++
Sbjct: 81 VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALA 138
Query: 113 LAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVS---TRWYRAPE 168
L H+H G +RDLKPEN+L+ + +K+ DFGL++E S+ + S T Y APE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPE 196
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
V+ + ++ + D W+ G ++ E+ T + F G +
Sbjct: 197 VVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMT------------------ 236
Query: 229 ISRLISISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQALQ-HPF 282
I +++ +P LS EA L+ L +P R P + ++ H F
Sbjct: 237 -----MILKAKLGMPQFLSP-------EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
Query: 283 FNVETW 288
F+ W
Sbjct: 285 FSTIDW 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKLN 58
+ K+L+ +G G G V VAVK +K + L E + +L
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIK------NDATAQAFLAEASVMTQLR 72
Query: 59 HPNIIKLKEVV-RENNELFFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAH 115
H N+++L V+ E L+ + EYM +L +R R + F + + + +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 116 MHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAP 167
+ N + HRDL N+LV+ ++V K++DFGL +E + +W AP
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWT-AP 183
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTL 195
E L + +S D+W+ G +L E+++
Sbjct: 184 EALRE-KKFSTKSDVWSFGILLWEIYSF 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 50/302 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRKL 57
M + L+ LG GT G V T A+K ++++ + + E + L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNT 62
Query: 58 NHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
HP + LK + ++ L F+ EY +H+ RER F+E R + ++++ L +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEY 120
Query: 116 MHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS---TRWYRAPEVLL 171
+H +RD+K ENL++ D +KI DFGL +E + + T Y APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE 178
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ Y A+D W +G ++ E+ F ++L++ IL
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFE--LILMEE------------- 221
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNVE 286
I + P LS EA L+ L DP +R A + ++H FF
Sbjct: 222 ---IRF----PRTLSP-------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
Query: 287 TW 288
W
Sbjct: 268 NW 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMN------LRE 50
ER ++ +G+G G V++ N VA+K K + L+E
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALA--VAIKTCK------NCTSDSVREKFLQE 66
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQM 109
+R+ +HP+I+KL V+ EN ++ I E L ++ R+ + + Q+
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 110 LQGLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST------- 161
LA++ + HRD+ N+LV +ND +K+ DFGL+R + + Y
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STYYKASKGKLPI 181
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+W APE + ++ A D+W G + E+
Sbjct: 182 KWM-APES-INFRRFTSASDVWMFGVCMWEILMH 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAF--NVETYEI-VAVKKMKRKFYFWEECMN------LREVK 52
E + LG+G G VY+ N + +I VAVK K ++C + E
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK------KDCTLDNKEKFMSEAV 65
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
++ L+HP+I+KL ++ E + I E + L H + + + + Q+ +
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 112 GLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RW 163
+A++ HRD+ N+LV + + +K+ DFGL+R + +Y +W
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED----EDYYKASVTRLPIKW 180
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+PE + ++ A D+W + E+ +
Sbjct: 181 M-SPES-INFRRFTTASDVWMFAVCMWEILSF 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMN-----LREV 51
+ ELG+G G V+ A + +VAVK +K + + RE
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK------DPTLAARKDFQREA 68
Query: 52 KALRKLNHPNIIKLKEVVRENNELFFIFEYMEH----------------NLYHIMRERQI 95
+ L L H +I+K V + + L +FEYM+H + R+ +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 96 PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154
++ SQ+ G+ ++ + HRDL N LV + ++KI DFG++R++ S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 155 YTEYVST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
Y T RW PE ++ ++ D+W+ G IL E+FT
Sbjct: 189 YRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTY 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 5 KILEELGDGTCGCVYKAF---NVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
K ++ LG G G VYK E +I VA+K+++ L E + +++P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ +L + + + I + M L +RE + + ++ Q+ +G+ ++
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST----RWYRAPEVLLQSS 174
HRDL N+LV T +KI DFGLA+ L + +W A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALES-ILHR 194
Query: 175 SYSPAIDMWAVGAILAELFTL 195
Y+ D+W+ G + EL T
Sbjct: 195 IYTHQSDVWSYGVTVWELMTF 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 68/308 (22%)
Query: 1 MERYKILEELGDGTCGCVY---KAFNVETYEIVAVKKMKRKFYFWE----ECMNLREVKA 53
E +++L LG G G V+ K T +I A+K +K+ E
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNI 74
Query: 54 LRKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
L ++ HP I+ L + +L+ I EY+ + RE F E +++++
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISM 132
Query: 112 GLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPP----YT-----EYVST 161
L H+H+ G +RDLKPEN+++ + +K+ DFGL +E S+ +T EY+
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYM-- 188
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221
APE+L++ S ++ A+D W++GA++ ++ T +P F G++ +
Sbjct: 189 ----APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTID----------- 231
Query: 222 AFPEATNISRLISISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQ 276
I ++ LP L+ EA DL+ +L + R P
Sbjct: 232 ------------KILKCKLNLPPYLTQ-------EARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 277 ALQ-HPFF 283
+Q HPFF
Sbjct: 273 EVQAHPFF 280
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 5 KILEELGDGTCGCVYKAF---NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+G G G VY + A+K + R + LRE +R LNHPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 62 IIKLKEVV-RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ L ++ + YM H +L +R Q + ++ SF Q+ +G+ ++
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST------RWYRAPEVLLQ 172
+ HRDL N ++ + +K+ADFGLAR++ Y+ +W A E LQ
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALES-LQ 201
Query: 173 SSSYSPAIDMWAVGAILAELFTL 195
+ ++ D+W+ G +L EL T
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTR 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 9 ELGDGTCGCVYKA-FNVETYEI-VAVKKMKRKFYFWEECMN------LREVKALRKLNHP 60
ELG G G V + + + +I VA+K +K + +RE + + +L++P
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK------QGTEKADTEEMMREAQIMHQLDNP 70
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
I++L V + L + E L+ + ++ + + Q+ G+ ++
Sbjct: 71 YIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 120 GYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVLL 171
+ HRDL N+L+ KI+DFGL++ L + Y Y + +WY APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWY-APEC-I 185
Query: 172 QSSSYSPAIDMWAVGAILAELFTL 195
+S D+W+ G + E +
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSY 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 9 ELGDGTCGCVYKA-FNVETYEI-VAVKKMKRKFYFWEECMN-------LREVKALRKLNH 59
ELG G G V K + ++ VAVK +K E + L E +++L++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK------NEANDPALKDELLAEANVMQQLDN 77
Query: 60 PNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
P I+++ + E + E E L +++ + + I + Q+ G+ ++
Sbjct: 78 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE 135
Query: 119 NGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVL 170
+ + HRDL N+L+ T KI+DFGL++ L + Y Y + +WY APE +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWY-APECI 192
Query: 171 LQSSSYSPAIDMWAVGAILAELFTL 195
+S D+W+ G ++ E F+
Sbjct: 193 NY-YKFSSKSDVWSFGVLMWEAFSY 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 49/297 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRKL 57
M ++ L+ LG GT G V T A+K +K++ + L E + L+
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNS 205
Query: 58 NHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
HP + LK + ++ L F+ EY +H+ RER FSE R + ++++ L +
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDY 263
Query: 116 MH-RNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTE-YVSTRWYRAPEVLLQ 172
+H +RDLK ENL++ D +KI DFGL +E + + T Y APEVL
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
+ Y A+D W +G ++ E+ F ++L++
Sbjct: 324 ND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFE---------------------- 359
Query: 233 ISISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PT-ADQALQHPFF 283
I EI P L EA L+ L DP +R A + +QH FF
Sbjct: 360 -LILMEEIRFPRTLGP-------EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 2 ERYKILEELGDGTCGCVYKA--FNVETYEI-VAVKKMKRKFYFWEECMN-LREVKALRKL 57
+ + LG+G G V + + + VAVK MK E L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 58 NHPNIIKLKEVV-----RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR-----SFM 106
+HPN+I+L V + + I +M++ +L+ + ++ I FM
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST---- 161
+ G+ ++ + HRDL N ++ + + +ADFGL++++ S Y +
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+W A E L Y+ D+WA G + E+ T
Sbjct: 214 KWI-AIES-LADRVYTSKSDVWAFGVTMWEIATR 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 5 KILEELGDGTCGCVYKA--FNVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E +G G GCVY + + +I AVK + R E L E ++ +HPN
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 62 IIKLKEVV-RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ L + R + YM+H +L + +R + ++ F Q+ +G+ +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST------RWYRAPEVLLQ 172
+ HRDL N ++ +K+ADFGLAR++ + + T +W A E LQ
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALES-LQ 269
Query: 173 SSSYSPAIDMWAVGAILAELFTL 195
+ ++ D+W+ G +L EL T
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTR 292
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN---LREVKALRKL 57
+ K+L+ +G G G V + VAVK +K + L E + +L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK---VAVKCIK------NDATAQAFLAEASVMTQL 243
Query: 58 NHPNIIKLKEVVRENNELFFI-FEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLA 114
H N+++L V+ E +I EYM +L +R R + F + + +
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST----RWYRAPEV 169
++ N + HRDL N+LV+ ++V K++DFGL +E + + +W APE
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWT-APEA 357
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTL 195
L + +S D+W+ G +L E+++
Sbjct: 358 LRE-KKFSTKSDVWSFGILLWEIYSF 382
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAF---NVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKL 57
+++ + LG G G V +A ++ VAVK +K + LRE +++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 58 NHPNIIKL------KEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR-----SF 105
+HP++ KL I +M+H +L+ + +I + + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 106 MSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST--- 161
M + G+ ++ + HRDL N ++ + + +ADFGL+R++ S Y + ++
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 162 -RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPG 201
+W A E L + Y+ D+WA G + E+ T +P + G
Sbjct: 203 VKWL-ALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAG 242
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 30/209 (14%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRK 56
E K++E LG G G V+ +N T VAVK +K + M+ L E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLK------QGSMSPDAFLAEANLMKQ 64
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLA 114
L H +++L VV + ++ I EYME+ +L ++ I + ++ +Q+ +G+A
Sbjct: 65 LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRA 166
+ Y HRDL+ N+LV+ KIADFGLAR + EY + +W A
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED----NEYTAREGAKFPIKWT-A 178
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTL 195
PE + +++ D+W+ G +L E+ T
Sbjct: 179 PEAINY-GTFTIKSDVWSFGILLTEIVTH 206
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 2 ERYKILEELGDGTCGCVYKA--FNVETYEI-VAVKKMKRKFYFWEECMN------LREVK 52
ER ++ +G+G G V++ + E + VA+K K + L+E
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK------NCTSDSVREKFLQEAL 443
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
+R+ +HP+I+KL V+ EN ++ I E L ++ R+ + + Q+
Sbjct: 444 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 112 GLAHMHRNGYFHRDLKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RW 163
LA++ + HRD+ N+LV +ND +K+ DFGL+R + + Y +W
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STYYKASKGKLPIKW 558
Query: 164 YRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
APE + ++ A D+W G + E+
Sbjct: 559 M-APES-INFRRFTSASDVWMFGVCMWEILMH 588
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 9 ELGDGTCGCVYKA-FNVETYEI-VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLK 66
ELG G G V + + + +I VA+K +K+ + +RE + + +L++P I++L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 67 EVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRD 125
V + L + E L+ + ++ + + Q+ G+ ++ + HR+
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 126 LKPENLLV-TNDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVLLQSSSYS 177
L N+L+ KI+DFGL++ L + Y Y + +WY APE + +S
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWY-APEC-INFRKFS 517
Query: 178 PAIDMWAVGAILAELFTL 195
D+W+ G + E +
Sbjct: 518 SRSDVWSYGVTMWEALSY 535
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
E+ + ELG G+ G VY+ E VA+K + E L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER---------QIPFSEGEIRSFM 106
N ++++L VV + I E M +L +R P S ++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE--YVST-- 161
++ G+A+++ N + HRDL N +V D +KI DFG+ R++ Y Y
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKGGK 199
Query: 162 -----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
RW +PE L ++ D+W+ G +L E+ TL
Sbjct: 200 GLLPVRWM-SPESLKD-GVFTTYSDVWSFGVVLWEIATL 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+ ++ LG G G VY+ N + VAVK + +E L E + K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ------IPFSEGEIRSFMSQM 109
NH NI++ V ++ F + E M +L +RE + + ++ +
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYTEYVST---- 161
G ++ N + HRD+ N L+T V KI DFG+AR++ Y +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+W PE ++ ++ D W+ G +L E+F+L
Sbjct: 210 KWM-PPEAFME-GIFTSKTDTWSFGVLLWEIFSL 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 32/212 (15%), Positives = 61/212 (28%), Gaps = 38/212 (17%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY----FWEECMNLREVKALRKLN 58
RY++L G ++A + VA+ + + +E L L +++
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQET--LSRTLRLSRID 89
Query: 59 HPNIIKLKEVVRENNELFFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
P + ++ +VV + E++ +L + P M + H
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAH 146
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
R G P + V+ D + +A
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------- 179
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQL 208
+P D+ +GA L L P L
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMN-----LREV 51
+ ELG+G G V+ A + +VAVK +K E + RE
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREA 94
Query: 52 KALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER--------------QIP 96
+ L L H +I++ V E L +FEYM H +L +R P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 97 FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY 155
G++ + SQ+ G+ ++ + HRDL N LV V+KI DFG++R++ S Y
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 156 TEYVST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
T RW PE +L ++ D+W+ G +L E+FT
Sbjct: 215 RVGGRTMLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTY 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/311 (24%), Positives = 140/311 (45%), Gaps = 56/311 (18%)
Query: 1 MERYKILEELGDGTCGCVY---KAFNVETYEIVAVKKMKRKFYFWE----EC-MNLREVK 52
+E +++L+ LG G G V+ K +T ++ A+K +K+ + E R+V
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 53 ALRKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQML 110
+ P ++ L + +L I +Y+ H+ + + F+E E++ ++ +++
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIV 169
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTNDV-LKIADFGLARELSSMPPYTEYVS----TRWYR 165
L H+H+ G +RD+K EN+L+ ++ + + DFGL++E + TE T Y
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIEYM 227
Query: 166 APEVLLQSSS-YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
AP+++ S + A+D W++G ++ EL T GA +T
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLT---------------------GASPFTVDG 266
Query: 225 EATNISRLI-SISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PT-ADQA 277
E + + + I SE P +S A DLI +L DP +R P AD+
Sbjct: 267 EKNSQAEISRRILKSEPPYPQEMSA-------LAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 278 LQHPFFNVETW 288
+H FF W
Sbjct: 320 KEHLFFQKINW 330
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 72/304 (23%), Positives = 134/304 (44%), Gaps = 63/304 (20%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKAL-RK 56
+ + L LG G+ G V + T E+ AVK +K+ + EC + E + L
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALP 77
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
P + +L + + L+F+ EY+ +YHI + + F E + +++ GL
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLF 135
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YT-----EYVSTRWY 164
+ G +RDLK +N+++ ++ +KIADFG+ +E ++ T +Y+
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYI----- 188
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
APE++ Y ++D WA G +L E+ F G+ E D+L++ I+
Sbjct: 189 -APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ--SIMEHN------ 237
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQALQ- 279
++Y P ++S EA+ + L + P +R P ++ ++
Sbjct: 238 ----------VAY----PKSMSK-------EAVAICKGLMTKHPGKRLGCGPEGERDIKE 276
Query: 280 HPFF 283
H FF
Sbjct: 277 HAFF 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 30/209 (14%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMN----LREVKALRK 56
E K+ ++LG G G V+ A +N T VAVK MK M+ L E ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMK------PGSMSVEAFLAEANVMKT 239
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLA 114
L H ++KL VV + ++ I E+M +L ++ + ++ F +Q+ +G+A
Sbjct: 240 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 115 HMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRA 166
+ + Y HRDL+ N+LV+ + V KIADFGLAR + EY + +W A
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWT-A 353
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTL 195
PE + S++ D+W+ G +L E+ T
Sbjct: 354 PEAINF-GSFTIKSDVWSFGILLMEIVTY 381
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMN------LRE 50
+ +EELG+ G VYK E + VA+K +K ++ E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK------DKAEGPLREEFRHE 62
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI-------------- 95
+L HPN++ L VV ++ L IF Y H +L+ + R
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 96 -PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153
+ ++Q+ G+ ++ + H+DL N+LV + +KI+D GL RE+ +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 154 PYTEYVST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
Y ++ RW APE ++ +S D+W+ G +L E+F+
Sbjct: 183 YYKLLGNSLLPIRWM-APEAIMY-GKFSIDSDIWSYGVVLWEVFSY 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+ ++ LG G G VY+ N + VAVK + +E L E + K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ------IPFSEGEIRSFMSQM 109
NH NI++ V ++ F + E M +L +RE + + ++ +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 110 LQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYTEYVST---- 161
G ++ N + HRD+ N L+T V KI DFG+AR++ Y +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 162 RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+W PE ++ ++ D W+ G +L E+F+L
Sbjct: 251 KWM-PPEAFME-GIFTSKTDTWSFGVLLWEIFSL 282
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 55/289 (19%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---EC-MNLREVKALRKLNHPNIIKL 65
LG G+ G V+ A +T + A+K +K+ + EC M + V +L HP + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHPFLTHM 83
Query: 66 KEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFH 123
+ LFF+ EY+ +YHI + F + ++++ GL +H G +
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVY 141
Query: 124 RDLKPENLLVTND-VLKIADFGLARELSSMPPYT-------EYVSTRWYRAPEVLLQSSS 175
RDLK +N+L+ D +KIADFG+ +E T +Y+ APE+LL
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI------APEILLG-QK 194
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
Y+ ++D W+ G +L E+ F G E ++L+ I
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFH--SIRMDN----------------P 235
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ-HPFF 283
Y P L EA DL+ +L +P +R ++ HP F
Sbjct: 236 FY----PRWLEK-------EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
E ++ +LG G G V+ +N T VA+K +K E L+E + ++KL H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAF--LQEAQVMKKLRHE 239
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPF-SEGEIRSFMSQMLQGLAHMHR 118
+++L VV E ++ + EYM +L ++ + ++ +Q+ G+A++ R
Sbjct: 240 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 119 NGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVL 170
Y HRDL+ N+LV N V K+ADFGLAR + EY + +W APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWT-APEAA 353
Query: 171 LQSSSYSPAIDMWAVGAILAELFTL 195
L ++ D+W+ G +L EL T
Sbjct: 354 LY-GRFTIKSDVWSFGILLTELTTK 377
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 72/313 (23%), Positives = 128/313 (40%), Gaps = 72/313 (23%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKA------- 53
+ L+ +G G+ G V A + AVK +++K + +E K
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA-----ILKKKEEKHIMSERNV 91
Query: 54 -LRKLNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQML 110
L+ + HP ++ L + ++L+F+ +Y+ YH+ RER F E R + +++
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIA 149
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YT-----EYVS 160
L ++H +RDLKPEN+L+ + + + DFGL +E ++ T EY+
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYL- 206
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDW 220
APEVL + Y +D W +GA+L E+ P F + ++Y
Sbjct: 207 -----APEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYD---------- 249
Query: 221 TAFPEATNISRLISISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTAD 275
+I + L N+++ A L+ L D +R
Sbjct: 250 -------------NILNKPLQLKPNITN-------SARHLLEGLLQKDRTKRLGAKDDFM 289
Query: 276 QALQHPFFNVETW 288
+ H FF++ W
Sbjct: 290 EIKSHVFFSLINW 302
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 77/305 (25%), Positives = 138/305 (45%), Gaps = 64/305 (20%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRK- 56
++ ++ + LG G+ G V A ET ++ AVK +K+ + EC + E + L
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLA 80
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
NHP + +L + + LFF+ E++ ++HI + R+ F E R + ++++ L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALM 138
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YT-----EYVSTRWY 164
+H G +RDLK +N+L+ ++ K+ADFG+ +E + T +Y+
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYI----- 191
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
APE+L + Y PA+D WA+G +L E+ F ++E D L++ IL
Sbjct: 192 -APEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFE--AILNDE------ 240
Query: 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQ 279
+ Y P L + +A ++ + +P R + A+
Sbjct: 241 ----------VVY----PTWLHE-------DATGILKSFMTKNPTMRLGSLTQGGEHAIL 279
Query: 280 -HPFF 283
HPFF
Sbjct: 280 RHPFF 284
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 38/242 (15%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
R + LG G G V +A + VAVK +K + E + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 57 L-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER-----------------QIPF 97
L NH NI+ L I EY + +L + +R + ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 98 SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156
++ SF Q+ +G+A + HRDL N+L+T+ + KI DFGLAR++ + Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 157 EYVST----RWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQL 208
+ +W APE + + S D+W+ G L ELF+L SP +PG +
Sbjct: 203 VKGNARLPVKWM-APESIFNCVYTFES---DVWSYGIFLWELFSLGSSP-YPGMPVDSKF 257
Query: 209 YK 210
YK
Sbjct: 258 YK 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+ + LG G G V +A + VAVK +K + E+ + E+K +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 57 L-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER-------------QIPFSEGE 101
L H NI+ L + I EY + +L + +R + S +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 102 IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160
+ F SQ+ QG+A + HRD+ N+L+TN V KI DFGLAR++ + Y+
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIV 222
Query: 161 T-------RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQLYK 210
+W APE + Y+ D+W+ G +L E+F+L +P +PG + YK
Sbjct: 223 KGNARLPVKWM-APESIFD-CVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYK 278
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 2 ERYKILEELGDGTCGCVYKA-FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
E ++ +LG G G V+ +N T VA+K +K E L+E + ++KL H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAF--LQEAQVMKKLRHE 322
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPF-SEGEIRSFMSQMLQGLAHMHR 118
+++L VV E ++ + EYM +L ++ + ++ +Q+ G+A++ R
Sbjct: 323 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 119 NGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPYTEYVST-------RWYRAPEVL 170
Y HRDL+ N+LV N V K+ADFGLAR + EY + +W APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWT-APEAA 436
Query: 171 LQSSSYSPAIDMWAVGAILAELFTL 195
L ++ D+W+ G +L EL T
Sbjct: 437 LY-GRFTIKSDVWSFGILLTELTTK 460
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 51/298 (17%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKAL-RK 56
+ + L LG G+ G V + T E+ AVK +K+ + EC + E + L
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALP 398
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
P + +L + + L+F+ EY+ +YHI + + F E + +++ GL
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLF 456
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS---TRWYRAPEVL 170
+ G +RDLK +N+++ ++ +KIADFG+ +E ++ + T Y APE++
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEII 514
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
Y ++D WA G +L E+ F G+ E D+L++ I+
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ--SIMEHN------------ 558
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFF 283
++Y P ++S EA+ + L + P +R +H FF
Sbjct: 559 ----VAY----PKSMSK-------EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 33/239 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+R K+ + LG G G V +A T VAVK +K E + E+K L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57 L-NHPNIIKLKEVV-RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR---------- 103
+ +H N++ L + L I E+ + NL +R ++ F ++
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 104 -----SFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157
+ Q+ +G+ + HRDL N+L++ V+KI DFGLAR++ P Y
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 158 YVST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--SPIFPGDSEIDQLYK 210
+W APE + Y+ D+W+ G +L E+F+L SP +PG ++ +
Sbjct: 207 KGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCR 262
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 57/245 (23%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMN------LRE 50
+ + + LG+G G V KA Y VAVK +K E L E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------ENASPSELRDLLSE 76
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER---------------- 93
L+++NHP++IKL ++ L I EY ++ +L +RE
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 94 -------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145
+ + G++ SF Q+ QG+ ++ HRDL N+LV +KI+DFGL
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 146 ARELSSMPPYTEYVST-------RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL--S 196
+R++ YV +W A E L Y+ D+W+ G +L E+ TL +
Sbjct: 197 SRDVYEED---SYVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 197 PIFPG 201
P +PG
Sbjct: 252 P-YPG 255
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 2 ERYKILEELGDGTCGCVYKAF--NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-N 58
K + +G+G G V KA A+K+MK + E++ L KL +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR-------------- 103
HPNII L L+ EY H NL +R+ ++ ++
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 104 -SFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVST 161
F + + +G+ ++ + + HRDL N+LV + V KIADFGL+R YV
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKK 198
Query: 162 -------RWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTL 195
RW A E L S ++ S D+W+ G +L E+ +L
Sbjct: 199 TMGRLPVRWM-AIESLNYSVYTTNS---DVWSYGVLLWEIVSL 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 47/301 (15%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRK- 56
++ + +L +G G+ V +T I A+K +K++ + + + E +
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQA 66
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
NHP ++ L + + LFF+ EY+ ++H+ R+R+ E R + +++ L
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALN 124
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS---TRWYRAPEVL 170
++H G +RDLK +N+L+ ++ +K+ D+G+ +E + P + T Y APE+L
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEIL 182
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
Y ++D WA+G ++ E+ F D
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------------QNTED 225
Query: 231 RLI-SISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQA--LQHPF 282
L I +I +P +LS +A ++ + DP R P A HPF
Sbjct: 226 YLFQVILEKQIRIPRSLSV-------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
Query: 283 F 283
F
Sbjct: 279 F 279
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 58/239 (24%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMN------LRE 50
+ + ++G+G G V++A E + +VAVK +K EE RE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK------EEASADMQADFQRE 100
Query: 51 VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER---------------- 93
+ + ++PNI+KL V + +FEYM + +L +R
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 94 -------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145
P S E Q+ G+A++ + HRDL N LV + V+KIADFGL
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 146 ARELSSMPPYTE--YVST-------RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+R + Y+ Y + RW PE + + Y+ D+WA G +L E+F+
Sbjct: 221 SRNI-----YSADYYKADGNDAIPIRWM-PPESIFY-NRYTTESDVWAYGVVLWEIFSY 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 71/258 (27%), Positives = 112/258 (43%), Gaps = 65/258 (25%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMN------LRE 50
E + + LG G G V A VAVK +K E+ + + E
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK------EKADSSEREALMSE 98
Query: 51 VKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR----- 103
+K + +L +H NI+ L + ++ IFEY + +L + +R ++ FSE EI
Sbjct: 99 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 104 -----------------SFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145
F Q+ +G+ + HRDL N+LVT+ V+KI DFGL
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 146 ARELSSMPPYTE--YVST-------RWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFT 194
AR++ ++ YV +W APE L + + S D+W+ G +L E+F+
Sbjct: 219 ARDI-----MSDSNYVVRGNARLPVKWM-APESLFEGIYTIKS---DVWSYGILLWEIFS 269
Query: 195 L--SPIFPGDSEIDQLYK 210
L +P +PG YK
Sbjct: 270 LGVNP-YPGIPVDANFYK 286
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 2 ERYKILEELGDGTCGCVYKA-------FNVETYEIVAVKKMKRKFYFWEECMNLREVKAL 54
++ + + LG+G G V A + VAVK +K + + E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 55 RKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER---------------QIPF 97
+ + H NII L ++ L+ I EY NL +R R +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98 SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156
+ ++ S Q+ +G+ ++ HRDL N+LVT + V+KIADFGLAR+++++ Y
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+ + +W APE L Y+ D+W+ G ++ E+FTL
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFTL 255
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 67/307 (21%), Positives = 127/307 (41%), Gaps = 59/307 (19%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE---ECMNLREVKALRK- 56
++ + +L +G G+ V +T I A++ +K++ + + + E +
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQA 109
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
NHP ++ L + + LFF+ EY+ ++H+ R+R+ E R + +++ L
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALN 167
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YT-----EYVSTRWY 164
++H G +RDLK +N+L+ ++ +K+ D+G+ +E + P T Y+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYI----- 220
Query: 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224
APE+L Y ++D WA+G ++ E+ F D
Sbjct: 221 -APEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------------- 263
Query: 225 EATNISRLI-SISYSEI-LPINLSDIIPNASMEAIDLIWQLCSWDPLRR----PTADQA- 277
L I +I +P +LS +A ++ + DP R P A
Sbjct: 264 -QNTEDYLFQVILEKQIRIPRSLSV-------KAASVLKSFLNKDPKERLGCHPQTGFAD 315
Query: 278 -LQHPFF 283
HPFF
Sbjct: 316 IQGHPFF 322
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 43/229 (18%)
Query: 2 ERYKILEELGDGTCGCVYKA-------FNVETYEIVAVKKMKRKFYFWEECMN------L 48
+R + + LG+G G V A VAVK +K + +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK------SDATEKDLSDLI 122
Query: 49 REVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIR--- 103
E++ ++ + H NII L ++ L+ I EY NL ++ R+ P E
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 104 ------------SFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150
S Q+ +G+ ++ HRDL N+LVT D V+KIADFGLAR++
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 151 SMPPYTEYVST----RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
+ Y + + +W APE L Y+ D+W+ G +L E+FTL
Sbjct: 243 HIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFTL 289
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 53/234 (22%)
Query: 2 ERYKILEELGDGTCGCVYKA-------FNVETYEIVAVKKMKRKFYFWEECMN------L 48
++ + + LG+G G V A + VAVK +K ++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK------DDATEKDLSDLV 134
Query: 49 REVKALRKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER------------- 93
E++ ++ + H NII L ++ L+ I EY NL +R R
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 94 --QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150
+ + ++ S Q+ +G+ ++ HRDL N+LVT + V+KIADFGLAR++
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI- 253
Query: 151 SMPPYTE--YVST-------RWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
Y T +W APE L Y+ D+W+ G ++ E+FTL
Sbjct: 254 ----NNIDYYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFTL 301
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 8/152 (5%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-P 60
RY++ ++G G+ G +Y ++ E VA+K K + E K + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGV 65
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I ++ E + + E + +L + FS + QM+ + ++H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 121 YFHRDLKPENLLV----TNDVLKIADFGLARE 148
+ HRD+KP+N L+ +++ I DFGLA++
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 34/153 (22%), Positives = 64/153 (41%), Gaps = 10/153 (6%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPN 61
+++ +++G G G + N+ T E VA+K K E + ++L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDG 66
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
I ++ + E + +L + FS + Q++ + ++H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 122 FHRDLKPENLLV------TNDVLKIADFGLARE 148
+RD+KPEN L+ T V+ I DF LA+E
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 8/152 (5%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HP 60
++++ ++G G+ G +Y N++T E VA+K K + L E K R L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGT 63
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I ++ E + + + + +L + S + QM+ + +H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 121 YFHRDLKPENLLV----TNDVLKIADFGLARE 148
+ HRD+KP+N L+ + + I DFGLA++
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 30/154 (19%), Positives = 65/154 (42%), Gaps = 10/154 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHP 60
YK+ +G+G+ G +++ N+ + VA+K R+ + E + + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 66
Query: 61 NIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I + +E + + + +L ++ FS + QML + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 121 YFHRDLKPENLLV------TNDVLKIADFGLARE 148
+RD+KP+N L+ +++ + DFG+ +
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (214), Expect = 4e-19
Identities = 46/276 (16%), Positives = 87/276 (31%), Gaps = 63/276 (22%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKK-------------MKRKFYFWEECMNL 48
E+ + E++G+G G V++ + VA+K K E +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 49 REVKALRKL---NHPNIIKLKEV------------------------------VRENNEL 75
+E+ L I L V ++++L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVT 134
F + E E + + R S +S + Q+ LA + + HRDL N+L+
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 135 NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194
LK + L + S++P VS Y + ++
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS------------RLERDGIVVFCDVSM 244
Query: 195 LSPIFPGDSEID-QLYKVCCILGAPDWTAFPEATNI 229
+F GD + +Y++ W + +N+
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNV 280
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 38/169 (22%), Positives = 72/169 (42%), Gaps = 27/169 (15%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHPN 61
++ + +++G G G +Y AF E A +K ++ +E L E+K +++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY---QENGPLFSELKFYQRVAKKD 94
Query: 62 IIKLKEVVRENNEL-------------------FFIFEYMEHNLYHIMRERQIPFSEGEI 102
IK ++ + L F + E + +L I + F + +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTV 153
Query: 103 RSFMSQMLQGLAHMHRNGYFHRDLKPENLLV---TNDVLKIADFGLARE 148
+ML L ++H N Y H D+K NLL+ D + +AD+GL+
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 27/170 (15%), Positives = 59/170 (34%), Gaps = 24/170 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETY--------EIVAVK--------KMKRKFYFWE-E 44
++K+ G +Y+A T + ++K ++ F+ +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 45 CMNLREVKALRKLNHPNIIKLKEV-VRENNELFFIFEYMEHNLYHIMRE--RQIPFSEGE 101
+ + + K L I V ++ F + + +L + + SE
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH-VLSERS 160
Query: 102 IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV---TNDVLKIADFGLARE 148
+ ++L L +H N Y H ++ EN+ V + +A +G A
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 44/184 (23%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMK-------RKFYFWEECMNLREVKALRKLNHPNI 62
+G G G VYK + VA+K+ +F E++ L HP++
Sbjct: 47 IGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF--------ETEIETLSFCRHPHL 97
Query: 63 IKLKEVVRENNELFFIFEYMEH-NL-YHIMRERQIPFSEGEIRSFMS--QML-------Q 111
+ L E NE+ I++YME+ NL H+ + MS Q L +
Sbjct: 98 VSLIGFCDERNEMILIYKYMENGNLKRHL-------YGSDLPTMSMSWEQRLEICIGAAR 150
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE-YVSTRW-----Y 164
GL ++H HRD+K N+L+ + V KI DFG+++ + ++ST Y
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLSTVVKGTLGY 207
Query: 165 RAPE 168
PE
Sbjct: 208 IDPE 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 24/175 (13%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-----WEECMNLREVKALRKLNHPNIIK 64
+G+G G VYK + T VAVKK+ ++ E+K + K H N+++
Sbjct: 39 MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQ--EIKVMAKCQHENLVE 94
Query: 65 LKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQML---QGLAHMHRN 119
L + ++L ++ YM + L + P +R G+ +H N
Sbjct: 95 LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR--CKIAQGAANGINFLHEN 152
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRW-----YRAPE 168
+ HRD+K N+L+ KI+DFGLAR +++R Y APE
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAYMAPE 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 38/177 (21%), Positives = 62/177 (35%), Gaps = 40/177 (22%)
Query: 3 RYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRK----FYFWEECMNLREVKA 53
+K+ +G G GC+Y A +V + VK F E+K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT---------ELKF 86
Query: 54 LRKLNHPNIIKLKEVVRENNEL-------------------FFIFEYMEHNLYHIMRERQ 94
++ P I+ R+ L F I + +L I
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 95 IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV---TNDVLKIADFGLARE 148
FS + ++L L ++H + Y H D+K NLL+ D + + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 33/180 (18%)
Query: 10 LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV 69
LG G G VYK + +VAVK++K + E EV+ + H N+++L+
Sbjct: 38 LGRGGFGKVYKG-RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 70 RENNELFFIFEYMEHN-LYHIMRER---QIPFS--------EGEIRSFMSQMLQGLAHMH 117
E ++ YM + + +RER Q P G R GLA++H
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAYLH 148
Query: 118 RNGY---FHRDLKPENLLVTNDVL-KIADFGLARELSSMPPYTEYVSTRW-----YRAPE 168
+ HRD+K N+L+ + + DFGLA+ M +V+T + APE
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL---MDYKDTHVTTAVRGTIGHIAPE 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 10/137 (7%)
Query: 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139
+ + + + Q+ +G+ + HRDL N+L++ V+K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 140 IADFGLARELSSMPPYTEYVSTR----WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL 195
I DFGLAR++ P Y R W APE + Y+ D+W+ G +L E+F+L
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFSL 291
Query: 196 --SPIFPGDSEIDQLYK 210
SP +PG ++ +
Sbjct: 292 GASP-YPGVKIDEEFCR 307
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 35/170 (20%), Positives = 62/170 (36%), Gaps = 13/170 (7%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+R K+ + LG G G V +A T VAVK +K E + E+K L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 57 L-NHPNIIKLKEVV-RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ +H N++ L + L I E+ + NL +R ++ F + ++ +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-----YKTKGARFR 136
Query: 114 AHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRW 163
G DLK +T+ + + + S E +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 3e-04
Identities = 64/490 (13%), Positives = 143/490 (29%), Gaps = 139/490 (28%)
Query: 5 KILEEL---------GDGTCGCVYKAFNVETYEIVAVKKMKRKFY---FWEECMNLRE-- 50
+ L EL G G K ++ K++ K FW +NL+
Sbjct: 142 QALLELRPAKNVLIDGVLGSG---KT--WVALDVCLSYKVQCKMDFKIFW---LNLKNCN 193
Query: 51 -----VKALRKLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFS------- 98
++ L+KL + ++ + ++ L +++ +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 99 --EGEIRSF--MSQML-----QGLA-HMHRNGYFHRDLKPENLLVTND--------VLKI 140
+F ++L + + + H L ++ +T D L
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 141 ADFGLARELSSMPPYT-----EYVS---TRW--YRAPEVLLQSSSYSPAIDMWAVGAI-- 188
L RE+ + P E + W ++ + + I+ ++ +
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK----HVNCDKLTTIIES-SLNVLEP 368
Query: 189 --LAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-----------------NI 229
++F +FP + I + ++ W ++
Sbjct: 369 AEYRKMFDRLSVFPPSAHIP--TILLSLI----WFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 230 SRLISIS--YSEILPINLSDIIPNASM-EAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286
ISI Y E+ ++ + S+ + ++ S D + P DQ F++
Sbjct: 423 ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI-PPYLDQY----FYS-- 475
Query: 287 TWVPYPLHDPLELRLNNMGSKPNLELNLW-DFGTEPDDCFLGLTLAVKPSNLEMVHNVPQ 345
+ + H L+ + L ++ DF FL K + N
Sbjct: 476 -HIGH--H----LKNIEHPERMTLFRMVFLDFR------FLE----QKIRHDSTAWNASG 518
Query: 346 GMQEDIL-------FCSDLKDHSEQTV-----FWSLLSPDQNRMRAPVESSLSLSFSSIQ 393
+ + + D E+ V F L ++N + + L ++
Sbjct: 519 SILNTLQQLKFYKPYICDNDPKYERLVNAILDF--LPKIEENLICSKYTDLLRIAL---M 573
Query: 394 HPSTGVPQSA 403
+ + A
Sbjct: 574 AEDEAIFEEA 583
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 432 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.29 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.31 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.86 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.43 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-64 Score=504.82 Aligned_cols=283 Identities=36% Similarity=0.634 Sum_probs=244.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEe------CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRE------NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~ 74 (432)
++|++++.||+|+||+||+|+++.+|+.||||++++...... .....+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 479999999999999999999999999999999986554333 3456799999999999999999999753 367
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC--
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-- 151 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-- 151 (432)
+|||||||+|+|.+.+... +++++.+++.|++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 9999999999988877654 589999999999999999999999999999999999999855 999999999987643
Q ss_pred ---CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-
Q 014039 152 ---MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT- 227 (432)
Q Consensus 152 ---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~- 227 (432)
.....+.+||++|+|||++.+...|+.++||||+|||+|||++|.+||.+.+..+++..|+...|.|+...+....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 2334678999999999999877788999999999999999999999999999999999999999999877553321
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.........++...+.++..+++.++++++|||++||++||++||||+|+|+||||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 1122223345666677788888999999999999999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-64 Score=487.43 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=223.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||+||+|+++.+|+.||||++.+.... .......+|+++|++++|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999754321 22344679999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---CC
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---PP 154 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---~~ 154 (432)
|||+|+ |.+.+.+. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+... ..
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999874 55555544 579999999999999999999999999999999999999855 9999999999987532 23
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..+.+||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+...+|.. +.+
T Consensus 191 ~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~---------------- 251 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEY---------------- 251 (311)
T ss_dssp BCCCCSCGGGCCHHHHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCC----------------
T ss_pred ccCcccCcccCCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC----------------
Confidence 45779999999999985 66799999999999999999999999999988887777743 111
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ------ALQHPFFNVETWVPY 291 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~e------lL~Hp~f~~~~~~~~ 291 (432)
.++..+++++++||++||++||++|+|++| +++||||++.+|...
T Consensus 252 ------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 252 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp ------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 112357899999999999999999999987 689999999999654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-64 Score=477.27 Aligned_cols=254 Identities=31% Similarity=0.485 Sum_probs=206.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||+||+|+++.+|+.||||++.+..... ......+|+++|++++|||||++++++.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997654322 233467999999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||++|++++.+.+++ ++++.+++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+.........+
T Consensus 92 mEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp EECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 9999999998887654 79999999999999999999999999999999999999855 999999999988776666677
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++.+...++.++||||+||++|||++|++||.+.+.......|.. +.+
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--~~~------------------- 229 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVY------------------- 229 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCC-------------------
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCC-------------------
Confidence 89999999999997555567899999999999999999999999887666655532 111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.++..+|+++++||++||++||++|||++|+|+||||+.
T Consensus 230 ---------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 ---------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 112357899999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-63 Score=485.00 Aligned_cols=254 Identities=25% Similarity=0.441 Sum_probs=220.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||+||+|+++.+|+.||||++...... ....+.+|+++|++++|||||+++++|.+++.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4699999999999999999999999999999999754332 233457899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
|+|+.+..+..++ .+++.+++.|+.||+.||+|||++||+||||||+||||+. +.+||+|||+|+.+... ......+
T Consensus 153 ~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 231 (346)
T 4fih_A 153 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 231 (346)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence 9986555555543 6999999999999999999999999999999999999985 49999999999987543 4456789
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
||++|+|||++ ....|+.++|||||||++|||++|.+||.+.+..+.+..|... .++..
T Consensus 232 GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~~------------------ 290 (346)
T 4fih_A 232 GTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRL------------------ 290 (346)
T ss_dssp SCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--SCCCC------------------
T ss_pred cCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--CCCCC------------------
Confidence 99999999988 4678999999999999999999999999999988887776431 11100
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+..+++++++||.+||++||++|||++|+|+||||+.
T Consensus 291 -------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 291 -------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp -------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 112357899999999999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-63 Score=488.21 Aligned_cols=255 Identities=28% Similarity=0.490 Sum_probs=216.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|+++++||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+++|++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 789999999999999999999999999999999998654433 3445679999999999999999999999999999999
Q ss_pred ecCCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CC
Q 014039 80 EYMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PY 155 (432)
Q Consensus 80 E~~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~ 155 (432)
|||+| +|.+.+..+ +..+++.+++.|+.||+.||+|||++||+||||||+||||+.+ .+||+|||+|+.+.... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 99986 566666544 3468999999999999999999999999999999999999854 99999999998775432 23
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+.+.+|+.. ..
T Consensus 183 ~~~~GT~~YmAPE~l~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~----------------- 242 (350)
T 4b9d_A 183 RACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SF----------------- 242 (350)
T ss_dssp HHHHSCCTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC-----------------
T ss_pred cccCCCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--CC-----------------
Confidence 4578999999999984 677999999999999999999999999999988887777531 11
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+...+++++++||.+||++||++|||++|+|+||||+.
T Consensus 243 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 ----------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1123468999999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=487.86 Aligned_cols=254 Identities=25% Similarity=0.440 Sum_probs=220.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||.||+|+++.+|+.||||++...... ....+.+|+++|++++|||||+++++|.+++.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4699999999999999999999999999999999754432 234467999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
|+|+.+..+...+ .+++.+++.|+.||+.||+|||++||+||||||+||||+. +.+||+|||+|+.+... ......+
T Consensus 230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 308 (423)
T 4fie_A 230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 308 (423)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCE
T ss_pred CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccc
Confidence 9986555555544 6999999999999999999999999999999999999985 49999999999987543 4456789
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
||++|+|||++ ....|+.++|||||||++|||++|.+||.+.+..+.+..|... .++.
T Consensus 309 GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~------------------- 366 (423)
T 4fie_A 309 GTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPR------------------- 366 (423)
T ss_dssp ECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC-------------------
T ss_pred cCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--CCCC-------------------
Confidence 99999999988 4677999999999999999999999999999988887776431 1110
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+..+++++++||.+||++||++||||+|+|+||||+.
T Consensus 367 ------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 367 ------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp ------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 0123468999999999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=472.94 Aligned_cols=256 Identities=25% Similarity=0.479 Sum_probs=213.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++++.||+|+||+||+|++. .+++.||||++++.... .......+|+++|++++|||||++++++++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999884 57889999999754322 122345689999999999999999999999999999
Q ss_pred EEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCC
Q 014039 78 IFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPP 154 (432)
Q Consensus 78 V~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~ 154 (432)
|||||+|+ |.+.+.+ .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.... ...
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 99999865 5555554 4579999999999999999999999999999999999999854 999999999987543 334
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..+.+||+.|+|||++. ...|+.++||||+||++|||++|.+||.+.+..+.+..|.. +.+
T Consensus 183 ~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~---------------- 243 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKL---------------- 243 (304)
T ss_dssp CCSCCCCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC----------------
T ss_pred ccccccCcccCCHHHhc-cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCC----------------
Confidence 56789999999999985 67799999999999999999999999999998888777743 111
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFFNVETWV 289 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f~~~~~~ 289 (432)
..+..+|+++++||++||++||++|||| +|+++||||+..+|.
T Consensus 244 ------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 244 ------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 1123579999999999999999999984 799999999998884
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-61 Score=460.47 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=209.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe----CCEEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE----NNELFFI 78 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV 78 (432)
|++.++||+|+||+||+|.++.+++.||+|++...... .....+.+|+++|++++|||||+++++|.+ ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 47888999999999999999999999999999765433 334456799999999999999999999865 3568999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeC--CeEEEeeeccceecCCCCC
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTN--DVLKIADFGLARELSSMPP 154 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~~ 154 (432)
||||+|+.+..+..+.+.+++..++.|+.||+.||+|||++| |+||||||+||||++ +.+||+|||+|+.... ..
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~ 186 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SF 186 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TS
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-Cc
Confidence 999997655544444568999999999999999999999998 999999999999973 5999999999975443 34
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..+.+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+.....++.+.+.. +..+
T Consensus 187 ~~~~~GTp~YmAPE~~~--~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~--------------- 248 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------------- 248 (290)
T ss_dssp BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------------
T ss_pred cCCcccCccccCHHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCC---------------
Confidence 56779999999999884 35999999999999999999999999887766655543211 0000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......++++.+||.+||+.||++|||++|+|+||||++
T Consensus 249 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0112357889999999999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-61 Score=475.28 Aligned_cols=278 Identities=27% Similarity=0.414 Sum_probs=218.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
++|+++++||+|+||+||+|+++ .+++.||+|++.+... .....+|+++|+.+ +|||||+++++|.+.+.+||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 57999999999999999999875 4688999999976532 23456899999998 79999999999999999999
Q ss_pred EEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCCC-
Q 014039 78 IFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSMP- 153 (432)
Q Consensus 78 V~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~- 153 (432)
||||++|+ +.+.+ +.+++.+++.+++||+.||+|||++||+||||||+|||++. +.+||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999865 55544 25999999999999999999999999999999999999985 499999999998654321
Q ss_pred ----------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCC-CCCCh
Q 014039 154 ----------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIF-PGDSE 204 (432)
Q Consensus 154 ----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF-~~~~~ 204 (432)
.....+||++|+|||++.+...|+.++||||+||++|||++|++|| .+.++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 2345689999999999987778999999999999999999999877 67788
Q ss_pred HHHHHHHHHHhCCCCCCCchhhh-------------------hhhhhhhcccccc-----CCCCccccCCCCCHHHHHHH
Q 014039 205 IDQLYKVCCILGAPDWTAFPEAT-------------------NISRLISISYSEI-----LPINLSDIIPNASMEAIDLI 260 (432)
Q Consensus 205 ~d~~~~i~~~~g~p~~~~~~~~~-------------------~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~dli 260 (432)
.+++..|+.++|.+......... ...+......+.. ......+.+..++++++|||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 89999999999865322111000 0000000001100 00111223467899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 261 WQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 261 ~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
++||++||++|+||+|+|+||||++.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-61 Score=468.89 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=211.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+.|++.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+++|++++|||||++++++.+++.+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 568999999999999999999999999999999986543 24799999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCCCCC----
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPP---- 154 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~~---- 154 (432)
|+|+ |.+.+.+ .+++++.+++.|+.||+.||+|||++||+||||||+||||+.+ .+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 132 LEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9975 5555544 4589999999999999999999999999999999999999854 699999999997754321
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+.+.+|.. +.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~--------------- 272 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--EP--------------- 272 (336)
T ss_dssp ---CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--SC---------------
T ss_pred ecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--CC---------------
Confidence 23458999999999985 67799999999999999999999999998876655555532 11
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA-------------LQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~el-------------L~Hp~f~~ 285 (432)
.++..+++.+++++.+||.+||++||++|||+.|+ |+|||+..
T Consensus 273 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 273 ----------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp ----------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred ----------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 11223456789999999999999999999999997 57999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-59 Score=487.94 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=215.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHH---HHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMN---LREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~---~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
|++|+++++||+|+||.||+|+++.+|+.||||++.+..... ..... .+++++++.++|||||+++++|++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 589999999999999999999999999999999997543211 11112 2456777788999999999999999999
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP 154 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~ 154 (432)
|||||||.|+.+..+..+.+.+++..++.|+.||+.||+|||++||+||||||+||||+. |.+||+|||+|+.+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 999999997544444444458999999999999999999999999999999999999985 499999999999876543
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
..+.|||+.|+|||++.++..|+.++|||||||++|||++|.+||.+.+..+...........+
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~---------------- 410 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------------- 410 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC----------------
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC----------------
Confidence 4567999999999999766789999999999999999999999998754332211111111000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVP 290 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~ 290 (432)
..++..+|+++++||++||++||.+|++ |+|+++||||++.+|..
T Consensus 411 -----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 411 -----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred -----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 0123468999999999999999999998 79999999999999943
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-59 Score=453.29 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=194.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC--------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN-------- 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-------- 73 (432)
++|++++.||+|+||+||+|+++.+|+.||||+++............+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 579999999999999999999999999999999986554444456779999999999999999999986543
Q ss_pred ----EEEEEEecCCCcHHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeecc
Q 014039 74 ----ELFFIFEYMEHNLYHIMRERQIP---FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGL 145 (432)
Q Consensus 74 ----~~~lV~E~~~~~ll~~~~~~~~~---l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~ 145 (432)
.+|||||||.++.+..+...... .++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 37999999987655544443333 455678999999999999999999999999999999985 4999999999
Q ss_pred ceecCCCC-------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014039 146 ARELSSMP-------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 146 a~~~~~~~-------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~ 212 (432)
|+.+.... .....+||+.|+|||++. +..|+.++|||||||++|||++ ||.+. .+....+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~ 238 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLT 238 (299)
T ss_dssp C--------------------------CCCTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHH
Confidence 98765422 124468999999999985 6789999999999999999996 56543 22222222
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~ 291 (432)
..... .+ ...+...++++.+||++||+.||++|||+.|+|+||||++.+|...
T Consensus 239 ~~~~~------------------~~--------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~ 291 (299)
T 4g31_A 239 DVRNL------------------KF--------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291 (299)
T ss_dssp HHHTT------------------CC--------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred HHhcC------------------CC--------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 21111 01 1112234678899999999999999999999999999998877543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-58 Score=479.91 Aligned_cols=263 Identities=30% Similarity=0.454 Sum_probs=230.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
|++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+|+++|+.++|||||+++++|.+.+.+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4789999999999999999999999999999999976543 233456789999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---CeEEEeeeccceecCCCCCCc
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~~lkL~DFG~a~~~~~~~~~~ 156 (432)
||+| +|.+.+..+.+.+++.+++.|++||+.||+|||++||+||||||+|||++. +.+||+|||+|+.+.......
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 9986 566777666668999999999999999999999999999999999999974 489999999999988776677
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||++|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+.+..|.......+
T Consensus 315 ~~~GT~~y~APEv~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 376 (573)
T 3uto_A 315 VTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----------------- 376 (573)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-----------------
T ss_pred eeEECccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC-----------------
Confidence 789999999999985 67799999999999999999999999999999888877743211111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~ 291 (432)
...++.+|.+++|||++||++||.+|||+.|+|+||||+..+|...
T Consensus 377 ---------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 377 ---------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp ---------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred ---------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 1223568999999999999999999999999999999998777544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=429.86 Aligned_cols=286 Identities=38% Similarity=0.695 Sum_probs=249.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|+++++||+|+||+||+|++. +|+.||+|++....... ......+|++++++++||||+++++++.+.+.+|+||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 478999999999999999999985 58899999997543322 2344678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..... .....
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence 999999999988877789999999999999999999999999999999999999855 9999999999876532 33455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++.+...++.++||||+||++|+|++|.+||.+....+.+..+...+|.+....++.......+....+
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 68899999999997667899999999999999999999999999999999999999999999888877666666666666
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.......+..+.+.+++++++||++||++||++|||++|+|+||||+..+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 66666667777788999999999999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=431.20 Aligned_cols=287 Identities=36% Similarity=0.607 Sum_probs=246.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
|++|++++.||+|+||.||+|++..+++.||+|++.............+|+++|++++||||+++++++.+.+..|+|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 78999999999999999999999999999999999754432222234579999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
|+++++.+.+...+..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+..... ......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 99999999988877789999999999999999999999999999999999999855 9999999999866432 233456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
++|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+++..+...+|.|....++.......+....++
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 88999999999977678999999999999999999999999999999999999999999998888776666666666666
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
......+....+.++.++.+||++||++||++|||++|+|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 6665666666778999999999999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=449.87 Aligned_cols=287 Identities=34% Similarity=0.600 Sum_probs=228.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe-----CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE-----NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~~~ 75 (432)
++|+++++||+|+||+||+|+++.+|+.||||++.+..... ......+|+++|+.++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999999999999999997654332 33456799999999999999999999843 3679
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP- 153 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~- 153 (432)
|+||||+++++.+.+... ..+++..++.+++||+.||+|||++||+||||||+||||+.+ .+||+|||+|+......
T Consensus 133 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 999999999888877654 479999999999999999999999999999999999999865 99999999998764221
Q ss_pred ---------------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-----------C
Q 014039 154 ---------------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-----------L 195 (432)
Q Consensus 154 ---------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-----------g 195 (432)
....++||++|+|||++.....|+.++||||||||+|||++ |
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~ 291 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence 23557899999999998777889999999999999999998 8
Q ss_pred CCCCCCCC--------------------hHHHHHHHHHHhCCCCCCCchhhh-hhhhhhhccccccCCCCccccCCCCCH
Q 014039 196 SPIFPGDS--------------------EIDQLYKVCCILGAPDWTAFPEAT-NISRLISISYSEILPINLSDIIPNASM 254 (432)
Q Consensus 196 ~~pF~~~~--------------------~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~ 254 (432)
.++|+|.+ ..+++..|...+|.|+.+.+.... .........++......+...++.+++
T Consensus 292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 99998876 368899999999999876543221 112222234555666777778889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 255 EAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 255 ~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
++++||++||++||++|||++|+|+||||+...|.
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 99999999999999999999999999999986654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=415.01 Aligned_cols=284 Identities=36% Similarity=0.640 Sum_probs=243.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|++++.||+|+||+||+|++..+|+.||+|++....... ......+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999997654332 2344678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||+++++++.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..... .....
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 999999999998877889999999999999999999999999999999999999855 9999999999876532 33455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS-PIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~-~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.++|+.|+|||++.+...++.++||||+||++|+|++|. ++|.+.+..+.+..+...++.+....++.......+....
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 688999999999976667999999999999999999754 5588888899999999999999888776544433332211
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.. .....+....+.++.++++||++||+.||++|||++|+|+||||+.
T Consensus 241 ~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 241 MY-PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CC-CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cc-cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 11 1122334455678999999999999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=416.68 Aligned_cols=284 Identities=38% Similarity=0.656 Sum_probs=239.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|++++.||+|+||.||+|++ .+|+.||+|++....... ......+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 78999999999999999999998 678999999997543222 1234568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||+++++.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..... .....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 999999988888776789999999999999999999999999999999999999854 9999999999876432 23445
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++.+...++.++||||+||++|||++|.+||.+.+..+.+..+...+|.+....++.......+ ...+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNF 238 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc-cccc
Confidence 688999999999976677999999999999999999999999999999999999999999887776544333222 1223
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
....+..+....+.++.++.+||++||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 3334455566667899999999999999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=422.23 Aligned_cols=250 Identities=25% Similarity=0.289 Sum_probs=201.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+++++.++||+|+||+||+|++.. .||||+++..... .....+.+|+++|++++|||||++++++.+ +.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 578899999999999999997543 4999999754433 233456799999999999999999998754 56899999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---CCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---PPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---~~~ 155 (432)
||++ +|.+.+.....++++.++..|+.||+.||+|||++||+||||||+||||+++ .+||+|||+|+..... ...
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 9986 5556666666789999999999999999999999999999999999999976 9999999999876432 234
Q ss_pred ccccCCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
...+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+..++..-..
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~---------------- 255 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA---------------- 255 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC----------------
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----------------
Confidence 56789999999999863 346899999999999999999999999988776666554321111
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
...+..+.+.++.++.+||.+||+.||++|||+.|+++
T Consensus 256 --------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 256 --------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp --------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred --------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11122344578999999999999999999999987754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=441.30 Aligned_cols=287 Identities=34% Similarity=0.594 Sum_probs=239.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVREN-----NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~ 75 (432)
++|++++.||+|+||.||+|+++.+|+.||||++.+..... ......+|+++|++++||||+++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 68999999999999999999999999999999998654332 334567999999999999999999998765 679
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP- 153 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~- 153 (432)
|+||||++++|.+.+... ..+++.+++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+......
T Consensus 106 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 999999999888877654 479999999999999999999999999999999999999865 99999999998765432
Q ss_pred ----------------------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-----------CCCCCC
Q 014039 154 ----------------------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-----------LSPIFP 200 (432)
Q Consensus 154 ----------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-----------g~~pF~ 200 (432)
....++||++|+|||++.....|+.++||||+||++|||++ |.++|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~ 264 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence 23678999999999998778889999999999999999997 788888
Q ss_pred CCC-----------------hHHHHHHHHHHhCCCCCCCchhhhh-hhhhhhccccccCCCCccccCCCCCHHHHHHHHH
Q 014039 201 GDS-----------------EIDQLYKVCCILGAPDWTAFPEATN-ISRLISISYSEILPINLSDIIPNASMEAIDLIWQ 262 (432)
Q Consensus 201 ~~~-----------------~~d~~~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 262 (432)
+.+ ..+++..|+..+|.|+.+.+..... ........++...+..+...++.+++++++||++
T Consensus 265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 344 (432)
T 3n9x_A 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344 (432)
T ss_dssp CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 865 4789999999999998765432111 1111112344555666667778899999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 263 LCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 263 ~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
||++||++|||++|+|+||||+...|.
T Consensus 345 mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 345 MLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HhcCCcccCCCHHHHhcChhhhhccCc
Confidence 999999999999999999999986554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=422.48 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=206.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|.+.++||+|+||+||+|++. .++..||||+++... ......+.+|+++|++++|||||++++++.+++.+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 47999999999999999999875 468899999997543 233445779999999999999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEee
Q 014039 77 FIFEYMEH-NLYHIMRER------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIAD 142 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~D 142 (432)
||||||++ +|.+.+... ...+++.++..++.||+.||+|||+++|+||||||+|||++++ .+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 99999986 555555442 2469999999999999999999999999999999999999866 999999
Q ss_pred eccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014039 143 FGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 143 FG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
||+|+....... ....+||+.|+|||++. ...|+.++|||||||++|||+| |++||.+.+..+.+..+.. |..
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~--~~~ 248 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ--GRV 248 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH--TCC
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--CCC
Confidence 999987644322 23346899999999985 5679999999999999999998 8999999888776666532 111
Q ss_pred CCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 219 DWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
...++.+++++.+||.+||+.||++|||+.|++ +|++
T Consensus 249 ---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 249 ---------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred ---------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 012346889999999999999999999999994 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=422.76 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=200.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|.+.++||+|+||+||+|++. .+++.||||+++... ......+.+|+++|++++|||||++++++.+.+.+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46889999999999999999865 468899999997543 233445779999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEE
Q 014039 77 FIFEYMEHN-LYHIMRER--------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKI 140 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~--------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL 140 (432)
||||||+++ |.+.+... .+++++.++..|+.||+.||+|||+++|+||||||+||||+++ .+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 999999875 55544432 2469999999999999999999999999999999999999976 9999
Q ss_pred eeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014039 141 ADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILG 216 (432)
Q Consensus 141 ~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g 216 (432)
+|||+|+...... .....+||+.|+|||++. ...|+.++|||||||++|||+| |+.||.+.+..+.+..+.. |
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~--g 276 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ--G 276 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH--T
T ss_pred cccccceeccCCCcceecCcccccccccChhhhc-CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--C
Confidence 9999998764432 234568999999999984 6779999999999999999998 8999999888776666532 1
Q ss_pred CCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.. .+.+..+++++.+||.+||+.||++|||++|++++
T Consensus 277 ~~---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 277 RE---------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CC---------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CC---------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 10 01224688999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=444.01 Aligned_cols=280 Identities=35% Similarity=0.589 Sum_probs=225.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|+++++||+|+||+||+|++..+|+.||||++.+..... ......+|+++|+.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 68999999999999999999999999999999998654332 334567999999999999999999999643 46
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+||||+++++.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+......
T Consensus 142 ~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred EEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 899999999998887743 48999999999999999999999999999999999999965 99999999999887666
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+||++|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+++.+|+..+|.|....+.......+..
T Consensus 219 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CC----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred ccCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 677789999999999996 5679999999999999999999999999999999999999999998755432221111111
Q ss_pred hccccccCCCCccccCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDIIPN------------ASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~------------~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+......+...++. .++++++||++||++||++|||++|+|+||||+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 111122222222222222 1678999999999999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=421.67 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=207.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++++++++||+|+||+||+|+.. .+++.||||+++..........+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46889999999999999999853 5678999999986554444456789999999999999999999999999999
Q ss_pred EEEecCCCc-HHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEE
Q 014039 77 FIFEYMEHN-LYHIMRER---------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLK 139 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~---------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lk 139 (432)
||||||+++ |.+.+..+ ...+++.++..++.||++||+|||+++|+||||||+||||+++ .+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 999999864 55555432 2369999999999999999999999999999999999999865 999
Q ss_pred EeeeccceecCCC---CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014039 140 IADFGLARELSSM---PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCIL 215 (432)
Q Consensus 140 L~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~ 215 (432)
|+|||+|+.+... ......+||+.|+|||++. ...|+.++|||||||++|||+| |.+||.+.+..+.+..+..
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~-- 262 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-- 262 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT--
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--
Confidence 9999999876432 2234568999999999985 5679999999999999999998 8999999988776665532
Q ss_pred CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 216 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
|. ..+.++.++.++.+|+.+||+.||++|||+.|++++
T Consensus 263 ~~---------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 263 RQ---------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 011234688999999999999999999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=432.19 Aligned_cols=283 Identities=35% Similarity=0.674 Sum_probs=220.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcC-CCcccccceEEEeC--CEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLN-HPNIIKLKEVVREN--NELF 76 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~ 76 (432)
+++|++++.||+|+||.||+|.+..+|+.||||++.+.... .......+|+.+|+.+. ||||+++++++... ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999999999999999999765433 23344679999999996 99999999999754 3799
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC----
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS---- 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~---- 151 (432)
+|||||++++...+... .+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+..
T Consensus 88 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 99999999888877653 69999999999999999999999999999999999999865 999999999987532
Q ss_pred ------------------CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014039 152 ------------------MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 152 ------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~ 213 (432)
......++||++|+|||++.+...|+.++||||+||++|||++|.+||++.+..+++.+|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 12235578999999999997768899999999999999999999999999999999999999
Q ss_pred HhCCCCCCCchhhh-hhhhhhhcccc---ccCCCCccccC-------------CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 014039 214 ILGAPDWTAFPEAT-NISRLISISYS---EILPINLSDII-------------PNASMEAIDLIWQLCSWDPLRRPTADQ 276 (432)
Q Consensus 214 ~~g~p~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~-------------~~~s~~~~dli~~~L~~dP~~Rpta~e 276 (432)
.+|.|....+.... ...+.....++ ..........+ ..+++++++||++||++||++|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 99998755332110 00000000000 00011111111 267999999999999999999999999
Q ss_pred HhcCCCCCC
Q 014039 277 ALQHPFFNV 285 (432)
Q Consensus 277 lL~Hp~f~~ 285 (432)
+|+||||+.
T Consensus 326 ~l~Hp~~~~ 334 (388)
T 3oz6_A 326 ALKHPFVSI 334 (388)
T ss_dssp HTTSTTTTT
T ss_pred HhCCHHHHH
Confidence 999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=437.62 Aligned_cols=278 Identities=34% Similarity=0.610 Sum_probs=239.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC------CEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN------NELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~~~ 76 (432)
+|++++.||+|+||.||+|++..+|+.||||++...... ..+|+++|+.++||||+++++++... ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 699999999999999999999999999999999754321 24799999999999999999988531 2367
Q ss_pred EEEecCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--eEEEeeeccceecCC
Q 014039 77 FIFEYMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSS 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~ 151 (432)
+||||+++++++.+.. ....+++..++.+++||++||+|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9999999988776653 45689999999999999999999999999999999999999943 789999999998876
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
......++||++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.++++.+|.|..+.+... ..+
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~--~~~ 287 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM--NPN 287 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH--CSC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh--Chh
Confidence 666778899999999999976678999999999999999999999999999999999999999999986655332 234
Q ss_pred hhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 232 LISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
+..+.++......+..++ +.+++++++||++||++||.+|||+.|+|+||||+...
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 444566666666665554 56899999999999999999999999999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-54 Score=430.82 Aligned_cols=315 Identities=23% Similarity=0.392 Sum_probs=240.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|+++++||+|+||.||+|+++.+++.||+|++++...... .....+|..+|+++ +||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999986543322 23356899999887 89999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecccee-cCCCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARE-LSSMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~-~~~~~~~ 155 (432)
||||++|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+. .......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 99999875554444444579999999999999999999999999999999999999855 999999999986 3344456
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhCCCCCCCchhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID--------QLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d--------~~~~i~~~~g~p~~~~~~~~~ 227 (432)
...+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+....+ .+.+.+
T Consensus 211 ~~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--------------- 274 (396)
T 4dc2_A 211 STFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------------- 274 (396)
T ss_dssp CCCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH---------------
T ss_pred ccccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH---------------
Confidence 6789999999999985 6779999999999999999999999997543211 111111
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCCCC---CCCChhh
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA------DQALQHPFFNVETWVPY---PLHDPLE 298 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta------~elL~Hp~f~~~~~~~~---~~~~~~~ 298 (432)
.... ..++..++.++++||++||+.||.+|+++ +|+++||||+..+|... .+..|..
T Consensus 275 -----~~~~---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~ 340 (396)
T 4dc2_A 275 -----LEKQ---------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK 340 (396)
T ss_dssp -----HHCC---------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCC
T ss_pred -----hccc---------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCc
Confidence 0000 01234689999999999999999999995 89999999999998432 2222332
Q ss_pred hhccCCCCCCCCccCCCCCCCCCCccccCccccccCChhhhhccCCccccccccccCC
Q 014039 299 LRLNNMGSKPNLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILFCSD 356 (432)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (432)
+...+. .+...|| . .|......+.|.+.+....+.+..+++|.|+..
T Consensus 341 p~~~~~-----~d~~~fd--~----~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 387 (396)
T 4dc2_A 341 PNISGE-----FGLDNFD--S----QFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 387 (396)
T ss_dssp CCCCSS-----TTGGGSC--H----HHHTSCCCCCCCCHHHHTTSCGGGGTTCCEECC
T ss_pred CCCCCc-----cchhhcC--h----hhccCCCccCCCcchhhccccccccCCcEeECc
Confidence 221111 1111122 1 122223345666666777788888899987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=428.81 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=215.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|+++++||+|+||.||+|+++.+|+.||+|++++.... .......+|+++++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 57899999999999999999999999999999999864321 1223356899999998 79999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~ 155 (432)
||||++|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+... .....
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence 99999875444444444579999999999999999999999999999999999999854 99999999998643 33345
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+....|.. +..
T Consensus 182 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~----------------- 241 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEV----------------- 241 (353)
T ss_dssp ----CCGGGCCHHHHH-HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-----------------
T ss_pred cccCCCcCeEChhhcC-CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC-----------------
Confidence 5678999999999985 56789999999999999999999999999998887777643 111
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA------DQALQHPFFNVETWVP 290 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta------~elL~Hp~f~~~~~~~ 290 (432)
.....++.++.+||++||++||++||++ +|+++||||+..+|..
T Consensus 242 -----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 242 -----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 1123478899999999999999999998 9999999999998853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-54 Score=430.23 Aligned_cols=280 Identities=36% Similarity=0.618 Sum_probs=243.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC------EE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN------EL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~~ 75 (432)
.+|+++++||+|+||+||+|++..+++ +|+|++...... ..+|+++|+.++||||+++++++...+ .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 369999999999999999999988877 888888654321 237999999999999999999985433 37
Q ss_pred EEEEecCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe--CCeEEEeeeccceecC
Q 014039 76 FFIFEYMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT--NDVLKIADFGLARELS 150 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~--~~~lkL~DFG~a~~~~ 150 (432)
|+||||+++++++.+.. ....+++..++.+++||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 89999999998876653 356799999999999999999999999999999999999998 3499999999999887
Q ss_pred CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.......++||++|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++.++++.+|.|....+.. ...
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~--~~~ 271 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT--MNP 271 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH--HCG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh--hCh
Confidence 777777889999999999997777899999999999999999999999999999999999999999998765432 234
Q ss_pred hhhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 231 RLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
++....++...+..+...+ +.+++++++||++||++||++|||+.|+|+||||+...|.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 5556667777777776655 4599999999999999999999999999999999986553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-54 Score=420.19 Aligned_cols=288 Identities=40% Similarity=0.696 Sum_probs=233.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|+++++||+|+||+||+|++..+++.||+|++........ .....+|++++++++||||+++++++.+.+.+|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4789999999999999999999999999999999975543222 233468999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC------eEEEeeeccceecCCC-
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND------VLKIADFGLARELSSM- 152 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~------~lkL~DFG~a~~~~~~- 152 (432)
||+++++.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.....
T Consensus 113 e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 113 EYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp ECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred ecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 999998888877654 69999999999999999999999999999999999999522 5999999999876532
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......++|+.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+..+...+|.|....++.......+
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 23455678999999999976677999999999999999999999999999999999999999999988776544332222
Q ss_pred hhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014039 233 ISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~ 290 (432)
. ..++......+.... ..++.++.+||++||++||++|||++|+|+||||+..+|.+
T Consensus 272 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 272 K-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp C-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred h-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 1 122222222222222 23789999999999999999999999999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=417.83 Aligned_cols=287 Identities=36% Similarity=0.604 Sum_probs=226.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+++|++++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 36899999999999999999999999999999999765433333456789999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-C
Q 014039 81 YMEHNLYHIMRERQ-----IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-P 153 (432)
Q Consensus 81 ~~~~~ll~~~~~~~-----~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~ 153 (432)
|+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..... .
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 99999888876542 469999999999999999999999999999999999999854 9999999999877543 2
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....++|+.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+++..+...+|.++...++.......+.
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 34566899999999999766679999999999999999999999999999999999999999998877665433322211
Q ss_pred hccccccCCCCcc-----ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 234 SISYSEILPINLS-----DIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 234 ~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
. .+....+..+. .....++.++.+||++||+.||++|||++|+|+||||+...+
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 244 P-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp T-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred c-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 1 11111111111 112367899999999999999999999999999999997544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=423.53 Aligned_cols=281 Identities=35% Similarity=0.581 Sum_probs=234.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|++++.||+|+||.||+|.+..+|+.||||++........ .....+|+++|+.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 579999999999999999999999999999999976543322 34467999999999999999999999764 35
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+||||+++++.+.+.. ..+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 105 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-- 180 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 180 (367)
T ss_dssp CEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc--
Confidence 699999997777776655 369999999999999999999999999999999999999865 999999999987654
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
....+++|++|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++..|+...|.|+.+.+.... ...+.
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 35567899999999999876789999999999999999999999999999999999999999998765432211 11111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
....++......+..+++.+++++++||++||+.||++|||++|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 222345556667778888999999999999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=414.66 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=221.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|++++.||+|+||.||+|++..+|+.||||++.+.... .......+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999999999999999999765433 23345679999999999999999999999999999999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||+++ ++.+.+... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..........
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 99976 565655554 479999999999999999999999999999999999999865 999999999988776666677
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||++|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+.. +..
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~------------------- 231 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKY------------------- 231 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-------------------
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC-------------------
Confidence 89999999999997665567899999999999999999999999887776666532 111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.+...+++++.+||++||+.||.+|||++|+++||||+..
T Consensus 232 ---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 232 ---------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp ---------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred ---------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 1123578999999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=425.80 Aligned_cols=278 Identities=31% Similarity=0.597 Sum_probs=239.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe----------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE---------- 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---------- 71 (432)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+++|+.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 6899999999999999999999999999999999754322 2379999999999999999999843
Q ss_pred ----------------------------CCEEEEEEecCCCcHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014039 72 ----------------------------NNELFFIFEYMEHNLYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120 (432)
Q Consensus 72 ----------------------------~~~~~lV~E~~~~~ll~~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~~g 120 (432)
...+++||||+++++.+.+. ..++.+++..++.+++||+.||+|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 33488999999998766654 35668999999999999999999999999
Q ss_pred CeeccCCCCceeEe--CCeEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCC
Q 014039 121 YFHRDLKPENLLVT--NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI 198 (432)
Q Consensus 121 ivHrDlkP~NILl~--~~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~p 198 (432)
|+||||||+|||++ ++.+||+|||+|+...........++|+.|+|||++.+...|+.++||||+||++|||++|.+|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 241 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence 99999999999997 3499999999999887777777889999999999997777799999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014039 199 FPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQA 277 (432)
Q Consensus 199 F~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~el 277 (432)
|.+.+..+++.++++.+|.|+.+.+.. ....+....++......+...+ ..++.++++||++||++||++|||+.|+
T Consensus 242 f~~~~~~~~~~~i~~~~g~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 242 FSGETSIDQLVRIIQIMGTPTKEQMIR--MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHH--HCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHH--hCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999999999999999999998665432 2234445566666666665554 4589999999999999999999999999
Q ss_pred hcCCCCCCC
Q 014039 278 LQHPFFNVE 286 (432)
Q Consensus 278 L~Hp~f~~~ 286 (432)
|+||||+..
T Consensus 320 l~hp~f~~~ 328 (383)
T 3eb0_A 320 MAHPFFDHL 328 (383)
T ss_dssp HTSGGGHHH
T ss_pred hcCHHHHHH
Confidence 999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=408.17 Aligned_cols=281 Identities=36% Similarity=0.617 Sum_probs=236.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch----HHHHHHHHHHHHHhc---CCCcccccceEEEeCC-
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW----EECMNLREVKALRKL---NHPNIIKLKEVVRENN- 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~- 73 (432)
++|++++.||+|+||+||+|++..+|+.||+|++....... ......+|+++++.+ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 68999999999999999999999999999999997433111 112345677777666 5999999999997654
Q ss_pred ----EEEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 74 ----ELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 74 ----~~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
.+++||||+++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 589999999998888887654 349999999999999999999999999999999999999855 99999999998
Q ss_pred ecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 148 ELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
...........++|+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+.+.++...+|.++...++...
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 169 IYSYQMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp TSTTCCCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred ccCCCcccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 877666667789999999999986 5668999999999999999999999999999999999999999999888775443
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+ ..++...+..+..+.+.++.++.+||.+||++||++|||+.|+|+||||+..
T Consensus 248 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 248 SLPR---GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCG---GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccc---cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 3222 2344444555666677899999999999999999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=421.39 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=207.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-----CeEEEEEEecccccchHHHHHHHHHHHHHhcCC-CcccccceEEEe-CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-----YEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-PNIIKLKEVVRE-NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~-~~~ 74 (432)
++|+++++||+|+||+||+|.+..+ ++.||+|+++..........+.+|+++|+++.| ||||+++++|.+ ++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 5799999999999999999987654 468999999876555555567899999999965 899999999865 467
Q ss_pred EEEEEecCCCc-HHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-e
Q 014039 75 LFFIFEYMEHN-LYHIMRER---------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-V 137 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~---------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~ 137 (432)
+|||||||+++ |.+.++.. ...+++.++..|+.||++||+|||+++|+||||||+|||++++ .
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence 89999999865 55555432 2358999999999999999999999999999999999999865 9
Q ss_pred EEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014039 138 LKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 138 lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~ 213 (432)
+||+|||+|+.+..... ....+||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+.+.+++.
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999987754432 23467899999999995 5679999999999999999998 9999998776555554432
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.-..+ ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 303 ~g~~~----------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 303 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 21111 1224678999999999999999999999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=412.79 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=220.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|+++.+|+.||+|++++... ........+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999975432 12233456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecC-CCCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELS-SMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~-~~~~~~ 156 (432)
|||++|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+... ......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 999987544444444457999999999999999999999999999999999999985 499999999998643 334456
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+.......+.. +..
T Consensus 164 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~------------------ 222 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEI------------------ 222 (337)
T ss_dssp CCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC------------------
T ss_pred ccccChhhCChhhhc-CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC------------------
Confidence 778999999999984 66799999999999999999999999998887666555532 111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.+...+++++.+||++||+.||++|| +++|+++||||+..+|.
T Consensus 223 ----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 11235789999999999999999999 89999999999999884
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=414.81 Aligned_cols=285 Identities=39% Similarity=0.671 Sum_probs=239.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH----HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE----ECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++++.||+|+||.||+|++..+|+.||+|++........ .....+|++++++++||||+++++++.+.+..|+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 689999999999999999999999999999999975432211 1245689999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..... ...
T Consensus 90 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (346)
T 1ua2_A 90 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169 (346)
T ss_dssp EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred EEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccC
Confidence 99999999988888777789999999999999999999999999999999999999865 9999999999876432 334
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++|+.|+|||++.+...++.++|||||||++|||++|.++|.+.+..+++.++....|.+....++.......+..
T Consensus 170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~- 248 (346)
T 1ua2_A 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT- 248 (346)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC-
T ss_pred CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc-
Confidence 5678999999999997667799999999999999999999999999999999999999999998877765444333322
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
+......++..++..++.++.+||++||+.||++|||++|+|+||||+...+
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 249 -FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp -CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred -ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 2223334445566788999999999999999999999999999999987544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=404.63 Aligned_cols=289 Identities=35% Similarity=0.593 Sum_probs=230.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|++|++++.||+|+||.||+|++..+|+.||+|++........ .....+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 6899999999999999999999999999999999976544332 334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||++++++..+....+.+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||+|...... .....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 999999888888777789999999999999999999999999999999999999854 9999999999876532 23456
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+...++.....................
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 68999999999997777899999999999999999999999999999999999888887654321111111111111111
Q ss_pred cccC-CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 238 SEIL-PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
+... ...+...+++++.++.+||++||+.||++|||++|+|+||||++..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 1111 111222346789999999999999999999999999999999986543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=416.32 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=219.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++++.||+|+||.||+|+++.+|+.||||++++... ........+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 5789999999999999999999999999999999976432 11233456899999887 99999999999999999999
Q ss_pred EEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCC
Q 014039 78 IFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPP 154 (432)
Q Consensus 78 V~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~ 154 (432)
||||++|+ |.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.... ...
T Consensus 96 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 99999875 5555444 4579999999999999999999999999999999999999854 999999999986532 334
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+....|.. +.+.
T Consensus 175 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~--------------- 236 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPF--------------- 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCC---------------
T ss_pred ccCCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCC---------------
Confidence 56778999999999985 56799999999999999999999999999888776666532 1111
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD-QALQHPFFNVETWV 289 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~-elL~Hp~f~~~~~~ 289 (432)
+...++.++.+||++||+.||++||++. |+++||||+..+|.
T Consensus 237 -------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 237 -------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred -------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 1235789999999999999999999998 99999999999884
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=413.54 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=213.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++++.||+|+||.||+|+++.+++.||+|++.+..... ......+|+.+++++ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999998654322 233456899999988 89999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~ 155 (432)
||||++++.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+... .....
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence 99999875444444444579999999999999999999999999999999999999854 99999999998643 33445
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCCCCCchhhh
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI--------DQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~--------d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
...+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.... +.+...+
T Consensus 168 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--------------- 231 (345)
T 3a8x_A 168 STFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------------- 231 (345)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH---------------
T ss_pred cccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH---------------
Confidence 6679999999999985 567899999999999999999999999753221 1111110
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA------DQALQHPFFNVETWV 289 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta------~elL~Hp~f~~~~~~ 289 (432)
.... ..+...++.++.+||++||+.||.+||++ +|+++||||+..+|.
T Consensus 232 -----~~~~---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 232 -----LEKQ---------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp -----HHCC---------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred -----HcCC---------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 0000 01224678999999999999999999996 899999999998884
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=420.51 Aligned_cols=280 Identities=36% Similarity=0.609 Sum_probs=221.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
++|++++.||+|+||.||+|.+..+|+.||||++...... .......+|+++|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5899999999999999999999999999999999765433 2334567999999999999999999998653 56
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+|||+++++|.+.+.. +.+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 109 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-- 184 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184 (367)
T ss_dssp CEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc--
Confidence 899999998877776654 469999999999999999999999999999999999999865 999999999987654
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
.....++|++|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++..|+..+|.|....+.... ...+.
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 34567899999999999766789999999999999999999999999999999999999999998755332211 11111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....++......+..+++.+++++++||++||++||++|||++|+|+||||+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 22234455556667777889999999999999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=412.43 Aligned_cols=286 Identities=36% Similarity=0.589 Sum_probs=236.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe--------
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE-------- 71 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-------- 71 (432)
+++|++++.||+|+||.||+|++..+|+.||+|++....... ......+|+++++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999999999999999987544322 22345689999999999999999999876
Q ss_pred CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 72 NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 72 ~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
.+.+|+||||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 45789999999999999988877789999999999999999999999999999999999999855 99999999998764
Q ss_pred C-----CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 151 S-----MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 151 ~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
. .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+....|.++...++.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 2 22335568899999999997667899999999999999999999999999999999999999999988776654
Q ss_pred hhhhhhhhhccccccCCCCccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIP--NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
......+............+..... ..++++.+||++||++||++|||++|+|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 4332222222211111111111000 137789999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=414.44 Aligned_cols=260 Identities=29% Similarity=0.415 Sum_probs=222.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|+++.+|+.||+|++.+..... ......+|+.+|++++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 47999999999999999999999999999999998654321 2344678999999999999999999999999999
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecCC
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~~ 151 (432)
+||||+.|+.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+++....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 999999865444444455689999999999999999999999999999999999999743 699999999998877
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.......+||+.|+|||++. ...|+.++||||+||++|+|++|.+||.+.+..+.+..|... .....
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~---------- 238 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--SYDFD---------- 238 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--CCCCC----------
T ss_pred CCccccCCCCccEECchHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCC----------
Confidence 66667789999999999984 567999999999999999999999999999887777666421 11100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
...+..++.++++||++||+.||++|||+.|+|+||||+..+|
T Consensus 239 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 239 --------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp --------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred --------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 1123467899999999999999999999999999999987554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=421.17 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=221.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999999753211 11223568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
||++|+.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+...... ...
T Consensus 149 E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp CCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 999775444444433 69999999999999999999999999999999999999854 99999999998765432 234
Q ss_pred cccCCccccchhhhcCCC---CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQSS---SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~---~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..+||+.|+|||++.+.. .|+.++|||||||++|||++|.+||.+.+..+...+|+......
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------- 292 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--------------- 292 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---------------
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---------------
Confidence 678999999999996433 28899999999999999999999999999888877775321111
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWVPYP 292 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~~~~ 292 (432)
.++ ....++.++++||++||+.+|.+ |++++|+++||||++.+|....
T Consensus 293 --~~p---------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~ 342 (410)
T 3v8s_A 293 --TFP---------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 342 (410)
T ss_dssp --CCC---------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTT
T ss_pred --cCC---------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHh
Confidence 111 11357899999999999999988 9999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=410.98 Aligned_cols=282 Identities=37% Similarity=0.634 Sum_probs=240.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN-----NELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (432)
++|++++.||+|+||.||+|++..+++.||||++.............+|+++|++++||||+++++++... ...|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 48999999999999999999999999999999998644434445567999999999999999999999654 4689
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-- 153 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-- 153 (432)
+||||+++++.+.+... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+......
T Consensus 107 iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 99999999988877654 59999999999999999999999999999999999999865 99999999998765322
Q ss_pred --CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-hh
Q 014039 154 --PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-IS 230 (432)
Q Consensus 154 --~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~~ 230 (432)
.....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...+|.|....+..... ..
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 234568999999999987777899999999999999999999999999999999999999999987654432111 11
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......+......+..+++.++.++.+||++||++||++|||++|+|+||||+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 1122234444455566677889999999999999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=414.34 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=219.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++++.||+|+||.||+|+++.+|+.||+|++++.... .......+|.++|..+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 57899999999999999999999999999999999764321 1233456899999988 89999999999999999999
Q ss_pred EEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCC
Q 014039 78 IFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPP 154 (432)
Q Consensus 78 V~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~ 154 (432)
||||++|+ |.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+... ....
T Consensus 99 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 99999875 5555544 3479999999999999999999999999999999999999854 99999999998643 3334
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+....|.. +.+
T Consensus 178 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~---------------- 238 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNV---------------- 238 (353)
T ss_dssp BCCCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC----------------
T ss_pred cccccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCC----------------
Confidence 56678999999999984 66789999999999999999999999999888777666643 111
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWVP 290 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~~ 290 (432)
.+...++.++.+||++||+.||.+||+ ++|+++||||+..+|..
T Consensus 239 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 239 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 112367899999999999999999994 69999999999998843
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=412.05 Aligned_cols=262 Identities=22% Similarity=0.379 Sum_probs=220.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|++..+++.||+|++.+.... .......+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999754321 1233456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||+.|+.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+..........
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceec
Confidence 9999887666666666689999999999999999999999999999999999999854 999999999998877667778
Q ss_pred ccCCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 158 YVSTRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
.+||+.|+|||++.. +..|+.++|||||||++|||++|.+||.+.+..+....+......
T Consensus 174 ~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------ 235 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------------------ 235 (384)
T ss_dssp CCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC------------------
T ss_pred cCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc------------------
Confidence 899999999999864 346899999999999999999999999865432221111100000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-ADQALQHPFFNVETWV 289 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-a~elL~Hp~f~~~~~~ 289 (432)
.......++.++.+||++||+.||.+||+ ++++++||||+..+|.
T Consensus 236 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 ---------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ---------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 01122457899999999999999999998 8999999999999884
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=406.10 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=220.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|+++.+|+.||+|++.+.... .......+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46899999999999999999999999999999999754321 1233456899999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||++| +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+..... ..
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~ 196 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cc
Confidence 999976 555555544 479999999999999999999999999999999999999854 9999999999877542 45
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+....|.. +.+
T Consensus 197 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~------------------ 255 (350)
T 1rdq_E 197 TLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKV------------------ 255 (350)
T ss_dssp CCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC------------------
T ss_pred cccCCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCC------------------
Confidence 678999999999985 56799999999999999999999999999888777666642 111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
.+...++.++.+||++||+.||.+||+ ++|+++||||+..+|.
T Consensus 256 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 112357899999999999999999998 9999999999999884
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=401.27 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=220.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|+++.+|+.||+|++.+.... .......+|+.+++.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 47899999999999999999999999999999999754321 1223456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||++|+.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+.... ....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~~ 162 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT 162 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCC
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cccc
Confidence 999987544444444557999999999999999999999999999999999999985 4999999999987654 3456
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+...++... ..
T Consensus 163 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~------------------- 220 (318)
T 1fot_A 163 LCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--EL------------------- 220 (318)
T ss_dssp CCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CC-------------------
T ss_pred ccCCccccCHhHhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------------
Confidence 78999999999985 667999999999999999999999999998887776666431 10
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
...+.++.++.+||++||+.||++|+ +++|+++||||+..+|.
T Consensus 221 ---------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 221 ---------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ---------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 11235788999999999999999999 89999999999998884
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=419.77 Aligned_cols=265 Identities=23% Similarity=0.373 Sum_probs=224.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||+||+|+++.+++.||+|++.+..... ......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997532211 1222568999999999999999999999999999999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--C
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--Y 155 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~ 155 (432)
|||+| +|.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....... .
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99976 5555555546689999999999999999999999999999999999999854 999999999987654332 2
Q ss_pred ccccCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
...+||+.|+|||++. +...|+.++|||||||++|||++|.+||.+.+..+...+|+...+..
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 300 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------------- 300 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------------
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-------------
Confidence 3468999999999986 25678999999999999999999999999999888887775321111
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLR--RPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--Rpta~elL~Hp~f~~~~~~~~ 291 (432)
.+ ......+++++++||++||+.+|++ |++++|+++||||+..+|...
T Consensus 301 ----~~--------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 301 ----QF--------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp ----CC--------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred ----cC--------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 11 1122468999999999999999988 999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=405.45 Aligned_cols=287 Identities=34% Similarity=0.589 Sum_probs=233.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|++++.||+|+||.||+|++..+|+.||+|++........ .....+|++++++++||||+++++++.+.+..|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 5799999999999999999999999999999999876544332 334568999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||++++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++..... .....
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCC
Confidence 999999999887777789999999999999999999999999999999999999855 9999999999865432 33455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|...............+.....
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 68999999999997666899999999999999999999999999999999999988888754332211111111222222
Q ss_pred cccC-CCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 238 SEIL-PINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 238 ~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
+... ........+.++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 2211 1222334467899999999999999999999999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=410.91 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=221.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.||+|+++.+|+.||+|++.+..... ......+|+.++..++||||+++++++.+.+.+|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997533211 1223568999999999999999999999999999999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC--C
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP--Y 155 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~--~ 155 (432)
||++| +|.+.+.+.+..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+....... .
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 99975 566666665568999999999999999999999999999999999999986 4999999999988755332 2
Q ss_pred ccccCCccccchhhhcC------CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQ------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~------~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
...+||+.|+|||++.. ...|+.++|||||||++|||++|.+||.+.+..+...+|+..-..
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------ 288 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH------------ 288 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------------
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------------
Confidence 34689999999999862 456899999999999999999999999999888877776531100
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR---PTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R---pta~elL~Hp~f~~~~~~~~ 291 (432)
..+ ......++.++++||++||+ +|.+| ++++|+++||||+..+|...
T Consensus 289 -----~~~--------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 289 -----LSL--------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp -----CCC--------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred -----cCC--------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 001 11124689999999999999 99998 59999999999999999765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=439.12 Aligned_cols=311 Identities=23% Similarity=0.357 Sum_probs=245.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|+++++||+|+||.||+|+++.+++.||||++++... ........+|..+|..+ +||||+++++++.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4689999999999999999999999999999999985432 12233456899999988 79999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~ 155 (432)
||||++|+.+..+....+.+++..++.|+.||+.||+|||++||+||||||+||||+.+ .+||+|||+|+... .....
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 99999875444444444579999999999999999999999999999999999999855 99999999998643 33445
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+....|+. +.+
T Consensus 500 ~~~~GT~~Y~APE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~----------------- 559 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNV----------------- 559 (674)
T ss_dssp CCCCSCSSSCCHHHHT-CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCC-----------------
T ss_pred ccccCCCcccCHhhhc-CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCC-----------------
Confidence 6789999999999984 67899999999999999999999999999988877777642 110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCCC---CCChhhhhccCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-----DQALQHPFFNVETWVPYP---LHDPLELRLNNMGSK 307 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta-----~elL~Hp~f~~~~~~~~~---~~~~~~~~~~~~~~~ 307 (432)
.+...++.++.+||++||++||++|+++ +||++||||+..+|.... +..|..++..+
T Consensus 560 -----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~---- 624 (674)
T 3pfq_A 560 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG---- 624 (674)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG----
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC----
Confidence 1224678999999999999999999997 999999999999994332 22233221111
Q ss_pred CCCccCCCCCCCCCCccccCccccccCChhhhhccCCcccccccccc
Q 014039 308 PNLELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQEDILFC 354 (432)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (432)
. +..+|+.+ |......+.|.+.+....+.+..+++|.|+
T Consensus 625 --~--~~~~f~~~----~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 663 (674)
T 3pfq_A 625 --R--NAENFDRF----FTRHPPVLTPPDQEVIRNIDQSEFEGFSFV 663 (674)
T ss_dssp --G--GHHHHTTT----TTSSCSSCCCCCHHHHTTCCGGGGTTCCEE
T ss_pred --C--chhhcCch----hccCCCccCCCchhhhhcccccccCCCccc
Confidence 0 11122211 111222355666666777888889999885
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=402.31 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=221.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+|+++|+.++||||+++++++.+.+.+|+||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 68999999999999999999999999999999997543 2344467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---CeEEEeeeccceecCCCCCCcc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
+++ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++..........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 986 566666555567999999999999999999999999999999999999984 4999999999998876665667
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++. ...++.++||||+||++|+|++|.+||.+.+..+....+.......+
T Consensus 163 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------ 223 (321)
T 1tki_A 163 LFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD------------------ 223 (321)
T ss_dssp EESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred ccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC------------------
Confidence 78999999999985 56689999999999999999999999999888777766643211110
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...++.++.++.+||++||+.||.+|||+.|+|+||||+.
T Consensus 224 --------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 224 --------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp --------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred --------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 0122467899999999999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=410.69 Aligned_cols=280 Identities=35% Similarity=0.578 Sum_probs=215.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCC------E
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENN------E 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~ 74 (432)
++|++++.||+|+||.||+|.+..+++.||||++....... ......+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 68999999999999999999999999999999998654332 3344678999999999999999999997654 7
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+||||+++++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+......
T Consensus 105 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 89999999999888775 258999999999999999999999999999999999999855 99999999998776555
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+..+++..++..+|.|....+..........
T Consensus 182 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp --------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred ccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 556678999999999985 5678999999999999999999999999999999999999888877543221111000000
Q ss_pred hccccccCCCCccccCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDIIP------------NASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~------------~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+......+...++ ..+.++++||++||+.||++|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00011111111111111 12568999999999999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=404.93 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=216.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|.+..+++.||+|++.+..... ......+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999997543211 123467899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||++|++++.+...+ .+++.+++.++.||+.||.|||++||+||||||+|||++++ .+||+|||++...........
T Consensus 88 ~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp ECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred EECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 9999999998887664 69999999999999999999999999999999999999965 999999999988776666677
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++.+...++.++||||+||++|+|++|..||.+........
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------------------- 218 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------------------- 218 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------------------
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------------------
Confidence 8999999999999655555899999999999999999999997654211000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. ...........+++++.+||++||+.||.+|||++|+++||||+.
T Consensus 219 -~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 219 -K-VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -C-CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -H-HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 0 000111233468999999999999999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=399.02 Aligned_cols=259 Identities=29% Similarity=0.404 Sum_probs=220.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.+.||+|+||.||+|.++.+|+.||+|++....... ....+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46999999999999999999999999999999997644321 2344678999999999999999999999999999
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecCC
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~~ 151 (432)
+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 999999875444444455689999999999999999999999999999999999999743 699999999998876
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.......+||+.|+|||++. ...++.++|||||||++|+|++|.+||.+....+.+..+.......
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 236 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF------------- 236 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC-------------
T ss_pred CCccccccCCcCcCCceeec-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc-------------
Confidence 55666778999999999984 6678999999999999999999999999988877766654321110
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
....+..++.++.+||++||+.||++|||+.|+|+||||+..+
T Consensus 237 -------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 237 -------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp -------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred -------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 0112246788999999999999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=399.22 Aligned_cols=285 Identities=36% Similarity=0.587 Sum_probs=235.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN-----NELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (432)
++|++.+.||+|+||.||+|.+..+|+.||||++.............+|++++++++||||+++++++... ...|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 58999999999999999999999999999999997544333444567899999999999999999987653 6789
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-- 153 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-- 153 (432)
+||||+.+++.+.+... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+......
T Consensus 91 lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 91 IIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 99999999888877653 69999999999999999999999999999999999999865 99999999998764321
Q ss_pred ---------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 154 ---------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 154 ---------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+....|.+......
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 12345789999999998777889999999999999999999999999999999999999999988754332
Q ss_pred hhhhhhhh--hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 225 EATNISRL--ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 225 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
......+. .....+......+...++.+++++.+||++||+.||++|||++|+|+||||+...+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 21111111 11122333334455566789999999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=403.40 Aligned_cols=256 Identities=32% Similarity=0.474 Sum_probs=219.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|++++++++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999999999998655433 33446789999999999999999999999999999999
Q ss_pred cCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCCCCC
Q 014039 81 YMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~~~~ 155 (432)
|+.++ +.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|.........
T Consensus 109 ~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99875 555554 44579999999999999999999999999999999999999742 6999999999888766666
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. ...|+.++|||||||++|+|++|.+||.+.+..+....+... .....
T Consensus 188 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~-------------- 250 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AYDYP-------------- 250 (362)
T ss_dssp CCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCC--------------
T ss_pred ccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCC--------------
Confidence 6789999999999984 567999999999999999999999999998877666655331 11100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+..+++++.+||.+||+.||++|||+.|+|+||||..
T Consensus 251 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 251 ----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ----------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 0112357889999999999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=411.61 Aligned_cols=256 Identities=31% Similarity=0.475 Sum_probs=217.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||+||+|.++.+|+.||+|++....... ......+|+++|+.++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 47999999999999999999999999999999998655332 33446799999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceecCCCC-C
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARELSSMP-P 154 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~~~~~-~ 154 (432)
|+.| ++.+.+..+ +.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+...... .
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9987 555665554 57999999999999999999999999999999999999973 489999999998765432 3
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....+||+.|+|||++. ...|+.++||||+||++|+|++|.+||.+.+..+....+.......+
T Consensus 170 ~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 233 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP--------------- 233 (444)
T ss_dssp CCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred eecccCCcccCCHHHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC---------------
Confidence 45678999999999984 56799999999999999999999999999888777766643211111
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...++.+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus 234 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 234 -----------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -----------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -----------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 1123467899999999999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=403.72 Aligned_cols=283 Identities=31% Similarity=0.565 Sum_probs=228.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch----------HHHHHHHHHHHHHhcCCCcccccceEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW----------EECMNLREVKALRKLNHPNIIKLKEVVRE 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 71 (432)
++|++++.||+|+||.||+|.+.. |+.||||++....... ......+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 689999999999999999998865 8899999996533211 12446789999999999999999999843
Q ss_pred -----CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 72 -----NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 72 -----~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
...+|+||||+++++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 34789999999999999998777789999999999999999999999999999999999999854 999999999
Q ss_pred ceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 146 ARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 146 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
++...........++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+....|.+.......
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence 98766655566778999999999997667899999999999999999999999999999999999999999887553321
Q ss_pred h--hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 226 A--TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 226 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. .....+............+....+..++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 1 11122222333334444555566788999999999999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=407.74 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=213.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHH-HHhcCCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKA-LRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++++.||+|+||.||+|+++.+++.||+|++.+..... ......+|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999999999999999998654322 22334567776 466899999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecC-CCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELS-SMPPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~-~~~~~ 155 (432)
||||++|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+... .....
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCcc
Confidence 9999987544444444457999999999999999999999999999999999999985 499999999998643 33445
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+....|+.. ..
T Consensus 197 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~----------------- 256 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PL----------------- 256 (373)
T ss_dssp CSBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CC-----------------
T ss_pred ccccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cc-----------------
Confidence 6779999999999985 667999999999999999999999999998887776666421 00
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA----DQALQHPFFNVETWVP 290 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta----~elL~Hp~f~~~~~~~ 290 (432)
.+.+.++.++.+||++||+.||.+|+++ .|+++||||+..+|..
T Consensus 257 -----------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 257 -----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp -----------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 1224678999999999999999999997 6999999999999843
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=402.64 Aligned_cols=279 Identities=37% Similarity=0.597 Sum_probs=230.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEE-----
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNEL----- 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~----- 75 (432)
++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 589999999999999999999999999999999986543332 34467899999999999999999999876544
Q ss_pred -EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 76 -FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 76 -~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
|+||||+.+++.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 122 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-- 196 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-- 196 (371)
T ss_dssp CEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc--
Confidence 999999998877665 3359999999999999999999999999999999999999865 999999999986644
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
.....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...|.+..+...... .....
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 34567899999999999766789999999999999999999999999999999999999999988654322111 01111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+......+..+++.+++++.+||++||++||++|||++|+|+||||+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 11223333444455566788999999999999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=404.57 Aligned_cols=282 Identities=32% Similarity=0.538 Sum_probs=223.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCE------
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNE------ 74 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~------ 74 (432)
+++|++.+.||+|+||.||+|++..+|+.||||++...... .....+|++.++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 47899999999999999999999999999999998654322 2234578888899999999999999865332
Q ss_pred -EEEEEecCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCceeEeC--CeEEEeeeccc
Q 014039 75 -LFFIFEYMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMH--RNGYFHRDLKPENLLVTN--DVLKIADFGLA 146 (432)
Q Consensus 75 -~~lV~E~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH--~~givHrDlkP~NILl~~--~~lkL~DFG~a 146 (432)
+++||||+++++...+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++. +.+||+|||+|
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 789999999998776653 4567999999999999999999999 999999999999999984 49999999999
Q ss_pred eecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 147 RELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
+...........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...+|.++...+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 98877666677889999999999977777999999999999999999999999999999999999999998875543221
Q ss_pred hhhhhhhhccccccCCCCccccC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 227 TNISRLISISYSEILPINLSDII----PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
. .......+.......+...+ ...+.++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 260 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 260 N--PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp C--TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred c--cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 1 11111122222222333332 2367899999999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=390.19 Aligned_cols=254 Identities=26% Similarity=0.498 Sum_probs=216.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|.+..+|+.||+|++...... ......+|+.++++++||||+++++++.+.+.+|+||||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 5799999999999999999999999999999999754432 233467899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~ 159 (432)
+.++.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|....... .....+
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 177 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCcc
Confidence 9765554444443 69999999999999999999999999999999999999854 99999999998765432 345568
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
||+.|+|||++. ...|+.++||||+||++|||++|..||.+.+..+....+... +.+...
T Consensus 178 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~------------------ 237 (297)
T 3fxz_A 178 GTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQ------------------ 237 (297)
T ss_dssp SCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCS------------------
T ss_pred CCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCC------------------
Confidence 999999999985 567899999999999999999999999998887776665432 211111
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....++.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 238 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 238 --------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp --------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 11357889999999999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=410.18 Aligned_cols=279 Identities=33% Similarity=0.543 Sum_probs=227.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc------CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL------NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~~~~~~~ 75 (432)
.+|+++++||+|+||.||+|.+..+++.||||++..... ......+|+++++.+ +|+||+++++++...+.+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 479999999999999999999999999999999976432 223345788888776 578999999999999999
Q ss_pred EEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-e--EEEeeeccceecCC
Q 014039 76 FFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-V--LKIADFGLARELSS 151 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~--lkL~DFG~a~~~~~ 151 (432)
|+||||+.+++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ . +||+|||+|+....
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9999999999999887654 459999999999999999999999999999999999999865 4 99999999987544
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....++|+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+++..++..+|.|+...+........
T Consensus 255 --~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 255 --RVYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp --CCCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred --cccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 345678999999999996 55689999999999999999999999999999999999999999887654322221111
Q ss_pred hhhc-cccc---------------------------cCCCCccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014039 232 LISI-SYSE---------------------------ILPINLSD-IIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282 (432)
Q Consensus 232 ~~~~-~~~~---------------------------~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~ 282 (432)
+... .++. .....+.. +....++++++||++||++||++|||++|+|+|||
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 1110 0000 00001111 11245889999999999999999999999999999
Q ss_pred CCC
Q 014039 283 FNV 285 (432)
Q Consensus 283 f~~ 285 (432)
|+.
T Consensus 412 ~~~ 414 (429)
T 3kvw_A 412 LRR 414 (429)
T ss_dssp TC-
T ss_pred hcc
Confidence 986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=399.13 Aligned_cols=258 Identities=27% Similarity=0.350 Sum_probs=212.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+++|++++.||+|+||.||+|++..+++.||+|++.............+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 57999999999999999999999999999999999765443334456789999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC---CCCc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM---PPYT 156 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~---~~~~ 156 (432)
|++++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++.+... ....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 9987555444445557999999999999999999999999999999999999986 49999999999865322 2334
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+................
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------- 226 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------- 226 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------------------
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------------------
Confidence 6789999999999976665688999999999999999999999876654332222110000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+..++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 227 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 227 --------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp --------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 00112357889999999999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=416.33 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=211.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|+++++||+|+||.||+|++..+|+.||||++...... .......+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999754321 2223456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecC-CCCCC
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPY 155 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~-~~~~~ 155 (432)
|||++++.+..+..+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+||+|||+|+... .....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 9999876554444444579999999999999999999998 999999999999999855 99999999998643 33345
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.+..+....+.. +..
T Consensus 307 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~----------------- 366 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEI----------------- 366 (446)
T ss_dssp CCSSSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-----------------
T ss_pred ccccCCccccCHhhcC-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCC-----------------
Confidence 6678999999999985 66799999999999999999999999999887766665532 110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.+...+++++.+||.+||++||.+|| |++|+++||||+..+|.
T Consensus 367 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 367 -----------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 11235789999999999999999999 99999999999998874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=397.39 Aligned_cols=263 Identities=24% Similarity=0.274 Sum_probs=187.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC----EEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN----ELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~l 77 (432)
++|.+.++||+|+||+||+|++ +|+.||||++..... ......+|+..+.+++|||||++++++.+.+ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 5799999999999999999976 689999999975432 2222335677777899999999999987543 6899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN--------GYFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~--------givHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
|||||+++.+..+.++. +++++.+..++.|++.||+|||++ ||+||||||+||||+.+ .+||+|||+|+.
T Consensus 79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999965444444433 699999999999999999999987 99999999999999865 999999999987
Q ss_pred cCCCCC-----CccccCCccccchhhhcCCC-----CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014039 149 LSSMPP-----YTEYVSTRWYRAPEVLLQSS-----SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 149 ~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
...... ....+||+.|+|||++.+.. .|+.++|||||||++|||++|.+||....... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~-----------~ 226 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-----------L 226 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC-----------C
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc-----------c
Confidence 654322 23468999999999986432 46789999999999999999998875433210 0
Q ss_pred CCCCc-hhhhhhhhhhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 219 DWTAF-PEATNISRLISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 219 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
++... +....................+...+ ..+...+.+|+.+||+.||++|||+.|+++.
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000 00000000000000000000111111 1234568899999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=403.75 Aligned_cols=257 Identities=31% Similarity=0.389 Sum_probs=199.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|+++.+++.||+|++....... ....+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC--HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc--HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 68999999999999999999999999999999997654322 3356899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC---eEEEeeeccceecCCCCCCcc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~---~lkL~DFG~a~~~~~~~~~~~ 157 (432)
+.+ ++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..........
T Consensus 98 ~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 176 (361)
T 3uc3_A 98 ASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176 (361)
T ss_dssp CCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence 976 45555544 4479999999999999999999999999999999999999854 499999999986555455566
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+........+++........ .+
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------~~ 241 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY---------------SI 241 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC---------------CC
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC---------------CC
Confidence 789999999999975554555699999999999999999999886554333333221111100 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+ ....+++++.+||++||+.||++|||+.|+++||||..
T Consensus 242 ~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 242 P---------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp C---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred C---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 0 11257899999999999999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=393.97 Aligned_cols=256 Identities=29% Similarity=0.509 Sum_probs=209.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc---hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF---WEECMNLREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
++|++++.||+|+||.||+|++. .+|+.||+|++++.... .......+|+++|+.++||||+++++++.+.+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 68999999999999999999985 68999999999865322 1223356899999999999999999999999999
Q ss_pred EEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-C
Q 014039 76 FFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-M 152 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~ 152 (432)
|+||||++++ +.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... .
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 9999999865 5555544 4579999999999999999999999999999999999999854 999999999976432 2
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.+..+....+... ..
T Consensus 176 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~-------------- 238 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KL-------------- 238 (327)
T ss_dssp ---CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC--------------
T ss_pred ccccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CC--------------
Confidence 3345678999999999985 567899999999999999999999999998887776666431 10
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.+.+.++.++.+||++||+.||++|| ++.|+++||||+..+|.
T Consensus 239 --------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 239 --------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp --------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred --------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 11235788999999999999999999 89999999999988873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.44 Aligned_cols=285 Identities=34% Similarity=0.598 Sum_probs=235.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-CCCeEEEEEEecccccch-HHHHHHHHHHHHHhc---CCCcccccceEEE-----e
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-ETYEIVAVKKMKRKFYFW-EECMNLREVKALRKL---NHPNIIKLKEVVR-----E 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~-----~ 71 (432)
++|++++.||+|+||.||+|++. .+|+.||+|++....... ......+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 57999999999999999999995 778999999997543221 112345677777766 8999999999986 4
Q ss_pred CCEEEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 72 NNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 72 ~~~~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
....++||||+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 56789999999999888887653 359999999999999999999999999999999999999854 9999999999876
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
..........+|+.|+|||++. ...++.++|||||||++|+|++|.+||.+....+.+..++..+|.+....++.....
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cCCCCccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 6544455678999999999985 566899999999999999999999999999999999999999998876655433222
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~ 290 (432)
.+ ..+.......+..+.+.++.++.+||.+||+.||++|||+.|+|+||||+...+..
T Consensus 250 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 250 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp CG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 21 11222233445556678999999999999999999999999999999999765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=401.49 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=221.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+|+++|++++||||+++++++.+...+|+||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 579999999999999999999999999999999976542 2333467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---CeEEEeeeccceecCCCCCCcc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
+.+ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+..........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 986 555555555557999999999999999999999999999999999999973 3799999999998876555566
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.+..+.+..+....-..
T Consensus 210 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------------- 269 (387)
T 1kob_A 210 TTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF------------------- 269 (387)
T ss_dssp ECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred eccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------------
Confidence 78999999999985 5678999999999999999999999999988877766653211000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
....+..++.++.+||++||+.||++|||+.|+|+||||+...+
T Consensus 270 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 270 -------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp -------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred -------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 01223468899999999999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=401.50 Aligned_cols=288 Identities=20% Similarity=0.219 Sum_probs=213.1
Q ss_pred CCeeEeeeEeec--CceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDG--TCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|+++++||+| +||.||+|+++.+|+.||||++........ .....+|+++++.++||||+++++++.+.+.+|+|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 589999999999 999999999999999999999986554433 33456899999999999999999999999999999
Q ss_pred EecCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC---
Q 014039 79 FEYMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM--- 152 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~--- 152 (432)
|||++++ +.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 9999865 55555443 357999999999999999999999999999999999999985 49999999998654221
Q ss_pred -----CCCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC--------C
Q 014039 153 -----PPYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA--------P 218 (432)
Q Consensus 153 -----~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~--------p 218 (432)
......+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+.+..++...-. +
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence 112334789999999999654 57999999999999999999999999988776665554321100 0
Q ss_pred CCCCchhhh------hhhhhhh--ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 219 DWTAFPEAT------NISRLIS--ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 219 ~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
......... ....... ...+.............+++++.+||++||++||++|||++|+|+||||+...+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 000000000 0000000 0000001111222345689999999999999999999999999999999986553
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=396.04 Aligned_cols=278 Identities=27% Similarity=0.414 Sum_probs=223.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-----CCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-----HPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~~~~~~~~~~~ 76 (432)
++|+++++||+|+||.||+|++..+++.||+|++..... ......+|+.+++.+. ||||+++++++...+..|
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH--HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh--hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 589999999999999999999999999999999975321 2333567999999986 999999999999999999
Q ss_pred EEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe---------------------
Q 014039 77 FIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT--------------------- 134 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~--------------------- 134 (432)
+||||+.++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 113 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 999999888888887653 4699999999999999999999999999999999999996
Q ss_pred -----CCeEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHH
Q 014039 135 -----NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY 209 (432)
Q Consensus 135 -----~~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~ 209 (432)
++.+||+|||+|+.... .....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 34899999999987554 345678999999999985 5679999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCchhhhhhhh--hhh-----ccccccCC---------CCccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 014039 210 KVCCILGAPDWTAFPEATNISR--LIS-----ISYSEILP---------INLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273 (432)
Q Consensus 210 ~i~~~~g~p~~~~~~~~~~~~~--~~~-----~~~~~~~~---------~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt 273 (432)
.+....+.++...+........ +.. ..++.... ..........++++.+||++||++||++|||
T Consensus 270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 349 (360)
T 3llt_A 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349 (360)
T ss_dssp HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence 9888887766432221110000 000 00000000 0000011123578889999999999999999
Q ss_pred HHHHhcCCCCC
Q 014039 274 ADQALQHPFFN 284 (432)
Q Consensus 274 a~elL~Hp~f~ 284 (432)
++|+|+||||+
T Consensus 350 a~elL~hp~f~ 360 (360)
T 3llt_A 350 PAELLKHKFLE 360 (360)
T ss_dssp HHHHTTSGGGC
T ss_pred HHHHhcCcccC
Confidence 99999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=406.75 Aligned_cols=282 Identities=34% Similarity=0.590 Sum_probs=213.3
Q ss_pred CeeE-eeeEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEE
Q 014039 3 RYKI-LEELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFF 77 (432)
Q Consensus 3 ~Y~~-~~~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (432)
.|++ .++||+|+||.||+|+++ .+++.||||++...... ....+|+++|++++||||+++++++.. ...+|+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 4777 458999999999999976 57889999999765432 235689999999999999999999954 678999
Q ss_pred EEecCCCcHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE----eC-CeEEEeeec
Q 014039 78 IFEYMEHNLYHIMRER--------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV----TN-DVLKIADFG 144 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~--------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl----~~-~~lkL~DFG 144 (432)
||||+.+++++.+... ...+++..++.++.||+.||+|||++||+||||||+|||+ +. +.+||+|||
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 9999999988877532 1259999999999999999999999999999999999999 33 499999999
Q ss_pred cceecCCC----CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Q 014039 145 LARELSSM----PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---------IDQLYKV 211 (432)
Q Consensus 145 ~a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~---------~d~~~~i 211 (432)
+|+..... ......+||++|+|||++.+...|+.++|||||||++|||++|.+||.+... .+++..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99876432 2335578999999999997667799999999999999999999999987665 5899999
Q ss_pred HHHhCCCCCCCchhhhhhhhhhhc----cccccCCCCc----cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 212 CCILGAPDWTAFPEATNISRLISI----SYSEILPINL----SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 212 ~~~~g~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~----~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
+..+|.|....|............ .........+ .......+.++.+||++||++||.+|||++|+|+||||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 999999998877543322221110 0000000000 01112347789999999999999999999999999999
Q ss_pred CCCC
Q 014039 284 NVET 287 (432)
Q Consensus 284 ~~~~ 287 (432)
....
T Consensus 338 ~~~~ 341 (405)
T 3rgf_A 338 LEDP 341 (405)
T ss_dssp TSSS
T ss_pred ccCC
Confidence 8743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=380.49 Aligned_cols=259 Identities=31% Similarity=0.450 Sum_probs=221.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+|++++++++||||+++++++.+.+..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 68999999999999999999999999999999998655433 33446689999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCCCCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~~~~ 155 (432)
|+.+ ++.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++.........
T Consensus 86 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 86 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 9987 455555544 479999999999999999999999999999999999999743 5999999999888766666
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.........+.......+
T Consensus 165 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 227 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP---------------- 227 (284)
T ss_dssp CCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----------------
T ss_pred cCCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC----------------
Confidence 6788999999999985 56789999999999999999999999999887766665533211111
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
...+..+++++.+||++||+.||++|||++|+|+||||++..+
T Consensus 228 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 228 ----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ----------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ----------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 1112467899999999999999999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=389.62 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=208.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||+||+|++..+|+.||||++....... ......+|+..+.++ +||||+++++++.+.+.+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999987654332 333445677666666 9999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||+.+++.+.+...+..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+...........
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 216 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CC
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCccc
Confidence 999999999988877789999999999999999999999999999999999999855 9999999999887765556667
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.||+.|+|||++.+ .++.++|||||||++|||++|..+|.+....+.+.. +. .
T Consensus 217 ~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-----~~-------------------~- 269 (311)
T 3p1a_A 217 EGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-----GY-------------------L- 269 (311)
T ss_dssp CCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT-----TC-------------------C-
T ss_pred CCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc-----cC-------------------C-
Confidence 89999999998853 689999999999999999999877765433222110 00 0
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......++.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 270 ------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 00122467899999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=387.78 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=207.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-------------------------HHHHHHHHHHHHH
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------------------------EECMNLREVKALR 55 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------------~~~~~~~Ei~~l~ 55 (432)
+++|++.+.||+|+||.||+|++..+++.||+|++....... ......+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999997543211 1234578999999
Q ss_pred hcCCCcccccceEEEe--CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE
Q 014039 56 KLNHPNIIKLKEVVRE--NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV 133 (432)
Q Consensus 56 ~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl 133 (432)
+++||||+++++++.+ .+.+|+||||++++.+..+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999986 578999999998765544433 3479999999999999999999999999999999999999
Q ss_pred eCC-eEEEeeeccceecCCCC-CCccccCCccccchhhhcCCCC--CCcccceechHHHHHHHHhCCCCCCCCChHHHHH
Q 014039 134 TND-VLKIADFGLARELSSMP-PYTEYVSTRWYRAPEVLLQSSS--YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY 209 (432)
Q Consensus 134 ~~~-~lkL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~ 209 (432)
+.+ .+||+|||+++...... .....+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 855 99999999998765432 2345689999999999864432 4789999999999999999999998877655444
Q ss_pred HHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 210 KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 210 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.+.. +... ++ ..+.++.++.+||.+||+.||++|||+.|+|+||||+
T Consensus 251 ~~~~--~~~~-----------------~~---------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 251 KIKS--QALE-----------------FP---------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHH--CCCC-----------------CC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHhc--ccCC-----------------CC---------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 4321 1100 00 1236789999999999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=382.02 Aligned_cols=255 Identities=30% Similarity=0.432 Sum_probs=210.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+|+++|++++||||+++++++.+....|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 47999999999999999999999999999999998765444445567899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceecCCCC
Q 014039 82 MEH-NLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARELSSMP 153 (432)
Q Consensus 82 ~~~-~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~~~~~ 153 (432)
+++ ++.+.+.. .+..+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 986 66666643 3467999999999999999999999999999999999999953 379999999998776655
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....++|+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.. +.+...
T Consensus 182 ~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~------------ 245 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--KEPNYA------------ 245 (285)
T ss_dssp -----CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCC------------
T ss_pred cCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc--CCcccc------------
Confidence 566778999999999883 5689999999999999999999999998876655444321 111110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus 246 -------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 -------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 111246889999999999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=392.04 Aligned_cols=279 Identities=37% Similarity=0.596 Sum_probs=229.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCE------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNE------ 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~------ 74 (432)
++|++.+.||+|+||.||+|.++.+|+.||||++........ .....+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 579999999999999999999999999999999976543332 3446789999999999999999999976543
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+||||+.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||+++....
T Consensus 104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-- 178 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-- 178 (353)
T ss_dssp CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC--
Confidence 59999999987766542 359999999999999999999999999999999999999865 999999999986543
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh-hhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-ISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~-~~~~ 232 (432)
.....++|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+++..+....|.++...+..... ....
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 344568999999999997667899999999999999999999999999999999999999999876442221110 0111
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+......+..+++.+++++.+||++||+.||++|||++|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 11223333444555667789999999999999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=392.95 Aligned_cols=256 Identities=32% Similarity=0.464 Sum_probs=198.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+|+++|++++||||+++++++.+.+..|+||||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 46999999999999999999999999999999998643 223356899999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe----CCeEEEeeeccceecCCCCCCcc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~----~~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
++++.+.......+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..........
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 98654444444455799999999999999999999999999999999999997 34999999999987765555566
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLY-KVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
.+||+.|+|||++. +..++.++|||||||++|||++|..||.+....+... .+.. +..
T Consensus 210 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~--~~~------------------ 268 (349)
T 2w4o_A 210 VCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN--CEY------------------ 268 (349)
T ss_dssp ---CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT--TCC------------------
T ss_pred ccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh--CCC------------------
Confidence 78999999999985 5678999999999999999999999998776654332 2211 000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
......++.++.++.+||++||+.||++|||+.|+|+||||....
T Consensus 269 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 269 ------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 001123356889999999999999999999999999999998644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=389.22 Aligned_cols=279 Identities=28% Similarity=0.502 Sum_probs=222.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEe--CCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRE--NNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~~~lV 78 (432)
++|++++.||+|+||.||+|++..+++.||+|++.... .....+|+++++++. ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 57999999999999999999999999999999997543 234678999999996 9999999999987 6778999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CC-eEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-ND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||+.++.+..+.. .+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|+.........
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 99999876665553 489999999999999999999999999999999999998 44 89999999999887666667
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCCCCchhhhhh--hhhh
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIF-PGDSEIDQLYKVCCILGAPDWTAFPEATNI--SRLI 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF-~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~--~~~~ 233 (432)
..++|+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+++..+...+|.+....+...... ....
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 7889999999999976678999999999999999999999887 566777888888777765332111000000 0000
Q ss_pred hccccccCCCCcccc-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 234 SISYSEILPINLSDI-----IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~-----~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
...........+... ...++.++.+||++||++||++|||++|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 000000011111111 123789999999999999999999999999999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=388.21 Aligned_cols=259 Identities=28% Similarity=0.387 Sum_probs=220.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|++..+|+.||+|++....... ......+|++++++++||||+++++++.+.+..|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46999999999999999999999999999999997543321 2344678999999999999999999999999999
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecCC
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~~ 151 (432)
+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 999999865444444455679999999999999999999999999999999999999754 699999999998876
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
........||+.|+|||++. ...++.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------- 237 (321)
T 2a2a_A 172 GVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF------------- 237 (321)
T ss_dssp TCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-------------
T ss_pred cccccccCCCCCccCccccc-CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc-------------
Confidence 66666778999999999984 5678999999999999999999999999988777766653211100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
....+..++.++.+||++||+.||++|||+.|+++||||+..+
T Consensus 238 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 -------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 0012246788999999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=411.30 Aligned_cols=256 Identities=29% Similarity=0.392 Sum_probs=219.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|++..+|+.||||++.+.... .......+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999754321 1233467899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++..........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccc
Confidence 9999875555455555689999999999999999999999999999999999999865 999999999998876666677
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+......++... ..
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~------------------- 233 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IF------------------- 233 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CC-------------------
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--Cc-------------------
Confidence 899999999999975555688999999999999999999999988776666655321 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....+++++.+||++||+.||++|||+.|+++||||+..
T Consensus 234 ---------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 ---------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1123578899999999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=387.90 Aligned_cols=284 Identities=36% Similarity=0.591 Sum_probs=221.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE-----------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR----------- 70 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----------- 70 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 58999999999999999999999999999999987543 223345678999999999999999999873
Q ss_pred ---eCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CC-eEEEeeecc
Q 014039 71 ---ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-ND-VLKIADFGL 145 (432)
Q Consensus 71 ---~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~-~lkL~DFG~ 145 (432)
+....|+||||+++++.+.+.. +++++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 3468899999999888777643 4699999999999999999999999999999999999997 34 999999999
Q ss_pred ceecCCC----CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSM----PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++..... .......+|++|+|||++.+...++.++|||||||++|||++|..||.+.+..+....+....+.+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 9876432 223455779999999998776789999999999999999999999999999988888887766554332
Q ss_pred Cchhhhh-hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 222 AFPEATN-ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 222 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
....... ...+..... ......+....+.++.++.+||++||+.||++|||++|+|+||||+...|.
T Consensus 248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDM-TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHTTSCHHHHHHT-TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhcCcccccccc-cCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 2111000 000111000 111223344556789999999999999999999999999999999875543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=394.75 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=211.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc----hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF----WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++++.||+|+||.||+|.++.+|+.||+|++...... .......+|+++++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4699999999999999999999999999999999643211 123446789999999999999999999999999999
Q ss_pred EEecCCC-cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceec
Q 014039 78 IFEYMEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLAREL 149 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~ 149 (432)
||||+++ +|.+.+... +..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999986 555555432 3469999999999999999999999999999999999999743 4999999999887
Q ss_pred CCCCC-CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 150 SSMPP-YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 150 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
..... ....+||+.|+|||++. ...|+.++|||||||++|+|++|.+||.+... +....+.. +.....
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~--~~~~~~------- 252 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIK--GKYKMN------- 252 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHH--TCCCCC-------
T ss_pred cCCCeeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHc--CCCCCC-------
Confidence 65432 34568999999999985 56789999999999999999999999988532 23333321 111100
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+..++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 253 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 253 -----------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -----------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 01123678999999999999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=417.72 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=216.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|+++++||+|+||.||+|+++.+|+.||+|++.+.... .......+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999999754321 12334568999999999999999999999999999999
Q ss_pred ecCCCcHH-HHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 80 EYMEHNLY-HIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 80 E~~~~~ll-~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
||++|+.+ ..+...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.........
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 343 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence 99987544 4444332 359999999999999999999999999999999999999854 99999999999887666666
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---DQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~---d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
..+||+.|+|||++. ...|+.++|||||||++|||++|.+||.+.... ..+...+.. ..
T Consensus 344 ~~~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~---------------- 405 (576)
T 2acx_A 344 GRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VP---------------- 405 (576)
T ss_dssp CCCSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CC----------------
T ss_pred ccCCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cc----------------
Confidence 779999999999985 567999999999999999999999999886532 222221110 00
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
..+...+++++.+||++||+.||.+|| +++|+++||||+..+|.
T Consensus 406 ------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 406 ------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred ------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 012246789999999999999999999 89999999999998884
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=380.41 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=199.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHH-HHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~-~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|++..+|+.||+|++............. ++...++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 68999999999999999999999999999999998654433333333 44555777899999999999999999999999
Q ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCC
Q 014039 81 YMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~ 155 (432)
|+++++.+.+.. .+..+++..++.++.||+.||+|||++ ||+||||||+||+++. +.+||+|||+|+........
T Consensus 87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 999988666543 566899999999999999999999998 9999999999999996 49999999999877665555
Q ss_pred ccccCCccccchhhh---cCCCCCCcccceechHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVL---LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS-EIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l---~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~-~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
....+|+.|+|||++ .....++.++||||+||++|+|++|..||.+.. ....+..+.. ...+.
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~------------ 233 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-EPSPQ------------ 233 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH-SCCCC------------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc-cCCCC------------
Confidence 566899999999997 356678999999999999999999999998743 3333333321 11100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 234 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 ---------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011357889999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=389.19 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=218.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+|++++.||+|+||.||+|++..+|+.||||++....... ......+|+++|++++||||+++++++.+.+..|+|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 5999999999999999999999999999999997644332 22346789999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+.|++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... ....+
T Consensus 135 ~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~ 211 (348)
T 1u5q_A 135 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV 211 (348)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCccc
Confidence 99999999887777789999999999999999999999999999999999999864 999999999987643 34568
Q ss_pred CCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
||+.|+|||++.. ...++.++|||||||++|||++|.+||.+.+..+.+..+... ..+.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~-~~~~------------------ 272 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPA------------------ 272 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCC------------------
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCC------------------
Confidence 9999999999853 567899999999999999999999999998887776665321 0000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....++.++.+||.+||+.||++|||++++++||||..
T Consensus 273 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 273 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 011356889999999999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=396.81 Aligned_cols=278 Identities=25% Similarity=0.428 Sum_probs=221.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC--------CCcccccceEEE---
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN--------HPNIIKLKEVVR--- 70 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~~~~~--- 70 (432)
++|+++++||+|+||.||+|++..+++.||+|++.... .......+|+++|+.+. |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 58999999999999999999999999999999997542 22344568999999984 788999999987
Q ss_pred -eCCEEEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-----------
Q 014039 71 -ENNELFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND----------- 136 (432)
Q Consensus 71 -~~~~~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~----------- 136 (432)
+...+|+||||+.+++++.+.... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456789999999999999887654 5799999999999999999999998 99999999999999744
Q ss_pred ---------------------------------------eEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCC
Q 014039 137 ---------------------------------------VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177 (432)
Q Consensus 137 ---------------------------------------~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~ 177 (432)
.+||+|||+|+.... .....+||+.|+|||++. ...|+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~ 271 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLI-GSGYN 271 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHH-TSCCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhc-CCCCC
Confidence 699999999987754 345668999999999996 45689
Q ss_pred cccceechHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc-----ccccCCCCc-
Q 014039 178 PAIDMWAVGAILAELFTLSPIFPGDS------EIDQLYKVCCILGAPDWTAFPEATNISRLISIS-----YSEILPINL- 245 (432)
Q Consensus 178 ~~~DiWSlG~il~ell~g~~pF~~~~------~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~- 245 (432)
.++|||||||++|||++|.+||.+.+ ..+++..+...+|.++...+........+.... .....+..+
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 99999999999999999999998765 567888888999987644321111111110000 000000000
Q ss_pred ------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 246 ------SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 246 ------~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.......+.++.+||.+||++||++|||++|+|+||||+
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 001123456789999999999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=411.18 Aligned_cols=255 Identities=33% Similarity=0.507 Sum_probs=215.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+++++||+|+||+||+|+++.+++.||+|++.+.... .......+|+++|+.++||||+++++++.+.+.+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3699999999999999999999999999999999764422 223446789999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCCCCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~~~~ 155 (432)
|+.+ ++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+........
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9987 555655554 479999999999999999999999999999999999999742 6999999999988766666
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||++|+|||++. ..|+.++||||+||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 196 ~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------- 257 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD---------------- 257 (494)
T ss_dssp CCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----------------
T ss_pred cccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 7789999999999884 4699999999999999999999999999988877776643211111
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+..++.++++||++||+.||.+|||+.|+|+||||+.
T Consensus 258 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 258 ----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ----------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ----------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 1123467899999999999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=377.34 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=217.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+..++..||+|++...... ......+|++++++++||||+++++++.+.+..|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4799999999999999999999999999999999765432 234467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE---eC-CeEEEeeeccceecCCCCCCc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV---TN-DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl---~~-~~lkL~DFG~a~~~~~~~~~~ 156 (432)
+++ ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+||++ +. +.+||+|||++..........
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence 987 455555444 479999999999999999999999999999999999999 43 489999999999887666667
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...+|+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+.......+
T Consensus 167 ~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 227 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP----------------- 227 (277)
T ss_dssp CCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------
T ss_pred ccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 778999999999984 3489999999999999999999999999888777666543211110
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+..+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 228 ---------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0111357889999999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=412.45 Aligned_cols=258 Identities=33% Similarity=0.465 Sum_probs=220.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++.++||+|+||.||+|+++.+|+.||+|++.+.... .......+|+++|++++||||+++++++.+.+.+|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999754322 23445679999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe----CCeEEEeeeccceecCCCCC
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPP 154 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~----~~~lkL~DFG~a~~~~~~~~ 154 (432)
||+.++ +.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.......
T Consensus 106 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 106 EVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred ecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 999865 555554 445799999999999999999999999999999999999994 34899999999988776666
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 185 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 248 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-------------- 248 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------------
T ss_pred cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--------------
Confidence 667789999999999853 6899999999999999999999999999988877776432111110
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
..+..+++++++||++||++||++|||+.|+|+||||+...+
T Consensus 249 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 249 ------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 112357899999999999999999999999999999986543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=396.22 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=214.8
Q ss_pred eeE--eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 4 YKI--LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 4 Y~~--~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
|.+ .+.||+|+||.||+|.+..+|+.||+|+++.... .....+.+|+++|++++||||+++++++.+.+.+|+||||
T Consensus 89 ~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 444 6789999999999999999999999999986543 2334567999999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe--C-CeEEEeeeccceecCCCCCCcc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT--N-DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~--~-~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
+++ +|.+.+......+++..++.++.||+.||+|||+.||+||||||+|||+. . +.+||+|||+++..........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 986 66677766666799999999999999999999999999999999999994 2 3899999999998876666667
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+.+..+.......+
T Consensus 248 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------------ 308 (373)
T 2x4f_A 248 NFGTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------------------ 308 (373)
T ss_dssp CCSSCTTCCHHHHT-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC------------------
T ss_pred ccCCCcEeChhhcc-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------------------
Confidence 78999999999884 66789999999999999999999999999998888777754211111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 309 --------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 --------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 11234678999999999999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=410.26 Aligned_cols=258 Identities=34% Similarity=0.506 Sum_probs=217.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+++++||+|+||+||+|+++.+++.||+|++.+... ........+|+++|++++||||+++++++.+.+.+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 579999999999999999999999999999999964322 1233456799999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceecCCCCCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~~~~~~~ 155 (432)
|+.+ ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+........
T Consensus 102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 9986 565666554 47999999999999999999999999999999999999953 27999999999877766666
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 181 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 243 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--------------- 243 (486)
T ss_dssp -CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---------------
T ss_pred CCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---------------
Confidence 77889999999999853 5999999999999999999999999999888877776432111110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
..+..++.++++||++||+.||++|||+.|+|+||||+....
T Consensus 244 -----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 -----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -----------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -----------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 112357899999999999999999999999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=386.27 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=216.4
Q ss_pred CeeEe-eeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 3 RYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~-~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+|.+. +.||+|+||.||+|.+..+|+.||+|++...... .......+|+.+++.+ .||||+++++++.+.+..|+||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 58887 8999999999999999999999999999864432 2234567899999999 5799999999999999999999
Q ss_pred ecCCCc-HHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceecCCCC
Q 014039 80 EYMEHN-LYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARELSSMP 153 (432)
Q Consensus 80 E~~~~~-ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~~~~~ 153 (432)
||+.++ +.+.+.. ..+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 999875 4444432 2357999999999999999999999999999999999999986 499999999999887665
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 189 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 254 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------------- 254 (327)
T ss_dssp -----CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------
T ss_pred ccccccCCcCccCCeeec-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-------------
Confidence 566778999999999984 667899999999999999999999999998887777666443222111
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~ 291 (432)
..+..++.++.+||.+||+.||++|||++|+|+||||+..+|...
T Consensus 255 -------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 -------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred -------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 223467899999999999999999999999999999998877544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=410.81 Aligned_cols=256 Identities=31% Similarity=0.466 Sum_probs=217.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc------------hHHHHHHHHHHHHHhcCCCcccccceEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF------------WEECMNLREVKALRKLNHPNIIKLKEVV 69 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~ 69 (432)
++|+++++||+|+||+||+|+++.+++.||+|++.+.... .......+|+++|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 5799999999999999999999999999999999764322 1123456899999999999999999999
Q ss_pred EeCCEEEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeec
Q 014039 70 RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFG 144 (432)
Q Consensus 70 ~~~~~~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG 144 (432)
.+...+|+||||+++ ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999986 566666554 479999999999999999999999999999999999999854 69999999
Q ss_pred cceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 145 LARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 145 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
+|+...........+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.+..+.+..+.. +.....
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~--- 267 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK--GKYYFD--- 267 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCC---
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCC---
Confidence 999887766667789999999999984 4689999999999999999999999999988877777643 111110
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...++.++.++++||++||++||.+|||++|+|+||||+..
T Consensus 268 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 268 ---------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp ---------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ---------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 01124678999999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.54 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=208.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|.++.+|+.||+|++.+.... ..+|++++.++ +||||+++++++.+.+.+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4799999999999999999999999999999999765422 24688889888 79999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecCCC-C
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSSM-P 153 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~~~-~ 153 (432)
|+.| ++.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||+.++ .+||+|||+|+..... .
T Consensus 97 ~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9986 5555554 44579999999999999999999999999999999999998532 5999999999876543 3
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS---EIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~---~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....++|+.|+|||++. ...|+.++|||||||++|||++|.+||.+.. ..+....+.. |....
T Consensus 176 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--~~~~~---------- 242 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--GKFSL---------- 242 (342)
T ss_dssp CBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--CCCCC----------
T ss_pred ceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--CCccc----------
Confidence 345678999999999985 4568999999999999999999999998642 2233333311 11110
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....++.++.++.+||++||+.||++|||+.|+++||||..
T Consensus 243 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 243 --------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp --------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred --------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 11233568999999999999999999999999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=392.40 Aligned_cols=281 Identities=35% Similarity=0.566 Sum_probs=223.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CC-----cccccceEEEeCCE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HP-----NIIKLKEVVRENNE 74 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~~~~~~~~ 74 (432)
+++|++++.||+|+||.||+|++..+++.||||+++.... ......+|+++++.+. |+ +|+++++++...+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH--HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4689999999999999999999999999999999975432 2233457888888874 55 48999999999999
Q ss_pred EEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCceeEeC---CeEEEeeecccee
Q 014039 75 LFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMH--RNGYFHRDLKPENLLVTN---DVLKIADFGLARE 148 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH--~~givHrDlkP~NILl~~---~~lkL~DFG~a~~ 148 (432)
.|+||||+++++.+.+.... +.+++..++.++.||+.||.||| +.||+||||||+|||+++ +.+||+|||+|+.
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999999999999887754 56999999999999999999999 579999999999999953 3899999999988
Q ss_pred cCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
... .....++|+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+++..+...+|.++...+.....
T Consensus 211 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 211 LGQ--RIYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred ccc--ccccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 754 345678999999999985 55699999999999999999999999999999999999999999876543221111
Q ss_pred hhhhhhc----ccc--c-------cCC---CCccccC-----------C-------CCCHHHHHHHHHhcccCCCCCCCH
Q 014039 229 ISRLISI----SYS--E-------ILP---INLSDII-----------P-------NASMEAIDLIWQLCSWDPLRRPTA 274 (432)
Q Consensus 229 ~~~~~~~----~~~--~-------~~~---~~~~~~~-----------~-------~~s~~~~dli~~~L~~dP~~Rpta 274 (432)
...+... .+. . ..+ ..+..+. . ..+.++++||++||++||++|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 1111000 000 0 000 0000000 0 011478999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 014039 275 DQALQHPFFNVE 286 (432)
Q Consensus 275 ~elL~Hp~f~~~ 286 (432)
+|+|+||||+..
T Consensus 368 ~e~L~hp~f~~~ 379 (382)
T 2vx3_A 368 YYALQHSFFKKT 379 (382)
T ss_dssp HHHTTSGGGCC-
T ss_pred HHHhcCcccccC
Confidence 999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=404.08 Aligned_cols=260 Identities=31% Similarity=0.497 Sum_probs=202.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-------hHHHHHHHHHHHHHhcCCCcccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-------WEECMNLREVKALRKLNHPNIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 74 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .......+|+++|++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 5799999999999999999999999999999999754321 111235689999999999999999999854 56
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELS 150 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~ 150 (432)
.|+||||++++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+...
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 89999999875444444445679999999999999999999999999999999999999742 59999999998877
Q ss_pred CCCCCccccCCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
........+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+......+...+.. +...
T Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-~~~~--------- 363 (419)
T 3i6u_A 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYN--------- 363 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-TCCC---------
T ss_pred CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-CCCC---------
Confidence 6555667889999999999853 467889999999999999999999999876543322222110 1100
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.....+..++.++.+||++||+.||++|||++|+|+||||++.+
T Consensus 364 ---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 364 ---------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp ---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred ---------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 01122346789999999999999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=408.77 Aligned_cols=257 Identities=27% Similarity=0.361 Sum_probs=214.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.... .......+|+++|++++||||+++++++.+.+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999999754322 12234568999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 80 EYMEHN-LYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 80 E~~~~~-ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
||++|+ |...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.......
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 999875 44444432 3469999999999999999999999999999999999999855 999999999988765433
Q ss_pred -CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 155 -YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE----IDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 155 -~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~----~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+... ......+.. +.
T Consensus 345 ~~~~~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~------------ 409 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QA------------ 409 (543)
T ss_dssp CBCCCCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CC------------
T ss_pred ccccccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cc------------
Confidence 34569999999999985 56799999999999999999999999987643 222222211 00
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
......++.++.+||++||+.||++||+ ++++++||||+..+|.
T Consensus 410 ----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 410 ----------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ----------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 0122467899999999999999999995 5999999999998884
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=372.82 Aligned_cols=261 Identities=32% Similarity=0.466 Sum_probs=218.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc---c-----hHHHHHHHHHHHHHhcC-CCcccccceEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY---F-----WEECMNLREVKALRKLN-HPNIIKLKEVVRE 71 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~-----~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~ 71 (432)
+++|++.+.||+|+||.||+|.++.+|+.||+|++..... . .......+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999975431 1 11233568999999995 9999999999999
Q ss_pred CCEEEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceec
Q 014039 72 NNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLAREL 149 (432)
Q Consensus 72 ~~~~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~ 149 (432)
.+..|+||||+++ ++.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999986 55555554 4579999999999999999999999999999999999999865 9999999999987
Q ss_pred CCCCCCccccCCccccchhhhc-----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLL-----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
..........+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 249 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG----- 249 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC-----
Confidence 7666667778999999999985 345689999999999999999999999998887666555533111100
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
...+..++.++.+||.+||+.||++|||+.|+|+||||+...+
T Consensus 250 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 250 ---------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp ---------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred ---------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 0112357889999999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=374.07 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=210.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|.+..+++.||+|++........ .....+|++++++++||||+++++++.+.+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 5789999999999999999999999999999999975432211 23456899999999999999999999999999999
Q ss_pred EecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||++++ +.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~ 165 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT 165 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-ccc
Confidence 9999865 55555444 479999999999999999999999999999999999999855 9999999998655432 334
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...+|+.|+|||++. +..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 166 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 224 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------------------- 224 (279)
T ss_dssp --CCCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------------
T ss_pred ccCCCCCccCHhHhc-cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------------------
Confidence 568999999999984 66789999999999999999999999998887766665532110
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 225 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 225 ----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp ----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 112347889999999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=386.84 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=209.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-------HHHHHHHHHHHHHhcCCCcccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-------EECMNLREVKALRKLNHPNIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 74 (432)
++|++++.||+|+||.||+|+++.+++.||+|++....... ......+|+++|++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 47999999999999999999999999999999998654221 12234579999999999999999999999999
Q ss_pred EEEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 75 LFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
+++||||+.++ .+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999998653 444444455579999999999999999999999999999999999999865 9999999999988776
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....
T Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------------- 236 (335)
T 3dls_A 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------------- 236 (335)
T ss_dssp CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------------
T ss_pred CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------------
Confidence 66677889999999999975555589999999999999999999999652210
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
... .......++.++.+||++||+.||++|||++|+++||||+.
T Consensus 237 ~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 VEA---------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TTT---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred Hhh---------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 000 00112347899999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=386.49 Aligned_cols=260 Identities=29% Similarity=0.406 Sum_probs=211.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccc----cchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF----YFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++++.||+|+||.||+|.+..+++.||+|++.... .........+|++++++++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 47999999999999999999999999999999997542 12234456789999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHc----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 014039 78 IFEYMEHNLYHIMRER----------------------------------------QIPFSEGEIRSFMSQMLQGLAHMH 117 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~----------------------------------------~~~l~~~~~~~i~~qIl~aL~~LH 117 (432)
||||++++.+..+... ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999987544443321 112468889999999999999999
Q ss_pred HCCCeeccCCCCceeEeCC---eEEEeeeccceecCCCC-----CCccccCCccccchhhhcCC-CCCCcccceechHHH
Q 014039 118 RNGYFHRDLKPENLLVTND---VLKIADFGLARELSSMP-----PYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAI 188 (432)
Q Consensus 118 ~~givHrDlkP~NILl~~~---~lkL~DFG~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~i 188 (432)
++||+||||||+|||++.+ .+||+|||+|+.+.... ......||+.|+|||++.+. ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 9999999999999999743 79999999998764321 23456799999999998642 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCC
Q 014039 189 LAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDP 268 (432)
Q Consensus 189 l~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 268 (432)
+|||++|..||.+.+..+....+......... ..+..+++++.+||.+||+.||
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFEN--------------------------PNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS--------------------------GGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCC--------------------------cccccCCHHHHHHHHHHcCCCh
Confidence 99999999999999888877766432111110 1112468899999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 014039 269 LRRPTADQALQHPFFNVET 287 (432)
Q Consensus 269 ~~Rpta~elL~Hp~f~~~~ 287 (432)
.+|||+.|+|+||||+...
T Consensus 320 ~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 320 DERFDAMRALQHPWISQFS 338 (345)
T ss_dssp TTSCCHHHHHHSHHHHTTS
T ss_pred hHCCCHHHHhcChhhccCh
Confidence 9999999999999998743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=384.90 Aligned_cols=275 Identities=24% Similarity=0.406 Sum_probs=211.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC--EEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN--ELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV~ 79 (432)
++|++++.||+|+||.||+|++..+|+.||+|++.............+|+++|++++||||+++++++.... ..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 479999999999999999999999999999999986544333445679999999999999999999987654 789999
Q ss_pred ecCCC-cHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE----eCC-eEEEeeeccceecCC
Q 014039 80 EYMEH-NLYHIMRERQ--IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV----TND-VLKIADFGLARELSS 151 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~--~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl----~~~-~lkL~DFG~a~~~~~ 151 (432)
||+++ ++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+ .+||+|||+|+....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 99986 5555554432 239999999999999999999999999999999999998 433 799999999998877
Q ss_pred CCCCccccCCccccchhhhcC-------CCCCCcccceechHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCC
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQ-------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSE----IDQLYKVCCILGAPDW 220 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~----~d~~~~i~~~~g~p~~ 220 (432)
.......+||+.|+|||++.. ...++.++|||||||++|||++|..||..... .+.+.+++. +.|.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~p~- 245 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS- 245 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH--HCCT-
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc--CCCc-
Confidence 666677889999999999852 46789999999999999999999999975433 333334332 2222
Q ss_pred CCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
..+...... ....+.+....+. ...+...++..+.+||++||++||++|||++|+|+||
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 246 GAISGVQKA-ENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TCCEEEECS-TTCCEEEESSCCT-TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred ccchhhhcc-cCCccccCccCCc-ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111110000 0000111111110 0122234567889999999999999999999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=395.05 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=198.7
Q ss_pred CCeeEe-eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHh-cCCCcccccceEEEe----CCEE
Q 014039 2 ERYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK-LNHPNIIKLKEVVRE----NNEL 75 (432)
Q Consensus 2 ~~Y~~~-~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~----~~~~ 75 (432)
++|+++ +.||+|+||+||+|.++.+|+.||||++.... ...+|+.++.+ .+||||+++++++.. ...+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch------hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 578887 68999999999999999999999999997432 24578888755 489999999999875 5678
Q ss_pred EEEEecCCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceec
Q 014039 76 FFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLAREL 149 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~ 149 (432)
||||||++| +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 999999987 5666665432 36999999999999999999999999999999999999984 48999999999987
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCCCCchh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID----QLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d----~~~~i~~~~g~p~~~~~~~ 225 (432)
.........+||+.|+|||++ ....|+.++|||||||++|||++|.+||.+..... ....+. .+..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--~~~~------- 284 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--MGQY------- 284 (400)
T ss_dssp C-----------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--HTCC-------
T ss_pred CCCCccccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--cCcc-------
Confidence 665556678899999999988 46779999999999999999999999998765422 111111 1110
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.++ ...+..++.++.+||++||+.||++|||+.|+|+||||...
T Consensus 285 ----------~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 285 ----------EFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ----------CCC-------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ----------cCC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 010 11234689999999999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=371.50 Aligned_cols=257 Identities=27% Similarity=0.354 Sum_probs=212.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|++.............+|+++++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 58999999999999999999999999999999997655444455667999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC---CCCcc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM---PPYTE 157 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~---~~~~~ 157 (432)
++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||.+...... .....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 987544444444457999999999999999999999999999999999999986 49999999999865432 22345
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++.+...++.++|||||||++|+|++|..||.+............ ....
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~------------------ 226 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKT------------------ 226 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH--TTCT------------------
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh--hccc------------------
Confidence 68999999999986555558899999999999999999999987665332222111 0000
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......++.++.+||.+||+.||++|||++|+++||||+.
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 227 -------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp -------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 00112357889999999999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=384.35 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=189.6
Q ss_pred CCeeEe---eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEE
Q 014039 2 ERYKIL---EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~---~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l 77 (432)
++|++. +.||+|+||.||+|.++.+|+.||+|++.+.. .....+|+.+++.+. ||||+++++++.+....|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 467776 78999999999999999999999999997542 234568999999996 9999999999999999999
Q ss_pred EEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCC
Q 014039 78 IFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSM 152 (432)
Q Consensus 78 V~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~ 152 (432)
||||++++ +.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 84 VMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999875 5555544 5689999999999999999999999999999999999999743 7999999999866442
Q ss_pred -CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCCCCchhhhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQ---LYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~---~~~i~~~~g~p~~~~~~~~~~ 228 (432)
......++|+.|+|||++. ...|+.++|||||||++|+|++|.+||.+...... ...+..........
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------- 234 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------- 234 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-------
T ss_pred CCcccccCCCcCccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-------
Confidence 3345668899999999984 66799999999999999999999999987543211 11111111111000
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....+..++.++++||++||+.||++|||++|+++||||+..
T Consensus 235 ---------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 235 ---------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ---------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ---------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 0011123578999999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=380.74 Aligned_cols=258 Identities=29% Similarity=0.435 Sum_probs=202.0
Q ss_pred CCeeEe-eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~-~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++. +.||+|+||.||+|++..+++.||||++..... .......+|+++|+++ +||||+++++++.+.+.+|+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 579985 789999999999999999999999999976532 2334567899999995 7999999999999999999999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCC--
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSM-- 152 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~-- 152 (432)
||+++ ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99985 565555544 479999999999999999999999999999999999999854 3999999999765321
Q ss_pred ------CCCccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHH---------------H
Q 014039 153 ------PPYTEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID---------------Q 207 (432)
Q Consensus 153 ------~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d---------------~ 207 (432)
......+||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+....+ .
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12234579999999999853 2458899999999999999999999998765321 1
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
...+.. +.. .++ ...+..++.++.+||++||+.||++|||++|+|+||||+...
T Consensus 250 ~~~i~~--~~~-----------------~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 250 FESIQE--GKY-----------------EFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHH--CCC-----------------CCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHhc--cCc-----------------ccC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 111100 000 000 011235788999999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=375.50 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=214.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
.|+..+.||+|+||.||+|++..+|+.||||++...... ......+|+.++++++||||+++++++...+..|+||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 378889999999999999999999999999999754432 2334568999999999999999999999999999999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccccC
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYVS 160 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~~ 160 (432)
+++.+..+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++..... ......+|
T Consensus 125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 88666665554 369999999999999999999999999999999999999854 9999999999876543 23456789
Q ss_pred CccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccccc
Q 014039 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEI 240 (432)
Q Consensus 161 t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 240 (432)
|+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+... ..+..
T Consensus 204 t~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------------------- 261 (321)
T 2c30_A 204 TPYWMAPEVIS-RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKL-------------------- 261 (321)
T ss_dssp CGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCC--------------------
T ss_pred CccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCc--------------------
Confidence 99999999984 567899999999999999999999999988877666554321 11100
Q ss_pred CCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 241 LPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 241 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+++++.+||.+||+.||++|||+.|+++||||..
T Consensus 262 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 262 ------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 001246889999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=368.78 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=207.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-chHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|.+..+++.||+|++..... ........+|+..+..+ +||||+++++++.+.+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 479999999999999999999999999999999986533 23445567899999999 9999999999999999999999
Q ss_pred ecCCC-cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-------------------C
Q 014039 80 EYMEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-------------------D 136 (432)
Q Consensus 80 E~~~~-~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-------------------~ 136 (432)
||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. .
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99987 666666543 257999999999999999999999999999999999999972 2
Q ss_pred -eEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014039 137 -VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCIL 215 (432)
Q Consensus 137 -~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~ 215 (432)
.+||+|||.+...... ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++....... .+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~-- 242 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQ-- 242 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHT--
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHc--
Confidence 6999999999877543 334699999999999766677889999999999999999998875543222 1110
Q ss_pred CCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 216 GAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 216 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+...++.++.+||.+||+.||++|||+.|+++||||..
T Consensus 243 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 243 ---------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp ---------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred ---------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 0111233468899999999999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=384.49 Aligned_cols=256 Identities=33% Similarity=0.496 Sum_probs=215.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--h-----HHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--W-----EECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~-----~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|++.+.||+|+||.||+|.++.+|+.||||++...... . ......+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 3699999999999999999999999999999998754311 1 123356899999999 8999999999999999
Q ss_pred EEEEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 74 ELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 74 ~~~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
..|+||||++++ +.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||++..+..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999874 5555544 4579999999999999999999999999999999999999865 999999999998877
Q ss_pred CCCCccccCCccccchhhhcC-----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQ-----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
.......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+......+..+... .....
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~----- 325 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG--QYQFS----- 325 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCC-----
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCC-----
Confidence 666677899999999999853 235899999999999999999999999988776666555321 11100
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
...+..++.++.+||++||+.||++|||+.|+|+||||+
T Consensus 326 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 326 -------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 011235788999999999999999999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=385.88 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=199.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC--------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN-------- 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-------- 73 (432)
++|++++.||+|+||.||+|+++.+|+.||||++.............+|+++|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 589999999999999999999999999999999986554445556789999999999999999999885432
Q ss_pred -------------------------------------------------EEEEEEecCCCcHHHHHHHcCC---CCCHHH
Q 014039 74 -------------------------------------------------ELFFIFEYMEHNLYHIMRERQI---PFSEGE 101 (432)
Q Consensus 74 -------------------------------------------------~~~lV~E~~~~~ll~~~~~~~~---~l~~~~ 101 (432)
.+|+||||++++.+..+..... ..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3899999998855554444332 356667
Q ss_pred HHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC-------------CCccccCCccccch
Q 014039 102 IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP-------------PYTEYVSTRWYRAP 167 (432)
Q Consensus 102 ~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~-------------~~~~~~~t~~y~aP 167 (432)
++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+...... .....+||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 8999999999999999999999999999999985 499999999998776532 23446799999999
Q ss_pred hhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccc
Q 014039 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSD 247 (432)
Q Consensus 168 E~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (432)
|++. ...++.++|||||||++|||++|..++. +....+.... ... ...
T Consensus 246 E~~~-~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~-~~~-------------------------~~~ 293 (332)
T 3qd2_B 246 EQIH-GNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVR-NLK-------------------------FPL 293 (332)
T ss_dssp HHHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHH-TTC-------------------------CCH
T ss_pred HHhc-CCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhh-ccC-------------------------CCc
Confidence 9985 5678999999999999999999876541 1111111111 000 001
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 248 IIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 248 ~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+...++++.+||.+||+.||++|||++|+|+||||++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11234678899999999999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=381.88 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=205.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCC--CcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNH--PNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV 78 (432)
++|++++.||+|+||.||+|.+ .+++.||+|++........ .....+|+++|+++.| |||+++++++.+.+.+|+|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4799999999999999999987 4688999999976544332 3446789999999976 9999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCC---CC
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMP---PY 155 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~---~~ 155 (432)
||+..+++.+.+... +.+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||+|+...... ..
T Consensus 88 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 88 MECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp ECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC---------
T ss_pred EeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccC
Confidence 998778888877765 47999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccCCccccchhhhcC----------CCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCch
Q 014039 156 TEYVSTRWYRAPEVLLQ----------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~----------~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~ 224 (432)
...+||+.|+|||++.+ ...++.++|||||||++|||++|..||.+.... ..+..+ ......
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~---- 239 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDPNHE---- 239 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---HCTTSC----
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH---hcCCcc----
Confidence 45689999999999853 267899999999999999999999999875432 222222 111110
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 ---------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 240 ---------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp ---------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 0112345778999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=372.57 Aligned_cols=257 Identities=29% Similarity=0.467 Sum_probs=212.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|++..+|+.||+|+++...... ......+|++++++++||||+++++++.+.+..|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 47999999999999999999999999999999997543221 2345678999999999999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecC
Q 014039 77 FIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELS 150 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~ 150 (432)
+||||+++ ++.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999976 55555544 4579999999999999999999999999999999999999743 69999999998876
Q ss_pred CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.........+|+.|+|||++. ...++.++|||||||++|+|++|..||.+....+....+.... ...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---------- 230 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN--YDF---------- 230 (283)
T ss_dssp --------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCC----------
T ss_pred CCCcccccCCCcCccCcceec-CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc--cCC----------
Confidence 655566678999999999884 5678999999999999999999999999988776665543211 000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
....+..++.++.+||++||+.||++|||+.|+++||||+..
T Consensus 231 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 231 --------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp --------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 011224678899999999999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=388.59 Aligned_cols=262 Identities=26% Similarity=0.448 Sum_probs=209.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccc---hHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 1 MERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYF---WEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
+++|++++.||+|+||.||+|++. .+++.||||++++.... .......+|+++|+.+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 58999999998753311 1122345799999999 7999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 74 ELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
.+|+||||+++ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999987 555555444 479999999999999999999999999999999999999865 999999999987643
Q ss_pred C--CCCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 152 M--PPYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 152 ~--~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
. ......+||+.|+|||++.+. ..++.++|||||||++|||++|..||...........+....-
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------ 279 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL------------ 279 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH------------
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh------------
Confidence 2 223456899999999999643 4578999999999999999999999976543222222211100
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.. .......++..+.+||.+||+.||++|| |++|+++||||+..+|.
T Consensus 280 -----~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 280 -----KS---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp -----HC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred -----cc---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 00 0112246788999999999999999999 99999999999987763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=387.89 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=205.9
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcC--CCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLN--HPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+|++++.||+|+||.||+|.+.. ++.||||++...... .......+|+++|+++. ||||+++++++...+.+|+||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 59999999999999999998865 889999999765433 23345679999999996 599999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCC---CCc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMP---PYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~---~~~ 156 (432)
|+..++|.+.+... +.+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||+|+...... ...
T Consensus 136 E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~ 214 (390)
T 2zmd_A 136 ECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKD 214 (390)
T ss_dssp ECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------C
T ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCC
Confidence 97777787777665 47999999999999999999999999999999999999998899999999998765432 234
Q ss_pred cccCCccccchhhhcC----------CCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchh
Q 014039 157 EYVSTRWYRAPEVLLQ----------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~----------~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~ 225 (432)
..+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.... ..+..++ .....
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~---~~~~~----- 286 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE----- 286 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---CTTSC-----
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh---Ccccc-----
Confidence 5689999999999864 246899999999999999999999999876432 3333321 11000
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......+.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 287 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 287 --------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp --------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred --------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 0111235788999999999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=369.60 Aligned_cols=254 Identities=32% Similarity=0.493 Sum_probs=190.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++.+.||+|+||.||+|++..+|+.||+|++....... ......+|++++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 478999999999999999999999999999999997543211 123467899999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCC
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
|||+++ ++.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... ...
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 999986 5555555555689999999999999999999999999999999999999855 9999999999876532 233
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++|+.|+|||++. ...++.++|||||||++|+|++|.+||.+....+.+..+. .
T Consensus 170 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------------~- 226 (278)
T 3cok_A 170 YTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---------------------L- 226 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC---------------------S-
T ss_pred eeccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh---------------------h-
Confidence 4567999999999884 5678999999999999999999999998765433222210 0
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.-......++.++.+||.+||+.||++|||++|+++||||..
T Consensus 227 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 227 --------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp --------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred --------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 000122457889999999999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=378.80 Aligned_cols=280 Identities=27% Similarity=0.419 Sum_probs=223.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC-eEEEEEEecccccchHHHHHHHHHHHHHhcCCCc------ccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY-EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN------IIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~~~~~~~ 74 (432)
++|++++.||+|+||.||+|.+..++ +.||+|+++... .......+|+++++.+.|++ ++.+++++...+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 68999999999999999999998777 789999997542 22334567999999987655 8899999999999
Q ss_pred EEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE-------------------e
Q 014039 75 LFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV-------------------T 134 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl-------------------~ 134 (432)
.|+||||+++++++.+.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 99999999999999887654 579999999999999999999999999999999999999 3
Q ss_pred -CCeEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014039 135 -NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 135 -~~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~ 213 (432)
++.+||+|||+++.... .....+||+.|+|||++. ...++.++|||||||++|||++|.+||.+....+.+..+..
T Consensus 177 ~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp SCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEeecCccccccc--cccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 34899999999987544 345568999999999985 56789999999999999999999999999999999988888
Q ss_pred HhCCCCCCCchhhhhh----------------hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014039 214 ILGAPDWTAFPEATNI----------------SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~el 277 (432)
..|.++...+...... .++.......... ........+.++.+||++||+.||++|||++|+
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS--YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG--GCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccc--cccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 8887654322111000 0000000000000 000011235688999999999999999999999
Q ss_pred hcCCCCCCCCC
Q 014039 278 LQHPFFNVETW 288 (432)
Q Consensus 278 L~Hp~f~~~~~ 288 (432)
|+||||+..++
T Consensus 332 l~hp~f~~~~~ 342 (355)
T 2eu9_A 332 LLHPFFAGLTP 342 (355)
T ss_dssp TTSGGGGGCCH
T ss_pred hcChhhcCCCh
Confidence 99999997543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=388.21 Aligned_cols=284 Identities=23% Similarity=0.309 Sum_probs=214.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|++.............+|++++++++||||+++++++.+.+..|+||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57999999999999999999999999999999998765444445577999999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
+++ +|.+.+.. .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.+ .+||+|||++...... .....
T Consensus 113 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 190 (360)
T 3eqc_A 113 MDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 190 (360)
T ss_dssp CTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----
T ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCC
Confidence 987 55555544 44799999999999999999999996 99999999999999855 9999999999765332 23456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCCCCchhhh----------
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCI-LGAPDWTAFPEAT---------- 227 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~-~g~p~~~~~~~~~---------- 227 (432)
+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+....+... .+.+.........
T Consensus 191 ~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 191 VGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp CCCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 8999999999985 567899999999999999999999999987765543332111 1111100000000
Q ss_pred ------hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014039 228 ------NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291 (432)
Q Consensus 228 ------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~~~ 291 (432)
............. ........++.++.+||++||++||++|||++|+|+||||+...+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEP---PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp ----CCCHHHHHHHHHHSC---CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred CCCCcccchhhhhHHhccC---CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence 0000000000000 000111347889999999999999999999999999999987554433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=369.83 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=215.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|++..+++.||+|++....... ......+|++++++++||||+++++++.+.+..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999997543211 123466899999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||+++ ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... ...
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 170 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRR 170 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-ccc
Confidence 999986 566665554 47999999999999999999999999999999999999985 49999999999766542 334
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++++.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 171 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~------------------ 229 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DL------------------ 229 (284)
T ss_dssp CCCSCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CC------------------
T ss_pred cccCCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--cc------------------
Confidence 568999999999985 567899999999999999999999999988776665554310 00
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.+.+.++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 230 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 ----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1123578899999999999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=374.92 Aligned_cols=277 Identities=29% Similarity=0.469 Sum_probs=221.8
Q ss_pred CCeeEeeeEeecCceEEEEEEE-cCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCC------cccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-VETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP------NIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hp------nIv~l~~~~~~~~~ 74 (432)
++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+|+++++.++|+ +|+++++++.+.+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 5899999999999999999998 5689999999997543 2233456899999988655 49999999999999
Q ss_pred EEEEEecCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC------------------
Q 014039 75 LFFIFEYMEHNLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN------------------ 135 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~------------------ 135 (432)
.|+||||+++++.+.+...+ .++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 99999999889998887654 36899999999999999999999999999999999999974
Q ss_pred --CeEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014039 136 --DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 136 --~~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~ 213 (432)
+.+||+|||+++.... .....+||+.|+|||++. ...++.++|||||||++|||++|.+||.+.+..+....+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp SCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred cCCCceEeeCcccccCcc--ccccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2699999999987554 345568999999999985 56789999999999999999999999999999998888888
Q ss_pred HhCCCCCCCchhhhh----------------hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014039 214 ILGAPDWTAFPEATN----------------ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~el 277 (432)
..+..+...+..... ..+......... ..........+.++.+||++||+.||++|||+.|+
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL--KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG--GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcch--hhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 888665332111000 000000000000 00001112346789999999999999999999999
Q ss_pred hcCCCCCC
Q 014039 278 LQHPFFNV 285 (432)
Q Consensus 278 L~Hp~f~~ 285 (432)
|+||||+.
T Consensus 327 l~hp~f~~ 334 (339)
T 1z57_A 327 LKHPFFDL 334 (339)
T ss_dssp TTSGGGGG
T ss_pred hcCHHHHH
Confidence 99999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=369.33 Aligned_cols=253 Identities=30% Similarity=0.405 Sum_probs=204.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++...... .......+|+++++.++||||+++++++.+.+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999999754311 12234568999999999999999999999999999999
Q ss_pred ecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 80 EYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||+++ ++.+.+... +.+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...........
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred eccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceec
Confidence 99986 565555544 479999999999999999999999999999999999999865 999999999987766555556
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.. +..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------------- 228 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVF------------------- 228 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-------------------
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--Ccc-------------------
Confidence 78999999999986554457899999999999999999999988776555544421 100
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+...++.++.++|.+||+.||++|||+.|+++||||+.
T Consensus 229 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 229 ---------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 112356889999999999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=368.58 Aligned_cols=254 Identities=25% Similarity=0.316 Sum_probs=208.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe----CCEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE----NNELFF 77 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~l 77 (432)
.|++.+.||+|+||.||+|.+..++..||+|++...... .......+|+.++++++||||+++++++.. ...+|+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 589999999999999999999999999999999865433 234456789999999999999999999865 456899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEe--CCeEEEeeeccceecCCCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVT--NDVLKIADFGLARELSSMP 153 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~--~~~lkL~DFG~a~~~~~~~ 153 (432)
||||++++.+..+....+.+++..++.++.||+.||.|||+.| |+||||||+|||++ ++.+||+|||++..... .
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-c
Confidence 9999987544444444457999999999999999999999999 99999999999997 34999999999975543 3
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
......+|+.|+|||++. ..++.++|||||||++|+|++|..||.+..........+.....
T Consensus 186 ~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 247 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------------- 247 (290)
T ss_dssp SBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------------
T ss_pred ccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----------------
Confidence 345568999999999884 45899999999999999999999999887665555443211000
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
........++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 248 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 248 -----------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -----------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -----------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 001123467899999999999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=380.55 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=208.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-------hHHHHHHHHHHHHHhcCCCcccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-------WEECMNLREVKALRKLNHPNIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 74 (432)
++|++++.||+|+||.||+|++..+++.||||++...... .......+|+++|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 4799999999999999999999999999999999754321 11223568999999999999999999987655
Q ss_pred EEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceec
Q 014039 75 LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLAREL 149 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~ 149 (432)
.|+||||+++ ++.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999987 4555544 45579999999999999999999999999999999999999743 4999999999887
Q ss_pred CCCCCCccccCCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
.........+||+.|+|||++. +...++.++|||||||++|+|++|.+||.+......+...+.. +...
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-------- 238 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYN-------- 238 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-TCCC--------
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-Cccc--------
Confidence 6543344567999999999974 3567899999999999999999999999876543222222111 1100
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.....+..++.++.+||++||+.||++|||++|+|+||||+...
T Consensus 239 ----------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 239 ----------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp ----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred ----------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 01122346788999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=372.02 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=213.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|++..+|+.||+|++...... ......+|++++++++||||+++++++.+.+..|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 4799999999999999999999999999999999854322 233456899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE---eC-CeEEEeeeccceecCCCCCCc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV---TN-DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl---~~-~~lkL~DFG~a~~~~~~~~~~ 156 (432)
+++ ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+||++ ++ +.+||+|||+++.... ....
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~ 165 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMS 165 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTH
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cccc
Confidence 986 566665554 479999999999999999999999999999999999999 43 4899999999976543 2344
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++|+.|+|||++. ...++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus 166 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------------ 226 (304)
T 2jam_A 166 TACGTPGYVAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF------------------ 226 (304)
T ss_dssp HHHSCCCBCCTTTBS-SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC------------------
T ss_pred cccCCCCccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 567999999999884 5678999999999999999999999999988776666653311100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
....+..++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 227 --------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp --------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred --------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 0112346789999999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=368.20 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=215.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 5799999999999999999999999999999999765422 23344678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||++++.+..+....+.+++..++.++.||+.||+|||++|++||||||+||+++.+ .+||+|||++...... .....
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence 999865444444444579999999999999999999999999999999999999865 9999999999876532 33455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
..+|+.|+|||++. ...++.++|||||||++|+|++|..||.+....+....+.. +.
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~-------------------- 231 (294)
T 2rku_A 175 LCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NE-------------------- 231 (294)
T ss_dssp CCSCCSSCCHHHHT-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TC--------------------
T ss_pred ccCCCCcCCcchhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--cc--------------------
Confidence 67999999999984 56789999999999999999999999998877665544421 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..+...++.++.+||++||+.||++|||++|+++||||...
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 232 --------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred --------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 01223578899999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=376.02 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=215.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|.+..+++.||+|++...... .......+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999765432 23344678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
||+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..... .....
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccc
Confidence 999965444444444579999999999999999999999999999999999999865 9999999999876532 33455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++|+.|+|||++. ...++.++|||||||++|+|++|..||.+....+....+... ..
T Consensus 201 ~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~------------------- 258 (335)
T 2owb_A 201 LCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EY------------------- 258 (335)
T ss_dssp CCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CC-------------------
T ss_pred cCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CC-------------------
Confidence 68999999999985 566899999999999999999999999988776655544221 00
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.+...++.++.+||++||+.||++|||++|+|+||||...
T Consensus 259 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 259 ---------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1123578899999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=369.56 Aligned_cols=256 Identities=34% Similarity=0.533 Sum_probs=216.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|++..+++.||+|++...... .......+|++++++++||||+++++++.+.+..|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 4799999999999999999999999999999999754332 233456789999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccceecCCCCCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLARELSSMPPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~~~~~~~~~ 155 (432)
|+.+ ++.+.+... +.+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.........
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9976 566666554 479999999999999999999999999999999999999742 7999999999877665555
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
....+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.. +.....
T Consensus 181 ~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~-------------- 242 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFD-------------- 242 (287)
T ss_dssp SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCC--------------
T ss_pred ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCC--------------
Confidence 56678999999999843 489999999999999999999999999887766665532 111100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...+..++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 243 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 243 ----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 01123578899999999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=377.95 Aligned_cols=280 Identities=26% Similarity=0.408 Sum_probs=217.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-----------CCcccccceEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-----------HPNIIKLKEVVR 70 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~~ 70 (432)
++|++++.||+|+||.||+|++..+++.||||++..... ......+|+++++++. ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 589999999999999999999999999999999975432 2334568999998885 899999999987
Q ss_pred eCC----EEEEEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeC-----C--e
Q 014039 71 ENN----ELFFIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTN-----D--V 137 (432)
Q Consensus 71 ~~~----~~~lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~-----~--~ 137 (432)
..+ .+++|||++.+++.+.+... ...+++..++.++.||+.||+|||++ ||+||||||+|||++. + .
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 643 78999999988888888764 34699999999999999999999998 9999999999999951 2 7
Q ss_pred EEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC------hHHHHHHH
Q 014039 138 LKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS------EIDQLYKV 211 (432)
Q Consensus 138 lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~------~~d~~~~i 211 (432)
+||+|||+|+.... .....++|+.|+|||++. +..++.++|||||||++|||++|..||.+.+ ..+.+..+
T Consensus 177 ~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 177 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEEcccccccccCC--CCCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 99999999987754 344568999999999986 5568999999999999999999999998765 56778888
Q ss_pred HHHhCCCCCCCchhhhhhhhhhhc-----cccccCCCCc-------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 212 CCILGAPDWTAFPEATNISRLISI-----SYSEILPINL-------SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 212 ~~~~g~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
+..+|.++...+........+... .........+ ..+....+.++.+||++||+.||++|||++|+|+
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 888888764322111111010000 0000000000 0112245678999999999999999999999999
Q ss_pred CCCCCCC
Q 014039 280 HPFFNVE 286 (432)
Q Consensus 280 Hp~f~~~ 286 (432)
||||+..
T Consensus 334 hp~f~~~ 340 (373)
T 1q8y_A 334 HPWLKDT 340 (373)
T ss_dssp CGGGTTC
T ss_pred Chhhhcc
Confidence 9999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=365.18 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=215.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|++.............+|+.+++.++||||+++++++.+....|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46999999999999999999999999999999998665444455677999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-CCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP-PYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~-~~~~~~ 159 (432)
++++.+..+... +.+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++....... ......
T Consensus 102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 180 (303)
T 3a7i_A 102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180 (303)
T ss_dssp CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCC
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccC
Confidence 997555554443 479999999999999999999999999999999999999855 99999999998765432 334567
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
+|+.|+|||++. ...++.++|||||||++|+|++|.+||.+.........+.. +.+
T Consensus 181 ~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~--------------------- 236 (303)
T 3a7i_A 181 GTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK--NNP--------------------- 236 (303)
T ss_dssp SCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--SCC---------------------
T ss_pred CCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc--CCC---------------------
Confidence 999999999984 56789999999999999999999999988776655444321 110
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+...++.++.+||.+||+.||++|||+.|+++||||..
T Consensus 237 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 237 ------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 1122467889999999999999999999999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=367.58 Aligned_cols=258 Identities=30% Similarity=0.446 Sum_probs=209.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|++...... ......+|+++++.++||||+++++++.+.+..|+||||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 5799999999999999999999999999999998754322 234466899999999999999999999999999999999
Q ss_pred CCCcHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCC-CCCCccc
Q 014039 82 MEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSS-MPPYTEY 158 (432)
Q Consensus 82 ~~~~ll~-~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~-~~~~~~~ 158 (432)
++++.+. .+......+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++..... .......
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence 9876554 44555667999999999999999999999999999999999999985 4999999998754321 1123456
Q ss_pred cCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 159 VSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 159 ~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.+|+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+..+....+... .++..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~------------- 242 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--DPPTL------------- 242 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCC-------------
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc--CCccc-------------
Confidence 7999999999984 4567899999999999999999999999988877665554321 11100
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.....++.++.+||.+||+.||++|||+.|+++||||+...
T Consensus 243 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 ------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 01134688999999999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=373.35 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=193.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+++.||+|++.............+|++++++++||||+++++++...+..|+||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 68999999999999999999999999999999987554333344467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 82 MEH-NLYHIMRE-------RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 82 ~~~-~ll~~~~~-------~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
+++ ++.+.+.. ....+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++......
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 976 55555543 24569999999999999999999999999999999999999855 9999999999765432
Q ss_pred C------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 153 P------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 153 ~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
. ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....... +.+....
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~---- 248 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPSLE---- 248 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCCTT----
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCccc----
Confidence 1 223457999999999986546789999999999999999999999998876655443321 1111000
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...........++.++.+||.+||+.||++|||+.|+++||||+..
T Consensus 249 --------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 --------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp --------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred --------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0001122345688999999999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=377.12 Aligned_cols=257 Identities=24% Similarity=0.334 Sum_probs=205.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCC----EE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENN----EL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~ 75 (432)
++|++++.||+|+||.||+|++..+++.||+|++....... ......+|++++++++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 68999999999999999999999999999999998654332 2234578999999999999999999986543 45
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP- 153 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~- 153 (432)
|+||||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++......
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 9999999875444444444579999999999999999999999999999999999999855 99999999998664321
Q ss_pred ---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 154 ---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 ---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....+||+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------ 238 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------------ 238 (311)
T ss_dssp ----------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC------------
T ss_pred ccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC------------
Confidence 233457899999999985 5678999999999999999999999999988877666543211110
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......++.++.+||.+||+.||++||++.+++.|+|++.
T Consensus 239 --------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 --------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 11122467899999999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=384.77 Aligned_cols=260 Identities=17% Similarity=0.171 Sum_probs=192.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhc--CCCcccccc-------eEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKL--NHPNIIKLK-------EVVRE 71 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l--~hpnIv~l~-------~~~~~ 71 (432)
+|++++.||+|+||.||+|++..+|+.||+|++...... .......+|+++++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 599999999999999999999999999999999875532 2223345675444444 699988754 55543
Q ss_pred C-----------------CEEEEEEecCCCcHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHHCCCeeccCCC
Q 014039 72 N-----------------NELFFIFEYMEHNLYHIMRERQIPFSEGEI------RSFMSQMLQGLAHMHRNGYFHRDLKP 128 (432)
Q Consensus 72 ~-----------------~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~------~~i~~qIl~aL~~LH~~givHrDlkP 128 (432)
. ..+||||||++++|.+.+...+..+.+..+ ..++.||+.||+|||++||+||||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 3 348999999999998888765445555555 67779999999999999999999999
Q ss_pred CceeEeCC-eEEEeeeccceecCCCCCCccccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHH
Q 014039 129 ENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEID 206 (432)
Q Consensus 129 ~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d 206 (432)
+|||++.+ .+||+|||+|+..... .....+|+.|+|||++.+. ..|+.++|||||||++|||++|..||.+.....
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred HHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 99999865 9999999999876542 2255778999999999532 578999999999999999999999998764310
Q ss_pred HHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCC-CCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 207 QLYKVCCILGAPDWTAFPEATNISRLISISYSEILP-INLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 207 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
. ..+. ......... .......+.++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 301 ~----------~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 301 K----------GSWK------------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp T----------TCCC------------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred c----------cchh------------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 0 0000 000000000 0011123478999999999999999999999999999999986
Q ss_pred C
Q 014039 286 E 286 (432)
Q Consensus 286 ~ 286 (432)
.
T Consensus 359 ~ 359 (371)
T 3q60_A 359 L 359 (371)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=366.68 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=212.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc---chHHHHHHHHHHHHHhcCCCcccccceEEE--eCCEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY---FWEECMNLREVKALRKLNHPNIIKLKEVVR--ENNEL 75 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~ 75 (432)
+++|++++.||+|+||.||+|.+..+++.||+|++..... ........+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999999999999999975432 123445678999999999999999999984 45678
Q ss_pred EEEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-
Q 014039 76 FFIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM- 152 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~- 152 (432)
|+||||+++++.+.+... .+.+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999999987777653 4579999999999999999999999999999999999999854 9999999999876432
Q ss_pred --CCCccccCCccccchhhhcCCC-CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 153 --PPYTEYVSTRWYRAPEVLLQSS-SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 153 --~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.. +..
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~----------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSY----------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCC-----------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCC-----------
Confidence 2234567999999999986432 347899999999999999999999998876665554421 100
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.+...++.++.+||++||+.||++|||++|+++||||+...
T Consensus 231 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 -----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp -----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred -----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 12235788999999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=391.25 Aligned_cols=246 Identities=18% Similarity=0.178 Sum_probs=196.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc--chHHHHHHHHH---HHHHhcCCCcccccc-------eEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY--FWEECMNLREV---KALRKLNHPNIIKLK-------EVV 69 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei---~~l~~l~hpnIv~l~-------~~~ 69 (432)
++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+ ++|++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 469999999999999999999999999999999975322 22334567899 455556899999998 666
Q ss_pred EeCC-----------------EEEEEEecCCCcHHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHHCCCeecc
Q 014039 70 RENN-----------------ELFFIFEYMEHNLYHIMRERQIPFSE-------GEIRSFMSQMLQGLAHMHRNGYFHRD 125 (432)
Q Consensus 70 ~~~~-----------------~~~lV~E~~~~~ll~~~~~~~~~l~~-------~~~~~i~~qIl~aL~~LH~~givHrD 125 (432)
.+.+ ..|+||||++|+|.+.+...+ .+++ ..++.++.||+.||+|||++||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 6553 278999999888888877542 3444 78888999999999999999999999
Q ss_pred CCCCceeEeCC-eEEEeeeccceecCCCCCCccccCCccccchhhhcCC----------CCCCcccceechHHHHHHHHh
Q 014039 126 LKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS----------SSYSPAIDMWAVGAILAELFT 194 (432)
Q Consensus 126 lkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiWSlG~il~ell~ 194 (432)
|||+|||++.+ .+||+|||+|+.... .....+| +.|+|||++.+. ..|+.++|||||||++|||++
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 99999999854 999999999986543 3445677 999999998644 278999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 014039 195 LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA 274 (432)
Q Consensus 195 g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta 274 (432)
|..||.+....+....+ ....+.+++++.+||.+||+.||++|||+
T Consensus 309 g~~Pf~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 309 ADLPITKDAALGGSEWI----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp SSCCC------CCSGGG----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred CCCCCcccccccchhhh----------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 99999765432111000 01124678999999999999999999999
Q ss_pred HHHhcCCCCCC
Q 014039 275 DQALQHPFFNV 285 (432)
Q Consensus 275 ~elL~Hp~f~~ 285 (432)
.|+++||||+.
T Consensus 355 ~e~l~hp~f~~ 365 (377)
T 3byv_A 355 LQAMETPEYEQ 365 (377)
T ss_dssp HHHHTSHHHHH
T ss_pred HHHhhChHHHH
Confidence 99999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=363.23 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=210.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+|++++++++||||+++++++.+.+..|+||||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 579999999999999999999999999999999976542 23456899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
+++ ++.+.+......+++..++.++.||+.||.|||+.|++||||||+||+++.+ .+||+|||++...... ......
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 185 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence 987 5656665556689999999999999999999999999999999999999854 9999999999876543 223456
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
.+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.........+.. +.+...
T Consensus 186 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~----------------- 245 (314)
T 3com_A 186 IGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT--NPPPTF----------------- 245 (314)
T ss_dssp CSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--SCCCCC-----------------
T ss_pred CCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--CCCccc-----------------
Confidence 7999999999985 56789999999999999999999999998877655444321 111000
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.....++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 246 --------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 246 --------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp --------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred --------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 01124678999999999999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=366.55 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=194.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHH-HHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~-~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+++|++++.||+|+||.||+|.++.+|+.||+|++............. ++..+++.++||||+++++++.+.+..|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999999999999999998655433333333 4445677889999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||+++.+..........+++..++.++.||+.||.|||+. ||+||||||+||+++.+ .+||+|||++...........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccc
Confidence 9996555555555566899999999999999999999995 99999999999999855 999999999987765555556
Q ss_pred ccCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 158 YVSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDS-EIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 158 ~~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~-~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
..+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.. ..+.+..+.. +.++.
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~------------ 249 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEPPL------------ 249 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH--SCCCC------------
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc--cCCCC------------
Confidence 78999999999985 34568999999999999999999999998743 3344443322 11110
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......++.++.+||.+||+.||.+|||++|+++||||+.
T Consensus 250 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 -------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp -------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred -------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0011357899999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=365.14 Aligned_cols=257 Identities=27% Similarity=0.382 Sum_probs=205.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|++..+++.||+|++...... .......+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5899999999999999999999999999999998654332 22344678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
||++++.+..+....+++++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++...... ...
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence 999875444444444579999999999999999999999999999999999999855 99999999998664432 234
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+...+.+. +..
T Consensus 171 ~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~------------------ 229 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSV------------------ 229 (294)
T ss_dssp ----CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCC------------------
T ss_pred ccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccC------------------
Confidence 467999999999985 56689999999999999999999999999887666544321 100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
+.......+.++.++.++|.+||+.||.+||+..+.+.+.|..
T Consensus 230 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 230 -----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp -----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred -----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 0001123356789999999999999999999777777666654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=369.27 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=190.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHH-HHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVK-ALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|.++.+|+.||||++.............+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 689999999999999999999999999999999986544334444556666 6677799999999999999999999999
Q ss_pred cCCCcHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 81 YMEHNLYHIMRE----RQIPFSEGEIRSFMSQMLQGLAHMHRN-GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 81 ~~~~~ll~~~~~----~~~~l~~~~~~~i~~qIl~aL~~LH~~-givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
|+++++.+.+.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.+ .+||+|||+++.......
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 999988777653 256799999999999999999999999 99999999999999855 999999999987765544
Q ss_pred CccccCCccccchhhhc---CCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLL---QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~---~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... +.+..+
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------------- 242 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------------------- 242 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-------------------
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-------------------
Confidence 55568999999999984 3456899999999999999999999999875432 111100
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.. ...+.........++.++.+||++||+.||++|||+.|+++||||...
T Consensus 243 --~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 243 --VK----GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp --CC----SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --hc----CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00 000000011224688999999999999999999999999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=374.67 Aligned_cols=273 Identities=18% Similarity=0.309 Sum_probs=213.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH----------------HHHHHHHHHHHHhcCCCccccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE----------------ECMNLREVKALRKLNHPNIIKL 65 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----------------~~~~~~Ei~~l~~l~hpnIv~l 65 (432)
++|++++.||+|+||.||+|.+ +|+.||+|++........ .....+|++++++++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 6899999999999999999998 899999999975432211 1456789999999999999999
Q ss_pred ceEEEeCCEEEEEEecCCC-cHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC
Q 014039 66 KEVVRENNELFFIFEYMEH-NLYHI------MRER-QIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND 136 (432)
Q Consensus 66 ~~~~~~~~~~~lV~E~~~~-~ll~~------~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~ 136 (432)
++++.+.+..|+||||+++ +|.+. +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999987 44443 3221 5689999999999999999999999 999999999999999855
Q ss_pred -eEEEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCc-ccceechHHHHHHHHhCCCCCCCCCh-HHHHHHHHH
Q 014039 137 -VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSP-AIDMWAVGAILAELFTLSPIFPGDSE-IDQLYKVCC 213 (432)
Q Consensus 137 -~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~~DiWSlG~il~ell~g~~pF~~~~~-~d~~~~i~~ 213 (432)
.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|||++|..||.+... .+....+..
T Consensus 189 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 9999999999876543 3456789999999999975546666 99999999999999999999998876 444444321
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
+.+....... . ................++.++.+||++||+.||.+|||++|+++||||+..+|
T Consensus 268 --~~~~~~~~~~-----~----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 268 --KNIEYPLDRN-----H----FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp --CCCCCCCSSS-----S----STTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred --cCcCCccchh-----h----hhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 1111110000 0 00000111112223568999999999999999999999999999999987544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=364.86 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=205.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe------CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE------NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~------~~~ 74 (432)
++|++++.||+|+||.||+|++..+|+.||+|++..... ......+|+.+++++ +||||+++++++.. .+.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 589999999999999999999999999999999975433 233466899999999 89999999999976 568
Q ss_pred EEEEEecCCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC
Q 014039 75 LFFIFEYMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~ 151 (432)
+|+||||+++ ++.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++.....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 9999999987 566665543 3579999999999999999999999999999999999999855 999999999987643
Q ss_pred C-CCCccccCCccccchhhhcC----CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 152 M-PPYTEYVSTRWYRAPEVLLQ----SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 152 ~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
. ......++|+.|+|||++.. ...++.++|||||||++|+|++|..||.+.........+... ..+.
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------- 253 (326)
T 2x7f_A 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PAPR------- 253 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCC-------
T ss_pred CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-cccc-------
Confidence 2 22345679999999999852 456899999999999999999999999888876665544211 0000
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 254 --------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 --------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp --------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred --------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0123578899999999999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=360.75 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=198.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe----------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE---------- 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---------- 71 (432)
++|++++.||+|+||.||+|++..+|+.||+|++.... .......+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 47999999999999999999999999999999996532 233446789999999999999999998754
Q ss_pred ---CCEEEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccc
Q 014039 72 ---NNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLA 146 (432)
Q Consensus 72 ---~~~~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a 146 (432)
.+..|+||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 4578999999986 6777776666678999999999999999999999999999999999999855 9999999999
Q ss_pred eecCCC---------------CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCC-ChHHHHHH
Q 014039 147 RELSSM---------------PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGD-SEIDQLYK 210 (432)
Q Consensus 147 ~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~-~~~d~~~~ 210 (432)
...... ......++|+.|+|||++.+...++.++|||||||++|+|++ ||... ...+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 765421 223456789999999999766679999999999999999998 44322 22222222
Q ss_pred HHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 211 VCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 211 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+.. +. ..++ .......+..+.+||++||+.||++|||+.|+++||||+.
T Consensus 241 ~~~--~~-----------------~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 241 LRS--VS-----------------IEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHS--TT-----------------CCCC-------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred ccc--cc-----------------cccC-------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 210 00 0000 1123456788999999999999999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=366.56 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=207.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.+..+++ .||||+++..........+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 579999999999999999999986554 59999998765544555678999999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-- 154 (432)
|||+++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 999977 5666665566689999999999999999999999999999999999999865 999999999987754322
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+....+....+......
T Consensus 209 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 273 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-------------- 273 (325)
T ss_dssp EECC---CCGGGSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--------------
T ss_pred eeccCCCCcccccCHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC--------------
Confidence 12234577899999985 5678999999999999999999 99999998877766655321100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+||.+||+.||++|||+.|+++.
T Consensus 274 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 274 ---------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1123678899999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=360.04 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=199.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++.+.||+|+||+||+|++ +|+.||+|++........ .....+|+++|++++||||+++++++.+.+.+|+|||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 5899999999999999999976 688899999986554333 3446789999999999999999999999999999999
Q ss_pred cCCCc-HHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeCC-eEEEeeeccceecCCC-C
Q 014039 81 YMEHN-LYHIMRERQ--IPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTND-VLKIADFGLARELSSM-P 153 (432)
Q Consensus 81 ~~~~~-ll~~~~~~~--~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~ 153 (432)
|++++ +.+.+.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ .+||+|||+++..... .
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 99875 545444322 13999999999999999999999999 9999999999999866 9999999999765432 2
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+||+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+......
T Consensus 195 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------------- 257 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR---------------- 257 (309)
T ss_dssp -------CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------------
T ss_pred ccccCCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence 234568999999999985 667899999999999999999999999988876655544211110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ--HPFFN 284 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~--Hp~f~ 284 (432)
..+...+++++.+||++||+.||.+|||++|+++ +++++
T Consensus 258 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 258 ------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1223468899999999999999999999999998 45544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=371.02 Aligned_cols=249 Identities=28% Similarity=0.403 Sum_probs=206.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-------CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-------ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|++++.||+|+||.||+|++. .++..||+|+++............+|+++|+.+ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57999999999999999999875 356789999998765444455677999999999 8999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
.+|+||||+++ +|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 99999999987 5666665432 358999999999999999999999999999999999999854
Q ss_pred eEEEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+|+...... ......+|+.|+|||++. ...|+.++|||||||++|||++ |.+||.+....+....+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 99999999998765432 223446788999999985 5679999999999999999999 999999877655444331
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. +. .......++.++.+||.+||+.||++|||+.|++++
T Consensus 320 ~--~~---------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 320 E--GH---------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp T--TC---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c--CC---------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 00 011224678899999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=373.94 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=209.7
Q ss_pred CCeeEeeeEeecCceEEEEEE-----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|+ +..+++.||+|++.............+|+.++++++||||+++++++.+....|
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 579999999999999999999 556788999999976554445556778999999999999999999999988999
Q ss_pred EEEecCCC-cHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeecc
Q 014039 77 FIFEYMEH-NLYHIMRERQ------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~ 145 (432)
+||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999976 6666665543 359999999999999999999999999999999999999832 699999999
Q ss_pred ceecCC---CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSS---MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
|+.... ........+|+.|+|||++. ...++.++|||||||++|||++ |.+||.+....+....+.... .
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~---- 304 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-R---- 304 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C----
T ss_pred ccccccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C----
Confidence 975422 22334567899999999985 5679999999999999999998 999999988776655543211 0
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
......++.++.+||.+||+.||++|||+.|+++|.++-
T Consensus 305 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 ------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011235788999999999999999999999999997764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=355.29 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=204.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
+|.....||+|+||.||+|.+..+++.||+|++..... .......+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34445599999999999999999999999999976532 23344678999999999999999999999999999999999
Q ss_pred CC-cHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecCCCC-CCc
Q 014039 83 EH-NLYHIMRERQ--IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELSSMP-PYT 156 (432)
Q Consensus 83 ~~-~ll~~~~~~~--~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~-~~~ 156 (432)
++ ++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++...... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 86 4555555442 35679999999999999999999999999999999999985 499999999998765432 234
Q ss_pred cccCCccccchhhhcCC-CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQS-SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~-~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+................
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------ 243 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------------ 243 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------------
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------------
Confidence 56799999999998643 34889999999999999999999999765443322111111110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...+...++.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 244 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 244 ---------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 01223467899999999999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=357.32 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=210.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (432)
+++|++++.||+|+||.||+|.+..+|+.||+|++...... .......+|++++++++||||+++++++.+ ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999999999999999999865433 233456789999999999999999998754 678999
Q ss_pred EEecCCC-cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 78 IFEYMEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRNG-----YFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~g-----ivHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
||||+++ +|.+.+... ...+++..++.++.||+.||.|||+.| |+||||||+||+++.+ .+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999986 666665532 345999999999999999999999999 9999999999999855 99999999998
Q ss_pred ecCCCCC-CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 148 ELSSMPP-YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 148 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
....... .....+|+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+....+.. +..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~-------- 233 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF-------- 233 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCC--------
T ss_pred eeccccccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh--ccc--------
Confidence 7654221 23457899999999985 55789999999999999999999999998877655554422 110
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+...++.++.++|.+||+.||++|||+.|+++|+|+..
T Consensus 234 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 -------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1122357889999999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.06 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=203.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+|++++++++||||+++++++.+.+..|+||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 68999999999999999999999999999999986532 23344567999999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC----
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---- 155 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~---- 155 (432)
+++ ++.+.+......+++.++..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 987 5666666656789999999999999999999999999999999999999865 9999999999876432211
Q ss_pred -----------ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 156 -----------TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 156 -----------~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
...+||+.|+|||++. ...++.++|||||||++|||++|..+|........ ..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--------------~~- 232 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--------------DF- 232 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--------------TS-
T ss_pred ccccccccccccccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--------------HH-
Confidence 1568999999999985 67789999999999999999999999876432100 00
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......... ...+.+++++.+||.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 -GLNVRGFLDR-----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -SBCHHHHHHH-----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhhccccc-----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000000 112467889999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=369.60 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=205.3
Q ss_pred CCeeEeeeEeecCceEEEEEE-----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC-E
Q 014039 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN-E 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~-~ 74 (432)
++|++++.||+|+||.||+|+ +..+++.||+|++.............+|+++++++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 589999999999999999998 55677999999998765544555678999999999 7999999999987754 4
Q ss_pred EEEEEecCCC-cHHHHHHHcCC----------------------------------------------------------
Q 014039 75 LFFIFEYMEH-NLYHIMRERQI---------------------------------------------------------- 95 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~~~---------------------------------------------------------- 95 (432)
+++||||+++ +|.+.+.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999987 45555544321
Q ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---CccccCCccc
Q 014039 96 -------PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YTEYVSTRWY 164 (432)
Q Consensus 96 -------~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y 164 (432)
.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....... .....+|+.|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 28999999999999999999999999999999999999854 999999999987644322 2345678899
Q ss_pred cchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCC
Q 014039 165 RAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPI 243 (432)
Q Consensus 165 ~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (432)
+|||++. ...++.++|||||||++|||++ |.+||.+....+.....+.....+
T Consensus 262 ~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------- 315 (359)
T 3vhe_A 262 MAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------------- 315 (359)
T ss_dssp CCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------------------------
T ss_pred EChhhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------------------------
Confidence 9999985 5678999999999999999998 999999887655554443321111
Q ss_pred CccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 244 NLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 244 ~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+++++.++|.+||+.||++|||+.|+++|
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=362.30 Aligned_cols=248 Identities=19% Similarity=0.192 Sum_probs=203.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|++..+|+.||||++..... .....+|+++++++ +||||+++++++.+.+..|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 579999999999999999999999999999999875432 12356899999999 99999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-e-----EEEeeeccceecCCCCC
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-V-----LKIADFGLARELSSMPP 154 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~-----lkL~DFG~a~~~~~~~~ 154 (432)
|+.++|.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ . +||+|||+|+.+.....
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 99778888877766789999999999999999999999999999999999999865 4 99999999987644322
Q ss_pred --------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCCCCc
Q 014039 155 --------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---DQLYKVCCILGAPDWTAF 223 (432)
Q Consensus 155 --------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~---d~~~~i~~~~g~p~~~~~ 223 (432)
....+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.. +....+.......
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 239 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT----- 239 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-----
T ss_pred CccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-----
Confidence 24678999999999985 567899999999999999999999999885432 2222221110000
Q ss_pred hhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
........++ ++.+||.+||+.||.+||+++++++
T Consensus 240 --------------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 --------------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp --------------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0001112334 8999999999999999999988876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=365.02 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=207.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcC--CCcccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLN--HPNIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~ 74 (432)
++|++++.||+|+||.||+|++..+++.||+|++....... ......+|+.+++++. |+||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 57999999999999999999999999999999997543221 1123457999999995 6999999999999999
Q ss_pred EEEEEecCC--CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-C-CeEEEeeeccceecC
Q 014039 75 LFFIFEYME--HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-N-DVLKIADFGLARELS 150 (432)
Q Consensus 75 ~~lV~E~~~--~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~-~~lkL~DFG~a~~~~ 150 (432)
.++|||++. +++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 999999997 4666666554 4799999999999999999999999999999999999998 4 499999999998776
Q ss_pred CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.. ......+|+.|+|||++.+...++.++|||||||++|||++|..||.+... +. .+..
T Consensus 202 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~--~~~~------------ 260 (320)
T 3a99_A 202 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II--RGQV------------ 260 (320)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--HCCC------------
T ss_pred cc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh--cccc------------
Confidence 43 345568999999999987655568899999999999999999999965421 10 0100
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....++.++.+||++||+.||++|||++|+++||||+..
T Consensus 261 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 261 ----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ----------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0123578999999999999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=358.52 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=203.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcC--CCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLN--HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++++.||+|+||.||+|.+. +++.||+|++....... ......+|+++++++. ||||+++++++.+.+..|+|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46999999999999999999885 48889999997654332 3344678999999996 59999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCC---C
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPP---Y 155 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~---~ 155 (432)
||+..+++.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||+++....... .
T Consensus 107 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 107 MECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp ECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC----------
T ss_pred EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccc
Confidence 997777888877665 479999999999999999999999999999999999999999999999999987644321 2
Q ss_pred ccccCCccccchhhhcC----------CCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCch
Q 014039 156 TEYVSTRWYRAPEVLLQ----------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~----------~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~ 224 (432)
...+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.... ..+..+. ....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~----- 257 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNH----- 257 (313)
T ss_dssp ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTS-----
T ss_pred cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---hccc-----
Confidence 34578999999999853 146889999999999999999999999776432 2222221 1100
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
........+.++.+||++||+.||++|||+.|+|+||||+.
T Consensus 258 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 258 --------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp --------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred --------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 00112345789999999999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=362.03 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=188.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEeccccc-chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEE--
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNIIKLKEVVRENNEL-- 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-- 75 (432)
++|++++.||+|+||.||+|++..+++ .||+|++..... ........+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 579999999999999999999887775 799999976532 23345567999999999999999999999776554
Q ss_pred ----EEEEecCCC-cHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeec
Q 014039 76 ----FFIFEYMEH-NLYHIMRER-----QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFG 144 (432)
Q Consensus 76 ----~lV~E~~~~-~ll~~~~~~-----~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG 144 (432)
++||||+.+ ++.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 999999987 555555432 1259999999999999999999999999999999999999865 99999999
Q ss_pred cceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCC
Q 014039 145 LARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDW 220 (432)
Q Consensus 145 ~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~ 220 (432)
+|+....... .....+++.|+|||++. ...++.++|||||||++|||++ |.+||.+....+....+....
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----- 256 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN----- 256 (323)
T ss_dssp C-----------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred ccccccccccccccccccCcccccCchhhc-CCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-----
Confidence 9987644322 22345677899999985 5678999999999999999999 999999887766555542110
Q ss_pred CCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCC
Q 014039 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-------ADQALQHPFFNVET 287 (432)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-------a~elL~Hp~f~~~~ 287 (432)
.....+.++.++.+||.+||+.||++||| .+++++|||+....
T Consensus 257 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 257 ------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred ------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 01122467889999999999999999999 88999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=352.26 Aligned_cols=250 Identities=17% Similarity=0.200 Sum_probs=208.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+|+++++.+ +|+|++++++++.+....|+|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 579999999999999999999999999999999875432 22356899999999 89999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC------eEEEeeeccceecCCCC-
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND------VLKIADFGLARELSSMP- 153 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~------~lkL~DFG~a~~~~~~~- 153 (432)
|+.++|.+.+...+..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 99778888887766679999999999999999999999999999999999999743 39999999998765432
Q ss_pred -------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCCCCc
Q 014039 154 -------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE---IDQLYKVCCILGAPDWTAF 223 (432)
Q Consensus 154 -------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~---~d~~~~i~~~~g~p~~~~~ 223 (432)
......||+.|+|||++. +..++.++|||||||++|||++|..||.+.+. ......+......
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 239 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------ 239 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH------
T ss_pred cccccccCccCCCCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC------
Confidence 234567999999999984 56789999999999999999999999988543 2333332211100
Q ss_pred hhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.+.++.++.+||.+||+.||++|||++++++.
T Consensus 240 -------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 240 -------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp -------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred -------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 01122334678999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=350.24 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=206.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+. +++.||+|++....... ....+|++++++++||||+++++++.+.+..|+||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH--HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 58999999999999999999987 46779999998655432 3467899999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCcc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTE 157 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~ 157 (432)
++++ +.+.+......+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||+++...... ....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9874 555665666679999999999999999999999999999999999999755 99999999998654321 2234
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+|+.|+|||++. ...++.++||||+||++|+|++ |.+||.+....+....+......
T Consensus 167 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 226 (269)
T 4hcu_A 167 TKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------------- 226 (269)
T ss_dssp TTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------------
T ss_pred cccccccCCHHHhc-CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-------------------
Confidence 45678899999985 5678999999999999999999 99999998877666555321000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......+.++.++|.+||+.||++|||+.|+++|
T Consensus 227 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123468899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=361.05 Aligned_cols=246 Identities=26% Similarity=0.465 Sum_probs=199.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhc----CCCcccccceEEEeC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKL----NHPNIIKLKEVVREN 72 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l----~hpnIv~l~~~~~~~ 72 (432)
++|++++.||+|+||.||+|++..+++.||+|++....... ......+|+.+++++ +||||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 57999999999999999999999999999999997543321 122235799999998 899999999999988
Q ss_pred CEEEEEEec-CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-C-CeEEEeeecccee
Q 014039 73 NELFFIFEY-MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-N-DVLKIADFGLARE 148 (432)
Q Consensus 73 ~~~~lV~E~-~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~-~~lkL~DFG~a~~ 148 (432)
+..++|||+ +.+ ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+||+++ + +.+||+|||+++.
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred CeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 899999999 565 566655554 4799999999999999999999999999999999999998 3 4999999999987
Q ss_pred cCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+... +.. ..
T Consensus 190 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--~~----------- 249 (312)
T 2iwi_A 190 LHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--AE----------- 249 (312)
T ss_dssp CCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--TC-----------
T ss_pred cccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--hc-----------
Confidence 7653 345678999999999987555556799999999999999999999965321 110 00
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
..+...++.++.+||.+||+.||++|||++|+++||||+.
T Consensus 250 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 250 -----------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred -----------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 0122467889999999999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=378.69 Aligned_cols=274 Identities=24% Similarity=0.405 Sum_probs=208.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC--EEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN--ELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV~ 79 (432)
++|++.++||+|+||.||+|++..+|+.||||++.............+|+++|++++||||+++++++.+.+ ..|+||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 479999999999999999999999999999999986544333445678999999999999999999997654 789999
Q ss_pred ecCCCc-HHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE----eCC-eEEEeeeccceecCC
Q 014039 80 EYMEHN-LYHIMRER--QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV----TND-VLKIADFGLARELSS 151 (432)
Q Consensus 80 E~~~~~-ll~~~~~~--~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl----~~~-~lkL~DFG~a~~~~~ 151 (432)
||++++ +.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.+ .+||+|||+|+....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 999875 54444432 2249999999999999999999999999999999999998 433 799999999998776
Q ss_pred CCCCccccCCccccchhhhcCC-------CCCCcccceechHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCC
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQS-------SSYSPAIDMWAVGAILAELFTLSPIFPGDS----EIDQLYKVCCILGAPDW 220 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiWSlG~il~ell~g~~pF~~~~----~~d~~~~i~~~~g~p~~ 220 (432)
.......+||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.. ..+.+.+++ .+.|..
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~~p~~ 246 (396)
T 4eut_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII--TGKPSG 246 (396)
T ss_dssp GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH--HSCCTT
T ss_pred CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh--cCCCcc
Confidence 6566677899999999998531 567889999999999999999999997533 233444432 233322
Q ss_pred CCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+....... ...+.+....+. ...+...++..+.++|++||++||++|||++|++++
T Consensus 247 -~~~~~~~~~-~~~~~~~~~~~~-~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 247 -AISGVQKAE-NGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp -CCEEEECST-TCCEEEESSCCT-TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred -cchhheecc-CCCcccCccCCc-ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111100000 000111111110 112223456688999999999999999999998765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=378.31 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=199.7
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+|++.++||+|+||+|+. ....+|+.||||++...... ...+|+++|+++ +||||+++++++.+....|+||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 599999999999999764 44678899999999754321 235899999999 899999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----C--eEEEeeeccceecCCC---
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----D--VLKIADFGLARELSSM--- 152 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~--~lkL~DFG~a~~~~~~--- 152 (432)
+++++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+|+.....
T Consensus 100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 999999988877666777788899999999999999999999999999999952 2 6889999999876543
Q ss_pred -CCCccccCCccccchhhhcC--CCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
......+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||....... ...+ .+.......
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~~~~~~~----- 250 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGACSLDCL----- 250 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTCCCCTTS-----
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---hccCCcccc-----
Confidence 22345689999999999864 3567889999999999999999 999996554322 2211 222111110
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
......+..+.+||.+||+.||++|||+.|+++||||....|
T Consensus 251 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 251 ------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp ------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred ------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 001123556899999999999999999999999999986544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.05 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=195.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.+..+ +..||+|++.............+|+.++++++||||+++++++. .+..|+|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 5899999999999999999998653 56799999876544344455679999999999999999999985 4568999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCC--
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~-- 154 (432)
|||+++ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccc
Confidence 999987 56666666666799999999999999999999999999999999999998 45999999999987654322
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+++.|+|||++. ...++.++|||||||++|||++ |.+||.+....+....+... .
T Consensus 174 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~--~---------------- 234 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--E---------------- 234 (281)
T ss_dssp -----CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--C----------------
T ss_pred cccCCCcccccChhhcc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC--C----------------
Confidence 22345678899999985 5678999999999999999996 99999988776665554210 0
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.+++++.++|.+||+.||++|||+.|++++
T Consensus 235 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 235 -----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011234678999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.58 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=206.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.+.||+|+||.||+|.+. .+++.||+|++.............+|++++++++||||+++++++.+.+..|
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 57999999999999999999883 4568999999986554444455779999999999999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcee
Q 014039 77 FIFEYMEH-NLYHIMRERQ-----------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLL 132 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~-----------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NIL 132 (432)
+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 99999985 5666555432 23899999999999999999999999999999999999
Q ss_pred EeCC-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHH
Q 014039 133 VTND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQ 207 (432)
Q Consensus 133 l~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~ 207 (432)
++.+ .+||+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+......
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9965 999999999987654322 23445778899999985 5678999999999999999999 9999988776544
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+.. +. .......++.++.+||.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~--~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKT--GH---------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHT--TC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhc--CC---------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 433311 00 011224678999999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=365.58 Aligned_cols=249 Identities=29% Similarity=0.391 Sum_probs=208.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-------CCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-------TYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|+++++||+|+||.||+|++.. .+..||+|+++............+|+++++++ +||||+++++++.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 579999999999999999999754 34679999998765544555677999999999 9999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
..|+||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence 99999999987 5666665543 359999999999999999999999999999999999999854
Q ss_pred eEEEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+|+...... ......+|+.|+|||++. +..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999998765432 234456788999999985 5678999999999999999999 999999887665544432
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
... .......++.++.+||++||+.||++|||+.|++++
T Consensus 308 ~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 308 EGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTC-----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 001123678999999999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=353.46 Aligned_cols=250 Identities=30% Similarity=0.386 Sum_probs=208.6
Q ss_pred CCeeEeeeEeecCceEEEEEEE-----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++++.||+|+||.||+|.+ ..+++.||+|++.............+|+++++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5799999999999999999985 4678899999998665444455677999999999 999999999999999999
Q ss_pred EEEEecCCC-cHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 76 FFIFEYMEH-NLYHIMRERQI-----------------PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~-----------------~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
++||||+++ +|.+.+..... .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 999999987 66666655432 48999999999999999999999999999999999999865
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....++
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 999999999987755432 23345678899999985 5678999999999999999998 999998877655555443
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+ .....++.++.+||.+||+.||.+|||+.|++++
T Consensus 262 ~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 262 KEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCC----------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 221110 1123578899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=370.02 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=206.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|++..+++.||+|+++..........+.+|+++|++++||||+++++++.+.+.+|+||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 57999999999999999999999999999999998654333334567899999999999999999999998999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC---Cc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP---YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~---~~ 156 (432)
+++ ++.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....... ..
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~ 273 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence 975 6777776666679999999999999999999999999999999999999854 999999999986543211 11
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+... ..+
T Consensus 274 ~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~----------------- 334 (377)
T 3cbl_A 274 LRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRL----------------- 334 (377)
T ss_dssp CCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCC-----------------
T ss_pred CCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC-----------------
Confidence 123467799999985 5568999999999999999998 99999988776554433210 000
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.....++.++.+||.+||+.||++|||+.++++
T Consensus 335 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 -----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112357889999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=363.84 Aligned_cols=254 Identities=30% Similarity=0.420 Sum_probs=179.2
Q ss_pred CCeeEee-eEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHH-HHHHhcCCCcccccceEEEe----CCEE
Q 014039 2 ERYKILE-ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREV-KALRKLNHPNIIKLKEVVRE----NNEL 75 (432)
Q Consensus 2 ~~Y~~~~-~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~----~~~~ 75 (432)
++|++++ .||+|+||.||+|+++.+|+.||+|++..... ..+|+ ..++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH------HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 5899966 59999999999999999999999999975421 22333 34566799999999999875 4568
Q ss_pred EEEEecCCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceec
Q 014039 76 FFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLAREL 149 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~ 149 (432)
|+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999987 5666665543 47999999999999999999999999999999999999974 26999999999876
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
... .....++|+.|+|||++ ....++.++|||||||++|+|++|..||.+................
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 247 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------ 247 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred ccc-ccccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------------
Confidence 542 34456889999999998 4667899999999999999999999999776543322111100000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+ ....+..++.++.+||++||+.||++|||++|+|+||||+.
T Consensus 248 ---~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 248 ---GQYGF-------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ------CC-------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---ccccc-------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 00000 01123468999999999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=361.10 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=207.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|++. .+++.||+|+++............+|++++++++||||+++++++.+.+..|
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 57999999999999999999987 4568999999986654444455779999999999999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcee
Q 014039 77 FIFEYMEH-NLYHIMRERQ-----------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLL 132 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~-----------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NIL 132 (432)
+||||+++ +|.+.+.... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 206 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence 99999987 5666665431 57999999999999999999999999999999999999
Q ss_pred EeCC-eEEEeeeccceecCCC---CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHH
Q 014039 133 VTND-VLKIADFGLARELSSM---PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQ 207 (432)
Q Consensus 133 l~~~-~lkL~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~ 207 (432)
++.+ .+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|||++ |..||.+....+.
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 9865 9999999999765432 1233456789999999985 5568999999999999999999 9999998877665
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+.. +. .......++.++.+||++||+.||++|||+.+++++
T Consensus 286 ~~~~~~--~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 IYYVRD--GN---------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHT--TC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhC--CC---------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 554421 10 011224678899999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=345.26 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=205.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+. ++..||+|++....... ....+|++++++++||||+++++++.+.+..|+||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH--HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 58999999999999999999776 56779999998655432 3467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Ccc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~~ 157 (432)
+++ ++.+.+...+..+++..++.++.||+.||+|||+.||+||||||+||+++.+ .+||+|||++........ ...
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 976 4666666666679999999999999999999999999999999999999865 999999999987654322 223
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+|+.|+|||++. ...++.++||||+||++|+|++ |..||.+....+....+... ...
T Consensus 165 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~----------------- 224 (268)
T 3sxs_A 165 TKFPVKWSAPEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG--HRL----------------- 224 (268)
T ss_dssp CCCCGGGCCHHHHH-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CCC-----------------
T ss_pred CCcCcccCCHHHHh-ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC--CCC-----------------
Confidence 45567899999985 5568999999999999999998 99999988877665554211 000
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......+.++.++|.+||+.||++|||+.|+++|
T Consensus 225 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ----------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467899999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=348.37 Aligned_cols=247 Identities=24% Similarity=0.306 Sum_probs=202.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHH------HHHHHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE------CMNLREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~------~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.+.||+|+||.||+|++..+++.||+|++......... ....+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5899999999999999999999999999999998754322111 34678999999999999999999987665
Q ss_pred EEEEecCC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeCC-e-----EEEeeeccc
Q 014039 76 FFIFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTND-V-----LKIADFGLA 146 (432)
Q Consensus 76 ~lV~E~~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~~-~-----lkL~DFG~a 146 (432)
++||||++ +++.+.+......+++..++.++.||+.||+|||++| |+||||||+|||++.+ . +||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 69999998 5677777777778999999999999999999999999 9999999999999743 3 999999999
Q ss_pred eecCCCCCCccccCCccccchhhhc-CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCCCCch
Q 014039 147 RELSSMPPYTEYVSTRWYRAPEVLL-QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYK-VCCILGAPDWTAFP 224 (432)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~aPE~l~-~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~-i~~~~g~p~~~~~~ 224 (432)
+.... ......+|+.|+|||++. ....++.++||||+||++|||++|..||.+....+.... .....+..
T Consensus 177 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 248 (287)
T 4f0f_A 177 QQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR------ 248 (287)
T ss_dssp BCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC------
T ss_pred ccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC------
Confidence 86543 345578999999999884 245678999999999999999999999987654333111 11111100
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..+...+++++.+||.+||+.||++|||++|+++
T Consensus 249 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 ---------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1123467899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=359.62 Aligned_cols=249 Identities=29% Similarity=0.362 Sum_probs=203.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEE--EEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIV--AVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|++..++..+ |+|.+.............+|+++++++ +||||+++++++.+.+.+|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999999998865 999987644444445567899999999 899999999999999999999
Q ss_pred EecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEe
Q 014039 79 FEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIA 141 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~ 141 (432)
|||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 999976 5666655432 379999999999999999999999999999999999999865 99999
Q ss_pred eeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCC
Q 014039 142 DFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDW 220 (432)
Q Consensus 142 DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~ 220 (432)
|||+++............+++.|+|||++. ...++.++|||||||++|||++ |..||.+....+....+...
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~------ 257 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 257 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT------
T ss_pred ccCcCccccccccccCCCCCccccChhhhc-cccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC------
Confidence 999998654433344556788999999984 5678999999999999999998 99999988766554433110
Q ss_pred CCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
. .......++.++.+||.+||+.||++|||++|+++|
T Consensus 258 ----------------~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 ----------------Y-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ----------------C-------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------C-------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 001123578899999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=346.20 Aligned_cols=247 Identities=28% Similarity=0.369 Sum_probs=193.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch---HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW---EECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+++|++.+.||+|+||.||+|.+. |+.||+|++....... ......+|+++++.++||||+++++++.+.+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999874 7899999987543221 12345689999999999999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCceeEeC---------CeEEEeeecc
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG---YFHRDLKPENLLVTN---------DVLKIADFGL 145 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g---ivHrDlkP~NILl~~---------~~lkL~DFG~ 145 (432)
||||++++.+..+... +.+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999987766666544 47999999999999999999999999 899999999999973 4799999999
Q ss_pred ceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 146 ARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 146 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
++...... .....+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.......+.. +..
T Consensus 163 ~~~~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~------- 231 (271)
T 3dtc_A 163 AREWHRTT-KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM--NKL------- 231 (271)
T ss_dssp --------------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--SCC-------
T ss_pred cccccccc-ccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--CCC-------
Confidence 98765432 33568999999999985 56789999999999999999999999998877665544321 000
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.++|.+||+.||++|||+.|+++|
T Consensus 232 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 232 -------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 011224678899999999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=358.99 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=203.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++++.||+|+||.||+|.+. .++..||+|++.............+|+++|+++ +||||+++++++.+.+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 57999999999999999999973 467789999998654434445567999999999 899999999999999999
Q ss_pred EEEEecCCC-cHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcee
Q 014039 76 FFIFEYMEH-NLYHIMRERQI----------------------PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLL 132 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~----------------------~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NIL 132 (432)
|+||||+++ +|.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 999999976 66666655432 3799999999999999999999999999999999999
Q ss_pred EeCC-eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHH
Q 014039 133 VTND-VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQ 207 (432)
Q Consensus 133 l~~~-~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~ 207 (432)
++.+ .+||+|||++........ .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+......
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 9865 999999999987654332 23345678899999985 5668999999999999999998 9999988776555
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...++...-. ......++.++.+||.+||+.||.+|||+.|+++|
T Consensus 284 ~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 284 FYKLIQNGFK----------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4444321000 01123578899999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=348.33 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=203.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+. ++..||+|++....... ....+|++++++++||||+++++++.+.+..|+||||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH--HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 58999999999999999999876 57789999998654432 3467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCcc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~~ 157 (432)
+++ ++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++...... ....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 976 5666665545679999999999999999999999999999999999999865 99999999997654321 1233
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+|+.|+|||++. ...++.++||||+||++|+|++ |..||.+....+....+......
T Consensus 181 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------- 240 (283)
T 3gen_A 181 SKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------------- 240 (283)
T ss_dssp TTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------------------
T ss_pred CccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-------------------
Confidence 45678899999985 5568999999999999999998 99999988877666655321110
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......+.++.+||.+||+.||++|||+.|+++|
T Consensus 241 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0113467899999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.50 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=194.9
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++++.||+|+||.||+|++..+++.||+|++........ .....+|++++++++||||+++++++.+.+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999976543222 24467899999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--C
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--P 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~ 154 (432)
|||+++ ++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++....... .
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999987 55555544 4579999999999999999999999999999999999999854 99999999997664422 2
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||.+..... +...+. ...
T Consensus 192 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~--~~~---------------- 251 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHIN--QAI---------------- 251 (309)
T ss_dssp -----CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHH--SCC----------------
T ss_pred ccccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhc--cCC----------------
Confidence 34567999999999985 5678999999999999999999999998876542 222211 110
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-TADQALQ 279 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-ta~elL~ 279 (432)
.......+.++.++.++|.+||+.||++|| |++++++
T Consensus 252 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 252 --------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 011123356888999999999999999999 7877775
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=350.88 Aligned_cols=244 Identities=16% Similarity=0.204 Sum_probs=200.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC-------eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY-------EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 74 (432)
++|++.+.||+|+||.||+|.+..++ ..||+|++..... .......+|++++++++||||+++++++.+.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 68999999999999999999998877 4699999875432 233446789999999999999999999999999
Q ss_pred EEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-e--------EEEeeec
Q 014039 75 LFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-V--------LKIADFG 144 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~--------lkL~DFG 144 (432)
.|+||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ . +||+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 9999999985 6666666655569999999999999999999999999999999999999854 3 9999999
Q ss_pred cceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q 014039 145 LARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAF 223 (432)
Q Consensus 145 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~ 223 (432)
++..... .....+|+.|+|||++.+...++.++|||||||++|||++ |.++|............ .. .
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~--~------ 234 (289)
T 4fvq_A 167 ISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-ED--R------ 234 (289)
T ss_dssp SCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HT--T------
T ss_pred ccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hc--c------
Confidence 9975533 2345688999999999765789999999999999999999 45666555543332221 10 0
Q ss_pred hhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 224 PEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......+.++.+||++||+.||++|||+.|+++|
T Consensus 235 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ----------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01122456789999999999999999999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=360.14 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=199.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeE----EEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEI----VAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++++.||+|+||.||+|.+..+++. ||+|.+.............+|+.++++++||||+++++++.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 6899999999999999999999888876 677776543322222334689999999999999999999864 56899
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC--
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP-- 153 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~-- 153 (432)
||||+.+ ++.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 9999985 677776665568999999999999999999999999999999999999975 499999999998764432
Q ss_pred -CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 154 -PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 154 -~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
......++..|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.. +.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~-------------- 234 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK--GE-------------- 234 (325)
T ss_dssp CC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT--TC--------------
T ss_pred ccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc--CC--------------
Confidence 234456788999999985 5668999999999999999999 9999998776554444321 00
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.++|.+||+.||.+|||+.|+++|
T Consensus 235 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 -------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001112456788999999999999999999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=356.17 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=196.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEE----EEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIV----AVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|+++++||+|+||.||+|++..+++.+ |+|.+...........+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57999999999999999999998887765 7777654433333445678999999999999999999998765 678
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC-
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~- 154 (432)
|+||+.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+.......
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 8888875 677777776778999999999999999999999999999999999999985 5999999999987654332
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....+|..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.... .
T Consensus 174 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~-------------- 237 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-R-------------- 237 (327)
T ss_dssp ------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-C--------------
T ss_pred ccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-C--------------
Confidence 22345678999999985 5678999999999999999999 999998877654433331100 0
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....+.++.++.++|.+||+.||++|||+.|++++
T Consensus 238 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 --------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01123578899999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=345.03 Aligned_cols=250 Identities=19% Similarity=0.198 Sum_probs=203.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEE-EeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV-RENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|++..+|+.||+|++...... ....+|+++++.+.|++++..+..+ ......++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 5899999999999999999999999999999998754432 2356899999999988876665554 67788899999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe----CCeEEEeeeccceecCCCCC--
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~----~~~lkL~DFG~a~~~~~~~~-- 154 (432)
|+.+++.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 997788888876667899999999999999999999999999999999999994 44999999999987654322
Q ss_pred ------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCCCCchh
Q 014039 155 ------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI---DQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 155 ------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~---d~~~~i~~~~g~p~~~~~~~ 225 (432)
.....||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.. .....+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 235 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM--------- 235 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---------
T ss_pred ccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc---------
Confidence 34568999999999985 566899999999999999999999999875332 22222211000
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......+...+++++.+||.+||+.||++|||+.++++.
T Consensus 236 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 236 ----------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp ----------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ----------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 001112234678999999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=356.06 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=207.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++.+.||+|+||.||+|.+. .+++.||+|++.............+|++++++++||||+++++++.+.+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 57999999999999999999876 4678899999986554444555779999999999999999999999989999
Q ss_pred EEEecCCC-cHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 77 FIFEYMEH-NLYHIMRERQ---------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~---------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 99999986 6666555421 467999999999999999999999999999999999999865 999999999
Q ss_pred ceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++....... .....+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+..+....+.. +.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~---- 257 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GG---- 257 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT--TC----
T ss_pred ccccccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc--CC----
Confidence 986543221 22345688999999985 5668999999999999999999 8999998877665554421 00
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+||.+||+.||++|||+.|+++|
T Consensus 258 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 -----------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011224678899999999999999999999999997
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=358.66 Aligned_cols=264 Identities=27% Similarity=0.302 Sum_probs=195.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC----CEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN----NELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----~~~~l 77 (432)
++|+++++||+|+||.||+|++. ++.||+|++..... ......+|+.+|++++||||+++++++.+. ..+|+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 58999999999999999999775 78999999975432 233345699999999999999999999764 34799
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN----------GYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~----------givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
||||+++ +|.+.+.. . .+++..++.++.||+.||+|||+. ||+||||||+|||++.+ .+||+|||+
T Consensus 100 v~e~~~~g~L~~~l~~-~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-N-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEECCTTCBHHHHHHH-C-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHh-c-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999987 55555544 3 599999999999999999999999 99999999999999866 999999999
Q ss_pred ceecCCCCC---CccccCCccccchhhhcCC----CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014039 146 ARELSSMPP---YTEYVSTRWYRAPEVLLQS----SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 146 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
|+....... ....+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+..............+.+
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 987654322 3446899999999998643 356678999999999999999999998764322111111111111
Q ss_pred CCCCchhhhhhhhhhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 219 DWTAFPEATNISRLISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.... .............+...+ ...+.++.+||.+||+.||++|||+.|+++.
T Consensus 258 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLED---------MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHH---------HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhh---------hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1000 000000000011111111 1234569999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.63 Aligned_cols=250 Identities=19% Similarity=0.207 Sum_probs=200.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEE-EeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV-RENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E 80 (432)
++|++++.||+|+||.||+|++..+++.||+|++...... ....+|+++++.+.|++++..+..+ .+.+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 5899999999999999999999999999999987654322 2356899999999888777766554 67788999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeE---e-CCeEEEeeeccceecCCCCC--
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLV---T-NDVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl---~-~~~lkL~DFG~a~~~~~~~~-- 154 (432)
|+.+++.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+|+.......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 99878888887666789999999999999999999999999999999999999 4 34899999999987654322
Q ss_pred ------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCCCCchh
Q 014039 155 ------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEID---QLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 155 ------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d---~~~~i~~~~g~p~~~~~~~ 225 (432)
.....+|+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+ ....+....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 234 (296)
T 4hgt_A 166 HIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---------- 234 (296)
T ss_dssp BCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH----------
T ss_pred cCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc----------
Confidence 23568999999999985 5668999999999999999999999998754321 111111100
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...........++.++.+||.+||+.||++|||++++++.
T Consensus 235 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 274 (296)
T 4hgt_A 235 ---------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp ---------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ---------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence 0001112234678899999999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.57 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=204.2
Q ss_pred CCeeEeeeEeecCceEEEEEEE-----cCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeC-CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVREN-NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~-~~ 74 (432)
++|++++.||+|+||.||+|.+ ..+++.||+|++.............+|+++++++ +||||+++++++... ..
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999985 4577899999998765544455677999999999 799999999998765 45
Q ss_pred EEEEEecCCC-cHHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-e
Q 014039 75 LFFIFEYMEH-NLYHIMRERQI---------------PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-V 137 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~~~---------------~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~ 137 (432)
+|+||||+++ +|.+.+..... .+++..++.++.||+.||.|||++||+||||||+||+++.+ .
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 8999999987 55555554332 28999999999999999999999999999999999999854 9
Q ss_pred EEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014039 138 LKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 138 lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~ 213 (432)
+||+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+.....+.
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 99999999987654332 23356788999999985 5678999999999999999998 9999988765544443322
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....+ .....+++++.++|.+||+.||.+|||+.|+++|
T Consensus 266 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 266 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCccC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11110 1123578899999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=353.27 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=205.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-------CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-------ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|++++.||+|+||.||+|++. .++..||+|++.............+|+++++++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 58999999999999999999976 467789999998665444455577999999999 8999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEH-NLYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
.+|+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence 99999999987 5655555432 248999999999999999999999999999999999999854
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 999999999987654322 23345678899999985 5668999999999999999999 999999887665544432
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
... . ......++.++.++|.+||+.||.+|||+.|++++
T Consensus 274 ~~~-~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 274 EGH-R----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTC-C----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-C----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 210 0 01224678899999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.53 Aligned_cols=250 Identities=27% Similarity=0.353 Sum_probs=206.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe-----EEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE-----IVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.+.||+|+||.||+|.+..+++ .||+|++.............+|+++|+++ +||||+++++++.+.+.+
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 579999999999999999999977664 79999998765444555677999999999 899999999999999999
Q ss_pred EEEEecCCC-cHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEE
Q 014039 76 FFIFEYMEH-NLYHIMRER-------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKI 140 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~-------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL 140 (432)
|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++++ .+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 999999986 666666542 3468999999999999999999999999999999999999865 9999
Q ss_pred eeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014039 141 ADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILG 216 (432)
Q Consensus 141 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g 216 (432)
+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|||++ |.+||.+....+....+.....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 284 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC
Confidence 99999986644322 23345678899999985 5668999999999999999998 9999998776555554432211
Q ss_pred CCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 217 APDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+ ......+.++.+||.+||+.||.+|||+.|++++
T Consensus 285 ~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 285 QM----------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 10 0123467899999999999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.35 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=205.4
Q ss_pred CCeeEee-eEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILE-ELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~-~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|.+++ .||+|+||.||+|.+. .++..||+|++.............+|++++++++||||+++++++ ..+..|+|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4688887 9999999999999854 578889999998765444455677999999999999999999999 45668999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC--
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~-- 154 (432)
|||+++ ++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 999987 555555555667999999999999999999999999999999999999985 4999999999987754322
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.. +.
T Consensus 168 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--~~-------------- 230 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--GK-------------- 230 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--TC--------------
T ss_pred eccccccccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc--CC--------------
Confidence 22345688999999985 5668999999999999999998 9999998877665544421 10
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
.....+.+++++.++|.+||+.||++|||+.|+++|.
T Consensus 231 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 -------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0112346789999999999999999999999999883
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=351.74 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=200.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC----eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY----EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++.+.||+|+||.||+|.+..++ ..||+|++.............+|++++++++||||+++++++.+.+..|+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 57999999999999999999887553 45999999865544445557799999999999999999999999999999
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~- 154 (432)
||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 9999987 5666666666789999999999999999999999999999999999999865 999999999987654221
Q ss_pred ---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 155 ---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 155 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....+|..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~------------- 269 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------------- 269 (333)
T ss_dssp -------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------
T ss_pred ccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-------------
Confidence 12234577899999985 5678999999999999999998 99999888776655544211000
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.++|.+||+.||++||++.|++++
T Consensus 270 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ----------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123578899999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=343.67 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=193.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|++.++||+|+||.||+|++.. .||+|+++...... ....+.+|++++++++||||++++++. .....++|||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 579999999999999999997543 49999998655433 334567899999999999999999965 4566899999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC---CCCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS---MPPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~---~~~~ 155 (432)
|+.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... ....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 9986 5556665566689999999999999999999999999999999999999855 999999999976543 2233
Q ss_pred ccccCCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
....||+.|+|||++. ....++.++|||||||++|+|++|..||.+....+....++.....+
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 244 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS--------------- 244 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC---------------
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC---------------
Confidence 4567999999999985 24568889999999999999999999999887777666554322111
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+..+...++.++.+||.+||+.||++|||+.|+++.
T Consensus 245 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 245 ---------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp ---------CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11223345688999999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=346.07 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=201.6
Q ss_pred CCeeEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN--NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 75 (432)
++|++++.||+|+||.||+|+ +..+++.||+|++.............+|++++++++||||+++++++.+. ..+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 469999999999999999998 57789999999998654333345567899999999999999999999765 678
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP 153 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~ 153 (432)
|+||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 999999986 666666566678999999999999999999999999999999999999974 599999999998775543
Q ss_pred C----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 P----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
. .....+|..|+|||++. ...++.++|||||||++|+|++|..|+.... . .+....+... ..... ...
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~-~~~~~-~~~ 252 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTH-GQMTV-TRL 252 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCC-GGGHH-HHH
T ss_pred cceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCcc-cccCH-HHH
Confidence 2 33456888899999985 5668899999999999999999998763321 1 1112222211 11100 000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..... ........+.+++++.+||++||+.||.+|||+.|+++
T Consensus 253 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHh-------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 01000 00111233578899999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=343.76 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=201.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC---CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.+.. ++..||+|++.............+|++++++++||||+++++++.++ ..|+|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 589999999999999999998653 34569999998765444555677999999999999999999998754 46899
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC--C
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP--P 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~--~ 154 (432)
|||+++ ++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++....... .
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 170 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK 170 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence 999985 566666666667999999999999999999999999999999999999985 599999999998765432 1
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.... .
T Consensus 171 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~---------------- 232 (281)
T 3cc6_A 171 ASVTRLPIKWMSPESIN-FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-R---------------- 232 (281)
T ss_dssp --CCCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-C----------------
T ss_pred cccCCCCcceeCchhhc-cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-C----------------
Confidence 23445688899999984 5678999999999999999998 999998776655544432210 0
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......+++++.++|.+||+.||++|||+.|++++
T Consensus 233 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 ------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 01123578899999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=362.98 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=195.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc---CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|++. .++..||||+++..........+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999877 567789999998655444455677999999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-- 154 (432)
|||+++ +|.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 999975 5666666556679999999999999999999999999999999999999865 999999999987654321
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 205 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-------------- 269 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-------------- 269 (373)
T ss_dssp ---------CTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--------------
T ss_pred eeccCCCcCCCccChhhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 11223467899999985 5678999999999999999998 99999888776655544211100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+||.+||+.||++||++.|+++.
T Consensus 270 ---------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 270 ---------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp ---------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 0123567899999999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.21 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=184.8
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEE--------eCC
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVR--------ENN 73 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~--------~~~ 73 (432)
+|++.++||+|+||.||+|++..+++.||+|++..... .......+|+.+++++. ||||+++++++. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 79999999999999999999999999999999865432 23344678999999995 999999999984 345
Q ss_pred EEEEEEecCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 74 ELFFIFEYMEHNLYHIMRE--RQIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~--~~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
.+++||||+.|++.+.+.. ..+.+++..++.++.||+.||.|||+.| |+||||||+|||++++ .+||+|||+++.
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 6899999999999888765 4557999999999999999999999999 9999999999999865 999999999987
Q ss_pred cCCCCCC-------------ccccCCccccchhhhc--CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014039 149 LSSMPPY-------------TEYVSTRWYRAPEVLL--QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 149 ~~~~~~~-------------~~~~~t~~y~aPE~l~--~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~ 213 (432)
....... ...++|+.|+|||++. ....++.++|||||||++|+|++|..||.+..........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-- 265 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK-- 265 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--
Confidence 6543221 2456899999999884 3556889999999999999999999999765432221110
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.. .......+.++.+||++||+.||++|||+.|+++|
T Consensus 266 -~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 266 -YS-----------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp -CC-----------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -cc-----------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 00113456789999999999999999999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=346.07 Aligned_cols=264 Identities=27% Similarity=0.330 Sum_probs=200.0
Q ss_pred CCeeEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (432)
++|++++.||+|+||.||+|+ +..+++.||+|++..... .......+|+++|++++||||+++++++.. ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 589999999999999999998 567899999999975432 233456789999999999999999999854 4568
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP 153 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~ 153 (432)
++||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 999999976 666666666556999999999999999999999999999999999999985 599999999998764432
Q ss_pred ----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 ----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
......++..|+|||++. ...++.++|||||||++|||++|..+|...... .....+.............
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHHHHH
T ss_pred ceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHHHHH
Confidence 123345778899999985 567899999999999999999999988653221 1122233222211100000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..... .........++.++.+||++||+.||++|||+.|+++.
T Consensus 243 ~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 243 ELLKN--------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHT--------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhc--------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00000 01112235688999999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=367.47 Aligned_cols=253 Identities=29% Similarity=0.399 Sum_probs=192.4
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEec
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
.|.+.+.||+|+||+||.+ ...+|+.||||++.... .....+|+++|+++ +||||+++++++.+.+.+|+||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4667789999999999875 45679999999987543 22356899999987 899999999999999999999999
Q ss_pred CCCcHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC--------------eEEEe
Q 014039 82 MEHNLYHIMRERQIP------FSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND--------------VLKIA 141 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~------l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~--------------~lkL~ 141 (432)
++++|.+.+...... .++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999888877654311 1333467899999999999999999999999999999642 79999
Q ss_pred eeccceecCCCCC-----CccccCCccccchhhhcC------CCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHH
Q 014039 142 DFGLARELSSMPP-----YTEYVSTRWYRAPEVLLQ------SSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLY 209 (432)
Q Consensus 142 DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~------~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~ 209 (432)
|||+|+....... ....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||.+..... .
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~ 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence 9999988754322 234589999999999864 2568999999999999999998 999997665432 1
Q ss_pred HHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 210 KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 210 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.++. +....... .. .....++.++.+||.+||+.||++|||+.|+++||||..
T Consensus 249 ~i~~--~~~~~~~~-----------------~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 249 NIIR--GIFSLDEM-----------------KC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHH--TCCCCCCC-----------------TT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHhc--CCCCcccc-----------------cc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 2211 11111100 00 001134678999999999999999999999999999964
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=360.30 Aligned_cols=259 Identities=20% Similarity=0.188 Sum_probs=198.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-----CeEEEEEEecccccchH-H---------HHHHHHHHHHHhcCCCcccccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-----YEIVAVKKMKRKFYFWE-E---------CMNLREVKALRKLNHPNIIKLK 66 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~-~---------~~~~~Ei~~l~~l~hpnIv~l~ 66 (432)
++|++++.||+|+||.||+|.+..+ ++.||+|++........ + ....+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4799999999999999999998765 57899999875432111 0 1123466677788899999999
Q ss_pred eEEEeC----CEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe--C-CeEE
Q 014039 67 EVVREN----NELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT--N-DVLK 139 (432)
Q Consensus 67 ~~~~~~----~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~--~-~~lk 139 (432)
+++... ...||||||+.++|.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++ . +.+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence 998653 45899999996677777777667899999999999999999999999999999999999997 4 3999
Q ss_pred EeeeccceecCCCC--------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014039 140 IADFGLARELSSMP--------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV 211 (432)
Q Consensus 140 L~DFG~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i 211 (432)
|+|||+|+.+.... .....+||+.|+|||++. +..++.++|||||||++|||++|..||.+..........
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~ 273 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence 99999998764322 123456999999999985 566999999999999999999999999875433332222
Q ss_pred HHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 212 CCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 212 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...... ..........++ ...++.++.+||.+||+.||.+||++.++++.
T Consensus 274 ~~~~~~---------~~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 274 SKIRYR---------ENIASLMDKCFP----------AANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHH---------HCHHHHHHHHSC----------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhh---------hhHHHHHHHhcc----------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 111000 001111111110 13678899999999999999999999998863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.47 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=204.4
Q ss_pred CCeeEeeeEeecCceEEEEEE-----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|+ +..+++.||+|++.............+|+.++++++||||+++++++.+....|
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 589999999999999999998 567888999999976544444556778999999999999999999999988999
Q ss_pred EEEecCCC-cHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---C-eEEEeeecc
Q 014039 77 FIFEYMEH-NLYHIMRERQ------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---D-VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~-~lkL~DFG~ 145 (432)
+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 99999975 5666665543 35899999999999999999999999999999999999983 2 799999999
Q ss_pred ceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++...... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+... ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~---- 263 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GR---- 263 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC----
T ss_pred ccccccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC-CC----
Confidence 97543221 223456789999999985 5668999999999999999998 99999988776555444211 00
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
......++.++.+||.+||+.||.+|||+.|+++|.|+-
T Consensus 264 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 ------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 011236788999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=338.85 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=206.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+. +++.||+|++....... ....+|++++++++||||+++++++.+.+..|+||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 58999999999999999999986 57789999998655432 3467899999999999999999999998999999999
Q ss_pred CCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--CCCcc
Q 014039 82 MEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM--PPYTE 157 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~--~~~~~ 157 (432)
+++ ++.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... .....
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 986 6666666666679999999999999999999999999999999999999855 9999999999765432 12234
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||++. ...++.++||||+||++|+|++ |.+||.+....+....+.....
T Consensus 165 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-------------------- 223 (267)
T 3t9t_A 165 TKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------------------- 223 (267)
T ss_dssp TTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------------------
T ss_pred ccccccccChhhhc-CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc--------------------
Confidence 46778899999985 5678999999999999999999 8999998877666555421100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......+.++.++|.+||+.||++|||+.|++++
T Consensus 224 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 ---------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123468899999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=345.41 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=206.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+|++++++++||||+++++++.+.+..|+||||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 579999999999999999999999999999999976443 344567899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Cc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~ 156 (432)
+++ ++.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||++........ ..
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 985 666666553 3469999999999999999999999999999999999999855 899999999986654321 23
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 171 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-------------------- 229 (288)
T 3kfa_A 171 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------------------- 229 (288)
T ss_dssp TEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------------------
T ss_pred CCccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC--------------------
Confidence 345678899999985 5578999999999999999999 999998877655444332100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+||++||+.||.+|||+.|+++.
T Consensus 230 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 230 ---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 001124678899999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=338.97 Aligned_cols=246 Identities=21% Similarity=0.274 Sum_probs=201.8
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeC--CEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVREN--NELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 77 (432)
+++|++.+.||+|+||.||+|++. ++.||+|++....... ......+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 368999999999999999999874 8889999998654332 334567899999999999999999999876 78899
Q ss_pred EEecCCC-cHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 78 IFEYMEH-NLYHIMRERQI-PFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~-~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
||||+++ +|.+.+..... .+++..++.++.||+.||+|||++| ++||||||+||+++.+ .++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999986 56665554432 5999999999999999999999999 9999999999999965 899999888755332
Q ss_pred CCCccccCCccccchhhhcCCC--CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSS--SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
....+|+.|+|||++.+.. .++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 230 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP------------ 230 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC------------
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC------------
Confidence 3457899999999986432 23348999999999999999999999888776655543211111
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+...++.++.++|.+||+.||++|||++|+++.
T Consensus 231 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 231 ----------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1234678999999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=350.90 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=197.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEE----EEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIV----AVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|+++++||+|+||.||+|.+..+++.+ |+|.+.............+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 58999999999999999999998888765 6666654433334455678999999999999999999998765 778
Q ss_pred EEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC-
Q 014039 78 IFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~- 154 (432)
|+|++.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+.......
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence 8888875 677777776778999999999999999999999999999999999999985 5999999999987643322
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....+|+.|+|||++. ...|+.++|||||||++|||++ |.+||.+....+....+....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---------------- 236 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---------------- 236 (327)
T ss_dssp ------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------------
T ss_pred ccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 23345677899999986 5678999999999999999999 999998877655444332110
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+||++||+.||.+|||+.|+++.
T Consensus 237 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 237 -------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 001123578899999999999999999999999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=344.40 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=201.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEE-EeCCEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVV-RENNELFFI 78 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV 78 (432)
+|++.+.||+|+||.||+|.+..+ +..+|+|.+.............+|+.++++++||||+++++++ ..++..|+|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 699999999999999999987543 3468999998755544555677999999999999999999986 456788999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--- 153 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--- 153 (432)
|||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+||+++++ .+||+|||+|+......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhc
Confidence 999987 5666666556679999999999999999999999999999999999999865 99999999998654321
Q ss_pred --CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 154 --PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 --~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
......+|+.|+|||++. ...++.++|||||||++|+|++ |.++|.+.+..+....+... ..
T Consensus 186 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~------------ 250 (298)
T 3f66_A 186 VHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR------------ 250 (298)
T ss_dssp C-----CCBCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--CC------------
T ss_pred cccccCCCCCccccChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--CC------------
Confidence 233456788999999985 5678999999999999999999 78888887766555444211 00
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.++|.+||+.||++|||+.|+++.
T Consensus 251 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 251 ---------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123568899999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.64 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=201.5
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEE-EEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNEL-FFI 78 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-~lV 78 (432)
.|++.++||+|+||.||+|.+..+++ .||+|++.............+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 47778999999999999999765544 79999998655444455667999999999999999999999765554 899
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC----
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---- 152 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---- 152 (432)
|||+.+ ++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999965 6666666656789999999999999999999999999999999999999866 9999999999765331
Q ss_pred -CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.......+++.|+|||++. ...++.++|||||||++|+|++ |.++|.+.+..+....+.....
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------------- 246 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-------------- 246 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHT-TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--------------
T ss_pred cccCcCCCCCccccChhhhc-cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--------------
Confidence 2234557789999999984 6678999999999999999999 6666766666554444321110
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.+||++||+.||.+|||+.++++.
T Consensus 247 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 247 ---------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=344.71 Aligned_cols=243 Identities=27% Similarity=0.361 Sum_probs=202.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe----------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE---------- 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---------- 71 (432)
++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 479999999999999999999999999999999975431 24589999999999999999998854
Q ss_pred ------CCEEEEEEecCCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEee
Q 014039 72 ------NNELFFIFEYMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIAD 142 (432)
Q Consensus 72 ------~~~~~lV~E~~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~D 142 (432)
...+|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 4558999999997 666666543 3579999999999999999999999999999999999999854 999999
Q ss_pred eccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q 014039 143 FGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTA 222 (432)
Q Consensus 143 FG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~ 222 (432)
||++.............+|+.|+|||++. ...++.++|||||||++|+|++|..+|..... ....+ .
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~----~------ 232 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDL----R------ 232 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHH----H------
T ss_pred chhheeccccccccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHh----h------
Confidence 99999887665566678999999999985 56789999999999999999999887742111 00000 0
Q ss_pred chhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 223 FPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
.. .+...++.++.+||.+||+.||++|||+.|+++|.+.-
T Consensus 233 -----------~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 233 -----------DG-----------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -----------TT-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------cc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 01235688999999999999999999999999997653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=341.71 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=198.4
Q ss_pred CCeeEee-eEeecCceEEEEEE--EcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILE-ELGDGTCGCVYKAF--NVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~-~IG~G~fg~V~~a~--~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|++.+ .||+|+||.||+|. +..+++.||+|++...... .......+|+++++.++||||+++++++ ..+..|+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4799998 99999999999995 4677899999999865432 2244567899999999999999999999 5667899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC--
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~-- 154 (432)
||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 9999986544444444557999999999999999999999999999999999999985 4999999999987754332
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+.. +.
T Consensus 175 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~-------------- 237 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GE-------------- 237 (291)
T ss_dssp EC----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TC--------------
T ss_pred cccccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC--------------
Confidence 12234568899999985 5568999999999999999999 9999998877655444321 10
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......++.++.++|.+||+.||++|||+.++++
T Consensus 238 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 -------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01122467899999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.87 Aligned_cols=252 Identities=28% Similarity=0.429 Sum_probs=191.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 36899999999999999999999999999999999753322 2334467899999999999999999999999999999
Q ss_pred EecCCC-cHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 79 FEYMEH-NLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
|||+++ ++.+.+.. ....+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999987 55554443 35679999999999999999999999999999999999999854 99999999998664422
Q ss_pred -CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 154 -PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 154 -~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
......+++.|+|||++. ...++.++|||||||++|+|++|..||.+.... ..+...+....
T Consensus 191 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 254 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------------- 254 (310)
T ss_dssp --------CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC---------------
T ss_pred ccccccCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc---------------
Confidence 234567899999999985 567899999999999999999999999765422 11111111100
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
++. .....++.++.+||.+||+.||++|||+.+++++
T Consensus 255 -----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 255 -----YPP-------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -----SCC-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCC-------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 100 0113578899999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=351.78 Aligned_cols=251 Identities=12% Similarity=0.134 Sum_probs=199.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC--------CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccc---------
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET--------YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK--------- 64 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~--------- 64 (432)
++|++++.||+|+||.||+|++..+ ++.||+|++.... ...+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------RLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS------THHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc------hHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5899999999999999999999874 8899999997652 3568999999999999988
Q ss_pred ------cceEEEe-CCEEEEEEecCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC
Q 014039 65 ------LKEVVRE-NNELFFIFEYMEHNLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND 136 (432)
Q Consensus 65 ------l~~~~~~-~~~~~lV~E~~~~~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~ 136 (432)
+++++.. .+..|+||||+.++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 5667665 7889999999966777777654 3579999999999999999999999999999999999999965
Q ss_pred ---eEEEeeeccceecCCCC--------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC-h
Q 014039 137 ---VLKIADFGLARELSSMP--------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS-E 204 (432)
Q Consensus 137 ---~lkL~DFG~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~-~ 204 (432)
.+||+|||+|+.+.... ......||+.|+|||++. +..++.++|||||||++|||++|..||.+.. .
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 79999999998664321 123458999999999985 5678999999999999999999999998764 3
Q ss_pred HHHHHHHHHH-hCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 205 IDQLYKVCCI-LGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 205 ~d~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.+.+...... ...+.. +.. .......++.++.+||.+||+.||++|||++++++.
T Consensus 275 ~~~~~~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGP----------------FVG-----PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHHHHHHSCCC----------------EEC-----TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhccCChhh----------------hhh-----hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3333332221 111110 000 000113578999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=348.29 Aligned_cols=263 Identities=25% Similarity=0.318 Sum_probs=202.7
Q ss_pred CCeeEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE--eCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR--ENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~ 75 (432)
++|++++.||+|+||.||+|+ +..+++.||+|++..... .......+|++++++++||||+++++++. +...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 589999999999999999998 567899999999976532 23344679999999999999999999886 45779
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP 153 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~ 153 (432)
|+||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 999999965 566666555557999999999999999999999999999999999999974 599999999998765432
Q ss_pred ----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 ----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
......+|+.|+|||++. ...++.++|||||||++|+|++|..||.+....... ..+.... .......
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~~ 253 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERD--VPALSRL 253 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC------CCHHHHH
T ss_pred ccceeeccCCccccccCHHHhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hcccccc--cccHHHH
Confidence 223456888899999985 566899999999999999999999998764332111 0110000 0000000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...... .........+++++.+||.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 254 LELLEE-------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHT-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhc-------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000000 01112235689999999999999999999999999655
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.72 Aligned_cols=249 Identities=24% Similarity=0.287 Sum_probs=193.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC---CCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCC----
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENN---- 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 73 (432)
++|++.+.||+|+||.||+|.+.. ++..||+|++....... ......+|++++++++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 479999999999999999998765 56689999997654332 3344678999999999999999999987644
Q ss_pred -EEEEEEecCCC-cHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 74 -ELFFIFEYMEH-NLYHIMRE-----RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 74 -~~~lV~E~~~~-~ll~~~~~-----~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
..|+||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||+++++ .+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 35999999987 55555532 33579999999999999999999999999999999999999865 999999999
Q ss_pred ceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
++...... ......+++.|+|||++. ...++.++|||||||++|+|++ |.+||.+....+....+... .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~---- 266 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--H---- 266 (313)
T ss_dssp C----------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--C----
T ss_pred ceecccccccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC--C----
Confidence 98764432 123345788999999985 5678999999999999999999 99999888766554443211 0
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+||.+||+.||.+|||+.+++++
T Consensus 267 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 -----------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123678899999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=361.58 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=199.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC-EEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN-ELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E 80 (432)
++|++++.||+|+||.||+|.+. |+.||||+++... ....+.+|+++|++++||||+++++++.+.. .+|+|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 57999999999999999999774 7799999998654 2334678999999999999999999986654 7999999
Q ss_pred cCCC-cHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 81 YMEH-NLYHIMRERQI-PFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~-~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|+++ +|.+.+...+. .+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++..... ...
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 345 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDT 345 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccC
Confidence 9986 67777766543 47999999999999999999999999999999999999855 9999999999865432 223
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.. |..
T Consensus 346 ~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--~~~------------------ 404 (450)
T 1k9a_A 346 GKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYK------------------ 404 (450)
T ss_dssp -CCCTTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT--TCC------------------
T ss_pred CCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CCC------------------
Confidence 46788999999985 5679999999999999999998 9999998776555444321 100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......+++++.+||.+||+.||++|||+.++++
T Consensus 405 ---------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122467899999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=353.73 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=200.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+ .+|+.||+|++..... .......+|+++++.++||||+++++++.+.+..|+||||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 6899999999999999999986 4688999999876533 2334567899999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---C
Q 014039 82 MEHN-LYHIMRERQ---IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---P 153 (432)
Q Consensus 82 ~~~~-ll~~~~~~~---~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---~ 153 (432)
++++ +.+.+.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||+++..... .
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9864 544443322 359999999999999999999999999999999999999865 9999999999875432 1
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCCCCchhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKV---CCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i---~~~~g~p~~~~~~~~~~~~ 230 (432)
......||+.|+|||++. ...++.++|||||||++|||++|..||.+....+....+ ......
T Consensus 197 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 262 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN------------- 262 (321)
T ss_dssp CBCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT-------------
T ss_pred cccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc-------------
Confidence 233456899999999985 557899999999999999999999999775432211100 000000
Q ss_pred hhhhccccccCCCC-ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPIN-LSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+....... ...+.+..+.++.++|.+||+.||++|||+.|+++|
T Consensus 263 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 263 ----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp ----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011111011 112223456788999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=363.66 Aligned_cols=262 Identities=20% Similarity=0.248 Sum_probs=210.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC-CcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-PNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+++++||+|+||.||+|++..+++.||||++...... ....+|+++++.+.| ++|..+..++......+||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 6899999999999999999999999999999998754432 235689999999976 556666666678889999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe----CCeEEEeeeccceecCCCCC--
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~----~~~lkL~DFG~a~~~~~~~~-- 154 (432)
|+.++|.+.+....+.+++..++.++.||+.||.|||++||+||||||+||||+ .+.+||+|||+|+.+.....
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 998888888877677899999999999999999999999999999999999993 45999999999987754322
Q ss_pred ------CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 155 ------YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 155 ------~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
....+||+.|+|||++. ...++.++|||||||++|||++|..||.+....+....+......
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-----------
T ss_pred ccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-----------
Confidence 23668999999999985 567899999999999999999999999886543222222111000
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc----------CCCCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ----------HPFFNVETWV 289 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~----------Hp~f~~~~~~ 289 (432)
.. ......+...++.++.+||.+||+.||++||++.++++ ++|+...+|.
T Consensus 232 ---~~--------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 232 ---KV--------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp ---HH--------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred ---cc--------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 00 00111222467889999999999999999999887654 7888888884
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=347.00 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=195.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe----CCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE----NNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~l 77 (432)
++|++++.||+|+||.||+|++..+|+.||+|++..... .......+|+++++.++||||+++++++.. ....|+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 479999999999999999999999999999999865432 234456789999999999999999999862 347899
Q ss_pred EEecCCC-cHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 78 IFEYMEH-NLYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 78 V~E~~~~-~ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
||||+.+ +|.+.+.. .+..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999987 56665554 35679999999999999999999999999999999999999754 9999999998765421
Q ss_pred CC----------CccccCCccccchhhhcCCC--CCCcccceechHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Q 014039 153 PP----------YTEYVSTRWYRAPEVLLQSS--SYSPAIDMWAVGAILAELFTLSPIFPGDSEID-QLYKVCCILGAPD 219 (432)
Q Consensus 153 ~~----------~~~~~~t~~y~aPE~l~~~~--~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d-~~~~i~~~~g~p~ 219 (432)
.. .....||+.|+|||++.... .++.++|||||||++|+|++|..||.+..... ....... .
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~--- 262 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--N--- 262 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--C---
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--c---
Confidence 11 12345799999999985433 37899999999999999999999995321100 0000000 0
Q ss_pred CCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 220 WTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.... ...+.++.++.+||.+||+.||.+|||+.|+++|
T Consensus 263 --------------~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 --------------QLSI---------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --------------C--C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCC---------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000 1124678899999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.87 Aligned_cols=236 Identities=28% Similarity=0.413 Sum_probs=186.3
Q ss_pred CCCeeEe-eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHH-HhcCCCcccccceEEEe----CCE
Q 014039 1 MERYKIL-EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKAL-RKLNHPNIIKLKEVVRE----NNE 74 (432)
Q Consensus 1 ~~~Y~~~-~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~----~~~ 74 (432)
+++|.++ +.||+|+||.||+|.+..+++.||+|++.... ...+|+.++ +.++||||+++++++.. ...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 3689888 78999999999999999999999999997532 245788888 55599999999999876 677
Q ss_pred EEEEEecCCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeecccee
Q 014039 75 LFFIFEYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARE 148 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~ 148 (432)
+|+||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 8999999986 6666666543 47999999999999999999999999999999999999985 4899999999965
Q ss_pred cCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
.. ...|+.++|||||||++|||++|.+||.+....+....+. ..
T Consensus 170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------~~------ 213 (299)
T 3m2w_A 170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TR------ 213 (299)
T ss_dssp CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--------CS------
T ss_pred cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--------HH------
Confidence 43 2347889999999999999999999998765432211000 00
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
............+..++.++.+||.+||+.||++|||+.|+|+||||...
T Consensus 214 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 --------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp --------SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred --------HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00000000001124678999999999999999999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=353.15 Aligned_cols=254 Identities=16% Similarity=0.154 Sum_probs=193.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC---CCeEEEEEEecccccchH----------HHHHHHHHHHHHhcCCCcccccceE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFWE----------ECMNLREVKALRKLNHPNIIKLKEV 68 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~----------~~~~~~Ei~~l~~l~hpnIv~l~~~ 68 (432)
++|++++.||+|+||.||+|.+.. ++..+|+|++........ .....+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 479999999999999999999987 888999999976432111 1123578899999999999999999
Q ss_pred EEe----CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C--eEEEe
Q 014039 69 VRE----NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D--VLKIA 141 (432)
Q Consensus 69 ~~~----~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~--~lkL~ 141 (432)
+.+ ....|+||||+.++|.+.+...+ .+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 977 67899999999555665554443 8999999999999999999999999999999999999984 3 89999
Q ss_pred eeccceecCCCC--------CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCCh--HHHHHHH
Q 014039 142 DFGLARELSSMP--------PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSE--IDQLYKV 211 (432)
Q Consensus 142 DFG~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~--~d~~~~i 211 (432)
|||+|+.+.... ......||+.|+|||++. +..++.++|||||||++|||++|..||.+... .......
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 999998764321 124568999999999985 56789999999999999999999999966322 2221111
Q ss_pred HHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 212 CCILGAPDWTAFPEATNISRLISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 212 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......+ .. +.... ..++.++.+||.+||+.||++|||++++++.
T Consensus 275 ~~~~~~~~-----------~~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 275 TNLLDELP-----------QS------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHTTT-----------HH------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred Hhhccccc-----------HH------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11111100 00 00011 2578899999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=352.88 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=198.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+ .+|+.||+|++.............+|+++++.++||||+++++++.+.+..++||||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 108 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence 5899999999999999999974 468899999998655433333567899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 82 MEH-NLYHIMRER---QIPFSEGEIRSFMSQMLQGLAHMHRN---GYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 82 ~~~-~ll~~~~~~---~~~l~~~~~~~i~~qIl~aL~~LH~~---givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+.+ ++.+.+... ...+++..++.++.||+.||+|||++ ||+||||||+|||++++ .+||+|||+|+......
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188 (326)
T ss_dssp CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence 987 455555443 23599999999999999999999999 99999999999999976 99999999998765322
Q ss_pred --CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCCCCchhhh
Q 014039 154 --PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS----EIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 154 --~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~----~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
......||+.|+|||++. ...++.++|||||||++|+|++|..||.... ......... .+.....
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~------ 259 (326)
T 3uim_A 189 THVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KGLLKEK------ 259 (326)
T ss_dssp SCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH--TTTTSSC------
T ss_pred ccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH--HHHhhch------
Confidence 234456999999999985 5568999999999999999999999995211 000000100 0000000
Q ss_pred hhhhhhhccccccCCCCc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 228 NISRLISISYSEILPINL-SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
.......... .......+.++.++|.+||+.||.+|||+.|+++|-
T Consensus 260 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 260 --------KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp --------CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred --------hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 0000000000 011123457899999999999999999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=366.71 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=206.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||.||+|.++.++..||||+++..... ...+.+|+++|++++||||+++++++.+...+||||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4699999999999999999999999999999999865432 34467899999999999999999999999999999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
+.+ +|.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+...... ...
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 985 677766653 3469999999999999999999999999999999999999855 99999999998765422 122
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 378 ~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------- 436 (495)
T 1opk_A 378 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------------------- 436 (495)
T ss_dssp TCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------------------
T ss_pred CCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 344567899999985 5678999999999999999999 999999887655443331100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+||.+||+.||++|||+.++++.
T Consensus 437 ---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 437 ---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 001224678999999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=386.73 Aligned_cols=278 Identities=26% Similarity=0.391 Sum_probs=209.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe------CCE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE------NNE 74 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~ 74 (432)
+++|++++.||+|+||.||+|.+..+|+.||+|++.............+|+++|++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999999999999999865544445557789999999999999999998754 677
Q ss_pred EEEEEecCCCc-HHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC----eEEEeeeccce
Q 014039 75 LFFIFEYMEHN-LYHIMRERQ--IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND----VLKIADFGLAR 147 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~~--~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~----~lkL~DFG~a~ 147 (432)
.|+||||++++ |.+.+.... ..+++..++.++.||+.||+|||+.||+||||||+||+++.+ .+||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 89999999764 555554322 269999999999999999999999999999999999999854 59999999999
Q ss_pred ecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 148 ELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 148 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
...........+||+.|+|||++. +..++.++||||+||++|+|++|..||.+..............+....... .
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~---~ 248 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY---D 248 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSC-CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC---C
T ss_pred ccccccccccccCCcccCChHHhc-cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh---h
Confidence 887766667789999999999984 667899999999999999999999999876544332111000000000000 0
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.... ...+....+ ....+...++.++.+||++||++||++|||+.|+++||||+.
T Consensus 249 ~l~g--~~~~~~~lp-~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 249 DLTG--AVKFSSVLP-TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSS--SCCCCSSSC-CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhcc--ccccccccC-CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000 011111111 112233457789999999999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=355.36 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=194.0
Q ss_pred CeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE-eCCEEEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR-ENNELFFI 78 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV 78 (432)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.............+|+.+|++++||||+++++++. .++..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 488999999999999999987643 24589999876555455566789999999999999999999864 45678999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC---
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--- 153 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--- 153 (432)
|||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++++ .+||+|||+|+......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 999986 6666666666679999999999999999999999999999999999999865 99999999998654322
Q ss_pred --CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 154 --PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 154 --~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
......+|+.|+|||++. ...++.++|||||||++|||++ |.+||.+.+..+....+.. +..
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~--~~~------------ 314 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRR------------ 314 (373)
T ss_dssp --------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT--TCC------------
T ss_pred ccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc--CCC------------
Confidence 123446778899999985 5678999999999999999999 7899988766554443321 110
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.++|.+||+.||++|||+.|++++
T Consensus 315 ---------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 ---------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=340.33 Aligned_cols=242 Identities=30% Similarity=0.415 Sum_probs=187.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|++. ++.||+|++.... ......+|+++|++++||||+++++++.+ ..|+||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 58999999999999999999774 7889999987542 33456789999999999999999998764 47899999
Q ss_pred CCC-cHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeeccCCCCceeEeCC--eEEEeeeccceecCCCC
Q 014039 82 MEH-NLYHIMRERQI--PFSEGEIRSFMSQMLQGLAHMHR---NGYFHRDLKPENLLVTND--VLKIADFGLARELSSMP 153 (432)
Q Consensus 82 ~~~-~ll~~~~~~~~--~l~~~~~~~i~~qIl~aL~~LH~---~givHrDlkP~NILl~~~--~lkL~DFG~a~~~~~~~ 153 (432)
+++ +|.+.+..... .+++..+..++.||++||+|||+ +||+||||||+|||++.+ .+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 987 55555543321 47899999999999999999999 899999999999999855 5899999999766432
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....||+.|+|||++. ...++.++|||||||++|||++|..||................+.
T Consensus 160 -~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 221 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------------- 221 (307)
T ss_dssp ------CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC----------------
T ss_pred -cccCCCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC----------------
Confidence 34457999999999985 567899999999999999999999999865432211111011111
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.......++.++.+||.+||+.||++|||++|++++
T Consensus 222 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 222 -----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp -----------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 011234678899999999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=334.16 Aligned_cols=244 Identities=27% Similarity=0.408 Sum_probs=199.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||.||+|.+. ++..||+|++...... .....+|++++++++||||+++++++.+ +..|+||||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 57999999999999999999875 5678999999765432 3346789999999999999999999864 458999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
+++ +|.+.+... +..+++..+..++.||+.||+|||++||+||||||+||+++++ .+||+|||++....... ...
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 976 555554432 2269999999999999999999999999999999999999865 99999999998765432 123
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 169 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------- 228 (279)
T 1qpc_A 169 GAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------------- 228 (279)
T ss_dssp TCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred CCCCccCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------------------
Confidence 345678899999985 5668999999999999999999 9999998877665554421100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++.++.+||.+||+.||++|||++++++
T Consensus 229 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112357889999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=337.50 Aligned_cols=249 Identities=27% Similarity=0.341 Sum_probs=188.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHh--cCCCcccccceEEEe----CCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK--LNHPNIIKLKEVVRE----NNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~----~~~~ 75 (432)
++|++++.||+|+||.||+|++ +|+.||+|++.... .....+|.+++.. ++||||+++++++.+ ...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 5899999999999999999977 68999999987542 2234456676666 799999999998643 3568
Q ss_pred EEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 76 FFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH--------RNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 76 ~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH--------~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
|+||||++++ |.+.+ +. ..+++..++.++.||+.||+||| +.||+||||||+|||++.+ .+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l-~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYL-QL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHH-TT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHH-hh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999874 55554 33 47999999999999999999999 9999999999999999855 999999999
Q ss_pred ceecCCCCC-----CccccCCccccchhhhcCCC-----CCCcccceechHHHHHHHHhC----------CCCCCCCCh-
Q 014039 146 ARELSSMPP-----YTEYVSTRWYRAPEVLLQSS-----SYSPAIDMWAVGAILAELFTL----------SPIFPGDSE- 204 (432)
Q Consensus 146 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiWSlG~il~ell~g----------~~pF~~~~~- 204 (432)
|+....... ....+||+.|+|||++.+.. .++.++|||||||++|||++| .+||.+...
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 986644322 23458999999999986443 345799999999999999999 788865322
Q ss_pred ---HHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 205 ---IDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 205 ---~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...........+..+ .. +........+.++.+||.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~--~~--------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRP--NI--------------------PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SCCHHHHHHHHTTSCCCC--CC--------------------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcchhhhhHHHhccCCCC--CC--------------------ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222222211101000 00 0000112356789999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=359.77 Aligned_cols=244 Identities=27% Similarity=0.393 Sum_probs=201.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+++|++++||||+++++++. ...+|+||||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 579999999999999999998854 67799999986543 2345679999999999999999999986 5678999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
+.+ +|.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+...... ...
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 986 566666533 2368999999999999999999999999999999999999865 99999999998764321 122
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 344 ~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------------ 404 (454)
T 1qcf_A 344 GAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------------------ 404 (454)
T ss_dssp SSSSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC------------------
T ss_pred CCcccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 345677899999985 5668999999999999999999 99999998877766555321111
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.....++.++.+||.+||+.||++|||++++++
T Consensus 405 -----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 -----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 012357889999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.07 Aligned_cols=260 Identities=26% Similarity=0.337 Sum_probs=197.3
Q ss_pred eeEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEE
Q 014039 4 YKILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFF 77 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (432)
|+++++||+|+||.||++. +..+++.||+|++.............+|+++|++++||||+++++++.+ ...+|+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 4999999999999998875 4468899999999876544445557799999999999999999999987 468899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-- 154 (432)
||||++++.+..+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++.......
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 99999875444444443 49999999999999999999999999999999999999865 899999999988765332
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
.....+|..|+|||++. ...++.++|||||||++|+|++|..||........ ...+... ... ........
T Consensus 192 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~-~~~-~~~~~~~~ 263 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQ-GQM-TVLRLTEL 263 (318)
T ss_dssp EC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCC-HHH-HHHHHHHH
T ss_pred ccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccc-cch-hHHHHHHH
Confidence 33456888899999985 55688999999999999999999999865432110 0011000 000 00000000
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
... .........++.++.+||++||+.||++|||+.|+++
T Consensus 264 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LER-------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHT-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hhc-------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 0111223468899999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.37 Aligned_cols=249 Identities=28% Similarity=0.347 Sum_probs=194.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-CCe--EEEEEEeccccc--chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-TYE--IVAVKKMKRKFY--FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-~~~--~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|++.. +++ .||+|+++.... ........+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 579999999999999999998643 333 689999875432 233445679999999999999999999998755 78
Q ss_pred EEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC
Q 014039 77 FIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP 154 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~ 154 (432)
+||||+.+ ++.+.+....+.+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++........
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence 99999985 677777766667999999999999999999999999999999999999974 5999999999987754332
Q ss_pred ----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 155 ----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 155 ----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.....+|..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 243 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------------ 243 (291)
T ss_dssp EEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC------------
T ss_pred chhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC------------
Confidence 23345778899999985 5568999999999999999999 99999988876665554211000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
......++.++.++|.+||+.||++|||+.+++++
T Consensus 244 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 244 ----------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01123678999999999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.72 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=191.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe-CCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE-NNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~ 79 (432)
+++|++++.||+|+||.||+|.+ +|+.||+|++.... ......+|++++++++||||+++++++.+ .+..|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 36899999999999999999976 48899999997653 23446789999999999999999998754 45789999
Q ss_pred ecCCC-cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 80 EYMEH-NLYHIMRERQ-IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 80 E~~~~-~ll~~~~~~~-~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
||+++ +|.+.+.... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... ..
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 172 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 172 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--cc
Confidence 99987 6666665443 238999999999999999999999999999999999999855 9999999999865542 23
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+++.|+|||++. ...++.++|||||||++|+|++ |.+||.+....+....+...
T Consensus 173 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------------------- 230 (278)
T 1byg_A 173 TGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------------- 230 (278)
T ss_dssp ---CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------------------
T ss_pred CCCccccccCHHHhC-CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---------------------
Confidence 346788999999985 5678999999999999999998 99999887665544433110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
........+++++.++|++||+.||++|||+.|+++
T Consensus 231 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 --------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001123467899999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=349.73 Aligned_cols=272 Identities=26% Similarity=0.313 Sum_probs=189.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe-----CCEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE-----NNEL 75 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~~~ 75 (432)
+++|++++.||+|+||.||+|++ +++.||+|++..... ......+|+..+..++||||+++++.+.. ...+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 57999999999999999999965 789999999975432 12122244444556899999999986542 3467
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCceeEeCC-eEEEeeec
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN---------GYFHRDLKPENLLVTND-VLKIADFG 144 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~---------givHrDlkP~NILl~~~-~lkL~DFG 144 (432)
|+||||+++ +|.+.+... ..++..++.++.||+.||.|||+. ||+||||||+|||++++ .+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 899999976 555555443 468999999999999999999999 99999999999999865 99999999
Q ss_pred cceecCCC---------CCCccccCCccccchhhhcCC------CCCCcccceechHHHHHHHHhCC-CCCCCCChHHHH
Q 014039 145 LARELSSM---------PPYTEYVSTRWYRAPEVLLQS------SSYSPAIDMWAVGAILAELFTLS-PIFPGDSEIDQL 208 (432)
Q Consensus 145 ~a~~~~~~---------~~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiWSlG~il~ell~g~-~pF~~~~~~d~~ 208 (432)
+|+.+... ......+||+.|+|||++.+. ..++.++|||||||++|||++|. ++|++....+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99876432 122355799999999998642 45677999999999999999995 445544322111
Q ss_pred HHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccC---CCCCHHHHHHHHHhcccCCCCCCCHHHH------hc
Q 014039 209 YKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDII---PNASMEAIDLIWQLCSWDPLRRPTADQA------LQ 279 (432)
Q Consensus 209 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~Rpta~el------L~ 279 (432)
..+....+..+... ........ ......+...+ ..++.++.+||.+||+.||++|||+.|+ +-
T Consensus 246 ~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 246 MAFQTEVGNHPTFE-----DMQVLVSR---EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CTTHHHHCSSCCHH-----HHHHHHTT---SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHH-----HHHhhhcc---cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11111111111100 00000000 00001111111 1245679999999999999999999999 45
Q ss_pred CCCCCCC
Q 014039 280 HPFFNVE 286 (432)
Q Consensus 280 Hp~f~~~ 286 (432)
++|-++.
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 6777653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.99 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=198.6
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
.++|++.+.||+|+||.||+|.+.. .+|+|++....... ......+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3689999999999999999998754 39999987543221 1223457999999999999999999999999999999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCC------C
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSS------M 152 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~------~ 152 (432)
||++++ +.+.+...+..+++..++.++.||+.||+|||++||+||||||+|||++++.+||+|||+++.... .
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------C
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccccccc
Confidence 999865 555555445579999999999999999999999999999999999999988999999999875432 1
Q ss_pred CCCccccCCccccchhhhcC--------CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCch
Q 014039 153 PPYTEYVSTRWYRAPEVLLQ--------SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFP 224 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~--------~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~ 224 (432)
.......||+.|+|||++.. ...++.++|||||||++|||++|..||.+.........+.. +..+.
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~---- 262 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT--GMKPN---- 262 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT--TCCCC----
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--CCCCC----
Confidence 22334568999999999864 34579999999999999999999999998877665544421 10000
Q ss_pred hhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 225 EATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.++|.+||+.||++|||+.++++.
T Consensus 263 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 ----------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp ----------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred ----------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0012467789999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=339.70 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=198.4
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc---chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY---FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
|...+.||+|+||.||+|.+ +++.||+|++..... ........+|++++++++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999975 678999999975432 2233456789999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--
Q 014039 81 YMEH-NLYHIMRE--RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 81 ~~~~-~ll~~~~~--~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-- 154 (432)
|+++ ++.+.+.. ...++++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9975 56565543 24569999999999999999999999999999999999999865 999999999987654222
Q ss_pred -CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 -YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 -~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+..+......... ....+.
T Consensus 191 ~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 261 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-------TIEDYI 261 (307)
T ss_dssp ECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-------CHHHHS
T ss_pred cccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-------hhhhhc
Confidence 23457999999999884 35899999999999999999999999876543332222221111000 000100
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+.......+.++.++|.+||+.||.+|||+.+++++
T Consensus 262 --------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 --------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111111222345678999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.50 Aligned_cols=245 Identities=18% Similarity=0.178 Sum_probs=185.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-------hHHHHHHHHHHHHHhcC---------CCccccc
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-------WEECMNLREVKALRKLN---------HPNIIKL 65 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~---------hpnIv~l 65 (432)
++|++++.||+|+||+||+|++ +|+.||||++...... .......+|+++|+.++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999987 7899999999865321 12244568898888885 5555555
Q ss_pred c-----------------eEEEe-------------CCEEEEEEecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 014039 66 K-----------------EVVRE-------------NNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLA 114 (432)
Q Consensus 66 ~-----------------~~~~~-------------~~~~~lV~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~ 114 (432)
. +++.+ .+.+||||||+.++ +++.+.+ +.+++..++.++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 4 44433 68899999999765 6666644 46899999999999999999
Q ss_pred HHH-HCCCeeccCCCCceeEeCC---------------------eEEEeeeccceecCCCCCCccccCCccccchhhhcC
Q 014039 115 HMH-RNGYFHRDLKPENLLVTND---------------------VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172 (432)
Q Consensus 115 ~LH-~~givHrDlkP~NILl~~~---------------------~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~ 172 (432)
||| ++||+||||||+|||++.+ .+||+|||+|+.... ...+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcC
Confidence 999 9999999999999999843 899999999987654 24589999999999864
Q ss_pred CCCCCcccceechHHH-HHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCC
Q 014039 173 SSSYSPAIDMWAVGAI-LAELFTLSPIFPGDSEIDQLY-KVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIP 250 (432)
Q Consensus 173 ~~~~~~~~DiWSlG~i-l~ell~g~~pF~~~~~~d~~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (432)
.. +.++||||+|++ .++++.|..||.+........ .+....... .......++
T Consensus 252 ~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~ 306 (336)
T 2vuw_A 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-----------------------TKCNTPAMK 306 (336)
T ss_dssp CS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-----------------------SCCCSHHHH
T ss_pred CC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-----------------------cccchhhhh
Confidence 33 889999998777 778888999885422111111 111100000 001111223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 014039 251 NASMEAIDLIWQLCSWDPLRRPTADQAL-QHPFFN 284 (432)
Q Consensus 251 ~~s~~~~dli~~~L~~dP~~Rpta~elL-~Hp~f~ 284 (432)
.+++++++||++||++| ||+|+| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 56889999999999987 999999 999995
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.66 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=199.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||.||+|.+..+ ..||||+++..... ...+.+|+++|++++||||+++++++.+ +.+|+||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 4799999999999999999998754 56999999865432 3346789999999999999999999876 668999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
+++ +|.+.+... +..+++..+..++.||+.||+|||++||+||||||+|||++++ .+||+|||+++...... ...
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 986 666666542 3469999999999999999999999999999999999999865 99999999998765322 122
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 340 ~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------- 399 (452)
T 1fmk_A 340 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------- 399 (452)
T ss_dssp ---CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred CCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 345678899999985 5578999999999999999999 9999999887766555421100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--CCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH--PFFN 284 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H--p~f~ 284 (432)
....+.++.++.+||.+||+.||++|||++++++. .++.
T Consensus 400 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 01124678899999999999999999999999873 4554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.08 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=185.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc--CCCcccccceEEEeC----CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL--NHPNIIKLKEVVREN----NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~~~~~~~----~~~ 75 (432)
++|++++.||+|+||.||+|++. |+.||+|++.... .....+|.+++..+ +||||+++++++... ..+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 47999999999999999999874 8999999986442 22234566666554 999999999999876 789
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN--------GYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~--------givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
|+||||+++ +|.+.+... .+++..++.++.||+.||.|||+. ||+||||||+|||++.+ .+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 999999987 565555443 699999999999999999999999 99999999999999855 999999999
Q ss_pred ceecCCCCC-----CccccCCccccchhhhcCCCCCCc------ccceechHHHHHHHHhC----------CCCCCCCCh
Q 014039 146 ARELSSMPP-----YTEYVSTRWYRAPEVLLQSSSYSP------AIDMWAVGAILAELFTL----------SPIFPGDSE 204 (432)
Q Consensus 146 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~------~~DiWSlG~il~ell~g----------~~pF~~~~~ 204 (432)
|+....... ....+||+.|+|||++.+. .++. ++|||||||++|||++| ..||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 987654322 2356899999999998543 3333 49999999999999999 555544221
Q ss_pred ----HHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 205 ----IDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 205 ----~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...........+. .... +.......++.++.+||.+||+.||++|||+.|+++|
T Consensus 268 ~~~~~~~~~~~~~~~~~--------------------~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKL--------------------RPSF--PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTTSCC--------------------CCCC--CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhhhcc--------------------Cccc--cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1122111100000 0000 0000012456789999999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.06 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=194.6
Q ss_pred eeEeecCceEEEEEEE--cCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFN--VETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++||+|+||.||+|.+ +.+++.||||+++...... ....+.+|+++|++++|||||++++++.+ +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4899999999999954 5677899999998654332 23456799999999999999999999865 458899999987
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC----Ccccc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP----YTEYV 159 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~----~~~~~ 159 (432)
+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+..... .....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 6555444555689999999999999999999999999999999999999854 999999999987654322 22334
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
+|+.|+|||++. ...|+.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 534 ~t~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------------------- 589 (635)
T 4fl3_A 534 WPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------------- 589 (635)
T ss_dssp -CGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------------
T ss_pred CceeeeChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------------
Confidence 678899999984 5679999999999999999998 999999988876655543210
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......++.++.+||.+||+.||++|||++++++
T Consensus 590 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00122467899999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.50 Aligned_cols=263 Identities=26% Similarity=0.344 Sum_probs=202.1
Q ss_pred CCeeEeeeEeecCceEEEEEE----EcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC--CEE
Q 014039 2 ERYKILEELGDGTCGCVYKAF----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN--NEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 75 (432)
++|++++.||+|+||.||+|+ +..+|+.||+|++.... ........+|++++++++||||+++++++... ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 469999999999999999998 46789999999997643 23444567999999999999999999998654 478
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP 153 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~ 153 (432)
++||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||+++......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999986 677777666667999999999999999999999999999999999999985 599999999998775433
Q ss_pred C----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 154 P----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 154 ~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
. .....++..|+|||++. ...++.++|||||||++|||++|..+|..... ......+........... .
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-~ 272 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMIVFH-L 272 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHHHHHH-H
T ss_pred cccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhhhHHH-H
Confidence 2 23345778899999985 45689999999999999999999988864311 112222322221110000 0
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
....... ........++.++.+||++||+.||++|||+.|+++
T Consensus 273 ~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNN-------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTT-------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcC-------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000000 001123468899999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=365.48 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=198.2
Q ss_pred CeeEee-eEeecCceEEEEEEEc--CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 3 RYKILE-ELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 3 ~Y~~~~-~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
+|.+.+ .||+|+||.||+|.++ .++..||||+++..........+.+|+++|++++||||+++++++.+ +.+|+||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 455666 8999999999999875 45667999999865444445567899999999999999999999976 5689999
Q ss_pred ecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCC--
Q 014039 80 EYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPY-- 155 (432)
Q Consensus 80 E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~-- 155 (432)
||+.++ |.+.+......+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+........
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999875 55556555667999999999999999999999999999999999999985 49999999999876432211
Q ss_pred --ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 156 --TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 156 --~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
....+++.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.. |..
T Consensus 495 ~~~~~~~~~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~--~~~-------------- 557 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--GKR-------------- 557 (613)
T ss_dssp -------CCTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT--TCC--------------
T ss_pred eccCCCCccceeCHhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCC--------------
Confidence 1223567899999985 5679999999999999999998 9999999887766555421 100
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++.++.+||.+||+.||++|||+.++++
T Consensus 558 -------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 -------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122468899999999999999999999999854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.83 Aligned_cols=246 Identities=17% Similarity=0.126 Sum_probs=192.6
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCC-Cccccc---------ceE--
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNH-PNIIKL---------KEV-- 68 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~h-pnIv~l---------~~~-- 68 (432)
+|+..+.||+|+||+||+|.+..+|+.||||++....... ....+.+|+.+++.+.| .|...+ .+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4888999999999999999999999999999987433221 13346689999999976 322111 111
Q ss_pred ----------EEe-----CCEEEEEEecCCCcHHHHHH------HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q 014039 69 ----------VRE-----NNELFFIFEYMEHNLYHIMR------ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLK 127 (432)
Q Consensus 69 ----------~~~-----~~~~~lV~E~~~~~ll~~~~------~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlk 127 (432)
+.. ...++++|+++.+++.+.+. ..++.+++..+..++.||+.||+|||++||+|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 111 23468899999998887774 224468888999999999999999999999999999
Q ss_pred CCceeEeCC-eEEEeeeccceecCCCCCCccccCCccccchhhhc---------CCCCCCcccceechHHHHHHHHhCCC
Q 014039 128 PENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL---------QSSSYSPAIDMWAVGAILAELFTLSP 197 (432)
Q Consensus 128 P~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~---------~~~~~~~~~DiWSlG~il~ell~g~~ 197 (432)
|+|||++.+ .+||+|||+|+..... ....+| +.|+|||++. ....|+.++|||||||++|||++|..
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999865 9999999999876543 455677 9999999984 45568899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014039 198 IFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA 277 (432)
Q Consensus 198 pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~el 277 (432)
||.+....+.... .+ .....++.++.+||.+||+.||++|||+.|+
T Consensus 316 Pf~~~~~~~~~~~-------------------------~~---------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 316 PNTDDAALGGSEW-------------------------IF---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp CCCTTGGGSCSGG-------------------------GG---------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcchhhhHHH-------------------------HH---------hhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9977643211000 00 0113578999999999999999999999999
Q ss_pred hcCCCCCC
Q 014039 278 LQHPFFNV 285 (432)
Q Consensus 278 L~Hp~f~~ 285 (432)
++||||+.
T Consensus 362 l~~~~~~~ 369 (413)
T 3dzo_A 362 METPEYEQ 369 (413)
T ss_dssp TTSHHHHH
T ss_pred HhCHHHHH
Confidence 99999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=346.42 Aligned_cols=241 Identities=15% Similarity=0.170 Sum_probs=190.5
Q ss_pred CCeeEeeeEeecCceEEEEE-----EEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC---CCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN---HPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~ 73 (432)
++|++.+.||+|+||.||+| .+..+++.||+|++.... .....+|+++++.+. |+||+++++++...+
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 46999999999999999999 477889999999997643 223457888888885 999999999999999
Q ss_pred EEEEEEecCCC-cHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC------------C
Q 014039 74 ELFFIFEYMEH-NLYHIMRE----RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN------------D 136 (432)
Q Consensus 74 ~~~lV~E~~~~-~ll~~~~~----~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~------------~ 136 (432)
..|+||||+++ +|.+.+.. ..+.+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999986 56665543 3457999999999999999999999999999999999999976 4
Q ss_pred eEEEeeeccceecC---CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014039 137 VLKIADFGLARELS---SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 137 ~lkL~DFG~a~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~ 213 (432)
.+||+|||+|+... ........+||+.|+|||++. +..|+.++|||||||++|||++|..||.......
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 99999999997654 223345678999999999985 5569999999999999999999999985432200
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHP 281 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp 281 (432)
+ .... .+... ..+..+.+++.+||+.+|.+|++..+.+.+.
T Consensus 293 ---------~------------~~~~----~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 ---------C------------KPEG----LFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ---------E------------EECS----CCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ---------e------------eech----hcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 0 0000 00000 2356789999999999999997765555543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=359.53 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=203.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||.||+|.+..+ ..||||+++..... ...+.+|+++|++++||||+++++++.+ +.+||||||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 4799999999999999999998754 56999999865432 3346789999999999999999999876 678999999
Q ss_pred CCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
+.+ +|.+.+... +..+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++...... ...
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 986 566666542 3469999999999999999999999999999999999999865 99999999998654321 122
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...++..|+|||++. ...++.++|||||||++|||++ |..||.+....+.+..+.....
T Consensus 423 ~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------- 482 (535)
T 2h8h_A 423 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------- 482 (535)
T ss_dssp STTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred CCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 345678899999985 5578999999999999999999 9999999887666555421100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--CCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH--PFFN 284 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H--p~f~ 284 (432)
......++.++.+||.+||+.||++|||++++++. .+|.
T Consensus 483 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 01124678899999999999999999999999874 4443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.75 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=203.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||.||+|.+..+ +..||+|++.............+|+.+|++++||||+++++++.+ +..|+|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 4799999999999999999998653 567999998765443444557799999999999999999999854 568999
Q ss_pred EecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe-CCeEEEeeeccceecCCCCC--
Q 014039 79 FEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~-~~~lkL~DFG~a~~~~~~~~-- 154 (432)
|||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 548 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCccee
Confidence 999985 56666666666799999999999999999999999999999999999998 45999999999987654322
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....+|+.|+|||++. ...++.++|||||||++|||++ |.+||.+....+....+.....
T Consensus 549 ~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~----------------- 610 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------- 610 (656)
T ss_dssp -----CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-----------------
T ss_pred ccCCCCCcceeCHHHhc-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 22345678999999985 5678999999999999999997 9999999888776666532110
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....+.+++++.+||.+||+.||++|||+.|+++.
T Consensus 611 ------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 611 ------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01224678999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.93 Aligned_cols=247 Identities=26% Similarity=0.340 Sum_probs=191.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHh--cCCCcccccceEEEeCC----EE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK--LNHPNIIKLKEVVRENN----EL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~----~~ 75 (432)
++|++.+.||+|+||.||+|++ +|+.||+|++.... .....+|+++++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 4799999999999999999987 58999999996542 2345678888888 68999999999998765 79
Q ss_pred EEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 76 FFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH--------RNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH--------~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
|+||||+++ +|.+.+... .+++..++.++.||+.||.||| +.||+||||||+|||++.+ .+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999987 566655443 6999999999999999999999 8999999999999999855 999999999
Q ss_pred ceecCCCC-----CCccccCCccccchhhhcCCCC-----CCcccceechHHHHHHHHhC----------CCCCCCCCh-
Q 014039 146 ARELSSMP-----PYTEYVSTRWYRAPEVLLQSSS-----YSPAIDMWAVGAILAELFTL----------SPIFPGDSE- 204 (432)
Q Consensus 146 a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~-----~~~~~DiWSlG~il~ell~g----------~~pF~~~~~- 204 (432)
++...... ......||+.|+|||++.+... ++.++|||||||++|||++| ..||.+...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 98765433 2345689999999999864432 33789999999999999999 667765422
Q ss_pred ---HHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccc--cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 205 ---IDQLYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSD--IIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 205 ---~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+.+...+. ... .. ..+.. ....++..+.+||.+||+.||++|||+.|+++
T Consensus 274 ~~~~~~~~~~~~--~~~------------------~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 274 DPSVEEMRKVVC--EQK------------------LR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp SCCHHHHHHHHT--TSC------------------CC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHH--HHH------------------hC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122222110 000 00 00000 01134457899999999999999999999998
Q ss_pred C
Q 014039 280 H 280 (432)
Q Consensus 280 H 280 (432)
|
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=370.80 Aligned_cols=241 Identities=23% Similarity=0.347 Sum_probs=198.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCE-----E
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNE-----L 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-----~ 75 (432)
++|+++++||+|+||.||+|.+.. +|+.||||++.............+|+++|++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 589999999999999999999976 7899999998765443344456789999999999999999999977554 7
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCCC
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPY 155 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~~ 155 (432)
||||||++|+.+..+... .+++.+++.++.||+.||.|||++||+||||||+|||++.+.+||+|||+++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~--- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF--- 234 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC---
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC---
Confidence 999999998655554433 699999999999999999999999999999999999999999999999999877543
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.++|.+.... +.+. .
T Consensus 235 ~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~--~------------- 287 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE--D------------- 287 (681)
T ss_dssp SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT--T-------------
T ss_pred CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc--c-------------
Confidence 45689999999999853 3489999999999999999999988653210 0000 0
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
......++++.+||.+||+.||++||++.+++.|+|+..
T Consensus 288 -----------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 -----------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000123568999999999999999999999999998853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=317.58 Aligned_cols=226 Identities=17% Similarity=0.117 Sum_probs=181.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||.||+|++..+|+.||||++....... ......+|++++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999999999999999998654432 2245678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCccc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY 158 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~ 158 (432)
||++|+.+..+...+ ....++..++.||+.||+|||++||+||||||+|||++++ .+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 999875555544433 4666789999999999999999999999999999999855 89987543
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
|++ .++.++|||||||++|||++|..||.+.+..+.+... ....
T Consensus 175 -----~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----------------------~~~~ 218 (286)
T 3uqc_A 175 -----TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----------------------ERDT 218 (286)
T ss_dssp -----CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------------------CBCT
T ss_pred -----ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------------------HHHh
Confidence 222 3789999999999999999999999886542210000 0000
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...........+.++.++.+||.+||+.||++| |+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 001112223446789999999999999999999 99999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-34 Score=300.24 Aligned_cols=183 Identities=14% Similarity=0.064 Sum_probs=130.5
Q ss_pred eEeecCceEEEEEEEcCCCeEEEEEEecccccc---------hHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 9 ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF---------WEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 9 ~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
..+.|++|.+..++....|+.||+|++.+.... .....+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356788888888888889999999999754211 1223456899999999 799999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~ 156 (432)
|||++|+.+..+..+++++++. +|+.||+.||+|||++||+||||||+|||++++ .+||+|||+|+..... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999997666666666788865 578999999999999999999999999999855 9999999999876543 3345
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCC
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS 196 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~ 196 (432)
+.+||+.|+|||++. ..+..++|+||+|+++++|.++.
T Consensus 398 t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 398 NLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred CceechhhccHHHhC--CCCCCcccccccccchhhhcccc
Confidence 678999999999984 34678899999999998886653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=255.19 Aligned_cols=183 Identities=18% Similarity=0.165 Sum_probs=138.9
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-------HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-------ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
..+.||+|+||.||+| ...++.+++|+...+..... .....+|+++|++++||||+++..++.+.+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 45677899998754332211 22357999999999999999776666677778999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccceecCCCCC----
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPP---- 154 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a~~~~~~~~---- 154 (432)
|||++++.+..+... +..++.||+.||.|||++||+||||||+|||+++ .+||+|||+|+.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccccccc
Confidence 999986544444332 5689999999999999999999999999999999 999999999998755321
Q ss_pred ----CccccCCccccchhhhcC-CCCCCcccceechHHHHHHHHhCCCCC
Q 014039 155 ----YTEYVSTRWYRAPEVLLQ-SSSYSPAIDMWAVGAILAELFTLSPIF 199 (432)
Q Consensus 155 ----~~~~~~t~~y~aPE~l~~-~~~~~~~~DiWSlG~il~ell~g~~pF 199 (432)
....+||++|+|||++.. ...|+..+|+|+.+.-..+.+.++..|
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 135689999999999852 145788899999888887777665544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=212.26 Aligned_cols=144 Identities=22% Similarity=0.244 Sum_probs=114.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-----------------hHHHHHHHHHHHHHhcCCCcccccc
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-----------------WEECMNLREVKALRKLNHPNIIKLK 66 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----------------~~~~~~~~Ei~~l~~l~hpnIv~l~ 66 (432)
|.+++.||+|+||.||+|.+ .+|+.||+|+++..... .......+|+++|++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 45569999999999999999 88999999999643211 12334678999999998 5 7777
Q ss_pred eEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccc
Q 014039 67 EVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLA 146 (432)
Q Consensus 67 ~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a 146 (432)
+++.. +..|+||||++|+.+..+. ......++.||+.||.|||++||+||||||+|||++++.+||+|||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYRVR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGGCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHHcc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCCC
Confidence 76654 4569999999875443331 133567999999999999999999999999999999669999999999
Q ss_pred eecCCCCCCccccCCccccchhhhc
Q 014039 147 RELSSMPPYTEYVSTRWYRAPEVLL 171 (432)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~aPE~l~ 171 (432)
+.. ..+.|||++.
T Consensus 240 ~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 240 VEV------------GEEGWREILE 252 (282)
T ss_dssp EET------------TSTTHHHHHH
T ss_pred eEC------------CCCCHHHHHH
Confidence 743 3468999873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6e-22 Score=187.15 Aligned_cols=140 Identities=14% Similarity=0.172 Sum_probs=107.3
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeE--EEEEEecccccc-----------------------hHHHHHHHHHHHHHhcC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEI--VAVKKMKRKFYF-----------------------WEECMNLREVKALRKLN 58 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~-----------------------~~~~~~~~Ei~~l~~l~ 58 (432)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... .......+|+++|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998888999 999997543211 01124568999999998
Q ss_pred CCcccccceEEEeCCEEEEEEecCCC------cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCce
Q 014039 59 HPNIIKLKEVVRENNELFFIFEYMEH------NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-RNGYFHRDLKPENL 131 (432)
Q Consensus 59 hpnIv~l~~~~~~~~~~~lV~E~~~~------~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH-~~givHrDlkP~NI 131 (432)
|++|....-+.. +..+|||||+++ .+.+. ... .++..+..++.||+.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~-~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVEL-GRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHH-GGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHH-hhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 876532222222 245899999953 33333 221 345578899999999999999 99999999999999
Q ss_pred eEeCCeEEEeeeccceecC
Q 014039 132 LVTNDVLKIADFGLARELS 150 (432)
Q Consensus 132 Ll~~~~lkL~DFG~a~~~~ 150 (432)
|+++ .++|+|||+|....
T Consensus 203 Ll~~-~~~liDFG~a~~~~ 220 (258)
T 1zth_A 203 MYID-KVYFIDMGQAVTLR 220 (258)
T ss_dssp EESS-SEEECCCTTCEETT
T ss_pred EEcC-cEEEEECcccccCC
Confidence 9999 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=170.05 Aligned_cols=138 Identities=11% Similarity=0.147 Sum_probs=98.1
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc---------------hH------HHHHHHHHHHHHhcCCCcc
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF---------------WE------ECMNLREVKALRKLNHPNI 62 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~------~~~~~~Ei~~l~~l~hpnI 62 (432)
|++.++||.|+||.||+|.+. +|+.||||+++..... .. .....+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999874 6889999987532110 00 0112356777777744443
Q ss_pred cccceEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC------
Q 014039 63 IKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND------ 136 (432)
Q Consensus 63 v~l~~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~------ 136 (432)
....-+.... .+|||||++|..+..+. .......++.||+.+|.+||++|||||||||.|||++++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 3222222222 37999999986543221 223456789999999999999999999999999999754
Q ss_pred -----eEEEeeeccceecC
Q 014039 137 -----VLKIADFGLARELS 150 (432)
Q Consensus 137 -----~lkL~DFG~a~~~~ 150 (432)
.+.|+||+.+....
T Consensus 248 ~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECCCTTCEETT
T ss_pred cccccceEEEEeCCcccCC
Confidence 28999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=5.6e-13 Score=125.16 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=108.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+.|++...+|.|+.+.||++.. .+..+++|........ ......+|+++|+.+ .+..+.++++++.+.+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 5799999999999999999964 3678999998753211 122366899999999 46778889999988899999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR------------------------------------------ 118 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~------------------------------------------ 118 (432)
+++|..+.... .+......++.++.++|+.||+
T Consensus 91 ~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99996655431 1222345788999999999998
Q ss_pred -----------------CCCeeccCCCCceeEeCC-eEEEeeeccce
Q 014039 119 -----------------NGYFHRDLKPENLLVTND-VLKIADFGLAR 147 (432)
Q Consensus 119 -----------------~givHrDlkP~NILl~~~-~lkL~DFG~a~ 147 (432)
..++|+|++|.||+++++ .+.|+||+.|.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999987 45799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=115.55 Aligned_cols=134 Identities=15% Similarity=0.076 Sum_probs=97.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc--ccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN--IIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~ 79 (432)
..|.+....+.|..+.||++.. .+|+.+++|...... .....+|+.+++.+.+.+ +.+++++..+.+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3466655445677799999953 556779999976541 123568999999985434 566888888777899999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG--------------------------------------- 120 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g--------------------------------------- 120 (432)
||++|..+. . . ... ...++.++.+.|..||+..
T Consensus 95 e~i~G~~l~-~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL-S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT-T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC-c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999986553 1 1 122 2356778888888888653
Q ss_pred -------------------CeeccCCCCceeEeCCe-EEEeeecccee
Q 014039 121 -------------------YFHRDLKPENLLVTNDV-LKIADFGLARE 148 (432)
Q Consensus 121 -------------------ivHrDlkP~NILl~~~~-lkL~DFG~a~~ 148 (432)
++|+|++|.||+++++. ++|+|||.|..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999999875 56999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=6.7e-11 Score=116.32 Aligned_cols=139 Identities=17% Similarity=0.271 Sum_probs=102.5
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEec--ccccchHHHHHHHHHHHHHhcC--CCcccccceEEEeC---CEEEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMK--RKFYFWEECMNLREVKALRKLN--HPNIIKLKEVVREN---NELFFI 78 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~---~~~~lV 78 (432)
.++.|+.|.++.||++... +..+++|+.. ............+|..+|+.+. +..+.+++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4678999999999998653 4568888876 3322222334678999999996 44578888887765 457899
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR---------------------------------------- 118 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~---------------------------------------- 118 (432)
|||++|..+.. ..-..+++.+...++.++.+.|+.||+
T Consensus 120 me~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99999864421 112247888899999999999999997
Q ss_pred ------------------CCCeeccCCCCceeEeCC---eEEEeeecccee
Q 014039 119 ------------------NGYFHRDLKPENLLVTND---VLKIADFGLARE 148 (432)
Q Consensus 119 ------------------~givHrDlkP~NILl~~~---~lkL~DFG~a~~ 148 (432)
.++||+|++|.|||++++ .+.|+||+.|..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 368999999999999854 369999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=4e-10 Score=108.19 Aligned_cols=180 Identities=15% Similarity=0.130 Sum_probs=117.4
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcc--cccceEEEeCC---EEEEEEe
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNI--IKLKEVVRENN---ELFFIFE 80 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnI--v~l~~~~~~~~---~~~lV~E 80 (432)
++.++.|....||++. ..+++|+.... .......+|.++|+.+ .+..+ .+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999873 34889986543 2334467899999988 44333 33433332222 3478999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR------------------------------------------ 118 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~------------------------------------------ 118 (432)
+++|..+..... ..++..+...++.|+...|+.||+
T Consensus 97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999854432221 247888888999999999999996
Q ss_pred ----------------CCCeeccCCCCceeEeC--C-eEEEeeeccceecCCCCCCccccCCccc---cchhhhcC-CCC
Q 014039 119 ----------------NGYFHRDLKPENLLVTN--D-VLKIADFGLARELSSMPPYTEYVSTRWY---RAPEVLLQ-SSS 175 (432)
Q Consensus 119 ----------------~givHrDlkP~NILl~~--~-~lkL~DFG~a~~~~~~~~~~~~~~t~~y---~aPE~l~~-~~~ 175 (432)
..+||+|++|.||++++ + .+.|+||+.+...... ........+ ..|+.... -..
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHHH
Confidence 13699999999999997 5 6889999998754321 111111111 22332100 001
Q ss_pred C------------CcccceechHHHHHHHHhCCCCC
Q 014039 176 Y------------SPAIDMWAVGAILAELFTLSPIF 199 (432)
Q Consensus 176 ~------------~~~~DiWSlG~il~ell~g~~pF 199 (432)
| ....+.|++|.+++.+.+|.++|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 12258999999999999988755
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.9e-07 Score=86.20 Aligned_cols=133 Identities=17% Similarity=0.136 Sum_probs=92.1
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCC---cccccceEEE-eCCEEEEEEecC
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP---NIIKLKEVVR-ENNELFFIFEYM 82 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~-~~~~~~lV~E~~ 82 (432)
++.++.|....||+. |..+++|+.... .......+|.++|+.+.+. .|.+++.+.. ..+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888999999998 455788885322 2234466899999999642 2455565553 345678999999
Q ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------
Q 014039 83 EHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN------------------------------------------- 119 (432)
Q Consensus 83 ~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~------------------------------------------- 119 (432)
+|..+....-. .++..+...+..|+.+.|+.||+.
T Consensus 96 ~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 99644432111 345666666666666666666643
Q ss_pred -----------------CCeeccCCCCceeEeC----Ce-EEEeeeccceec
Q 014039 120 -----------------GYFHRDLKPENLLVTN----DV-LKIADFGLAREL 149 (432)
Q Consensus 120 -----------------givHrDlkP~NILl~~----~~-lkL~DFG~a~~~ 149 (432)
.++|+|++|.||+++. +. +.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3499999999999987 54 589999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=9.7e-07 Score=82.59 Aligned_cols=131 Identities=15% Similarity=0.162 Sum_probs=92.7
Q ss_pred EeecCce-EEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEecCCCcHH
Q 014039 10 LGDGTCG-CVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFEYMEHNLY 87 (432)
Q Consensus 10 IG~G~fg-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~~ll 87 (432)
+..|.-| .||+......+..+.+|+-... ......+|...|+.+. +--+.+++.++.+.+..|+|||+++|..+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 3445444 7999877777778889986543 2334568999999883 33367788888888999999999998654
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------------
Q 014039 88 HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN------------------------------------------------ 119 (432)
Q Consensus 88 ~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~------------------------------------------------ 119 (432)
....... ......+..++...|.-||+.
T Consensus 108 ~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 108 FQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 4333221 122345666677777777741
Q ss_pred ----------CCeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 120 ----------GYFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 120 ----------givHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
.++|+|+.+.|||++++ .+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 27899999999999987 456999998853
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-06 Score=87.04 Aligned_cols=77 Identities=18% Similarity=0.249 Sum_probs=48.6
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-c-----hHHHHHHHHHHHHHhcC-C-Cc-ccccceEEEeCCEEE
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-F-----WEECMNLREVKALRKLN-H-PN-IIKLKEVVRENNELF 76 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~-----~~~~~~~~Ei~~l~~l~-h-pn-Iv~l~~~~~~~~~~~ 76 (432)
-++.||.|..+.||++....+++.+++|....... . .......+|.++|+.+. . +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997666678899998653211 0 01223457889988873 2 33 3455543 344568
Q ss_pred EEEecCCC
Q 014039 77 FIFEYMEH 84 (432)
Q Consensus 77 lV~E~~~~ 84 (432)
+|||++++
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.4e-05 Score=75.29 Aligned_cols=134 Identities=18% Similarity=0.273 Sum_probs=74.8
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc---C--CCcccccc-e--EEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL---N--HPNIIKLK-E--VVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l---~--hpnIv~l~-~--~~~~~~~~~lV 78 (432)
++.|+.|..+.||++... + ..+++|+..... . ....|..+++.| + .|.++... + +....+..++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~~---~--~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRPE---K--KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEET-T-EEEEEEEECSCH---H--HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeC-C-CCEEEEecCCCH---H--HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 445666788999998653 3 358899987521 1 122455555544 2 23333311 1 22456788999
Q ss_pred EecCCCcH---------------HHHHHH--cCC--C--------C-CHH--------H---------------------
Q 014039 79 FEYMEHNL---------------YHIMRE--RQI--P--------F-SEG--------E--------------------- 101 (432)
Q Consensus 79 ~E~~~~~l---------------l~~~~~--~~~--~--------l-~~~--------~--------------------- 101 (432)
|||++|.. +..+.. ... + + ... .
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 99998731 111111 110 0 0 000 0
Q ss_pred --HHHHHHHHHHHHHHHHH-------------CCCeeccCCCCceeEe-CCeEEEeeeccce
Q 014039 102 --IRSFMSQMLQGLAHMHR-------------NGYFHRDLKPENLLVT-NDVLKIADFGLAR 147 (432)
Q Consensus 102 --~~~i~~qIl~aL~~LH~-------------~givHrDlkP~NILl~-~~~lkL~DFG~a~ 147 (432)
+..+..++..++.+|++ .++||+|+++.|||++ ++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666652 5799999999999996 4589999999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=3.1e-06 Score=82.57 Aligned_cols=80 Identities=8% Similarity=0.101 Sum_probs=52.0
Q ss_pred EeeeE-eecCceEEEEEEEc--C----CCeEEEEEEeccccc--chHHHHHHHHHHHHHhcC-C--CcccccceEEEeC-
Q 014039 6 ILEEL-GDGTCGCVYKAFNV--E----TYEIVAVKKMKRKFY--FWEECMNLREVKALRKLN-H--PNIIKLKEVVREN- 72 (432)
Q Consensus 6 ~~~~I-G~G~fg~V~~a~~~--~----~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-h--pnIv~l~~~~~~~- 72 (432)
.++.| +.|....+|+.... . +++.+++|+...... ........+|..+|+.+. + -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88888999988653 1 256788888654320 001123567888888883 3 3466777776554
Q ss_pred --CEEEEEEecCCCc
Q 014039 73 --NELFFIFEYMEHN 85 (432)
Q Consensus 73 --~~~~lV~E~~~~~ 85 (432)
+..|+|||+++|.
T Consensus 104 ~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 104 VLGTPFFLMDYVEGV 118 (357)
T ss_dssp TTSSCEEEEECCCCB
T ss_pred ccCCceEEEEecCCC
Confidence 3568999999873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.82 E-value=6.2e-05 Score=75.24 Aligned_cols=32 Identities=22% Similarity=0.277 Sum_probs=28.1
Q ss_pred HCCCeeccCCCCceeEeCCeEEEeeeccceec
Q 014039 118 RNGYFHRDLKPENLLVTNDVLKIADFGLAREL 149 (432)
Q Consensus 118 ~~givHrDlkP~NILl~~~~lkL~DFG~a~~~ 149 (432)
...++|+|++|.|||++++.++|+||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDSTQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSCEEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCCCEEEeCcccccC
Confidence 46799999999999999777999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=5.2e-05 Score=72.12 Aligned_cols=135 Identities=16% Similarity=0.132 Sum_probs=74.6
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcc-cccceEEEeCCEEEEEEecC
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI-IKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 82 (432)
+.-++.|+.|....+|++ +.+++|+...... ......+|..+++.+...++ .+++.+ +...-++|+||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 333678999999999998 3478888764321 11123468888877732223 455544 333346899999
Q ss_pred -CCcHHH------------HH-------HHcCCCCC-----HHHHHHHHHH--------------HHHHHHHHH----H-
Q 014039 83 -EHNLYH------------IM-------RERQIPFS-----EGEIRSFMSQ--------------MLQGLAHMH----R- 118 (432)
Q Consensus 83 -~~~ll~------------~~-------~~~~~~l~-----~~~~~~i~~q--------------Il~aL~~LH----~- 118 (432)
+|..+. .+ ......+. ...+..+..+ +...+..+. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 663111 00 00011111 1111122111 111111111 1
Q ss_pred ---CCCeeccCCCCceeEeCCeEEEeeecccee
Q 014039 119 ---NGYFHRDLKPENLLVTNDVLKIADFGLARE 148 (432)
Q Consensus 119 ---~givHrDlkP~NILl~~~~lkL~DFG~a~~ 148 (432)
..+||+|+.+.||+.+++.+.|+||..|..
T Consensus 170 ~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEEECCCCEEEEecccccC
Confidence 248999999999997777899999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00045 Score=66.24 Aligned_cols=74 Identities=19% Similarity=0.183 Sum_probs=56.2
Q ss_pred EeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC---CCcccccceEEEeCCEEEEEEecC
Q 014039 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN---HPNIIKLKEVVRENNELFFIFEYM 82 (432)
Q Consensus 6 ~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~E~~ 82 (432)
-++.|+.|....+|+... ++..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 356789999999999864 4567888887643 1334567888888883 356778888887778899999999
Q ss_pred CCc
Q 014039 83 EHN 85 (432)
Q Consensus 83 ~~~ 85 (432)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0026 Score=57.18 Aligned_cols=96 Identities=17% Similarity=0.089 Sum_probs=63.0
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCccccCCc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTR 162 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~~~~t~ 162 (432)
+|.+.+..++.+++|+++|.+++|.+.+|.-+-. +.-..+=+.|..|++.. |.|.+.+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 5888888889999999999999999999877632 22224445568888874 4666653 1110 1223
Q ss_pred cccchhhhcCCCCCCcccceechHHHHHHHHh
Q 014039 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFT 194 (432)
Q Consensus 163 ~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~ 194 (432)
.+.|||.. ....+.+.=|+|||+++|.-+-
T Consensus 102 ~~~~pe~~--~~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 102 PPVAGKLG--YSQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----CCS--SSSSCHHHHHHHHHHHHHHHHT
T ss_pred CCCChhhc--cccchHHHHHHHHHHHHHHHhh
Confidence 45688865 2445678889999999999764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00077 Score=65.87 Aligned_cols=135 Identities=15% Similarity=0.158 Sum_probs=73.8
Q ss_pred eeeEeecCceEEEEEEEcC--------CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc-ccccceEEEeCCEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVE--------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN-IIKLKEVVRENNELFF 77 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~l 77 (432)
++.|+.|....||++.... .++.+++|+...... ......+|.++++.+...+ +.++++.. .+ ++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 5567888888999997643 135788888654321 1112346888888874323 34565443 23 68
Q ss_pred EEecCCCcHH-----------HHH----H--Hc----C---CCCC-----HHHHHHHHHH--------------------
Q 014039 78 IFEYMEHNLY-----------HIM----R--ER----Q---IPFS-----EGEIRSFMSQ-------------------- 108 (432)
Q Consensus 78 V~E~~~~~ll-----------~~~----~--~~----~---~~l~-----~~~~~~i~~q-------------------- 108 (432)
||||++|..+ ..+ . +. . ..+. ...+..+..+
T Consensus 112 v~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (369)
T 3c5i_A 112 IEEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKE 191 (369)
T ss_dssp EEECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHH
T ss_pred EEEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHH
Confidence 9999987311 010 0 00 0 0111 0112222211
Q ss_pred HHHHHHHHHH----------CCCeeccCCCCceeEeCCeEEEeeeccce
Q 014039 109 MLQGLAHMHR----------NGYFHRDLKPENLLVTNDVLKIADFGLAR 147 (432)
Q Consensus 109 Il~aL~~LH~----------~givHrDlkP~NILl~~~~lkL~DFG~a~ 147 (432)
+-..+++|.+ .++||+|+++.|||++++.+.|+||..|.
T Consensus 192 ~~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~ 240 (369)
T 3c5i_A 192 SDKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKCLRLIDFEYSG 240 (369)
T ss_dssp HHHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred HHHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCcEEEEEecCCC
Confidence 1122334432 25999999999999998889999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.014 Score=55.46 Aligned_cols=136 Identities=12% Similarity=0.108 Sum_probs=74.7
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc--ccccce------EEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN--IIKLKE------VVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~------~~~~~~~~~lV 78 (432)
++.|+.|....||+.... +| .+++|....... ......|+.+++.+...+ +.+++. +....+..++|
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 456778888999998653 33 578998875311 122345777777662111 233321 12335677899
Q ss_pred EecCCCcH---------------HHHHHHc--C--CC----CCHHHHHH---------------HHHHHHHHHHHHHH--
Q 014039 79 FEYMEHNL---------------YHIMRER--Q--IP----FSEGEIRS---------------FMSQMLQGLAHMHR-- 118 (432)
Q Consensus 79 ~E~~~~~l---------------l~~~~~~--~--~~----l~~~~~~~---------------i~~qIl~aL~~LH~-- 118 (432)
|++++|.. +..+... . .+ ........ +...+...++.+.+
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998731 1111111 0 01 11110000 00113445555553
Q ss_pred -----CCCeeccCCCCceeEeCCeE-EEeeeccce
Q 014039 119 -----NGYFHRDLKPENLLVTNDVL-KIADFGLAR 147 (432)
Q Consensus 119 -----~givHrDlkP~NILl~~~~l-kL~DFG~a~ 147 (432)
.++||+|+++.|||++++.+ .|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 37999999999999998855 799999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0019 Score=63.51 Aligned_cols=136 Identities=13% Similarity=0.132 Sum_probs=79.0
Q ss_pred eeeEeecCceEEEEEEEcC-------CCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVE-------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 78 (432)
++.|..|-...+|++.... +++.+++|+.-.... ......+|.++++.|. +.-..++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 3466668788899987642 356788998633211 1233458999998883 3333556655543 289
Q ss_pred EecCCCcHH-----------HHH----H---Hc----CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 014039 79 FEYMEHNLY-----------HIM----R---ER----QIPF--SEGEIRSFMSQMLQ-------------------GLAH 115 (432)
Q Consensus 79 ~E~~~~~ll-----------~~~----~---~~----~~~l--~~~~~~~i~~qIl~-------------------aL~~ 115 (432)
|||++|..+ ..+ . .- ++.. -..++.+|..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999987311 111 1 01 1111 23566666655532 2333
Q ss_pred HH----H----CCCeeccCCCCceeEeCC-----eEEEeeecccee
Q 014039 116 MH----R----NGYFHRDLKPENLLVTND-----VLKIADFGLARE 148 (432)
Q Consensus 116 LH----~----~givHrDlkP~NILl~~~-----~lkL~DFG~a~~ 148 (432)
|. . ..+||+|+.+.||+++++ .+.|+||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33 2 259999999999999854 899999998853
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0011 Score=66.50 Aligned_cols=71 Identities=14% Similarity=0.067 Sum_probs=47.2
Q ss_pred eeeEeecCceEEEEEEEcC-------CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc-ccccceEEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVE-------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN-IIKLKEVVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV 78 (432)
++.|+.|....||++.... .++.+++|+...... .....+|..+++.+...+ ..++++.+. + .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 5678888889999997653 256788998843211 122347999988884333 355666543 2 289
Q ss_pred EecCCC
Q 014039 79 FEYMEH 84 (432)
Q Consensus 79 ~E~~~~ 84 (432)
+||++|
T Consensus 151 ~e~l~G 156 (429)
T 1nw1_A 151 EEYIPS 156 (429)
T ss_dssp ECCCCE
T ss_pred EEEeCC
Confidence 999986
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0078 Score=56.44 Aligned_cols=75 Identities=12% Similarity=0.078 Sum_probs=49.8
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCC---cccccceEEEeCCEEEEEEe
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP---NIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~~~~~lV~E 80 (432)
..-++.+|.|..+.||+... .+|+.|.+|+....... ....+.+|...|+.|.-. -+.+++.+ +. -++|||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 45577899999999999974 56788999986543221 122345799999988422 23334433 33 368999
Q ss_pred cCCC
Q 014039 81 YMEH 84 (432)
Q Consensus 81 ~~~~ 84 (432)
|+.+
T Consensus 91 ~l~~ 94 (288)
T 3f7w_A 91 WVDE 94 (288)
T ss_dssp CCCC
T ss_pred eecc
Confidence 9875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0028 Score=60.57 Aligned_cols=73 Identities=15% Similarity=0.091 Sum_probs=45.1
Q ss_pred eeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCC--cccccceE-----EEeCCEEEEEEe
Q 014039 8 EELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP--NIIKLKEV-----VRENNELFFIFE 80 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~-----~~~~~~~~lV~E 80 (432)
..++ |....||++.. .+|+.+++|........ .....+|..+++.+... .+.+++.. ....+..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 77789998753 34567899998643221 22344678777777311 23444332 233567789999
Q ss_pred cCCC
Q 014039 81 YMEH 84 (432)
Q Consensus 81 ~~~~ 84 (432)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9987
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.002 Score=61.76 Aligned_cols=31 Identities=29% Similarity=0.345 Sum_probs=26.8
Q ss_pred CCCeeccCCCCceeEeC-----CeEEEeeeccceec
Q 014039 119 NGYFHRDLKPENLLVTN-----DVLKIADFGLAREL 149 (432)
Q Consensus 119 ~givHrDlkP~NILl~~-----~~lkL~DFG~a~~~ 149 (432)
..+||+|+.+.||+++. +.+.|+||+.|..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 47999999999999986 57999999988643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0062 Score=58.79 Aligned_cols=31 Identities=26% Similarity=0.318 Sum_probs=26.5
Q ss_pred CCCeeccCCCCceeEeC-CeEEEeeeccceec
Q 014039 119 NGYFHRDLKPENLLVTN-DVLKIADFGLAREL 149 (432)
Q Consensus 119 ~givHrDlkP~NILl~~-~~lkL~DFG~a~~~ 149 (432)
..+||+|+.+.||++++ +.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999985 48999999887643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.032 Score=56.21 Aligned_cols=72 Identities=21% Similarity=0.124 Sum_probs=46.6
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcc-cccceEEEeCCEEEEEEecCCC
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI-IKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++.|+.|-...+|++.....+..+++|+...... ......+|..+++.|...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 5678888889999998755457888998743221 11112479999999864444 45666652 3 259999987
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.27 E-value=0.084 Score=52.54 Aligned_cols=73 Identities=10% Similarity=0.028 Sum_probs=46.1
Q ss_pred eeeEeecCceEEEEEEEcCC-------CeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVET-------YEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 78 (432)
++.+..|.-..+|+...... ++.+++|+...... ......+|.++++.+. +.-..++++.+ .+ ++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 56677788889999976521 56788988643221 1112347888888883 33244555433 33 689
Q ss_pred EecCCCc
Q 014039 79 FEYMEHN 85 (432)
Q Consensus 79 ~E~~~~~ 85 (432)
|||++|.
T Consensus 149 ~efI~G~ 155 (424)
T 3mes_A 149 EEFIDGE 155 (424)
T ss_dssp EECCCSE
T ss_pred EEEeCCc
Confidence 9999983
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.86 E-value=0.31 Score=47.90 Aligned_cols=29 Identities=24% Similarity=0.410 Sum_probs=24.1
Q ss_pred CCeeccCCCCceeEeC-------CeEEEeeecccee
Q 014039 120 GYFHRDLKPENLLVTN-------DVLKIADFGLARE 148 (432)
Q Consensus 120 givHrDlkP~NILl~~-------~~lkL~DFG~a~~ 148 (432)
.+||+|+.+.|||+.+ +.+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 3789999999999942 3799999998853
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.43 E-value=0.074 Score=53.57 Aligned_cols=61 Identities=10% Similarity=-0.036 Sum_probs=16.9
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEE------EEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAV------KKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVR 70 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAi------K~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 70 (432)
.+.|| ||.||++........||+ |..+...... ......+|..+++.++|||+++.+.+..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 45565 999999987665567888 6665432221 2223568899999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 432 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-79 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-78 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-77 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-77 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-76 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-76 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-76 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-74 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-74 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-73 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-73 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-73 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-72 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-72 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-71 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-69 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-69 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-67 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-67 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-65 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-64 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-62 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-61 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-60 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-58 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 2e-79
Identities = 69/298 (23%), Positives = 130/298 (43%), Gaps = 18/298 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ ++ + ELG G G V+K + + ++A K + + +RE++ L + N P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH-RNG 120
I+ + E+ E+M+ + ++ E + +++GL ++ ++
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRD+KP N+LV + +K+ DFG++ +L + +V TR Y +PE LQ + YS
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPER-LQGTHYSVQ 183
Query: 180 IDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
D+W++G L E+ PI P D++ +L C + G T T L S
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 239 EILPINLSDIIPNA-------------SMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
P+ + +++ S+E D + + +P R Q + H F
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 3e-78
Identities = 119/306 (38%), Positives = 180/306 (58%), Gaps = 13/306 (4%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
ME ++ +E++G+GT G VYKA N T E+VA+KK++ +RE+ L++LNH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQI-PFSEGEIRSFMSQMLQGLAHMHR 118
PNI+KL +V+ N+L+ +FE++ +L M + I+S++ Q+LQGLA H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSY 176
+ HRDLKP+NLL+ + +K+ADFGLAR + YT V T WYRAPE+LL Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S A+D+W++G I AE+ T +FPGDSEIDQL+++ LG PD +P T++ S
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK-PS 239
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
+ + + S ++P + L+ Q+ +DP +R +A AL HPFF + P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ-------DVTKP 292
Query: 297 L-ELRL 301
+ LRL
Sbjct: 293 VPHLRL 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 243 bits (621), Expect = 7e-78
Identities = 81/300 (27%), Positives = 122/300 (40%), Gaps = 32/300 (10%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
++ Y I EELG G G V++ T A K + +E + +E++ + L HP
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHP 83
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
++ L + ++NE+ I+E+M L+ + + SE E +M Q+ +GL HMH N
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 120 GYFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
Y H DLKPEN++ T LK+ DFGL L T + APEV +
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPV 202
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
DMW+VG + L + F G+++ + L V D
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----------------- 245
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
S + D I +L DP R T QAL+HP+ P
Sbjct: 246 ---------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 2e-77
Identities = 106/317 (33%), Positives = 163/317 (51%), Gaps = 24/317 (7%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNH 59
+ +Y+ L ++G GT G V+KA + +T + VA+KK+ + LRE+K L+ L H
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 60 PNIIKLKEVVRE--------NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQ 111
N++ L E+ R ++ +F++ EH+L ++ + F+ EI+ M +L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-----MPPYTEYVSTRWYR 165
GL ++HRN HRD+K N+L+T D VLK+ADFGLAR S YT V T WYR
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 166 APEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225
PE+LL Y P ID+W G I+AE++T SPI G++E QL + + G+ +P
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 226 ATNISRLISISYSEILPINLSDIIPN--ASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
N + + + D + A+DLI +L DP +R +D AL H FF
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 284 NVETWVPYPLHDPLELR 300
+ P +L+
Sbjct: 309 WSD-------PMPSDLK 318
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (612), Expect = 3e-77
Identities = 110/285 (38%), Positives = 165/285 (57%), Gaps = 8/285 (2%)
Query: 6 ILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEE----CMNLREVKALRKLNHPN 61
L+ LG+G VYKA + T +IVA+KK+K + LRE+K L++L+HPN
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
II L + + + +F++ME +L I+++ + + I+++M LQGL ++H++
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 122 FHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSSSYSPA 179
HRDLKP NLL+ + VLK+ADFGLA+ S YT V TRWYRAPE+L + Y
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 180 IDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239
+DMWAVG ILAEL P PGDS++DQL ++ LG P +P+ ++ +++
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD--YVTFKS 239
Query: 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
I L I A + +DLI L ++P R TA QAL+ +F+
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 238 bits (608), Expect = 1e-76
Identities = 108/286 (37%), Positives = 165/286 (57%), Gaps = 5/286 (1%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNH 59
ME+Y LE++G+GT G VYKA N E A+KK++ + +RE+ L++L H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+KL +V+ L +FE+++ +L ++ + +SF+ Q+L G+A+ H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRDLKP+NLL+ + LKIADFGLAR + YT + T WYRAP+VL+ S YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
ID+W+VG I AE+ +P+FPG SE DQL ++ ILG P+ +P T + + ++
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNF 238
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ P+ + IDL+ ++ DP +R TA QAL+H +F
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 1e-76
Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 35/296 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ ++I+ ELGDG G VYKA N ET + A K + K E + E+ L +HPN
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPN 70
Query: 62 IIKLKEVVRENNELFFIFEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+KL + N L+ + E+ + +M E + P +E +I+ Q L L ++H N
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLL----QSS 174
HRDLK N+L T D +K+ADFG++ + + + ++ T ++ APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y D+W++G L E+ + P + + L K+ P A P
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKSEPPTLAQP---------- 238
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
S D + + + R T Q LQHPF V++ P
Sbjct: 239 ---------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 5e-76
Identities = 101/320 (31%), Positives = 167/320 (52%), Gaps = 27/320 (8%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
Y + +G+G+ G VY+A ++ E+VA+KK+ + ++ RE++ +RKL+H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 63 IKLKEVVRENNE------LFFIFEYMEHNLYHIMRE---RQIPFSEGEIRSFMSQMLQGL 113
++L+ + E L + +Y+ +Y + R + ++ +M Q+ + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 114 AHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
A++H G HRD+KP+NLL+ D VLK+ DFG A++L P Y+ +R+YRAPE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
++ Y+ +ID+W+ G +LAEL PIFPGDS +DQL ++ +LG P E
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PN 253
Query: 232 LISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
+ +I + + P EAI L +L + P R T +A H FF+
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD------ 307
Query: 291 YPLHDPLELRLNNMGSKPNL 310
L DP ++L N P L
Sbjct: 308 -ELRDP-NVKLPNGRDTPAL 325
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-74
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 31/287 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E + +++ LG+G G V A N T E VAVK + K +E+ + LNH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
++K RE N + EY E I E + + F Q++ G+ ++H G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 122 FHRDLKPENLLVT-NDVLKIADFGLAREL---SSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+KPENLL+ D LKI+DFGLA + + T Y APE+L + ++
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
+D+W+ G +L + + S+ Q Y
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------------------- 219
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
+ + L+ ++ +P R T + ++N
Sbjct: 220 --KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 233 bits (596), Expect = 5e-74
Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 32/286 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ Y ILEELG G G V++ T + K + + + + E+ + +L+HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHPK 87
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+I L + + E+ I E++ L+ + SE E+ ++M Q +GL HMH +
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 121 YFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
H D+KPEN++ +KI DFGLA +L+ +T + APE+ +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPVG 206
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
DMWA+G + L + F G+ +++ L V D
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------------------ 248
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
D + S EA D I L +P +R T AL+HP+
Sbjct: 249 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (591), Expect = 2e-73
Identities = 107/323 (33%), Positives = 169/323 (52%), Gaps = 20/323 (6%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
RY L +G+G G V A++ VA+KK+ + LRE+K L + H N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 62 IIKLKEVVRE-----NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
II + +++R +++ + M +LY +++ + S I F+ Q+L+GL ++
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI 125
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS----MPPYTEYVSTRWYRAPEVLL 171
H HRDLKP NLL+ LKI DFGLAR TEYV+TRWYRAPE++L
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
S Y+ +ID+W+VG ILAE+ + PIFPG +DQL + ILG+P N+
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 232 L-ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVP 290
+S + + + PNA +A+DL+ ++ +++P +R +QAL HP+
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE------ 299
Query: 291 YPLHDPLELRLNNMGSKPNLELN 313
+DP + + K ++EL+
Sbjct: 300 -QYYDPSDEPIAEAPFKFDMELD 321
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 3e-73
Identities = 105/300 (35%), Positives = 167/300 (55%), Gaps = 12/300 (4%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
M++Y+ LE++G+GT G V+KA N ET+EIVA+K+++ + LRE+ L++L H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI++L +V+ + +L +FE+ + +L ++SF+ Q+L+GL H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 120 GYFHRDLKPENLLVT-NDVLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRDLKP+NLL+ N LK+A+FGLAR + Y+ V T WYR P+VL + YS
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 178 PAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
+IDMW+ G I AEL P+FPG+ DQL ++ +LG P +P T +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
+L +++P + DL+ L +P++R +A++ALQHP+F+ P
Sbjct: 241 MYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS-------DFCPP 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 3e-73
Identities = 68/286 (23%), Positives = 121/286 (42%), Gaps = 35/286 (12%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
+E ++I LG G G VY A ++ I+A+K + + + REV+ L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HPNI++L + ++ I EY + ++ F E ++++++ L++ H
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRD+KPENLL+ + LKIADFG + S T T Y PE++ + +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMI-EGRMHD 182
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
+D+W++G + E P F ++ + ++ +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------------------- 219
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
D + A DLI +L +P +RP + L+HP+
Sbjct: 220 ----EFTFPDFVTE---GARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 3e-73
Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 33/286 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E+Y I E+LG G G V++ + + K +K K ++ + +E+ L H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ L E EL IFE++ +++ + +E EI S++ Q+ + L +H +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 121 YFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
H D++PEN++ +KI +FG AR+L + + Y APEV Q S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVS 181
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
A DMW++G ++ L + F ++ + + D
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD------------------ 223
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
+ S+EA+D + +L + R TA +ALQHP+
Sbjct: 224 --------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (584), Expect = 8e-73
Identities = 81/314 (25%), Positives = 134/314 (42%), Gaps = 33/314 (10%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ Y + LG G V A + T ++VA+K + +K +E E+ L K+ HPN
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ L ++ L+ I + + L+ + E+ ++E + + Q+L + ++H G
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLG 127
Query: 121 YFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
HRDLKPENLL + + I+DFGL++ + T Y APEV L Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-LAQKPY 186
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S A+D W++G I L P F +++ ++ D
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----------------- 229
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
S + S A D I L DP +R T +QALQHP+ +T + +H
Sbjct: 230 ---------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
Query: 297 LELRLNNMGSKPNL 310
+ ++ +K
Sbjct: 281 VSEQIKKNFAKSKW 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 228 bits (583), Expect = 1e-72
Identities = 77/317 (24%), Positives = 135/317 (42%), Gaps = 37/317 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
+ + L E+G G+ G VY A +V E+VA+KKM E ++EV+ L+KL H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
PN I+ + + + + EY + ++ + P E EI + LQGLA++H +
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS--Y 176
HRD+K N+L++ ++K+ DFG A ++ +V T ++ APEV+L Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 191
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
+D+W++G EL P + + LY +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------------AQNE 230
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHDP 296
+ + S+ + + P RPT++ L+H F E P + D
Sbjct: 231 SPALQSGHWSE-------YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER-PPTVIMDL 282
Query: 297 LELRLNNMGSKPNLELN 313
++ + + NL+
Sbjct: 283 IQRTKDAVRELDNLQYR 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 4e-72
Identities = 97/295 (32%), Positives = 162/295 (54%), Gaps = 16/295 (5%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETY-EIVAVKKMKRKFYFWEECMN-LREVKALRKL-- 57
++Y+ + E+G+G G V+KA +++ VA+K+++ + ++ +REV LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 58 -NHPNIIKLKEVV-----RENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQML 110
HPN+++L +V +L +FE+++ ++ + + I+ M Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 111 QGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEV 169
+GL +H + HRDLKP+N+LVT+ +K+ADFGLAR S T V T WYRAPEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
L SSY+ +D+W+VG I AE+F P+F G S++DQL K+ ++G P +P +
Sbjct: 187 -LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
R S S + + + DL+ + +++P +R +A AL HP+F
Sbjct: 246 PRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 6e-72
Identities = 70/287 (24%), Positives = 132/287 (45%), Gaps = 34/287 (11%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
++Y E++G G G VY A +V T + VA+++M + +E + + E+ +R+ +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I+ + +EL+ + EY+ +L ++ E EG+I + + LQ L +H N
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELS-SMPPYTEYVSTRWYRAPEVLLQSSSYSP 178
HRD+K +N+L+ D +K+ DFG +++ + V T ++ APEV+ +Y P
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGP 195
Query: 179 AIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238
+D+W++G + E+ P + ++ + LY + G P+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL------------------ 236
Query: 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
S D + + D +R +A + LQH F +
Sbjct: 237 --------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 1e-71
Identities = 99/292 (33%), Positives = 152/292 (52%), Gaps = 13/292 (4%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHP 60
Y+ L+ +G G G V A + T VA+KK+ R F RE++ L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 61 NIIKLKEVVRENN------ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N+I L +V + + + + +M +L +M+ E I+ + QML+GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
++H G HRDLKP NL V D LKI DFGLAR+ S T YV TRWYRAPEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNW 193
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN-ISRL 232
Y+ +D+W+VG I+AE+ T +F G +DQL ++ + G P + ++
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284
E+ + + I+ NAS A++L+ ++ D +R TA +AL HP+F
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 219 bits (560), Expect = 1e-69
Identities = 84/298 (28%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--------LREVKA 53
E Y+ E LG G V + + T + AVK + L+EV
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 54 LRKLN-HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQ 111
LRK++ HPNII+LK+ N F +F+ M+ L+ + E+ SE E R M +L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLE 121
Query: 112 GLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
+ +H+ HRDLKPEN+L+ +D +K+ DFG + +L E T Y APE++
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 171 LQS-----SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225
S Y +DMW+ G I+ L SP F ++ L +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM------------- 228
Query: 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S + S DL+ + P +R TA++AL HPFF
Sbjct: 229 -------------SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 219 bits (559), Expect = 6e-69
Identities = 83/301 (27%), Positives = 151/301 (50%), Gaps = 20/301 (6%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-H 59
+ Y+++ +LG G V++A N+ E V VK +K ++ RE+K L L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGG 89
Query: 60 PNIIKLKEVVRE--NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
PNII L ++V++ + +FE++ + + + + ++ +IR +M ++L+ L + H
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 146
Query: 118 RNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSS 175
G HRD+KP N+++ ++ L++ D+GLA Y V++R+++ PE+L+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 176 YSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR--- 231
Y ++DMW++G +LA + P F G DQL ++ +LG D + + NI
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 232 ----LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287
L S S+ S EA+D + +L +D R TA +A++HP+F
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
Query: 288 W 288
Sbjct: 327 K 327
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-67
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 43/299 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
E +K + LG+G+ V A + T A+K ++++ E + RE + +L+H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
P +KL +++ +L+F Y ++ + F E R + ++++ L ++H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLAREL---SSMPPYTEYVSTRWYRAPEVLLQSSS 175
G HRDLKPEN+L+ D ++I DFG A+ L S +V T Y +PE+ L S
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEKS 186
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
+ D+WA+G I+ +L P F +E K+ D FPE
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYD---FPE---------- 231
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA------LQHPFFNVETW 288
+A DL+ +L D +R ++ HPFF TW
Sbjct: 232 ---------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-67
Identities = 103/291 (35%), Positives = 161/291 (55%), Gaps = 13/291 (4%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNHP 60
ERY+ L +G G G V AF+ +T VAVKK+ R F RE++ L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 61 NIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLA 114
N+I L +V E N+++ + M +L +I++ + ++ ++ + Q+L+GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 115 HMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQS 173
++H HRDLKP NL V D LKI DFGLAR T YV+TRWYRAPE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNW 193
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS-RL 232
Y+ +D+W+VG I+AEL T +FPG IDQL + ++G P + ++ S R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
S +++ +N +++ A+ A+DL+ ++ D +R TA QAL H +F
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-67
Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 37/297 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-----LREVKALRK 56
+ Y EELG G V K T A K +K++ REV L++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
+ HPN+I L EV ++ I E + + +E E F+ Q+L G+ ++
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 117 HRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
H H DLKPEN+++ + +KI DFGLA ++ + T + APE+ +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 188
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
DMW++G I L + + F GD++ + L V + +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE------------ 236
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+ N S A D I +L DP +R T +LQHP+ +
Sbjct: 237 --------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-67
Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHP 60
E Y++L +G G+ G K +I+ K++ E+ M + EV LR+L HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 61 NIIKLKEVV--RENNELFFIFEYMEH-NLYHIMR---ERQIPFSEGEIRSFMSQMLQGLA 114
NI++ + + R N L+ + EY E +L ++ + + E + M+Q+ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 115 HMHR-----NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-TEYVSTRWYRAP 167
HR + HRDLKP N+ + +K+ DFGLAR L+ + +V T +Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 168 EVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227
E + SY+ D+W++G +L EL L P F S+ + K
Sbjct: 184 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----------------- 225
Query: 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPF 282
I I S E ++I ++ + RP+ ++ L++P
Sbjct: 226 ------------IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-65
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 39/289 (13%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHPNI 62
K E+G G+ VYK + ET VA +++ + E E + L+ L HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 63 IKLKEV----VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
++ + V+ + + E M +R +RS+ Q+L+GL +H
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 119 NGY--FHRDLKPENLLVT--NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
HRDLK +N+ +T +KI D GLA + + T + APE+ +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK- 188
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y ++D++A G + E+ T + Q+Y+ + +F
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFD---------- 235
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283
A E ++I + R + L H FF
Sbjct: 236 ---------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-64
Identities = 83/316 (26%), Positives = 134/316 (42%), Gaps = 42/316 (13%)
Query: 1 MERYKILEE-LGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-N 58
++ YK+ + LG G G V + FN T E A+K ++ REV+ +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQ 63
Query: 59 HPNIIKLKEVVR----ENNELFFIFEYMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQG 112
P+I+++ +V L + E ++ L+ +++R F+E E M + +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 113 LAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYTEYVSTRWYRAPE 168
+ ++H HRD+KPENLL T N +LK+ DFG A+E +S T T +Y APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 169 VLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228
V L Y + DMW++G I+ L P F + + + + + FP
Sbjct: 184 V-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FP---- 237
Query: 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288
+ S E LI L +P +R T + + HP+ T
Sbjct: 238 -----------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
Query: 289 VPY-PLHDPLELRLNN 303
VP PLH L+ +
Sbjct: 281 VPQTPLHTSRVLKEDK 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-64
Identities = 102/321 (31%), Positives = 156/321 (48%), Gaps = 31/321 (9%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN-LREVKALRKLNH 59
++RY+ L+ +G G G V A++ VA+KK+ R F RE+ ++ +NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 60 PNIIKLKEVVR------ENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
NII L V E +++ + E M+ NL +++ + + QML G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ 172
H+H G HRDLKP N++V +D LKI DFGLAR + T YV TR+YRAPEV+L
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 173 SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232
Y +D+W+VG I+ E+ +FPG IDQ KV LG P + R
Sbjct: 193 -MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 233 ISISYSEILPINLSDIIPNA------------SMEAIDLIWQLCSWDPLRRPTADQALQH 280
+ + + + P++ + +A DL+ ++ DP +R + D ALQH
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 281 PFFNVETWVPYPLHDPLELRL 301
P+ NV +DP E+
Sbjct: 312 PYINV-------WYDPAEVEA 325
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-62
Identities = 67/287 (23%), Positives = 108/287 (37%), Gaps = 36/287 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-REVKALRKLNHP 60
+ + + +G G+ G VYK + + VAVK + ++ EV LRK H
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 61 NIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
NI+ L + ++ E +LYH + + F ++ Q QG+ ++H
Sbjct: 65 NILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVSTRWYRAPEVLL--QS 173
HRDLK N+ + D +KI DFGLA S + + + APEV+
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 174 SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
+ YS D++A G +L EL T + + DQ+ +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------------------- 223
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
L +LS + N L+ + RP Q L
Sbjct: 224 ----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 200 bits (510), Expect = 3e-61
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 39/299 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNL-----REVKALR 55
M + + +G G G VY +T ++ A+K + +K ++ L + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 56 KLNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
+ P I+ + ++L FI + M H + FSE ++R + ++++ GL H
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 116 MHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSS 174
MH +RDLKP N+L+ ++I+D GLA + S P+ V T Y APEVL +
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGV 181
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
+Y + D +++G +L +L F D+ L
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------------- 225
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETW 288
++ + S E L+ L D RR A + + PFF W
Sbjct: 226 -----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-60
Identities = 77/311 (24%), Positives = 119/311 (38%), Gaps = 53/311 (17%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKM-KRKFYFWEECMN----LREVKALRKL 57
+Y++ LG G G VY V VA+K + K + W E N EV L+K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 58 N--HPNIIKLKEVVRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ +I+L + + I E E L+ + ER E RSF Q+L+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAV 123
Query: 114 AHMHRNGYFHRDLKPENLLVTND--VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL 171
H H G HRD+K EN+L+ + LK+ DFG L YT++ TR Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+ + +W++G +L ++ F D EI +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV--------------------- 221
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPY 291
S E LI + P RPT ++ HP+ V
Sbjct: 222 ---------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD---VLL 263
Query: 292 PLHDPLELRLN 302
P + E+ L+
Sbjct: 264 P-QETAEIHLH 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-60
Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 39/295 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKAL-RKL 57
+E + + + LG G+ G V+ A +T + A+K +K+ ++ + + E + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
HP + + + LFF+ EY+ +L + ++ F + ++++ GL +
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL 119
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYTEYVSTRWYRAPEVLLQSS 174
H G +RDLK +N+L+ D +KIADFG+ +E + T Y APE+ L
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI-LLGQ 178
Query: 175 SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234
Y+ ++D W+ G +L E+ F G E + + + D +P
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPR--------- 224
Query: 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTA-DQALQHPFFNVETW 288
EA DL+ +L +P +R QHP F W
Sbjct: 225 ----------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-58
Identities = 84/377 (22%), Positives = 147/377 (38%), Gaps = 63/377 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
M + L+ LG GT G V T A+K ++++ ++ + + E + L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HP + LK + ++ L F+ EY R+ F+E R + ++++ L ++H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLAREL-SSMPPYTEYVSTRWYRAPEVLLQSSSY 176
+RD+K ENL++ D +KI DFGL +E S + T Y APE +L+ + Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDY 182
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
A+D W +G ++ E+ F + ++ +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRF---------------- 224
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWVPY 291
P LS EA L+ L DP +R A + ++H FF W
Sbjct: 225 -----PRTLSP-------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW--- 269
Query: 292 PLHDPLELRLNNMGSKPNL--ELNLWDFGTEPDDCFLGLTLAVKPSNLEMVHNVPQGMQE 349
+ + KP + E++ F DD F ++ + P + +
Sbjct: 270 ---QDVVQKKLLPPFKPQVTSEVDTRYF----DDEFTAQSITITPPD-----------RY 311
Query: 350 DILFCSDLKDHSEQTVF 366
D L +L EQ +F
Sbjct: 312 DSLGLLELDQREEQEMF 328
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 190 bits (483), Expect = 1e-57
Identities = 62/291 (21%), Positives = 120/291 (41%), Gaps = 41/291 (14%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
++ ++IL LG G+ G V+ + A+K +K++ + + E L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
HP II++ ++ ++F I +Y+E + + F + + +++ L ++H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
+RDLKPEN+L+ + +KI DFG A+ + + T Y APEV+ + Y+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVV-STKPYN 179
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
+ID W+ G ++ E+ F + + K+ FP
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELR---FP------------- 221
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFF 283
P + + DL+ +L + D +R + HP+F
Sbjct: 222 ------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 185 bits (471), Expect = 2e-56
Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 38/295 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLNH 59
+RY++ E LG G V+ A ++ + VAVK ++ RE + LNH
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 60 PNIIKLKEVVRENNE----LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
P I+ + + + + EY++ + + P + ++ Q L
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 116 MHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVL 170
H+NG HRD+KP N++++ + +A +S+ + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ- 185
Query: 171 LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
+ S D++++G +L E+ T P F GDS + Y+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------------------ 227
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285
PI S S + ++ + + +P R ++ V
Sbjct: 228 --------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 6e-55
Identities = 65/296 (21%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMN--LREVKALRKLN 58
++++ ++ LG G+ G V + E+ A+K + ++ + + L E + L+ +N
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR 118
P ++KL+ ++N+ L+ + EY+ R FSE R + +Q++ ++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 119 NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYS 177
+RDLKPENLL+ +++ DFG A+ T APE+ + S Y+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEI-ILSKGYN 216
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
A+D WA+G ++ E+ P F D I K+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------------------------ 252
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRR-----PTADQALQHPFFNVETW 288
+ S + DL+ L D +R + H +F W
Sbjct: 253 ------GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-54
Identities = 61/285 (21%), Positives = 107/285 (37%), Gaps = 42/285 (14%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHP 60
M+ K+L+ +G G G V VAVK +K L E + +L H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHS 60
Query: 61 NIIKLKEV-VRENNELFFIFEYMEHN--LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
N+++L V V E L+ + EYM + ++ + + F + + + ++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSY 176
N + HRDL N+LV+ D V K++DFGL +E SS + APE L+ +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEA-LREKKF 177
Query: 177 SPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
S D+W+ G +L E+++ +P D + +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------------------- 212
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+ D +++ D RP+ Q +
Sbjct: 213 ----VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 2e-53
Identities = 49/298 (16%), Positives = 96/298 (32%), Gaps = 42/298 (14%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
RY++ ++G G+ G +Y ++ E VA+K K + E K + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGVG 64
Query: 63 IK-LKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGY 121
I ++ E + + E + +L + FS + QM+ + ++H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 122 FHRDLKPENLLVTND----VLKIADFGLARELSS--------MPPYTEYVSTRWYRAPEV 169
HRD+KP+N L+ ++ I DFGLA++ T Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
S D+ ++G +L S + G + K
Sbjct: 185 -HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------------------- 224
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD---QALQHPFFN 284
+ + + + E + S +P Q ++ F
Sbjct: 225 ---YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-53
Identities = 61/283 (21%), Positives = 115/283 (40%), Gaps = 36/283 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
++E+G G G V+ + + + VA+K ++ E+ + E + + KL+HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDF--IEEAEVMMKLSHPK 61
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+++L V E + +FE+MEH L +R ++ F+ + + +G+A++
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSS--MPPYTEYVSTRWYRAPEVLLQSSSYS 177
HRDL N LV + V+K++DFG+ R + T + +PEV S YS
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV-FSFSRYS 180
Query: 178 PAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237
D+W+ G ++ E+F+ I + ++ + IS +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------------------DISTGF 219
Query: 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
P S ++ P RP + L+
Sbjct: 220 RLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-53
Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 40/290 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMN--LREVKALRK 56
+ ++LE+LGDG+ G V + VAVK +K E M+ +REV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAH 115
L+H N+I+L VV + + E +L +R+ Q F G + + Q+ +G+ +
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 116 MHRNGYFHRDLKPENLLVT-NDVLKIADFGLARELSSMPPY---TEYVSTRWYRAPEVLL 171
+ + HRDL NLL+ D++KI DFGL R L + E+ + L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 172 QSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
++ ++S A D W G L E+FT + G + L+K+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------------------- 227
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
E LP + + +++ Q + P RPT
Sbjct: 228 ----DKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-52
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 42/290 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E K++E LG G G V+ + + VAVK +K+ + L E +++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69
Query: 62 IIKLKEVVRENNELFFIFEYMEHNLY--HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
+++L VV ++ I EYME+ + I + ++ +Q+ +G+A +
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLAREL--SSMPPYTEYVSTRWYRAPEVLLQSSSY 176
Y HRDL+ N+LV++ KIADFGLAR + + + APE + ++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA-INYGTF 187
Query: 177 SPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
+ D+W+ G +L E+ T +PG + + + + PE
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------- 237
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ--HPFF 283
E L+ P RPT D FF
Sbjct: 238 -------------------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-52
Identities = 75/313 (23%), Positives = 123/313 (39%), Gaps = 63/313 (20%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEI-----VAVKKMKRKFYFWEECMNLREVKALRK 56
E + + LG G G V A + VAVK +K K E + E+K + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 57 L-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEG-------------- 100
L +H NI+ L + ++ IFEY + +L + +R ++ FSE
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 101 --------EIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151
++ F Q+ +G+ + HRDL N+LVT+ V+KI DFGLAR++ S
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 152 MPPYTEY---VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQ 207
Y + APE L Y+ D+W+ G +L E+F+L +PG
Sbjct: 217 DSNYVVRGNARLPVKWMAPES-LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWD 267
YK+ N ++ D A+ E ++ ++D
Sbjct: 276 FYKLI--------------QNGFKM--------------DQPFYATEEIYIIMQSCWAFD 307
Query: 268 PLRRPTADQALQH 280
+RP+
Sbjct: 308 SRKRPSFPNLTSF 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-52
Identities = 64/304 (21%), Positives = 127/304 (41%), Gaps = 42/304 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYFWEECMN---LREVKAL 54
+E +++L+ LG G G V+ + +T ++ A+K +K+ + E + L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 55 RKLNH-PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ P ++ L + +L I +Y+ ++ F+E E++ ++ +++ L
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 114 AHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP---PYTEYVSTRWYRAPEV 169
H+H+ G +RD+K EN+L+ ++ + + DFGL++E + Y + + V
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 170 LLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
S + A+D W++G ++ EL T + F D E + ++ + +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---------- 252
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFN 284
S A DLI +L DP +R AD+ +H FF
Sbjct: 253 ----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
Query: 285 VETW 288
W
Sbjct: 297 KINW 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 5e-52
Identities = 60/283 (21%), Positives = 114/283 (40%), Gaps = 36/283 (12%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ +LG G G VY+ + VAVK +K EE L+E ++++ HPN
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIKHPN 74
Query: 62 IIKLKEVVRENNELFFIFEYMEH--NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
+++L V + I E+M + L ++ + S + +Q+ + ++ +
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSS--MPPYTEYVSTRWYRAPEVLLQSSSY 176
+ HRDL N LV + ++K+ADFGL+R ++ + + APE L + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES-LAYNKF 193
Query: 177 SPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
S D+WA G +L E+ T ++ Q+Y++
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------------------------- 228
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279
+ + + +L+ W+P RP+ + Q
Sbjct: 229 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 7e-52
Identities = 53/297 (17%), Positives = 107/297 (36%), Gaps = 44/297 (14%)
Query: 2 ERYKILE-ELGDGTCGCVYKAFNVETYE--IVAVKKMKRKFYFWEECMNLREVKALRKLN 58
+ I + ELG G G V + + VA+K +K+ + +RE + + +L+
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
+P I++L V + L + E L+ + ++ + + Q+ G+ ++
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 118 RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEY----VSTRWYRAPEVLLQ 172
+ HRDL N+L+ N KI+DFGL++ L + Y + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC-IN 185
Query: 173 SSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
+S D+W+ G + E + + + +
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------------------- 224
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD---QALQHPFFNV 285
I + P E L+ + RP Q ++ ++++
Sbjct: 225 --------IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 8e-52
Identities = 59/284 (20%), Positives = 107/284 (37%), Gaps = 38/284 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ L+ELG G G V VA+K +K +E + E K + L+H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEF--IEEAKVMMNLSHEK 60
Query: 62 IIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
+++L V + +F I EYM + L + +RE + F ++ + + + ++
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 121 YFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--TEYVSTRWYRAPEVLLQSSSYS 177
+ HRDL N LV + V+K++DFGL+R + + PEV L S +S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV-LMYSKFS 179
Query: 178 PAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236
D+WA G ++ E+++L + + + + L E
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE----------- 228
Query: 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+ +++ RPT L +
Sbjct: 229 ------------------KVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-51
Identities = 69/291 (23%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
E ++ +LG G G V+ T VA+K +K E + +E + ++KL H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL--QEAQVMKKLRHEK 73
Query: 62 IIKLKEVVRENNELFFIFEYMEH--NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
+++L VV ++ + EYM L + E ++ +Q+ G+A++ R
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY--TEYVSTRWYRAPEVLLQSSSY 176
Y HRDL+ N+LV + V K+ADFGLAR + + APE +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGRF 191
Query: 177 SPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
+ D+W+ G +L EL T +PG + L +V P
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP--------------- 236
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ--HPFFN 284
P DL+ Q +P RPT + +F
Sbjct: 237 --------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 174 bits (442), Expect = 3e-51
Identities = 72/323 (22%), Positives = 128/323 (39%), Gaps = 45/323 (13%)
Query: 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNI 62
RY ++ +LG G V+ A ++ VA+K ++ + E E+K L+++N +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDADN 71
Query: 63 IKLKEVVREN-NELFFIFEYMEHN---------------LYHIMRERQIPFSEGEIRSFM 106
K + + +L F + N L I + ++
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 107 SQMLQGLAHMH-RNGYFHRDLKPENLLVTND-----VLKIADFGLARELSSMPPYTEYVS 160
Q+L GL +MH R G H D+KPEN+L+ +++I L YT +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS------EIDQLYKVCCI 214
TR YR+PEVLL + + D+W+ ++ EL T +F D + D + ++ +
Sbjct: 192 TREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 215 LGAPD-------------WTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIW 261
LG + + NIS+L ++L + + E D +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY-KFSKDEAKEISDFLS 309
Query: 262 QLCSWDPLRRPTADQALQHPFFN 284
+ DP +R A + HP+
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 3e-51
Identities = 60/291 (20%), Positives = 109/291 (37%), Gaps = 40/291 (13%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKL 57
+ KI + +G G G V VA+K +K + + L E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
+HPN+I L+ VV ++ + I E+ME+ +L +R+ F+ ++ + + G+ ++
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLL---- 171
Y HRDL N+LV ++ V K++DFGL+R L Y S + P
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 172 -QSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229
Q ++ A D+W+ G ++ E+ + + + D + + P P
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS---- 260
Query: 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
L+ D RP Q +
Sbjct: 261 -------------------------ALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-50
Identities = 57/298 (19%), Positives = 110/298 (36%), Gaps = 45/298 (15%)
Query: 2 ERYKILEE--LGDGTCGCVYKAF--NVETYEIVAVKKMKRKFYFWEECMN-LREVKALRK 56
+ LE+ LG G G V K + + + VAVK +K + L E +++
Sbjct: 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
L++P I+++ + E + E E + ++ + I + Q+ G+ ++
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY----TEYVSTRWYRAPEVLL 171
+ + HRDL N+L+ KI+DFGL++ L + Y T + APE +
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-I 182
Query: 172 QSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230
+S D+W+ G ++ E F+ + G +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------------------- 222
Query: 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ---ALQHPFFNV 285
+ E DL+ ++D RP L++ +++V
Sbjct: 223 ---------LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 169 bits (430), Expect = 3e-50
Identities = 45/293 (15%), Positives = 88/293 (30%), Gaps = 41/293 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
YK+ +G+G+ G +++ N+ + VA+K R+ + E + + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 61
Query: 62 II-KLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG 120
I + +E + + + +L ++ FS + QML + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 121 YFHRDLKPENLLVTND------VLKIADFGLARELSS--------MPPYTEYVSTRWYRA 166
+RD+KP+N L+ ++ + DFG+ + T Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 167 PEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226
L S D+ A+G + S + G K I
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ------- 233
Query: 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279
L ++ E + + P D
Sbjct: 234 ---------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-50
Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 39/287 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNV---ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN 58
ER ++ +G+G G V++ + VA+K K L+E +R+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 59 HPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMH 117
HP+I+KL V+ EN ++ I E L ++ R+ + + Q+ LA++
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 118 RNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPY--TEYVSTRWYRAPEVLLQSS 174
+ HRD+ N+LV++ D +K+ DFGL+R + Y ++ + APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 184
Query: 175 SYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233
++ A D+W G + E+ F G D + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----------------------- 221
Query: 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
I E LP+ PN L+ + ++DP RRP +
Sbjct: 222 -IENGERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-49
Identities = 54/303 (17%), Positives = 104/303 (34%), Gaps = 37/303 (12%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYE----IVAVKKMKRKFYFWEECMNLREVKALRKLNH 59
+K ++ LG G G VYK + E VA+K+++ L E + +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 60 PNIIKLKEVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRN 119
P++ +L + + L +RE + + ++ Q+ +G+ ++
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 120 GYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVSTRWYRAPEVLLQSSS 175
HRDL N+LV +KI DFGLA+ L + + A E +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-ILHRI 189
Query: 176 YSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
Y+ D+W+ G + EL T ++ + +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----------------------L 226
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWVPYPLHD 295
E LP P +++ ++ + D RP + + Y +
Sbjct: 227 EKGERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281
Query: 296 PLE 298
E
Sbjct: 282 GDE 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 3e-49
Identities = 69/312 (22%), Positives = 119/312 (38%), Gaps = 64/312 (20%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+ + ++G+G G V++A E + +VAVK +K + + RE + +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQ--------------------- 94
++PNI+KL V + +FEYM + +L +R
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 95 --IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS 151
P S E Q+ G+A++ + HRDL N LV + V+KIADFGL+R + S
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 152 MPPY---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS-PIFPGDSEIDQ 207
Y + PE + + Y+ D+WA G +L E+F+ + G + +
Sbjct: 193 ADYYKADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWD 267
+Y + N+ N +E +L+ S
Sbjct: 252 IYY-----------------------------VRDGNILACPENCPLELYNLMRLCWSKL 282
Query: 268 PLRRPTADQALQ 279
P RP+ +
Sbjct: 283 PADRPSFCSIHR 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-48
Identities = 75/306 (24%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 2 ERYKILEELGDGTCGCVYKA-----FNVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
R + LG G G V +A + VAVK +K + E + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 57 L-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRER-----------------QIPF 97
L NH NI+ L I EY + +L + +R + ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 98 SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155
++ SF Q+ +G+A + HRDL N+L+T+ + KI DFGLAR++ + Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 156 --TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213
+ APE + + Y+ D+W+ G L ELF+
Sbjct: 203 VKGNARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFS------------------- 242
Query: 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
LG+ + P + ++I + + P +A E D++ DPL+RPT
Sbjct: 243 -LGSSPYPGMPVDSKFYKMIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPT 294
Query: 274 ADQALQ 279
Q +Q
Sbjct: 295 FKQIVQ 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-48
Identities = 62/304 (20%), Positives = 109/304 (35%), Gaps = 42/304 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN 61
+ E +G G G V++ E VAVK + E+ L H N
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHEN 58
Query: 62 IIKLKEVVRENN----ELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
I+ ++N +L+ + +Y EH +L+ + + + GLAH+
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHL 116
Query: 117 H--------RNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-----TEYVSTR 162
H + HRDLK +N+LV + IAD GLA S V T+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 163 WYRAPEVL-----LQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGA 217
Y APEVL ++ D++A+G + E+ I +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL---------- 226
Query: 218 PDWTAFPEATNISRLISISYSEILPINLSDIIPN--ASMEAIDLIWQLCSWDPLRRPTAD 275
P + P ++ + + + L N+ + + A ++ + + R TA
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286
Query: 276 QALQ 279
+ +
Sbjct: 287 RIKK 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-48
Identities = 63/288 (21%), Positives = 110/288 (38%), Gaps = 39/288 (13%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVET----YEIVAVKKMKRKFYFWEECMNLREVKALRKL 57
+ +G G G VYK + VA+K +K + + L E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEHNLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHM 116
+H NII+L+ V+ + + I EYME+ +RE+ FS ++ + + G+ ++
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 117 HRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS----TRWYRAPEVLL 171
Y HRDL N+LV ++ V K++DFGL+R L P T S + APE +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-I 185
Query: 172 QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231
++ A D+W+ G ++ E+ T + ++ K
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-------------------- 225
Query: 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279
I + L+ Q + RRP +
Sbjct: 226 --------INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-47
Identities = 71/300 (23%), Positives = 113/300 (37%), Gaps = 49/300 (16%)
Query: 1 MERYKILEELGDGTCGCVYKAFNVET--YEIVAVKKMKRKFYFWEECMNLREVKALRKL- 57
K + +G+G G V KA + A+K+MK + E++ L KL
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 58 NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQI---------------PFSEGE 101
+HPNII L L+ EY H NL +R+ ++ S +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 102 IRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVS 160
+ F + + +G+ ++ + + HRDL N+LV + V KIADFGL+R T
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 161 TRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDW 220
+ A E L S Y+ D+W+ G +L E+ +L +LY+
Sbjct: 189 PVRWMAIES-LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---------- 237
Query: 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
++ + N E DL+ Q P RP+ Q L
Sbjct: 238 ------------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-45
Identities = 65/308 (21%), Positives = 117/308 (37%), Gaps = 56/308 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFN-----VETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
E+ + ELG G+ G VY+ E VA+K + E L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 57 LNHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMR---------ERQIPFSEGEIRSFM 106
N ++++L VV + I E M +L +R P S ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 107 SQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY---TEYVSTR 162
++ G+A+++ N + HRDL N +V D +KI DFG+ R++ Y + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 163 WYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLS-PIFPGDSEIDQLYKVCCILGAPDWT 221
+ +PE L + ++ D+W+ G +L E+ TL+ + G S L
Sbjct: 200 RWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----------- 247
Query: 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ-- 279
++ L D N +L+ ++P RP+ + +
Sbjct: 248 ------------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 280 ----HPFF 283
P F
Sbjct: 290 KEEMEPGF 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-44
Identities = 59/285 (20%), Positives = 110/285 (38%), Gaps = 42/285 (14%)
Query: 8 EELGDGTCGCVYKAFNVE---TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK 64
E +G G GCVY ++ AVK + R E L E ++ +HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 65 LKEV-VRENNELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYF 122
L + +R + YM+H +L + +R + ++ F Q+ +G+ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 123 HRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYVSTR-----WYRAPEVLLQSSSY 176
HRDL N ++ +K+ADFGLAR++ + + T + A E L Q+ +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-QTQKF 211
Query: 177 SPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235
+ D+W+ G +L EL T +P +P + D +
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------------------- 249
Query: 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280
+ P D +++ + RP+ + +
Sbjct: 250 GRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-43
Identities = 73/307 (23%), Positives = 125/307 (40%), Gaps = 57/307 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAFNVETYE-------IVAVKKMKRKFYFWEECMNLREVKAL 54
+R + + LG+G G V A + + VAVK +K + + E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 55 RKL-NHPNIIKLKEVVRENNELFFIFEYMEH-NLYHIMRERQIP---------------F 97
+ + H NII L ++ L+ I EY NL ++ R+ P
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 98 SEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156
S ++ S Q+ +G+ ++ HRDL N+LVT D V+KIADFGLAR++ + Y
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 157 E---YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCC 213
+ + APE L Y+ D+W+ G +L E+FTL +++L+K+
Sbjct: 193 KTTNGRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-- 249
Query: 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
+ + D N + E ++ P +RPT
Sbjct: 250 --------------------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 283
Query: 274 ADQALQH 280
Q ++
Sbjct: 284 FKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-43
Identities = 63/307 (20%), Positives = 113/307 (36%), Gaps = 57/307 (18%)
Query: 2 ERYKILEELGDGTCGCVYKAF-----NVETYEIVAVKKMKRKFYFWEECMNLREVKALRK 56
+R K+ + LG G G V +A T VAVK +K E + E+K L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 57 LNHPNIIKLKE--VVRENNELFFIFEYMEH-NLYHIMRER---------------QIPFS 98
+ H + + L I E+ + NL +R + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 99 EGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY-- 155
+ + Q+ +G+ + HRDL N+L++ V+KI DFGLAR++ P Y
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 156 -TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCC 213
+ + APE + Y+ D+W+ G +L E+F+L + +PG ++ +
Sbjct: 193 KGDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-- 249
Query: 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT 273
+ + E + +P +RPT
Sbjct: 250 --------------------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 274 ADQALQH 280
+ ++H
Sbjct: 284 FSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 100 bits (249), Expect = 2e-25
Identities = 31/200 (15%), Positives = 70/200 (35%), Gaps = 22/200 (11%)
Query: 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMK---------RKFYFWEECMNLREVKAL 54
I + +G+G V+ ++ E + VK K ++ + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 55 RKLNHPNIIKLKEV-VRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGL 113
+ + KL+ + V + ME + ++ + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVEN----PDEVLDMILEEV 116
Query: 114 AHMHRNGYFHRDLKPENLLVTNDVLKIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQ- 172
A + G H DL N+LV+ + + I DF + E+ + E + R ++
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGE-EGWREIL----ERDVRNIITY 171
Query: 173 -SSSYSPAIDMWAVGAILAE 191
S +Y D+ + + +
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 432 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-62 Score=464.19 Aligned_cols=258 Identities=27% Similarity=0.350 Sum_probs=214.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+++|++++.||+|+||+||+|+++.+|+.||||++.............+|+++|++++|||||++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 58999999999999999999999999999999999765544344456799999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCC---CCCc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSM---PPYT 156 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~---~~~~ 156 (432)
|++++.+..+....+.+++.+++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+..... ....
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9987544434444558999999999999999999999999999999999999985 59999999999876432 2345
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++.+...++.++||||+||++|||++|++||.+.....+........ +.
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~--~~----------------- 224 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KT----------------- 224 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT--CT-----------------
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC-----------------
Confidence 67899999999999765666789999999999999999999998876554443332111 00
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....++.+++++++||++||+.||++|||++|+|+||||+.
T Consensus 225 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 --------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 00112357899999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=467.79 Aligned_cols=280 Identities=39% Similarity=0.671 Sum_probs=240.8
Q ss_pred eEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH----HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 5 KILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE----ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+.+++||+|+||+||+|+++.+|+.||||+++....... .....+|+++|++++|||||++++++.+++.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 457899999999999999999999999999975432211 2346799999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
|+.++++..+...++.+++.+++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..... ......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 99999998888877889999999999999999999999999999999999999864 9999999999876543 334567
Q ss_pred cCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 159 VSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 159 ~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
+||++|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++.+|.+.+|.|....++......... .+.
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~--~~~ 238 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--TFK 238 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC--CCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh--hhc
Confidence 899999999999877889999999999999999999999999999999999999999999988776544332222 233
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....++..+++.++++++|||++||++||++||||+|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 334455666677899999999999999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-61 Score=469.29 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=223.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|++++.||+|+||.||+|+++.+|+.||||++.+.... .......+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 68999999999999999999999999999999999864322 2234467899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCC-CCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSS-MPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~-~~~~~ 156 (432)
||||+|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.... .....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 999997665555555568999999999999999999999999999999999999985 5999999999987643 34556
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+....+.. +.+
T Consensus 164 ~~~GT~~Y~aPE~~~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~------------------ 222 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEI------------------ 222 (337)
T ss_dssp CCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC------------------
T ss_pred cceeCHHHhhhhhcc-CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCC------------------
Confidence 789999999999985 67799999999999999999999999999988766665532 111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
.+++.+|+++++||++||++||.+|++ ++|+++||||++.+|.
T Consensus 223 ----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 122468999999999999999999994 9999999999998873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-60 Score=458.26 Aligned_cols=285 Identities=40% Similarity=0.710 Sum_probs=243.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
||+|++++.||+|+||+||+|+++.+|+.||||+++...... ......+|+++|++++|||||++++++.+++.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 799999999999999999999999999999999997543221 2334678999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCC-CCCCc
Q 014039 80 EYMEHNLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSS-MPPYT 156 (432)
Q Consensus 80 E~~~~~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~-~~~~~ 156 (432)
||+.++++..+.. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.|+.... .....
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 9999988877654 35579999999999999999999999999999999999999855 999999999987654 33455
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+++.++....|.+....+......... ...
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY-KPS 239 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTT
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc-ccc
Confidence 6789999999999877777899999999999999999999999999999999999999999887776544332222 223
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
++...........+.++.+++|||++||++||++|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 33334444555667899999999999999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-61 Score=453.61 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=217.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|++++.||+|+||+||+|+++.+|+.||+|++.+.... .......+|+++|++++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 58999999999999999999999999999999999754321 1233456899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||||+++.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+..... ....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT 163 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence 9999875444444444579999999999999999999999999999999999999854 9999999999876543 3456
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+....+.. +.+
T Consensus 164 ~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--~~~------------------- 221 (263)
T d2j4za1 164 LCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEF------------------- 221 (263)
T ss_dssp TTEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCC-------------------
T ss_pred cCCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC-------------------
Confidence 78999999999985 56789999999999999999999999999888777666532 110
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+++.+++++++||.+||+.||++|||++|+|+||||..
T Consensus 222 ---------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 ---------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 112357899999999999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-60 Score=462.70 Aligned_cols=260 Identities=30% Similarity=0.418 Sum_probs=204.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+|+++|++++|||||++++++.+++.+||||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 46999999999999999999999999999999998665444444566899999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe----CCeEEEeeeccceecCCCCCCc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT----NDVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~----~~~lkL~DFG~a~~~~~~~~~~ 156 (432)
|+|+ |.+.+. ..+.+++.+++.++.||+.||+|||++||+||||||+|||+. ++.+||+|||+|+.........
T Consensus 89 ~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 89 VSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred cCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9864 555554 455899999999999999999999999999999999999995 3489999999999877666667
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+....+...-..+
T Consensus 168 ~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 228 (307)
T d1a06a_ 168 TACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF------------------ 228 (307)
T ss_dssp -----CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC------------------
T ss_pred eeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC------------------
Confidence 789999999999985 6679999999999999999999999999988877766664311110
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
.....+.+|+++.+||++||++||++|||++|+|+||||++....
T Consensus 229 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 273 (307)
T d1a06a_ 229 --------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273 (307)
T ss_dssp --------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC
T ss_pred --------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc
Confidence 012335789999999999999999999999999999999875443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-60 Score=466.15 Aligned_cols=261 Identities=30% Similarity=0.455 Sum_probs=228.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
|++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+++|++++|||||++++++.+.+.+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5789999999999999999999999999999999976543 233456799999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC---CeEEEeeeccceecCCCCCCc
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN---DVLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~---~~lkL~DFG~a~~~~~~~~~~ 156 (432)
||+| +|.+.+....+.+++.+++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.+.......
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 9986 566666566668999999999999999999999999999999999999963 489999999999887766677
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+.+..|......++.
T Consensus 184 ~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 246 (350)
T d1koaa2 184 VTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------------- 246 (350)
T ss_dssp EECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC----------------
T ss_pred eecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------------
Confidence 789999999999985 567899999999999999999999999999988888777542221111
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
..++++++++++||++||++||++|||++|+|+||||+..++.
T Consensus 247 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 247 ----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1224678999999999999999999999999999999976553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-60 Score=453.98 Aligned_cols=254 Identities=26% Similarity=0.499 Sum_probs=220.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|+++.+|+.||||++...... ......+|+++|++++|||||++++++.+.+.+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4799999999999999999999999999999999755432 234567999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~~ 159 (432)
|+|+.+..+..++ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+... ......+
T Consensus 99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 177 (293)
T d1yhwa1 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177 (293)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccc
Confidence 9986665555544 69999999999999999999999999999999999999854 9999999999987543 3456678
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYSE 239 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 239 (432)
||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+.+..+... +.+...
T Consensus 178 gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~~------------------ 237 (293)
T d1yhwa1 178 GTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQ------------------ 237 (293)
T ss_dssp SCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCS------------------
T ss_pred cCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCCCC------------------
Confidence 999999999985 567899999999999999999999999999988877766432 111111
Q ss_pred cCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 240 ILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 240 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.++.+++++++||++||+.||++|||++|+|+||||+.
T Consensus 238 --------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 238 --------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 12357899999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=472.66 Aligned_cols=286 Identities=23% Similarity=0.297 Sum_probs=214.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
|+|+++++||+|+||+||+|+++.+|+.||+|+++............+|+++|++++|||||+++++|.+.+.+||||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 58999999999999999999999999999999998665444455677999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 82 MEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 82 ~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
|+|+.+..+..+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++++ .+||+|||+|+.+... ...+.+
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~ 164 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 164 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---C
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-cccccc
Confidence 9976555554444579999999999999999999997 599999999999999854 9999999999876542 345679
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhhhhhccc-
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRLISISY- 237 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~- 237 (432)
||++|+|||++. +..|+.++||||+||++|||++|+.||.+.+.. .+...+....|.+...................
T Consensus 165 GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T d1s9ja_ 165 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243 (322)
T ss_dssp CSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred CCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence 999999999996 567999999999999999999999999876543 33333333344322211000000000000000
Q ss_pred -----------cccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 238 -----------SEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 238 -----------~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
..........+. ...|.+++|||++||++||++||||+|+|+||||+..+|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence 000000011111 2368999999999999999999999999999999865443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-59 Score=450.48 Aligned_cols=283 Identities=38% Similarity=0.653 Sum_probs=244.4
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
||||+++++||+|+||+||+|+++ +|+.||||+++...... ....+.+|+.+|++++||||+++++++.+.+..|++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 799999999999999999999985 78999999997654321 2345679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
|++.++++..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.+ .+||+|||.|...... .....
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 999999999998888899999999999999999999999999999999999999865 9999999999876542 23455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.++++.|+|||++.+...++.++||||+||++|||++|++||.+.+..+++.++...+|.+....+.......+. ...+
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNF 238 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc-cccc
Confidence 679999999999987788899999999999999999999999999999999999999999988877654433332 3334
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+.......+.++++++|||++||++||++||||+|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 445556666777889999999999999999999999999999999973
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-60 Score=455.22 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=218.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... .......+|+++|++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999754321 22334679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---CCC
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---PPY 155 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---~~~ 155 (432)
||++|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+.+... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999975444444444589999999999999999999999999999999999999865 9999999999987532 234
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+...+|.. +.+
T Consensus 168 ~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--~~~----------------- 227 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEY----------------- 227 (288)
T ss_dssp --CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--TCC-----------------
T ss_pred ccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc--CCC-----------------
Confidence 4578999999999985 56799999999999999999999999999988877776642 111
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQ------ALQHPFFNVETWVPY 291 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~e------lL~Hp~f~~~~~~~~ 291 (432)
.++..+++++++||++||+.||++|||++| +++||||++.+|...
T Consensus 228 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 228 -----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp -----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 122367899999999999999999999987 689999999988643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-60 Score=464.29 Aligned_cols=276 Identities=34% Similarity=0.612 Sum_probs=238.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe------CCEEE
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE------NNELF 76 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~~~ 76 (432)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+++|++++||||++++++|.. ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 599999999999999999999999999999999765422 2479999999999999999999853 34588
Q ss_pred EEEecCCCcHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C-eEEEeeeccceecCC
Q 014039 77 FIFEYMEHNLYHIMR---ERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D-VLKIADFGLARELSS 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~---~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~-~lkL~DFG~a~~~~~ 151 (432)
||||||+++++..+. .....+++.+++.+++||+.||+|||++||+||||||+|||++. + .+||+|||+|+....
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999999998776664 34557999999999999999999999999999999999999984 3 899999999998877
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.......+||+.|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++.++++.+|.+..+.+... ...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~--~~~ 253 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM--NPN 253 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH--CC-
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh--ccc
Confidence 777788899999999999987788999999999999999999999999999999999999999999886654332 233
Q ss_pred hhhccccccCCCCccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 232 LISISYSEILPINLSDII-PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
+....++......+.... +..+++++|||++||++||++||||.|+|+||||++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 344455555555544443 568999999999999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=452.31 Aligned_cols=261 Identities=29% Similarity=0.412 Sum_probs=221.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+++|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999999999999999997543221 2345679999999999999999999999999999
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-----eEEEeeeccceecCC
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-----VLKIADFGLARELSS 151 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-----~lkL~DFG~a~~~~~ 151 (432)
||||||+|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 999999875444444444579999999999999999999999999999999999999743 599999999998877
Q ss_pred CCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 152 MPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 152 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.......++|+.|+|||++. ...|+.++||||+||++|||++|..||.+.+..+.+..+... ....
T Consensus 170 ~~~~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~----------- 235 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--NYEF----------- 235 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCC-----------
T ss_pred CccccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCC-----------
Confidence 66677789999999999985 667999999999999999999999999999888877766421 1110
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETWV 289 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~~ 289 (432)
....+++++.++++||++||+.||++|||++|+|+||||+..+|.
T Consensus 236 -------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 236 -------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp -------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred -------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 011234689999999999999999999999999999999976553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=450.68 Aligned_cols=256 Identities=31% Similarity=0.448 Sum_probs=218.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
+.|++++.||+|+||+||+|+++.+|+.||+|++..... .......+|+++|++++|||||++++++.+.+.+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 359999999999999999999999999999999976432 2334567899999999999999999999999999999999
Q ss_pred CCCcHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCccc
Q 014039 82 MEHNLYH-IMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTEY 158 (432)
Q Consensus 82 ~~~~ll~-~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~~ 158 (432)
|+++.+. .+.+..+++++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+..... ......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 9876554 445556689999999999999999999999999999999999999854 9999999999765432 123457
Q ss_pred cCCccccchhhhc----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 159 VSTRWYRAPEVLL----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 159 ~~t~~y~aPE~l~----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
+||+.|+|||++. ....|+.++||||+||++|||++|.+||.+.+..+.+.++.. +.++..
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~--~~~~~~------------- 235 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPPTL------------- 235 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH--SCCCCC-------------
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CCCCCC-------------
Confidence 8999999999985 345689999999999999999999999999888877776643 111110
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+++++++||++||+.||++|||++|+|+||||+.
T Consensus 236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 ------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 112357899999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-59 Score=461.18 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=225.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 579999999999999999999999999999999986543 2344567899999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEe---CCeEEEeeeccceecCCCCCCcc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVT---NDVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~---~~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|+|+ |.+.+...+.++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 9865 5566666666799999999999999999999999999999999999997 34899999999999887766777
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..+.+..|......++
T Consensus 188 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 248 (352)
T d1koba_ 188 TTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------------------ 248 (352)
T ss_dssp ECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------------------
T ss_pred ccCcccccCHHHHc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence 89999999999984 67799999999999999999999999999999888877754222111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
...++++++++++||++||++||.+|||++|+|+||||+..
T Consensus 249 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 12335789999999999999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-59 Score=452.46 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=220.1
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+|+.++.||+|+||+||+|+++.+|+.||||++........ .....+|+++|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999986543322 2346799999999999999999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCcccc
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYTEYV 159 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~~~~ 159 (432)
||.+++++.+...++++++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.... ....+
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV 172 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccc
Confidence 99999888777777789999999999999999999999999999999999999855 999999999987654 34578
Q ss_pred CCccccchhhhcC--CCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 160 STRWYRAPEVLLQ--SSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 160 ~t~~y~aPE~l~~--~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.+..+.+..+... ..+.
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~--~~~~----------------- 233 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPA----------------- 233 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC-----------------
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCC-----------------
Confidence 9999999999863 346899999999999999999999999998888777766431 1100
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.....+++++++||.+||+.||++|||++|+|+||||..
T Consensus 234 ---------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ---------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 011357899999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-59 Score=453.11 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=225.1
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|++++.||+|+||+||+|+++.+|+.||||++++.... .......+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 68999999999999999999999999999999999754321 2233467899999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
||||.|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.... ....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~ 160 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT 160 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--cccc
Confidence 999998877777777778999999999999999999999999999999999999985 4999999999998764 3456
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++ .+..|+.++||||+||++|||++|+.||.+.+..+...+++. +.+
T Consensus 161 ~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~------------------- 218 (316)
T d1fota_ 161 LCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AEL------------------- 218 (316)
T ss_dssp CCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCC-------------------
T ss_pred ccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCC-------------------
Confidence 7999999999998 466799999999999999999999999999988887777643 111
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
.+++.+++++.++|++||++||.+|+ |++|+|+||||++.+|.
T Consensus 219 ---------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 219 ---------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 12246789999999999999999996 99999999999998884
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-59 Score=458.84 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=221.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
|++|++++.||+|+||.||+|+++.+|+.||||++.+.... .......+|+++|+.++|||||++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 57999999999999999999999999999999999754321 2233467999999999999999999999999999999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCCCcc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPPYTE 157 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~~~~ 157 (432)
|||+.++.+.....+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+.+.. ....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~ 197 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWT 197 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--cccc
Confidence 999987655444444457999999999999999999999999999999999999985 4999999999998765 3456
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhccc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISY 237 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 237 (432)
.+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+....+.+|... .+
T Consensus 198 ~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~------------------- 255 (350)
T d1rdqe_ 198 LCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KV------------------- 255 (350)
T ss_dssp CEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------------------
T ss_pred ccCccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CC-------------------
Confidence 78999999999985 677999999999999999999999999999887777776431 11
Q ss_pred cccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 238 SEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 238 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
..+..+++++.+||++||++||.+|+ |++|+++||||+..+|.
T Consensus 256 ---------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 256 ---------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ---------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ---------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 11246789999999999999999995 99999999999998884
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=448.16 Aligned_cols=282 Identities=34% Similarity=0.610 Sum_probs=236.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC-CeEEEEEEecccccch-HHHHHHHHHHHHHhc---CCCcccccceEEEe-----
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET-YEIVAVKKMKRKFYFW-EECMNLREVKALRKL---NHPNIIKLKEVVRE----- 71 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~----- 71 (432)
++|+++++||+|+||+||+|++..+ ++.||||+++...... ......+|+++|+.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5899999999999999999999765 6789999997543221 122345788777766 79999999999853
Q ss_pred CCEEEEEEecCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceec
Q 014039 72 NNELFFIFEYMEHNLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLAREL 149 (432)
Q Consensus 72 ~~~~~lV~E~~~~~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~ 149 (432)
...+|++|||+.++++..... ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 357899999999987765544 4557999999999999999999999999999999999999986 59999999999877
Q ss_pred CCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 150 SSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 150 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.........+||+.|+|||++. ...|+.++||||+||++|||++|++||.+.+..+++..++..+|.+....++.....
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 6666667789999999999985 677999999999999999999999999999999999999999999887766543332
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVET 287 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~ 287 (432)
.+. .+..............++++++|||++||++||++||||+|+|+||||++.+
T Consensus 246 ~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 246 PRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CGG---GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhh---hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 222 2233344455566778999999999999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-59 Score=452.49 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=219.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc--hHHHHHHHHHHHHH-hcCCCcccccceEEEeCCEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF--WEECMNLREVKALR-KLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~l 77 (432)
|++|+++++||+|+||+||+|+++.+|+.||||++++.... .......+|..++. .++|||||++++++.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 79999999999999999999999999999999999754321 12233456777665 6899999999999999999999
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCC
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPY 155 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~ 155 (432)
|||||+++.+..+....+.+++.+++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+..... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 99999975555555455579999999999999999999999999999999999999864 9999999999876543 344
Q ss_pred ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 156 TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+||+.|+|||++. +..|+.++||||+||++|||++|+.||.+.+..+....+.. +.+.
T Consensus 161 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~---------------- 221 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPF---------------- 221 (320)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCC----------------
T ss_pred cccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC----------------
Confidence 5678999999999995 66799999999999999999999999999988777766632 2221
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD-QALQHPFFNVETWV 289 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~-elL~Hp~f~~~~~~ 289 (432)
+++.+++++.+||++||++||++|||+. |+++||||+..+|.
T Consensus 222 ------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 222 ------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp ------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 1235789999999999999999999995 89999999988774
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=440.25 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=203.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEe--CCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRE--NNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV 78 (432)
|+|++++.||+|+||+||+|+++.+|+.||+|++....... ....+.+|+++|++++|||||++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 78999999999999999999999999999999998655332 33446799999999999999999999854 5668999
Q ss_pred EecCCCc-HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 79 FEYMEHN-LYHIMRE---RQIPFSEGEIRSFMSQMLQGLAHMHRNG-----YFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~---~~~~l~~~~~~~i~~qIl~aL~~LH~~g-----ivHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
||||+++ |.+.+.+ .++.+++..++.++.||+.||+|||+.| |+||||||+|||++.+ .+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999874 5554432 3567999999999999999999999976 9999999999999855 999999999987
Q ss_pred cCCCC-CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh
Q 014039 149 LSSMP-PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT 227 (432)
Q Consensus 149 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~ 227 (432)
+.... .....+||+.|+|||++. ...|+.++|||||||++|||++|++||.+.+..+....+.. +.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--~~---------- 230 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GK---------- 230 (269)
T ss_dssp C-----------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TC----------
T ss_pred cccCCCccccCCCCcccCCHHHHc-CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc--CC----------
Confidence 75432 345678999999999984 66799999999999999999999999999888776666532 11
Q ss_pred hhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014039 228 NISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFF 283 (432)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f 283 (432)
...+...+++++.+||++||+.||++|||++|+|+|||+
T Consensus 231 -----------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 -----------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 112234688999999999999999999999999999995
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-58 Score=458.56 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=216.2
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH--HHHH---HHHHHHHHhcCCCcccccceEEEeCCEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE--ECMN---LREVKALRKLNHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~---~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 75 (432)
|++|+++++||+|+||.||+|+++.+|+.||||++.+...... .... .+|+++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 7899999999999999999999999999999999975432211 1112 3457777788999999999999999999
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP 154 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~ 154 (432)
|+|||||+|+.+..+..+...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.+... .
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~ 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence 999999997554444444457999999999999999999999999999999999999986 59999999999987654 3
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....+||+.|+|||++..+..|+.++|||||||++|||++|.+||.+.+..+...........
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~----------------- 224 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------------- 224 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-----------------
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----------------
Confidence 456789999999999976778999999999999999999999999886554332211111000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPT-----ADQALQHPFFNVETWV 289 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpt-----a~elL~Hp~f~~~~~~ 289 (432)
...++..+++++++||.+||++||++||| |+|+++||||++.+|.
T Consensus 225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 225 ----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp ----------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 01223468999999999999999999999 7999999999998884
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=438.30 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=208.4
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe----CCEEEEE
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE----NNELFFI 78 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV 78 (432)
|++.++||+|+||+||+|+++.+++.||+|++...... .....+.+|+++|++++|||||++++++.+ +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 47888999999999999999999999999999865433 333456799999999999999999999865 4568999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceeEeC--CeEEEeeeccceecCCCCC
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNG--YFHRDLKPENLLVTN--DVLKIADFGLARELSSMPP 154 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~g--ivHrDlkP~NILl~~--~~lkL~DFG~a~~~~~~~~ 154 (432)
|||++++.+..+..+.+.+++..++.++.||+.||+|||++| |+||||||+|||+++ +.+||+|||+|+.... ..
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~ 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SF 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TS
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-Cc
Confidence 999997655544444457999999999999999999999998 999999999999963 4999999999976543 34
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLIS 234 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 234 (432)
....+||+.|+|||++. ..|+.++||||+||++|||++|+.||.+.....++.+.+.. +..+
T Consensus 170 ~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~--------------- 231 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------------- 231 (270)
T ss_dssp BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------------
T ss_pred cCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC---------------
Confidence 45678999999999884 35999999999999999999999999887666555443210 1000
Q ss_pred ccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 235 ISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
..+....++++.+||++||++||++|||++|+|+||||+
T Consensus 232 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011235788999999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.5e-58 Score=435.76 Aligned_cols=257 Identities=32% Similarity=0.494 Sum_probs=220.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--------HHHHHHHHHHHHHhcC-CCcccccceEEEeC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--------EECMNLREVKALRKLN-HPNIIKLKEVVREN 72 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--------~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~ 72 (432)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ......+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 79999999999999999999999999999999997643221 1123568999999996 99999999999999
Q ss_pred CEEEEEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 73 NELFFIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 73 ~~~~lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
+.+|||||||++ +|.+.+..+ +++++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999986 566666554 589999999999999999999999999999999999999855 99999999999887
Q ss_pred CCCCCccccCCccccchhhhc-----CCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLL-----QSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
........+||+.|+|||.+. ....|+.++||||+||++|||++|+.||.+.+..+....+... .....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~---- 235 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFG---- 235 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCC----
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCC----
Confidence 766667789999999999985 2346799999999999999999999999999988877766431 11100
Q ss_pred hhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
....+++|+++++||.+||++||++|||++|+|+||||++
T Consensus 236 --------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 --------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp --------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred --------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1122468999999999999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-58 Score=450.02 Aligned_cols=281 Identities=35% Similarity=0.580 Sum_probs=234.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeCC------E
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVRENN------E 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~ 74 (432)
++|+++++||+|+||+||+|+++.+|+.||||++++..... ......+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 58999999999999999999999999999999998654332 2345679999999999999999999997543 5
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+||||+++.+...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....
T Consensus 98 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-- 173 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173 (346)
T ss_dssp CEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC--
Confidence 799999997666665543 369999999999999999999999999999999999999855 999999999988754
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
..+..+||+.|+|||++.+...++.++||||+||++|||++|.+||.+.+..+.+..+....|.++...+.... .....
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 34667899999999999877788999999999999999999999999999999999999999988755332211 11122
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
.....+......+..+.++++++++|||++||++||++||||+|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 223455556667777888999999999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=449.20 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=223.9
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
.+||++++.||+|+||+||+|+++.+|+.||+|+++.+.. ......+|+++|++++|||||++++++.+++.+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4799999999999999999999999999999999976542 33446799999999999999999999999999999999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC---eEEEeeeccceecCCCCCCc
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND---VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~---~lkL~DFG~a~~~~~~~~~~ 156 (432)
||+| +|.+.+...+..+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++.........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 9986 5666666566689999999999999999999999999999999999999743 89999999999887666667
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++|+.|+|||++. ...|+.++||||+||++|+|++|.+||.+.+..+....|......++
T Consensus 162 ~~~~t~~y~ape~~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 223 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----------------- 223 (321)
T ss_dssp EEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred ccccccccccchhcc-CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 778999999999884 66799999999999999999999999999998888877754211110
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
...++.+|+++++||++||++||++|||++|+|+||||+.
T Consensus 224 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 224 ---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1123467999999999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=432.68 Aligned_cols=284 Identities=36% Similarity=0.627 Sum_probs=244.0
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 79 (432)
|+||+++++||+|+||+||+|+++.+|+.||||+++..... .......+|+.+|+.++||||+++++++.+....++|+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 79999999999999999999999999999999999755433 23445679999999999999999999999999999999
Q ss_pred ecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC-CCCcc
Q 014039 80 EYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-PPYTE 157 (432)
Q Consensus 80 E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-~~~~~ 157 (432)
|++.++.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.+ .+||+|||.|+..... .....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 999999888888888899999999999999999999999999999999999999854 9999999999987643 33455
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPI-FPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~p-F~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..++++|+|||++.....++.++||||+||++|||++|..| |.+.+..+++.++....+.+....+.............
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 67889999999997777789999999999999999998766 67788888899999999998887776554444333322
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
... .........+.++++++|||++||++||.+||||+|+|+||||++
T Consensus 241 ~~~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 241 MYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccc-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 222 123444556788999999999999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=443.48 Aligned_cols=285 Identities=36% Similarity=0.587 Sum_probs=230.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEe--------
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRE-------- 71 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-------- 71 (432)
++||+++++||+|+||+||+|+++.+|+.||||++...... .......+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47999999999999999999999999999999998654332 223346799999999999999999998754
Q ss_pred CCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecC
Q 014039 72 NNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELS 150 (432)
Q Consensus 72 ~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~ 150 (432)
++.+|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 45689999999999998888777789999999999999999999999999999999999999855 99999999998765
Q ss_pred CC-----CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchh
Q 014039 151 SM-----PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPE 225 (432)
Q Consensus 151 ~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~ 225 (432)
.. ......+||++|+|||++.+...|+.++||||+||++|||++|++||.+.+..+.+..+....|.+....+..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 32 2344568999999999998777899999999999999999999999999999999999999999887665543
Q ss_pred hhhhhhhhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 226 ATNISRLISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......................+ ...+++++|||.+||++||++||||+|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 322222222211111111111111 124788999999999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-57 Score=429.31 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=207.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-----HHHHHHHHHHHHHhcC--CCcccccceEEEeCCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-----EECMNLREVKALRKLN--HPNIIKLKEVVRENNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~ 74 (432)
++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ......+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 58999999999999999999999999999999997543221 1122458999999996 8999999999999999
Q ss_pred EEEEEecCCC-c-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC--CeEEEeeeccceecC
Q 014039 75 LFFIFEYMEH-N-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN--DVLKIADFGLARELS 150 (432)
Q Consensus 75 ~~lV~E~~~~-~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~--~~lkL~DFG~a~~~~ 150 (432)
.|+||||+.+ + +.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999975 3 4444444 457999999999999999999999999999999999999983 389999999998765
Q ss_pred CCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 151 SMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 151 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
. ......+||+.|+|||++.+...++.++||||+||++|||++|..||.+.+. +.. +..
T Consensus 163 ~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--~~~------------ 221 (273)
T d1xwsa_ 163 D-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQV------------ 221 (273)
T ss_dssp S-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCC------------
T ss_pred c-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--ccc------------
Confidence 4 3456678999999999997666678889999999999999999999976421 110 110
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.+.+.+|+++++||++||++||++|||++|+|+||||++
T Consensus 222 ----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 222 ----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp ----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 112468999999999999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-56 Score=437.02 Aligned_cols=280 Identities=28% Similarity=0.470 Sum_probs=225.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe--CCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE--NNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--~~~~~lV 78 (432)
++|+++++||+|+||+||+|+++.+|+.||||+++... .....+|+++|+++ +||||+++++++.. ...+|+|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 68999999999999999999999999999999997543 23456899999999 59999999999974 4569999
Q ss_pred EecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-C-eEEEeeeccceecCCCCCCc
Q 014039 79 FEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-D-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 79 ~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
|||+.++.+..+ .+.+++..++.+++||+.||+|||++||+||||||+|||++. + .+||+|||+|+.........
T Consensus 111 ~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 111 FEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp EECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred EeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 999998765443 346999999999999999999999999999999999999984 4 79999999999888777778
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCCCCchhhhhhhhhh--
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPG-DSEIDQLYKVCCILGAPDWTAFPEATNISRLI-- 233 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~-~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~-- 233 (432)
..++|+.|+|||++.+...|+.++||||+||++|||++|..||.. .+..++...+...+|.+....+..........
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 889999999999998777899999999999999999999998865 45667788888888764332221111000000
Q ss_pred hccccccCCCCcc-----ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014039 234 SISYSEILPINLS-----DIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVETW 288 (432)
Q Consensus 234 ~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~~~ 288 (432)
...........+. .....++++++|||++||++||++||||+|+|+||||+...|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0000000111111 112347899999999999999999999999999999998765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-56 Score=437.56 Aligned_cols=282 Identities=36% Similarity=0.619 Sum_probs=233.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeC-----CEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVREN-----NELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (432)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+|+++|++++||||+++++++... ..+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 57999999999999999999999999999999997654434445567999999999999999999998654 3467
Q ss_pred EEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---
Q 014039 77 FIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM--- 152 (432)
Q Consensus 77 lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~--- 152 (432)
+++++++++|.+.+..+ .+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+.....
T Consensus 88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 77777777888777654 69999999999999999999999999999999999999864 9999999999876432
Q ss_pred -CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhh
Q 014039 153 -PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NIS 230 (432)
Q Consensus 153 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~ 230 (432)
......+||+.|+|||++.....|+.++||||+||++|||++|.+||.+.+..++...+...++.+......... ...
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 224557899999999998777788999999999999999999999999999999999999888887755322111 111
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
.......+.....++...+++++.++++||.+||++||++||||+|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1222344455556666778889999999999999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-57 Score=440.65 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=209.3
Q ss_pred CCCeeEee-eEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe----CCE
Q 014039 1 MERYKILE-ELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE----NNE 74 (432)
Q Consensus 1 ~~~Y~~~~-~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~~ 74 (432)
+++|++++ .||+|+||+||+|+++.+|+.||||++++.. ...+|++++.++ +|||||+++++|++ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 47899986 5999999999999999999999999997532 256899987655 89999999999875 467
Q ss_pred EEEEEecCCC-cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeecccee
Q 014039 75 LFFIFEYMEH-NLYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARE 148 (432)
Q Consensus 75 ~~lV~E~~~~-~ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~ 148 (432)
+|||||||+| +|.+.+..+ ...+++.+++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 8999999986 566666554 347999999999999999999999999999999999999974 2799999999998
Q ss_pred cCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 149 LSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 149 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
..........+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+.......+........
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~--------- 233 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------- 233 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS---------
T ss_pred ccCCCccccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC---------
Confidence 8777777788999999999988 466799999999999999999999999988766544433321111000
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNVE 286 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~~ 286 (432)
..++ ...+..+|+++++||++||++||++|||+.|+|+||||...
T Consensus 234 ------~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 ------YEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ------SSCC-------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ------CCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0000 01123578999999999999999999999999999999753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=437.65 Aligned_cols=281 Identities=35% Similarity=0.570 Sum_probs=218.7
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchH-HHHHHHHHHHHHhcCCCcccccceEEEe------CC
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWE-ECMNLREVKALRKLNHPNIIKLKEVVRE------NN 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~ 73 (432)
+++|+++++||+|+||+||+|+++.+|+.||||++.+...... .....+|+.+|++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4789999999999999999999999999999999987654433 3346799999999999999999999953 47
Q ss_pred EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
.+|+||||+.+++++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999999888763 368999999999999999999999999999999999999955 9999999999888776
Q ss_pred CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 153 PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 153 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......++|+.|+|||++. +..++.++||||+||+++||++|++||.+.+..++..+++..++.+....+.........
T Consensus 173 ~~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 6777889999999999985 568999999999999999999999999999999999999999988765544322111111
Q ss_pred hhccccccCCCCcccc------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDI------------IPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~------------~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
................ ....+++++|||++||++||++||||+|+|+||||++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 1111111111111111 1124778999999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=433.67 Aligned_cols=280 Identities=36% Similarity=0.607 Sum_probs=227.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch-HHHHHHHHHHHHHhcCCCcccccceEEEeC------CE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW-EECMNLREVKALRKLNHPNIIKLKEVVREN------NE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 74 (432)
+||+++++||+|+||+||+|+++.+|+.||||++.+..... ......+|+++|++++|||||++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 68999999999999999999999999999999998655433 334467999999999999999999998532 23
Q ss_pred EEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC
Q 014039 75 LFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP 153 (432)
Q Consensus 75 ~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~ 153 (432)
+|+++++..|+|.+.+ .. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+|++|||+|.....
T Consensus 98 ~~i~~~~~gg~L~~~~-~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIV-KC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CEEEEECCSEEHHHHH-TT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEEEEeecCCchhhhc-cc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 4555444445565554 33 369999999999999999999999999999999999999855 999999999976644
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhh-hhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEAT-NISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~-~~~~~ 232 (432)
.....+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+....+.+......... .....
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 34567899999999998877788999999999999999999999999999999999999998887654322111 11122
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFNV 285 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~~ 285 (432)
............+...+.+++++++|||++||++||++||||+|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 22334455556666677889999999999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-54 Score=411.38 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=204.6
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccch--HHHHHHHHHHHHHhcCCCcccccceEEEeCC----EE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFW--EECMNLREVKALRKLNHPNIIKLKEVVRENN----EL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~ 75 (432)
++|++++.||+|+||+||+|+++.+|+.||||+++...... ....+.+|+++|++++||||+++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999999999999999998654332 2334679999999999999999999987543 48
Q ss_pred EEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC--
Q 014039 76 FFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM-- 152 (432)
Q Consensus 76 ~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~-- 152 (432)
||||||++|+.+.......+++++.+++.++.||+.||+|||++||+||||||+|||++.+ .++|+|||.++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 9999999986655555555689999999999999999999999999999999999999855 9999999998765432
Q ss_pred --CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 153 --PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 153 --~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
......+||+.|+|||++. +..|+.++||||+||++|||++|.+||.+.+..+.+.+++.. .+.
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~--~~~----------- 232 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DPI----------- 232 (277)
T ss_dssp ------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCC-----------
T ss_pred cccccccccCcccccCHHHHc-CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc--CCC-----------
Confidence 2345678999999999984 667999999999999999999999999999888777766431 111
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQHPFFN 284 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~Hp~f~ 284 (432)
......+.+|+++.+||++||++||++||+..+.|.|+|.+
T Consensus 233 -------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 -------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11122357899999999999999999999555555566553
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-53 Score=411.46 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=198.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe---EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE---IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.+.||+|+||+||+|+++.+++ .||||++...........+.+|+++|++++|||||++++++.+.+.+|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 579999999999999999999987664 58999987665544555678999999999999999999999999999999
Q ss_pred EecCCCcHHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCC-
Q 014039 79 FEYMEHNLYHI-MRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPY- 155 (432)
Q Consensus 79 ~E~~~~~ll~~-~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~- 155 (432)
||||+++.+.. +....+.+++.++..++.||+.||+|||++||+||||||+||||+.+ .+||+|||+|+........
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 99999765554 55556679999999999999999999999999999999999999865 9999999999876543221
Q ss_pred -----ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 156 -----TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 156 -----~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
....+|+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------ 252 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------------ 252 (299)
T ss_dssp ----------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------------
T ss_pred eeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 2245789999999985 5679999999999999999998 89999998887766655321100
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....++.++.+||.+||+.||++|||+.|++++
T Consensus 253 -----------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 -----------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123578899999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=420.30 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=214.3
Q ss_pred CCCeeEeeeEeecCceEEEEEEE---cCCCeEEEEEEecccccc---hHHHHHHHHHHHHHhcCC-CcccccceEEEeCC
Q 014039 1 MERYKILEELGDGTCGCVYKAFN---VETYEIVAVKKMKRKFYF---WEECMNLREVKALRKLNH-PNIIKLKEVVRENN 73 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~---~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~ 73 (432)
|++|+++++||+|+||+||+|++ +.+|+.||||++++.... .......+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 57899999999999999999987 457999999999754321 122335689999999966 89999999999999
Q ss_pred EEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC
Q 014039 74 ELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM 152 (432)
Q Consensus 74 ~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~ 152 (432)
.+|++|||+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.+...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999875555444444578999999999999999999999999999999999999855 9999999999876442
Q ss_pred C--CCccccCCccccchhhhcCCC-CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 153 P--PYTEYVSTRWYRAPEVLLQSS-SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 153 ~--~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
. ......|++.|+|||++.... .++.++||||+||++|||++|..||.+.+..+....+........
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~---------- 252 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---------- 252 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----------
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC----------
Confidence 2 234578999999999996543 578899999999999999999999998876555444432211000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRP-----TADQALQHPFFNVETWV 289 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rp-----ta~elL~Hp~f~~~~~~ 289 (432)
..++..+++++++||++||++||++|+ ||+|+|+||||+..+|.
T Consensus 253 ----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 253 ----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 112346899999999999999999999 58999999999988763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=415.72 Aligned_cols=250 Identities=28% Similarity=0.380 Sum_probs=205.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe-----EEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE-----IVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|+++++||+|+||+||+|++..+++ .||+|++.............+|+.+|+++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 579999999999999999999876553 69999997655444455577999999998 899999999999999999
Q ss_pred EEEEecCCC-cHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcee
Q 014039 76 FFIFEYMEH-NLYHIMRERQ----------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLL 132 (432)
Q Consensus 76 ~lV~E~~~~-~ll~~~~~~~----------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NIL 132 (432)
|+|||||++ +|.+.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 999999986 5555554432 24899999999999999999999999999999999999
Q ss_pred EeCC-eEEEeeeccceecCCCCCC---ccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHH
Q 014039 133 VTND-VLKIADFGLARELSSMPPY---TEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQ 207 (432)
Q Consensus 133 l~~~-~lkL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~ 207 (432)
++.+ .+||+|||+|+........ ...+||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+.
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 9865 9999999999876554332 3456799999999985 5679999999999999999997 8999999877766
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+.+++..-..+ +.+..+++++.+||.+||+.||++|||++||++|
T Consensus 276 ~~~~~~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 276 FYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66654311111 1224678999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=405.01 Aligned_cols=251 Identities=26% Similarity=0.307 Sum_probs=203.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEeccccc-chHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFY-FWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+++++||+|+||+||+|+.. ..||||+++.... ......+.+|+++|++++|||||++++++.+ +.+|+|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 57999999999999999999643 3599999975433 2334456799999999999999999998754 56899999
Q ss_pred cCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCC---CCC
Q 014039 81 YMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSM---PPY 155 (432)
Q Consensus 81 ~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~---~~~ 155 (432)
||++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+..... ...
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9996 5666666666689999999999999999999999999999999999999866 9999999999876432 233
Q ss_pred ccccCCccccchhhhcCC--CCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 156 TEYVSTRWYRAPEVLLQS--SSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 156 ~~~~~t~~y~aPE~l~~~--~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
....||+.|+|||++... ..|+.++|||||||++|||++|+.||.+.+..+++..++..--.+
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------------- 228 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--------------- 228 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC---------------
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 456899999999998532 358999999999999999999999999988777666554321111
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+..+..++++++.+||.+||+.||++|||++|+++|
T Consensus 229 ---------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 229 ---------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11223445789999999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=400.91 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=197.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++++.||+|+||+||+|+++ +++.||||+++..... ...+.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 58999999999999999999876 5678999999865433 33467999999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Ccc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTE 157 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~~ 157 (432)
++++ |.+.+......+++..+..++.||+.||+|||++||+||||||+|||++++ .+||+|||+|+....... ...
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9865 555566666779999999999999999999999999999999999999965 999999999987654322 234
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..||+.|+|||++. ...|+.++|||||||++|||++ |.++|.+.+..+....+.. |...
T Consensus 162 ~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--~~~~----------------- 221 (263)
T d1sm2a_ 162 TKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--GFRL----------------- 221 (263)
T ss_dssp ---CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH--TCCC-----------------
T ss_pred eecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh--cCCC-----------------
Confidence 57899999999985 5679999999999999999998 6788877776666555532 1100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+..+++++.+||.+||+.||++|||++|+++|
T Consensus 222 ----------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ----------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123568899999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=402.95 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=208.1
Q ss_pred CCeeEeee-EeecCceEEEEEEEcC--CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEE-LGDGTCGCVYKAFNVE--TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~-IG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|.+.+. ||+|+||+||+|.++. ++..||||+++..........+.+|+++|++++|||||++++++.+ +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 46888884 9999999999998754 4557999999876554455567899999999999999999999875 458999
Q ss_pred EecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--
Q 014039 79 FEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP-- 154 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~-- 154 (432)
||||+++ |.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999975 445555556689999999999999999999999999999999999999854 999999999998754322
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+....+.. |..
T Consensus 167 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~--~~~------------- 230 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--GKR------------- 230 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--TCC-------------
T ss_pred ccccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CCC-------------
Confidence 23456889999999985 5679999999999999999998 9999999887666555421 110
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA---LQHPFFN 284 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~el---L~Hp~f~ 284 (432)
.+.++.+++++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 231 --------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 --------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12234688999999999999999999999877 6788775
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-53 Score=405.24 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=203.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.++||+|+||+||+|+++.+|+.||||+++..... ...+.+|+++|++++|||||++++++.+.+.+|+||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4799999999999999999999999999999999765443 33467999999999999999999999999999999999
Q ss_pred CCC-cHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Cc
Q 014039 82 MEH-NLYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YT 156 (432)
Q Consensus 82 ~~~-~ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~ 156 (432)
|++ ++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||||+++ .+||+|||+|+....... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 986 55565554 34579999999999999999999999999999999999999865 999999999987654322 22
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
...|++.|+|||++. ...|+.++||||+||++|||++|..||......+++.+++.. +.
T Consensus 175 ~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~~------------------- 233 (287)
T d1opja_ 175 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DY------------------- 233 (287)
T ss_dssp TEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TC-------------------
T ss_pred cccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-CC-------------------
Confidence 345788999999985 567999999999999999999965554443334444433211 00
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......+++++.+||.+||+.||++|||++|+++
T Consensus 234 --------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 --------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01123468899999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=396.75 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=209.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||+||+|+++ ++..||||++++..... ..+.+|++++++++||||+++++++.+++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH--HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH--HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 68999999999999999999984 77889999998755432 3467999999999999999999999999999999999
Q ss_pred CCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC--Ccc
Q 014039 82 MEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP--YTE 157 (432)
Q Consensus 82 ~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~--~~~ 157 (432)
++++ +...+......+++..++.++.||++||+|||++||+||||||+|||++++ .+||+|||+|+....... ...
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9865 555556666689999999999999999999999999999999999999975 999999999987654332 334
Q ss_pred ccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcc
Q 014039 158 YVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISIS 236 (432)
Q Consensus 158 ~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 236 (432)
..+|+.|+|||++. ...|+.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 161 ~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------------- 220 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------------- 220 (258)
T ss_dssp SCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------------
T ss_pred cCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 67899999999985 5678999999999999999998 89999999877766655321100
Q ss_pred ccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 237 YSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+..+++++.+||++||+.||++|||++|+++|
T Consensus 221 ----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-53 Score=400.27 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=204.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|+++++||+|+||+||+|.++ ++..||||+++..... ...+.+|+++|++++|||||++++++.+ +.+|+||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 57999999999999999999875 5778999999765433 3346799999999999999999998755 567999999
Q ss_pred CCCcHHHHHH-H-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEHNLYHIMR-E-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~~ll~~~~-~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
++++.+..+. . ...++++..+..++.||++||.|||++||+||||||+||||+++ .+||+|||+|+...... ...
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 9876554433 2 23369999999999999999999999999999999999999966 99999999999875432 234
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...||+.|+|||++. ...|+.++|||||||++|||++ |.++|.+.+..+.+..+.. |..
T Consensus 169 ~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~--~~~----------------- 228 (272)
T d1qpca_ 169 GAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYR----------------- 228 (272)
T ss_dssp TCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TCC-----------------
T ss_pred ccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--cCC-----------------
Confidence 567899999999985 5678999999999999999999 5677777766665555421 100
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ--HPFFN 284 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~--Hp~f~ 284 (432)
......+++++.+||.+||+.||++|||++|+++ |+||.
T Consensus 229 ----------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 ----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0112467899999999999999999999999998 78874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=401.17 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=198.1
Q ss_pred eeEeecCceEEEEEEEc--CCCeEEEEEEecccccc-hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEecCCC
Q 014039 8 EELGDGTCGCVYKAFNV--ETYEIVAVKKMKRKFYF-WEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEYMEH 84 (432)
Q Consensus 8 ~~IG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 84 (432)
++||+|+||+||+|.+. .+++.||||+++..... .....+.+|+++|++++|||||++++++.++ ..||||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 45688999999754332 2334577999999999999999999998654 57899999998
Q ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCCC----Ccccc
Q 014039 85 NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMPP----YTEYV 159 (432)
Q Consensus 85 ~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~~----~~~~~ 159 (432)
+.+..+......+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.+..... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 666555555668999999999999999999999999999999999999985 5999999999987654322 23356
Q ss_pred CCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhcccc
Q 014039 160 STRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISISYS 238 (432)
Q Consensus 160 ~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 238 (432)
||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+....+.. |..
T Consensus 172 gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--~~~-------------------- 228 (277)
T d1xbba_ 172 WPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GER-------------------- 228 (277)
T ss_dssp CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TCC--------------------
T ss_pred CCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--CCC--------------------
Confidence 899999999985 5678999999999999999997 8999999887665554421 110
Q ss_pred ccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 014039 239 EILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQA---LQHPFFN 284 (432)
Q Consensus 239 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~el---L~Hp~f~ 284 (432)
...+..++.++.+||.+||+.||++|||++++ |+|+|++
T Consensus 229 -------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 11234678999999999999999999999998 5676654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=397.24 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=198.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCC---CeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVET---YEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++++.||+|+||.||+|++..+ +..||||+++............+|+++|++++|||||++++++. ++.+|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 5899999999999999999998754 45689999876555445556789999999999999999999986 4678999
Q ss_pred EecCCCc-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC-CeEEEeeeccceecCCCC--C
Q 014039 79 FEYMEHN-LYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN-DVLKIADFGLARELSSMP--P 154 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~-~~lkL~DFG~a~~~~~~~--~ 154 (432)
|||++++ +.+.+....+.+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||+|+...... .
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~ 165 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCccee
Confidence 9999865 55555666678999999999999999999999999999999999999985 599999999998765432 2
Q ss_pred CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhh
Q 014039 155 YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLI 233 (432)
Q Consensus 155 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~ 233 (432)
.....||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+....+.. |.
T Consensus 166 ~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~--~~---------------- 226 (273)
T d1mp8a_ 166 ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--GE---------------- 226 (273)
T ss_dssp -----CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--TC----------------
T ss_pred ccceecCcccchhhHhc-cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC----------------
Confidence 34456899999999985 5679999999999999999997 8999999888776665532 11
Q ss_pred hccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 234 SISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..++++++++++.+||.+||+.||++|||+.|+++|
T Consensus 227 -----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 -----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012335789999999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=401.35 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=200.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCe----EEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYE----IVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
++|+++++||+|+||+||+|.+..+|+ .||+|+++..........+.+|+++|++++|||||++++++.++. .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence 479999999999999999999988876 588888875544334455789999999999999999999998765 556
Q ss_pred EEecCC-CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-
Q 014039 78 IFEYME-HNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~-~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~- 154 (432)
++|++. +++++.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 666665 67888888877889999999999999999999999999999999999999865 999999999987654332
Q ss_pred --CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhh
Q 014039 155 --YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISR 231 (432)
Q Consensus 155 --~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~ 231 (432)
.....||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+....+... ..+
T Consensus 168 ~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~------------- 232 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERL------------- 232 (317)
T ss_dssp -------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCC-------------
T ss_pred ccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC-------------
Confidence 23346899999999986 5679999999999999999998 89999887765544433211 000
Q ss_pred hhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 232 LISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...+.+++++.+||.+||+.||++|||+.|+++|
T Consensus 233 ---------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1224678999999999999999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=391.55 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=196.8
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC----eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY----EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (432)
+.|+..+.||+|+||+||+|.++.++ ..||||++...........+.+|+++|++++|||||++++++.+.+.+++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 56999999999999999999987654 46999999866555455567799999999999999999999999999999
Q ss_pred EEecCCCcHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC-
Q 014039 78 IFEYMEHNLY-HIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP- 154 (432)
Q Consensus 78 V~E~~~~~ll-~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~- 154 (432)
||||+.++++ +.+....+.+++.++..++.||+.||+|||++||+||||||+||||+++ .+||+|||+|+.+.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 9999987644 4555666789999999999999999999999999999999999999966 999999999987654321
Q ss_pred ---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhh
Q 014039 155 ---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNIS 230 (432)
Q Consensus 155 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~ 230 (432)
.....||+.|+|||++. ...|+.++|||||||++|||++| .++|.+.+..+....+... ..
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~------------- 231 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FR------------- 231 (283)
T ss_dssp -------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CC-------------
T ss_pred ceEeccCCCCccccCHHHHc-cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CC-------------
Confidence 23356899999999885 66899999999999999999985 5556555554444333210 00
Q ss_pred hhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 231 RLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
......++.++.+||.+||+.||++|||+.|+++
T Consensus 232 ---------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ---------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0122357889999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=390.71 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=200.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEEEEEec
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELFFIFEY 81 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 81 (432)
++|++.+.||+|+||+||+|+++.+ +.||||+++..... ...+.+|+.+|++++|||||++++++.+ +.+|+||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 6899999999999999999998765 56999999765433 2346799999999999999999999855 567999999
Q ss_pred CCCc-HHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC--CCc
Q 014039 82 MEHN-LYHIMRE-RQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP--PYT 156 (432)
Q Consensus 82 ~~~~-ll~~~~~-~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~--~~~ 156 (432)
++++ +...+.. ..+.+++.++..++.||+.||+|||++||+||||||+||||+++ .+||+|||+|+.+.... ...
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9976 4444443 33469999999999999999999999999999999999999865 99999999998764432 233
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+|+.|+|||++. ...++.++||||+||++|||++ |.++|.+....+.+..+.....
T Consensus 173 ~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~------------------- 232 (285)
T d1fmka3 173 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------- 232 (285)
T ss_dssp ---CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred cccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------------------
Confidence 467899999999985 6678999999999999999999 5666777766666555432110
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ--HPFFNV 285 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~--Hp~f~~ 285 (432)
..+.+.++.++.+||.+||+.||++|||++++++ |+||..
T Consensus 233 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1123467899999999999999999999999998 889975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=392.86 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=195.0
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEe-CCE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRE-NNE 74 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (432)
++|+++++||+|+||.||+|.+.. +++.||||+++............+|..++.++ +|+||+.+++++.. +..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 579999999999999999999754 45789999998665555555567888888887 68999999998755 457
Q ss_pred EEEEEecCCCc-HHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-e
Q 014039 75 LFFIFEYMEHN-LYHIMRER---------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-V 137 (432)
Q Consensus 75 ~~lV~E~~~~~-ll~~~~~~---------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~ 137 (432)
+++|||||+++ +.+.+..+ ...+++.+++.++.||++||.|||++||+||||||+||||+++ .
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 89999999865 55555432 2358999999999999999999999999999999999999865 9
Q ss_pred EEEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 014039 138 LKIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCC 213 (432)
Q Consensus 138 lkL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~ 213 (432)
+||+|||+|+...... .....+||+.|+|||++. ...|+.++||||+||++|||++| .+||.+.+..+.+..++.
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999998764432 234568999999999985 56789999999999999999986 678988776665555432
Q ss_pred HhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 214 ILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 214 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.--.+ .....+++++.+||.+||+.||++|||++|+++|
T Consensus 252 ~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21111 1234678999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=395.01 Aligned_cols=249 Identities=29% Similarity=0.366 Sum_probs=203.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeE--EEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEEEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEI--VAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 78 (432)
++|++.++||+|+||+||+|+++.+|.. ||||+++............+|+++|+++ +|||||++++++.+++.+|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999988875 6788876554444455578999999999 799999999999999999999
Q ss_pred EecCCCc-HHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEe
Q 014039 79 FEYMEHN-LYHIMRER---------------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIA 141 (432)
Q Consensus 79 ~E~~~~~-ll~~~~~~---------------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~ 141 (432)
|||++++ +.+.+..+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999965 55554322 3579999999999999999999999999999999999999865 99999
Q ss_pred eeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCC
Q 014039 142 DFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDW 220 (432)
Q Consensus 142 DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~ 220 (432)
|||+|+............+|..|+|||.+. ...|+.++|||||||++|||++| .+||.+.+..+....+.. |.
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~--~~--- 243 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--GY--- 243 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG--TC---
T ss_pred cccccccccccccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--cC---
Confidence 999998776555555667999999999985 56789999999999999999996 567888776665544421 00
Q ss_pred CCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 221 TAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+.+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 244 ------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 ------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011234678999999999999999999999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-50 Score=388.74 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=206.1
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||+||+|+.+ .+++.||||+++..........+.+|+++|++++||||+++++++.+.+..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 57999999999999999999875 4668899999986655445556789999999999999999999999999999
Q ss_pred EEEecCCC-cHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcee
Q 014039 77 FIFEYMEH-NLYHIMRERQ-----------------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLL 132 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~-----------------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NIL 132 (432)
+||||+++ ++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 99999986 4555554321 24899999999999999999999999999999999999
Q ss_pred EeCC-eEEEeeeccceecCCC---CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHH
Q 014039 133 VTND-VLKIADFGLARELSSM---PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQ 207 (432)
Q Consensus 133 l~~~-~lkL~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~ 207 (432)
++.+ .+||+|||+|+..... ......++|+.|+|||++. ...|+.++|||||||++|||++| .+||.+.+..+.
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 9966 9999999999865432 2234567899999999985 66799999999999999999998 578988888776
Q ss_pred HHHHHHHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 208 LYKVCCILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 208 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
+..+.. |. ...++..+++++.+||.+||+.||++|||+.|+++
T Consensus 252 ~~~v~~--~~---------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRD--GN---------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHT--TC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHc--CC---------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 665531 11 11223468899999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=382.97 Aligned_cols=248 Identities=27% Similarity=0.339 Sum_probs=195.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-CCC--eEEEEEEecccccc--hHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-ETY--EIVAVKKMKRKFYF--WEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-~~~--~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|++++.||+|+||.||+|+.. .++ ..||||++++.... .....+.+|+++|++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999864 333 36899998754322 223456799999999999999999999976 4678
Q ss_pred EEEecCCC-cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCC
Q 014039 77 FIFEYMEH-NLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPP 154 (432)
Q Consensus 77 lV~E~~~~-~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~ 154 (432)
+||||+++ ++.+.+..+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999985 5666666666689999999999999999999999999999999999999855 999999999998754332
Q ss_pred ----CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhh
Q 014039 155 ----YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNI 229 (432)
Q Consensus 155 ----~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~ 229 (432)
.....++..|+|||++. ...++.++|||||||++|||++ |.+||.+.+..+....+...--.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~------------ 233 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------------ 233 (273)
T ss_dssp EEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC------------
T ss_pred cceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC------------
Confidence 23446788999999985 5679999999999999999998 89999999888877766321000
Q ss_pred hhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 230 SRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.+..+.++.++.+||.+||+.||++|||+.|+++
T Consensus 234 ----------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 ----------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0123467899999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=385.88 Aligned_cols=248 Identities=29% Similarity=0.401 Sum_probs=200.9
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCC-------eEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCC
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETY-------EIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENN 73 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 73 (432)
++|++++.||+|+||.||+|++..++ ..||||+++............+|...+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 68999999999999999999876554 469999998766555556677899999888 8999999999999999
Q ss_pred EEEEEEecCCCc-HHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 74 ELFFIFEYMEHN-LYHIMRERQ---------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 74 ~~~lV~E~~~~~-ll~~~~~~~---------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
.+|+||||+.++ +.+.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 999999999865 555554332 358999999999999999999999999999999999999865
Q ss_pred eEEEeeeccceecCCCC---CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMP---PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||+++...... .....++|+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~ 251 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 99999999998765432 234567899999999985 5689999999999999999997 799998877655443331
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
. |.. ......+++++.+||.+||++||++|||+.|+++
T Consensus 252 ~--~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 E--GHR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp T--TCC---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c--CCC---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 1 110 0122467899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=383.68 Aligned_cols=249 Identities=29% Similarity=0.386 Sum_probs=208.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEc-----CCCeEEEEEEecccccchHHHHHHHHHHHHHhc-CCCcccccceEEEeCCEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNV-----ETYEIVAVKKMKRKFYFWEECMNLREVKALRKL-NHPNIIKLKEVVRENNEL 75 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (432)
++|++.++||+|+||.||+|++. .+++.||||+++..........+.+|+.+++++ +|||||++++++.+...+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57999999999999999999863 567889999998766555555677999999999 799999999999999999
Q ss_pred EEEEecCCCcHH-HHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-
Q 014039 76 FFIFEYMEHNLY-HIMRERQ-----------------IPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND- 136 (432)
Q Consensus 76 ~lV~E~~~~~ll-~~~~~~~-----------------~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~- 136 (432)
|+|||||+++.+ +.+.... ..+++..+..++.||+.||+|||++|++||||||+|||++.+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 999999987544 4444321 258999999999999999999999999999999999999855
Q ss_pred eEEEeeeccceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014039 137 VLKIADFGLARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVC 212 (432)
Q Consensus 137 ~lkL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~ 212 (432)
.+||+|||.++....... ....++|+.|+|||++. ...++.++|||||||++|||++ |.++|.+.+..+.+.+++
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999987754332 23467899999999985 5678999999999999999998 788888888777766664
Q ss_pred HHhCCCCCCCchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 213 CILGAPDWTAFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
..--.+ .....++.++.+||.+||+.||++|||++|+++
T Consensus 262 ~~~~~~----------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 262 KEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCC----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 321111 112357889999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=378.97 Aligned_cols=243 Identities=27% Similarity=0.384 Sum_probs=193.5
Q ss_pred CCCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEE-eCCEEEEEE
Q 014039 1 MERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVR-ENNELFFIF 79 (432)
Q Consensus 1 ~~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~ 79 (432)
+++|+++++||+|+||.||+|++ +|..||||+++++.. ...+.+|+++|++++||||+++++++. +++.+|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 57899999999999999999987 477899999976542 234678999999999999999999885 456689999
Q ss_pred ecCCCc-HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCCCCc
Q 014039 80 EYMEHN-LYHIMRER-QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMPPYT 156 (432)
Q Consensus 80 E~~~~~-ll~~~~~~-~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~~~~ 156 (432)
||++++ +.+.+..+ ...+++..++.++.||+.||.|||+.+|+||||||+|||++.+ .+||+|||+++..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cc
Confidence 999865 55555443 2358999999999999999999999999999999999999955 9999999999876543 34
Q ss_pred cccCCccccchhhhcCCCCCCcccceechHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhhhhhhhhc
Q 014039 157 EYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFT-LSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATNISRLISI 235 (432)
Q Consensus 157 ~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~-g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 235 (432)
...+|..|+|||++. ...++.++|||||||++|||++ |.+||.+.+..+....+.. |
T Consensus 159 ~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~--~------------------- 216 (262)
T d1byga_ 159 TGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--G------------------- 216 (262)
T ss_dssp ---CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT--T-------------------
T ss_pred cccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--C-------------------
Confidence 457899999999986 4678999999999999999998 7999988777665555421 0
Q ss_pred cccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 236 SYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
...++.+.+++++.+||++||+.||++|||+.|++++
T Consensus 217 --------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 --------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0112334678999999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-49 Score=379.90 Aligned_cols=257 Identities=20% Similarity=0.213 Sum_probs=205.2
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccc-cceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIK-LKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~~~~lV~E 80 (432)
++|++++.||+|+||+||+|++..+|+.||||++..+... ....+|+++++.++|+|++. +.+++.+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4799999999999999999999999999999998754322 23568999999998776555 5556678889999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC----CeEEEeeeccceecCCCC---
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN----DVLKIADFGLARELSSMP--- 153 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~----~~lkL~DFG~a~~~~~~~--- 153 (432)
|+++++...+....+.+++..+..++.||+.||+|||++||+||||||+|||++. ..+||+|||+|+.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 9999999988887888999999999999999999999999999999999999863 279999999999775432
Q ss_pred -----CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhhhh
Q 014039 154 -----PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEATN 228 (432)
Q Consensus 154 -----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~~~ 228 (432)
.....+||+.|+|||++. +..|+.++|||||||++|||++|..||.+....+....+......
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----------- 231 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----------- 231 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-----------
T ss_pred ceeccccCCcCCCccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-----------
Confidence 234568999999999985 667999999999999999999999999887665544433211100
Q ss_pred hhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCCC
Q 014039 229 ISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTAD---QALQHPFFN 284 (432)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~---elL~Hp~f~ 284 (432)
. ...+.....+++++++.+||.+||+.||++||+++ ++|+|+|.+
T Consensus 232 ---~--------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 232 ---K--------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---H--------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---c--------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0 00112223457899999999999999999999986 456776553
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=383.24 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=206.5
Q ss_pred CCeeEeeeEeecCceEEEEEEEcC-----CCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCCEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVE-----TYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENNELF 76 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (432)
++|+++++||+|+||+||+|.+.. ++..||||+++..........+.+|++++++++||||+++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 689999999999999999998753 457899999986554445555789999999999999999999999989999
Q ss_pred EEEecCCCc-HHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeecc
Q 014039 77 FIFEYMEHN-LYHIMRER---------QIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGL 145 (432)
Q Consensus 77 lV~E~~~~~-ll~~~~~~---------~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~ 145 (432)
+||||+.++ +.+.+... ...+++..+..++.||++||.|||+++|+||||||+|||++++ .+||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 999999865 44444321 1357899999999999999999999999999999999999976 999999999
Q ss_pred ceecCCCCC---CccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCC
Q 014039 146 ARELSSMPP---YTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTL-SPIFPGDSEIDQLYKVCCILGAPDWT 221 (432)
Q Consensus 146 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g-~~pF~~~~~~d~~~~i~~~~g~p~~~ 221 (432)
|+....... .....+|+.|+|||.+. ...++.++|||||||++|||++| .+||.+.+..+.+..+.. |.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~--~~---- 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GG---- 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT--TC----
T ss_pred ceeccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--CC----
Confidence 986644322 23446899999999985 66789999999999999999998 588988877766665531 10
Q ss_pred CchhhhhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 222 AFPEATNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
.....+.+++++.+||.+||+.||++|||+.|++++
T Consensus 253 -----------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 253 -----------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 112234678999999999999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-48 Score=381.27 Aligned_cols=279 Identities=26% Similarity=0.378 Sum_probs=210.3
Q ss_pred CeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-----------CCcccccceEEEe
Q 014039 3 RYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-----------HPNIIKLKEVVRE 71 (432)
Q Consensus 3 ~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~~~ 71 (432)
||+++++||+|+||+||+|+++.+|+.||||++++... ......+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 69999999999999999999999999999999986532 2234567888888774 5789999998754
Q ss_pred --CCEEEEEEecCCC--cHHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceeEeCC-------eE
Q 014039 72 --NNELFFIFEYMEH--NLYHI-MRERQIPFSEGEIRSFMSQMLQGLAHMHR-NGYFHRDLKPENLLVTND-------VL 138 (432)
Q Consensus 72 --~~~~~lV~E~~~~--~ll~~-~~~~~~~l~~~~~~~i~~qIl~aL~~LH~-~givHrDlkP~NILl~~~-------~l 138 (432)
....+++++++.+ +.... .......+++..++.++.||+.||+|||+ .||+||||||+|||++.+ .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 4566667766543 33333 33445679999999999999999999998 899999999999999732 59
Q ss_pred EEeeeccceecCCCCCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCC------hHHHHHHHH
Q 014039 139 KIADFGLARELSSMPPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDS------EIDQLYKVC 212 (432)
Q Consensus 139 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~------~~d~~~~i~ 212 (432)
|++|||.|..... .....+||+.|+|||++. ...|+.++||||+||++++|++|+.||.+.+ ..+.+..++
T Consensus 172 kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYDE--HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETTB--CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeeccccccccc--ccccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 9999999987654 345678999999999986 5678999999999999999999999997643 456778888
Q ss_pred HHhCCCCCCCchhhhhhhhhhhc-----cccccCCCCc-------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 213 CILGAPDWTAFPEATNISRLISI-----SYSEILPINL-------SDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 213 ~~~g~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
..+|.++............+... .........+ ....+..+++++|||.+||++||.+||||+|+|+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 89998765433221111111110 0001000000 01122357789999999999999999999999999
Q ss_pred CCCCCC
Q 014039 281 PFFNVE 286 (432)
Q Consensus 281 p~f~~~ 286 (432)
|||++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 999853
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-48 Score=370.52 Aligned_cols=252 Identities=18% Similarity=0.193 Sum_probs=206.7
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC-CcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH-PNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E 80 (432)
++|+++++||+|+||+||+|++..+|+.||||++...... ....+|++.++.+.| +||+.+++++......|+|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 5899999999999999999999999999999998654322 235679999999964 899999999999999999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeC------CeEEEeeeccceecCCC--
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTN------DVLKIADFGLARELSSM-- 152 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~------~~lkL~DFG~a~~~~~~-- 152 (432)
|+++++.+.+...+..+++..+..++.|++.||+|||++||+||||||+|||++. +.+||+|||+|+.+...
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9999999888887778999999999999999999999999999999999999963 48999999999876432
Q ss_pred ------CCCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCchhh
Q 014039 153 ------PPYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAPDWTAFPEA 226 (432)
Q Consensus 153 ------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p~~~~~~~~ 226 (432)
......+||+.|+|||++. +..|+.++|||||||++|||++|..||.+................
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK--------- 231 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH---------
T ss_pred ccceeecccCceEEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc---------
Confidence 1234568999999999985 667999999999999999999999999876543322221111000
Q ss_pred hhhhhhhhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014039 227 TNISRLISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQ 279 (432)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~ 279 (432)
.......++.+++++++.+++..|+..+|++||+.+.+.+
T Consensus 232 -------------~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 -------------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -------------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------------cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0001122334578899999999999999999999877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=372.05 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=195.1
Q ss_pred eEeeeEeecCceEEEEEEEcCCC---eEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEe-CCEEEEEEe
Q 014039 5 KILEELGDGTCGCVYKAFNVETY---EIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRE-NNELFFIFE 80 (432)
Q Consensus 5 ~~~~~IG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E 80 (432)
.+.++||+|+||+||+|++..++ ..||||++++.........+.+|+++|++++||||+++++++.+ ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 34678999999999999986643 35899999765444455667899999999999999999999765 578999999
Q ss_pred cCCCcHHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCC-eEEEeeeccceecCCCC-----
Q 014039 81 YMEHNLYHI-MRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTND-VLKIADFGLARELSSMP----- 153 (432)
Q Consensus 81 ~~~~~ll~~-~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~-~lkL~DFG~a~~~~~~~----- 153 (432)
||+++.+.. +......+++..+..++.||+.||.|||+.||+||||||+|||++++ .+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 999765554 44455678899999999999999999999999999999999999866 99999999998765432
Q ss_pred CCccccCCccccchhhhcCCCCCCcccceechHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCCCCchhhhhhhhh
Q 014039 154 PYTEYVSTRWYRAPEVLLQSSSYSPAIDMWAVGAILAELFTLSPIFPGDSEI-DQLYKVCCILGAPDWTAFPEATNISRL 232 (432)
Q Consensus 154 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiWSlG~il~ell~g~~pF~~~~~~-d~~~~i~~~~g~p~~~~~~~~~~~~~~ 232 (432)
......||+.|+|||.+. ...++.++|||||||++|||++|..||...... +....+.. |..
T Consensus 190 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~-------------- 252 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRR-------------- 252 (311)
T ss_dssp CTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCC--------------
T ss_pred ecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCC--------------
Confidence 223456899999999985 567899999999999999999977666554332 22222211 110
Q ss_pred hhccccccCCCCccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 233 ISISYSEILPINLSDIIPNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
....+.+++++.+||.+||+.||++|||+.|+++|
T Consensus 253 -------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 -------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01224678899999999999999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=365.35 Aligned_cols=263 Identities=24% Similarity=0.274 Sum_probs=186.3
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCcccccceEEEeCC----EEEE
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPNIIKLKEVVRENN----ELFF 77 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~l 77 (432)
++|.+.+.||+|+||.||+|+. +|+.||||+++.... ......+|+..+++++||||+++++++.+.+ .+|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4799999999999999999975 688999999975432 2222334566667789999999999986543 6899
Q ss_pred EEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeccCCCCceeEeCC-eEEEeeecccee
Q 014039 78 IFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR--------NGYFHRDLKPENLLVTND-VLKIADFGLARE 148 (432)
Q Consensus 78 V~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~--------~givHrDlkP~NILl~~~-~lkL~DFG~a~~ 148 (432)
|||||.++.+..+.++. ++++..+..++.|++.||+|||+ +||+||||||+||||+.+ .+||+|||+++.
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999875554444443 69999999999999999999996 599999999999999865 999999999987
Q ss_pred cCCCC-----CCccccCCccccchhhhcCCC-----CCCcccceechHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014039 149 LSSMP-----PYTEYVSTRWYRAPEVLLQSS-----SYSPAIDMWAVGAILAELFTLSPIFPGDSEIDQLYKVCCILGAP 218 (432)
Q Consensus 149 ~~~~~-----~~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiWSlG~il~ell~g~~pF~~~~~~d~~~~i~~~~g~p 218 (432)
..... .....+||+.|+|||++.... .++.++|||||||++|||++|.++|........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~----------- 226 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL----------- 226 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-----------
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-----------
Confidence 65432 234568999999999985332 267799999999999999999988754332100
Q ss_pred CCCCc-hhhhhhhhhhhccccccCCCCccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014039 219 DWTAF-PEATNISRLISISYSEILPINLSDII--PNASMEAIDLIWQLCSWDPLRRPTADQALQH 280 (432)
Q Consensus 219 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~Rpta~elL~H 280 (432)
+.... ....................++...+ .....++.+|+.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000 00000000000000000000111111 1233468899999999999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.7e-26 Score=206.38 Aligned_cols=163 Identities=19% Similarity=0.187 Sum_probs=122.3
Q ss_pred eeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccc-----------------hHHHHHHHHHHHHHhcCCCcccccc
Q 014039 4 YKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYF-----------------WEECMNLREVKALRKLNHPNIIKLK 66 (432)
Q Consensus 4 Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----------------~~~~~~~~Ei~~l~~l~hpnIv~l~ 66 (432)
|.+.++||+|+||+||+|.+. +|+.||||+++..... .......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999885 6889999987532110 0112234688999999999998877
Q ss_pred eEEEeCCEEEEEEecCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceeEeCCeEEEeeeccc
Q 014039 67 EVVRENNELFFIFEYMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHRNGYFHRDLKPENLLVTNDVLKIADFGLA 146 (432)
Q Consensus 67 ~~~~~~~~~~lV~E~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~~givHrDlkP~NILl~~~~lkL~DFG~a 146 (432)
++. . .+++|||+++.... .+++..+..++.||+.+|+|||++||+||||||+|||++++.++|+|||.|
T Consensus 81 ~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~a 149 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQS 149 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred Eec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCCc
Confidence 652 2 27999999985432 255666788999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCccccCCccccc------hhhhcCCCCCCcccceechHH
Q 014039 147 RELSSMPPYTEYVSTRWYRA------PEVLLQSSSYSPAIDMWAVGA 187 (432)
Q Consensus 147 ~~~~~~~~~~~~~~t~~y~a------PE~l~~~~~~~~~~DiWSlG~ 187 (432)
....... . ..|.. .+.+ .+.|+.++|+||+.-
T Consensus 150 ~~~~~~~--~-----~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 150 VEVGEEG--W-----REILERDVRNIITYF--SRTYRTEKDINSAID 187 (191)
T ss_dssp EETTSTT--H-----HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHH
T ss_pred ccCCCCC--c-----HHHHHHHHHHHHHHH--cCCCCCcccHHHHHH
Confidence 8764321 1 11211 1222 356899999999643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.4e-07 Score=85.72 Aligned_cols=138 Identities=17% Similarity=0.168 Sum_probs=92.4
Q ss_pred CCeeEeeeEeecCceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEEEe
Q 014039 2 ERYKILEELGDGTCGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFIFE 80 (432)
Q Consensus 2 ~~Y~~~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 80 (432)
+.|++++..+.++.+.||+.. .++..+.+|+....... ......+|...++.+. +=-+.+++.+..+.+..|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 567888776666678999874 45556778887643321 1223467888888873 3335677888888899999999
Q ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014039 81 YMEHNLYHIMRERQIPFSEGEIRSFMSQMLQGLAHMHR------------------------------------------ 118 (432)
Q Consensus 81 ~~~~~ll~~~~~~~~~l~~~~~~~i~~qIl~aL~~LH~------------------------------------------ 118 (432)
+++|..+...... ......+..++.+.|+.||+
T Consensus 91 ~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 91 EADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9998654322111 11122334444555555553
Q ss_pred -----------------CCCeeccCCCCceeEeCCeE-EEeeeccce
Q 014039 119 -----------------NGYFHRDLKPENLLVTNDVL-KIADFGLAR 147 (432)
Q Consensus 119 -----------------~givHrDlkP~NILl~~~~l-kL~DFG~a~ 147 (432)
..++|+|+.|.|||++++.+ -|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12789999999999998855 699999885
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.13 E-value=2.8e-06 Score=82.02 Aligned_cols=76 Identities=17% Similarity=0.211 Sum_probs=47.7
Q ss_pred eeeEeecCceEEEEEEEcCCCeEEEEEEecccc------cchHHHHHHHHHHHHHhc-CC--CcccccceEEEeCCEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVETYEIVAVKKMKRKF------YFWEECMNLREVKALRKL-NH--PNIIKLKEVVRENNELFF 77 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~Ei~~l~~l-~h--pnIv~l~~~~~~~~~~~l 77 (432)
.+.||.|....||++.+..+++.+++|.-.... ......+..+|.+.|+.+ .+ ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567999999999999887888889999754211 111122345688888877 33 234555544 4445578
Q ss_pred EEecCCC
Q 014039 78 IFEYMEH 84 (432)
Q Consensus 78 V~E~~~~ 84 (432)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999976
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=1.8e-05 Score=70.76 Aligned_cols=71 Identities=14% Similarity=0.060 Sum_probs=48.0
Q ss_pred EeecC-ceEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCC--CcccccceEEEeCCEEEEEEecCCCc
Q 014039 10 LGDGT-CGCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNH--PNIIKLKEVVRENNELFFIFEYMEHN 85 (432)
Q Consensus 10 IG~G~-fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~~ 85 (432)
+..|. -+.||+... .++..+++|....... ....+|...|+.+.. -.+.+++.+..+.+..++|||+++|.
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 34444 468998864 4566688887654321 224578888887732 23566787778888899999999873
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.00085 Score=62.19 Aligned_cols=129 Identities=17% Similarity=0.169 Sum_probs=72.7
Q ss_pred eEEEEEEEcCCCeEEEEEEecccccchHHHHHHHHHHHHHhcCCCc--cc---cc--ceEEEeCCEEEEEEecCCCcH--
Q 014039 16 GCVYKAFNVETYEIVAVKKMKRKFYFWEECMNLREVKALRKLNHPN--II---KL--KEVVRENNELFFIFEYMEHNL-- 86 (432)
Q Consensus 16 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv---~l--~~~~~~~~~~~lV~E~~~~~l-- 86 (432)
-.||++.. ++|+.|++|+........ ..+..|...|..|.... ++ .. -..+...+..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~--~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTA--DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCH--HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCH--HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 47999964 567889999987544322 23456888887773211 11 11 112355677889999998621
Q ss_pred -------------HHHHHH--cC------CCCC-------------------HHHHHHHHHHHHHHHHHHHH-------C
Q 014039 87 -------------YHIMRE--RQ------IPFS-------------------EGEIRSFMSQMLQGLAHMHR-------N 119 (432)
Q Consensus 87 -------------l~~~~~--~~------~~l~-------------------~~~~~~i~~qIl~aL~~LH~-------~ 119 (432)
+..+.. .. ..++ ......+...+-..++.+.. .
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 111110 00 1111 11111222222223333332 3
Q ss_pred CCeeccCCCCceeEeCCeEEEeeecccee
Q 014039 120 GYFHRDLKPENLLVTNDVLKIADFGLARE 148 (432)
Q Consensus 120 givHrDlkP~NILl~~~~lkL~DFG~a~~ 148 (432)
++||+|+.+.|||++++. .++||+-|..
T Consensus 193 ~liHgDlh~~NvL~~~~~-~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDGP-MFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSSE-EECCCTTCCE
T ss_pred eeecCCCCcccEEEeCCc-eEEechhccc
Confidence 689999999999998764 4789998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.92 E-value=0.0011 Score=63.13 Aligned_cols=71 Identities=14% Similarity=0.042 Sum_probs=47.5
Q ss_pred eeeEeecCceEEEEEEEcC-------CCeEEEEEEecccccchHHHHHHHHHHHHHhcC-CCcccccceEEEeCCEEEEE
Q 014039 7 LEELGDGTCGCVYKAFNVE-------TYEIVAVKKMKRKFYFWEECMNLREVKALRKLN-HPNIIKLKEVVRENNELFFI 78 (432)
Q Consensus 7 ~~~IG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 78 (432)
++.|+.|---.+|++.... ..+.|.+++.-.... .....+|..+++.+. +.-..++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4678888888999997653 345677777653221 223458999999884 4334567776542 578
Q ss_pred EecCCC
Q 014039 79 FEYMEH 84 (432)
Q Consensus 79 ~E~~~~ 84 (432)
+||++|
T Consensus 120 ~efi~g 125 (395)
T d1nw1a_ 120 EEYIPS 125 (395)
T ss_dssp ECCCCE
T ss_pred EEEecc
Confidence 999987
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.019 Score=52.08 Aligned_cols=29 Identities=31% Similarity=0.435 Sum_probs=25.5
Q ss_pred CCCeeccCCCCceeEeCCe-EEEeeeccce
Q 014039 119 NGYFHRDLKPENLLVTNDV-LKIADFGLAR 147 (432)
Q Consensus 119 ~givHrDlkP~NILl~~~~-lkL~DFG~a~ 147 (432)
.|+||+|+.+.||+++++. .-|.||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 4799999999999999884 5899999884
|